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Ar. Ardipithecus
BAT brown adipose tissue
BHT butylhydroxytoluene
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BP before present
C3/C4 C3- and C4-photosynthetic pathway
ChREBP carbohydrate responsive element binding protein




DEE daily energy expenditure
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DNL de novo lipid synthesis or de novo lipogenesis
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DS disaccharides
EBM evidence based medicine
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EN% energy %
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NIMR National Institute for Medical Research in Tanzania
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PP postpartum
PS polysaccharides
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SCD-1 stearoyl-Coenzyme A desaturase family member 1
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WAT white adipose tissue
WHO World Health Organization
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Scope of the thesis
SCOPE OF THE THESIS
The studies in this thesis aim at the gathering of information on our ancient diet. This information
is important to both public health and health care. We believe that its incorporation in nutritional
science will be of crucial importance to achieve an increase of our number of years in health, by
some referred to as ‘healthy aging’.
To gather information on the composition of our ancient diet, we reconstructed, by theoretical
means, the macronutrient and fatty acid (FA) compositions of the diets consumed by our ancestors
living in the East-African land-water ecosystems. Secondly, we studied traditionally living people in
East-Africa and compared their nutritional status with that of people living in Western countries. In
the various studies we focussed notably on FA and especially arachidonic (AA) and docosahexaenoic
acid (DHA), since the current evidence supports that both these long-chain polyunsaturated (LCP)
FA were abundantly present from our diets in the past. Both, the reconstructed dietary composition
and the dietary composition of some of the traditionally living East African people may serve as
platforms for future intervention studies using the currently reigning paradigm of “Evidence Based
Medicine”, that is referred to as “Evidence Based Nutrition” in nutritional sciences.
Chapter 1 provides the background of the concept of Evolutionary Medicine, its common arguments
and counterarguments and its implications. Secondly, the available evidence for the ecological
niche, and hence the diet, of our early ancestors is reviewed. Finally, we discuss the intervention
trials that have thus far been conducted with diets that mimic our Paleolithic nutrition.
Chapter 2 describes the composition of the foods available in the East-African land-water ecosystem.
From both laboratory analyses and the available information in the literature, we reconstructed the
macronutrient and FA compositions of the diets that could have been consumed by our earliest
ancestors living in the East-African cradle of mankind.
Chapter 3 contains several studies on the FA composition of human milk in traditionally eating
East-African populations. The locations of research are shown in Figure 1, the characteristics of the
project and the project subjects are in Figure 2-11. Chapter 3.1 describes the FA composition of
the milk of women living in lake-shore communities in the mainland of Tanzania, where freshwater
!sh is the main source of protein. In Chapter 3.2 we describe the milk FA compositions of several
Tanzanian tribes with markedly di"erent dietary habits. The outcomes are compared with the
recommendations that have been issued by Western Nutritional Boards. Chapter 3.3 provides a
discussion on the discrepancy between the current recommendation for the composition of infant
formulas and the recommendation for LCP intakes by adults (i.e. 2 times/week of which 1 time fatty
!sh; or 450 mg eicosapentaenoic acid (EPA) + DHA/day). The current recommendation for infant
13
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S
formulas derives from the average milk composition of women who do not comply with the 450
mg EPA+DHA/day recommendation. Chapter 3.4 describes the FA dierences between preterm and
term milks from an African population with high intakes of LCP from freshwater sh. The possible
causes for the observed dierences are discussed.
Figure 1. The dierent locations of research throughout Tanzania. From North to South: 1. Ukerewe island, home
to the WaKerewe; 2. Sengerema, home to the WaSukuma and WaZinza; 3. Mwanza, home to the WaSukuma;
4. Wasso, home to the Maasai; 5. Digodigo, home to the WaSonjo; 6. Yaeda Chini, home to the Hadzabe
(WaTindiga); 7. Haidom, home to the WaIraqw and the WaBarabaig (WaDatoga); 8. Kiomboi and Lake Kitangiri,
home to the WaNyiramba; 9. Same, home to the WaPare and WaSambaa; 10. Ruvu on the Maasai Plains, home
to the Maasai; 11. Dar es Salaam, mixed Afro-Arab peoples; 12. Chole island, Maa Archipelago, mixed Afro-Arab
peoples; 13. Matema beach, Lake Malawi, home to the WaNyakius.
14
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Figure 2. Getting there and away: by chessna, canoe or car
15
Figure 3. Collecting samples in the bush
S
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Figure 4. Mzee Ndevu and myself at a local sh market looking for dried sh such as tilapia, catsh
and lungsh
S17
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Figure 5. How to conserve the sh. Up: frying tilapia (Lake Kitangiri). Down: drying local “furu“
(cichlidae) in the sun (Lake Victoria)
18
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Figure 6. The Barabaig around Haidom and their houses
S19
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Figure7. The Hadzabe around Lake Eyasi and their houses
20
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Figure 8: The Hadzabe lifestyle. Gathering honey and hunting small animals such as the hyrax
S21
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Figure 9. A traditional Maasai family and their mud house at their boma
22
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Figure 10. A traditional Maasai meat preparation includes suocation of the animal an subsequent
raw consumption of most of the animal’s organs and blood
S23
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Figure 11. Hunting and gathering the Indian Ocean beach on Chole Island for local food sources
24
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Chapter 4 addresses the erythrocyte (RBC) FA composition in three distinct Tanzanian populations
(for locations, see Figure 1). RBC-FA are established parameters for the FA status. Chapter 4.1
describes the courses of RBC-AA and RBC-DHA during pregnancy in female and infant members
of three tribes with dierent intakes of freshwater sh. Chapter 4.2 describes the courses of the
maternal and infant RBC-LCP during lactation in relation to the concurrent sh intakes. Chapter
3.3 comprises a detailed analysis of the relation between AA and DHA in RBC and also in umbilical
vessel walls of worldwide populations with a wide variety in their LCP intakes. The possible causes
and consequences of the observed relations are discussed.
Chapter 5 provides a description of the FA compositions of brain, liver and adipose tissue from
African infants who were stillborn to women with very high intakes of freshwater sh. The FA-
compositions of these tissues are compared with those of counterpart Western infants born to
mothers with relatively low sh intakes.
Chapter 6 describes the development of the adipose tissue compartment in a migrant African
population living in the former Netherlands Antilles. Chapter 6.1 presents the FA composition of
fetal adipose tissue at several stages during gestation. In Chapter 6.2 the whole fetal body LCP
content is reconstructed from the available data from our previous studies and from the literature.
From these data, the daily FA increment rates in the fetal body during gestation were calculated.
These data might be useful for the compilation of infant formulas.
Chapter 7 focuses on the mechanisms that might be at the basis of the observed dierences in FA
status between certain cases and controls and on the observed changes in FA status with advancing
gestation and after delivery. Chapter 7.1 provides the dierences in umbilical vessel wall FA status
between women after preeclamptic and uncomplicated gestation. The observed dierences are
related to dierences in glucose and insulin metabolism. Chapter 7.2 elaborates on the possible
in!uences of insulin sensitivity and DHA status on the FA composition of maternal and infant RBC
during pregnancy and subsequent lactation. Chapter 7.3 discusses the possible in!uences of insulin
sensitivity on the observed dierences in the milk FA composition between preterm and term milks
and the changes with advancing lactation.
Chapter 8 provides a review of the available evidence on the roles of carbohydrates (CHO) and
saturated fatty acids (SAFA) in cardiovascular disease (CVD).
In Chapter 9 we summarize the main conclusions and we discuss the limitations and the implications
of our ndings.
25
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General introduction
A multidisciplinary reconstruction of Paleolithic nutrition
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Evolutionary medicine acknowledges that many chronic degenerative diseases result from conicts
between our rapidly changing environment, our dietary habits included, and our genome, which
has remained virtually unchanged since the Palaeolithic. Reconstruction of the diet prior to the
agricultural and industrial revolutions is therefore indicated, but hampered by the ongoing debate
on our ancestors’ ecological niche. Arguments and their counterarguments regarding evolutionary
medicine are updated and the evidence for the long-reigning hypothesis of human evolution on the
arid savannah is weighed against the hypothesis that they evolved in the proximity of water. Evidence
from various disciplines is discussed, including the study of palaeoenvironments, comparative
anatomy, biogeochemistry, archaeology, anthropology, (patho)physiology and epidemiology.
Although our ancestors had much lower life expectancies, the current evidence does neither
support the misconception that during the Palaeolithic there were no elderly nor that they had poor
health. Rather than rejecting the possibility of ‘healthy ageing’, the default assumption should be
that healthy ageing posed an evolutionary advantage for human survival. There is ample evidence
that our ancestors lived in a land-water ecosystem and extracted a substantial part of their diets
from both terrestrial and aquatic resources. Rather than rejecting this possibility by lack of evidence,
the default assumption should be that hominins, living in coastal ecosystems with catchable aquatic
resources, consumed these resources. Finally, the composition and merits of so-called ‘Palaeolithic
diets,’ based on di!erent hominin niche-reconstructions, are evaluated. The bene"ts of these diets





In the Origin of Species,1 Darwin recognized that there are two forces of evolution, i.e. natural
selection and the conditions of existence, where the latter was considered the most powerful.2
For example, important steps in evolution are the origin of eukaryotic life approximately 1.6-2.7
billion years ago3,4 and the appearance of photosynthetic cyanobacteria that began to oxygenate
the atmosphere around 2,400 million years ago.5 However, there was relatively little alteration in
the design of life forms before the Cambrian explosion about 600 million years ago. Only when
the oxygen tension in the atmosphere rose above the Pasteur point, aerobic metabolism became
thermodynamically possible6 resulting in an explosion from simple prokaryotics to a diversity of
eukaryotic life forms.7
During the past millions of years of evolution, with relatively little alteration in life forms and
environmental circumstances, the human genome has become optimally adapted to its local
environment.8-11 In other words, our genome may have reached a state of homeostasis, de!ned as
the ‘optimal interaction between environment and genome’ or ‘nature in balance with nurture’, to
support optimal survival for reproductive success. The etiologies of many typically Western diseases,
also known as diseases of a"uence or civilization, have been attributed to the disturbance of this
delicate balance, secondary to the rapid changes in the conditions of existence, while our genome
has remained basically unchanged since the beginning of the Palaeolithic era. The former include
changes in physical activity, stress, sleep duration, environmental pollution and others,12,13 but one
of the most rapidly changing conditions of existence has been the human diet.
Since the onset of the agricultural revolution, some 10.000 years ago, and notably in the last
200 years following the start of the industrial revolution, humans have markedly changed their
dietary habits. Consequently, it has been advocated that the current pandemic of diseases of
civilization result in part from the mismatch between the current diet and our Palaeolithic genome.
In other words, “we are what we eat, but we should be what we ate”.14,15 The ensuing poorly-
adapted phenotype may !nd its origin as early as in the fetal period16,17 and possibly as far back as
in the maternal grandmother’s womb.18 This phenotype might be laid down in, inherently labile,
epigenetic marks that are meant for the short and intermediate term adaptation of a phenotype
to the conditions of existence. With clear evolutionary advantages they may become transmitted
to the next generations as a memory of the environmental conditions that can be expected after
birth.19 They thereby give rise to a seemingly high contribution of genetics in some of the associated
‘typically Western’ degenerative diseases, which are in fact complex diseases that by de!nition do
not inherit by Mendel’s law, illustrating that epigenetic marks can also become erased.
From a pathophysiological point of view, the currently poorly-adapted phenotype in western
countries, ensuing from the con#ict between the changing lifestyle and our Paleolithic genome,
centers on chronic low-grade in#ammation and the metabolic syndrome (also named the insulin
resistance syndrome); which are risk factors for many of the diseases and conditions typical for
a"uent countries, such as cardiovascular disease, diabetes mellitus type 2, osteoporosis, certain
28
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types of cancer (notably colon, breast, prostate), fertility problems (polycystic ovary syndrome),
pregnancy complications (gestational diabetes, preeclampsia), some psychiatric diseases (major
and postpartum depression, schizophrenia, autism) and neurodegenerative diseases (Alzheimer’s
disease, Parkinson’s disease).20-22 The genetically-determined exibility to adapt to a changing
environment appears to have been exceeded and the genetically most vulnerable have become
sick rst, but ultimately all individuals will become sick with increasing dose and exposure time.
Environment, nutrients and their interaction with the genome
Adjustment of the DNA base sequence is a slow process that in an individual cannot support
adaptation to environmental changes occurring at intermediate or rapid pace. Flexibility for rapid
adaptation is provided by genetically-encoded mechanisms that allow adjustment of phenotype
by epigenetics and by the interaction of the environment with sensors, such as those of the sensory
organs, but also by the many that remain unnoticed.23-25 The role of nutrients in (epi)genetics and
their direct interaction with the genome become increasingly acknowledged.26 Examples of such
nutrients are iodine, selenium, vitamins A and D, and  3-fatty acids, which are direct or indirect
ligands of the thyroid hormone (TR), retinoid X (RXR), retinoic acid (RAR), vitamin D (VDR) and
peroxisome proliferator (PPAR) receptors. Homodimerization and heterodimerization of these
receptors facilitate gene transcription and thereby keep our phenotype optimally adapted to the
reigning conditions of existence. The roles of these nutrients, their respective receptors and the
interaction between their receptors are indicative for the importance of their dietary presence and
of a certain balance between their dietary intakes to arrive at optimal interaction with the genome.
Lessons for this optimal interaction, and hence for the development of randomized controlled trials
aiming at the study of diet or lifestyle, rather than single nutrients, might derive from knowledge
on human evolution and the conditions of existence to which our ancestors have been exposed.
These lessons might provide us with valuable information on what we should genuinely dene as
a ‘healthy diet’.
Evolutionary medicine
The concept that thorough understanding of evolution is important in prevention and treatment
of (human) diseases has long been recognized. For example, in the early sixties Theodosius
Dobzhansky stated that “nothing in biology makes sense except in the light of evolution”27, while
the Dutch ethologist Nikolaas Tibergen made a distinction between proximate and ultimate (also
named evolutionary) causes.28 Proximate explanations provide a direct mechanism for certain
behavior in an individual organism. They explain how biomolecules induce certain behavior or for
example an allergic reaction. Proximate explanations, however, provide insu!cient information
to answer the question why this behavior or this allergic reaction occurred. Ultimate explanations
provide answers explaining why things happen from an evolutionary point of view. Many, if not




searching for the latter explanations has become known as Evolutionary Medicine. Unfortunately,
modern medicine deals mostly with proximate explanations,29,30 while ultimate explanations seem
more prudent targets for long-time disease prevention.29
The term ‘Evolutionary Medicine’ (also named Darwinian Medicine) was launched by Randolph
M. Nesse and George C. Williams.31,32 They provided evolutionary answers for the understanding of
human diseases. Many diseases do not result from a single biological, anatomical or physiological
abnormality, but rather from a complex web of interactions. They often reect the collateral damage
of the survival and reproduction strategies of our genes and the genes of other organisms in our
environment. For example, both fever and diarrhea are human defence-mechanisms to clear foreign
pathogens, while con icts between a mother and her unborn child, a human and its vegetable
food, or a human and an ingested pathogen, can result in pre-eclampsia, celiac disease or auto-
immune diseases (streptococcus induced rheumatoid arthritis), respectively. Another example
of the inuence of evolution in human disease comes from so- called trade-o"s between human
genes and other (hostile) genes in the environment. The most notorious being the survival of
the sickle cell gene in malaria endemic regions: the heterozygous carriers (HbAS) have a survival
advantage compared to the wild-type (HbAA), despite the death of homozygous subjects (HbSS).
Another example is the equilibrium between the not yet full grown, but yet relatively large,
brain of a newborn and the small birth canal in its turn is constrained by an upright posture and
provides. An often overlooked example is coincidence, which may be illustrated by the blind spot
on the back of the retina resulting from the inside-out structure of the eye. Although this inside-
out structure is not ideal, a possible turning point has long been past, and we simply have to deal
with this imperfection of human evolution. The location of the birth canal on its turn also provides
an example of an evolutionary coincidence that urges to deal with an, in retrospect, imperfect
evolutionary design. These examples illustrate that evolution builds on the past: it is not possible
to start a completely new design from scratch on, which argues against ‘intelligent design’. Another
important inuence of coincidence lies in exaptation33, which is a feature that is not acquired in the
context of any function to which it might eventually be put. A well known example comes from
feathers which were only used for ying after they had been present for a di!erent purpose, such as
thermal insulation, in several species for millions of years. Several human features, such as blue eyes,
white skin, our hairlessness and large skull might also have been evolved in another context than
they were "nally used in. The most important example of an evolutionary explanation for human
disease, however, comes from the mismatch between our slowly adapting genome and the rapidly
changing environment, notably our diet.
Evolutionary medicine argues that the chronic degenerative diseases causing most morbidity
and mortality in a#uent countries occur because of the current mismatch between the rapidly
changing conditions of existence and our Palaeolithic genome.34 These mismatches will persist,
notably in the light of our long generation time. The genetic adjustments needed to adapt to the
new environment are also unlikely to occur, since the mismatch exerts little selection pressure. That
30
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is, they do not cause death prior to reproductive age, but rather reduce the numbers of years in
health at the end of the life cycle.35 Consequently, Evolutionary Medicine acknowledges a return to
the lifestyle prior to the onset of the Agricultural revolution as translated to the culture of the 21th
century and as popularized by the expression: “how to become a 21th century hunter-gatherer”.36
Skeptics of Evolutionary Medicine often raise the intuitive criticism that the human ancestor had
a very short life expectancy compared to contemporary people.35 Consequently, they argue, there
was no selection pressure on longevity or ‘healthy ageing’, since there were virtually no old people,
while the few individuals reaching old (e.g. postmenopausal) age provided no evolutionary benet
to younger individuals who were still able to reproduce. The counterargument is multileveled.
Arguments and counterarguments in evolutionary health promotion35
The rst argument provides a quantitative explanation for ageing and states that our genes have
simply been selected to make the individual become old, because older individuals generate more
o!spring, which clearly provides an evolutionary survival advantage. The next arguments, however,
provide explanations which emphasize the importance of an increased quality of life in the o!spring,
rather than their absolute numbers.
It needs emphasis that Evolutionary Medicine predicts no further increase in life expectancy, but
rather a decrease in the numbers in deteriorating health at the end of the life cycle. It was estimated
that the complete elimination of nine leading risk factors in chronic degenerative diseases would
increase life expectancy at birth by only 4 years, since these diseases only a!ect late-life mortality.37
Secondly; the increased life expectancy at present originates mostly from the greatly diminished
in"uence of some unfavorable conditions of existence, including (childhood) infections, famine,
homicide and tribal wars34,38 secondary to the high levels of medical sciences and continuing
civilization. Thus, to achieve the average life expectancy of 40 years in a present day hunter-gatherer
society, for every child that does not survive beyond 1 year of age, another should reach the age
of 80. In fact, about 20% of modern hunter-gatherers reach at least the age of 60 years.39-41 In other
words, the popular argument35 that very few people in these societies live past 50 is unsupported
by ethnographic data. The third, often raised, argument is that due to the higher life expectancy
in present day humans, it is invalid to compare the mortality gures for cancer and degenerative
disease of present day hunter-gatherers (with low life expectancies) with those of Western
populations (with a life expectancy of 80 years). However, early biomarkers of degenerative diseases
such as obesity, high blood pressure, atherosclerosis and insulin resistance are also less common
in younger, age-matched, members of present hunter-gatherer compared to members of a#uent
societies,9,42 while measurements indicative for ‘good health’ such as muscular strength and aerobic
power are more favorable in the former43. Moreover, even the oldest individuals in hunter-gatherer
societies appear virtually free from chronic degenerative diseases.44-46 A fourth counterargument
against the assumption that our human ancestors before the Agricultural Revolution died at young




about 10.000 years ago, life expectancy dropped from about 40 years (as it is in recently studied
hunter-gatherers, but also was among students of the Harvard College Class born in 188047 to about
20 years.48-50 This seemingly evolutionary disadvantage, secondary to a decrease in nutritional
quality, is substantiated by a decrease in general health that has become noticeable from a decrease
of nal height, while skeletal markers of infection and nutritional stress became more common in
archaeological nds.49-52 These setbacks were eliminated by a net increase in population growth,
secondary to an increased productivity per land area that resulted in more calories per capita. Life
expectancy remained stable throughout the Neolithic until the late 18th century, seldom exceeding
25 years in ‘civilized’ nations.35 From this time, improvements in hygiene, food production and
manufacturing, energy generation, per capita income, shelter, transportation, clothing and caloric
intakes substantiated an increase to and beyond the life expectancy that prevailed before the onset of
the Agricultural Revolution. Greater energy availability enhanced e.g. the energy requirements of the
immune system and for reproduction, both improving longevity.35,53 Importantly, it was concluded
that medical treatments had little impact on mortality reduction, while public health achievements
(sanitation, food and water hygiene, quarantine and immunizations) have critically improved life
expectancy. The fth counterargument is that old people do provide an evolutionary benet to
the younger generations. Male fertility remains largely intact and male provisioning might help in
the problem of high female reproductive costs, although the latter is contested.54,55 The benets of
older females have been put forward in the grandmother hypothesis. This hypothesis, in which the
presence of older females within a certain group benets reproductive success of their ospring, is
supported, by studies in human hunter-gatherer56-62 and primate societies.56,60,63 Interestingly, these
tness benets of grandmothering proved insucient to fully explain the evolution of increased
longevity62, suggesting that other evolutionary benets, such as grandfathering, might also be
involved in the long reproductive and non-reproductive lifespan of Homo sapiens. A recent analysis
supports such benets for both older males and females, since the presence of post-reproductive
women increased the numbers of newborns by 2.7%, while 18.4% of the infants in a polygamous
society in rural Africa was sired by males aged 50 and above.61 In support of the statement that
‘nothing in biology makes sense except in the light of evolution’ we therefore conclude that, unless
proven otherwise, the presence of a substantial part of older males and postmenopausal females in
hunter-gatherer, in contrast to primate societies, should be considered as proof for the evolutionary
benet that these individuals are to their progeny. Finally, we propose that this assumption would
only be convincible if these individuals were reasonably t; thereby supporting the concept of
healthy ageing. Hence, healthy ageing seems both supported by ethnographic data and its benet
to hunter-gatherer societies. Other commonly raised arguments against the genome-environment
mismatch hypothesis are the potential genetic changes since the Agricultural Revolution, the
heterogeneity of ancestral environments and innate human adaptabilty35. Counterarguments to
these critics have been discussed in great detail elsewhere.35
In this review, a multidisciplinary approach is used, including palaeo-environmental
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reconstruction, comparative anatomy, biogeochemistry, archaeology, anthropology, (patho)
physiology and epidemiology, to assess the characteristics of the ecosystem that supported human
evolution. Based on this assessment, an approximation is made of the dietary composition that
derives from this ecosystem. Finally, the potential benet of a return to this ‘Palaeolithic diet’ is
discussed and an update is provided for the evidence for the positive health eects of these diets.
3. Human evolution
Hominins are dened as members of the taxon Hominini, which comprises modern Homo sapiens
and its extinct relatives over the past ~7 million years. The oldest-known hominins (Figure 1) are
Sahelanthropus tchadensis from Chad (~7 million years ago (Mya)64) and Orrorin tugenensis from
Kenya (~6-5.7 Mya65). The next oldest are Ardipithecus kadabba (Ethiopia, ~5.8 Mya66) and A. ramidus
(Ethiopia, ~4.4 Mya67), Australopithecus anamensis (Kenya, ~4.1-3.9 Mya68), Au. afarensis (Ethiopia,
Tanzania and may be Kenya, 3.6-3.0 Mya69,70), Au. bahrelghazali (Chad, ~3.5 Mya71), Kenyanthropus
platyops (Kenya, ~3.5 Mya72), Au. garhi (Ethiopia, ~2.5 Mya73) and Au. africanus (South Africa, ~2.9
-2.0 Mya74). From these earliest hominins evolved the genera Paranthropus (3 known subspecies)
and Homo. The earliest species that have been designated Homo are Homo rudolfensis, Homo
habilis and Homo erectus sensu lato –including H. ergaster (Eastern Africa, ~2-1.8 Mya): these in turn
are the presumed ancestors of Asian H. erectus, H. heidelbergensis (Africa, Eurasia 0.6-0.3 Mya), H.
neanderthalensis (Eurasia, 0.4-0.03 Mya) and H. sapiens (from ~0.2 Ma onwards)75-77. The recently
discovered H. !oresiensis (0.095 - 0.013 Mya78) and the previously unknown hominins from Denisova
Cave (~0.05-0.03 Mya79) show that in the recent past several dierent hominin lines co-existed with
modern humans.
Africa is now generally accepted as the ancestral homeland of Homo sapiens.76,80,81 In several
subsequent Out-of Africa waves,82 hominins of the genus Homo colonized Asia, Australia, Europe
and nally the Americas (Figure 2). Archaic Homo species reached as far as the island of Flores
in South-East Asia, East-China and Southern-Europe (Spain). Homo heidelbergensis remains were
found in Africa, Europe and Eastern-Asia, while Homo neanderthalensis was restricted to Europe,
Western-Asia and the Levant. At last, in the later Out-of-Africa diaspora starting about 100 kya,
Homo sapiens nally reached Australia and the Americas, while likely replacing earlier hominins in
Africa, Europe and Asia that had left during the earlier Out-of-Africa waves. However, there remains
some debate81,83-85 whether or not the gene pool of archaic hominins contributed to that of modern
humans. In the replacement theory, archaic hominins make no contribution to the gene pool of
modern humans, whereas in the hybridization theories (either through assimilation or gene !ow),
newly arriving hominins from the later Out-of-Africa wave mixed with archaic predecessors. Current
evidence from DNA analyses supports the concept that the gene pool of archaic hominins, notably
Neanderthals,86 but also Denisovans79 contributed to the gene pool of Homo sapiens (Figure 3).
The African cradle of human kind is supported by micro-satellite studies87 that reveal that within




Figure 1. Scheme of the possible phylogenetic relationships within the family Hominidae. Note that at many
time points of evolution, several dierent hominin species coexisted. © Ian Tattersall, with permission. 63
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Asia>Oceania>America, with the hunter-gatherer Hadzabe of Tanzania separated from the
Ju|’hoansi (previously called !Kung) from Botswana by a genetic distance greater than between any
other pair of populations,88 which indicates the chronology of continent inhabitation and points to
South or East Africa as the cradle of humankind.88,89 Human evolution was characterized by several
large-scale decimations, and it has been estimated that the current world population derives from
only 1,000 surviving individuals at a certain time point.90 Such bottlenecks91, characterized by
strong population decrease, or where groups of hominids were separated due to global climate
changes, volcanic winters or geographic boundaries as mountain ridges or seas, caused gene ow
and genetic drift. As a result di"erent phenotypic races emerged in di"erent geographic regions.87,91
However, di"erences among these populations contribute only 3-5% to genetic diversity, while
within-population di"erences among individuals account for 93-95% of genetic variation.92 In
other words, genetically we belong to one species that originally evolved in Africa and that for the
great majority genetically still resides in the Palaeolithic era. Most of the current inter-individual
genetic di"erences were already existent when Homo sapiens emerged, some 200,000 years ago.77
Bipedalism, hairlessness, speech and the ability to store fat di"erentiates humans from the closest
relatives, the primates, but it is the uniquely large brain, which allowed for symbolic consciousness
and pose ‘what if’ questions, that #nally made humanity.75
Figure 2. Coasting out of Africa. The assumed dispersal routes of archaic and anatomically modern humans
out of Africa and the supportive fossil evidence for hominin presence. Source: National Geographic Society




3.1 Changing habitat and increasing brain size
It is assumed that during the early stages of human evolution early hominins introduced more
animal food into their diets, at the expense of plant foods.93,94 Subsequent hominins further increased
the amount of animal food and consequently the energy density and (micro)nutrient content of
their diet, i.e. the dietary quality (DQ). While increasing their dietary intake from animal food, early
hominins grew taller and increased their brain mass relative to body mass (encephalization quotient,
EQ). Brain mass in primates relates to the number of neurons95 and global cognition,96 while the
human cortex also has more cycles of cell division compared to other primates97. During hominin
evolution the rst signicant increase in EQ occurred around 2 Mya (Table 1). From ~2 million to
200-thousand years ago (kya) the human ancestors tripled their brain size from Australopithecus
species with an EQ of 1.23-1.92 to an EQ of 1.41-4.26 for the genus Homo.98,99 The increase in brain
size and the number of neurons di!erentiates Homo from their closest primate relatives. However, a
large brain requires an adaptation or an exaptation to accommodate it, and notably su"cient intake
of so-called ‘brain-selective nutrients’99,100 to build and conserve it.
3.2 Buiding a big brain
Compared to other primates, humans have extraordinarily large brains.101,102 To understand the
expansion of the human brain during evolution, it is important to comprehend its composition and
its biochemistry. Brain tissue has a unique prole of long-chain polyunsaturated fatty acids (LCP)98.
Comparison of the brain ethanolamine phosphoglycerols of 42 studied animal species shows an
Table 1. The development of brain weight relative to body dimensionsa
Species Brain weight Brain-to-body Relative EQb
(g) ratio (%)
Gorilla gorilla 500 0.3 25
Pongo pygmaeus 400 0.5 32
Pan troglodytes 400 0.9 42
Australopithecus afarensis 455 1.7 41
Australopithecus africanus 450 1.0 44
Paranthropus aethiopicus 405 1.1 44
Paranthropus boisei 510 0.9 46
Paranthropus robustus 520 1.1 50
Homo rudolfensis 750 1.7 59
Homo habilis 600 1.7 57
Homo ergaster 855 -
Homo erectus 863 1.6 63
Homo heidelbergensis 1200 1.8 74
Homo neanderthalensis 1450 1.9 75
Homo sapiens (Cro-Magnon) 1490 2.4 102
Modern Homo sapiens 1360 2.3 100
a, adapted from Cunnane 99
b, relative to modern Homo sapiens
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almost identical LCP pattern, independent of the grade of encephalization, containing approximately
equal proportions of arachidonic (AA) and docosahexaenoic (DHA) acids. Consequently, for normal
neuronal function, mammalian brain tissue appears to have an invariant structural requirement for
both AA and DHA. This shows that both these fatty acids are important building blocks for building
a big brain and for encephalization. The weight of a newborn human brain is about 340 g103 and it
contains about 9 g lipid104; the brain of a 10 months old infant is 850 g and contains 52 g lipid. At 3
years, the brain is 1,100 g and contains 130 g lipid. Thus, the major part of the human brain spurt
occurs postnatally,105 implying that especially the newborn infant has high demands for AA and
DHA.
Toothed whales (brain weight 9,000 g) and African elephants (4,200 g) have brains much
larger than humans, but they have lower cognitive abilities and a lower EQ.106 These observations
substantiated an EQ-centered approach to explain variation in cognition between species. Recent
analyses, however, showed remarkable di!erences between primate and non-primate brains,
assuring that primate brain contains many more neurons than a non-primate brain of similar
size95,107,108 and that the absolute number of neurons, rather than body relative to brain ratio (EQ)
best predicts cognitive ability96; although it still needs to be determined whether humans have
the largest number of brain neurons among all mammals. From this new neuron-centered view,
there seems to be nothing special about the human compared to the primate brain, except for
Figure 3. The three models of human evolution and their posterior probabilities. Dark grey represents
anatomically modern humans, lighter gray the archaic populations. The width of the gray areas indicates
the population size over time. The arrow in B indicates the possibility of a genetic contribution of archaic
humans to modern populations via admixture. The double-headed arrows in C indicate gene-"ow between
two populations. Adapted from A. Templeton, with permission.83-85
Posterior Probability =0.781 Posterior Probability = 0.001 Posterior Probability = 0.218
Africa Eurasia America Africa Eurasia America Africa Eurasia America








its size,95 which basically determines both the number of neurons and non-neurons.109,110 Detailed
comparisons of human and primate brains revealed other dierences, such as dierent levels of
gene expression,111-113 secondary to chromosomal rearrangements,114 dierences in the relative
extent of the neocortical areas95,115, the distribution of cell types116 and the decrease of brain structure
volumes with increasing age in humans in contrast to chimpanzees.117,118 The best predictor of
cognitive ability in humans compared to non-primates, however, still needs to be established, but
rather than EQ or brain size, the absolute number of neurons seems a prudent candidate,96,107 since
there is no clear relation between neuron number and the absolute brain size among the dierent
animal species.95,107,108
In contrast to intuitive belief, growing a large brain and a large skull to accommodate it is
less dicult to achieve than it seems at rst glance. It was recently shown that dierent levels of
expression of a single gene might have resulted in the markedly dierent beak shapes and lengths of
Darwin’s nches. Experimental overexpression of the calmodulin gene in chicken embryos resulted
in a signicant increase in the length of their beaks.119,120 These experiments suggest that small and
seemingly insignicant changes can have profound implications for the evolution of anatomical size
and shape and thereby provide great potential for explaining the origins of phenotypic variation,121
including increases in brain and skull size. Analogously, many mutations in humans are associated
with either microcephaly122 or macrocephaly,123 while the growth of the skull in hydrocephaly shows
that the increased skull-size is secondary to the increase of its contents, suggesting that brain rather
than skull size is the limiting factor here. The evolution of certain genetic variants associated with
brain size has accelerated signicantly since the divergence from the chimpanzee some 5-6 million
years ago. A recent variation that occurred 37,000 years ago, has spread more rapidly through
the human population than could be explained by genetic drift,124-127 suggesting that it conferred
evolutionary advantage.
The anatomical and metabolic changes encoded in the genome (see ‘Comparative anatomy’)
might have provided hominins with the anatomical and energetic opportunity to, over a period of
several million years, steadily increase their brain size, but these mutations per se did not fulll the
nutrient requirements for brain expansion.100,128-130 The underlying small number of mutations should
rather have been accompanied, and most probably have been preceded, by increased availability
of ‘brain specic nutrients’ such as LCP for their ultimate conservation through the process of
mutation/selection, which basically underlines both Darwin’s concept of the crucial importance of
‘the conditions of existence’ and the secondary role of mutation. An example may come from the
current knowledge on the sources of AA and DHA. In humans, both AA and DHA can be synthesized
from their precursor essential fatty acids alpha-linolenic (ALA) and linoleic (LA) acids (Figure 4),
respectively. ALA and LA are present in various natural food resources. ALA is predominantly found
in plant foods, while LA is mainly found in vegetable oils such as sun!ower oil. Both AA and DHA
may derive from their synthesis from abundantly consumed precursor fatty acids ALA and LA, but
in humans and especially neonates, these synthetic activities are insucient to cope with metabolic
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demands.131 Consequently both these long-chain polyunsaturated fatty acids (LCP), but especially
those of the ω3 series, need to be present in sucient quantities in our diet. It is still under debate
what dietary resource(s) provided the LCP that enabled us to grow a large brain.100,132-136
4. The probability of hunting on the savanna
It has been a longstanding paradigm in palaeoanthopology that early human evolution occurred in
a dry and open savanna environment.137-139 Recent studies from the Afar Basin,67,140 although recently
contested,141-143 indicated that the habitat of Ardipithecus ramidus at ~4.4 Ma was characterized
not by savanna but by woodland to grassy woodland conditions. Human characteristics, such as
the poor water drinking capacity, excessive urination and transpiration and poor water retention
support the argument that we would be poorly-adapted savannah dwellers.139
A second long reigning paradigm was “Man the Hunter”, which was the standard version of
human origins advocated for many years. Washburn and Lancaster93 referred at most to our most
recent antecessors, Homo sapiens and possibly H. neanderthalensis, when they claimed that our
intellect, interests, emotions and basic social life are evolutionary products of the hunting adaptation.
The strongest argument against this hunting paradigm comes from combined studies of past and
present day hunter-gatherer societies indicating that the role of hunting is exaggerated, notably
(around the camp!re) in hunter-gatherer societies, since the majority of the dietary protein is in
reality obtained by women gathering nuts, tubers and small animals.144-146 Cordain et al.147 showed
Figure 4. Metabolism of dietary fatty acids and endogenously synthesized fatty acids. Abbreviations:
∆x: ∆x-desaturase; CE: chain elongation; CS: chain shortening through peroxisomal  -oxidation. 18:3!3,
"-linolenic acid (ALA); 18:2!6, linoleic acid (LA); 18:1!9, oleic acid; 20:5!3, eicosapentaenoic acid (EPA);




that only 25-35 energy% (en%) of subsistence in worldwide hunter-gatherer communities derived
from hunting, while the remainder derived from both plant and shed food. Thus while meat from
large game may have been the most valued food, it is highly unlikely that it was the most valuable
(nutritionally important) food resource from a dietary perspective.41,148 At present, the niche of early
hominins and thus the environment of human evolution, and most importantly for this review, the
nutritional composition of the early human diet, is still heavily debated.149
5. Reconstruction of our ancient diet
In next paragraphs we will discuss various views on (changes in) the hominin ecological niche that
over time shaped the human genome to what it currently is.
5.1 Palaeoenvironments
Sahelanthropus, Orrorin and Ardipithecus
In the late Miocene (up to 5.3 Mya), the African continent became more arid, which resulted in
fragmenting of the (sub)tropical forests and the appearance of more open environments.150
The widespread dispersal of some of the earliest hominins such as Sahelanthropus,64,151 and
Australopithecus bahrelghazali from Chad, might be explained by the presence of the relatively
low-lying humid East-West corridor constituted by the remnants of the Cretaceous Central
African and Sudan Rifts between western and eastern Africa.152,153 The reconstructed environment
of Sahelanthropus (~7 Mya) suggests a mosaic from gallery forest at the edge of a deep, well-
oxygenized lake, swampy and vegetated areas, and extensive grasslands.154 Since there is no
indication of carnivore modication or !uvial transport of its bones, Sahelanthropus chadensis likely
lived in this area.155 The palaeo-environment of Orrorin (~6 Mya) was probably characterized by open
woodland; with dense stands of trees in the vicinity and possibly fringing the lake margin and/or
streams that drained into the lake.156 Ardipithecus kadabba (5.6 Mya) remains are associated with wet
and closed, grassy woodland and forest habitats around lake or river margins.157 Ardipithicus ramidus
(4.4 Mya) lived in or near a groundwater-supported grassy woodland to forest.158 Additionally,
the abundance of fossilized shallow-water aquatic species such as catsh, barbus, cichlidae and
crocodiles additionally suggest an episodically present !ood plain environment.158
Early Australopithecus species
Australopithecus anamensis appeared at ~4.2 Mya and its environment was characterized by a mix
of wetlands and terrestrial environments, such as lacustrine and !uvial !oodplains, woodland and
gallery forest.155,159-162 The later Australopithecus afarensis survived in a variety of habitats,163 but
apparently thrived better in the more wooded and humid conditions in the Afar Basin than in the
relatively dry Laetoli area.164 Stewart155 pointed out that in Africa the only environmental constant
in hominin sites throughout the period from 3.4-2.9 Mya was a wetlands habitat, characterized by
aquatic herbaceous vegetations around lakes and rivers, with large populations of wetland fauna
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such as reduncines and hippos. Hence, these wetlands could have been refugee for early hominins
throughout an extensive period of human evolution.
Paranthropus, late Australopithecus and Homo species
About 2.9-2.5 Mya tectonic and global climatic changes made Africa cooler and drier.165-168 The great
wet forests of middle Africa retreated and made place for more savannah grasslands. It is around
this time, from ~2.6 Mya onwards, that the !rst traces of the new hominin genus Homo appeared
in the archaeological record.139 It has been suggested that alternating wet and dry periods after 2.7
Mya could have isolated hominin populations around sources of potable water, while forcing them
to the extremes of their conditions of existence155 and thus facilitating specialization,169 either by
adaptation or exaptation. Compared to Australopithecus, Paranthropus existed in slightly more open
habitats, including wetlands and grasslands, but also in woodland and bushland areas. The habitats
of Homo species seems similar to those utilized by Paranthropus species,160 but Homo remains at
Olduvai Gorge and Koobi Fora are associated with well-vegetated swamps, lakes and river margins,
and (semi-) aquatic fauna.170,171 Only the later Homo species are also found in assemblages that
indicate extremely arid and open landscapes such as savannah.160 Also, it has been suggested that
hominins and other (aquatic) species dispersed throughout Africa along water systems, while even
the last Out-of-Africa migration might have occurred via the “green Sahara” that existed during the
last interglacial (125 kya).155,172
In conclusion, the palaeo-environmental evidence suggests that early hominins lived in the
proximity of water. However, it is frequently argued that bones are preferentially preserved in lake,
river or "uvial sediments making their recovery in any other than an aquatic setting unlikely.173
Alternatively, hominin remains may have been relocated to the water by carnivores,161 including
crocodiles. Nevertheless, the combined evidence strongly suggests that early hominins frequented
the land-water ecosystem and thus lived there. Joordens et al.153 proposed, based on comparison
with other terrestrial omnivores, that the default assumption should be that hominins living in
freshwater or marine coastal ecosystems with catchable aquatic resources, could have consumed
these aquatic resources.153,174
5.2 Comparative anatomy
The diet of our closest relatives
Field studies on our closest relatives, the extant apes, show that their preferred food items are
primarily fruits and/or leaves and stems from terrestrial forests. Lowland Gorillas for example
derive 57% of their metabolizable energy (en%) from short-chain fatty acids derived from colonic
fermentation of !ber, 2.5 en% from fat, 24 en% from protein and 16 en% from carbohydrate.175
“Fallback foods”are consumed when preferred foods are unavailable176 and are generally composed
of herbaceous plants and high !ber fruits from aquatic and terrestrial environments.155 Like our




foods, while, although speculative, this niche might eventually have proven favorable with regard
to subsequent encephalization.
Teeth morphology and dental microwear
Comparative anatomy (Figure 5) of the hominins might confer some information about these
fallback and preferred foods of our ancestors. Dental studies of Sahelanthropus (Figure 1) describe
that it had thick enamel,64 similar to orang-utans, suggesting that it could eat hard and tough
foods,181 such as available from the lakeshore vegetation.155 Ardipithecus ramidus, however, had thin
molar enamel and smaller teeth compared to later hominins. This dental morphology is consistent
with a partially terrestrial, omnivorous/frugivorous niche.182 Studies on cranio-dental changes such
as tooth size, tooth shape, enamel structure and jaw biomechanics indicate that Australopithecus
and Paranthropus had prominent jaws, relatively !at molar teeth, small incisors and thick enamel,
suitable for breaking and crushing small hard, brittle foods such as fruits, nuts and underground
storage organs,149 but unsuitable for breaking down tough plant foods or tearing meat. Together,
this would allow early hominins to eat both hard and soft, abrasive and non-abrasive foods, which
suits well for life in a variety of habitats.183
In addition to studies on teeth morphology, micro-wear studies are essential. Dental microwear
studies analyse tooth-wear, showing evidence for where teeth were actually used for and thus
what an animal in reality ate.184 While adaptive morphology will give important clues about what
a species was capable of eating, microwear studies re!ect what an animal ate during some point
at its lifetime. In these studies, “complexity” is used as an indicator for hard and brittle items, while
“anisotrophy” is an indicator for tough foods.185
Most primates show either low complexity combined with high anisotrophy indicative for
consumption of tough foods such as leaves, stems and meat; or high complexity with low anisotrophy





Figure 5. Lower jaw of a chimpanzee (Pan troglodytes), Australopithecus africanus and Homo sapiens.




for an omnivorous/frugivorous diet was conrmed by microwear studies182; suggesting a diet of
eshy fruits and soft, young leaves.149 Conversely, microwear textures of Australopithicus afarensis
and anamensis show striations rather than pits (low complexity and low anisotrophy), i.e. patterns
similar to those of grass-eating and folivorous monkeys instead of the predicted diets predominated
by hard and brittle foods.186,187 Australopithecus africanus showed microwear patterns that were
more anisotropic, suggestive for consumption of tough leaves, grasses and stems.188 Paranthropus
robustus, also know as the “Nutcracker Man,” has enormous, at, thickly enamelled teeth, that are
combined with a robust cranium, mandible and powerful chewing muscles, suggestive for breaking
hard and brittle foods.185 After microwear analysis of its teeth, however, Ungar et al.149,185 showed
that P. robustus had low complexity and anisotrophy, thus Paranthropus might only have consumed
mechanically challenging items as fallback foods when preferred foods were unavailable. Similarly,
microwear studies support the notion that the diet of P. boisei contained large quantities of low-
quality vegetation, rather than hard objects.189
Generally, micro-wear studies conrm earlier dental topography studies,190 which revealed
the incorporation of more fracture-resistant foods, i.e. tougher foods as leaves, woody plants,
underground storage organs and animal tissues, in the diet of Australopithecus africanus compared
with Australopithecus afarensis and for P. robustus compared with Australopithecus africanus.186 Dental
topographic analysis suggested that successive Homo species emphasized more on tougher and
elastic foods, perhaps including meat.190 The latter suggestion is in line with the optimal foraging
theory, which states that humans prefer foods with high energy density over those with low energy
density.191,192
Microwear studies conrmed that early Homo, such as H. erectus and H. habilis did not prefer
fracture resistant foods, although some H. erectus specimens showed more small pits than H. habilis
members, suggesting that none of the early Homo specialized on very hard-brittle or tough foods,
but rather could consume a varied diet.193 This does not imply that early Homo had very broad diets,
but rather that early Homo was adapted to subsist in a range of di!erent environments, providing
evolutionary advantage in the climatic uctuations and the mosaic of habitats in Africa during
the late Pliocene.194 A study on dental microwear of 300,000 year old H. heidelbergensis teeth from
Sima de los Huesos in Spain, showed striation patterns that indicated a highly abrasive diet, with
substantial dependence on poorly processed plant foods such as roots, stems and seeds.195 Lalueza
et al.196 compared teeth of very recent hunter-gatherers (Inuit, Fueguians, Bushmen, Aborigines,
Andamanese, Indians, Veddahs, Tasmanians, Laps and Hindus) with Middle and Upper Pleistocene
fossils. Their results indicate that some Neandertals resemble carnivorous groups, while archaic H.
sapiens show a more abrasive diet, partly dependent on vegetable materials.
Overall, remarkably few studies have related microwear patterns to hominin diet for the period
between 1.5 million years and 50,000 years ago (Ungar, pers. communication). Studies in more
recent hominins, such as from an Upper Palaeolithic site in the Levant (22,500-23,500 BP) showed




aquatic foods rather than a diet with hard foods that needed compressive force.197,198 A study of
subsequent local hunter-gatherers (12,500-10,250 BP) and farmers (10,250-7,500 BP) living in the
Levant showed larger dental pits and wider scratches among the farmers compared to the hunter-
gatherers, suggesting that the implementation of agriculture led to a more fracture resistant diet.198
Gut morphology, energy expenditure and muscularity
Gut morphology studies199,200 support the introduction of animal foods at the expense of vegetable
foods, in the diet of early Homo. The dominance of the colon (>45%) in apes indicates adaptation to a
diet rich in bulky plant material, such as plant !ber and woody seeds. In contrast, the proportions of
the human gut, dominated by the small intestine (>56%), suggests adaptation to a diet that is highly
digestible, indicating a closer structural analogy with carnivores than to folivorous or frugivorous
mammals. Importantly, the shorter gut in Homo, as compared to primates, might have had some
other advantage. During the evolution from Ardipithecus and Australopithecines to early Homo, the
improvement of DQ coincided with an increase in height, the size of our brain and its metabolic
activity. However, an increase in body size coincides with increased daily energy demands, notably
during gestation201 and lactation.202 It was e.g. calculated that
daily energy expenditure (DEE) for a Homo erectus female is
about 66% higher compared to an Australopithicine female, while
being almost 100% higher in a lactating Homo erectus female
compared to a non-lactating, non-pregnant Australopithicine.203
These high energy demands might have been met by increased
female fat reserves,204,205 such as demonstrated by the presence
of female steatopygia in some traditional human populations,
such as the Khoisan of southern Africa (Figure 6).
Apart from the extra energy need for reproduction and
increasing height, the human brain of a modern adult uses 20-
25 en% of the total resting metabolic rate (RMR), while this value
is 8-9 en% for a primate.206 It has been postulated that the extra
energy needs did not derive from a general increase in RMR,
but partly from a concomitant reduction of the gastrointestinal
tract207 and a reduction in muscularity.206 These features are
combined in the ‘expensive tissue hypothesis’ of Aiello and
Wheeler207 that points at the observation that the mass of the
human gastrointestinal tract is only 60% of that expected for
a similar-sized primate and that humans are relatively under-
muscled compared to other primates.206 Interestingly, the
negative relation between gut and brain size across anthropoid
primates208 was con!rmed in a study with highly encephalized




sh,209 whereas it became falsied in mammals.101 Unfortunately, however, the latter study did not
include marine mammals,101 while it is questionable whether with respect to brain development
humans adhere to general mammalian rules.102 Other adaptations might have saved energy
expenditure as well. The short human inter-birth interval,203 compared to inter-birth intervals of 4-8
years in gorilla, chimpanzee and orangutang210 reduces the most expensive part of reproduction,
i.e. lactation,211,212 while the shift from quadrupedal to bipedal locomotion also reduced DEE.213
Together, all of these adaptations allow for an increased DEE, including the reallocation of energy
to the metabolically active brain, but were only possible after Homo included more energy dense
foods into its diet. Brain mass in primates is positively related to DQ and inversely to body weight.206
Generally, a shift towards more energy dense foods includes a shift from primarily carbohydrate-rich
vegetables to fat- and protein-rich animal foods. However, it has also been suggested that a shift
from the complex carbohydrates in leafy vegetables towards underground storage organs, such as
tubers, might have provided easy to digest carbohydrates199,214 to support a larger hominin body
mass.
A phenotypic specialization on non-preferred resources, without compromising the ability to
use preferred resources, is also known as Liem’s Paradox.215 This paradox is important to keep in
mind during attempts to reconstruct the preferred diet from the available evidence. Interestingly,
Stewart155 recently noted that in the case of Paranthropus’ phenotype with regard to its fallback
food, there is just as much evidence to talk about a “Nutcracker Man”, as there is to talk about a
“Shellcracker Man”. Thus, a phenotypic characterization needs support from other studies to
conrm adaptation to preferred rather than fallback foods. In other words, it should be noted that
not all physical characteristics might be taken as unambiguous proof for the preferred diet of early
hominins (Liem’s Paradox). The increasing absolute body size and brain size and the reduction in gut
size, however, do indicate a shift from low to high DQ foods for more recent hominins.
5.3 Biogeochemistry
Evidence from the strontium/calcium ratio
Based upon the principle ‘you are what you eat’216 several techniques were developed to study early
hominin diets217. Trace element studies rst started with strontium to calcium ratios (Sr/Ca), which
decrease as an animal moves up the food chain, secondary to the biological discrimination against
strontium.218 A rst study219 suggested that Paranthropus robustus (Figure 1) had lower Sr/Ca ratios
compared to contemporaneous Papio (baboon) and Procavia (hyrax), suggesting that Paranthropus
was not an exclusive herbivore. However, a subsequent study showed that two Homo specimens
had a higher Sr/Ca ratio than Paranthropus.220 Since Homo had been assumed to consume more
animal foods than Paranthropus and thus have a lower Sr/Ca ratio, these higher Sr/Ca ratios needed
explanation. For example, consumption of specic foods with a high Sr/Ca ratio might have
increased the ratio in Homo compared to Paranthropus. Foods in the area of research with elevated




storage organs, such as roots, bulbs, tubers, corms, or rhizomes. Consequently, this discrepancy has
been attributed to the consumption of underground storage organs by early Homo.214,220 The use of
these underground storage organs may have become necessary from the start of a !rst period of
aridity around 2.8 Mya, when forest was replaced by drier woodlands, forcing hominins to search for
the available resources around water margins.221
Although promising at !rst, the use of Sr/Ca ratios was found to su"er from several limitations.
For example, a problem is that hominin Sr/Ca ratios in fossilized bones alter with time;222 a process
that is known as diagenesis. This problem can be circumvented by the use of tooth enamel, which
is less susceptible to diagenesis than bone.222 Subsequent studies showed that Australopithecus
africanus had a higher Sr/Ca ratio in its enamel compared to Paranthropus and contemporaneous
browsers, grazers, baboons and carnivores.223-225 The interpretation of these !ndings, however,
remains a subject of debate. For example, a group of brown seaweeds and some aquatic plants
discriminate against calcium, resulting in an increase in the Sr/Ca ratio, and likewise in the Sr/Ca
ratio of the !sh feeding on them.225,226 Similarly, leaves from trees have lower Sr/Ca ratios compared
to grasses, which becomes subsequently re#ected in the Sr/Ca ratios of browsers and grazers,
respectively.227 Thus, it might be argued that the relatively high Sr/Ca ratios in Australopithicines and
Homo re#ect their consumption of aquatic resources or of animals such as insects or other small
animals feeding on grasses. For now, the exploration of especially Sr/Ca ratios as a dietary proxy
method has largely been stalled.228
Evidence from the barium/calcium ratio
Another trace element ratio that might provide information on the composition of the early hominin
diet is the barium to calcium ratio (Ba/Ca), particularly when used in a multiple element analysis
with Sr/Ca and Sr/Ba ratios.223,229 Combined Ba/Ca and Sr/Ba ratios clearly di"erentiate grazers from
browsers and carnivores in both modern and fossil mammals229. Hominins have a lower Ba/Ca and
higher Sr/Ba ratio compared to grazers and browsers. Paranthropus shows considerable similarity
for both ratios with both carnivores and Papionins (baboons), while Australopithecus shows an even
higher Sr/Ba ratio. The unusual combination of a high Sr/Ca and low Ba/Ca ratio in hominins (and
baboons) was further observed for some animals as warthogs and mole rats that make extensive
use of underground resources.230 Finally, the high Sr/Ba ratio, as observed in Australopithecus, might
derive from the consumption of grass seeds, which have Sr/Ba ratios 3-4 times higher than grass
straw, while consumption of these grasses is also consistent with stable isotope evidence (see below)
showing that Australopithecus derived a substantial part of its diet from C4 resources. Although not
included in any study so far, Sr/Ba ratios in aquatic foods might add to the understanding of the
unusual combination of low Ba/Ca and high Sr/Ba ratios.
Evidence from the13C/12C ratio
Fractionation studies of carbon isotopes di"erentiate between di"erent routes of photosynthesis.
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While most tropical African woody plants from forests (like fruits, leaves, trees, roots, bushes, shrubs
and forbs) use the C3-photosynthetic pathway, some South-
231 and East-African232 grasses and sedges,
use the C4-photosynthetic pathway. C4-plants such as sedges (e.g. Cyperus papyrus) typically occur
in a mosaic of extensive seasonal and perennial shallow-freshwater wetlands that can also be found
in savannah and ‘bushvelds’ receiving summer rainfall.233 The real impact of C4-plants occurred with
their spread into Eastern and Southern Africa during the Pliocene.234 Tissues of plants that utilize the
C4-pathway have a relatively high content of the stable carbon isotope
13C (about 1.1% of carbon),
since C3-plants discriminate more strongly against
13CO2 during photosynthesis. As a result C3- and
C4-plants have quite dierent
13C/12C ratios in their tissues, as have the herbivorous animals that feed
on these plants227,231 and the carnivores that prey on these herbivores.235,236 Dierences are expressed
as δ13C values (δ13C (in ‰) = [(13C/12C)sample - (
13C/12C)standard]*1000/(
13C/12C)standard) in parts per thousand
(‰) relative to the 13C/12C ratio in the reference standard (named Pee Dee Belemnite, PDB), i.e. the
carbonate obtained from the fossil of a marine Cretaceous cephalopod (Belemnitella Americana)
which is highly enriched in 13C (13C/12C ratio=0.0112372). Consequently, most animals have negative
δ13C values (Figure 7). The δ13C ranges from -35 to -21‰ (mean -26‰) in C3-plants and from -14 to
-10‰ (mean -12‰) in C4-plants.
224 Studies that attempted to reconstruct mammalian food webs,
indicated that carbon is slightly enriched (1-2‰) with each trophic step.193,206 To facilitate comparison
of current and historical animals, δ13C analyses are predominantly performed in hard tissues, such as
bone collagen and enamel (notably apatite), since these constitute the majority of the fossil record.
It was shown that enamel mineral is enriched by about 13‰ compared with dietary δ13C237, while
collagen is enriched by about 5‰ compared with dietary δ13C224. Collagen from terrestrial mammal
C3-herbivores shows a value of -21‰ (range -22 to -14‰), while in collagen of C4-herbivores this
value is -7‰ (-12 to -6‰). Their respective carnivores show collagen values of -19‰ (-21 to -14‰)
and -5‰ (-8 to -2‰), respectively224. Marine phytoplankton, which uses the C3-pathway, shows an
average value of -22‰ (238). Collagen of marine !sh shows a range from -15‰ to -10‰, while the
values in collagen of reef !sh range from -8‰ to -4‰239. Marine carnivores have, similar to terrestrial
carnivores, intermediate values of -14‰, ranging from -10‰ in collagen of sea otters to -15‰ in
collagen of the common dolphin238,239. Thus, also the δ13C values of marine carnivores compare well
with those of their prey. Finally, δ13C values for the muscle of freshwater !sh species ranges from
-24 to -13‰, but considerable variation may exist between dierent lakes.240 Unfortunately, no
δ13C data are available for terrestrial piscivorous carnivores, but the consistency of the other data
suggests that these might be between -24 to -13‰, i.e. comparable to their prey (Figure 7).
Consistent with the data above, Schoeninger et al.241 showed that European agriculturalists
consuming C3-grasses had much lower δ
13C values in bone collagen (-21 to -19‰) compared to
Mesoamerican agriculturalist consuming C4-corn (-7 to -5‰), while North American and European
!sher-gatherers had intermediate values (-15 to -11‰). However, bone collagen proved less reliable
to study early hominin diets. For that purpose the 13C/12C ratio is preferably measured in tooth




to be made. Similar to the clear distinctions between bone collagen of modern grazers, browsers
and their carnivores, tooth enamel data from fossilized fauna from South-Africa showed similar
dierences for Plio-Pleistocene C3-feeders (-11.5‰) and C4-feeders (-0.5‰), with Australopithecus,
Paranthropus and Homo taking intermediate positions (-10 to -4‰)230,233,236,242, which compared
well with the values for contemporaneous felids (-10 to -0.5‰)230,236,243 (Figure 7). These results
clearly demonstrated that a signi!cant portion of the diets of the early hominins from Swartkrans,
Makapansgat and Sterkfontein derived from C4-resources. Using these data it was calculated that
South-African Paranthropus derived 14-47% of its diet from C4-sources, compared to 5-64% in
Australopithecus and 20-35% in Homo.244
Figure 7. The normalized collagen δ13C values (mean, range; in ‰) in plankton, crustaceans, sea grasses,
C3- and C4-plants; of marine crustaceans, !sh and freshwater !sh and their respective carnivores, of
terrestrial C3- and C4-herbivores and their carnivores; and of human groups in historic and prehistoric
times. * Corrected228 for collagen (-5‰). ** Corrected237 for enamel (-13‰). *** Arbitrary range of  1 ‰ due
to a lack of data. **** As predicted from other predator-prey relationships and after correction238 for tropic
level (+1‰). Adapted from Ambrose et al.227, Sponheimer et al.230,237,242,246-248, Peters et al.233 ,Lee-Thorpe et
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A second study in Olduvai showed that the Tanzanian Paranthropus boisei derived 77-81%
and Homo 23-49% from its diet from C4-resources
244. The low nutritional value of grasses, and
microwear studies (see above), render it unlikely that humans were directly eating grass.230,242
Analogously, sizeable carnivory of C4-consuming mammals (such as cane rats, hyraxes or juvenile
bovis) was argued to be practically impossible and thus unable to leave a strong C4-signature.
242
However, at ~1.8 Mya, there were extensive wetlands in the Olduvai area, where a river from the
Ngorongoro mountains entered the area, while at 1.5 Mya the Peninj river produced wetlands near
Lake Natron.155 Some researchers investigated the edible plants in a present day wetland (Okavango
Delta) and found that the rhizomes and culms of three species of C4-sedges were edible, the most
common one of which is Cyperus papyrus.244 However, it seems unlikely that the C4-signature in all
early hominins derived from the consumption of papyrus. It was recently suggested that P. robustus
and especially P. boisei had a diet of primarily C4-resources, most likely grasses or sedges, from
savanna or wetland environments, respectively.189 Theoretically, a good source of C4 foods would
be a seasonal freshwater wetland with !oodplains and perennial marshlands, with an abundance
of easy accessible aquatic foods, large aggregations of nesting birds and calving ungulates.233
Consumption of termites could have contributed to the high C4-signature observed in hominin
fossils (Figure 7), but it seems unlikely that termites could explain values as high as 50% of the diet
from C4
242. Finally, an enamel C4-signature of -10 to -4‰ in hominins, which translates into a soft
tissue signature of -23 to -17‰ and a collagen signature of -18 to -12‰ (see above), might also
derive from the consumption of small freshwater aquatic animals/"sh, since they compare well
with the δ13C values of -24 to -13‰ for freshwater "sh240 and -18 to -9‰ in collagen of crustaceans
and anthropods239, respectively. Moreover, δ13C values for hominins are similar to those reported
for marine mammal hunters, freshwater "sh, crustaceans, "sher gatherers, marine and freshwater
carnicores and marine "sh (Figure 7).
InagreementwiththevariabilityselectionhypothesisofPotts169,whichstatesthat largedisparities
in environmental conditions were responsible for important episodes of adaptive evolution, the
wide range in δ13C values in particularly Australopithecus suggests that early hominins utilized a
wide range of dietary sources, including C4-resources. This contrasts with chimpanzees, which, even
in the most arid and open areas of their range, are known to consume negligible amounts of C4-
resources, despite their local abundancy. Consequently chimpanzees show very little variability in
their δ13C carbon signature245,246. This underscores that even if contemporaneous chimpanzees and
early hominins inhabited similar habitats, hominins had broadened their dietary range su$ciently
to survive in habitats uninhabitable by chimpanzees. The latter assumption provides an interesting
perspective on the recent data, which suggest that C4-foods were absent in the diet of Ardipithecus
ramidus at 4.4 Ma. Consequently, it has been proposed that the origins of the introduction of C4-




Limited evidence from the 15N/14N ratio
Another stable isotope ratio that has received considerable attention is the nitrogen isotope (15N/14N)
ratio. A number of food web studies have shown that each step in the food chain is accompanied
by 3-4‰ enrichment in δ15N227,238 and that δ15N can therefore be useful as a trophic level indicator.
Additionally, animals feeding in marine ecosystems have higher values compared to animals
feeding on terrestrial resources.241 For example, North-American and European sher gatherers and
North-American marine mammal hunters and salmon shers had much higher δ15N values (+13 to
+20‰) compared to agriculturalists (+6 to +12‰). Analyses of phyto- and zooplankton suggest
that freshwater organisms have δ15N values intermediate to terrestrial and marine organisms.241
δ15N values are routinely measured in bone collagen, but it was shown that good quality collagen
(preserving the original δ15N value) can, and only under favorable conditions, survive up to a
maximum of 200,000 years.224 This limits δ15N isotopic studies to Late Pleistocene hominins (see
below), but with improved technology, future studies using collagen extracted from tooth enamel
may expand their application to early hominins.237
Limited evidence from the18O/16O ratio,
A nal isotope that might provide information about an animal’s diet and thermophysiological
adaptations is the oxygen isotope ratio (18O/16O). More energy is needed to vaporize H2
18O than
H2
16O. When ocean water evaporates and during evapotranspiration, i.e. the sum of evaporation
and plant transpiration from the earth’s land surface to atmosphere, more of the lighter isotope
evaporates as H2
16O. The ensuing 18O-enrichment of transpiring leaves results in 18O enrichment in
typical browsers such as kudu and gira!e who rely less on free drinking water and derive most of
their water from the consumption of the 18O-enriched plant water. As the 16O-enriched water vapor
in clouds moves inland, some of it condenses as rain, during which more of the heavier isotope
(as H2
18O) rains out, making the δ18O of coastal rain only slightly less enriched than the original
vaporated ocean water, while the δ18O of the remaining water vapor that eventually comes down is
highly negative (i.e. more 18O depleted). Consequently, river water from rain and melting ice is more
δ18O negative than seawater. Roots derive their water from meteoric or underground water that
is thus relatively depleted from 18O and so become animals that are consuming these roots.247,248
Browsers of leaves undergoing evapotranspiration and consumers of roots may thus be expected
to have high and low δ18O values, respectively.
Australopiths showed lower δ18O values compared to Paranthropus, but the meaning of this
di!erence remains uncertain. However, one might argue that Australopithecus preferred less arid
conditions compared to Paranthropus or was more dependent on seasonal drinking water.230
Low δ18O were additionally found in primates and suids, which might be linked to frugivory,
although this is not supported by the higher 18O values found in Ardipithecus ramidus compared
to Australopithicines.67,228 Taken together, the use of δ18O for exploration of ancient human diets
is still in its infancy, but might, especially in combination with other isotope ratios, become more
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appreciated in the future.
Isotopic data for more recent hominins
It would be of high interest to explore the hominin diet during the last spurt of encephalization
between 1.9 million to 100 kya, when brain size tripled in size to volumes between 1,200-1,490 cc
for Homo erectus, H. heidelbergensis, H. neanderthalensis and modern H. sapiens.99 Isotopic data for
this period are however absent. Due to limited preservation of collagen beyond 200,000 years, and
the near absence of C4-plants in Europe, these answers will have to come from further studies with
tooth enamel in Africa and Asia. So far, there is no isotope evidence for the diet of Homo between 1.5
millions years up to 50,000 years ago (kya) (M.P. Richards, personal communication).
Dietary information from more recent humans comes from data on δ13C, supplemented with
data on δ15N and the 13C/15N ratio. The 15N-isotope values of bone collagen241 for di"erentiation
between aquatic and agricultural diets were additionally veri#ed by the study of the sulfur isotope
rations (34S/32S), since high intakes of marine organisms also result in higher δ34S values.249 Combined
isotope studies reveal high intakes of animal protein, with substantial portions derived from
freshwater #sh by Upper and Middle Palaeolithic (40-12 kya) humans in Eurasia, indicating that in
some populations about 30% of dietary protein came from marine sources.249-255 In contrast, isotopic
evidence indicates that Neandertals were top-level carnivores that obtained most of their dietary
protein from large terrestrial herbivores, although even Neandertals certainly exploited shell#sh
such as clams, oysters, mussels and #sh on occasion.249-251 At the onset of the Neolithic period (5,200
years ago), there was a rapid and complete change from aquatic to terrestrial derived proteins
among both coastal and inland Britons compared to Mesolithic (9,000-5,200 years ago) British
humans253, which coincides precisely with the local onset of the agricultural revolution in Europe.
Conclusions from isotope studies
The isotope systems that have been studied thus far in hominin bone and teeth provide evidence that
early hominins were opportunistic feeders.256 The spread of C4-foods in East-Africa and subsequently
in the hominin food chain between 3-4 Mya, is in agreement with a niche of early hominins that
locates close to the water. This conception is in agreement with the palaeo-environmental
evidence. However, many questions still remain unanswered. With regard to the possible niche in
the water-land interface, it seems interesting to include aquatic as well as terrestrial piscivorous
animals into future studies. The data of combined studies of early hominins and the more recent
hominins suggest a gradual increase in dietary animal protein, a part of which may derive from
aquatic resources. In the more recent human ancestors, a substantial part of the dietary protein
irrefutably derived from marine resources, and this habit was only abandoned in some cases after





The oldest stone tools found so far are dated to 2.6 Mya257,258 and it has been suggested that these
have been used for esh removal and percussion on long bones for marrow access. From this time
onward stone tools were apparently used for deeshing and butchering of large animals. However,
again there is a pitfall in putting too much emphasis on the association between stone tools and
hunting and butchering of large animals as the sole food source of the human ancestors, especially
with regard to brain foods such as long-chain polyunsaturated fatty acids (LCP). As stated by Liem’s
Paradox; the apparently overwhelming evidence for the consumption of bone marrow, or even
brain from cracked skulls, by the ndings of cut marks on animal bone may not be evidence for
the primary food resources of human ancestors, but only for its fall-back food. Bones, especially
long bones, are also better preserved than vegetable material. Moreover, cut marks on bone are
easier ascribed to human utilization than any nearby found fossilized sh bones or molluscan shells
that only seldomly bear cut marks259,260 and are often not even examined. Hence, while human
remains are nearly always found in the vicinity of water and the fossil record of nearby found sh is
extensive,73,261 the exploitation of aquatic resources is dicult to relate to early humans.262
The current review is about the diet that allowed early humans to increase their brain size and
thereby become intelligent enough to develop e.g. symbolic thinking and the controlled use of
re. Hunting and/or scavenging is often invoked as important source of LCP, but, as pointed out
by Crawford9, even in the more recent certainly ‘hunting’ ancestors ‘a [scavenged] small brain
was not going to go far among the ladies [and children] even if it was still in an edible condition
when they [the male hunters] got it back [from the savannah]’2; not even in the scenario263 that we
were specialized, as suggested264, in endurance running. Apart from organ tissue (liver and brain)
and bone marrow (whether scavenged or hunted), sh, shellsh and other aquatic foods are also
mentioned as rich sources of the nutrients involved in brain expansion.98,129,265 Therefore, the question
arises whether the archeological evidence for human habitation in the land-water-ecosystem only
represents facilitated fossilization or indicates the true ecological niche. The following section will
focus on comparable evidence for the concurrent exploitation of aquatic resources.
Living in the water-land ecosystem
Because sea levels have risen up to 150 m in the past 17,000 years, a substantial part of the evidence
for the exploitation of aquatic resources is hidden below sea level, if not permanently destroyed by
the water.266,267 However, in Kenya, a site in East-Turkana provides solid evidence that at ~1.95 Mya
hominins enjoyed carcasses of both terrestrial and aquatic animals including turtles, crocodiles and
sh, which were associated with Oldowan artifacts.260 More ambiguous evidence for the exploitation
of freshwater sh, crocodiles, turtles, amphibians and molluscs by Homo habilis in the Olduvai Gorge
in Tanzania goes back as far as 1.8-1.1 Mya.266,268 Subsequent tentative evidence from Olduvai Gorge
dates the use of similar aquatic resources by Homo erectus to 1.1-0.8 Mya.266,268 Also the Out-of-Africa
Diaspora has likely taken place largely via the coastlines,80 even after the crossing of the Bering
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Strait into North America269 (Figure 2). In Koa Pah Nam, Thailand, 700 kya old piles of freshwater
oyster shells were associated with Homo erectus.270,271 In Holon, Israel, freshwater turtles, shells and
hippo bones were associated with Homo erectus and dated to 500-400 kya.272 Homo erectus fossils
associated with seal remains in Mas del Caves (Lunel-Viel, France) were dated to 400 kya.273
The archeological evidence for aquatic resource use increases with the appearance of archaic
Homo sapiens.266 Although dominated by land mammal bones, 400-200 ky old remains from penguin
and cormorants in Duinefontein, South-Africa, were associated with early Homo.274 Shell!sh and
possibly !sh remains, dated 300-230 kya, were associated with the French coastal campsite at Terra
Amata,275,276 while marine shell!sh and associated early human remains, dated 186-127 kya, were
found in Lazaret, France.273 Marrean et al.277 found evidence for the inclusion of marine resources,
at 164 kya, in the diet of anatomical modern humans from the Pinnacle Point Caves (South-Africa).
At the Eritrea Red Sea coast, Middle Stone Age artefacts on a fossil reef support the view that early
humans exploited near-shore marine food resources by at least 125 kya.278 In several North-African
sites, dated to 40-150 kya266, human remains were associated with shell middens and aquatic
resources such as aquatic snails, monk seals, mussels and crabs. Several European sites, dated to
30-125 kya, are comparable to archeological sites that reveal evidence ranging from thick layers
of mussels and large heaps of marine shells in Gibraltar266 to diverse marine shells in Italy,279 and
to a casual description of the presence of marine shells of unknown density in Gruta da Figueira in
Portugal266. Further evidence for the use of shell!sh, sea mammals and "ightless birds comes from:
Klasies River Mouth (South Africa) dated between 130-55 kya266,280,281; from Boegoeberg, where 130-
40 ky old shell middens and cormorant bones were associated with Homo sapiens266,282; from Herolds
Bay Cave, where 120-80 ky old shell middens, shell!sh, mussels and otter remains were associated
with human hearths266; from Die Kelders (75-55 kya), where abundant remains of sea mammals,
birds and shell!sh were found in cave deposits266,283; and from Hoedjies Punt (70-60 kya), Sea Harvest
(70-60 kya) and Blombos Cave (60-50 kya) for use of shell!sh, sea mammals and !sh.266,284 From
this period onwards, human settlements are strongly associated with the exploitation of aquatic
resources.266,267,281,285-287 Evidence for more sophisticated !shing by use of barbed bone harpoon
points dates back to 90-75 kya in Katanda, Semlike River, Zaire288,289 and to 70 kya in South Africa.290
Finally, indications for seafaring are dated to 42-15 kya.291-293 Possibly, seafaring dates as far back as
800 kya, as indicated by the !nding of Homo erectus stone tools at the Indonesian island of Flores,
which is located on the other side of a deep sea strait.78,294-298 In general, many archeological sites
are found along channels, lake- and seashores98,265,266,281 and reveal aquatic fauna, such as cat!sh,
crocodile and hippo,299 but its proves di#cult to relate their possible utilization to our early ancestors.
Several events within the time span of the past ~2 million years have been attributed to the
increase in brain size and intelligence. The introduction of meat in the hominin diet, which resulted
in a higher dietary quality (DQ), has been discussed above. Claims for controlled !re in Olduvai Gorge
(Tanzania) and Koobi Fora (Kenya) go as far back as 1.5 Mya.214,300,301 Evidence for cooking is as old as




present. However, recently it has been concluded that solid evidence for systematic use of re is only
found from 400-300 kya onwards.303 Evidence that cooking provided increased DQ were recently
provided by Wrangham et al.214 According to archeological evidence, this could only have played an
important role since the appearance of Homo sapiens214,300 and Neandertals.304 Also, the inclusion of
aquatic resources as an attributor to human brain evolution has been suggested,2,98-100,129,265,305-307 but
remains a matter of debate.133,134,267,308
From hunting-gathering to agriculture
The hunter-gatherer lifestyle continued worldwide for several millions of years and ended quite
abruptly with the introduction of agriculture. The rst indications for the abandonment of the
hunter-gatherer lifestyle towards settlement come from a 23,000 years old sher-hunter-gatherer’s
camp at the shore of the Sea of Galilee.309,310 The associated return from diets containing substantial
amounts of protein (from hunting and gathering) back to substantial amounts of carbohydrates is
supported by indications for the ground collecting of wild cereals.311 This was slowly followed by the
large scale utilization of cereals starting with the onset of the agricultural revolution some 10,000
years ago.
As indicated above (see ‘Biogeochemistry’), there is much controversy about the diet of the
earliest humans and until now it is often stated that shing was only introduced until more recently.
From an anthropological perspective this might be true, since certain types (e.g. deepwater) shing
requires advanced techniques.293 However, from a nutritional point of view, ‘shing’ might include
anything from collecting sessile shellsh to the seasonal hand capture or clubbing of migrating or
spawning sh in very shallow water. Since fresh drinking water is the single most important aquatic
resource for humans, hominins probably observed predators and scavengers feeding on aquatic
animals. This makes it unlikely that they would not have participated in opportunistic harvesting of
the shallow water !ora and fauna, such as mollusks, crab, sea urchins, barnacles, shrimp, sh, sh
roe or spawn, amphibians, reptiles, small mammals, birds or weeds.174,266 There are many indications
suggesting that the evolution of early Homo and its development to Homo sapiens did not take
place in the “classical” hot, arid and waterless savannah, but occurred in African ecosystems that
were notably located in places where the land meets the water (with the land ecosystem possibly
consisting of -depending on rainfall- wooded grasslands). Compared with terrestrial hunting and/
or scavenging in the savannah, food from this land-water ecosystem is relatively easy to obtain and
is rich in the afore mentioned combination of haem-iron, iodine, selenium, vitamins A and D, and
long chain ω3-fatty acids.99,100,265
In conclusion, there is ample archeological evidence for a shift from consumption of plant
towards animal foods. Secondly, although there is an extensive archeological record for aquatic
fossils (representing the possible food) in the vicinity of human remains, their co-occurence is
usually attributed to the preferential conservation of human remains in the vicinity of water. The
current review provides support for the notion that the exploitation of these aquatic resources
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by hominins in coastal areas should be the default assumption, unless proven otherwise.153 For a
long time period in hominin evolution, hominins derived large amounts of energy from (terrestrial
and aquatic) animal fat and protein. This habit became reversed only by the onset of the Neolithic
Revolution in the Middle East starting about 10,000 years ago.
5.5 Anthropology
The hunter-gatherer diet
The Homo genus has been on earth for at least 2.4 My312 and for over 99% of this period they lived as
hunter-gatherers.313 Surprisingly, very little information is available on the macro- and micronutrient
compositions of their diet in this extended and important period of human evolution.34,147 Since the
onset of agriculture, about 10 kya, agriculturalists and nomadic pastoralists have been expanding
at the expense of hunter-gatherers,313 with agricultural densities increasing by a factor 10-1,000
compared to the highest hunter densities. For this reason, present day hunter-gatherers are often
found in marginal environments, unattractive for crop cultivation or animal husbandry.
In order to study the original hunter-gatherer way of life, it is appropriate to aim at the few
hunter-gatherers communities living in the richer environments that bear closer resemblance to
those in which the evolution of the genus Homo probably took place. Most studies on hunter-
gatherers and their diets are, however, performed by anthropologists,314 whose primary interests
di!erent from those of nutritionists. Anthropologists would for example conclude that ‘"shing was
so unimportant as to be a type of food collection,315 or consider collecting both small land fauna and
shell"sh313 as part of ‘gathering’, whereas from a nutritional point of view considerable di!erences
exist in caloric density, macro- and micronutrient composition between plants, terrestrial and
aquatic animal foods.
Hunting vs. gathering
Studies on food procurement of present day hunter-gatherer societies show, in terms of energy
gain versus expenditure, the advantage of hunting compared with plant foraging.191 Nevertheless,
three distinct studies41,147,313 showed that hunting makes up only ~35% of the subsistence base for
worldwide hunter-gatherers, independent of latitude or environment. However, collection of small
land fauna and shell"sh was included as gathering in these studies. While gathering evidently played
an important role over the whole of human evolution; hunting, although introduced later, coincided
with ‘a major leap for mankind’ and has ever since played the most dominating cultural role. While
hunting may have overtaken gathering in cultural importance, gathering continued to play a very
important nutritional role, because: i) gathering still contributes about 65% to the subsistence base,
ii) many micronutrients derive only from plant sources, iii) gathering of e.g. shell"sh provides a
substantial amount of LCP and other nutrients essential for brain development, and iv) gathering
plays an important cultural role since women, children and grandparents can participate.56,57,316




the probability for a kill in !Kung bushmen is only 23%313 and the subsistence of Hadza, as described
by Marlowe41 and Woodburn144, is composed for 75-80% of plant foods. Conversely, studies of
North-American hunting-gathering societies describe the dietary role of shellsh as similar to‘bread
and butter’, being the staple food317 in these societies. The anthropological remark313 that for many
studied hunter-gatherer-tribes ‘shing was only a type of food collection’ also adds to the notion
that the collection of aquatic foods might have preceded scavenging and hunting. Collecting
aquatic foods is still daily practice in eastern Africa and picking up, clubbing or spearing stranded
aquatic-animals seems much easier and safer than either scavenging or hunting game on the
Serengeti plains.
We conclude that gathering plays, and most likely always played, the major role in food
procurement of humans. Although hunting doubtlessly leaves the most prominent signature in
the archaeological record, gathering of vegetables and the collection of animal, notably aquatic,
resources (regardless of whether their collection is considered as either hunting or gathering);
seems much easier compared to hunting on the hot and arid savannah. We suggest that it seems fair
to consider these types of foods as an important part of the human diet, unless proven otherwise.153
Conversely, while hunting might have played a much more important role at higher latitudes,
dietary resources in these ecosystems are rich in  3-fatty acids (e.g. fatty sh and large aquatic
mammals), while the hominin invasion of these biomes occurred only after the development of
more developed hunting skills.
5.6 (Patho)physiology
Brain selective nutrients
Nutrients and other environmental factors are increasingly recognized to in"uence epigenetic
marks,318-322 either directly or indirectly via many bodily sensors. Food from the diverse East-African
aquatic ecosystems is rich in haem-iron, iodine, selenium, vitamins A and D, and 3-fatty acids from
both vegetable origin and sh.100 All of these nutrients seem to act at the crossroads of metabolism
and in"ammation.24 For example, peroxisome proliferator receptors (PPARs)323,324 are lipid-driven
nuclear receptors with key cellular functions in metabolism and in"ammation.26 Thyroid hormone
receptors (TR),325 the vitamin D receptor (VDR),326 the retinoid X receptors (RXR) and the retinoic
acid receptors (RAR)327 are other examples of nuclear transcription factors that serve functions as
ligand-driven sensors. The iodine and selenium-dependent hormone triiodothyronine (T3)
328-330 is a
ligand of TR,325 many fatty acids and their derivatives are ligands of PPARs,331 the vitamin D derived
1,25-dihydroxyvitamin D hormone is a ligand of the VDR,332 9-cis retinoic acid and the sh oil fatty
acid docosahexaenoic acid (DHA) are ligands of RXR,327 while RAR interacts with vitamin A (retinol)
and many of its derivatives such as all-trans retinoic acid, retinal and retinyl acetate.327 The ligated
nuclear transcription factors usually do not support transcription by themselves, but need to
homodimerize or heterodimerize notably with RXR to facilitate gene transcription. Examples of the
latter are TR/RXR, PPAR/RXR, VDR/RXR, and RAR/RXR. It has become clear that their modes of action
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illustrate the need of balance between e.g. iodine, selenium, sh oil fatty acids and vitamins A and
D; a balance that is notably found in the land-water ecosystem.
Deciencies of the above ‘brain selective nutrients’ are among the most widely encountered in
the current world population.100,333 While iodide is added to table salt in many countries, margarines
and milk have become popular food products for fortication with vitamins A and D. After discussing
some general health dierences between traditionally living people and those living in westernized
countries, we focus on the importance of LCP and notably those of the ω3-series, as examples of the
above mentioned nutrients that are especially abundant in the land-water ecosystem,
Hunter-gatherer vs. ‘Western’ physiology
There are many dierences in health indicators between traditionally living people and those living
in Western societies. For instance, primary and secondary intervention trials with statins indicate
lowest coronary heart disease risk at an LDL cholesterol of 50-70 mg/dL (1.3-1.8 mmol/L), which is
consistent with levels encountered in primates in the wild and hunter-gatherer populations with
few deaths from cardiovascular disease.334-338 Another example of the healthy lifestyle of present day
hunter-gatherers comes from the observed ‘insulinopenia’ or ‘impaired insulin secretion’ following
an oral glucose tolerance test (Figure 8) in Central African Pygmies and Kalahri Bushmen,339,340
respectively. As opposed to the ‘impairments’ noted by these authors, it may also be argued that
these researchers were actually witnessing an insulin sensitivity that has become sporadic in Western
countries as a consequence of the decrease in physical activity and tness, increase in fat mass and
as a result of the quantity and quality of the foods consumed.36,132,341 The current consensus is that
‘fat is bad’ and especially saturated fats have become associated with cardiovascular disease.342-344
However, traditional Maasai consumed diets high in protein and fat (milk and meat) and low in
carbohydrates.345,346 They had high intakes of saturated fat and cholesterol, showed extensive
atherosclerosis with lipid inltration and brous changes, but had very few complicated lesions, and
were virtually devoid of cardiovascular disease.347 The average total- and LDL-cholesterol in these
societies was low and did not increase with age.347 Finally, the physical tness of people in such
traditional societies, such as the Maasai, is often remarkable.336
In Kalahari Desert Bushmen and Central African Pygmies, observers could not nd any case of
high blood pressure and blood pressure did not increase with age.334,348 Dental surveys of Kalahari
Bushmen349 and other hunter-gatherers49 showed a remarkable absence of caries. The absence was
explained by the repetitive annual abstinence of fermentable sugars in their diet, with a consequent
inability to build a cariogenic oral lactobacillus !ora.349 Inhabitants of Kitava (Trobriand Islands, Papua
New Guinea) have high intakes (70 en%) of carbohydrates from yams, high intakes of saturated
fatty acids from coconuts, and a high sh intake.44,45,350 Although both high intakes of carbohydrates
and saturated fat have been related to the metabolic syndrome and cardiovascular disease, these
traditional Kitavians do not show symptoms of the metabolic syndrome and are virtually free from




Evidence based medicine as applied to LCP in cardiovascular disease and depression
Despite some compelling examples of the healthy lifestyles of traditional populations, current
dietary recommendations derive preferably from randomized clinical trials (RCTs) with single
nutrients and preferably hard endpoints.351 This approach clearly oversimplies the eects of dietary
nutrients,352 since neither macronutrients, nor micronutrients, are consumed in isolation and their
eects may be the result of a complex web of interactions between all the nutrients present in the
biological systems that we consume, such as a banana or a sh.
The current recommendations from many Nutritional Boards for a daily intake of 450 mg
EPA+DHA in adults derives from epidemiological data that demonstrated a negative association
of sh consumption with coronary heart disease353-356 that has subsequently become supported
Figure 8. ‘Abnormal’ insulin response but normal glucose response after oral glucose tolerance test
in African Bushmen and Pygmy, compared to Western controls. A: Plasma glucose response after a 50g
(Bushmen and white controls) and 100g (Pygmy, Bantu and American control) oral glucose load. (d) indicates
two weeks daily supplementation of 150g carbohydrates before testing. Of notion is that Bushmen and
Pygmy have signicant lower body weights as compared to Bantu and white/American controls (average
weight Bushmen/Pygmy males 46 kg, females 38 kg; controls 65 kg) while each group received the same
unadjusted glucose loading dose of 50g or 100g glucose. B: The so called ‘abnormal’ insulin response or
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by landmark trials with ALA357 and sh oil358-360 in cardiovascular disease. However, not all trials in
cardiovascular disease have been positive.361 In addition, a negative association was observed for
sh consumption and depression362-364 and for homicide mortality.365 The causality of these relations
was supported by some, but not all, trials with sh oil in depression,366-370 while a recent meta-
analysis demonstrated the benecial eect of eicosapentaenoic acid (EPA) supplements with ≥60%
EPA of total EPA+DHA in a dose range of 200-2,200 mg/day of EPA in excess of DHA.371
The inuence of polymorphisms in the genome is increasingly recognized, but seldom
interpreted in an evolutionary context. As argued above, most polymorphisms were already amongst
us when Homo sapiens emerged, some 200,000 years ago, while that also holds true for most, if not
all, currently identied ‘disease susceptibility genes’ that are usually abundant but confer low-risk.372
A loss-of-function mutation in a specic biosynthetic pathway might be an evolutionary advantage
if the specic end-product has been a consistent part of the diet, such as is probably applicable to
all vitamins, e.g. vitamin C.373,374 Applied to our LCP status, it is nowadays well established that all
humans synthesize DHA with di!culty.375,376 Analogously, the recently discovered polymorphisms
of fatty acid desaturases 1 (FADS1; also named delta-5 desaturase) and FADS2 (delta-6 desaturase)
with lower activities in their conversion of the parent EFA to LCP suggest that from at least the time
of their appearance, the dietary intakes of AA, EPA and DHA have been of su!cient magnitude to
balance the LCPω3/LCPω6 ratio377,378 to maintain good health.
LCP bene!ts in pregnancy and early life
Another indication for the importance of LCP comes from the higher LCP contents in the fetal
circulation compared to the maternal circulation, a process named biomagnication,379-381 which
occurs at the expense of the maternal LCP status.382,383 The decreasing maternal LCPω3 status
during pregnancy in Western countries is associated with postpartum depression,362,363 although
intervention studies with LCP in postpartum depression have been negative so far.369,370,384,385
However, a positive eect was seen for LCPω3 supplementation on depression during pregnancy386
and it has been advocated to start supplementation earlier in pregnancy and with higher dosages.387
Maternal LCP intakes have also been related to infant health. AA and DHA in premature and low
birth weight infants correlated positively with anthropometrics, AA to increased birth weight388 and
DHA to prolonged gestation.389-391 Studies with supplementation of DHA during pregnancy yielded
e.g. evidence for: i) the maturation of the brain, visual system and retina of the newborn at 2.5 and
4 months, but not at 6 months392-396; ii) increased problem solving at 9 months but no dierence in
memory397; and iii) superior eye-hand coordination at 2.5 years398 and higher IQ at 4 years,399 but not
at 7 years of age.400 In contrast to the inconclusive human studies, animal studies and combined
human and animal studies showed abnormal behavior together with disturbed cognition at lower
brain DHA levels.401 The importance of dietary AA during pregnancy seems less pronounced, but
a positive association between umbilical AA and neonatal neurological development388 and a




reduced DHA status in the brain is associated with a mildly increased AA status,403 which is in its turn
associated with low-grade inammation.404
Infant health starts with maternal health, thus dietary recommendations issued for pregnant
women indirectly also apply to their infants. The recommendation for adults to consume 450 mg
DHA+EPA/day translates into a DHA composition in breast milk of about 0.79%.405 However, current
recommendations for the composition of infant formulae derive mainly from the range of human
milk FA compositions as observed in Western countries, which on their turn derive from women
with recorded intakes below the 450 mg recommended daily intake of EPA+DHA.406,407
The same paradox holds for other fatty acids (FA) in breast milk. For instance, there are few
recommendations for the medium chain saturated FA (MCSAFA) content of human milk. High
MCSAFA contents in some traditional societies derive from their high intakes of 12:0 and 14:0 from
coconuts.408 Conversely, the high MCSAFA contents in Western populations are primarily inuenced
by the maternal carbohydrate intakes,409 since the mammary gland has the unique ability to convert
glucose into MCSAFA (6:0-14:0), mainly lauric (12:0) and myristic (14:0) acids. However, women with
regular consumption of coconuts have a much higher 12:0/14:0 ratio compared to women with
high carbohydrate intakes. Both MCSAFA are readily absorbed in the gastrointestinal tract, while
antiviral as well as antibacterial properties have been attributed to some MCSAFA, but mainly to
12:0.410,411
The PUFA content of Western milk has increased over the last decades.412,413 While the human
milk LA content in the US increased by at least 250%, its DHA content decreased by almost 50% %413.
The (from an evolutionary point of view) abnormally high LA intake is, despite a lack of evidence,414
advocated for cardiovascular health.415 The resulting high LA status is likely to interfere with both the
incorporation of AA and DHA into phospholipids and also inhibits their synthesis from their parent
EFA.416 Major dierences are noted in the comparison of the human milk fatty acid compositions of
Western mothers compared to some traditional African women,408,417 with unknown consequences
for infant health or the occurrence of disease at adult age (i.e. the‘Barker hypothesis’).16,418 It has been
proposed that the high concentrations of EPA, DHA as well as AA in human milk, such as described
for many sh consuming societies408,419,420 might be a more appropriate reection of the Palaeolithic
breast milk composition and may therefore constitute a better reference for infant formulae than do
Western human milks.421
The inuence of environment
It is estimated that 70% of all cases of stroke and colon cancer, 80% of all cardiovascular diseases
and 90% of all cases of type 2 diabetes mellitus have been caused by lifestyle and could have been
prevented by paying more attention to modiable behavior factors, including specic aspects
of diet, overweight, inactivity and smoking.422 The mismatch between the human diet and the
Palaeolithic genome might therefore be responsible for many typically Western diseases. In addition
to the evidence from many other disciplines, evidence from (patho)physiology and epidemiology
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adds to the notion that a great deal of information on healthy diets might derive from the study of
the diets of the early human ancestors. The metabolic syndrome, characterized by impaired insulin
sensitivity, is at the center of many diseases of civilization. High intakes of rened carbohydrates
as well as low intakes of LCP have been implicated in the development of insulin resistance. As
such, low carbohydrate intakes423,424 and high LCP8,34,425,426 intakes by the early human ancestor might
explain in part the low incidence of diseases of civilization in current hunter-gatherer societies. The
available evidence from pathophysiology and epidemiology supports the hypothesis that the land-
water ecosystem contributed important and indispensable nutrients to evolving hominins.
5.7 Dietary reconstruction of the nutrients available in eastern Africa
The debate on the ecological niche of human ancestors is unlikely to reach a consensus shortly.
The millions of years of human evolution concurred with marked and abrupt climatic changes,
which renders a single ecological niche of human ancestry unlikely. However, it is at the same time
clear that in a short period of time humans have made tremendous changes in their lifestyle, their
diet included, that lie at the basis of the diseases of Western civilization. This prompted various
investigators to reconstruct the possible compositions of diets that could have been consumed by
our Palaeolithic ancestors. Their studies are e.g. based on the plausibility that prior to the agricultural
revolution, when humans lived as hunter-gatherers, cereals were no appreciable part of the diet and
that wild animals living in the eastern African savannah and in eastern African aquatic ecosystems
have di!erent fatty acid compositions compared to the domesticated animals that have now
become staple foods. For example, the lean savannah animals that inhabit the eastern African plains
have much lower fat contents, and the available fat is much more enriched in PUFA427. Similarly, high
latitude (fatty) sh have much higher EPA and DHA contents, but lower AA contents compared to
low latitude (lean) sh from tropical waters.428-431
Eaton and Konner8 where the rst to use this approach in reconstructing a Palaeolithic diet;
their pioneer study was published in the New England Journal of Medicine in 1985. The authors
estimated that late Palaeolithic humans consumed diets containing 35% meat and 65% vegetable
foods, containing 34 energy% (en%) from protein, 45 en% from carbohydrate and 21 en% from
fat, while the ratio between polyunsaturated and saturated fat equaled 1.41 and their ber intake
amounted to 46 g/d.8 These outcomes contrast with the average American diet at date, that consisted
of 12 en% protein, 46 en% carbohydrate and 42 en% fat, with a polyunsaturated/saturated fat (P/S)
ratio of 0.44 and a ber intake of 20 g/d. After twenty-ve years of additional study, they conrmed
their previous ndings by estimating that the Palaeolithic diet provided 25-30 en% protein, 35-40
en% carbohydrate and 20-35 en% fat,432 while the P/S ratio was 1.40433. Moreover, they concluded
that “it has become clear since our initial publications that marine, lacustrine, and riverine species
were important sources of animal "esh during the evolution of modern Homo sapiens, and may
have played a role in the evolution of brain ontogeny.”432 In addition to the earlier studies, they also




folate, riboavin, thiamin, vitamins A and E, calcium, magnesium, phosphorus, zinc, and notably
ascorbate, vitamin D (sunlight), copper, iron, manganese and potassium, while the Palaeolithic diet
contained much lower sodium compared to contemporary U.S. intakes and recommendations.432-434
In a subsequent study they estimated that in dierent ancient hunting and gathering populations,
fatty acid intakes would have ranged from 5.19-20.6 g LA/d, 0.26-4.8 g AA/d, 3.45-25.2 g ALA/d and
0.03-1.52 g DHA/d, which contrasted with the much higher LA (22.5 g/d) and lower ALA (1.2 g/d), AA
(0.6 g/d) and DHA (0.08 g/d) intakes as observed in current Western populations.34
In a meticulous analysis of world wide hunter-gatherer diets, Cordain et al.147,435 estimated that
the most plausible percentages total energy from dietary macronutrients would be 19-35 en% from
protein, 22-40 en% from carbohydrate and 28-58 en% from fat, which reects a markedly higher
contribution of dietary fat, a similar amount of protein, but a lower contribution of carbohydrates,
compared to Eaton and Konner’s earlier estimates.8,433 The main dierences were explained by the
assumption that, wherever it was ecologically possible, hunter-gatherers would have consumed 45-
65% of total energy from animal foods,147 while in the earlier estimations8,433 only 35% derived from
animal foods. These higher animal food intakes were explained by their inclusion of both worldwide
hunting and shing hunting-gathering societies into their new calculation models,147 also including
mounted and arctic hunters. Those latter possibilities, however, seem insignicant with regard to
early human evolution, which explains why they seem to overestimate the amount of the diet that is
derived from animal foods. For example, Marlowe41 estimated that in a warm-climate sample about
53% of the diet derives from gathering, 26% from hunting and 21% from shing (i.e. about 47%
from hunting).
To subsequently investigate the nutrient compositions of such diets, sh consumption was
incorporated as a separate variable to plant and meat consumption in the earlier models, since
aquatic and terrestrial animals have markedly dierent fatty acid compositions. In this most recent
analysis436 3,000 kcal Palaeolithic diets were investigated with plant/animal food intake ratios ranging
from 70/30 to 30/70 en%/en% under the conditions of four dierent foraging strategies in which
the animal part ranged from exclusive meat consumption including the selective consumption of
energy- and LCP-rich fat from bone marrow and brain, respectively,426 to the consumption of an
entirely aquatic diet in an eastern African water-land ecosystem.437,438 It was found that that the
energy intakes from the macronutrients were: 25-29 en% (range 8-35) from protein, 39-40 en% (19-
48) from carbohydrate and 30-39 en% (range 20-72) from fat. Dietary LA ranged from 1.7-6.2 en%/
day, AA from 1.15-10.7 g/day, ALA from 2.1-5.8 en%/day and EPA+DHA intakes from 0.87-28.3 g/
day.436 From these data, despite its wide range in outcomes, it can again be concluded that there
are substantial dierences with respect to the average composition of the current Western diet,
notably because of its higher proportions of carbohydrates and LA, and its much lower protein and
ALA and LCP contents. It became also conceivable that ancestors living in the East African water-
land ecosystem had daily intakes of gram amounts of EPA+DHA. As such, these LCPω3 intakes were
comparable with those of the traditionally living Eskimos in Greenland, who because of their low
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cardiovascular disease risk353,354 initiated the current interest in the role of LCPω3 in both primary
and secondary prevention of cardiovascular disease. In addition to these  3-fatty acids, the water-
land ecosystem is also a rich source of haem-iron, iodine, selenium and the vitamins A and D100,
which have important functions and interactions in gene transcription and metabolism.24,26,439
6. Dietary changes since the agricultural revolution
Whatever the speci!c composition and wide range of early hunter-gatherer diets, the current
consensus is that our diet has changed markedly from the time of large-scale utilization of cereals
and animal domestication (i.e. the agricultural revolution) starting some 10,000 years ago. Contrary
to earlier belief, the advent of agriculture coincided with an overall decline in nutrition and general
health, but at the same time provided an evolutionary advantage since it increased birth rates and
thereby promoted net population growth.49,50
Whilethedeclineofnutritionalqualityandgeneralhealthstartedwiththeonsetoftheagricultural
revolution, these processes became even more pronounced with the advent of the industrial
revolution some 100-200 years ago.9,11,132 Among the many dietary and lifestyle changes (Figure 9)
are: a grossly decreased ω3/ω6 fatty acid ratio, the combined high intakes of saturated fatty acids
(SAFA) and carbohydrates,440-442 the introduction of industrially produced trans fatty acids, reduced
intakes of LCPω3 and LCPω6 fatty acids, reduced exposure to sunlight, low intakes of vitamins D and
K, disbalanced antioxidant status and high intakes of carbohydrates with high glycemic indices and
loads, such as sucrose and industrially produced high fructose corn syrup.36,132,443,444 Many of these
changes act in concert, which points at the serious limitations of conclusions from contemporary
investigations that study the many nutrients in isolation and form the basis of modern nutritional
guidelines. An example is the interaction of dietary carbohydrates with saturated fatty acids.440-442,445
7. Potential bene!ts of a Palaeolithic diet
Evidence for the bene!cial e"ects of Palaeolithic diets may derive from their in#uence on weight
reduction and classical CAD risk factors. In an uncontrolled study with healthy adults, Osterdahl
et al.446 showed a decrease in weight, BMI and waist circumference after 3 weeks ad libitum
consumption of a Palaeolithic-like diet (i.e. 1,584 kcal/day; carbohydrate 40, protein 24, fat 36 en%),
compared with their baseline usual diet (2,478 kcal/day; carbohydrate 54, protein 14, fat 30 en%).
Additionally, they showed favorable e"ects on systolic blood pressure and plasminogen activator
inhibitor-1. Jonsson et al.447 performed a cross-over study of 2*3 months in type 2 diabetic patients
receiving a Palaeolithic diet (1,581 kcal/day, carbohydrate 32, protein 24, fat 39 en%) or a diabetes
diet (1,878 kcal/day, carbohydrate 42, protein 20, fat 34 en%). They showed a reduction of body
weight, BMI and waist circumference and lower HbA1c, triglycerides, diastolic blood pressure, and
higher HDL-cholesterol after consumption of the Palaeolithic diet.
In a randomized trial in patients with ischemic heart disease plus glucose intolerance or type




Palaeolithic diet (1,344 kcal/day; carbohydrate 40, protein 28, fat 27 en%) as compared to an ad
libitum Mediterranean-like Consensus diet (1,795 kcal/day; carbohydrate 52, protein 21, fat 25
en%). They also observed a larger improvement in glucose tolerance in the Palaeolithic diet-group,
independent of decreased waist circumference. The most convincing evidence so far derives from an
uncontrolled trial449 showing that 10 days consumption of an isocaloric Palaeolithic diet (2,701 kcal/
day; carbohydrate 38, protein 30, fat 32 en%) improved blood pressure, arterial distensibility, insulin
sensitivity and total-, HDL- and LDL-cholesterol in healthy sedentary humans, when compared with
their baseline usual diet (2,372 kcal/day, carbohydrate 44, protein 18, fat 38 en%). Importantly,
there were no changes in energy intakes, activity levels and body weight, which indicates that the
improved CAD risk pro!le was unrelated to weight reduction or well other known determinants.
8. Conclusions
The optimal nutrient combination to support good health can be expected to re"ect a certain
balance. This balance is present in the foods that were consumed by Palaeolithic and possibly by
pre-Palaeolithic ancestors, because it is this balance on which the human genome has evolved.
This genome has been shaped by millions of years of evolution, during which it adapted to the
conditions of existence, including the diet. There are ample indications from many disciplines that
the human ancestors evolved in a water-land interface that provided food from both terrestrial and
Figure 9. The seven dietary characteristics that have been changed since the agricultural and industrial























aquatic resources. For instance, the availability of both LCPω6 and LCPω3 from the aquatic food
chain was one of the many factors that provided early humans the unique combination of brain
selective nutrients for brain growth2. The recent deviation from this Palaeolithic diet and lifestyle in
general might be at the basis of many, if not all, current diseases of civilization. Detailed studies with
respect to the health eects of the diets of these earlier ancestors are therefore warranted.
Acknowledgements
None of the authors has any con!ict of interest to declare. This research received no speci"c grant
from any funding agency in the public, commercial or not-for-pro"t sectors. RSK wrote the initial
manuscript. After "nishing a "rst outline, all authors contributed to their speci"c "elds of knowledge,
i.e. RSK and FAJ re"ned paragraphs 1, 2, 3, 5.2, 5.3, 5.5, 5.6, 5.7, 6, 7; JACJ re"ned paragraphs 4, 5.1,






1 Darwin C. The Illustrated Origin of Species. Ede:
Zomer & Keuning Boeken B.V.; 1979.
2 Crawford MA. Long-chain polyunsaturated fatty
acids in human brain evolution. In: Cunnane SC,
Stewart KM, editors. Human Brain Evolution.
The Inuence of Freshwater and Marine
Food Resources Hoboken, New Jersey: Wiley-
Blackwell; 2010. p. 13-31.
3 Knoll AH, Javaux EJ, Hewitt D, et al. Eukaryotic
organisms in Proterozoic oceans. Philos Trans R
Soc Lond B Biol Sci 2006;361:1023-38.
4 Brocks JJ, Logan GA, Buick R, et al. Archean
molecular fossils and the early rise of eukaryotes.
Science 1999;285:1033-6.
5 Buick R. When did oxygenic photosynthesis
evolve? Philos Trans R Soc Lond B Biol Sci
2008;363:2731-43.
6 Holland HD. The oxygenation of the atmosphere
and oceans. Philosophical Transactions
of the Royal Society B-Biological Sciences
2006;361:903-15.
7 Crawford MA, Marsh DE. Nutrition and Evolution:
Food in Evolution and the Future. Keats: New
Canaan; 1995.
8 Eaton SB, Konner M. Paleolithic nutrition.
A consideration of its nature and current
implications. N Engl J Med 1985;312:283-9.
9 Eaton SB, Konner M, Shostak M. Stone agers
in the fast lane: chronic degenerative diseases
in evolutionary perspective. Am J Med
1988;84:739-49.
10 Eaton SB, Eaton SB,III, Konner MJ, et al.
An evolutionary perspective enhances
understanding of human nutritional
requirements. J Nutr 1996;126:1732-40.
11 Eaton SB, Cordain L. Evolutionary aspects of diet:
old genes, new fuels. Nutritional changes since
agriculture. World Rev Nutr Diet 1997;81:26-37.
12 Egger G, Dixon J. Should obesity be the main
game? Or do we need an environmental
makeover to combat the inammatory
and chronic disease epidemics? Obes Rev
2009;10:237-49.
13 Egger G, Dixon J. Inammatory eects of
nutritional stimuli: further support for the need
for a big picture approach to tackling obesity
and chronic disease. Obes Rev 2010;11:137-49.
14 Wood B, Brooks A. Human evolution. We are
what we ate. Nature 1999;400:219-20.
15 Muskiet FAJ. Evolutionaire geneeskunde. U bent
wat u eet, maar u moet weer worden wat u at.
Ned Tijdsch Klin Chem Labgeneesk 2005;30:163-
84.
16 Barker DJ. The fetal and infant origins of adult
disease. BMJ 1990;301:1111.
17 Godfrey KM, Barker DJ. Fetal nutrition and adult
disease. Am J Clin Nutr 2000;71:1344S-52S.
18 Drake AJ, Walker BR. The intergenerational
eects of fetal programming: non-genomic
mechanisms for the inheritance of low birth
weight and cardiovascular risk. J Endocrinol
2004;180:1-16.
19 Gluckman PD, Hanson MA, Morton SM, et
al. Life-long echoes--a critical analysis of the
developmental origins of adult disease model.
Biol Neonate 2005;87:127-39.
20 Cordain L, Eades MR, Eades MD.
Hyperinsulinemic diseases of civilization: more
than just Syndrome X. Comp Biochem Physiol A
Mol Integr Physiol 2003;136:95-112.
21 Reaven GM. The insulin resistance syndrome:
denition and dietary approaches to treatment.
Annu Rev Nutr 2005;25:391-406.
22 Pasinetti GM, Eberstein JA. Metabolic syndrome
and the role of dietary lifestyles in Alzheimer’s
disease. J Neurochem 2008;106:1503-14.
23 Muskiet FA, Kemperman RF. Folate and long-
chain polyunsaturated fatty acids in psychiatric
disease. J Nutr Biochem 2006;17:717-27.
24 Muskiet FA. Pathophysiology and evolutionary
aspects of dietary fats and long chain
polyunsaturated fatty acids across the life
cycle. In: Montmayeur JP, le Coutre J, editors.
Fat detection. Taste, texture, and post ingestive
eects Boca Raton USA: CRC Press Taylor &
Francis Group; 2010. p. 19-79.
25 Muskiet FAJ, Kuipers RS. Lessons from shore-
based hunter-gatherer diets in East Africa. In:
Cunnane SC, Stewart KM, editors. Human Brain
Evolution. The Inuence of Freshwater and
Marine Food resources Hoboken, New Jersey:
Wiley-Blackwell; 2010. p. 77-103.
26 Feige JN, Gelman L, Michalik L, et al. From




are nuclear receptors at the crossroads of key
cellular functions. Prog Lipid Res 2006;45:120-
59.
27 Dobzhansky T. Biology, Molecular and
Organismic. Am Zool 1964;4:443-52.
28 Tinbergen N. On the aims and methods of
ethology. Zeit Tierpsy 1963;20:410-63.
29 Harris EE, Malyango AA. Evolutionary
explanations in medical and health profession
courses: are you answering your students’“why”
questions? BMC Med Educ 2005;5:16.
30 Purushotham AD, Sullivan R. Darwin, medicine
and cancer. Ann Oncol 2010;21:199-203.
31 Williams GC, Nesse RM. The dawn of Darwinian
medicine. Q Rev Biol 1991;66:1-22.
32 Nesse RM, Williams GC. Why We Get Sick. The
New Science of Darwinian Medicine. New York:
Times Books, Random House, Inc; 1994.
33 Gould SJ, Vrba ES. Exaptation - a Missing Term in
the Science of Form. Paleobiology 1982;8:4-15.
34 Eaton SB, Eaton SB,III, Sinclair AJ, et al. Dietary
intake of long-chain polyunsaturated fatty acids
during the paleolithic. World Rev Nutr Diet
1998;83:12-23.
35 Eaton SB, Cordain L, Lindeberg S. Evolutionary
health promotion: a consideration of common
counterarguments. Prev Med 2002;34:119-23.
36 O’Keefe JH,Jr, Cordain L. Cardiovascular disease
resulting from a diet and lifestyle at odds with
our Paleolithic genome: how to become a
21st-century hunter-gatherer. Mayo Clin Proc
2004;79:101-8.
37 Hahn RA, Teutsch SM, Rothenberg RB, et al.
Excess deaths from nine chronic diseases in the
United States, 1986. JAMA 1990;264:2654-9.
38 Hill K, Hurtado AM, Walker RS. High adult
mortality among Hiwi hunter-gatherers:
implications for human evolution. J Hum Evol
2007;52:443-54.
39 Howell N. Demography of the Dobe !Kung. 2nd
ed.: Walter de Gruyter Inc; 1979.
40 Hill K, Hurtado A. Ache Life History: the Ecology
and Demography of a Foraging People. : Aldine;
1996.
41 Marlowe FM. The Hadza: Hunter-Gatherers
of Tanzania. Los Angeles: The University of
California Press; 2010.
42 Eaton SB, Eaton SBI. The evolutionary context
of chronic degenerative diseases. In: Stearns SC,
editor. Evolution in health and disease Oxford:
Oxford University Press; 1999. p. 251-259.
43 Shephard RJ, Roy J. The health consequences
of modernization: evidence from circumpolar
peoples. Cambridge: Cambridge University
Press; 1996.
44 Lindeberg S, Lundh B. Apparent absence
of stroke and ischaemic heart disease in a
traditional Melanesian island: a clinical study in
Kitava. J Intern Med 1993;233:269-75.
45 Lindeberg S, Nilsson-Ehle P, Terent A, et al.
Cardiovascular risk factors in a Melanesian
population apparently free from stroke and
ischaemic heart disease: the Kitava study. J
Intern Med 1994;236:331-40.
46 Trowell HC, Burkitt DP. Western diseases: their
emergence and prevention. Cambridge, MA:
Harvard University Press; 1981.
47 Blacklow RS. Actuarially speaking: an overview
of life expectancy. What can we anticipate? Am J
Clin Nutr 2007;86:1560S-2S.
48 Angel JL. Health as a factor in the changes from
hunting to developed farming in the eastern
Mediterranean. In: Cohen MN, Armelagos
GJ, editors. Paleopathology at the Origins of
Agriculture New York: Academic Press; 1984. p.
51-73.
49 Larsen CS. Biological Changes in Human-
Populations with Agriculture. Annu Rev
Anthropol 1995;24:185-213.
50 Larsen CS. Animal source foods and human
health during evolution. J Nutr 2003;133:3893S-
7S.
51 Larsen CS. Dietary reconstruction and
nutritional assessement of past peoples: the
bioanthropological record. In: Kiple KF, Ornelas
KC, editors. The Cambridge world history of
food Cambridge: Cambridhe University Press;
2000. p. 13-34.
52 Cohen MN. Editors summation. In: Cohen MN,
Armelagos GJ, editors. Paleopathology at the
origins of ariculture New York: Academic Press;
1984. p. 585-601.
53 McKeown T, Brown RG, Record RG. An
interpretation of the modern rise of population




54 Blurton-Jones NG, Marlowe FW, Hawkes K,
O’Connell JF. Paternal investment and hunter-
gatherer divorce. In: Cronk L, Chagnon N, Irons
W, editors. Adaptation and Human Behavior: An
Anthropological Perspective New York: Aldine
de Gruyter; 2000. p. 61-90.
55 Hawkes K, O’Connell JF, Blurton-Jones NG.
Hunting and nuclear families: some lessons
from the Hadza about men’s work. Current
Anthropology 2001;42:681-709.
56 Hawkes K, O’connell JF, Jones NG, et al.
Grandmothering, menopause, and the
evolution of human life histories. Proc Natl Acad
Sci U S A 1998;95:1336-9.
57 O’Connell JF, Hawkes K, Blurton Jones NG.
Grandmothering and the evolution of homo
erectus. J Hum Evol 1999;36:461-85.
58 Sear R, Mace R, McGregor IA. Maternal
grandmothers improve nutritional status and
survival of children in rural Gambia. Proc Biol Sci
2000;267:1641-7.
59 Bogin B. Childhood, adolescence, and longevity:
A multilevel model of the evolution of reserve
capacity in human life history. Am J Hum Biol
2009;21:567-77.
60 Hawkes K. Colloquium paper: how grandmother
eects plus individual variation in frailty shape
fertility and mortality: guidance from human-
chimpanzee comparisons. Proc Natl Acad Sci U
S A 2010;107 Suppl 2:8977-84.
61 van Bodegom D, Rozing M, May L, et al.
When grandmothers matter. Gerontology
2010;56:214-6.
62 Kachel AF, Premo LS, Hublin JJ. Grandmothering
and natural selection. Proc Biol Sci 2011;278:384-
91.
63 Strier KB, Chaves PB, Mendes SL, et al. Low
paternity skew and the inuence of maternal
kin in an egalitarian, patrilocal primate. Proc
Natl Acad Sci U S A 2011;108:18915-9.
64 Brunet M, Guy F, Pilbeam D, et al. A new hominid
from the Upper Miocene of Chad, Central Africa.
Nature 2002;418:145-51.
65 Senut B, Pickford M, Gommery D, et al. First
hominid from the Miocene Lukeino Formation,
Kenya. Comptes Rendus de l’Academie des
Sciences, Series II A Earth and Planetary Science
2001;332:137-44.
66 Haile-Selassie Y, Suwa G, White TD. Late
Miocene teeth from Middle Awash, Ethiopia,
and early hominid dental evolution. Science
2004;303:1503-5.
67 White TD, Asfaw B, Beyene Y, et al. Ardipithecus
ramidus and the paleobiology of early hominids.
Science 2009;326:75-86.
68 Leakey MG, Feibel CS, McDougall I, et al.
New specimens and conrmation of an early
age for Australopithecus anamensis. Nature
1998;393:62-6.
69 Kimbel WH, Delezene LK. “Lucy” redux: a review
of research on Australopithecus afarensis. Am J
Phys Anthropol 2009;140 Suppl 49:2-48.
70 Harrison T. Hominins from the Upper Laetolil
and Upper Ndolanya Beds, Laetoli. In: Harrison
T, editor. Paleontology and Geology of Laetoli:
Human Evolution in Context. Fossil Hominins
and Associated Fauna ed. Dordrecht: Springer;
2011. p. 141-188.
71 Brunet M, Beauvilain A, Coppens Y, et al. The rst
australopithecine 2,500 kilometres west of the
Rift Valley Chad. Nature 1995;378:273-5.
72 Leakey MG, Spoor F, Brown FH, et al. New
hominin genus from eastern Africa shows
diverse middle Pliocene lineages. Nature
2001;410:433-40.
73 Asfaw B, White T, Lovejoy O, et al.
Australopithecus garhi: a new species of early
hominid from Ethiopia. Science 1999;284:629-
35.
74 Herries AI, Hopley PJ, Adams JW, et al.
Letter to the editor: Geochronology and
palaeoenvironments of Southern African
hominin-bearing localities--A reply to
Wrangham et al., 2009. “Shallow-water habitats
as sources of fallback foods for hominins”. Am J
Phys Anthropol 2010;143:640-6.
75 Tattersall I. Macroevolutionary patterns,
exaptation, and emergence in the evolution of
the human brain and cognition. In: Cunnane
SC, Stewart KM, editors. Human Brain Evolution.
The inuence of freshwater and marine food
resources. Hoboken, New Jersey: Wiley-
Blackwell; 2010. p. 1-11.
76 Stringer C. Human evolution: Out of Ethiopia.
Nature 2003;423:692,3, 695.
77 White TD, Asfaw B, DeGusta D, et al. Pleistocene




78 Brown P, Sutikna T, Morwood MJ, et al. A new
small-bodied hominin from the Late Pleistocene
of Flores, Indonesia. Nature 2004;431:1055-61.
79 Reich D, Patterson N, Kircher M, et al. Denisova
admixture and the rst modern human
dispersals into Southeast Asia and Oceania. Am
J Hum Genet 2011;89:516-28.
80 Stringer C. Palaeoanthropology. Coasting out of
Africa. Nature 2000;405:24,5, 27.
81 Templeton A. Out of Africa again and again.
Nature 2002;416:45-51.
82 Oppenheimer S. The great arc of dispersal of
modern humans: Africa to Australia. Quaternary
International 2009;202:2-13.
83 Templeton AR. Haplotype trees and modern
human origins. Am J Phys Anthropol 2005;Suppl
41:33-59.
84 Templeton AR. Genetics and recent human
evolution. Evolution 2007;61:1507-19.
85 Templeton AR. Coherent and incoherent
inference in phylogeography and human
evolution. Proc Natl Acad Sci U S A
2010;107:6376-81.
86 Green RE, Krause J, Ptak SE, et al. Analysis of one
million base pairs of Neanderthal DNA. Nature
2006;444:330-6.
87 Zhivotovsky LA, Rosenberg NA, Feldman
MW. Features of evolution and expansion of
modern humans, inferred from genomewide
microsatellite markers. Am J Hum Genet
2003;72:1171-86.
88 Knight A, Underhill PA, Mortensen HM, et al.
African Y chromosome and mtDNA divergence
provides insight into the history of click
languages. Curr Biol 2003;13:464-73.
89 Henn BM, Gignoux CR, Jobin M, et al. Hunter-
gatherer genomic diversity suggests a southern
African origin for modern humans. Proc Natl
Acad Sci U S A 2011;108:5154-62.
90 Behar DM, Villems R, Soodyall H, et al. The dawn
of human matrilineal diversity. Am J Hum Genet
2008;82:1130-40.
91 Ambrose SH. Late Pleistocene human
population bottlenecks, volcanic winter, and
dierentiation of modern humans. J Hum Evol
1998;34:623-51.
92 Rosenberg NA, Pritchard JK, Weber JL, et al.
Genetic structure of human populations.
Science 2002;298:2381-5.
93 Washburn SL, Lancaster CS. The Evolution of
Hunting. In: Lee RB, DeVore I, editors. Man the
Hunter New York: Aldine Publishing Company;
1968. p. 293-303.
94 Sailer LD, Gaulin SC, Voster JS, et al. Measuring
the relationship between diatary quality and
body size in primates. Primates 1985;26:14-27.
95 Herculano-Houzel S. The human brain in
numbers: a linearly scaled-up primate brain.
Front Hum Neurosci 2009;3:31.
96 Deaner RO, Isler K, Burkart J, et al. Overall brain
size, and not encephalization quotient, best
predicts cognitive ability across non-human
primates. Brain Behav Evol 2007;70:115-24.
97 Hill RS, Walsh CA. Molecular insights into human
brain evolution. Nature 2005;437:64-7.
98 Broadhurst CL, Cunnane SC, Crawford MA. Rift
Valley lake sh and shellsh provided brain-
specic nutrition for early Homo. Br J Nutr
1998;79:3-21.
99 Cunnane SC. Human brain evolution: a question
of solving key nutritional and metabolic
constraints on mammalian brain development.
In: Cunnane SC, Stewart KM, editors. Human
Brain Evolution. The inuence of freshwater and
marine food resources Hoboken, New Jersey:
Wiley-Blackwell; 2010. p. 33-76.
100 Cunnane SC. Origins and evolution of the
Western diet: implications of iodine and seafood
intakes for the human brain. Am J Clin Nutr
2005;82:483-4.
101 Navarrete A, van Schaik CP, Isler K. Energetics
and the evolution of human brain size. Nature
2011;480:91-3.
102 Potts R. Evolution: Big brains explained. Nature
2011;480:43-4.
103 Blinkov SM, Glezer II. The human brain in gures
and tables. : Basic Books, Inc., Publishers Plenum
Press; 1968.
104 White DR, Widdowson EM, Woodard HQ, et al.
The composition of body tissues II. Fetus to
young adult. Br J Radiol 1991;64:149-59.
105 Dobbing J, Sands J. Quantitative growth and
development of human brain. Arch Dis Child
1973;48:757-67.




intelligence. Trends Cogn Sci 2005;9:250-7.
107 Herculano-Houzel S. Scaling of brain metabolism
with a xed energy budget per neuron:
implications for neuronal activity, plasticity and
evolution. PLoS One 2011;6:e17514.
108 Herculano-Houzel S. Not all brains are made the
same: new views on brain scaling in evolution.
Brain Behav Evol 2011;78:22-36.
109 Azevedo FA, Carvalho LR, Grinberg LT, et al. Equal
numbers of neuronal and nonneuronal cells
make the human brain an isometrically scaled-
up primate brain. J Comp Neurol 2009;513:532-
41.
110 Herculano-Houzel S. Coordinated scaling of
cortical and cerebellar numbers of neurons.
Front Neuroanat 2010;4:12.
111 King MC, Wilson AC. Evolution at two levels
in humans and chimpanzees. Science
1975;188:107-16.
112 Gu J, Gu X. Induced gene expression in human
brain after the split from chimpanzee. Trends
Genet 2003;19:63-5.
113 Caceres M, Lachuer J, Zapala MA, et al. Elevated
gene expression levels distinguish human from
non-human primate brains. Proc Natl Acad Sci U
S A 2003;100:13030-5.
114 Marques-Bonet T, Caceres M, Bertranpetit J,
et al. Chromosomal rearrangements and the
genomic distribution of gene-expression
divergence in humans and chimpanzees. Trends
Genet 2004;20:524-9.
115 Finlay BL, Darlington RB. Linked regularities in
the development and evolution of mammalian
brains. Science 1995;268:1578-84.
116 Stimpson CD, Tetreault NA, Allman JM, et al.
Biochemical specicity of von economo neurons
in hominoids. Am J Hum Biol 2011;23:22-8.
117 Sherwood CC, Subiaul F, Zawidzki TW. A natural
history of the human mind: tracing evolutionary
changes in brain and cognition. J Anat
2008;212:426-54.
118 Sherwood CC, Gordon AD, Allen JS, et al. Aging
of the cerebral cortex diers between humans
and chimpanzees. Proc Natl Acad Sci U S A
2011;108:13029-34.
119 Abzhanov A, Kuo WP, Hartmann C, et al. The
calmodulin pathway and evolution of elongated
beak morphology in Darwin’s nches. Nature
2006;442:563-7.
120 Patel NH. Evolutionary biology: how to build a
longer beak. Nature 2006;442:515-6.
121 Schneider RA. How to tweak a beak: molecular
techniques for studying the evolution of size
and shape in Darwin’s nches and other birds.
Bioessays 2007;29:1-6.
122 Kaindl AM, Passemard S, Kumar P, et al. Many
roads lead to primary autosomal recessive
microcephaly. Prog Neurobiol 2010;90:363-83.
123 Williams CA, Dagli A, Battaglia A. Genetic
disorders associated with macrocephaly. Am J
Med Genet A 2008;146A:2023-37.
124 Evans PD, Anderson JR, Vallender EJ, et
al. Adaptive evolution of ASPM, a major
determinant of cerebral cortical size in humans.
Hum Mol Genet 2004;13:489-94.
125 Evans PD, Anderson JR, Vallender EJ, et al.
Reconstructing the evolutionary history of
microcephalin, a gene controlling human brain
size. Hum Mol Genet 2004;13:1139-45.
126 Evans PD, Gilbert SL, Mekel-Bobrov N, et al.
Microcephalin, a gene regulating brain size,
continues to evolve adaptively in humans.
Science 2005;309:1717-20.
127 Evans PD, Vallender EJ, Lahn BT. Molecular
evolution of the brain size regulator genes
CDK5RAP2 and CENPJ. Gene 2006;375:75-9.
128 Speth JD. Early Hominid Hunting and
Scavenging - the Role of Meat as an Energy-
Source. J Hum Evol 1989;18:329-43.
129 Crawford MA, Bloom M, Broadhurst CL,
et al. Evidence for the unique function of
docosahexaenoic acid during the evolution
of the modern hominid brain. Lipids 1999;34
Suppl:S39-47.
130 Gibbons A. American Association of Physical
Anthropologists meeting. Humans’ head
start: new views of brain evolution. Science
2002;296:835-7.
131 Crawford MA. Cerebral evolution. Nutr Health
2002;16:29-34.
132 Cordain L, Eaton SB, Sebastian A, et al. Origins
and evolution of the Western diet: health
implications for the 21st century. Am J Clin Nutr
2005;81:341-54.
133 Carlson BA, Kingston JD. Docosahexaenoic acid,
the aquatic diet, and hominin encephalization:
70
Chapter 1
diculties in establishing evolutionary links.
Am J Hum Biol 2007;19:132-41.
134 Joordens JC, Kuipers RS, Muskiet FA. Preformed
dietary DHA: The answer to a scientic question
may in practice become translated to its
opposite. Am J Hum Biol 2007;19:582-4.
135 Joordens FCA, Kuipers RS, Muskiet FAJ. On
breast milk, diet, and large human brains. Curr
Anthropol 2005;46:122-4.
136 Langdon JH. Has an aquatic diet been necessary
for hominin brain evolution and functional
development? Br J Nutr 2006;96:7-17.
137 Dart RA. Australopithecus africanus: The Man-
Ape of South Africa. Nature 1925;115:195-9.
138 Tobias PV. Water and Human Evolution. Out
There 1998.;35:38-44.
139 Tobias PV. Foreword: Evolution, encephalization,
environment. In: Cunnane SC, Stewart KM,
editors. Human Brain Evolution. The inuence of
freshwater and marine food resources Hoboken,
New Jersey: Wiley-Blackwell; 2010. p. vii-xii.
140 White TD, Ambrose SH, Suwa G, et al.
Macrovertebrate paleontology and the Pliocene
habitat of Ardipithecus ramidus. Science
2009;326:87-93.
141 Cerling TE, Levin NE, Quade J, et al. Comment on
the paleoenvironment of Ardipithecus ramidus.
Science 2010;328:1105; author reply 1105.
142 Feibel CS. Anthropology: Shades of the
savannah. Nature 2011;476:39-40.
143 Cerling TE, Wynn JG, Andanje SA, et al. Woody
cover and hominin environments in the past 6
million years. Nature 2011;476:51-6.
144 Woodburn J. An Introduction to Hadza Ecology.
In: Lee RB, DeVore I, editors. Man the Hunter
New York: Aldine Publishing Company; 1968. p.
49-55.
145 Tanner NM, Zihlmann AL. Women in evolution,
part 1: Innovation and selection in human
origins. Signs: Journal of Women, Culture , and
Society 1: 585-608; 1976;1:585-608.
146 Stanford CB. Chapter 5. The Hunting people. The
hunting Apes: Meat eating and the origins of
human behaviour.; 1999.
147 Cordain L, Miller JB, Eaton SB, et al. Plant-animal
subsistence ratios and macronutrient energy
estimations in worldwide hunter-gatherer diets.
Am J Clin Nutr 2000;71:682-92.
148 Stanford CB. Chapter 2. Man the Hunter and
Other stories. The hunting Apes: Meat eating
and the origins of human behaviour.; 1999.
149 Ungar PS, Sponheimer M. The diets of early
hominins. Science 2011;334:190-3.
150 Bernor RL. New apes ll the gap. Proc Natl Acad
Sci U S A 2007;104:19661-2.
151 Lebatard AE, Bourles DL, Duringer P, et al.
Cosmogenic nuclide dating of Sahelanthropus
tchadensis and Australopithecus bahrelghazali:
Mio-Pliocene hominids from Chad. Proc Natl
Acad Sci U S A 2008;105:3226-31.
152 Bosworth W, Morley CK. Structural and
stratigraphic evolution of the Anza rift, Kenya.
In: Prodehl C, Keller GR, Khan MA, editors. Crustal
and Upper Mantle Structure of the Kenya Rift.
Tectonophysics ed.; 1994. p. 93-115.
153 Joordens JC. The power of place: climate
changes as driver of hominin evolution and
dispersal over the past ve million years. 2011:1-
120.
154 Vignaud P, Duringer P, Mackaye HT, et al.
Geology and palaeontology of the Upper
Miocene Toros-Menalla hominid locality, Chad.
Nature 2002;418:152-5.
155 Stewart KM. The case for exploitation of
wetlands environments and foods by pre-
sapiens hominins. In: Cunnane SC, Stewart KM,
editors. Human Brain Evolution. The inuence
of freshwater and marine food resources.
Hoboken, New Jersey: Wiley-Blackwell; 2010. p.
137-171.
156 Pickford M, Senut B. The geological and faunal
context of Late Miocene hominid remains from
Lukeino, Kenya. Comptes Rendus De L Academie
Des Sciences Serie Ii Fascicule A-Sciences De La
Terre Et Des Planetes 2001;332:145-52.
157 WoldeGabriel G, Haile-Selassie Y, Renne PR,
et al. Geology and palaeontology of the Late
Miocene Middle Awash valley, Afar rift, Ethiopia.
Nature 2001;412:175-8.
158 WoldeGabriel G, Ambrose SH, Barboni D, et al.
The geological, isotopic, botanical, invertebrate,
and lower vertebrate surroundings of
Ardipithecus ramidus. Science 2009;326:65e1-5.
159 Feibel CS, Harris JM, Brown FH.
Paleoenvironmental context for the late
Neogene of the Turkana basin. In: Harris JM,




Clarendon Press; 1991. p. 321-346.
160 Reed KE. Early hominid evolution and ecological
change through the African Plio-Pleistocene. J
Hum Evol 1997;32:289-322.
161 Ward C, Leakey M, Walker A. The new
hominid species Australopithecus anamensis.
Evolutionary Anthropology 1999;7:197-205.
162 Schoeninger MJ, Reeser H, Hallin K.
Paleoenvironment of Australopithecus
anamensis at Allia Bay, East Turkana, Kenya:
evidence from mammalian herbivore enamel
stable isotopes. Journal of Anthropological
Archaeology 2003;22:200-7.
163 Reed KE. Paleoecological patterns at the Hadar
hominin site, Afar Regional State, Ethiopia. J
Hum Evol 2008;54:743-68.
164 Su DF, Harrison T. Ecological implications of the
relative rarity of fossil hominins at Laetoli. J Hum
Evol 2008;55:672-81.
165 Veldkamp A, Buis E, Wijbrands JR, et al.
Quaternary Science Reviews 2004;26:2897-912.
166 Sepulchre P, Ramstein G, Fluteau F, et al. Tectonic
uplift and Eastern Africa aridication. Science
2006;313:1419-23.
167 Trauth MH, Maslin MA, Deino AL, et al. High- and
low-latitude forcing of Plio-Pleistocene East
African climate and human evolution. J Hum
Evol 2007;53:475-86.
168 Bartoli G, Sarnthein M, Weinelt M, et al. Final
closure of the Panama and the onset of northern
hemisphere glaciation. Earth and Planetary
Science Letters 2005;237:33-44.
169 Potts R. Environmental hypotheses of hominin
evolution. Yearbook of Physical Anthropology,
Vol 41 - 1998 1998;41:93-136.
170 Pobiner BL, Rogers MJ, Monahan CM, et al.
New evidence for hominin carcass processing
strategies at 1.5 Ma, Koobi Fora, Kenya. J Hum
Evol 2008;55:103-30.
171 Ashley GM, Tactikos JC, Owen RB. Hominin
use of springs and wetlands: Paleoclimate and
archaeological records from Olduvai Gorge
similar to 1.79-1.74 Ma. Palaeogeography
Palaeoclimatology Palaeoecology 2009;272:1-
16.
172 Drake NA, Blench RM, Armitage SJ, et al. Ancient
watercourses and biogeography of the Sahara
explain the peopling of the desert. Proc Natl
Acad Sci U S A 2011;108:458-62.
173 Sikes NE. Early Hominid Habitat Preferences in
East-Africa - Paleosol Carbon Isotopic Evidence.
J Hum Evol 1994;27:25-45.
174 Joordens JC, Wesselingh FP, de Vos J, et
al. Relevance of aquatic environments for
hominins: a case study from Trinil Java,
Indonesia. J Hum Evol 2009;57:656-71.
175 Popovich DG, Jenkins DJ, Kendall CW, et al. The
western lowland gorilla diet has implications for
the health of humans and other hominoids. J
Nutr 1997;127:2000-5.
176 Marshall AJ, Wrangham RW. Evolutionary
consequences of fallback foods. Int J Primatol
2007;28:1218-35.
177 Nishida T. Local-Dierences in Responses to
Water among Wild Chimpanzees. Folia Primatol
1980;33:189-209.
178 Sakamaki T. First record of algae-feeding by a
female chimpanzee at Mahale. Pan-Africa News
1998;5:1.
179 Kempf E. Patterns of water use in primates. Folia
Primatol Basel 2009;80:275-94.
180 Wrangham R, Cheney D, Seyfarth R, et al.
Shallow-water habitats as sources of fallback
foods for hominins. Am J Phys Anthropol
2009;140:630-42.
181 Vogel ER, van Woerden JT, Lucas PW, et al.
Functional ecology and evolution of hominoid
molar enamel thickness: Pan troglodytes
schweinfurthii and Pongo pygmaeus wurmbii. J
Hum Evol 2008;55:60-74.
182 Suwa G, Kono RT, Simpson SW, et al.
Paleobiological implications of the Ardipithecus
ramidus dentition. Science 2009;326:94-9.
183 Teaford MF, Ungar PS. Diet and the evolution of
the earliest human ancestors. Proc Natl Acad Sci
U S A 2000;97:13506-11.
184 Walker A, Hoeck HN, Perez L. Mecrowear of
mammalian teeth as an indicator of diet.
Science 1978;201:908-10.
185 Ungar PS, Grine FE,Teaford MF. Dental Microwear
and Diet of the Plio-Pleistocene Hominin
Paranthropus boisei. Plos One 2008;3:e2044.
186 UngarPS,ScottRS,GrineFE,etal.Molarmicrowear
textures and the diets of Australopithecus
anamensis and Australopithecus afarensis.




187 Grine FE, Ungar PS, Teaford MF, et al. Molar
microwear in Praeanthropus afarensis: Evidence
for dietary stasis through time and under
diverse paleoecological conditions. J Hum Evol
2006;51:297-319.
188 Scott RS, Ungar PS, Bergstrom TS, et al. Dental
microwear texture analysis shows within-
species diet variability in fossil hominins. Nature
2005;436:693-5.
189 Cerling TE, Mbua E, Kirera FM, et al. Diet of
Paranthropus boisei in the early Pleistocene
of East Africa. Proc Natl Acad Sci U S A
2011;108:9337-41.
190 Ungar P. Dental topography and diets of
Australopithecus afarensis and early Homo. J
Hum Evol 2004;46:605-22.
191 Ulijaszek SJ. Human eating behaviour in an
evolutionary ecological context. Proc Nutr Soc
2002;61:517-26.
192 Goldstone AP, de Hernandez CG, Beaver JD, et
al. Fasting biases brain reward systems towards
high-calorie foods. Eur J Neurosci 2009;30:1625-
35.
193 Ungar PS, Grine FE, Teaford MF, et al. Dental
microwear and diets of African early Homo. J
Hum Evol 2006;50:78-95.
194 Ungar PS, Grine FE, Teaford MF. Diet in early
Homo: A review of the evidence and a new
model of adaptive versatility. Annu Rev
Anthropol 2006;35:209-28.
195 Perez-Perez A, De Castro JMB, Arsuaga JL.
Nonocclusal dental microwear analysis of
300,000-year-old Homo heilderbergensis teeth
from Sima de los Huesos Sierra de Atapuerca,
Spain. Am J Phys Anthropol 1999;108:433-57.
196 Lalueza C, PerezPerez A, Turbon D. Dietary
inferences through buccal microwear analysis
of middle and upper pleistocene human fossils.
Am J Phys Anthropol 1996;100:367-87.
197 Mahoney P. Human dental microwear from
Ohalo II 22,500-23,500 cal BP, Southern Levant.
Am J Phys Anthropol 2007;132:489-500.
198 Mahoney P. Dental microwear from Natuan
hunter-gatherers and early neolithic farmers:
Comparisons within and between samples. Am
J Phys Anthropol 2006;130:308-19.
199 Milton K. Nutritional characteristics of wild
primate foods: do the diets of our closest
living relatives have lessons for us? Nutrition
1999;15:488-98.
200 Milton K. The critical role played by animal
source foods in human Homo evolution. J Nutr
2003;133:3886S-92S.
201 Gittleman JL, Thompson SD. Energy Allocation
in Mammalian Reproduction. Am Zool
1988;28:863-75.
202 Oftedal TO. Milk composition, milk yield and
energy output a peak lactation: a comparative
review. Symposium of the Zoological Society of
London ;51:33-85.
203 Aiello LC, Key C. Energetic consequences of
being a Homo erectus female. Am J Hum Biol
2002;14:551-65.
204 Aiello LC, Wells JCK. Energetics and the evolution
of the genus Homo. Annu Rev Anthropol
2002;31:323-38.
205 Cunnane SC, Crawford MA. Survival of the
fattest: fat babies were the key to evolution of
the large human brain. Comp Biochem Physiol
A Mol Integr Physiol 2003;136:17-26.
206 Leonard WR, Robertson ML, Snodgrass JJ,
et al. Metabolic correlates of hominid brain
evolution. Comp Biochem Physiol A Mol Integr
Physiol 2003;136:5-15.
207 Aiello LC, Wheeler P. The Expensive-Tissue
Hypothesis - the Brain and the Digestive-
System in Human and Primate Evolution. Curr
Anthropol 1995;36:199-221.
208 Aiello LC. Notes on the implications of the
expensive tissue hypothesis for human
biological and social evolution. In: Roebroeks W,
editor. Guts and Brains. An integrative approach
to the Hominin record Leiden: Leiden University
Press; 2007. p. 17-28.
209 Kaufman JA, Hladik CM, Pasquet P. On the
expensive-tissue hypothesis: independent
support from highly encephalized sh. Curr
Anthropol 2003;44:705-7.
210 Galdikas BM, Wood JW. Birth spacing patterns
in humans and apes. Am J Phys Anthropol
1990;83:185-91.
211 Isler K, van Schaik CP. The Expensive Brain: a
framework for explaining evolutionary changes
in brain size. J Hum Evol 2009;57:392-400.




and ospring production: Marsupials conrm
a general mammalian pattern. Bioessays
2011;33:173-9.
213 Pontzer H, Raichlen DA, Sockol MD. The
metabolic cost of walking in humans,
chimpanzees, and early hominins. J Hum Evol
2009;56:43-54.
214 Wrangham RW, Jones JH, Laden G, et al. The
Raw and the Stolen. Cooking and the Ecology of
Human Origins. Curr Anthropol 1999;40:567-94.
215 Robinson BW, Wilson DS. Optimal foraging,
specialization, and a solution to Liem’s paradox.
Am Nat 1998;151:223-35.
216 Harris WS. You are what you eat applies to sh,
too. J Am Diet Assoc 2008;108:1131-3.
217 Sponheimer M, Dufour DL. Chapter 18.
Increased dietary breadth in early Hominin
evolution: Revisiting arguments and evidence
with a focus on biogeochemical contributions.
The Evolution of Hominin Diets; 2009. p. 229-
240.
218 Sillen A, Kavanagh M. Strontium and
paleodietary research: A review. American
Journal of Physical Anthropology 1982;25:67-
90.
219 Sillen A. Strontium Calcium Ratios Sr/ca of
Australopithecus-Robustus and Associated
Fauna from Swartkrans. J Hum Evol 1992;23:495-
516.
220 Sillen A, Hall G, Armstrong R. Strontium Calcium
Ratios Sr/ca and Strontium Isotopic-Ratios Sr-87/
sr-86 of Australopithecus-Robustus and Homo
Sp from Swartkrans. J Hum Evol 1995;28:277-85.
221 Conklin-Brittain NL, Wrangham RW, Hunt
KD. Dietary response of chimpanzees and
cercopithecines to seasonal variation in fruit
abundance. II. Macronutrients. Int J Primatol
1998;19:971-98.
222 Lee-Thorp J, Sponheimer M. Three case studies
used to reassess the reliability of fossil bone and
enamel isotope signals for paleodietary studies.
Journal of Anthropological Archaeology
2003;22:208-16.
223 Sponheimer M, de Ruiter D, Lee-Thorp J, et al. Sr/
Ca and early hommin diets revisited: new data
from modern and fossil tooth enamel. J Hum
Evol 2005;48:147-56.
224 Lee-Thorp J, Sponheimer M. Contributions
of biogeochemistry to understanding
hominin dietary ecology. Yearbook of Physical
Anthropology, Vol.49 2006 2006;49:131-48.
225 Balter V, Simon L. Diet and behavior of the
Saint-Cesaire Neanderthal inferred from
biogeochemical data inversion. J Hum Evol
2006;51:329-38.
226 Ophel IL, Fraser CD. Calcium and Strontium
Discrimination by Aquatic Plants. Ecology
1970;51:324,&.
227 Ambrose SH, Deniro MJ. The Isotopic Ecology of
East-African Mammals. Oecologia 1986;69:395-
406.
228 Lee-Thorp JA, Sponheimer M, Passey BH, et al.
Stable isotopes in fossil hominin tooth enamel
suggest a fundamental dietary shift in the
Pliocene. Philosophical Transactions of the Royal
Society B-Biological Sciences 2010;365:3389-96.
229 Sponheimer M, Lee-Thorp JA. Enamel
diagenesis at South African Australopith sites:
Implications for paleoecological reconstruction
with trace elements. Geochim Cosmochim Acta
2006;70:1644-54.
230 Sponheimer M, Lee-Thorp J, de Ruiter D, et al.
Hominins, sedges, and termites: new carbon
isotope data from the Sterkfontein valley and
Kruger National Park. J Hum Evol 2005;48:301-
12.
231 Vogel JC. Isotopic Assessment of Dietary Habits
of Ungulates. S Afr J Sci 1978;74:298-301.
232 Cerling TE, Harris JM, MacFadden BJ, et al. Global
vegetation change through the Miocene/
Pliocene boundary. Nature 1997;389:153-8.
233 Peters CR, Vogel JC. Africa’s wild C-4 plant foods
and possible early hominid diets. J Hum Evol
2005;48:219-36.
234 Segalen L, Lee-Thorp JA, Cerling T. Timing of C-4
grass expansion across sub-Saharan Africa. J
Hum Evol 2007;53:549-59.
235 Sponheimer M, Reed KE, Lee-Thorp JA.
Combining isotopic and ecomorphological data
to rene bovid paleodietary reconstruction: a
case study from the Makapansgat Limeworks
hominin locality. J Hum Evol 1999;36:705-18.
236 Lee-Thorp J, Thackeray JF, van der Merwe N. The
hunters and the hunted revisited. J Hum Evol
2000;39:565-76.
237 Sponheimer M, Lee-Thorp JA, de Ruiter DJ.
74
Chapter 1
Icarus, Isotopes, and Australopith Diets.
Evolution of the human diet: the known, the
unknown, and the unknowable; 2007. p. 132-
149.
238 Kelly JF. Stable isotopes of carbon and nitrogen
in the study of avian and mammalian trophic
ecology. Canadian Journal of Zoology-Revue
Canadienne De Zoologie 2000;78:1-27.
239 Schoeninger MJ, Deniro MJ. Nitrogen and
Carbon Isotopic Composition of Bone-Collagen
from Marine and Terrestrial Animals. Geochim
Cosmochim Acta 1984;48:625-39.
240 Mbabazi D, Makanga B, Orach-Meza F, et al. Intra-
lake stable isotope ratio variation in selected
sh species and their possible carbon sources
in Lake Kyoga Uganda: implications for aquatic
food web studies. Afr J Ecol 2010;48:667-75.
241 Schoeninger MJ, Deniro MJ, Tauber H. Stable
Nitrogen Isotope Ratios of Bone-Collagen
Reect Marine and Terrestrial Components of
Prehistoric Human Diet. Science 1983;220:1381-
3.
242 Sponheimer M, Lee-Thorp JA. Dierential
resource utilization by extant great apes
and australopithecines: towards solving the
C-4 conundrum. Comparative Biochemistry
and Physiology A-Molecular & Integrative
Physiology 2003;136:27-34.
243 Lee-Thorp JA, Sponheimer M, Luyt J. Tracking
changing environments using stable carbon
isotopes in fossil tooth enamel: an example
from the South African hominin sites. J Hum
Evol 2007;53:595-601.
244 van der Merwe NJ, Masao FT, Bamford MK.
Isotopic evidence for contrasting diets of early
hominins Homo habilis and Australopithecus
boisei of Tanzania. S Afr J Sci 2008;104:153-5.
245 Schoeninger MJ, Moore J, Sept JM. Subsistence
strategies of two “savanna” chimpanzee
populations: The stable isotope evidence. Am J
Primatol 1999;49:297-314.
246 Sponheimer M, Loudon JE, Codron D, et al. Do
“savanna”chimpanzees consume C-4 resources?
J Hum Evol 2006;51:128-33.
247 Sponheimer M, Lee-Thorp JA. Oxygen isotopes
in enamel carbonate and their ecological
signicance. Journal of Archaeological Science
1999;26:723-8.
248 Sponheimer M, Lee-Thorp JA. The oxygen
isotope composition of mammalian enamel
carbonate from Morea Estate, South Africa.
Oecologia 2001;126:153-7.
249 Hu Y, Shang H, Tong H, et al. Stable isotope
dietary analysis of the Tianyuan 1 early modern
human. Proc Natl Acad Sci U S A 2009;106:10971-
4.
250 Richards MP, Pettitt PB, Trinkaus E, et al.
Neanderthal diet at Vindija and Neanderthal
predation: The evidence from stable isotopes.
Proc Natl Acad Sci U S A 2000;97:7663-6.
251 Richards MP, Pettitt PB, Stiner MC, et al. Stable
isotope evidence for increasing dietary breadth
in she European mid-Upper Paleolithic. Proc
Natl Acad Sci U S A 2001;98:6528-32.
252 Richards MP. A brief review of the archaeological
evidence for Palaeolithic and Neolithic
subsistence. Eur J Clin Nutr 2002;56.
253 Richards MP, Schulting RJ, Hedges RE.
Archaeology: sharp shift in diet at onset of
Neolithic. Nature 2003;425:366.
254 Richards MP, Jacobi R, Cook J, et al. Isotope
evidence for the intensive use of marine foods
by Late Upper Palaeolithic humans. J Hum Evol
2005;49:390-4.
255 Richards MP, Trinkaus E. Isotopic evidence for
the diets of European Neanderthals and early
modern humans. Proc Natl Acad Sci U S A
2009;106:16034-9.
256 van der Merwe NJ, Thackeray JF, Lee-Thorp
JA, et al. The carbon isotope ecology and diet
of Australopithecus africanus at Sterkfontein,
South Africa. J Hum Evol 2003;44:581-97.
257 Semaw S, Rogers MJ, Quade J, et al. 2.6-million-
year-old stone tools and associated bones from
OGS-6 and OGS-7, Gona, Afar, Ethiopia. J Hum
Evol 2003;45:169-77.
258 McPherron SP, Alemseged Z, Marean CW, et al.
Evidence for stone-tool-assisted consumption
of animal tissues before 3.39 million years ago
at Dikika, Ethiopia. Nature 2010;466:857-60.
259 Willis LA, Eren MI, Rick TC. Does butchering
sh leave cut marks? Journal of Archaeological
Science 2008;35:1438-44.
260 Braun DR, Harris JW, Levin NE, et al. Early
hominin diet included diverse terrestrial and
aquatic animals 1.95 Ma in East Turkana, Kenya.




261 de Heinzelin J, Clark JD, White T, et al.
Environment and behavior of 2.5-million-year-
old Bouri hominids. Science 1999;284:625-9.
262 Leonard WR, Robertson ML, Snodgrass JJ.
Energetics and the evolution of brain size in
early Homo. In: Roebroeks W, editor. Guts and
Brains. An Integrative Approach to the Hominin
Record Leiden: Leiden University Press; 2007. p.
29-46.
263 Simpson SW, Quade J, Levin NE, et al. A female
Homo erectus pelvis from Gona, Ethiopia.
Science 2008;322:1089-92.
264 Bramble DM, Lieberman DE. Endurance
running and the evolution of Homo. Nature
2004;432:345-52.
265 Broadhurst CL, Wang Y, Crawford MA, et al.
Brain-speci!c lipids from marine, lacustrine, or
terrestrial food resources: potential impact on
early African Homo sapiens. Comp Biochem
Physiol B Biochem Mol Biol 2002;131:653-73.
266 Erlandson JM. The archaeology of aquatic
adaptations: Paradigms for a new millennium.
Journal of Archaeological Research 2001;9:287-
350.
267 Marean CW. Coastal South Africa and the co-
evolution of the modern human lineage and
the coastal adaptation. In: Bicho N, Haws JA,
Davis LG, editors. Trekking the Shore: changing
Coastlines and the Antiquity of Coastal
Settlement New York: Springer; 2010.
268 Stewart KM. Early Hominid Utilization of Fish
Resources and Implications for Seasonality and
Behavior. J Hum Evol 1994;27:229-45.
269 Wang S, Lewis CM, Jakobsson M, et al. Genetic
variation and population structure in native
Americans. PLoS Genet 2007;3:e185.
270 Pope GG. Bamboo and Human-Evolution.
Natural History 1989:48-57.
271 Fagan BM. The Journey from Eden: The Peopling
of Our World. London: Thames and Hudson;
1990.
272 Bar-Yosef O. The lower paleolithic of the Near
East. Journal of World Prehistory 1994;8:211-65.
273 Cleyet-Merle J, Madelaine S. Inland evidence
of human sea coast exploitation in Palaeolithic
France. In: Fischer A, editor. Man and Sea in
the Mesolithic Oxford: Oxbow Monographs in
Archaeology; 1995. p. 303-308.
274 Klein RG, Avery G, Cruz-Uribe K, et al. Duinefontein
2: an Acheulean Site in the Western Cape
Province of South Africa. J Hum Evol
1999;37:153-90.
275 de Lumley H. A Paleolithic camp at Nice.
Scienti!c American 1969;22:33-41.
276 Villa P. Terra Amata and the Middle Pleistocene
archaeological record of southern France.
University of California publications in
anthropology ed. Berkeley: University of
California Press; 1983.
277 Marean CW, Bar-Matthews M, Bernatchez J, et
al. Early human use of marine resources and
pigment in South Africa during the Middle
Pleistocene. Nature 2007;449:905-8.
278 Walter RC, Bu"er RT, Bruggemann JH, et al.
Early human occupation of the Red Sea coast
of Eritrea during the last interglacial. Nature
2000;405:65-9.
279 Stiner MC. Honor among thieves: A
zooarchaeological study of Neandertal ecology.
Princeton NJ: Princeton University Press; 1993.
280 von den Driesch A. The Middle Stone Age !sh
fauna from the Klassies River main site, South
Africa. Anthropozoologica 2004;39:33-59.
281 Erlandson JM. Food for thought: The role of
coastlines and aquatic resources in human
evolution. In: Cunnane SC, Stewart KM, editors.
Human Brain Evolution. The in#uence of
freshwater and marine food resources; 2010. p.
125-136.
282 Klein RG, Cruz-Uribe K, Halkett D, et al.
Paleoenvironmental and human behavioral
implications of the Boegoeberg 1 late
pleistocene hyena den, Northern Cape Province,
South Africa. Quatern Res 1999;52:393-403.
283 Marean CW, Goldberg P, Avery G, et al. Middle
Stone Age stratigraphy and excavations at Die
Kelders Cave 1 Western Cape Province, South
Africa: The 1992, 1993, and 1995 !eld seasons. J
Hum Evol 2000;38:7-42.
284 Henshilwood C, Sealy J. Bone artefacts from the
Middle Stone Age at Blombos Cave, southern
cape, South Africa. Curr Anthropol 1997;38:890-
5.
285 Klein RG, Avery G, Cruz-Uribe K, et al. The
Ysterfontein 1 Middle Stone Age site, South
Africa, and early human exploitation of




286 Avery G, Halkett D, Orton J, et al. The
Ysterfontein 1 Middle Stone Age rock shelter
and the evolution of coastal foraging. South
African Archaeological Society Goodwin Series
2008;10:66-89.
287 Henshilwood C, d’Errico F, Vanhaeren M, et al.
Middle Stone Age shell beads from South Africa.
Science 2004;304:404.
288 Harris JW, Williamson PG, Morris PJ, de Heinzelin
J, Verniers J, Helgren D, et al. Archaeology of
the Lusso beds. In: Boaz NT, editor. Evolution
of Environments and Hominidae in the African
Western Rift Valley Martinsville: Virginia
Museum of Natural History; 1990. p. 237-272.
289 Meylan P. Fossil turtles from the upper
Semliki, Zaire. In: Boaz NT, editor. Evolution of
Environments and Hominidae in the African Rift
Valley Martinsville: Virginia Museum of Natural
History; 1990. p. 163-170.
290 Henshilwood CS, Sealy JC, Yates R, et al. Blombos
Cave, Southern Cape, South Africa: Preliminary
report on the 1992-1999 excavations of
the Middle Stone Age Levels. Journal of
Archaeological Science 2001;28:421-48.
291 Wickler S, Spriggs M. Pleistocene Human
Occupation of the Solomon-Islands, Melanesia.
Antiquity 1988;62:703-6.
292 Allen J, Gosden C, Jones R, et al. Pleistocene
dates for the human occupation of New Ireland,
northern Melanesia. Nature 1988;331:707-9.
293 O’Connor S, Ono R, Clarkson C. Pelagic shing
at 42,000 years before the present and the
maritime skills of modern humans. Science
2011;334:1117-21.
294 Morwood MJ, O’Sullivan PB, Aziz F, et al.
Fission-track ages of stone tools and fossils on
the east Indonesian island of Flores. Nature
1998;392:173-6.
295 Morwood MJ, Aziz F, O’Sullivan P, et al.
Archaeological and palaeontological research
in central Flores, east Indonesia: Results of
eldwork 1997-98. Antiquity 1999;73:273-86.
296 Morwood MJ, Brown P, Jatmiko, et al. Further
evidence for small-bodied hominins from the
Late Pleistocene of Flores, Indonesia. Nature
2005;437:1012-7.
297 Westaway KE, Morwood MJ, Roberts RG, et
al. Establishing the time of initial human
occupation of Liang Bua, western Flores,
Indonesia. Quaternary Geochronology
2007;2:337-43.
298 Brumm A, Jensen GM, van den Bergh GD, et al.
Hominins on Flores, Indonesia, by one million
years ago. Nature 2010;464:748-U123.
299 Sept JM. Plant Foods and Early Hominids at
Site Fxjj 50, Koobi-Fora, Kenya. J Hum Evol
1986;15:751-70.
300 Gibbons A. Paleoanthropology. Food for
thought. Science 2007;316:1558-60.
301 Wobber V, Hare B, Wrangham R. Great apes
prefer cooked food. J Hum Evol 2008;55:340-8.
302 Goren-Inbar N, Alperson N, Kislev ME, et al.
Evidence of hominin control of re at Gesher
Benot Ya’aqov, Israel. Science 2004;304:725-7.
303 Roebroeks W, Villa P. On the earliest evidence for
habitual use of re in Europe. Proc Natl Acad Sci
U S A 2011;108:5209-14.
304 Henry AG, Brooks AS, Piperno DR. Microfossils
in calculus demonstrate consumption of plants
and cooked foods in Neanderthal diets Shanidar
III, Iraq; Spy I and II, Belgium. Proc Natl Acad Sci U
S A 2011;108:486-91.
305 Crawford MA, Bloom M, Cunnane S, et al.
Docosahexaenoic acid and cerebral evolution.
World Rev Nutr Diet 2001;88:6-17.
306 Parkington J. Middens and moderns: shellshing
and the Middle Stone Age of the Western Cape,
South Africa. S Afr J Sci 2003;99:243-7.
307 Parkington J, Roggenpoel C, Halkett D, Hart
T. Initial observations on the Middle Stone
Age coastal settlement in the Western Cape,
South Africa. In: Conard NJ, editor. Settlement
Dynamics of the Middle Paleolithic and Middle
Stone Age Tubingen: Tubingen Publications in
Prehistory; 2009. p. 5-22.
308 Cordain L, Eaton SB, Sebastian A, et al. Origins
and evolution of the Western diet: implications
of iodine and seafood intakes for the human
brain - Reply. Am J Clin Nutr 2005;82:483-4.
309 Nadel D, Weiss E, Simchoni O, et al. Stone Age
hut in Israel yields world’s oldest evidence of
bedding. Proc Natl Acad Sci U S A 2004;101:6821-
6.
310 Weiss E, Wetterstrom W, Nadel D, et al. The




remains. Proc Natl Acad Sci U S A 2004;101:9551-
5.
311 Kislev ME, Weiss E, Hartmann A. Impetus for
sowing and the beginning of agriculture:
Ground collecting of wild cereals. Proc Natl
Acad Sci U S A 2004;101:2692-5.
312 Kimbel WH, Walter RC, Johanson DC, et al. Late
Pliocene Homo and Oldowan Tools from the
Hadar Formation Kada Hadar Member, Ethiopia.
Journal of Human Evolution 1996;31:549-61.
313 Lee RB. What Hunters Do for a Living, or, How
To Make Out on Scarce Resources. In: Lee RB,
DeVore I, editors. Man the Hunter New York:
Aldine Publishing Company; 1968. p. 30-48.
314 Murdock GV. Ethnographic Atlas. : University of
Pittsburgh Press; 1967.
315 Stewart JH. Causal Factors and Processes in the
Evolution of Pre-farming Societies. In: Lee RB,
DeVore I, editors. Man the Hunter New York:
Aldine Publishing Company; 1968. p. 321-334.
316 Meehan B. Shell bed to shell midden. Canberra:
Humanity Press; 1982.
317 Moss ML. Shellsh, Gender, and Status on the
Northwest Coast - Reconciling Archaeological,
Ethnographic, and Ethnohistorical Records
of the Tlingit. American Anthropologist
1993;95:631-52.
318 Godfrey KM, Lillycrop KA, Burdge GC, et al.
Epigenetic mechanisms and the mismatch
concept of the developmental origins of health
and disease. Pediatr Res 2007;61:5R-10R.
319 Burdge GC, Hanson MA, Slater-Jeeries JL, et
al. Epigenetic regulation of transcription: a
mechanism for inducing variations in phenotype
fetal programming by dierences in nutrition
during early life? Br J Nutr 2007;97:1036-46.
320 Waterland RA, Jirtle RL. Early nutrition,
epigenetic changes at transposons and
imprinted genes, and enhanced susceptibility
to adult chronic diseases. Nutrition 2004;20:63-
8.
321 Lillycrop KA, Burdge GC. Epigenetic changes in
early life and future risk of obesity. Int J Obes
Lond 2010.
322 Godfrey KM, Sheppard A, Gluckman PD, et
al. Epigenetic gene promoter methylation at
birth is associated with child’s later adiposity.
Diabetes 2011;60:1528-34.
323 Bensinger SJ, Tontonoz P. Integration of
metabolism and inammation by lipid-activated
nuclear receptors. Nature 2008;454:470-7.
324 Castrillo A, Tontonoz P. PPARs in atherosclerosis:
the clot thickens. J Clin Invest 2004;114:1538-40.
325 Song Y, Yao X, Ying H. Thyroid hormone action
in metabolic regulation. Protein Cell 2011;2:358-
68.
326 Bouillon R, Bischo-Ferrari H, Willett W. Vitamin
D and health: perspectives from mice and man.
J Bone Miner Res 2008;23:974-9.
327 McGrane MM. Vitamin A regulation of gene
expression: molecular mechanism of a
prototype gene. J Nutr Biochem 2007;18:497-
508.
328 Venturi S, Donati FM, Venturi A, et al. Role
of iodine in evolution and carcinogenesis of
thyroid, breast and stomach. Adv Clin Path
2000;4:11-7.
329 Kohrle J, Gartner R. Selenium and thyroid. Best
Pract Res Clin Endocrinol Metab 2009;23:815-27.
330 Gilbert ME, McLanahan ED, Hedge J, et al.
Marginal iodide deciency and thyroid function:
dose-response analysis for quantitative
pharmacokinetic modeling. Toxicology
2011;283:41-8.
331 Desvergne B, Wahli W. Peroxisome proliferator-
activated receptors: nuclear control of
metabolism. Endocr Rev 1999;20:649-88.
332 Norman AW, Bouillon R. Vitamin D nutritional
policy needs a vision for the future. Exp Biol Med
Maywood 2010;235:1034-45.
333 Holick MF, Chen TC. Vitamin D deciency: a
worldwide problem with health consequences.
Am J Clin Nutr 2008;87:1080S-6S.
334 Mann GV, Roels OA, Price DL, et al. Cardiovascular
disease in African Pygmies. A survey of the
health status, serum lipids and diet of Pygmies
in Congo. J Chron Dis 1962;15:341-71.
335 Mann GV, Shaer RD, Anderson RS, et al.
Cardiovascular Disease in the Masai. J
Atheroscler Res 1964;4:289-312.
336 Mann GV, Shaer RD, Rich A. Physical tness
and immunity to heart-disease in Masai. Lancet
1965;2:1308-10.
337 Shaper AG, Leonard PJ, Jones KW, et al.
Environmental eects on the body build, blood
pressure and blood chemistry of nomadic
78
Chapter 1
warriors serving in the army in Kenya. East Afr
Med J 1969;46:282-9.
338 O’Keefe JH,Jr., Cordain L, Harris WH, et al.
Optimal low-density lipoprotein is 50 to 70 mg/
dl: lower is better and physiologically normal. J
Am Coll Cardiol 2004;43:2142-6.
339 Joe BI, Jackson WP, Thomas ME, et al. Metabolic
responses to oral glucose in the Kalahari
Bushmen. Br Med J 1971;4:206-8.
340 Merimee TJ, Rimoin DL, Cavalli-Sforza LL.
Metabolic studies in the African pygmy. J Clin
Invest 1972;51:395-401.
341 Ramsden CE, Faurot KR, Carrera-Bastos P,
et al. Dietary fat quality and coronary heart
disease prevention: a unied theory based on
evolutionary, historical, global, and modern
perspectives. Curr Treat Options Cardiovasc
Med 2009;11:289-301.
342 Keys AB. Seven countries: a multivariate analysis
of death and coronary heart disease. London,
England: Harvard University Press, Cambridge
Massachusetts; 1980.
343 Clarke R, Frost C, Collins R, et al. Dietary lipids and
blood cholesterol: quantitative meta-analysis of
metabolic ward studies. BMJ 1997;314:112-7.
344 Kuipers RS, de Graaf DJ, Luxwolda MF, et al.
Saturated fat, carbohydrates and cardiovascular
disease. The Netherlands Journal of Medicine
2011;69:22-8.
345 Ho KJ, Biss K, Mikkelson B, et al. The Masai of East
Africa: some unique biological characteristics.
Arch Pathol 1971;91:387-410.
346 Biss K, Ho KJ, Mikkelson B, et al. Some unique
biologic characteristics of the Masai of East
Africa. N Engl J Med 1971;284:694-9.
347 Mann GV, Spoerry A, Gray M, et al. Atherosclerosis
in the Masai. Am J Epidemiol 1972;95:26-37.
348 Kaminer B, Lutz WPW. Blood Pressure in
Bushmen of the Kalahari Desert. Circulation
1960;22:289-95.
349 Clement AJ, Fosdick LL, Plotkin R. The formation
of lactic acid in dental plaques. II. Oral conditions
of primitive Bushmen of the Western Kalahari
Desert. J Dent Res 1956;35:786.
350 Lindeberg S, Berntorp E, Nilsson-Ehle P, et al.
Age relations of cardiovascular risk factors in a
traditional Melanesian society: the Kitava Study.
Am J Clin Nutr 1997;66:845-52.
351 Sackett DL, Rosenberg WM, Gray JA, et al.
Evidence based medicine: what it is and what it
isn’t. BMJ 1996;312:71-2.
352 Blumberg J, Heaney RP, Huncharek M, et al.
Evidence-based criteria in the nutritional
context. Nutr Rev 2010;68:478-84.
353 Dyerberg J, Bang HO, Hjorne N. Fatty acid
composition of the plasma lipids in Greenland
Eskimos. Am J Clin Nutr 1975;28:958-66.
354 Bang HO, Dyerberg J, Sinclair HM. The
composition of the Eskimo food in north western
Greenland. Am J Clin Nutr 1980;33:2657-61.
355 Burr ML, Fehily AM, Gilbert JF, et al. Eects
of changes in fat, sh, and bre intakes on
death and myocardial reinfarction: diet and
reinfarction trial DART. Lancet 1989;2:757-61.
356 Mozaarian D, Rimm EB. Fish intake,
contaminants, and human health: evaluating
the risks and the benets. JAMA 2006;296:1885-
99.
357 de Lorgeril M, Salen P, Martin JL, et al.
Mediterranean diet, traditional risk factors, and
the rate of cardiovascular complications after
myocardial infarction: nal report of the Lyon
Diet Heart Study. Circulation 1999;99:779-85.
358 Dietary supplementation with n-3
polyunsaturated fatty acids and vitamin E
after myocardial infarction: results of the GISSI-
Prevenzione trial. Gruppo Italiano per lo Studio
della Sopravvivenza nell’Infarto miocardico.
Lancet 1999;354:447-55.
359 Marchioli R, Barzi F, Bomba E, et al. Early
protection against sudden death by n-3
polyunsaturated fatty acids after myocardial
infarction: time-course analysis of the results
of the Gruppo Italiano per lo Studio della
Sopravvivenza nell’Infarto Miocardico GISSI-
Prevenzione. Circulation 2002;105:1897-903.
360 Yokoyama M, Origasa H, Matsuzaki M, et al.
Eects of eicosapentaenoic acid on major
coronary events in hypercholesterolaemic
patients JELIS: a randomised open-label, blinded
endpoint analysis. Lancet 2007;369:1090-8.
361 Kromhout D, Giltay EJ, Geleijnse JM, et al.
N-3 Fatty Acids and Cardiovascular Events
After Myocardial Infarction. N Engl J Med
2010;363:2015-26.





363 Hibbeln JR. Seafood consumption, the DHA
content of mothers’ milk and prevalence rates
of postpartum depression: a cross-national,
ecological analysis. J Aect Disord 2002;69:15-
29.
364 Hibbeln JR. Depression, suicide and deciencies
of omega-3 essential fatty acids in modern
diets. World Rev Nutr Diet 2009;99:17-30.
365 Hibbeln JR. Seafood consumption and homicide
mortality. A cross-national ecological analysis.
World Rev Nutr Diet 2001;88:41-6.
366 Lin PY, Su KP. A meta-analytic review of
double-blind, placebo-controlled trials of
antidepressant ecacy of omega-3 fatty acids.
J Clin Psychiatry 2007;68:1056-61.
367 Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty
acids as treatments for mental illness: which
disorder and which fatty acid? Lipids Health Dis
2007;6:21.
368 Sinclair AJ, Begg D, Mathai M, et al. Omega 3
fatty acids and the brain: review of studies in
depression. Asia Pac J Clin Nutr 2007;16 Suppl
1:391-7.
369 Freeman MP. Omega-3 fatty acids in psychiatry:
a review. Ann Clin Psychiatry 2000;12:159-65.
370 Freeman MP, Hibbeln JR, Wisner KL, et al.
Omega-3 fatty acids: evidence basis for
treatment and future research in psychiatry. J
Clin Psychiatry 2006;67:1954-67.
371 Sublette ME, Ellis SP, Geant AL, et al. Meta-
analysis of the eects of eicosapentaenoic
acid EPA in clinical trials in depression. J Clin
Psychiatry 2011.
372 Wellcome Trust Case Control Consortium.
Genome-wide association study of 14,000 cases
of seven common diseases and 3,000 shared
controls. Nature 2007;447:661-78.
373 Challem JJ. Did the loss of endogenous
ascorbate propel the evolution of Anthropoidea
and Homo sapiens? Med Hypotheses
1997;48:387-92.
374 Nishikimi M, Fukuyama R, Minoshima S, et al.
Cloning and chromosomal mapping of the
human nonfunctional gene for L-gulono-
gamma-lactone oxidase, the enzyme for
L-ascorbic acid biosynthesis missing in man. J
Biol Chem 1994;269:13685-8.
375 Burdge GC, Wootton SA. Conversion of
alpha-linolenic acid to eicosapentaenoic,
docosapentaenoic and docosahexaenoic acids
in young women. Br J Nutr 2002;88:411-20.
376 Burdge GC. Metabolism of alpha-linolenic
acid in humans. Prostaglandins Leukotrienes
Essential Fatty Acids 2006;75:161-8.
377 Kuipers RS, Luxwolda MF, Janneke Dijck-
Brouwer DA, et al. Intrauterine, postpartum and
adult relationships between arachidonic acid AA
and docosahexaenoic acid DHA. Prostaglandins
Leukot Essent Fatty Acids 2011.
378 Luxwolda MF, Kuipers RS, Smit EN, et al. The
relation between the omega-3 index and
arachidonic acid is bell shaped: Synergistic at
low EPA+DHA status and antagonistic at high
EPA+DHA status. Prostaglandins Leukot Essent
Fatty Acids 2011.
379 Crawford MA, Hassam AG, Williams G, et al.
Essential Fatty-Acids and Fetal Brain Growth.
Lancet 1976;1:452-3.
380 Kuhn DC, Crawford M. Placental essential fatty
acid transport and prostaglandin synthesis.
Prog Lipid Res 1986;25:345-53.
381 Crawford MA, Hassam AG, Rivers JP. Essential
fatty acid requirements in infancy. Am J Clin
Nutr 1978;31:2181-5.
382 Hornstra G. Essential fatty acids in mothers and
their neonates. Am J Clin Nutr 2000;71:1262S-
9S.
383 Hornstra G. Essential fatty acids during
pregnancy. Impact on mother and child. Nestle
Nutr Workshop Ser Pediatr Program 2005;55:83-
96.
384 Makrides M, Gibson RA, McPhee AJ, et al. Eect
of DHA supplementation during pregnancy on
maternal depression and neurodevelopment of
young children: a randomized controlled trial.
JAMA 2010;304:1675-83.
385 Doornbos B, van Goor SA, Dijck-Brouwer DA,
et al. Supplementation of a low dose of DHA
or DHA+AA does not prevent peripartum
depressive symptoms in a small population
based sample. Prog Neuropsychopharmacol
Biol Psychiatry 2009;33:49-52.
386 Su KP, Huang SY, Chiu TH, et al. Omega-3 fatty
acids for major depressive disorder during
pregnancy: results from a randomized, double-




387 Wojcicki JM, Heyman MB. Maternal omega-3
fatty acid supplementation and risk for perinatal
maternal depression. J Matern Fetal Neonatal
Med 2011;24:680-6.
388 Koletzko B, Braun M. Arachidonic acid and early
human growth: is there a relation? Ann Nutr
Metab 1991;35:128-31.
389 Szajewska H, Horvath A, Koletzko B. Eect
of n-3 long-chain polyunsaturated fatty acid
supplementation of women with low-risk
pregnancies on pregnancy outcomes and
growth measures at birth: a meta-analysis of
randomized controlled trials. Am J Clin Nutr
2006;83:1337-44.
390 Olsen SF, Osterdal ML, Salvig JD, et al. Duration
of pregnancy in relation to seafood intake
during early and mid pregnancy: prospective
cohort. Eur J Epidemiol 2006;21:749-58.
391 Olsen SF, Osterdal ML, Salvig JD, et al.
Duration of pregnancy in relation to sh oil
supplementation and habitual sh intake: a
randomised clinical trial with sh oil. Eur J Clin
Nutr 2007;61:976-85.
392 Malcolm CA, McCulloch DL, Montgomery
C, et al. Maternal docosahexaenoic acid
supplementation during pregnancy and visual
evoked potential development in term infants:
a double blind, prospective, randomised trial.
Arch Dis Child Fetal Neonatal Ed 2003;88:F383-
90.
393 Malcolm CA, Hamilton R, McCulloch DL,
et al. Scotopic electroretinogram in term
infants born of mothers supplemented with
docosahexaenoic acid during pregnancy. Invest
Ophthalmol Vis Sci 2003;44:3685-91.
394 Judge MP, Harel O, Lammi-Keefe CJ. A
docosahexaenoic acid-functional food during
pregnancy benets infant visual acuity at four
but not six months of age. Lipids 2007;42:117-
22.
395 Birch EE, Carlson SE, Homan DR, et al. The
DIAMOND DHA Intake And Measurement Of
Neural Development Study: a double-masked,
randomized controlled clinical trial of the
maturation of infant visual acuity as a function
of the dietary level of docosahexaenoic acid. Am
J Clin Nutr 2010;91:848-59.
396 Smithers LG, Gibson RA, McPhee A, et al. Higher
dose of docosahexaenoic acid in the neonatal
period improves visual acuity of preterm
infants: results of a randomized controlled trial.
Am J Clin Nutr 2008;88:1049-56.
397 Judge MP, Harel O, Lammi-Keefe CJ. Maternal
consumption of a docosahexaenoic acid-
containing functional food during pregnancy:
benet for infant performance on problem-
solving but not on recognition memory tasks at
age 9 mo. Am J Clin Nutr 2007;85:1572-7.
398 Dunstan JA, Simmer K, Dixon G, et al. Cognitive
assessment of children at age 21/2 years after
maternal sh oil supplementation in pregnancy:
a randomised controlled trial. Arch Dis Child
Fetal Neonatal Ed 2008;93:F45-50.
399 Helland IB, Smith L, Saarem K, et al. Maternal
supplementation with very-long-chain n-3 fatty
acids during pregnancy and lactation augments
children’s IQ at 4 years of age. Pediatrics
2003;111:e39-44.
400 Helland IB, Smith L, Blomen B, et al. Eect
of supplementing pregnant and lactating
mothers with n-3 very-long-chain fatty acids on
children’s IQ and body mass index at 7 years of
age. Pediatrics 2008;122:e472-9.
401 McCann JC, Ames BN. Is docosahexaenoic
acid, an n-3 long-chain polyunsaturated fatty
acid, required for development of normal
brain function? An overview of evidence from
cognitive and behavioral tests in humans and
animals. Am J Clin Nutr 2005;82:281-95.
402 Dijck-Brouwer DA, Hadders-Algra M, Bouwstra
H, et al. Lower fetal status of docosahexaenoic
acid, arachidonic acid and essential fatty acids
is associated with less favorable neonatal
neurological condition. Prostaglandins Leukot
Essent Fatty Acids 2005;72:21-8.
403 Moriguchi T, Loewke J, Garrison M, et al. Reversal
of docosahexaenoic acid deciency in the
rat brain, retina, liver, and serum. J Lipid Res
2001;42:419-27.
404 Rao JS, Ertley RN, DeMar JC,Jr., et al. Dietary n-3
PUFA deprivation alters expression of enzymes
of the arachidonic and docosahexaenoic acid
cascades in rat frontal cortex. Mol Psychiatry
2007;12:151-7.
405 van Goor SA, Smit EN, Schaafsma A, et al. Milk
of women with lifetime consumption of the
recommended daily intake of sh fatty acids




of infant formula. J Perinat Med 2008;36:548-9.
406 Brenna JT, Varamini B, Jensen RG, et al.
Docosahexaenoic and arachidonic acid
concentrations in human breast milk worldwide.
Am J Clin Nutr 2007;85:1457-64.
407 Koletzko B, Lien E, Agostoni C, et al. The
roles of long-chain polyunsaturated fatty
acids in pregnancy, lactation and infancy:
review of current knowledge and consensus
recommendations. J Perinat Med 2008;36:5-14.
408 Kuipers RS, Smit EN, van der Meulen J, et al. Milk
in the island of Chole Tanzania is high in lauric,
myristic, arachidonic and docosahexaenoic
acids, and low in linoleic acid reconstructed diet
of infants born to our ancestors living in tropical
coastal regions. Prostaglandins Leukot Essent
Fatty Acids 2007;76:221-33.
409 Hachey DL, Silber GH, Wong WW, et al. Human
lactation. II: Endogenous fatty acid synthesis by
the mammary gland. Pediatr Res 1989;25:63-8.
410 Kabara JJ. Lipids as host-resistance factors of
human milk. Nutr Rev 1980;38:65-73.
411 Bergsson G, Steingrimsson O, Thormar
H. Bactericidal eects of fatty acids and
monoglycerides on Helicobacter pylori. Int J
Antimicrob Agents 2002;20:258-62.
412 Widdowson EM, Dauncey MJ, Gairdner DM, et al.
Body fat of British and Dutch infants. Br Med J
1975;1:653-5.
413 Ailhaud G, Massiera F, Weill P, et al.
Temporal changes in dietary fats: role of n-6
polyunsaturated fatty acids in excessive adipose
tissue development and relationship to obesity.
Prog Lipid Res 2006;45:203-36.
414 Ramsden CE, Hibbeln JR, Majchrzak SF, et al. n-6
fatty acid-specic and mixed polyunsaturate
dietary interventions have dierent eects
on CHD risk: a meta-analysis of randomised
controlled trials. Br J Nutr 2010;104:1586-600.
415 Harris WS, Mozaarian D, Rimm E, et al.
Omega-6 fatty acids and risk for cardiovascular
disease: a science advisory from the American
Heart Association Nutrition Subcommittee of
the Council on Nutrition, Physical Activity, and
Metabolism; Council on Cardiovascular Nursing;
and Council on Epidemiology and Prevention.
Circulation 2009;119:902-7.
416 Gibson RA, Muhlhausler B, Makrides M.
Conversion of linoleic acid and alpha-linolenic
acid to long-chain polyunsaturated fatty acids
LCPUFAs, with a focus on pregnancy, lactation
and the rst 2 years of life. Matern Child Nutr
2011;7 Suppl 2:17-26.
417 Koletzko B, Thiel I, Abiodun PO. The fatty acid
composition of human milk in Europe and
Africa. J Pediatr 1992;120:S62-70.
418 Godfrey K, Robinson S, Barker DJ, et al. Maternal
nutrition in early and late pregnancy in relation
to placental and fetal growth. BMJ 1996;312:410-
4.
419 Innis SM, Kuhnlein HV. Long-chain n-3 fatty
acids in breast milk of Inuit women consuming
traditional foods. Early Hum Dev 1988;18:185-9.
420 Ruan C, Liu X, Man H, et al. Milk composition
in women from ve dierent regions of China:
the great diversity of milk fatty acids. J Nutr
1995;125:2993-8.
421 Muskiet FA, Kuipers RS, Smit EN, et al. The basis
of recommendations for docosahexaenoic and
arachidonic acids in infant formula: absolute or
relative standards? Am J Clin Nutr 2007;86:1802-
3.
422 Willett WC. Balancing life-style and genomics
research for disease prevention. Science
2002;296:695-8.
423 Yudkin J. Dietary Carbohydrate and Ischemic
Heart Disease. Am Heart J 1963;66:835-6.
424 Yudkin J. Evolutionary and historical changes
in dietary carbohydrates. Am J Clin Nutr
1967;20:108-15.
425 Eaton SB. Humans, lipids and evolution. Lipids
1992;27:814-20.
426 Cordain L, Watkins BA, Mann NJ. Fatty acid
composition and energy density of foods
available to African hominids. Evolutionary
implications for human brain development.
World Rev Nutr Diet 2001;90:144-61.
427 Crawford MA. Fatty-acid ratios in free-living
and domestic animals. Possible implications for
atheroma. Lancet 1968;1:1329-33.
428 O’Dea K, Sinclair AJ. Increased proportion of
arachidonic acid in plasma lipids after 2 weeks
on a diet of tropical seafood. Am J Clin Nutr
1982;36:868-72.
429 Sinclair AJ, O’Dea K, Naughton JM. Elevated
levels of arachidonic acid in sh from northern
Australian coastal waters. Lipids 1983;18:877-81.
82
Chapter 1
430 Gibson RA, Kneebone R, Kneebone GM.
Comparative levels of arachidonic acid and
eicosapentaenoic acid in Malaysian sh. Comp
Biochem Physiol C 1984;78:325-8.
431 Naughton JM, O’Dea K, Sinclair AJ. Animal
foods in traditional Australian aboriginal
diets: polyunsaturated and low in fat. Lipids
1986;21:684-90.
432 Konner M, Eaton SB. Paleolithic nutrition: twenty-
ve years later. Nutr Clin Pract 2010;25:594-602.
433 Eaton SB, Eaton SB,III, Konner MJ. Paleolithic
nutrition revisited: a twelve-year retrospective
on its nature and implications. Eur J Clin Nutr
1997;51:207-16.
434 Eaton SB, Eaton SB,III. Paleolithic vs. modern
diets--selected pathophysiological implications.
Eur J Nutr 2000;39:67-70.
435 Cordain L, Miller JB, Eaton SB, et al. Macronutrient
estimations in hunter-gatherer diets. Am J Clin
Nutr 2000;72:1589-92.
436 Kuipers RS, Luxwolda MF, Dijck-Brouwer DA,
et al. Estimated macronutrient and fatty acid
intakes from an East African Paleolithic diet. Br
J Nutr 2010;104:1666-87.
437 Morgan E. The Aquatic Ape Hypothesis. London:
Souvenir Press; 1997.
438 Horrobin DF. The madness of Adam and Eve.
How schizophrenia shaped humanity. Berkshire
UK: Cox & Wyman Ltd Reading; 2001.
439 Hotamisligil GS, Erbay E. Nutrient sensing and
inammation in metabolic diseases. Nat Rev
Immunol 2008;8:923-34.
440 Forsythe CE, Phinney SD, Fernandez ML, et al.
Comparison of low fat and low carbohydrate
diets on circulating fatty acid composition and
markers of inammation. Lipids 2008;43:65-77.
441 Volek JS, Phinney SD, Forsythe CE, et al.
Carbohydrate restriction has a more favorable
impact on the metabolic syndrome than a low
fat diet. Lipids 2009;44:297-309.
442 Forsythe CE, Phinney SD, Feinman RD, et al.
Limited eect of dietary saturated fat on
plasma saturated fat in the context of a low
carbohydrate diet. Lipids 2010;45:947-62.
443 Simopoulos AP. Essential fatty acids in health and
chronic disease. Am J Clin Nutr 1999;70:560S-9S.
444 Simopoulos AP. Evolutionary aspects of diet
and essential fatty acids. World Rev Nutr Diet
2001;88:18-27.
445 Feinman RD, Volek JS. Low carbohydrate diets
improve atherogenic dyslipidemia even in
the absence of weight loss. Nutr Metab Lond
2006;3:24.
446 Osterdahl M, Kocturk T, Koochek A, et al. Eects
of a short-term intervention with a paleolithic
diet in healthy volunteers. Eur J Clin Nutr
2008;62:682-5.
447 Jonsson T, Granfeldt Y, Ahren B, et al. Benecial
eects of a Paleolithic diet on cardiovascular risk
factors in type 2 diabetes: a randomized cross-
over pilot study. Cardiovasc Diabetol 2009;8:35.
448 Lindeberg S, Jonsson T, Granfeldt Y, et al. A
Palaeolithic diet improves glucose tolerance
more than a Mediterranean-like diet in
individuals with ischaemic heart disease.
Diabetologia 2007;50:1795-807.
449 Frassetto LA, Schloetter M, Mietus-Synder M,
et al. Metabolic and physiologic improvements
from consuming a paleolithic, hunter-gatherer






Estimated macronutrient and fatty acid intakes from an




S. Boyd Eaton 2
Michael A. Crawford 3
Loren Cordain 4
Frits A.J. Muskiet1
1Laboratory Medicine, University Medical Center Groningen, The Netherlands,
 2Departments of Anthropology and Radiology, Emory University, Atlanta, USA.
3Imperial College, Bio-molecular Medicine, London, United Kingdom.
4Department of Health and Exercise Science, Colorado State University, USA.




Background: Our genome slowly adapts to changing conditions of existence. Many diseases of
civilization result from mismatches between our Paleolithic genome and the rapidly changing
environment, including our diet.
Objective: Reconstruction of multiple Paleolithic diets to estimate the ranges of nutrient-intakes
upon which humans evolved.
Design: A database of, predominantly East-African, plant and animal-foods (meat/!sh) was
employed to model multiple Paleolithic diets, using two pathophysiological constraints [i.e.
protein<35 energy% (en%); linoleic acid (LA)>1.0 en%], at known hunter-gatherer plant/animal-
food intake ratios (range 70/30-30/70 en%/en%). We investigated selective and non-selective
savannah, savannah/aquatic and aquatic hunter-gatherer/scavenger foraging-strategies.
Results:We found (range of medians in en%) intakes of: moderate-high protein25-29 moderate-high
fat30-39 and moderate carbohydrates.39-40 The fatty acid (FA) composition was: saturated-FA (11.4-12.0),
monounsaturated-FA (5.6-18.5) and polyunsaturated-FA (8.6-15.2). The latter was high in alpha-
linolenic acid (ALA) (3.7-4.7 en%), low in LA (2.3-3.6 en%), and high in long-chain polyunsaturated-
FA (LCP; 4.75-25.8 g/day), LCPω3 (2.26-17.0 g/day), LCPω6 (2.54-8.84 g/day), ALA/LA-ratio (1.12-1.64
g/g) and LCPω3/LCPω6-ratio (0.84-1.92 g/g). Consistent with the wide range of employed variables,
nutrient intakes showed wide ranges.
Conclusions: Compared to Western diets, Paleolithic diets contained consistently higher protein
and LCP, and lower LA. These are likely to contribute to the known bene!cial e#ects of Paleolithic-
like diets, e.g. through increased satiety/satiation. Disparities between Paleolithic, contemporary
and recommended intakes might be important factors underlying the etiology of common Western
diseases. Data on Paleolithic diets and lifestyle, rather than the investigation of single nutrients,
might be useful for the rational design of clinical trials.
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INTRODUCTION
Our genome is the product of millions of years of evolution in which it slowly adapted to ensure
reproductive success under the environmental selective pressures imposed upon our species.1
Evolutionary medicine predicts that many complex degenerative diseases originate from unfavorable
changes in our environment that, in the light of our long generation time, are too rapid to cause
appropriate adaptation of our slowly adapting genome.2 Such genetic adaptations are also unlikely
to occur, since these unfavorable changes exert little selection pressure. That is, they do not cause
death prior to reproductive age, but rather reduce years in health at the end of the life cycle.1,3 Our
nevertheless increased life expectancy, originates mostly from technological achievements (e.g. the
introduction of public health sanitation, the prevention of (childhood) infections, famine, homicide
and tribal warfare),4 which diminish the inuence of certain unfavorable conditions of existence.
Since the agricultural revolution (some 10,000 years ago) and notably since the industrial revolution
(some 200 years ago) we introduced numerous unfavorable changes into our environment and
lifestyle. These factors include changes in diet, physical activity, stress, sleep duration, environmental
pollution among others. Important dietary and environmental changes, especially in auent
countries, that may adversely aect health and well being include: a decreased ω3/ω6 fatty acid
ratio, the combining of high intakes of saturated fatty acids (SAFA) and carbohydrates,5 introduction
of industrially produced trans fatty acids, reduced exposure to sunlight, lower intakes of vitamins D
and K, imbalanced intake of antioxidants, high intakes of carbohydrates with high glycemic indices
and loads, and little dietary !ber. Together with a sedentary lifestyle, these dietary alterations gave
rise to an unprecedented body composition characterized by increased fat mass and sarcopenia.6
These culturally driven environmental changes have exceeded the exibility of our epigenotype to
adapt and have resulted in a maladapted phenotype, primarily after reproductive age.
It has been hypothesized1 that the range of optimal nutrient combinations to support good
health are present in the foods that were consumed by our Paleolithic ancestors living from 2.5
million to 10.000 years ago. Their diets and environment represent the selective pressures under
which our genome evolved. The !sh oil fatty acids EPA and DHA (and their derivatives), vitamin D
(1,25-dihydroxyvitamin D) and vitamin A (retinoic acid) are examples of nutrients that act in concert,
while each of these have multiple actions.7,8 Consequently, criteria for establishing optimum
nutrient intakes via randomized controlled trials (RCT) with single nutrients at a given dose and
with a single endpoint have serious limitations. They are usually based upon poorly researched
dose-response relationships and typically ignore many possible nutrient interactions and metabolic
interrelationships. For instance the adequate intake of LA to prevent LA-de!ciency is dependent
upon concurrent intakes of e.g. alpha-linolenic acid (ALA), γ-linoleic acid and arachidonic acid
(AA). Consequently, the nutritional balance on which our genome evolved is virtually impossible
to determine by using the reigning paradigm of ‘evidence based medicine’ with RCTs. Nutritional
research rather needs an organizational template that focuses upon optimal homeostasis. This
template may be obtained from the reconstruction of Paleolithic diets. Disparity between the range
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of nutrients found in the current Western diet and reconstructed Paleolithic diets, will provide
direction for guiding future dietary interventions.
The composition of Paleolithic diets may be derived from many disciplines, including biology,
archeology, anthropology, comparative anatomy, genetics, food science and (patho)physiology. For
instance, the sites at which fossil remains of our hominin ancestors have been discovered suggest
that the evolution to anatomically modern humans took place on a long chain ω3-fatty acid rich diet
in an East-African water-land ecosystem.9-12 Additionally, the last Out-of-Africa Diaspora, starting
some 100,000 years ago, largely took place via the coastal lines,13 including crossing into the
Americas via the Bering Strait.14 Compared with hunting in the savanna, food from these ecosystems
is relatively easy to obtain and rich in heme-iron, iodine, zinc, copper, selenium, vitamins A and
D, and ω3-fatty acids from both vegetables and sh, which are collectively referred to as ‘brain-
selective nutrients’.15,16 Epidemiological data as well as landmark trials with ω3-fatty acids or sh
consumption demonstrated favorable outcomes for coronary heart disease (CAD),17-19 (postpartum)
depression,20,21 homicide mortality21 and neurodevelopment.22 The importance of dietary LCP is also
supported by our low capability to synthesize LCP during the entire life cycle,23 suggesting that
ancestral human intakes of AA, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were
sucient for survival and reproductive success. The recently discovered polymorphisms24 of fatty
acid desaturases 1 (FADS1; also named delta-5 desaturase) and FADS 2 (delta-6 desaturase) with
lower activities in their conversion of ALA and LA to LCP add to the notion that at the time of the
rst occurrence of these mutations, dietary LCP intakes compensated for the concomitantly lower
LCP synthesis.
Eaton et al.1,3,25,26 were the rst to reconstruct a Paleolithic diet. They assumed a savannah-type
diet with non-selective consumption of animals, implying that all available organs were consumed.
This model was further rened by Cordain et al.,27,28 who assumed a savannah diet with multiple
subsistence ratios and an ‘optimal foraging’ strategy. ‘Optimal foraging’ assumes the preferred
consumption of energy dense foods28-30 (e.g. by the selective consumption of plants with high
fat percentages and the selective consumption of energy dense animal organs, such as brain and
bone marrow). Compared to contemporary intakes, both models26-28 suggested lower carbohydrate
and higher intakes of protein and LCP. None of the earlier models separately evaluated food intake
from the water-land ecosystem, which is the presumed niche of our ancestors10-14 and an abundant
source of EPA and DHA.
We estimated the dietary macronutrient (carbohydrate, protein, fat) and fatty acid compositions
for four foraging strategies ascribed to Paleolithic hunter-gatherer/scavengers who foraged in
the savannah (Model 1), a water-land ecosystem (Model 4) and a combination of both (Models 2
and 3). The aim was to determine the composition and range of dietary macronutrients and fatty
acids under which the human genome evolved and which likely would support modern day health
and well-being. In contrast to Eaton et al.26 our modeling of the savannah diet assumed selective
consumption of organs, while compared to the savanna diet of Cordain et al.,28 we additionally
87
Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet
2
varied the contributions from muscle, marrow and brain. Our purely aquatic foraging strategy
(Model 4) has not been previously evaluated. For the reconstruction we dierentiated between
selective (Models 1 and 3) and non-selective (Models 2 and 4) meat consumption. Within each
model we varied the plant/animal subsistence ratios, the meat/sh ratios (Models 2 and 3), the fat
contents of the consumed plants, meat and sh (Models 2-4) and the muscle/marrow/brain ratios
(Models 1 and 3). The nal outcome was subjected to certain pathophysiological constraints, since
not all dietary combinations were considered to be compatible with health. In evolutionary terms,
health may be dened as evolutionary tness to survive up to reproductive age and beyond for
successful reproduction and to take care of the younger (the so called grandmother hypothesis31,32),
respectively.
METHODS
Background for the models
For the calculation of the average macronutrient and fatty acid intakes we divided the diet into
two main components (i.e. plant and animal foods). In contrast to earlier models,26,28 we subdivided
animal food into meat and sh, in which the former was further subdivided into ve edible
components, namely skeletal muscle, brain, marrow, liver and adipose tissue. Additional organs
(e.g. kidney, adrenals, spleen, heart, blood etc.) were considered to be of minor interest. They were
not included due to limited data on nutrient compositions and a relatively small contribution to
overall weight. Since we aimed at investigating the possible ranges of nutrient intakes from multiple
Paleolithic diets, we included a wide, but necessarily possible, range of variables. In all models (see
below), the plant/animal food ratios in energy% (en%) were varied from 70/30 to 30/70 en%/en%,
which is in the range of the most commonly observed hunter-gatherer subsistence ratios.26,28 The
fat contents by weight (g/100 g edible material; g%) of all plants, meat and sh were varied from
2.5-5.0 g%, 5.0-30 g% and 2.5-10.0 g%, respectively, for which justication is given in each particular
section below. The macronutrient and fatty acids contents of edible material were taken from the
literature, internet food databases33 and our own data. Detailed information on energy and fat
contents and the fatty acid compositions of the various foods and their literature references are
given in supplementary Table 1. Table 1 presents the means, as compiled from these raw data.
Using the above approach, we calculated the outcomes of four dierent models, representing four
foraging strategies ascribed to early Homo and assuming a daily energy intake of 12,500 kJ.
Description of the models
Model 1 describes a selective hunter-gatherer/scavenger savannah diet that is composed of plant
and animal foods that are eectively available on the savannah, while the consumption of aquatic
food was excluded. The employed hard data are in supplemental Table 1 and Table 1. ‘Selectivity’
implies that from the animal food only the skeletal muscle, marrow and brain were consumed and
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1-80 en% (bone marrow) and 1-20 en% (brain) of the total meat intake. Model 2 describes a non-
selective hunter-gatherer/scavenger savannah/aquatic diet that contains plant and animal foods
that are available on the savannah and in an aquatic environment. In accordance with Eaton,26 this
model assumes the whole animal carcass was consumed (i.e. non-selective), including most animal
organs and also the skin and the head in case of !sh. The meat and !sh intakes were varied from
100-0 and 0-100 en% of total animal consumption, respectively. For the !sh we used the energy,
fat and fatty acid contents of East-African lake and marine !sh because of their speci!c fatty acid
compositions.34,35 Model 3 describes a selective hunter-gatherer/scavenger savannah/aquatic diet.
The model assumes a diet from aquatic resources and the selective scavenging of muscle, bone
marrow and brain from savannah animals. The meat and !sh intakes were again varied from 100-0
and 0-100 en% of total animal consumption, respectively. In this model we varied the intakes from
muscle, bone marrow and brain from 0-50 en% (muscle), 40-80 en% (bone marrow) and 10-20 en%
(brain) of total meat intake. The !sh and plant fat contents were both set at 5 g% in this model,
while the average fat contents of the combined muscle/marrow/brain in meat varied from 10-30
g%. Model 4 describes a non-selective hunter-gatherer/scavenger aquatic diet that is composed of
plants and !sh, while the consumption of meat was not included. Consequently, the !sh intakes
were 100% of animal foods in all applied subsistence ratios. The !sh fat content was varied from 2.5
to 10.0 g%. For the energy, fat and fatty acid content of consumed aquatic foods we only applied
data for East African !sh species.
Justication for the models
The range of the subsistence ratios applied in our models needed evaluation because of the
absence of accurate data on human nutritional (plant/animal en%/en%) subsistence ratios in the
Paleolithic. Unfortunately, plant/animal (en/en%) subsistence ratios cannot simply be derived from
gathering/hunting subsistence ratios. Anthropological studies that di"erentiate between gathering
and hunting often include gathered plant as well as unimportant36 and small37,38 animal foods into
‘gathering’. They also report the contribution of gathering as a percentage of subsistence economy
rather than a percentage of energy (en%). Secondly, in contrast to common belief, hunting probably
played a less dominant role from a nutritional point of view as compared to gathering and on average
makes up 35% of the subsistence base for present day worldwide hunter-gatherers, independent
of latitude or environment.27,38 For example, hunting by some surviving hunter-gatherers is still
not very successful: the probability for a kill in !Kung bushmen is only 23%38 and the subsistence
of Hadzabe, as described by Woodburn39 consists of 80% plant foods. In the Paleolithic however,
hunting might have been more productive, due to both higher animal biomass and since hunter-
gatherers had not been displaced yet into marginal environments, unattractive for crop cultivation
or cattle. Consequently, we chose the employed ratios within the range of the most commonly
observed hunter-gatherer subsistence ratios.26,27
The justi!cation for the employed energy densities comes from the common misconception
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that members of present day auent societies are taller than our ancestors. The average height of
Paleolithic humans would have placed them within the tallest 15% of our population.40 Our former
nomadic lifestyle as a hunter-gatherer was characterized by vigorous physical activity and lean body
mass in contrast to the present day sedentary lifestyle and worldwide increasing body mass indices.
The anatomical features and physical activity of pre-agricultural humans probably demanded a
greater caloric intake than necessary for current Western populations. The total energy expenditure
of Homo habilis was estimated to be 10,000 kJ/day41 and 8,961 kJ/day for !Kung bushmen,38 but
was probably somewhat higher for early Homo sapiens.42 Energy intakes should be in concordance
with the physical activity level (PAL); that represents the ratio between the variable total energy
expenditure (TEE) and the constant resting metabolic rate (RMR). A typical PAL in the Paleolithic
would be 1.74, compared to 1.4 for a typical sedentary American and 1.75 as recommended by the
WHO.43 The daily energy expenditure, as physical activity, in the Paleolithic, however was estimated
at 5,193 kJ, with a total caloric intake of 12,144 kJ, but sedentary humans consume 8,500 kJ/day,
while spending only 2,324 kJ/day on physical activity. Adjustment of the caloric intake to the current
PAL, would however inherently imply lower nutrient intakes (i.e. LCP and micronutrients), compared
to our Paleolithic ancestors. To preclude underestimation of the Paleolithic nutrient intakes, we
therefore employed the daily intake of 12,500 kJ/day.
We employed selective hunter-gathering/scavenging (i.e. including brain and bone marrow)
in Models 1 and 3, but non-selective hunter-gathering/scavenging (i.e. including all edible organs)
in Models 2 and 4. Selective organ consumption would increase both the fat (hence the caloric)
and the LCP content of the meat (Table 1 and Table 2). To elucidate this net e"ect of selective
organ consumption we modeled the in#uence of increased organ tissue consumption44-47 on the
macronutrient and fatty acid intakes. The exclusion of liver and adipose tissue in Models 1 and 3
comes from the observation that scavenged leftovers from carnivore kills seldom contain energy
dense organs such as the liver and adipose tissue.45 Liver and adipose tissue are the $rst to be
consumed by the obligate carnivore, while the head and bones are the most likely leftovers because
of their inaccessibility.44 Although it has been suggested that, apart from the remaining muscle
meat,44,45,47,48 tool-using hunter-gatherer scavengers48 could have had selective access to brain and
marrow44-47 for the main period of human evolution; it seems unlikely that brain or marrow would
have been as easily accessible for consumption, especially for women and children, as aquatic LCP-
rich animal foods. Although both marrow and brain are sizeable, energy dense, organs45-47 (Table 3),
a substantial contribution from marrow and brain to any regular diet seems unlikely with regard to
their sizes and perishability. The high (80/20 en%/en% from marrow/brain to the total meat en%)
was therefore included to investigate one of the possible ranges of nutrient intakes, rather than the
most realistic or average. From approximately the middle Stone Age on, after humans became top
predators, brain and marrow, but also liver and adipose tissue would have become more frequently
accessible (i.e. Model 2). The selective consumption of energy dense organs (fat) is consistent with
the optimal foraging theory and their preferential consumption was indeed observed in present
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day hunter-gatherers (RSK and MFL; personal observations). In support of optimal foraging, it was
recently shown that after fasting the human brain responded more actively to pictures of high-
calorie foods compared to low-calorie foods.30
Plant composition
The macronutrient composition and caloric value of plant foods (Table 2) were derived from Eaton
et al.26 (fat 19 en%; protein 13 en% and carbohydrate 68 en%) and Cordain et al.27 (fat 24 en%;
protein 14 en% and carbohydrate 62 en%). They assumed a range from 469 kJ/100 g at 2.1 g% plant
fat26 to 699 kJ/100 g at 5 g% plant fat.27,49 For Model 1 we adopted a 2.5 g% plant fat !gure, while
for Models 2-4, we varied the plant fat contents from 2.5-5 g%. Cordain27 used a mean plant fat
content of 5 g%, as derived from 829 wild plant foods consumed by Australian Aboriginals.49 The
fatty acid compositions of plant foods (Table 1) were derived from Guil et al.,50 as also used by Eaton
et al.,26 with additional data for African vegetables such as terrestrial leaves, seeds, roots, tubers,
nuts and fruits.51-55 Edible seaweed, sea grasses and algae,56-59 like insects,60,61 were not included,
but are shown for comparison in Supplemental Table 1. Marine, terrestrial plants and insects have
comparable FA contents, except for the high LCP and lower precursor content in marine plants.
Justi!cation for using the range of plant fat percentages in our models may come from examples
of currently consumed plant foods in East-Africa. Tubers eaten by the Hadzabe in Tanzania contain
up to 5 g% fat.52 Although indigenous to North-America, Congolese tribes consume avocados with
19 g% fat.55 Coconuts contain 46 g% fat and could have been available to our ancestors,35 while palm
nuts and peanuts contain 46 and 49 g% fat, respectively.55 Nigerian wild plant seeds contain up to 59
g% fat,53 nuts eaten by Australian Aborigines contain on average 29 g% fat49 and the !Kung Bushmen
consume fat-rich mongongonuts (57 g% fat) as staple food when available.51 The preference of nuts
or fatty fruits above low-fat leaves is consistent with optimal foraging.29,30
Meat composition
Non-selective meat consumption
Animal foods were subdivided into muscle, brain, bone marrow, liver and adipose tissue/separable
fat. About 50% of the total body weight of game animals is edible.62 For the calculation of the energy
density and the energy contributions of protein and fat from an average edible portion of non-
selectively consumed meat we assumed the following weight distribution and fat contents: skeletal
muscle 90.2 g% containing 2.9 g% fat; brain 1.0 g% with 9.1 g% fat; liver 3.8 g% with 6.7 g% fat;
bone marrow 3.0 g% with 51.0 g% fat and adipose tissue 2.0 g% with 84.2 g% fat.26,45,47,55,63-70 The
cumulative fat percentage of a non-selectively eaten portion of meat amounts to 4.89 g/100 g,26
which for practical purposes was rounded to 5.0 g% fat, with a corresponding energy density of
549 kJ/100 g (see Table 2). For the various fat contents of non-selectively consumed meat (i.e. 2.5-10
g%) we calculated the energy densities and the energy contributions of protein and fat. For meat,
the relations between energy density and fat content, and between energy from protein and fat
93
Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet
2
content, are linear, as previously noted by Cordain et al.27 The employed relationships are:
Energy density for meat (in kJ/g) = 3.616 + 0.371*body fat (% by wt) (1)
Energy contribution for protein (in kJ/g) = 96.79 – (7.92 * body fat (% by wt)) +
(0.403 * (body fat (% by wt))2) – (0.0090 * (body fat (% by wt))3)27 (2)
The fat contents of meat (in en%) were calculated by taking 100 en% minus the protein en%. The
nal outcomes are in Table 2.
Selective meat consumption
The energy density and the contributions of protein and fat from an average portion of selectively
consumed meat were calculated at 3 fat contents (i.e. 10.0; 19.0 and 30.0 g%). These fat percentages
were derived from 3 di!erent combinations of muscle, marrow and brain, i.e. 50/40/10, 20/64/16
and 0/80/20 en%/en%/en%, respectively. Justication for these combinations comes from the
observation (see Results section) that protein intakes exceed the stated protein constraint (see
below) from about 50 en% muscle consumption. Since brain and bone marrow have similar total
weights (Table 3),45-47 but bone marrow has about 4 times higher energy density (Table1), we kept
the bone marrow/brain constant at a ratio of 4 en%/en%.
The calculations of the fat content (g%), energy from all macronutrients (kJ/100 g), and protein
and fat contributions (in en%) may be illustrated as follows. A 20/64/16 en%/en%/en% ratio from
muscle, bone marrow and brain, respectively, implies that for each 4,188 kJ selectively eaten
meat of this composition 838, 2,680 and 670 kJ are derived from muscle, bone marrow and brain,
respectively. Using the energy densities of these organs from Table 1, these energy quantities
translate into 838/452 = 185 g muscle; 2,680/2,044 = 131 g bone marrow; and 670/528 = 127 g
brain. These gures add to a total of 443 g selectively eaten meat, of which 41.7 g% is derived from
muscle, 29.6 g% from marrow and 28.7 g% from brain. The total fat content of this 443 g portion was
calculated by using the fat contents of the individual organs from Table 1, yielding 19 g% fat (see
Table 2). The energy contribution from all macronutrients and the contribution from protein were
subsequently calculated by using equations 1 and 2, respectively (see above), yielding 1,072 kJ/100
g selectively consumed meat and 30 en% from protein. The fat content (in en%) was calculated
by taking 100 en% minus the protein en%. The fat content (g%), energy from all macronutrients
(kJ/100 g), and protein and fat contributions (in en%) for the 50/40/10 and 0/80/20 en%/en%/
en% compositions were calculated in a similar manner. These calculations needed extrapolation
for the 0/80/20 composition, since the original data of Cordain’s27 equation 2 did not consider fat
percentages above 25 g%. The nal outcomes of the calculations for each of the organ combinations
for selectively consumed meat are presented in Table 2.
Justication for the use of variable fat percentages in our models comes from the available data
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from East-African animal and hunter-gatherer studies. The nutrient composition of the various tissue
compartments in animals is variable. For instance, the fat content of skeletal muscle from game
animals is much lower than that of livestock47,64,71 and ranged from 2.0 g% in the Ugandan Eland68 to
4.6 g% in monkey bush meat from Zaire55 in our database, but can be as high as 25 g% in domestic
cattle.64 The fat content of bone marrow is strongly dependent upon season and the animal’s age
and physical condition.45,47 Also the size of the adipose tissue mass of game animals is dependent on
season, condition and age.45-47 In contrast to the above organs, the fat contents of liver and brain are
rather constant.47 In view of this variance and the optimal foraging theory29,30 we varied the average
fat content of the consumed whole carcass edible meat from 5.0-10.0 en% and for (very) selective
organ consumption in Models 1 and 3 to a maximum of 30.0 en% to calculate the caloric value and
the macronutrient and fatty acid compositions of the possible diets. It is important to realize that
the consumption of ‘meat’ containing 30 g% fat does not refer to consumption of lean muscle meat
only, since the maximum lean meat fat% of some East African mammal species was 13.0 g% in a
female hippopotamus in Ledger’s classical study.62 We rather point at the selective consumption of
fatty organs as the brain and bone marrow or liver and adipose tissue. Secondly, selective hunting
would be part of optimal foraging strategies,29 meaning that hunter-gatherers would spend more
e!ort in hunting fat than in hunting lean animals. With reference to the employment of a wide range
of dietary fat, we emphasize that the current study is rather designed to show the range of possible
dietary intakes from a constantly changing environment in the past, than to point at one speci"c
dietary composition.
Fish composition
At various "sh body fat contents (i.e. 2.5; 5.0; 7.5 and 10.0 g%) we calculated the energy density
and the contributions of protein and fat (in en%). We found that the energy densities for "sh
Table 3. Average weight of whole animal. edible portion of whole animal and average weight of brain and
marrow for African savannah animals
Animal Weight Flesh Brain Marrow
(kg) (% of wt)) (g) (g)
Thompson’s Gazelle. adult 16.3 48 60
Thompson’s, juvenile 12.5 47 41
Impala, adult 55.4 54 102 154
Grant’s Gazelle, adult 57.3 53 202
Grant’s, juvenile 12 53 34
Warthog, adult 61.4 55 91
Topi, adult 114 54 353
Hartebeest, adult 130 58 140 293
Wildebeest, adult 165 44 238 365
Zebra, adult 273 341 119
Data adapted from Blumenschine & Madrigal45 and Lupo46
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Figure 1. Relation between body fat (in g%) and energy density (in kJ/g) for sh. All the data on freshwater
sh are derived from the USDA internet database (n=87), accessed on 15 August 2008.33 y = 0.0366x + 3.425,
R2 = 0.94
from the USDA food database33 correlate excellently with the corresponding body fat contents
(Figure 1). Using the linear relationship: energy density (kJ/g) = 0.366 * body fat (in g%) + 3.425 (R2
= 0.94) we subsequently calculated the energy densities at the various sh body fat contents. The
corresponding energy contributions for protein were calculated from the following equation:
Protein (en%) = 97.67 – (9.45 * body fat (g%)) + (0.535 * (body fat (g%))2) –
(0.0127 * (body fat (g%))3)27 (3)
The sh fat contents (in en%) were calculated by taking 100 en% minus the protein en%. The nal
outcomes are in Table 2.
Justication for the employed fat percentages from sh may come from the following data. The
fat content of most pelagic sh is around 2.5 g%, but African catsh have fat contents above 10
g%.72 In most studies, the fat content is derived from analyses of the llet, while Pauletto et al.72
specically examined a portion including the fat-rich skin (37-44 g% of total fat).73 In addition to
the consumption of skin, the rst part of a sh to be eaten by Africans is the head, which contains
10-17 g% of total fat.73 Another 3.5-6 g% of fat may come from the consumption of the backbone.73
Although large sh were reportedly caught with bare hands back to 2 million years ago,9 especially
in smaller sh the skin would have been a substantial part of the total edible portion. For instance
we estimate that 2-20 g% fat would be derived from the whole consumption of a 10 cm sh with
a diameter of 3 cm and a 2 mm skin. Taking these assumptions into account for the approximation
of the average fat content of the sh consumed by early humans, we varied the average sh fat
content in our models from 2.5-10.0 g%. Since ‘you are what you eat’ also applies to sh, we only
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used fatty acid data on East-African sh species. The dierential fatty acid status of worldwide and
East-African sh species10,34,35,72,73 are presented in supplemental Table 1. Data for the FA composition
of some other typical marine animals, such as crustaceans, cephalopods and certain marine reptiles,
birds, mammals, including their eggs, livers and adipose tissue are presented in Supplemental Table
1, but are not included in the models. The FA compositions are quite similar to that of the employed
African sh species.
Calculation example
The example assumes a 12,500 kJ/day diet that is composed of 70 en% plant (containing 2.5 g%
fat) and 30 en% animal food. The latter is composed 15 en% sh with 2.5 g% fat and 15 en% meat.
The meat was either non-selectively consumed meat with 5 g% fat, or selectively eaten meat with
19 g% fat.
Macronutrient composition
The plant protein contribution in this example would be 12,500 kJ/day * 70 en% * 13 en% (Table 2)
= 1.143 kJ/day. Similarly, the protein contribution from meat would be 12,500 * 15% * 66% (Table
2) = 1,244 kJ/day, while the protein contribution from sh is 12,500 * 15% * 77% (Table 2) = 1,453
kJ/day. Taken together, the total protein intake from this 12,500 kJ/day diet would be 1,143 + 1,244
+ 1,453 = 3,840 kJ/day, which equals 30.6 en% of total energy intake. The corresponding fat and
carbohydrate intakes were 2,747 kJ/day (21.9 en%) and 5,980 kJ/day (47.5 en%), respectively.
The macronutrient contribution for 19% fat in selectively consumed meat is calculated in a
similar manner. The plant protein contribution would again be 1,143 kJ/day (see above). The protein
contribution from meat would be 12,500 * 15% * 30% (Table 2) = 565 kJ/day, while the contribution
from sh protein would again be 1,453 kJ/day (see above). Taken together, the total protein intake
from this 12,500 kJ/day diet would be 1,143 + 565 + 1,453 = 3,161 kJ/day, which equals 25.2 en% of
total energy intake. The corresponding fat and carbohydrate intakes were 3,425 kJ/day (27.3 en%)
and 5,980 kJ/day (47.5 en%) respectively.
Fatty acid composition: arachidonic acid as an example
Table 4 shows the outcome of the arachidonic acid (AA) content per 100 g of consumed meat, as
calculated by assuming non-selective and selective meat consumption, respectively. Data for all
other fatty acids in Table 1 were also calculated (not shown). The employed AA data in plants and
sh are presented in Table 1.
A 12,500 kJ/day diet with 70 en% from plants corresponds with 8,794 kJ/day from plants. The
plant energy density at 2.5 g% fat is 469 kJ/100 g (Table 2), which translates the 8,794 kJ/day into
an intake of 8,794/4.69 = 1,875 g plants/day. The plants were assumed to contain 2.5 g% fat with
an AA content of 0.64 g/100 g fat (Table 1), which implies a total daily AA intake of 1,875 * 2.5/100
* 0.64/100 = 0.30 g from plants. Similarly, 15 en% from sh with 2.5 g% fat translates into 12,500
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Table 4. Arachidonic acid AA) content of 100 g consumed meat assuming non-selective (whole carcass)
consumption or selective organ consumption.
Tissue Organa (g) Fatb (g%) AAc (g%) AAd (mg)
Non-selective consumptione
Muscle 90.2 2.9 6.40 167
Brain 1.0 9.1 5.74 5
Liver 3.8 6.7 9.40 24
Bone marrow 3.0 51.0 0.16 2
Adipose tissue 2.0 84.2 0.21 3
Total 100.0 203
Selective consumptionf
Muscle 41.7 2.9 6.40 80
Brain 28.7 9.1 5.74 150
Liver 0.0 6.7 9.40 0
Bone marrow 29.6 51.0 0.16 24
Adipose tissue 0.0 84.2 0.21 0
Total 100.0 254
a, Organ, contribution (in g) of the indicated organ to the consumption of 100 g meat at di"erent foraging
strategies
b, Fat, gram fat per 100 g of indicated organ
c, AA: gram AA per 100 g fat in indicated organ
d, calculated
e, data from Eaton et al.26 (organ contribution) and the literature (fat g% and AA g%; see suppl. Table 1)
f, calculated (organ contribution) and data from the literature (fat g% and AA g%; supplemental Table 1)
* 15/100 * 100/436 (Table 2) * 2.5/100 * 8.45/100 = 0.91 g AA per day. The daily amount of meat
from non-selective consumption at 15 en% would be: 12,500 * 15/100 * 100/549 (Table 2) = 344
g meat. With an average content of 203 mg AA per 100 g non-selectively eaten meat (Table 4),
this #gure adds up to 344 * 0.203/100 = 0.70 g AA per day. Assuming selective consumption of
meat the daily intake of AA would become: 12,500 * 15/100 * 100/1,072 (Table 2) * 0.254/100 (Table
4) = 0.45 g. Taken together, the intake of AA in this example from plants, #sh and non-selectively
consumed meat would be 0.30 + 0.91 + 0.70 = 1.91 g, while for selective meat consumption the
intake would be 0.30 + 0.92 + 0.45 = 1.67 g AA/day. Additional calculation of the daily intakes of all
other fatty acids and subsequent normalization to g/100 g fatty acids gave rise to the dietary fatty
acid composition (detailed data not shown).
Constraints
Since not all dietary combinations are compatible with good health, we introduced two
pathophysiological constraints. First the contribution of protein is not to exceed 35 en%, since this
may cause ‘rabbit starvation’, probably by exceeding the maximum capacity of the liver to convert
the excess nitrogen into urea.74 Some studies even suggest that in adult male hunter-gatherers the
protein intake may be closer to 40-50 en%.75 The constraint to restrict the average protein intake at
35 en% seems, however, justi#ed by hunter-gatherer observations.76 Second, LA intakes were to be
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above 1.0 en% to prevent LA deciency, especially in children. This constraint is derived from the
original data of Burr and Burr;77 as revisited by Cuthbertson,78 who even stated that ‘the minimum
requirements for LA are in fact less than 0.5% of calories;’ and set at a minimum requirement of
at least 1.0% of calories as LA to prevent biochemical LA-deciency. In animals, the minimum
requirement for LA could also be met by 18:3ω6 and AA,79 which would actually imply that the
currently employed constraint for LA would be superuous for any diet containing substantial
amounts of LCPω6 (see also discussion). In addition to these two constraints we tested whether the
reconstructed diets provide the daily intake of 450-500 mg EPA+DHA per day to lower CAD risk, as
recommended by e.g. the UK Scientic Advisory Committee on Nutrition, the WHO and ISSFAL.80
RESULTS
Means and ranges of the models
The extremes for Models 1, 2 and 3, i.e. the 70/30 and 30/70 en%/en% plant/animal subsistence
ratios, are depicted in Figures 2 and 3, respectively. For Model 1 a total of 105 di!erent diets were
evaluated. Of these 71 (68%) met the protein constraint, where after all models met the LA constraint
and the EPA+DHA recommendation. For Model 2 we evaluated a total of 1,320 di!erent diets; 674
(51%) met the protein constraint and thereafter all models met the LA constraints and the EPA+DHA
recommendation. Model 3 considered a total of 165 di!erent diets; 115 (70%) met the protein
constraint, where after again all models met the LA constraint and the EPA+DHA recommendation.
Model 4 is an extreme of Model 2 (or 3) and describes plant and sh intakes only. Since the model
is two, instead of multidimensional, it is not depicted separately. The model evaluated 40 options,
for which 22 (55%) met the protein constraint where after all models met the LA constraint and the
EPA+DHA recommendation.
Model 1 in Figure 2 represents data for a 70/30 en%/en% plant/animal subsistence ratio,
assuming the following fat contents: plants 2.1 g%, muscle 3.0 g%, bone marrow 51 g% and brain
9.1 g%. The contribution of muscle/marrow/brain to the consumed meat (in en%) was varied from
98/1/1 to 0/80/20 en%/en%/en%. The short hand notations of these extremes (see x-axis labels)
would be 70/98/1/1 to 70/0/80/20, in which the rst gure represents the en% from plants and the
last three gures the en% contributions from muscle/marrow/brain in the remaining 30 en% animal
food (i.e. only meat in Model 1), all at the xed fat contents (in g/100 g material). The data in this
example show that replacing muscle for bone marrow and brain (i.e. x-axis from left to right) causes
a decrease in the contributions of LA and protein (both in en%), and increases in the ALA/LA and
(EPA+DHA)/AA ratios (both in g/g). All investigated meat compositions within the depicted 70/30
en%/en% plant/animal example of Model 1 complied with the <35 en% protein, >1.0 en% LA and
met the >450 mg EPA+DHA recommendation.
Similarly, Figure 3 shows data for Model 1 at the 30/70 en%/en% plant/animal subsistence ratio.
The same plant, muscle/marrow/brain fat contents and the same animal compositions were used.
The protein constraint was met from a ratio of 30/50/40/10. All animal compositions complied with
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the energy constraints for LA and the 450 mg EPA+DHA recommendation.
For Model 2, examples are shown for 5 g% fat in plants, 5.0 g% fat in sh and 7.5 g% fat in whole
carcass meat (Model 2, Figures 2 and 3, left panels) and for 5 g% fat in plants, 7.5 g% fat in sh and
5.0 g% fat in whole carcass meat (Model 2, Figures 2 and 3, right panels). The meat/sh compositions
were varied from 100/0 to 0/100 en%/en% of total animal food. In the left panel for Model 2 in Figure
2, compliance with the protein and LA constraints and the EPA+DHA recommendation was reached



































LA (en %) EPA+DHA/AA (g/g) ALA/LA (g/g) Total energy from protein (en%)
Plant(5 g%)/Meat(7,5 g%)/Fish (5 g% fat)
Plant(5 g%)/Meat(5 g%)/Fish (7.5 g% fat)
Plant(2.5 g%)/Muscle(2.9 g%)/
Marrow (51.0 g%)/Brain(9.1 g% fat)
Model 2: non-selective hunter-gatherer/scavenger
aquatic diet
Model 3: selective hunter-gatherer/scavenger
savannah/aquatic diet
Protein ceiling = 35 en%
LA = 1.0 en%
Model 1: selective hunter- gatherer/scavenger
savannah diet





























































































































































Plant(5 g%)/Meat(30 g%)/Fish(5 g% fat)
Figure 2. The courses of the protein (total energy from protein, - -, en%) and linoleic acid (LA) intakes (-!-,
in en%) and the  -linolenic acid (ALA)/LA (- -) and EPA + DHA)/arachidonic acid (AA) ratios (-"-, in g/g)
with changing composition of animal food at a 70/30 en%/en% plant/animal subsistence ratio. Animal food
was composed of organ meat (skeletal muscle, brain, bone marrow, liver and adipose tissue) and sh. Meat
consumption was either selective (Models 1 and 3) or non-selective (Model 2). The shorthand notation on
the X-axes indicates plant/muscle/marrow/brain (Model 1) and plant/meat/sh (Models 2 and 3). Note the
di!erences of the left and right scales of the Y-axes. The range of dietary combinations within the box in
Model 1 was used for the construction of Model 3 (see text). Horizontal lines depict the employed protein
(<35 en%) and LA (>1.0 en%) constraints. The data for Model 1 (a selective hunter-gatherer/scavenger
savannah diet) were calculated by assuming the selective consumption of plant, muscle, bone marrow and
brain with the fat contents of 2.5, 2.9, 51.0 and 9.1 g%, respectively. Their intakes were varied between 98
and 0 en% (skeletal muscle), 1 and 80 en% (bone marrow) and 1 and 20 en% (brain) of the total meat intake.
The data for Model 2 (a non-selective hunter-gatherer/scavenger aquatic diet) were calculated by assuming
non-selective consumption of edible meat with the following weight distribution and fat contents: skeletal
muscle 90.2 g% containing 2.9 g% fat; brain 1.0 g% with 9.1 g% fat; bone marrow 3.0 g% with 51.0 g% fat;
liver 3.8 g% with 6.7 g% and adipose tissue 2.0 g% with 84.2 g% fat.25,45,47,55,62-68,70 The fat percentages were 5
g% for plants 5.0 g% for sh and 7.5 g% for whole carcass meat (left panel of Model 2), and 5 g% for plants,
7.5 g% for sh and 5.0 g% for whole carcass meat (right panel of Model 2). The data for Model 3 (a selective
hunter-gatherer/scavenger savannah/aquatic diet) were calculated by assuming the selective consumption
of muscle, bone marrow and brain with the fat contents of 2.9, 51.0 and 9.1 g%, respectively. The meat and
sh intakes were varied from 100 to 0 and 0 to 100 en% of total animal consumption, respectively. The
intakes from muscle, bone marrow and brain were varied (from left to right panel of Model 3) from 0 to 50
en% (muscle), 40 to 80 en% (bone marrow) and 10 to 20 en% (brain) of total meat intake. The fat contents
of sh and plants were both set at 5 g%, while the average fat contents of the combined muscle/marrow/
brain in meat varied from 10 (left panel of Model 3) to 30 g% (right panel of Model 3).
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Finally, for Model 3, examples are given again for the 70/30 en%/en% (Figure 2) and 30/70 en%/
en% (Figure 3) plant/animal subsistence ratios, but here at 50/40/10 (left panels) and 0/80/20 (right
panels) for the muscle/marrow/brain ratios. The fat contents were: 5 g% for plants, 10 g% for meat
and 5 g% for sh (left panels), and 5 g% for plants, 30 g% for meat and 5 g% for sh (right panels).
Justications for these fat percentages came from the application of the protein constraints to
Model 1 in Figure 3, which xed the muscle/marrow/brain ratios in meat between 50/40/10 and
0/80/20, and consequently also xed the fat percentages.
Table 4 presents the medians (ranges) from all investigated models together with the original data
from the savannah diet of Eaton et al.26 for a 65/35 en/en% plant/animal
subsistence ratio and from Cordain et al.27 for a 45/55 en/en% plant/animal subsistence ratio. All
presented data from Model 1 complied with the protein and LA constraint and the EPA+DHA
recommendation. All presented data of Models 1-4 (Table 5) complied with the protein and
LA constraints and, after application of these constraints, all models also met the EPA+DHA
recommendation.
Model outcomes
Model 1, selective hunter-gatherer/scavenger savannah diet
All the models met the EPA+DHA recommendation. It was found that with the exception of the
70/30 en%/en% plant/animal subsistence ratio, all investigated dietary options were limited by
the 35 en% protein ceiling. This ceiling was reached when more than 45 en% of animal food was
consumed as muscle meat. LA, AA and EPA+DHA intakes increased with decreasing plant intakes,
whereas ALA intakes decreased. At low plant intakes, only those options with high intakes of bone
Figure 3. The courses of the protein (total energy from protein, - -, en%) and linoleic acid (LA) intakes (-!-,
in en%) and the  -linolenic acid (ALA)/LA (- -) and EPA + DHA)/arachidonic acid (AA) ratios (-"-, in g/g)



























LA (en%) (EPA+DHA)/AA (g/g) ALA/LA (g/g) Protein (en%)
Model 1: selective hunter- gatherer/scavenger
savannah diet
Model 2: non-selective hunter-gatherer/scavenger
aquatic diet
Model 3: selective hunter-gatherer/scavenger
savannah/aquatic diet
Protein ceiling = 35 en%
LA = 1.0 en%
Plant(2.5 g%)/Muscle(2.9 g%)/Marrow(51.0 g%)
/Brain(9.1 g% fat)
Plant(5 g%)/Meat(7,5 g%)/Fish (5 g% fat)
Plant(5 g%)/Meat(5 g%)/Fish (7.5 g% fat)
Plant(5 g%)/Meat(10 g%)/Fish(5 g% fat)
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marrow and brain, relative to muscle, fullled the <35 en% protein constraint. At 70 en% intake from
plants, 0 en% from muscle, 80 en% from bone marrow and 20 en% from brain, the intakes of bone
marrow and brain would be 141 and 148 g/day, respectively. At he lowest intake of plants (i.e. 30
en%) and at contributions of muscle, bone marrow and brain ranging from 0-50, 40-80 and 10-20
en% respectively, the intakes on a weight basis for muscle, bone marrow and brain ranged from
0-867, 189-344 and 181-328 g/day, respectively. LA intakes ranged from 2.83-3.52 en% in a 70 en%
plant food diet and from 2.69-4.30 en% in a 30 en% plant food diet. With protein and LA complying
with their recommendations the intakes of EPA+DHA ranged from 0.88 -1.63 g/day at 70 en% plant
food, and from 2.20-2.98 g/day at 30 en% plant food, while the (EPA+DHA)/AA ratios ranged from
0.41-1.41 and 0.77-1.40 g/g, respectively.
Model 2, non-selective hunter-gatherer/scavenger savannah/aquatic diet
In this model, several plant/(meat/sh) ratios that were investigated at di!erent fat percentages
fullled the two constraints. All options that met these constraints also met the EPA+DHA
recommendation. Also here, the options became restricted by the protein ceiling, when the intake
of animal food increased. Reaching the protein ceiling proved dependent on the fat contents of
the consumed meat and sh, as can be concluded from Figures 2 and 3. Not unexpectedly, these
indicate that the lower the fat content of the animal foods (i.e. the leaner the meat), the sooner the
protein ceiling is reached. Since LA is relatively abundant in plants, muscle and liver, but not sh
(Table 1), the constraint for LA (>1.0 en%) could not be reached if 70 en% was consumed as animal
food that is composed of high fat meat (e.g. 100 en% meat with ≥ 7.5 g% fat) in combination with
low fat plants (e.g. 2.5 g% fat) (Figure 2, left panel for Model 2). Models 2 in Figures 2 and 3 show that
the slope of the (EPA+DHA)/AA curve steepens with increasing fat content in sh and decreasing
fat content in meat. This steepening of the (EPA+DHA)/AA curve takes place at an increase of both
the EPA+DHA and AA intakes, indicating that the EPA+DHA content of the various dietary options,
and not the AA content, is the most variable factor determining the (EPA+DHA)/AA ratio in Model 2.
Model 3, selective hunter-gatherer/scavenger savannah/aquatic diet
Model 3 combines the favorable foraging strategies for hunting, gathering and scavenging from
Models 1 and 2. All dietary options that met the constraints for protein and LA also met the
EPA+DHA recommendation (Table 5). The protein ceiling becomes limiting at the combination of
low plant intake and the consumption of low fat meat, as can be derived from Figure 3 (left panel).
This limitation became circumvented by the consumption of high fat meat (Figure 3, right panel),
while it also becomes circumvented by the consumption of high fat plants and sh (data not shown).
Model 4, non-selective hunter-gatherer/scavenger aquatic diet
In this model, 55% of the investigated plant/sh ratios that were investigated at di!erent fat
percentages fullled the protein constraint. All options meeting this constraint also met the LA































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































We estimated the median and ranges of the dietary macronutrient and fatty acid compositions
for multiple foraging strategies ascribed to Paleolithic hunter-gatherer/scavengers living in the
savannah, the water-land ecosystem and combinations of these. Most importantly we found
that the macronutrient composition averaged 25-29 (range 8-35) en% from protein, 39-40 (range
19-48) en% from carbohydrate and 30-39 en% (range: 20-72) from fat. These outcomes indicate
moderate-to-high protein and fat intakes, with moderate carbohydrate intakes. Compared to
current Western intakes and recommendations, the fatty acid composition was high in SAFA (range
of medians 11.4-12.0; total range 6.8-19 en%), and moderate-to-high in MUFA (5.6-18.5; 3.1-39 en%)
and PUFA (8.6-15.2; 8.1-21 en%). The PUFA were high in ALA (3.7-4.7; 2.1-5.8 en%), low in LA (2.3-
3.6; 1.7-6.2 en%), and high in LCP (4.75-25.8; 3.38-51.3 g/day); both LCPω3 (2.26-17.0; 1.47-33.9 g/
day) and LCPω6 (2.54-8.84; 1.91-17.4 g/day). Consequently, the ALA/LA ratio (1.12-1.64; 0.61-1.79
g/g) was remarkably higher compared to the present ALA/LA ratio (ALA/LA=0.09; .81 The LCPω3/
LCPω6 (0.84-1.92; 0.22-3.07 g/g) ratio was comparable to the current (0.85;81), but the absolute
intakes of both LCPω3 and LCPω6 were remarkably higher. A comparison with other employed
diets,18,82,83 some current worldwide intakes81,84-87 and recommendations,88-90 and a qualication of
the macronutrient,91 fatty acid and cholesterol composition is given in Table 6.
Our ecological niche
From 1.9 million to 200,000 years ago hominins have tripled their brain mass relative to body mass,
as usually expressed in terms of the encephalization quotient (EQ). The predominantly vegetarian
Australopithecines were estimated to have an EQ of 1.23-1.92, while the Homo genus has an EQ of
1.41-4.26.10 The Ardipithecus ramidus may have persisted in a more closed wooded habitat,92 but the
Australopithecines are assumed to have left the forest to enter the open93 where they were able to
introduce more energy dense animal food into their diets at the expense of energy poor plants.94
Improvement of dietary density and quality may have enabled an increase in brain size, while it also
provided the higher energy needs for the expanding, metabolically expensive, brain. It has been
Legend table 5
ALA, α-linolenic acid; DPA, docosapentaenoic acid; LCP, long-chain PUFA; LA, linoleic acid; AA, arachidonic acid;
P/S, polyunsaturated/saturated.
* Values in the models of Eaton et al.26 and Cordain et al.27 without reference were calculated by using the
present models. Protein, carbohydrate and fat contents were converted into kJ/g using conversion factors of
19.68; 17.50 and 39.53 kJ/g, respectively. Some of the calculated data on LCP, LCPω3 and LCPω6 from the
literature may su"er from underestimation, since authors seldomly give information on the complete fatty acid
prole used to calculate these sums. Also for some fatty acid contents, more data were available in the
literature than for others. As a consequence, for example, the sum of EPA+DPA+DHA (all regularly given) might
be higher than the sum of LCPω3, which is seldomly given.
† Adapted from Eaton et al.2
‡ Adapted from Eaton et al.3
 Adapted from Eaton et al.26
§ Adapted from Cordain et al.27
¶ Adapted from Frassetto et al.122
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hypothesized that brain growth was preceded by the development of a sizeable adipose tissue
compartment95 to ensure continuous availability of energy, which is also known as ‘the survival
of the fattest’.96 Other physical adjustments might have been necessary, since the adult primate
brain usually consumes 8-9 % of the total resting metabolic rate, while this amounts to 20-25 %
in anatomically modern humans.97 One of these adjustments is the loss of muscle.97 Additional
energy reallocation might have come from adjustment of the gastrointestinal tract. The size of our
current gastrointestinal tract comprises only 60% of expected for a similarly-sized primate, probably
because of its devotion to easily-digested energy dense foods rather than a ber-rich, bulky and
consequently energy-poor vegetarian diet that requires a large colon.98 The trade-o with the
energetically expensive gastrointestinal tract is also known as the ‘expensive tissue hypothesis’ of
Aiello and Wheeler.99
Brain expansion not only necessitates energy for its growth and maintenance, but also the
availability of building blocks such as AA and DHA, and many other factors, collectively referred to
as ‘brain-selective nutrients’.10,15 The question is what ecological niche would have supported the
growth of our brain and especially the increment of DHA within a species characterized by low DHA
synthetic capacity but yet high DHA needs. Comparison of the brain ethanolamine phosphoglycerols
of 42 species shows an almost identical LCP pattern that, independent of EQ, is composed of about
equal percentages AA and DHA.10 A low dietary DHA intake by rats lowers DHA in the frontal cortex,
downregulates DHA turnover, and increases AA turnover, which is a condition that has been related
to neuroinammation.100 Accretion of brain DHA in newborn baboons101 and newborn humans102 is
dependent on the postnatal dietary DHA supply during the brain growth spurt, which in humans
occurs from the last trimester up to 2 years after birth. An experiment with diets varying in ALA, LA,
AA and DHA administered to female mice from 3 days prior to conception showed that, in contrast
to the relatively static maternal brain, the growing fetal brain is extremely sensitive to low maternal
dietary DHA.103 Many RCT aimed at the consequences of low brain DHA in human newborns have
been performed. The results are at most inconclusive,22 but various re-commendations for DHA
intakes by formula and breastfed infants have been issued.104
Taken the above together, it seems clear that the evolution of our brain growth is unlikely to
have been hampered by poor availability of dietary DHA, which is abundant in the brain of the
animals that we might have consumed in the savanna, but notably the food that is available in
a water-land ecosystem. Our derivation from the land-water ecosystem is strengthened by the
African10 and European11 fossil records and the many pathophysiological consequences of a low
DHA status and a low intake of brain food in general. The many indications for the exploitation of
aquatic resources by early hominins date back as far as 2.3-2.0 million years ago in Semliki River,
Zaire.11 Collection of aquatic foods is still daily practice in East-Africa and picking up, clubbing,
spearing or killing aquatic-animals from a distance105 seems much easier than either scavenging or
hunting game on the Serengeti plains.10 Contrary to popular belief, our ancient ancestors did not
need shing gear to benet from the abundance of LCPω3 and LCPω6 in such ecosystems, where it
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is relatively easy to hunt and gather anything ranging from spawning (cat)sh, shellsh, crustaceans
and cephalopods (lobster, crab, shrimp, squid, octopus, etc) to sea urchins, amphibians, birds and
reptiles and their respective eggs.11 All of these species ultimately receive their LCPω3 from plankton
via the local food chain.106 We seem to have experienced a diminishing consumption of food from
this ecosystem since the Out-of-Africa Diaspora.107 For instance, analysis of 13C-collagen from
bones108 showed a sharp shift from a marine-based to a terrestrial-based diet in Britain at the onset
of the Neolithic (4,000 years ago). Also the consumption of animal brain is conceivable, but may not
solely be responsible because of its lack of many other constituents of ‘brain food’, notably iodine16
Abundantly available iodine is characteristic for marine-ecosystems. The wide occurrence of iodine
deciency in people living in the inland suggests that hominin encephalization likely occurred in the
land-water ecosystem. Although some traditional inland hunter-gatherers might circumvent this
problem by organ consumption, including e.g. the iodine-rich thyroid of their prey, many ‘modern’
humans, living far from the water-land ecosystem, have abolished organ consumption and may
consequently suer from iodine deciencies if the element is not added to table salt.
Macronutrients
Total protein intake from the presumed Paleolithic diet contributed 25-29 en% of the daily energy
intake (range 8-36), which is remarkably higher than the average present day intake of 15 en% in
the USA,84 at the high range of the 10-35 en% RDA of the National Institute of Medicine,88 somewhat
lower than the data of Eaton (37 en%)26 and comparable to the data of Cordain (30 en%, range 19-
35).27 The current estimate may be rated as a moderate-high protein diet. On a weight basis, the
protein intake from a 12,500 kJ Paleolithic diet was estimated at 160-185 g/day (range 51-223) (RDA
for adults 46-52 g/day{Institute of Medicine, 2005 338 /id}, of which animal protein was 108-140, and
plant protein 45-54 g/day. By contrast, modern humans consume less than one-half that amount of
animal protein (i.e. 64-68 g/day), and about two-thirds that amount of plant protein (i.e. 32-36 g/
day) from an average diet of 10,850 kJ for men and 7,312 kJ for women.86,109 Our models show that
a Paleolithic diet results in a moderate carbohydrate intake of 39-40 (range 19-48) en%, which is
similar to the 41 en% of Eaton’s model.26 The 34 en% (range 22-40 en%) intake in Cordain’s model27
was somewhat lower than current estimates, because of an assumed higher animal food intake at
the expense of carbohydrate-rich plants. Current carbohydrate intakes in a!uent countries average
49 en% for men and 52 en% for women,84 while recommendations range from 40-65 en%.88 From
1971-2000, carbohydrate intakes in the USA have increased (men: from 42 to 49; women 45 to 52
en%), at the expense of fat (men: 37 to 33; women 36 to 33 en%), saturated fat (men: 14 to 11;
women 13 to 11 en%) and protein (men: 17 to 16; women 17 to 15 en%).84 This may at least partially
originate from the advice to lower fat intake, especially SAFA, and to replace by carbohydrates.88 In
our models a moderate to high 30-39 en% (range: 20-72) came from fat, which is comparable with
the current Western intakes of about 33 en%,84 at the high range of the recommended 20-35 en%,88
higher than the 22 en% fat intake in the model of Eaton,26 but comparable with the 36 en% (range
108
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28-58 en%) of Cordain’s model.27
Beasley et al.110 showed that a carbohydrate intake in the low range of recommended (i.e. 48
en%), together with protein (25 en%) intakes at the high range of recommended and a fat intake
at the recommended average (27 en%) reduces self-reported appetite, compared with diets with
higher carbohydrates (58 en%) or high unsaturated fat (37 en%). In addition, compared with three
other diets the low-carbohydrate/high protein ‘Atkins’ diet proved superior for weight loss within
a one year randomized trial with overweight premenopausal women.82 The eect is likely to be
caused by better dietary adherence,111 which was obviously superior in those receiving the high
protein Atkins diet.82,111 A high protein diet induces satiation via the anorectic hormone peptide
YY112 and satiety by its high diet-induced energy expenditure. The latter amounts to 0-3% for fat,
5-10% for carbohydrate and 20-30% for protein and is needed for intestinal absorption, initial
metabolism and storage of the nutrient products that are not immediately utilized. The concomitant
oxygen consumption and rise in body temperature leads to a feeling of oxygen deprivation, which
promotes satiety.113 Similar appetite-controlling eects may be expected from the Paleolithic
diets (Table 5 and 6), which contain even lower carbohydrate, but higher fat, compared with the
low carbohydrate/high protein diet of Beasley et al.110 The Paleolithic diets have, however, higher
carbohydrate, similar protein and lower fat, compared with the ‘Atkins diet’ as employed by Gardner
et al.82 The high volume of the Paleolithic diet, that is partially composed of bulky ber in vegetables
and fruits, may also enhance satiety and satiation.114
The weight controlling eect of a Paleolithic diet was indeed shown by Osterdahl et al.,115 who
in an uncontrolled study with healthy adults, demonstrated a decrease in weight, BMI and waist
circumference after 3 weeks ad libitum consumption of a Paleolithic-like diet (i.e. 6,633 kJ/day;
carbohydrate 40, protein 24, fat 36 en%), compared with their baseline usual diet (10,377 kJ/day;
carbohydrate 54, protein 14, fat 30 en%). Similarly improved reduction of weight, BMI and waist
circumference were shown in the study of Jonsson et al.,116 who performed a 2*3 months cross-
over study in type 2 diabetic patients receiving a Paleolithic diet (6,620 kJ/day, carbohydrate 32,
protein 24, fat 39 en%) or a Diabetes diet (7,864 kJ/day, carbohydrate 42, protein 20, fat 34 en%). In a
randomized trial in patients with ischemic heart disease plus glucose intolerance or type 2 diabetes,
Lindeberg et al.117 showed a reduced caloric intake after ad libitum consumption of a Paleolithic diet
(5,628 kJ/day; carbohydrate 40, protein 28, fat 27 en%) as compared to an ad libitum Mediterranean-
like Consensus diet (7,517 kJ/day; carbohydrate 52, protein 21, fat 25 en%). The studies of Osterdahl
et al.,115 Jonsson et al.116 and Lindeberg et al.117 suggest that the underlying reduced energy intake
was due to improved appetite control. They may also have been accompanied by improved body
composition, since studies on high protein intakes during body weight loss and subsequent
maintenance have shown preserved or increased fat free mass at the expense of fat mass, and an
improved metabolic prole.113 Contrary to widespread belief, high protein diets do not have adverse
eects upon bone mass, and especially not if the diet is also rich in fruits and vegetables.118 They are
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more likely to promote bone health and reduce the incidence of osteoporotic fractures.113
The current carbohydrate intake in auent countries is not only high compared with that of
our Paleolithic ancestors, but there is also a marked qualitative dierence. In the era before the
agricultural revolution the majority of carbohydrates were derived from fresh fruits and vegetables,
together with roots and tubers, and very little from cereal grains or rened carbohydrates with
high glycemic indices (e.g. highly processed grains, sucrose, fructose).1 For hunter-gatherers wild
honey provides the only type of so called ‘empty calories’*, but it is only seasonably accessible and
accounts for no more than 0.4-1.2 en% in the studied foragers.3 Food products with high glycemic
loads, especially when consumed in isolation, cause transient hyperinsulinemia (which is associated
with CAD) and postprandial hypoglycemia (which is associated with increased hunger and lowered
satiety).119-121 There is increasing evidence that carbohydrates, especially rened carbohydrates with
high glycemic indices, and food products with high glycemic loads, play important roles in the
etiology of the diseases associated with the metabolic syndrome, such as diabetes mellitus type 2
and CAD.119-121
Evidence for the benecial eects of Paleolithic diets may also be derived from their inuence
on classical CAD risk factors. The uncontrolled study of Osterdahl et al.115 showed favorable eects
on systolic blood pressure and plasminogen activator inhibitor-1, while the study of Jonson et al.116
in type 2 diabetic patients resulted in lower HbA1c, triglycerides, diastolic blood pressure, and higher
HDL-cholesterol, when compared to the Diabetes diet. The trial of Lindeberg et al.117 in patients with
ischemic heart disease showed a larger improvement in glucose tolerance, independent of decreased
waist circumference, for a Paleolithic diet, when compared with a Mediterranean-like Consensus
diet. In an uncontrolled trial, Frassetto et al.122 showed that 10 days consumption of an isocaloric
Paleolithic type of diet (11,311 kJ/day; carbohydrate 38, protein 30, fat 32 en%): improved blood
pressure, arterial distensibility, insulin sensitivity and total-, HDL- and LDL-cholesterol in healthy
sedentary humans, when compared with their baseline usual diet (9,933 kJ/day, carbohydrate 44,
protein 18, fat 38 en%). Importantly, there were no statistically signicant changes in energy intakes,
activity levels and body weight, showing that the improved CAD risk prole was unrelated to weight
reduction.
Dietary cholesterol
Current recommendations for the intake of cholesterol range from ‘as low as possible’ to <300 mg/
day.88 Estimated intakes from the models of Eaton et al.26 and Cordain27 (recalculated from our data)
were 480 and 830 mg/day, respectively, while the current estimates from Models 2-4 are 498, 914
and 523 mg/day. The sizeable intakes of cholesterol in Models 1 and 3 are derived from the very high
amounts of cholesterol in brain (2,037 mg/100 g)33 and marrow (119.6 mg/100 g),123 as compared to
an average of 65.96 in meat and 60.2 mg/100 g33 in sh. The estimated Paleolithic cholesterol intakes
are well above the present intakes of 320 mg/day in the USA124 and the proclaimed ‘high cholesterol
* High energy food without essential amino acids, essential fatty acids or micronutrients
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intakes’ of Japanese men (446 mg/day) and women (359 mg/day).124 Hunter-gatherers125 have low
serum total- and LDL-cholesterol, typically ranging from 2.1-3.6 and 1.0-1.8 mmol/l, respectively,
that do not increase with age.126 The pastoral living Maasai have high intakes of fat (about 300
g/day), SAFA and cholesterol (about 600 mg/day) from both milk and meat. Yet they exhibit low
serum total-cholesterol (about 3.3 mmol/L) with extensive atherosclerosis with lipid inltration and
brous changes of their aortas, together with intimal thickening of their coronary arteries. They are
nevertheless virtually free from signs of CAD, have smaller hearts, their blood pressure exhibits only a
slight tendency to increase with age, they have low body mass indices and they are remarkably t.127
The currently estimated cholesterol intakes by our ancient ancestors and data from the Japanese
and the Maasai do not support the limitation of dietary cholesterol intake to 300 mg or ‘as low as
possible’. Cholesterol intakes above these recommendations might at most be disadvantageous by
their interaction with other unfavorable changes in diet or lifestyle.
Fatty acids
SAFA. The average (range) SAFA intake from our reconstructed diets was 11.4 (7.2-18), 12.0 (6.9-19),
11.5 (9.9-16) and 12.0 (6.8-17) en% for Models 1-4, respectively. It is currently recommended to keep
the SAFA intake ‘as low as possible’ and preferably below 10 en%. The association that is usually
presented to illustrate that SAFA are hypercholesterolemic88 is not only characterized by high inter-
individual variation, but also by a slope that indicates that one en% SAFA increases serum total- and
LDL-cholesterol by no more than 0.052 and 0.036 mmol/L, respectively.128 It was recently concluded
that there is insu!cient evidence that SAFA is causally related to CAD risk.129 Replacement of SAFA
by carbohydrates at low total fat intake might even be associated with greater CAD progression.130
A SAFA (notably 16:0) rich diet might only be hypercholesterolemic in the context of a
carbohydrate-rich diet. When carbohydrate is replaced by SAFA, the increase in HDL-cholesterol is
even higher compared with replacement by MUFA or PUFA, although a signicant decrease in the
total/HDL-cholesterol ratio is only observed when carbohydrates are replaced by PUFA and MUFA.131
Volek et al.5 showed that a SAFA-rich carbohydrate-restricted hypocaloric diet (carbohydrate 12
en%, fat 60 en%, SAFA 36 g), as compared with a hypocaloric low-fat diet (carbohydrate 56 en%,
fat 34 en%, SAFA 12 g; both 6,281 kJ), was not only superior in improving CAD risk factors, but also
that the subjects consuming the carbohydrate-restricted SAFA-rich diet had lower SAFA in serum
triglycerides and cholesterol esters. It seems that a carbohydrate-rich diet prolongs circulatory
exposure to SAFA, causing a more intense interaction with Toll Like Receptors- 4 and -2,132 and
thereby the release of proin"ammatory cytokines such as Monocyte Chemoattractant Protein-1 by
adipocytes.133 This mimicking of lipopolysaccharide action by SAFA may trigger the hyperlipidemia
of sepsis.134 It is increasingly acknowledged that metabolism and in"ammation are intimately
related.8 The saturated lauric acid (12:0) exhibits a signicant decrease of the total cholesterol/HDL-
cholesterol ratio when 1 en% carbohydrates is replaced by lauric acid. Isoenergetic replacement of
10 en% of the average USA diet by carbohydrates causes a higher increase of the total cholesterol/
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HDL-cholesterol ratio than butter, while coconut oil decreases this ratio.131 It is possible that our
ancient ancestors living in tropical areas at the sea experienced all benets of the combination of
moderate carbohydrate and SAFA intakes and that they had abundant access to coconut-derived
lauric acid, which is not only readily absorbed but also known for its antimicrobial properties.35
MUFA. The MUFA intakes in Models 2 and 4 (i.e. 7.4 and 5.6) are somewhat lower and equal to
those of Eaton (7.4) and Cordain (9.2),26,27 and on the low side, when compared with the world wide
intakes ranging from 8 en% in parts of China135 to more than 20 en% in the Mediterranean.136 The
average MUFA intake in Model 3 (i.e. 13.0 en%) is similar to the 13 en% in the USA81 while the 18.5 en%
from Model 1 is intermediate to this 13 en% and the high intakes in the Mediterranean. Populations
consuming high MUFA diets show low incidence of CAD.137 However, although Japanese have low
(9 en%) MUFA intakes,135 they also have low CAD risk.138 When replacing SAFA by MUFA (11 en%) or
carbohydrate (20 en%), MUFA provided a greater risk reduction in CAD than did carbohydrate,139
while replacement of 1 en% carbohydrates with cis-MUFA caused a steep decrease in the total
cholesterol/HDL-cholesterol ratio.131 Taken together it seems that MUFA are notably benecial at
isocaloric low-moderate carbohydrate intakes.
ALA and LA. In our models the median ALA consumption and its range (Table 5) indicate that
the mixing of sh and the introduction of selective consumption of meat into the savannah-derived
Paleolithic diets of Eaton and Cordain1,26-28, increases the ALA intake to an average of 3.7-4.7 (range
2.1-5.8) en%. The models also show consistently low LA intakes (2.3-3.6, range 1.7-6.2 en%). After
employment of the protein constraint it proved unnecessary to additionally employ the 1.0 en%
LA constraint, since all of the remaining options within the 4 foraging strategies provided over 1.0
en% of LA.
The average daily intake of ALA in British omnivores was 0.4 (1.3 g/day) and 0.7 en% (2.2) for
vegans,140 which are both remarkably lower than the ALA intakes from the current and earlier
Paleolithic diets of Eaton and Cordain,26,27 It is possible that the easily recycled141 dietary ALA
constituted an important precursor for the synthesis of SAFA, MUFA, cholesterol and ketone bodies
for energy generation. The higher ALA intakes, as compared to LA, might additionally explain why
ALA is β-oxidized twice as fast as LA.142 High ALA intakes from a Paleolithic diet might also be in
line with the indications that ALA plays an important role in CAD prevention.143 Anti-in#ammatory
e$ects of a high ALA-intake include reductions of C-reactive protein, soluble intercellular adhesion
molecule 1, soluble vascular adhesion molecule 2, IL-6, IL-1beta and TNF-alpha.143,144 Inconclusive
evidence for the role of ALA in CAD129 might be explained by low intakes of ALA in combination with
relatively high LA intakes and would be consistent with the stronger evidence linking increased
ALA intake to low CAD risk, as observed for subjects with low sh intakes.145 The current models
with ALA/LA ratios ranging from 0.61-1.79 g/g (Table 5) reassert the unfavorable ALA/LA ratio in the
Western diet, while such ratios were also used in many, if not all, intervention trials.
The LA intake of the models did not exceed 6.2 en%. These outcomes are comparable with the
earlier data of Eaton26 and Cordain.27 It is currently advised to augment the LA intake to 5-10 en%,
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since it was concluded that aggregate data from RCTs, case-control and cohort studies, and long-
term animal feeding experiments indicated that these intakes reduce CAD risk.146 This, recently
reinforced, advice by the AHA has taken the daily LA intake in Western countries to 4-9 en%.71
It also caused an increase of the breast milk LA content to >15 g% in many Western countries,71
which is signicantly higher compared with the 4.2-5.2 g% LA in the milk of traditionally eating
Tanzanian populations.35 Our data indicate that such an LA status can not be achieved without the
consumption of rened vegetable oils. These have never been part of the diet on which our genome
has been evolved to what it currently is. Correction of our current high CAD risk, by the introduction
of nutrient intakes that have never been reached in the past, harbors the risk of introducing new
imbalances. Employing the Hill-criteria for causality, Mente et al.129 recently concluded that there is
insucient evidence that PUFA is causally related to CAD risk. In addition it seems that despite the
ensuing recommendation to consume 5-10 en% LA, these RCT with positive outcomes have been
conducted at 11-21 en% LA.146 Moreover, these high LA intakes, which were even combined with
increased intakes of ALA, sh or cod liver oil, replaced SAFA in the included trials.146 High intakes
of LA, but not AA,147 have been related to the etiology of ulcerative colitis,148 while the LA intake
was positively associated with a risk of severely depressed mood149 and homicide.21 Studies with
human endothelial cells suggest that LA might promote inammation through activation of NFκB,
and increased production of TNF-α, IL-6 and other inammatory mediators.150 The high prevalence
of CAD, hypertension, type 2 diabetes mellitus and obesity in Israel, also referred to as the ‘Israelian
paradox’,151 might be related to the nationwide 8-12% higher PUFA intakes in Israel, as compared to
other Western countries. Ailhaud et al.71 considered the decreasing dietary ALA/LA ratio, due to both
an increase in LA and decrease in ALA, in Western diets as a possible cause of obesity. Finally, it has
become clear that the current high LA intake causes inhibition of the conversion of ALA to EPA and
DHA, and thereby contributes to our currently low LCPω3 status.152
LCP. In Models 2, 3 and 4 the average sum of the intakes of the sh oil fatty acids EPA and DHA
were 6.1 (range: 0.88-28.3), 5.8 (range: 1.38-11.6) and 14.2 (range: 5.34-28.3) g/day. Because of the
inclusion of food from the water-land ecosystem these gures were much higher than those of
Eaton26 and Cordain.27 The calculated average AA intakes of 3.65, 2.84 and 5.46 (ranges: 1.69-10.7;
1.15-4.61; 2.14-10.7) g/day, respectively, are also considerably higher compared to the 1.81-2.41
(range: 1.15-2.77) g/day of the savannah models.
The high LCPω3 intake (median 7.64 g/day) in Model 2 is about half the intake of Inuit who have
lifetime consumption of about 14 g LCPω3/day,17 while the 17.0 g LCPω3/day of Model 4 is even
somewhat higher. The similarity between the milk LCPω3 contents of Tanzanian mothers with high
daily consumption of fresh water sh from Lake Victoria35 and the milk LCPω3 contents of Canadian
Inuit153 adds to this notion. Both model outcomes are also in line with estimates of Broadhurst et
al.12 who calculated a daily intake of 29 g sh oil from a 9,196 kJ diet by current native Africans living
on the shore of Lake Malawi. With a 15 g% average EPA+DHA content of the local sh, this would
imply an intake of at least 6 g LCPω3 per day, which is remarkably comparable with the intakes from
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Models 2 and 3. Crawford et al.154 estimated the daily intake of contemporary populations living
at East African lakes (Lakes Nyasa and Turkana) at 1-4 g LCPω3 and 0.5-1.0 g AA, respectively. All
of the above data suggest that in the Paleolithic era the intakes of EPA plus DHA greatly exceeded
those currently recommended in Western societies (450-500 mg/day155,156), while also the AA
intake was much higher than at present (about 200 mg/day157). Of interest is the lower (EPA+DHA)/
AA ratio in African sh (2.67 g/g) and consequently in the sh-based Paleolithic diets (1.82-2.60
g/g), as compared to Northern latitude sh (7.48 g/g in cold water sh; 8.74 g/g in European sh)
(Supplemental Table 1). It seems that many, if not all, intervention trials have been conducted with
high (EPA+DHA)/AA ratios and certainly with relatively low absolute amounts of (EPA+DHA), while
the intake of AA is usually ignored.
Our nding of high LCP intakes compared with the parent precursors LA and ALA, and the
knowledge that about 75 g% of dietary LA and ALA is fully β-oxidized, even under extreme dietary
LCPω3 deciency,141 put the FADS polymorphisms,158 the concept of ‘essential fatty acid deciency’
and also the ω3/ω6 ratio into dierent perspectives. In contrast to the present, both the FADS
polymorphisms and our diculty to synthesize DHA might have been unimportant in the past. The
chain elongation/desaturation pathway might not have been used at all and LA and ALA deciency
might never have occurred. LA deciency may be dened clinically in terms of symptoms such as
a scaly dry skin and reproductive failure,159 and ALA deciency in terms of numbness, paresthesia,
weakness, pain and blurred vision,160 while these deciencies are biochemically characterized in
terms of the accumulation of Mead acid161 or an increased Mead acid/AA ratio.142 Neither symptoms,
nor Mead acid accumulation will occur when the intakes of AA and DHA are high, since these would
inhibit FADS1 and 2 activities. Also the specic function of LA in the synthesis of skin ceramides
might be conserved and thereby skin’s water barrier function, since dietary AA might in such
circumstances become retroconverted to LA.162 Retroconversion of DHA to EPA163 and possibly to
ALA may also have taken place. Since under these conditions neither LA nor ALA would be essential,
it was suggested142,164 to consider AA and DHA as the genuine essential fatty acids. It would also
imply that the presently employed constraint of 1.0 en% LA would be superuous and that the
vigorously debated ‘healthy’ dietary ω3/ω6 ratio107 and the currently depicted (EPA+DHA)/AA ratio
might have been unimportant in the past. AA, EPA and DHA might under these circumstances not
compete with each other, but rather jointly compete with other fatty acids causing full saturation
of tissues with LCP. This is currently not the case. For instance, Hsieh et al.101 showed that raising
the milk DHA content from 0.3 to 1.0 g%, both at 0.7 g% AA, caused an increase of DHA in virtually
all investigated brain regions of the newborn baboon without aecting their AA contents. This
suggests that newborns in Western countries have low brain DHA, since many of their mothers have
milk DHA contents in the 0.3 g% range.34 Finally, Liou and Innis152 recently showed that minimum
LA requirements for AA synthesis are below 3.8 en% and suggested that the encountered two
fold inter-individual variance of AA status might be due to FADS polymorphism. The estimated AA
intakes by our Paleolithic ancestors suggest that neither of these problems might have been of
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importance in the past.
The suggested high dietary intakes of LCP, notably those of AA, raise questions regarding their
toxicities. In a recent study it was concluded that estimated DHA intakes of up to 315 mg/day by 1-6
months infants are safe and that no consistent adverse eects in platelet function, lipid levels, in vivo
oxidation parameters, glycemic control, or immune function have been observed in adults taking up
to 7.5 g DHA per day.165 Inuit17,153 and the many sh eating populations in other countries, including
Africa,34,35 are living testimony of this thesis. AA is, however, invariably feared for its role in coagulation
and inammatory reactions. A human feeding study with 6 g AA/day (supplemented as ethyl ester)
was terminated because of a marked increase in in vitro platelet aggregation.166 In subsequent well-
controlled studies, Nelson and co-workers observed no changes in blood coagulation, thrombotic
tendencies167 or immune functions,168 but also a small increase in neutrophil count and immune
response to inuenza vaccine,169 together with increases in thromboxane, PGI2,
170 PGE2 and LTB4
168
in healthy male adults consuming 1.5 g AA for 50 days. They attributed the near absence of
changes in the immune functions tested to derive from the opposing eects of prostaglandins and
thromboxanes. Recently, Kusumoto et al.171 showed that 4 weeks supplementation of 840 mg AA
per day did not aect metabolic parameters or platelet function. Moreover, the ‘pro-inammatory’
AA is also needed for the synthesis of AA-derived lipoxines, which are pro-resolving and mediate the
switch to the synthesis of the anti-inammatory resolvins and protectins synthesized from EPA and
DHA.172 It should nally be noted that all these studies were performed with high AA, low LCPω3,
supplements. In our models, the increase in EPA+DHA is more pronounced compared to the increase
in AA [see ratio (EPA+DHA)/AA in Figures 2 and 3], with increasing LCP intakes. Other studies relating
AA with or without concomitant EPA+DHA intakes to eicosanoid production showed that dietary
AA enhanced in vivo eicosanoid production,173 while even low doses of AA were able to reverse
EPA+DHA induced decreases in PGI2 and TxA2 production.
174 Although short term AA-rich meat diets
did not aect platelet aggregation, TXB2, PGI2 or TXA2 production,
175 O’Dea et al.176 showed a rise in
bleeding time after consumption of LA and AA-rich meat and sh. Together, the health eects of
AA are still controversial and there is as yet insu"cient evidence to decide whether high AA, with
or without concurrent high LCPω3 intakes, are harmless or benecial,150,177 but high intakes of AA
clearly need caution. However, it is likely that at high dietary AA and DHA intakes, the surpluses will
for a great deal be used for retroconversion, energy generation, or both, although to our knowledge
no hard data are available in support of this notion.
Limitations
The outcome of our models should be viewed upon as indicative for the range of the dietary
compositions of our ancestors, since we have obviously no hard data on their foraging strategies
and the nutrient compositions of the plants and animals that they consumed. Our data rely on the
comparability of the compositions of contemporary foods with the foods available in the Paleolithic
and on the representativeness of the foods that have been analyzed. Whether our earliest ancestors
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employed cooking remains controversial, but its employment would increase the digestibility of
certain plant foods and consequently the availability of certain nutrients. While for sh species an
increasing amount of literature on energy density, macronutrient content and fatty acid composition
is available, comparable literature on wild animals and plants is scarce or inaccessible. With respect
to East-African plant specimen the literature provides even less information. For example, the plant
AA contents are derived from a single publication and those analyses were not conrmed by mass
spectrometry. Despite the even higher AA content of seaweed and insects, the AA contents of many
plant foods are probably lower, and their AA contents certainly warrant further studies. In other words,
a better approximation of the Paleolithic diet would be possible when more complete information
on fatty acids in African nuts, fruits, roots, bulbs, gums and tubers would become available. There is
no evidence that our ancestors have used shing gear prior to 300,000 years ago.11 However, there is
circumstantial evidence that sh up to 1 meter in length were caught bare handed, when spawning
during the rainy periods or when trapped in pools during drought.9 Nevertheless, the current use
of the fatty acid composition of East-African sh might not be appropriate, and in reality better be
described by some combination of the fatty acid compositions of a variety of animals living in the
land-water ecosystem, who ultimately receive their LCP from plankton. Apart from sh however, we
could not recover any data on the fatty acid composition of such African species. Taken together,
an increasingly complex multidimensional model dierentiating between African plant foods
(seaweeds, nuts, seeds etc), land animals (all edible organs) and marine animals (sh, shellsh, eggs)
and in which all separate intakes and nutrient compositions are varied within their most realistic
ranges would certainly improve the current estimates. Finally, due to dierences in environmental
circumstances, Paleolithic and modern humans might have (had) dierent benets from the intake of
fatty acids, such as AA. High AA intakes might confer unfavorable eects in Western societies, where
morbidity and mortality stem mostly from chronic diseases with inammation and thrombosis, but
might have been favorable to Paleolithic humans who were mainly confronted with morbidity and
mortality from infection and trauma. The latter suggests that AA might have conferred antagonistic
pleiotrophy in the past.
CONCLUSIONS
We found that the macronutrient composition of the presumed Paleolithic diet averaged 25-29
(range 8-35) en% from protein, 39-40 (19-48) en% from carbohydrate and 30-39 (20-72) en% from
fat. These data imply that Paleolithic diets provided moderate-to-high protein and fat intakes, and
moderate carbohydrate intakes. The fatty acid composition was moderate-to-high in MUFA and
PUFA, but relatively high in SAFA.The PUFA were notably high in ALA, LCPω3 and LCPω6, but low in LA,
compared to current Western intakes and recommendations. With the previous limitations in mind,
the current data reect the nutritional balance on and selection pressure under which our genome
evolved. Our models reveal consistent dierences between estimated Paleolithic macronutrient
and fatty acid intakes and those found in contemporary Western diets as well as recommendations.
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Together with other human caused environmental changes, these disparities are likely to play an
important role in the etiology of Western disease. For example, the hypercholesterolemic eect of
carbohydrates, the positive relation between protein intake, satiety and satiation as well as the many
benecial eects attributed to LCP suggest a benecial role for the consumption of Paleolithic-like
diets. These diets do not as much aect our life expectancy, but rather our years in good health.
Interestingly, many of the dietary disparities are at present heavily debated, suggesting that both
the approaches via intervention trials and evolutionary medicine identify critical dietary factors that
are important to current Western diseases. We suggest that the present data represent a unique and
powerful rationale for the design of future intervention studies.
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Addendum and units
‘Plant’ refers to any edible component from the kingdom of Plantae and Fungi, while ‘animal’ refers
to edible components from the kingdom of Animalia. For meat consumption, only 50 g% of the
total carcass weight was considered as edible material.62 The weights of the consumed organs are
therefore presented as a percentage of the total edible material, i.e. 3.8 g% for the liver, rather than
as a percentage of total carcass weight (i.e. 1.9 g% for the liver). Plant food and sh were considered
to be consumed completely. Fat contents are consistently presented as g/100 g edible material (g%).
Fat contents refer either to the specic fat% of a particular organ (e.g. the brain) or the fat% of all
edible material (i.e. the fat% of all combined edible material, including lean meat, brain, liver, bone
marrow and adipose tissue. Plant/animal and meat/sh ratios and ratios between skeletal muscle,
brain, bone marrow, liver and adipose tissue are given in energy% (en%). Fatty acid compositions
are given in g/100 g fatty acids (g/100 g, g%). Organ weight contributions to selectively and non-
selectively consumed meat are presented as g/100 g meat.
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Current recommendations for arachidonic (AA) and docosahexaenoic (DHA) acids in infant formulae
are based on milk of Western mothers. Validity may be questioned in view of the profound dietary
changes in the past 100 years, as opposed to our slowly adapting genome. Hominin evolution
occurred in the proximity of East-African freshwater lakes and rivers and early homo sapiens had
higher intakes of AA and DHA from a predominantly lacustrine-based diet. In search of milk AA
and DHA contents of our African ancestors we investigated the milk of 29 lactating women living
in Doromoni near lake Kitangiri (Tanzania). They consumed sun!ower oil-fried local "sh as only
animal lipid sources, maize and local vegetables. AA and DHA contents of Doromoni milk may be
close to that of early homo sapiens, because of the similarity of their life-long consumption of East-
African lacustrine-based foods. Human milk fatty acid relationships from our historical worldwide
database and the literature revealed that disparities between the Doromoni diet and the presumed
ancient diet (i.e. higher carbohydrate and linoleic acid intakes) are unlikely to a#ect milk AA and
DHA contents. Doromoni milk had high contents of AA (median 0.70 mol%), DHA (0.75) and
eicosapentaenoic acid (EPA, 0.17), and low AA/DHA ratios (median 0.91; 0.55-2.61). This tracks down
to consumption of "sh with high AA and DHA contents, and AA/EPA ratios. We conclude that the
milk AA, DHA and EPA contents of Doromoni women might provide us with clues to optimize infant
formulae and perhaps the milk of Western women.
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INTRODUCTION
The long chain polyunsaturated fatty acids (LCP) docosahexaenoic (DHA, 22:6 3) and arachidonic
(AA, 20:4 6) acids are major constituents of brain phospholipids.1-3 Many studies have shown
their prenatal importance and the postnatal importance of notably DHA in early human (brain)
development.4-6 The addition of both DHA and AA to formulae for premature infants and to lesser
extent term infants, is nowadays widely accepted. Current recommendations for their addition to
formulae are largely based on the concentrations observed in milk from Western mothers. Typical
recommendations would be AA≥0.40%, DHA≥0.35% for prematures and AA!0.35%, DHA≥0.20%
for terms7 or AA=0.50%, DHA=0.20%, eicosapentaenoic acid (EPA; 20:5 3) <0.10%.7 However, the
worldwide human milk fatty acid composition is subject to high interindividual biological variation,
mostly because of di"erent maternal diets. EPA (interindividual biological variation: 100%) and DHA
(68%), exhibit the highest biological variation, whereas palmitic acid (16:0; 12.7%) and AA (28%)
rank among the lowest. Consequently, one may question the basis of current recommendations,
and notably whether milk from Western mothers, if any, should serve as the gold standard.8
Adequate amounts and ratios of LCP in newborn nutrition are important, since LCP do not only
serve as structural building blocks and precursors of eicosanoids, but are increasingly recognized to
impact the expression of our genome in their capacity to act as activators or repressors of a number of
nuclear receptors that function as ligand-activated transcription factors.9-12 Our genome has largely
evolved on a hunter-gatherer diet and it is unlikely that our genes have completely adapted to the
change of diet since the agricultural revolution some 10,000 years ago and notably the rapid dietary
changes that occurred in the past 100 years.13,14 There is ample evidence that hominin evolution
took place on the shores of freshwater lakes, rivers and the sea in (East) Africa and that early homo
sapiens had higher intakes of LCP from a predominantly lacustrine- and marine-based diet that
is rich in both LCP of the  3 series (LCP 3) and AA.15-17 In contrast, most of the #sh consumed in
Western countries, especially fatty #sh, is rich in DHA and to lesser extent EPA, but relatively poor
in AA.16,18 Fish consumption in Western countries, e.g. The Netherlands, is limited as compared with
e.g. some Caribbean countries, which explains the high worldwide biological variation of DHA and
EPA.8 The resulting low LCP 3 status in Western countries is related to coronary heart disease (CHD)
and mental and psychiatric disturbances,19 and randomized controlled trials with LCP 3 showed
reduced mortality from CHD and a reduction of schizophrenic symptoms by EPA supplements.20
Analogously, low maternal LCP 3 status gives rise to low newborn LCP 3 status,21 which will be
maintained by low milk LCP 3 concentrations with as yet unknown (long term) consequences.
In contrast to LCP 3, there seems to be less doubt regarding recommendations for the formulae
AA content. Vegetarians and vegans have similar human milk AA contents as compared to omnivores
and supplementation of lactating women with 300 mg AA for one week did not augment their milk
AA content.22 Consequently, as also re$ected by its relatively low worldwide biological variation,8
the milk AA content seems less dependent on the dietary AA intake, which might imply that it can
safely serve as a basis for infant formulae recommendations. AA and LCP 3 are on the other hand
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known for their competitive behavior, but collaboration has also been noticed.23,24 It seems that in
reality little is known on the LCP 3-LCP 6 interaction in terms of competition or collaboration and
that from a practical point of view the most valuable data for recommendations should come from
the study of milk from women who consume our presumed ancient diet, or a diet that contain the
LCP 3 and AA-rich East-African freshwater lake !sh as the major lipid source.
We hypothesized that human milk from hunter-gatherers living in the vicinity of the East-
African lakes would provide us with the closest as yet available information on the evolutionary
background of the human milk LCP contents. A possible study group would be the Hadzabe
people living near lake Eyasi (NE Tanzania), but these are unfortunately not easily accessible for
such studies. We therefore decided to investigate lactating women who live in Doromoni near lake
Kitangari (Tanzania). These women consume sun"ower oil-fried !sh as the only source of animal
lipid and protein, together with 'ugali' (maize porridge) and various types of local vegetables. A high
carbohydrate intake is known to rapidly increase the milk medium chain fatty acid (MCSAFA; 6:0 up
to 14:0) content,25-27 but has negligible e#ect on the milk LCP content. This was apparent from the
human milk fatty acid database of a variety of di#erent countries that we8,28 have compiled during
the past 25 years (further referred to as our ‘world’ human milk fatty acid database). As a control
group we selected women living in Mwanga (about 55 km in the "at-land East from Doromoni), who
predominantly eat vegetarian diets. The milk fatty acid data from Doromoni were also compared
with historical data from the Netherlands and the Caribbean. In addition, we sampled the !sh
from various Tanzanian freshwater lakes and compared their fatty acid compositions with those of
counterparts from Caribbean waters (i.e. Curaçao, Netherlands Antilles) and the North Sea (i.e. the
Netherlands).
Materials and methods
Milk was sampled from women attending local dispensaries in Doromoni and Mwanga (Tanzania).
Women were eligible to participate if they were apparently healthy, well nourished as derived from
anthropometric data, and had delivered an apparently healthy child more than 10 days prior to
their visit. Anthropometric data were recorded. Data on parity, number of living children, lactation
duration, diet and tribe were obtained from their medical records or from a translator-assisted
interview by one of us. The characteristics of the women are depicted in Table 1. The study was
approved by the National Institute of Medical Research (NIMR/HQ/R.8a/Vol. IX/145, Dar es Salaam,
dated June 16, 2003) and was in agreement with the Helsinki declaration of 1975 as revised in 2000.
About 5 mL of milk was collected by manual expression. Following gentle mixing, 100 !L was
immediately pipetted into a te"on-sealable tube that contained 1 mL methanol-6 mol/L HCl (5:1 v/v)
and 1 mg butylated hydroxytoluene (BHT, antioxidant). Fatty acids are stable in this mixture at room
temperature for months. Fish were caught by line or purchased from local !shermen or in markets
at lakes Kitangiri, Victoria and Nyasa (also named lake Malawi). An approximately 1 cm3 sample of
the edible proportion was taken from a site just below the dorsal !n and just above the backbone.
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The sample was transferred to a teon-sealable tube that contained the same preservation/
transmethylation mixture (see above). The local sunower oil was also sampled and preserved for
further analysis of its fatty acid composition. All samples were kept at room temperature and in the
dark until transportation to the Groningen University Hospital (the Netherlands) for analysis of their
fatty acid contents.
Analyses of fatty acid methyl esters (FAME) were performed with capillary gas chromatography
following the addition of a series of odd-chain numbered fatty acid internal quantication standards
(5:0 up to 17:0), transmethylation and extraction of FAME according to previously reported methods.29
Long-chain fatty acids ( 16:0) were quantied on the basis of the added 17:0. Medium chain fatty
acids (6:0 up to 14:0) were quantied with use of 5:0 - 15:0 as internal quantication standards.30
Fatty acid compositions were expressed in mol% and ratios in mol/mol. Between-group di!erences
were tested with the Mann-Whitney U-test at p<0.01 (i.e. with correction for type 1 errors, according
to Bonferroni). We used multiple linear regression to investigate whether the ‘world’ human milk
fatty acid database and the fatty acid data bases of Dormoni and Mwanga exhibited di!erences
in the relations between MCSAFA on the one hand and oleic acid (18:1!9), linoleic acid (18:2!6),
LCP!3 and LCP!6 on the other hand. The variables were log-transformed to obtain linear relations,
if necessary.
Table 1. Subject characteristics
Doromoni (n=29) Mwanga (n=26)
Age (years) 24 (16-36) 24 (18-42)
Length (m) 1.56 (1.43-1.72) 1.58 (1.43-1.68)
Weight (kg) 55.5 (41-70) 55.5 (40-74)
BMI (kg/m2) 22.7 (18.2-30.3) 22.1 (17.9-28.8)
Upper arm circumference (cm) 27.2 (23.0-32.0) 25.3 (22.0-32.0)
Parity (number)a 2.0 (1-7) 2.5 (1-10)
Children alive (number)a 2.0 (1-6) 2.5 (1-7)
Duration of lactation (days)a 107 (13-380) 104 (23-405)
Diet
Days of sh/week(%) 7 (7-7) 0.5b (0-5)






Data are means (range) unless otherwise indicated.
a. Median (range)




Table 2 shows the fatty acid compositions of milk from women living in Doromoni and Mwanga, as
compared with historical data from The Netherlands and the Caribbean.8 The latter were obtained
with use of the same analytical method. The LCP 3 (notably EPA, 22:5 3 and DHA) and LCP 6
(notably AA, 22:4 6 and 22:5 6) contents of milk from women living in Doromoni was higher
and the  9 (notably 18:1 9) content was lower than corresponding contents in the Netherlands,
Caribbean and Mwanga. Doromoni milk had higher MCSAFA (notably 12:0 and 14:0) content
compared with The Netherlands, but similar MCSAFA contents as in the Caribbean and Mwanga.
The milk polyunsaturated fatty acid (PUFA, notably 18:2 6) content in Doromoni was higher than
that in the Netherlands and Caribbean, but similar to that in Mwanga. The Doromoni milk had the
lowest AA/DHA ratio and the highest EPA/DHA ratio. The milk from mothers living in Mwanga had
higher LCP 3 content compared with the Netherlands, but its DHA content was lower compared
with both the Netherlands and the Caribbean. Its MCSAFA, AA, 22:4 6 and 22:5 6 contents were
higher than in the Netherlands, but these contents were similar to those in the Caribbean.
Figure 1 and 2 depict the relations between DHA and AA (Figure 1) and EPA and AA (Figure 2)
in milk of mothers from Doromoni and Mwanga, as compared with historical data from our ‘world’
human milk fatty acid database.9
The contents of AA, DHA and EPA in milk from Doromoni proved exceptionally high, both when
compared with Mwanga and our ‘world’database. In contrast to the relation between milk DHA and
AA in Doromoni, our data for the ‘world’ suggested that the milk AA content decreased when milk
DHA exceeded 0.6-0.7 mol% (Figure 1).
Seventeen mothers (58.6%) from Doromoni had milk DHA and AA contents above 0.65 and 0.61
mol%, respectively, as compared with none of the mothers in our ‘world’ database. The number
of samples with DHA percentages above an arbitrary chosen cut o! value at 0.60 mol% in the
‘world’ database amounted to 18/454 (4.0%), as opposed to 22/29 (75.9%) for Doromoni and 0/26
(0%) for Mwanga. The ‘world’ samples with DHA>0.60 mol% derived from Dominica (n=5; 29.4%
of all samples), Antigua (n=3; 13.0%), St. Lucia (n=3; 25.0%), Netherlands (n=3; 1.3%), St. Vincent
(n=2; 6.7%), Curaçao (n=1; 2.1%) and Surinam (n=1; 5.0%). The number of samples with AA>0.60
mol% amounted to 38/454 (8.4%) for ‘world’, our 10/26 (38.5%) for Mwanga, and 22/29 (75.9%) for
Doromoni. Samples from the ‘world’ with AA>0.60% were from Curaçao (n=18; 38.3%), Jerusalem
(n=5; 17.9%), St. Vincent (n=3; 10.0%), Antigua (n=3; 13.0%), St. Lucia (n=2; 16.7%), Palestine (n=2;
5.7%), Belize (n=2; 20.0%), Surinam (n=2; 10.0%), the Netherlands (n=1; 0.5%), and Dominica (n=5;
29.4%). There was a similar discrepancy between the relations of EPA and AA in Doromoni and the
‘world’ (Figure 1, bottom). Sixteen mothers (55.2%) from Doromoni had milk EPA and AA contents
above 0.13 and 0.63 mol%, respectively, as compared to none of the mothers in our‘world’database.
Figure 3 shows the AA, EPA and DHA contents (top) and ratios (bottom) in #sh from the Caribbean
Sea, North Sea and Tanzanian freshwater lakes. Tanzanian lake #sh had relatively high AA contents
(Tanzania>North Sea; p=0.036) and high AA/DHA ratios (AA/DHA: Tanzania>Caribbean=North Sea;
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Table 2. Doromoni and Mwanga milk FA composition compared with historical Dutch and Caribbean
milk samples
Doromoni (n = 29) Mwanga (n = 26) Dutch (n = 222) Caribbean (n = 159)
median(min-max) median(min-max) median(min-max) median(min-max)
6:0 0.31 (0.21-0.40)a 0.35 (0.19-0.60) 0.30 (0.17-0.52)a 0.17 (0.03-0.48)
8:0 0.58 (0.28-0.74)a 0.53 (0.32-0.97)a 0.66 (0.45-0.94) 0.67 (0.24-1.76)
10:0 3.06 (1.43-4.16)a 2.72 (1.47-5.35)a 2.73 (1.58-4.27)a 3.62 (0.57-6.15)
12:0 13.2 (4.37-20.4)a.b 10.9 (6.61-21.9)a 8.20 (2.91-15.7) 13.8 (4.12-34.9)b
14:0 12.9 (4.31-25.1)a 11.4 (8.23-21.9)a 7.89 (3.68-14.2) 11.5 (4.09-26.0)a
16:0 20.5 (15.0-26.4)a 22.6 (13.4-28.4)a.b 23.2 (14.5-28.8)b 20.9 (14.3-29.2)a
18:0 4.00 (1.87-6.45)a 4.08 (1.75-9.01)a 7.18 (4.84-9.68) 5.45 (2.14-8.77)
20:0 0.13 (0.05-0.52)a 0.13 (0.05-0.29)a 0.21 (0.03-0.37) 0.20 (0.07-0.91)
22:0 0.08 (0.04-0.33)a.b 0.07 (0.04-0.11)a 0.10 (0.05-0.21) 0.09 (0.00-0.34)b
24:0 0.09 (0.04-0.19) 0.07 (0.04-0.10)a 0.07 (0.03-0.16)a 0.07 (0.00-0.31)a
MCSAFA 30.4 (10.7-50.3)a 25.6 (17.3-46.7)a 19.9 (9.19-35.2) 30.6 (9.90-67.9)a
LCSAFA 24.9 (20.7-32.5)a 27.2 (15.5-37.9)a 30.8 (20.5-37.5) 26.8 (17.5-35.5)a
SAFA 55.6 (40.8-73.4)a 56.1 (41.8-66.9)a 51.0 (39.3-63.4) 57.5 (37.8-85.4)a
18:3ω3 1.21 (0.33-2.02)a 0.73 (0.26-1.80)b 1.02 (0.64-2.71)a 0.67 (0.27-2.00)b
20:5ω3 0.17 (0.05-0.35) 0.05 (0.02-0.11)a 0.05 (0.00-0.29)a 0.05 (0.00-0.36)a
22:5ω3 0.36 (0.13-0.65) 0.12 (0.04-0.25)a 0.12 (0.08-0.24)a 0.13 (0.00-0.31)a
22:6ω3 0.75 (0.25-1.47) 0.13 (0.04-0.35) 0.19 (0.09-0.84) 0.33 (0.09-1.63)
LCPω3 1.66 (0.53-2.83) 0.45 (0.22-0.67)a 0.36 (0.20-1.33) 0.52 (0.16-1.68)a
ω3 2.92 (0.92-4.73) 1.12 (0.49-2.43)a 1.42 (0.90-3.08) 0.98 (0.16-2.79)a
14:1ω5 0.08 (0.04-0.17) 0.18 (0.05-0.70)a 0.37 (0.03-0.69) 0.23 (0.05-0.52)a
18:2ω6 16.1 (8.95-23.2)a 15.4 (7.18-28.4)a.b 12.8 (6.01-28.2)b 11.3 (3.51-25.9)
18:3ω6 0.14 (0.09-0.33)a 0.11 (0.04-0.26)a.b 0.09 (0.03-0.20)b 0.07 (0.00-0.23)
20:2ω6 0.37 (0.21-0.44)a 0.35 (0.17-0.63)a.b 0.31 (0.17-0.57)b 0.32 (0.08-0.99)a
20:3ω6 0.52 (0.29-0.93)a 0.46 (0.26-0.78)a 0.33 (0.18-0.78) 0.38 (0.20-0.68)
20:4ω6 0.70 (0.50-0.93) 0.52 (0.27-0.79)a 0.37 (0.21-0.62) 0.50 (0.19-0.99)a
22:4ω6 0.16 (0.09-0.27) 0.12 (0.06-0.21)a 0.07 (0.04-0.16) 0.12 (0.00-0.50)a
22:5ω6 0.10 (0.02-0.17) 0.06 (0.02-0.10)a 0.03 (0.00-0.08) 0.05 (0.00-0.18)a
LCPω6 1.60 (0.96-2.26) 1.27 (0.64-1.90)a 1.11 (0.71-1.72)a 1.40 (0.59-3.25)a
ω6 17.5 (10.8-24.7)a 17.0 (8.04-30.5)a.b 14.0 (7.22-29.5)b 12.8 (4.14-27.4)
16:1ω7 1.39 (0.87-2.46)a 1.43 (0.66-2.61)a 2.33 (0.76-4.99) 2.58 (0.89-5.89)
18:1ω7 2.47 (1.26-5.98)a 2.48 (0.91-4.27)a 3.13 (1.57-5.34) 2.98 (0.79-7.63)
ω7 3.87 (2.26-8.44)a 3.89 (1.69-6.82)a 5.50 (2.66-9.40) 5.55 (1.96-10.3)
18:1ω9 17.8 (8.66-30.8) 22.4 (12.3-26.9)a 26.5 (19.1-34.5) 21.4 (7.17-34.6)a
20:1ω9 0.19 (0.08-0.47)a 0.23 (0.10-0.33)a 0.37 (0.22-0.69) 0.38 (0.06-1.10)
20:3ω9 0.05 (0.02-0.11)a 0.06 (0.03-0.11)a 0.05 (0.00-0.09) 0.06 (0.00-0.20)a
24:1ω9 0.05 (0.03-0.08)a 0.05 (0.03-0.08)a 0.04 (0.00-0.46)a 0.05 (0.00-0.27)a
ω9 18.2 (8.86-31.4) 22.8 (12.6-27.5)a 27.0 (19.5-35.1) 21.8 (7.28-35.6)a
MUFA 22.4 (12.5-38.9)a 27.0 (14.4-31.9)a.b 33.0 (22.2-44.7) 28.1 (9.54-42.9)b
PUFA 20.2 (13.3-26.5)a 18.6 (9.13-31.4)a.b 15.5 (8.41-32.2)b 13.9 (5.03-27.8)
LCPω3+LCPω6 3.15 (1.45-4.65) 1.64 (1.01-2.44)a 1.50 (1.05-2.21)a 1.92 (1.09-3.96)
ω3/ω6 0.15 (0.04-0.35) 0.08 (0.03-0.17)a 0.10 (0.04-0.28) 0.09 (0.01-0.27)a
LCPω3/LCPω6 1.09 (0.33-1.50) 0.38 (0.17-0.64)a 0.31 (0.17-1.50)a 0.35 (0.10-2.48)a
ALA/LA 0.08 (0.01-0.18)a.b 0.05 (0.02-0.15)a 0.08 (0.03-0.21)b 0.07 (0.03-0.11)b
AA/DHA 0.91 (0.55-2.61) 3.69 (1.70-9.29) 2.04 (0.30-3.75) 1.60 (0.15-3.83)
EPA/DHA 1.93 (0.48-4.11) 0.28 (0.08-1.10)a 0.25 (0.00-0.54)a 0.14 (0.00-0.50)
Data are in mol%. Statistics: data with a similar symbol do NOT dier, p<0.01. Note that NO comparison was
performed between Dutch and Caribbean milk samples.
Abbreviations: FA, fatty acids; MCSAFA, medium chain saturated FA (sum of 6:0 up to 14:0); LCSAFA, long chain
SAFA (sum with C>16); SAFA, saturated FA; LCPω3 and LCPω6, long chain polyunsaturated FA (C>20) of the ω3
and ω6 series; MUFA, monounsaturated FA; PUFA, polyunsaturated FA; LA, linoleic acid (18:2ω6); ALA, α-linolenic




Figure 1. Relation between DHA and AA in human milk from Doromoni and Mwanga, as compared with
data from or ‘world’ database.  , Doromoni (n=29); !, Mwanga (n=26);  , World (n=454). AA, arachidonic
acid; DHA, docosahexaenoic acid. Solid straight lines represent relation between data from Doromoni;
the second grade polynomials are for data from the ‘world’ database. Samples from the ‘world’ derived
from: Antigua (n=23), Belize (n=10), Curaçao (n=47), Dominica (n=17), Jerusalem (n=28), the Netherlands
(n=222), Pakistan (n=10), Palestine (n=35), St. Lucia (n=12), St. Vincent (n=30) and Surinam (n=20).
Horizontal and vertical lines represent arbitrary boundaries (see text) at DHA=0.65 and AA=0.61 mol%.
For Doromoni the percentage samples with contents above these values were: 58.6%. Note the linear
relationship between DHA and AA in Doromoni and the drop of AA at higher DHA contents in data from
the ‘world’.
Figure 2. Relation between EPA and AA in human milk from Doromoni and Mwanga, as compared with
data from or ‘world’ database.  , Doromoni (n=29); !, Mwanga (n=26);  , World (n=454). AA arachidonic
acid; EPA eicosapentaenoic acid. Solid straight lines represent relation between data from Doromoni;
the second grade polynomials are for data from the ‘world’ database. For ‘world’ samples, see legend to
"gure 1. Horizontal and vertical lines represent arbitrary boundaries (see text) at EPA=0.13 and AA=0.63
mol%. For Doromoni the percentage samples with contents above these values was 55.2%. Note the linear
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p<0.015). The EPA content of the North Sea sh (North Sea>Caribbean>Tanzania; p<0.027) and its
EPA/DHA ratio (North Sea>Tanzania; p<0.036) were relatively high, whereas the Caribbean sh had
relatively high DHA contents (Caribbean>Tanzania; p=0.009). The AA/EPA ratio of the Tanzanian sh





















































































































































Caribbean salt water sh East African fresh water sh
North European
salt water sh
Caribbean salt water sh East African fresh water sh
North European
salt water sh
Figure 3. AA, EPA and DHA contents (top), and AA/DHA and EPA/DHA ratios (bottom) in sh from the
Caribbean Sea, North Sea and Tanzanian freshwater lakes. Top: AA, arachidonic acid (closed bars); EPA
eicosapentaenoic acid (open bars); DHA, docosahexaenoic acid (grey bars). Bottom: AA/DHA (closed bars);
EPA/DHA (open bars). Gutu and Parrot promentu are parrot sh that live from coral, and grunt is a reef sh.
These sh are not abundantly eaten in the Caribbean. Carco is the local name for a conch. Note the relatively
high AA contents and AA/DHA ratio of the Tanzanian lake sh, the relatively high EPA content and EPA/DHA
ratio of the North Sea sh, and the relatively high DHA content of the Caribbean sh.
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and was much higher than that of the North Sea sh (0.17; 0.06-0.29, p<0.009) (not shown in
Figure 2). Figure 3 and Table 3 show the relations between the milk MCSAFA content on the one
hand and 18:1 9, 18:2 6, LCP 3 and LCP 6 on the other for data from ‘world’ database, Doromoni
and Mwanga.,
The inverse relations between MCSAFA, and 18:1 9 and 18:2 6 exhibited similar slopes for all
groups. However, inspection of the intercepts revealed that Doromoni and Mwanga had lower 18:1 9
(Doromoni<Mwanga) and higher 18:2 6 (Doromoni=Mwanga) at all MCSAFA contents, compared
with the ‘world’. Although there was a positive relation between MCSAFA and LCP 3MCSAFA had
negligible e!ect on LCP 3 (see Figure 4 and slope in Table 3). MCSAFA proved unrelated to LCP 6.
Doromoni milk had higher LCP 3 and LCP 6 at all MCSAFA contents, compared to both Mwanga
and the ‘world’.
The fatty acid composition (in mol%) of the local con"ower oil was: 14:0 (0.33); 16:0 (8.05); 18:0
(4.40); 22:0 (1.35); 18:3 3 (0.33); 18:2 6 (52.30); 16:1 7 (0.63); 18:1 7 (1.24); and 18:1 9 (31.37).
Figure 4. Relation between milk MCSAFA and 18:1 9, 18:2 6, LCP 3 and LCP 6, for data from the ‘world’
database, Doromoni and Mwanga.  , Doromoni (n=29); !, Mwanga (n=26);  , World (n=454). MCSAFA,
medium chain fatty acids (sum of 6:0 up to 14:0); 18:1 9, oleic acid; 18:2 6, linoleic acid; LCP 3 and
LCP 6, long chain polyunsaturated fatty acids (C≥20) of the  3 and  6 series, respectively. For results of
multilinear regression analyses see Table 3. Note that MCSAFA compete with 18:1 9 and 18:2 6, but not to
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High milk DHA and AA contents in women around Kitangiri, Tanzania
DISCUSSION
In search of the milk AA and DHA contents of our African ancestors we investigated the milk of
29 lactating women living in Doromoni near lake Kitangiri (Tanzania). These women consume
sunower oil-fried local sh as the only animal lipid source, together with maize and local vegetables.
The dietary macronutrient composition of the Doromoni women is not comparable with what
is nowadays assumed to be our ancient diet. Based on the study of hunter-gatherers, O’Keefe et
al.14 estimated that the diet of homo sapiens up to 10,000 years ago was high in protein (19-35
energy%), moderate in carbohydrates (22-40%) and moderate in fat (28-47%). The fat fraction was
composed of moderate saturated fat, high monounsaturated fat and moderate polyunsaturated
fat, and provided a high  3 fatty acid intake from !-linolenic acid and lacustrine- or marine-based
foods (EPA and DHA). In contrast to this composition, the diet of the Doromoni women is rich in
carbohydrates and linoleic acid from sunower oil, as became apparent from the interviews and
their milk fatty acid composition (Table 2). High carbohydrate intakes increase the milk MCSAFA
content.25-27 The linoleic acid content of the Doromoni milk proved even higher than the linoleic
acid content in Western countries (such as the Netherlands) with typically abundant consumption
of polyunsaturated fats from vegetable oils. Based on fatty acid interrelationships (Figure 4, Table 3)
and literature data, we nevertheless consider the LCP content of the Doromoni milk close to that of
the diet of early homo sapiens. The de novo synthesized MCSAFA from glucose in the lactating breast
do not compete with LCP for incorporation into milk lipids, but rather with oleic acid and others like
linoleic acid (Figure 3). This is in line with the observation that a high carbohydrate intake increases
the milk MCSAFA content at the expense of oleic, stearic and to lesser extent palmitic acids.25,26 In
addition, milk linoleate and AA do not correlate,31 and increases of the milk EPA and DHA do not
Table 3. Relations of MCSAFA with 18:1w9, 18:2w6, LCPw3 and LCPw6, as obtained from multiple linear
regression analyses
y-variable Explained variance(%) World Doromoni Mwanga
Ln(18:1w9) 79 Slope - 0.022 - 0.022 - 0.022
Intercept 3.724 3.541 3.675
Ln(18:2w6) 24 Slope - 0.018 - 0.018 - 0.018
Intercept 2.976 3.275 a 3.195 a
Ln(LCPw3) 38 Slope 0.010 0.010 0.010
Intercept - 1.174 a 0.141 - 1.174 a
Ln(LCPw6) 5 Slope 0 0 0
Intercept 0.195 a 0.432 0.195 a
Best linear models were obtained after Ln-transformation of the y-variables (i.e. 18:1ω9, 18:2ω6, LCPω3 and
LCPω6)
All slopes are signicantly di#erent from zero at p<0.001, except for MCSAFA-Ln(LCPω6) relationships, similarly
p<0.001 for all between-group di#erences of intercepts, except for those indicated with (a)
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occur at the expense of linoleic acid.32,33 The ‘relative resistance’ of milk LCP towards exchange with
MCSAFA is unlikely to be due to the preferential location of LCP in the milk phospholipid fraction
and MCSAFA in the triglyceride fraction.31 MCSAFA in milk from mothers with carbohydrate-rich
diets incorporate equally in phospholipids and triglycerides, and depress both the PUFA and LCP
contents of the phospholipid fraction.34 Reduction of LCP in milk phospholipids by a carbohydrate-
rich diet might be important since LCP (at least AA) from dietary phospholipids are 2.1 fold more
eective than LCP from triglycerides for accretion in neonatal brain.35 On the other hand, the vast
majority of the milk MCSAFA and LCP derive from triglycerides, which are on a weight bases 100
times more abundant than phospholipids.31 Taken together, we suggest that the LCP content of the
Doromoni milk may be close to that of early homo sapiens, because of the similarity of the abundant
consumption of East-African lacustrine-based foods, the resulting life-time high intakes of both AA
and DHA, and because the disparities in the Doromoni and ancient diets (i.e. dierent carbohydrate
and linoleic acid intakes) are unlikely to have aected the human milk AA and DHA contents. It is,
however, likely that the higher carbohydrate intake in Doromoni, as compared with the ancient diet,
lowered the LCP content of the Doromoni milk phospholipid fraction to some extent.
The high contents of both AA and DHA in the milk of Doromoni women proved unprecedented
when compared with the data of our‘world’human milk fatty acid database (Figure 1). The Doromoni
milk AA content was higher and its DHA content lower than previously reported data on the milk of
Malays and Indians living in Penang,36 who were also noted to consume AA and DHA rich local !sh.
Their AA (0.70 vs 0.64 mol%) and DHA (0.75 vs 0.71 mol%) were however comparable with those of
Chinese women living in Penang, who, next to vegetable oil-fried !sh, consume a variety of, AA-rich,37
meat products, including chicken, beef and pork. Compared with Inuit women, those in Doromoni
had considerably lower milk DHA (0.75 vs 1.4%) and EPA (0.17 vs 1.1%), but somewhat higher AA
(0.70 vs 0.6%).38 The rather unique high Doromoni milk LCP contents in combination with its almost
1:1 AA/DHA ratio is without doubt due to the consumption of !sh from the East-African freshwater
lakes. These !sh have high contents of both AA and DHA, with AA/DHA ratio’s of about 0.75 in
conjunction with relatively low EPA contents (Figure 3). Oppose this notion seems to be that no
increase of milk AA could be detected in Palestinian women during short term AA supplementation
(300 mg/day; one week).22 It is on the other hand known that prolonged AA supplementation (1.7 g/
day, 50 days) augments the AA contents of various lipid compartments, notably those of the plasma
phospholipids, but also of erythrocytes, platelets and fasting plasma triglycerides, free fatty acids
and cholesterol esters.39,40 In agreement with this, higher whole plasma AA was found in a !sh eating
community living at the shore of lake Nyasa (Tanzania), as compared with a vegetarian community
living 50 miles inland.41 These subjects also had higher whole plasma EPA and DHA, and higher EPA/
AA and DHA/AA ratios. Reaching high whole body LCP status comparable with these communities
might be a prerequisite to increase the milk LCP content to the extent of Doromoni, since milk LCP
derive mostly from body stores and to lesser extent directly from the diet. It was estimated that
90% of milk AA does not derive from direct intestinal absorption, while this amounts to 70-80% for
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linoleic acid and DHA.33,42 Taken together this implies that the higher milk AA content in Doromoni
derives mainly from a life-long abundant AA intake from local sh and that this applies to DHA to
somewhat lesser extent. It also implies that, given the large distribution volumes for body fatty acids
(i.e. cellular phospholipids and adipose tissue triglyceride stores), Western mothers may require a
sizeable combination of time and LCP dosage to reach milk AA and DHA contents comparable with
those in Doromoni.
The AA/EPA ratio of the Tanzanian fresh water sh was higher than that of the Caribbean sh
and much higher than that of the North Sea sh. This dierence tracks down to the origination of
the LCP 3 in salt water sh from EPA-rich marine phytoplankton and zooplankton, whereas most
freshwater sh are capable of producing their own DHA from !-linolenic acid.18 It is possible that
the high AA contents and high AA/EPA ratio of the East-African lake sh prevented AA and EPA from
becoming competitors for augmentation of AA body status, as suggested by comparison of the
milk EPA-AA and DHA-AA relations in Doromoni and certain other countries with high EPA and DHA
intakes from sh (Figure 1 and Figure 2). The latter countries were notably Caribbean islands, such
as Dominica, Antigua, St. Lucia and St. Vincent, where sh is eaten with lower AA content but also
lower AA/EPA ratio. In addition it has been reported that collaboration, rather than competition,
between AA and EPA, and possibly also between AA and DHA, may occur in certain circumstances
notably at low EPA and DHA dosages.23,24 In line with this notion we have previously reported that
short term supplementation with AA did not increase human milk AA, but that supplementation
with AA, EPA and DHA tended to increase both AA and LCP 3 after 1 week.23 This suggests that
not only dietary AA and DHA intakes are determinants of their ultimate body status, but that the
AA/EPA and possibly the AA/DHA ratio, might be of importance as well. Apart from this dietary
‘LCP balance’ it might also be important in which dietary lipid fraction(s) the AA, EPA and DHA are
located. As previously noted, AA in dietary phospholipids was found to be a more e!cient dietary
source to augment the brain AA content of neonatal baboons, when compared with AA in dietary
triglycerides.34 Lean sh, like those from the East-African lakes and Caribbean Sea, are in this respect
dierent from the fatty sh from the North Sea, in the sense that AA and DHA are both located in
phospholipids of lean sh, and that in fatty sh AA is mainly located in phospholipids and DHA is
located in both phospholipids and the abundant triglycerides. Consumption of sh with balanced
AA/EPA/DHA composition and with AA and DHA located in phospholipids, i.e. East-African lake sh,
may be the most e!cient way to augment the AA and DHA body status.
The present results shed doubt on the validity to use milk from Western mothers as the gold
standard for the addition of LCP to infant formulae. Although there is no solid evidence for long
term adverse eects of feeding infant formulae without LCP, it is becoming increasingly clear that
dietary LCP have many eects ranging from their nowadays well known in"uence on visual and
neurological function to the more recently discovered and currently intensely studied in"uence
on the expression of our genome.10-13 The consequences of subclinical deciencies are di!cult
to objectify, since they may operate over long periods that confound their identication as the
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causative insults. For instance, a link between perinatal LCP status and obesity, hypertension, insulin
resistance, and coronary heart disease has been suggested,43 but how are we to get proof with hard
endpoints according to the rules of evidence based medicine? As much as we criticize the LCP 3
content and the out of proportion linoleic acid/!-linolenic acid ratio of contemporarily Western
diets, we might criticize the milk fatty acid composition of Western mothers. The DHA and EPA
contents are the most variable human milk fatty acid components worldwide and the previously
established low biological variation of its AA content8 has in this study been refuted as deriving
from a selection bias. It is virtually impossible and certainly una!ordable to perform randomized
controlled trials with each of the components of our diet and preferably their combinations, which
argues in favor of clues that should come from the diet on which our genome has evolved. The milk
AA, DHA and EPA contents of the Doromoni women might provide us with a clue to optimize infant
formulae and perhaps also the milk fatty acid composition of Western women.
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Background. We need information on the diet on which our genes evolved.
Objective. We studied the milk fatty acid (FA) composition of mothers living in the island of Chole
(Tanzania, Indian Ocean). These mothers have high intakes of boiled marine !sh and coconut, and
consume plenty amounts of fruits and vegetables.
Design. The outcome was compared with 3 !sh-eating tribes living along Tanzanian freshwater
lakes (Kerewe, Nyakius, Nyiramba), 4 tribes living in the Tanzanian inland (Hadzabe, Maasai, Sonjo,
Iraqw) and our milk FA database.
Results. Milk from Chole contained high levels of 12:0 (20.17 g%), 14:0 (21.19), 12:0/14:0 ratio (0.92
g/g), arachidonic acid (AA, 0.50 g%) and docosahexaenoic acid (DHA, 0.73), but low levels of linoleic
acid (LA, 4.23). The combination of a high medium chain fatty acid (MCSAFA; <C16) content and
12:0/14:0 ratio derives notably from coconut consumption, as opposed to a carbohydrate rich diet,
while non-existent use of vegetable oils explains low LA. Milk AA/DHA ratios of the 4 !sh-eating
groups were related to the AA/DHA ratios of the available !sh. Chole MCSAFA and LA did not ful!ll
Western recommendations for formulae, while AA and DHA were well above minimum levels.
Conclusions. The Chole milk FA composition is likely to re"ect the dietary FA composition of
babies born to our ancient ancestors living in East-African coastal regions. The poor compliance
with present recommendations raises questions regarding the validity of recommendations that
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INTRODUCTION
Evolutionary medicine acknowledges that our genes have been selected against the background of
a certain environment, including diet, and that this environment consequently supports a state of
optimal homeostatic control. We have since the agricultural revolution (i.e. some 10,000 years ago)
gradually changed our diet and accelerated these changes from the beginning of the industrial
revolution (i.e. 100-200 years ago).44-47 These changes, together with a sedentary lifestyle have
caused a mismatch with our slowly adapting genome. The resulting conict between our genes
and the current environment is at the basis of many, if not all, typically Western diseases, including
coronary artery disease (CAD), type 2 diabetes mellitus, osteoporosis, acne vulgaris and certain
cancers, including those of the prostate, breast and colon. Return to our ancient diet as translated
to modern society is indicated, since it might increase our number of years in health, rather than
increase our life expectancy.48
The dietary composition of our ancient ancestors may to some extent be reconstructed
from archeological discoveries. The sites at which their fossil remains have been discovered are
in support of the notion that evolution to Homo sapiens took place on an  3-rich diet from East-
African ecosystems that were notably located in places where the land meets with water.16,49,50 Food
from these ecosystems is rich in iodine, vitamins A and D, and  3-fatty acids from both vegetable
origin and !sh. This composition seems somewhat abandoned since the Out-of-Africa Diaspora,
since de!ciencies of these particular nutrients are among the most widely encountered in the
current world population.16,50-52 Iodine is added to table salt in many countries, and margarines
and milk have become popular food products for forti!cation with vitamins A and D. The dietary
composition of our ancestors has also become clear from our (patho)physiology. Epidemiological
data demonstrated a negative association of !sh oil with CAD,53,54 and of !sh consumption with
(postpartum) depression,55,56 while landmark trials with alpha-linolenic acid (ALA) {de Lorgeril, 1999
205 /id} and !sh oil57 in CAD, and with eicosapentaenoic acid (EPA) in depression and schizophrenia58
supported the causality of these relations.
We28,59 recently criticized recommendations for the fatty acid composition of infant formulas as
issued by various nutritional authorities7,60-69. These recommendations are based on human milk
data from Western mothers who consume Western diets and who are consequently at high risk
for typically Western diseases. For instance, there is no rationale in a recommendation of 8-35 g%
linoleic acid (LA; 18:2 6), when we take into account that LA consumption has sharply increased
in the past decades because of augmented consumption of  3-poor vegetable oils, there is no
scienti!c evidence to restrict the medium chain saturated fatty acids (MCSAFA; <C16) 12:0 and 14:0
to ≤15 g%, and the criteria for the long chain polyunsaturated fatty acid (LCP; ≥20 carbon atoms and
≥3 methylene-interrupted cis-double bonds) arachidonic acid (AA)≥ 0.35 g% and docosahexaenoic
acid (DHA)≥ 0.20 g% seem to neglect the declining intakes of LCP 3 and possibly AA. Tanzanian
mothers with high consumption of freshwater !sh as only source of animal protein and fat had both
high AA and DHA contents in their milk, when compared with those of Western mothers and the
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recommendations derived of these.59 Above 15 g% 12:0 and 14:0 milk contents are, on the other
hand, especially encountered in women with high intakes of carbohydrates from grains and corn.
Carbohydrate-rich diets are not consistent with present notions on the macronutrient composition
of our ancient diet45 and it may consequently be questioned whether the resulting high MCSAFA
contents in milk have been part of newborn diets in the past.
Also consumption of coconuts is known to increase milk MCSAFA, notably 12:0 and 14:0,70 since
coconut oil characteristically contains about 47 g% 12:0, 18 g% 14:0, 8% 8:0, 6% 10:0 and 1% 6:0.71
Availability of coconuts is currently typical for most tropical seashores. Whether coconuts have been
part of the diet of early Homo sapiens is uncertain, since no coconut fossils have been found in East
Africa. On the other hand not many fossilized coconuts have been found anywhere, which is probably
because eventually they tend to become fully recycled on the seashores of the hot and humid
tropics.72 One of the exceptions is a silici!ed coconut fruit from the Chinchilla sands in southern
Queensland (Australia), which was dated to the late Pliocene, about 2 mya, suggesting an already
wide distribution range at that time.73 Coconuts are capable of developing after having "oated in
the sea for up to 110 days and their theoretical range of dissemination by "oating is estimated
to be anywhere between the African East coast and the American West coast, wherever currents
are favourable.74 It seems therefore plausible that coconuts have been available to early humans
and that they may have served as easy meals and drinks for opportunistic hunter-gatherers72 living
along the African coast, while also the Out-of-Africa Diaspora is likely to have occurred along the
shores of the Indian Ocean into Asia.75,76
In the present study we investigated the milk from mothers living in Chole, which is a small
island in the Indian Ocean, close to the Tanzanian mainland, located South of the much larger Ma!a
Island. The inhabitants of Chole have high intakes of local marine !sh and coconut, and consume
plenty amounts of fruits and vegetables. In contrast to our former !sh-eating study population59 they
do not use vegetable oils for cooking and have low intakes of carbohydrates from grains or corn,
which is likely to cause much lower milk LA and de novo synthesized MCSAFA from glucose. Their
consumption of coconut may be expected to increase milk 14:0, but especially 12:0. For comparison
with the milk from Chole we carefully selected 3 populations or tribes living along Tanzanian
freshwater lakes (i.e. Lakes Victoria, Malawi and Kitangiri) and 4 living in the Tanzanian inlands. For
a better understanding of the milk LCP contents we also analyzed the fatty acid composition of
various local freshwater and marine !shes.
SUBJECTS AND METHODS
Study design and study groups
Tanzania is inhabited by about 126 di#erent tribes.77 Intermarriage is rare and, dependent on the
directly surrounding environmental circumstances, many of the tribes have remained unique with
respect to their diets. Our primary interest was the people living in the island of Chole. In addition
we recruited 3 groups of !sh-eating controls (Kerewe, Nyakius, Nyiramba), 4 groups from the inlands
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(Hadzabe, Maasai, Sonjo, Iraqw) and also compared with historical milk fatty acid data from Dar-es-
Salaam.8 The latter group was composed of lactating mothers who attended the local University
maternity ward of the Muhimbili Medical Center in Dar-es-Salaam in 1970. The milk samples were
collected by one of us (ERB) who at that time worked in the University Hospital of Dar-es-Salaam as
a pediatrician. The Chole population is composed of a mixture of people from the African inlands,
who were transported and concentrated in the coastal areas by Arab slave traders in the 19th century.
The staple foods are coconut and preferably boiled marine sh, which are combined with free fruits
(oranges, mangos and bananas) growing all over the island and an occasional ying fox, of which
one of the last colonies in the world resides in this island. Fish-eating controls were recruited from
the people of Ukerewe (the Kerewe), the Nyakius people and the Nyiramba people. Ukerewe is an
island located in the South-East of Lake Victoria. The island is abundant in fruits (mandarin, orange,
mango and several species of bananas) and the Kerewe diet is rich in, preferably boiled, freshwater
lake sh. The carbohydrate-rich porridge ‘ugali’ (local name for corn wheat porridge) is consumed
as part of their daily diet. The Nyakius people are members of a tribe living on the northern shores
of Lake Malawi (also named lake Nyasa or Nyassa) around Matema Beach. The area is extraordinarily
fertile and provides plenty of fruits (e.g. mango, orange, banana), as well as abundant freshwater sh
from the lake. Corn wheat is to a lesser extent part of their diet, while cassava (‘muhogo’, in Kiswahili)
is their major carbohydrate source. The Nyiramba people live around a freshwater lake in the village
of Doromoni, which is located at the shores of Lake Kitangiri, 100 km south-west of the alkaline lake
Eyasi. Their diet consists of freshwater sh that is mostly fried in local corn oil (52 g% LA; 31 g% oleic
acid). Vegetables and especially fruits are scarce and dicult to obtain, and therefore not part of the
daily dietary intake. The fatty acid composition of the milk from the Nyiramba people has previously
been described59 but is incorporated to facilitate comparison.
Controls living in the Tanzanian inlands were recruited from the Hadzabe, the Maasai, the
Sonjo and the Iraqw people. The Hadzabe are among the last hunter-gathering tribes in the world.
Largely driven out of their original territory into the arid areas, unattractive for crop cultivation, they
nowadays depend at least partially on food distribution (corn our) from a local Lutheran Hospital.
Hunting is still daily practice, while roots, honey and berries are gathered. Corn and corn oil have
inevitably become a large part of their contemporary diet. The second group is the Maasai. After
having been forced out of the Serengeti National Park they still live relatively traditional lives in
the Conservation Area of Ngorongoro since 1958, where they are the only ones allowed living and
herding their stock. They are pastoral people and the diet of those not involved in daily (eco) tourism
consists of curdled milk and occasional meat that has recently become replenished with some ugali
(corn porridge). In between the Maasai, in a heavily fortied village located in the only green valley
in miles, live the Sonjo. They combine hunting with agriculture and in their palisade-surrounded
valley they have to their disposal a wide variety of fruits. Small local markets contribute to the trade
of milk and fruits between the Maasai and Sonjo women. Finally we recruited from the Iraqw people,
who reside in the region south of Lake Eyasi, where they live as farmers in villages within the Mbulu
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district. Subjects were recruited in Mwanga, a small village in the dry highlands between Kiomboi
and Mbulu, close to the Haidom Lutheran Hospital. Most of the mothers are well nourished. Due
to poor herding grounds and consequently small herds of cattle that are kept for the production
of milk, notably the women should be regarded as vegetarians. Fish is not eaten because of the
traditional beliefs that it is a snake-like creature and therefore not edible. The fatty acid composition
of the milk from the Iraqw people has previously been described (59) but again shown to facilitate
comparison.
Samples and analyses
About 5 mL milk samples were collected by one of us or by one of the local medical doctors or
nurses in local dispensaries. Women were eligible to participate if they gave informed consent, were
breastfeeding, apparently healthy and well nourished, and had delivered an apparent healthy child
more than 10 days prior to their visit to the local dispensary. Anthropometric data were recorded
and are presented in Table 1. Data on age, parity, dietary habits and duration of lactation were
obtained from the medical records or by interviews in Kiswahili as conducted by one of us (RSK). Fish
were caught by line, purchased from local !sherman or bought at local markets at Lake Victoria, Lake
Malawi and in Dar-es-Salaam by one of us (RSK). Small (1 cm3) portions of edible meat were taken
from just above the backbone, in front of the dorsal !n. The study was approved by the National
Institute for Medical Research in Dar-es-Salaam (NIMR/HQ/R.8a/Vol. IX/145, dated June 16, 2003)
and was in agreement with the Helsinki declaration of 1975 as revised in 2000.
All samples were immediately processed after collection. Following gentle mixing an aliquot of
100  L of milk was pipetted into a te"on-sealable tube containing 2 mL of methanol-6 mol/L HCl
(5:1 v/v), 1 mg butylated hydroxytoluene (antioxidant) and internal standard (50 μg 17:0 in 100
μL methanol). In this ready-to-transmethylate mixture fatty acids are stable for months at room
temperature and in the dark. Samples of !sh were stored in the same methanol-HCl mixture. All
samples were transported at room temperature to the University Medical Center Groningen (The
Netherlands) for fatty acid analysis.
Analyses of fatty acid methyl esters (FAME) in milk and !sh were performed by capillary gas
chromatography/"ame ionization detection according to previously described procedures78
Brie"y, milk samples were forti!ed with a series of odd-carbon chain numbered fatty acid internal
quanti!cation standards (5:0 up to 17:0). Transmethylation of both milk and !sh occurred at 90 !C
for 4 h and FAME were subsequently extracted into hexane. Long-chain fatty acids (≥16:0) were
quanti!ed on the basis of the added 17:0. Medium chain fatty acids (6:0 up to 14:0) were quanti!ed
with use of 5:0 - 15:0 as internal quanti!cation standards.30 Fatty acid compositions and their ratios
were expressed in g%, mol%, g/g and mol/mol.
Data evaluation
Statistical analyses were performed with SPSS version 12.0.1 (SPSS Inc, Chicago, IL). Correlations
3.2
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were studied with the aid of the Pearson correlation test. Between-group dierences were tested by
Mann Whitney U-test at p<0.05. Correction was made for type-1 errors. Most of the dierences were
however evaluated by visual comparison with the aid of box plots, since it was rather our intention to
point at dierences in trends between e.g. Tanzanian data and those of other countries, or between
sh-eating and inland-living tribes within Tanzania. A multitude of between-group comparisons
was not considered to add to our line of reasoning. For comparison with other countries we used
the ‘world data base’ on human milk fatty acid compositions that we have collected in the past 25
years, using the same milk sampling techniques and analytical methods. Our present ‘world data
base’consists of people from Antigua (AG); Curaçao-Netherlands Antilles (NA); Belize (BZ); Dominica
(DM); Jerusalem-Israel (IL); St. Lucia (LC); The Netherlands (NL); Pakistan-Islamabad (PK); Jerusalem-
Palestine (PS); Surinam (SR); St. Vincent (VC) and the previously mentioned historical milk fatty acid
data from Dar-es-Salaam (TZ-DAR). The milk fatty acid compositions in Tanzania were also evaluated
in the context of current recommendations for infant formulae fatty acid compositions, as issued
by various organization (7,60-69). The outcomes were compared with the corresponding data as
derived from our ‘world data base’.8,28
RESULTS
Relatively high numbers of women in Chole (25%) and Kerewe (33%) had low BMI according to
Western standards (Table 1, BMI <18.5 kg/m2). Between group analyses of BMI <18.5 and BMI ≥18.5
kg/m2 for Chole showed a signicant dierence for the milk 12:0/14:0 ratio (p=0.047), with higher
values for subjects with high BMIs. For Chole, negative relationships were observed between BMI
and 14:0 (r=-0.542; p=0.040), BMI and 24:0 (r=-0.473; p=0.030), and a positive relation between BMI
and the 12:0/14:0 ratio (r=0.601; p=0.004). For the Kerewe, between group analyses between BMI
<18.5 and BMI ≥18.5 kg/m2 gave signicant dierences with higher 18:0 (p=0.037), LA (p=0.009), 6
(p=0.009) and PUFA (p=0.017) for subjects with high BMI. The Kerewe showed positive relationships
between BMI on the one hand and 20:0 (r=0.389; p=0.037), LA (r=0.407; p=0.028), 20:2 6 (r=0.439;
p=0.017), 20:3 6 (r=0.513; p=0.004),  6 (r=0.416; p=0.025) and PUFA (r=0.369; p=0.049), on the
other hand. The results of the fatty acid analyses (in g% and g/g) for milk samples from Chole, the
Kerewe, the Nyakius, the Nyiramba, the Hadzabe, the Maasai, the Sonjo and the Iraqw people,
together with the historical data from Dar-es-Salaam, are presented in Table 2. All data have been
obtained by using a single analytical method {Steege van der, 1987 46 /id} Comparisons of Tanzanian
milk fatty acid contents with those of our ‘world data base’ are presented as box plots for 12:0, 14:0,
16:0, LA, DHA and AA in Figure 1. Table 3 shows the percentages of milk samples from the various
groups in Tanzania that do not fulll the recommendations for 12:0, 14:0, LA, 18:3 3, AA, EPA, DHA,
LCP 3 and LCP 6 in infant formulae. Milk of Chole mothers showed high contents of 12:0 (Table 2,
20.17 g%), compared with all other groups. These levels were only approximated by those of Dar-
es-Salaam (16.89 g%) and the Kerewe (12.28 g%). Chole and Dar-es-Salaam are both located in the
Tanzanian coastal region, where palm trees are abundant and coconuts freely available. High levels
151
3.2









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































High lauric, myristic, AA and DHA contents, but low LA contents in milk from women from Chole, Tanzania
of 12:0 were also observed in our world data set for the Caribbean islands of Dominica, St. Vincent
and St. Lucia and for Surinam (Figure 1). Ninety percent of the samples from Chole exceeded the ≤15
g% recommendation for formula milk, whereas for the Kerewe this amounted to 10% (Table 3). An
apparently similar picture emerged for 14:0, which is less abundant in coconut compared with 12:0.
Also here Chole scored highest (Table 1, 21.19 g%), but this time followed by the Kerewe (20.26 g%),
who do not consume coconuts but have high carbohydrate intakes. The 12:0/14:0 ratio in coconuts
is about 2.61 g/g, while this ratio in the milk from Chole, Dar-es-Salaam and the Kerewe amounted to
0.92, 1.15 and 0.62, respectively. These ratios were statistically signicant by Mann Whitney U-tests
(Chole vs Kerewe, p<0.0001; Chole vs Dar-es-Salaam, p=0.045; Kerewe vs Dar-es-Salaam, p<0.0001),
in which the Kerewe ratio proved most distinctive. Eighty-ve and 87% of milk from Chole and the
Kerewe, respectively, did not comply with the recommendation of ≤ 15 g% 14:0, while 26-100% of
the samples from the various Tanzanian groups did not comply with the (12:0 plus 14:0) ≤ 20 g%
criterion (Table 3). In contrast, none of the 222 milk samples from The Netherlands in our world data
base exceeded the ≤ 5 g% recommendations for 12:0 or 14:0.
Highest 16:0 was encountered in the Maasai (Table 1, 27.90 g%), followed by Pakistan (Figure
1). For the Maasai this observation relates to their consumption of fermented milk, while the high
16:0 in Islamabad-Pakistan may be caused by the consumption of ghee22. Both milk and butterfat
are abundant in 16:0.
Milk LA contents (Figure 1) were low in both Chole (Table 1, 4.23 g%) and the Kerewe (5.20 g%),
notably when compared with the Nyiramba (18.11 g%) and the Iraqw (15.52 g%) who use abundant
corn oil for frying and cooking. Also the Maasai and the Nyakius had relatively low milk LA, but most
of the Tanzanian groups exhibited LA levels comparable with the auent countries in our world
data set.
Highest levels in the latter were reached by Jerusalem-Israel (Figure 1). Sixty-ve and 47 percent
of Chole and the Kerewe samples, respectively, did not comply with the LA ≥ 5 g% recommendation,
while 100 and 93% did not comply with LA ≥ 11 g% (Table 3). The Nyiramba, Hadzabe, Sonjo and
Figure 1. Selected fatty acids in the milk of Tanzanian tribes and locations, as compared with countries in our
world data set. Data (in g%) are indicated as box plots, showing medians (black bar), interquartile range (box
length), minimum and maximum of the sample or smallest and largest values inside a ‘reasonable’ distance
from the end of the box (crossbars at the far ends of whiskers), values between 1.5-3 box lengths from either
end of the box (outliers, indicated by  ) and values >3 box lengths from either end of the box (extremes,
indicated by *).
Countries were denoted according to ISO 3166-1 and the corresponding ISO 3166-1-alpha-2 code elements
for countries. Investigated tribes and locations in Tanzania are denoted as TZ, followed by the rst three letters
of the tribe or alternatively by the rst three letters of the sampling location in case the local population has
become mixed due to 19th century gathering of people from all over East-Africa, such as notably has occurred
in coastal regions. AG, Antigua; BZ, Belize; DM, Dominica; IL, Jerusalem-Israel; LC, St. Lucia; NA, Curaçao-
Netherlands Antilles; NL, The Netherlands; PK, Pakistan-Islamabad; PS, Jerusalem-Palestine; SR, Surinam;
TZ-CHO, Chole; TZ-DAR, Dar-es-Salaam; TZ-HAD, Hadzabe; TZ-IRA, Iraqw; TZ-KER, Kerewe; TZ-MAA, Maasai;
TZ-NYA, Nyakius; TZ-NYI, Nyarimba; TZ-SON, Sonjo; VC, St. Vincent.
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Table 3. Percentages of human milk samples that do not ful!ll the recommendation as issued by the indicated
organization
committee recommendation CHO KER NYA NYI HAD MAA SON IRA ALL
CD91, EU 12:0<=15 g% 90 10 3 3 4 0 0 11 13
CD91, EU 14:0<=15 g% 85 87 27 17 32 7 0 28 37
EU, ESP05 12:0+14:0<=20 g% 100 100 63 63 86 26 33 50 68
ESP05 18:2ω6>=5 g% 65 47 3 0 0 0 11 0 15
LSRO, EU 18:2ω6>=8 g% 100 87 27 0 4 33 22 6 34
CD91 18:2ω6>=9 g% 100 90 37 0 4 56 22 11 40
GR, WS 18:2ω6>=10 g% 100 93 50 0 14 67 33 22 47
FAO, ESP 18:2ω6>=11 g% 100 93 63 3 21 81 44 22 53
ESP, CD91 18:2ω6<=20 g% 0 0 3 46 32 0 0 33 16
ESP, EU 18:2ω6<=27 g% 0 0 0 3 4 0 0 0 1
LSRO 18:2ω6<=35 g% 0 0 0 0 0 0 0 0 0
FAO, ESP05, EU 18:3ω3>=1.0 g% 100 93 73 37 96 96 78 78 80
GR 18:3ω3>=1.4 g% 100 97 97 66 100 100 89 89 91
SI, WS 18:3ω3>=1.5 g% 100 97 100 69 100 100 89 89 92
LSRO 18:3ω3>=1.75 g% 100 97 100 83 100 100 89 89 95
LSRO 18:3ω3<=4.0 g% 0 0 0 0 0 0 0 0 0
CHF, EU 20:4ω6>=0.35 g% 0 0 0 0 0 41 0 6 7
WS 20:4ω6>=0.5 g% 50 20 53 0 7 85 89 33 37
GR 20:4ω6>=0.6 g% 85 50 73 14 36 100 100 44 58
FAO 20:4ω6>=0.8 g% 100 87 93 49 75 100 100 78 82
SI 20:4ω6<=1.0 g% 0 3 0 17 0 0 0 0 4
WS 20:5ω3<=0.10 g% 70 97 20 71 14 11 22 11 43
CHF, EU 22:6ω3>=0.2 g% 0 0 3 6 25 56 44 67 22
WS 22:6ω3>=0.35 g% 0 0 23 20 57 93 56 94 40
FAO, GR 22:6ω3>=0.4 g% 5 0 27 20 68 93 78 100 44
CD96, SI, EU 20:5ω3<=22:6ω3 0 0 0 0 0 0 0 0 0
EU LCPω6<=22:6ω3 5 93 3 0 0 0 0 0 15
SI, ESP, CD96, EU LCPω6<=2 g% 0 3 3 83 46 0 0 28 25
SI, ESP, CD96, EU LCPω3<=1 g% 60 97 23 71 4 0 11 0 38
Cho, Chole (n=20); Ker, Kerewe (n=30); Nya, Nyakius (n=30); Nyi, Nyiramba (n=35); Had, Hadzabe (n=26);
Maa, Maasai (n=27); Son, Sonjo (n=9); Ira, Iraqw (n=18); All (n=197) CD91, Commission Direcetive 1991; CD96,
Commission Directive 1996; CHF, Child Health Foundation, 2001; ESP, ESPHGAN 1991 and 2005; EU, European
Commission, Scienti!c Committee on Food 2003; FAO, Food and Agriculture Organization of the United Nations,
1994; GR, Health Council of the Netherlands (Gezondheidsraad), 2001; LSRO, Life Science Research O$ce, 1998;
SI, Statutory Instruments, 2001; WS, Workshop Statement, 2000. LCP, long-chain polyunsaturated fatty acids
Iraqw were the only groups in which over 50% ful!lled the LA ≥ 11 g% recommendation, whereas
for The Netherlands this !gure amounts to 76%28.
Although their LA was low, AA in milk from the !sh-eating Chole mothers (Table 1, 0.50 g%) was
comparable with AA in both the milks of the !sh-eating Nyakius (0.50 g%) and Kerewe (0.58 g%),
but much lower than in the !sh-eating Nyiramba (0.80 g%). From the groups living in the inland,
the Hadzabe show highest AA (0.71 g%), while the Maasai (0.37 g%) had levels comparable with
Pakistan and The Netherlands (Figure 1). Except for the Maasai, all milk samples in Tanzania ful!lled
3.2
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the ≥ 0.35 g% AA recommendation (Table 3), while in The Netherlands 14% do not comply (28).
Forty-one percent of the Maasai did not reach the ≥ 0.35 g% AA recommendation, while 51% of
the samples from the !sh-eating Nyiramba reached the AA ≥ 0.8 g% criterion (Table 3). None of the
samples in The Netherlands reached the AA ≥ 0.8 g% criterion.28
Three out of the 4 investigated !sh-eating groups showed high EPA percentages that did not
ful!ll the ≤ 0.1 g% recommendation. The percentages that did not comply amounted to 97, 71 and
70% for the Kerewe, Nyiramba and Chole groups, respectively (Table 3). In the Netherlands only 9%
did not comply to this criterion.28
The 4 !sh-eating groups had highest milk DHA levels, ranging from 0.53 g% for the Nyakius up to
1.79 g% for the Kerewe, and with Chole (0.73 g%) and the Nyiramba (0.91 g%) holding intermediate
positions (Table 2). These levels were well above those of the groups living in the inland, with the
vegetarian Iraqw (0.16 g%) and the pastoral Maasai (0.20 g%) showing lowest levels. Many of the
groups living in the inlands showed DHA levels comparable with a#uent countries such as The
Netherlands (Figure 1). Five and 0% of the samples from Chole and the Kerewe, respectively, did
not comply with the DHA ≥ 0.40 g% recommendation, whereas for The Netherlands and Jerusalem-
Palestine these !gures amount to 92 and 97%, respectively.28
Figure 2 compares the AA/DHA ratios in the milk of the 4 !sh-eating groups with the
corresponding AA/DHA ratios in the !shes that are available to them. Neither of the locations
Figure 2. Comparison between AA/DHA ratios in milk and !sh. Data (in g/g) are presented as box plots (see
legend of Figure 1). They derive from the Kerewe (Lake Victoria), mothers living in Chole (Indian Ocean), the
Nyakius (living at Lake Malawi) and the Nyiramba (living at Lake Kitangiri). AA, arachidonic acid (20:4ω6); DHA,
docosahexaenoic acid (22:6ω3).













































showed dierences between the sh and milk AA/DHA ratios. However, except for the comparison
between Lake Malawi and Lake Kitangiri, there were signicant dierences between the milk AA/
DHA ratios for the various locations (Lake Victoria vs Indian Ocean p<0.0001, Lake Victoria vs Lake
Malawi p<0.0001, Lake Victoria vs Lake Kitangiri p<0.0001, Indian Ocean vs Lake Malawi p=0.003,
Indian Ocean vs Lake Kitangiri p=0.003.
The AA/DHA ratio in sh does not seem dependent on their derivation from fresh or saltwater, since
there were signicant dierences between the AA/DHA ratios of the sh from Lake Kitangiri and
Lake Victoria (p=0.042) and Lake Kitangiri and Lake Malawi (p=0.024). The largest variation of the
AA/DHA ratio was observed in sh from the Indian Ocean, which may relate to the wide variety of
marine locations from which the investigated shes originated.
DISCUSSION
There is no ‘uniformity of human milk’ and this applies notably for the human milk fatty acid
composition.8,79 Within the limitations of the genetically-determined preferences within the
mammary gland triacylglycerol assembly machinery, the human milk fatty acid composition seems
predominantly dependent on the fatty acid composition that is submitted to this machinery. Strong
preferences for incorporation of certain fatty acids at certain sn-positions of the glycerol backbone
may provide some structural uniformity, such as the high preference to incorporate 16:0 on sn-2,80
but the dietary composition and to a lesser extent maternal extra-mammary physiology are by far
the most important modiable factors of the total milk fatty acid composition. Consequently, the
large variance in the world-wide human milk fatty acid compositions F, but also within a single
country such as Tanzania (Table 2), is testimony of the wide varieties of foods that are tolerated
by human beings, with dietary fatty acid composition and macronutrient composition (notably
carbohydrate content) as major determinants. This remarkable !exibility is however not to be
taken as proof for unimportance, since criticizing the current Western diet for its ability to cause
diseases typical for a"uent societies might be a synonym for criticizing the current Western milk
fatty acid composition. Concerns regarding adequate intakes of LCP by neonates to support optimal
brain development are an example81-83, while also the consistently found epidemiological relation
between early environmental factors and adult disease84-86 become rapidly supported by the
elucidation of the underlying (epigenetic) mechanisms.87,88
In view of the overwhelming in!uence of the maternal diet, the question arises what human
milk fatty acid composition supports infant development at best. Many randomized controlled trials
with fatty acid-enriched formulae have been, and are presently, conducted, using many dierent
endpoints, such as those of neurological development in case of LCP.81-83 The limitations of these
studies are that they are performed with infants that have been pre-exposed to an intrauterine
environment that is characterized by Western dietary habits, that the tested LCP contents are based
on their contents in milk from Western mothers, that use of formula precludes investigation of
interaction of the supplement with human milk constituents, while it is virtually impossible to study
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all potential interactions by performing trials with formulae. Consequently, randomized controlled
trials with formula-fed Western infants, using LCP contents as encountered in human milk from
Western mothers, will at most conrm ‘optimality’ of Western human milk and will subsequently
lead to recommendations based on the underlying ‘evidence of optimality’. In other words, human
milk is not a popular subject to become questioned for its optimality. To avoid this vicious circle and
to limit laborious dose-response studies and studies addressing interactions, we seem to be in need
of some ‘clues’ for the optimal milk fatty acid composition, which by denition has been established
by millions of years of evolution occurring in the context of a more constrained diet as presently
consumed worldwide.
In search of such clues we previously reported the human milk fatty acid composition of
Tanzanian women consuming freshwater sh as the only source of animal protein and fat;59 (see
Table 2, Nyiramba). Given the notion that Homo sapiens evolved in such eco-systems, we suggested
that their high milk AA and DHA contents might closely re!ect our ancient diet. On the other hand,
the Nyiramba diet was also composed of high carbohydrates and rened vegetable oils, which
were unavailable to our ancient ancestors. High carbohydrate intakes, causing high milk MCSAFA
contents, and abundant use of LA-rich vegetable oils were however unlikely to in!uence milk AA
and DHA, since there is no appreciable competition between LCP on the one hand and MCSAFA
and LA on the other, for their incorporation into milk triacylglycerols59. The Nyiramba milk may
consequently have provided valuable information on the LCP status of ancient communities, but
failed to provide clues for the intakes of carbohydrates and LA. In the present study we extended
our search for the evolutionary established human milk fatty acid composition by studying the milk
from Chole. The Chole inhabitants combine animal protein and fat from the local land-sea interface
with vegetables, fruits and coconuts. Their milk is characterized by a high DHA content (0.73 g%),
which is comparable with milk from the freshwater sh eating Nyakius (0.53 g%) and Nyiramba (0.91
g%), but was well below that of the extremely high DHA levels encountered in the freshwater sh
eating Kerewe (1.79 g%). Milk DHA of Kerewe mothers was even higher than the DHA content that
was previously reported for Inuit (38) milk (i.e. 1.4 g%). The Kerewe milk DHA content was, however,
not as high as that of sh eating Chinese mothers (i.e. 2.8 g%),89 while the Inuit milk EPA content was
higher than that of Kerewe mothers (Inuits: 1.1 g%; Kerewe 0.41 g%)38. The high milk DHA in Chole
could be traced to the consumption of marine sh and shows that abundant consumption of both
marine and freshwater sh gives rise to milk DHA contents that are well above those encountered
in people living in the Tanzania inlands, most Western countries and the recommendations derived
from the latter (Figure 1, Table 3). Regarding its AA content, Chole milk seems to hold an intermediate
position among both Tanzanian sh-eating populations and those living in the inlands. Chole
median milk AA levels (0.50 g%, Table 2) are clearly higher than those of the Maasai (0.37 g%) but
comparable with those encountered in a country like The Netherlands (0.43 g%). All Chole samples
showed AA levels above the 0.35 g% recommendation, whereas for the Maasai and The Netherlands
41% and 14%28 of samples did not comply with this criterion, respectively.
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The milk fatty acid composition of Chole also reminds us of the tremendous increase of LA
consumption in past decades that seems subsequently to have become adopted as the basis for
LA intake from infant formulae. Newborns in Chole do not show the skin problems associated
with LA deciency, which relates to the unique function of LA in skin ceramides.90 Moreover, milk
LA contents in the USA prior to augmentation of LA intake were typically in the 5-7 g% range.91
Interestingly, only 35% of the Chole samples complied with LA >5 g%, whereas none of them
complied with LA >8 g% and consequently the even higher recommendations (Table 3). Lower LA
in milk from Chole seems predominantly caused by the almost nonexistent use of LA-rich vegetable
oils for cooking, but may in part also be caused by the high consumption of coconuts. Ingestion of
a single dose of 12:0-rich coconut oil has previously been shown to rapidly augment the milk 12:0
content with peak concentrations being reached after 12-14 h (70). Both 12:0 and 14:0 compete
with LA for incorporation into milk triacylglycerols.59 High milk 12:0 and 14:0 from coconut oil seems
to some extent distinguishable from similar increases as derived from a carbohydrate-rich diet.
Indications for this may be taken from the higher 12:0/14:0 ratio in Chole, as e.g. compared with the
corresponding ratio in the milk of the Kerewe (0.92 vs 0.62 g/g). The Kerewe population does not
have access to coconuts or coconut oil, and their high 12:0 and 14:0, but lower 12:0/14:0, derives
almost exclusively from carbohydrate consumption. High 12:0/14:0 ratio as deriving from coconut
consumption became conrmed from the historical milk data from Dar-es-Salaam (12:0/14:0 1.15
g/g), since in Dar-es-Salaam coconuts are both consumed and its oil used for cooking.
A high milk MCSAFA might have been part of the ancient diet of newborns living in tropical
coastal areas, where coconuts were abundant. It is however unlikely that abundant dietary
carbohydrates have in the past served as substrates for mammary gland MCSAFA production to the
extent as observed in the Kerewe and Nyiramba, since carbohydrate-rich diets were not introduced
until the start of the agricultural revolution, some 10,000 years ago. Milk MCSAFA may confer many
favorable properties to the newborn. Their contents increase with advancing lactation,80,92 they
serve as easily absorbable energy sources, and they exhibit broad-spectrum antiviral and anti-
microbial properties.93-95 These anti-microbial eects seem notably on account of 8:0 and 12:0, and
to a much lesser extent on 6:0, 10:0 and 14:0.95 Interestingly, both the milks from coconut-eating
Chole and Dar-es-Salaam exhibited the highest 8:0 and 12:0 contents (Table 2). The atherosclerotic
eect of coconut oil in adults, is uncertain, but at least its eect on cholesterol deserves some
nuance.96 Both 12:0 and 14:0 raise LDL-cholesterol, but they also decrease the total cholesterol/HDL-
cholesterol ratio. Actually, 12:0 (lauric acid) has a more favorable eect on the total cholesterol/HDL-
cholesterol ratio than any other fatty acid, either saturated or unsaturated, while the corresponding
eect of the 2.6 times less abundant 14:0 (myristic acid) in coconuts is less pronounced. In contrast,
on an isocaloric basis, carbohydrates induce the highest increase in total cholesterol/HDL96 which
suggests an atherosclerosis promoting eect of the carbohydrate-rich diet in the Kerewe adult
population, but also in their ospring because of the carbohydrate-induced lower 12:0/14:0 ratio
in their milk, compared with Chole. Finally, coconut water is isotonic97 and provides an excellent
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source of sterile uid to compensate for losses in a hot tropical climate with little freshwater in the
immediate surroundings.
In summary, the human milk fatty acid composition in Chole has provided valuable information
on the possible dietary composition of babies born to our ancient East-African ancestors living in
coastal areas. Compared with current Western counterparts, their diet might have been abundant
in AA, DHA and MCSAFA (notably 12:0 and 14:0) and poor in LA. Whether this composition supports
optimal homeostasis and exerts antimicrobial eects is conceivable, but should be tested in
randomized controlled trials using clearly dened end points. The apparent lack of adverse eects
in the children in Chole, but also in other children living in Tanzanian land-water interfaces, seems
to argue against the validity of current recommendations that are merely based on the human milk
composition of Western mothers.
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Brenna et al.98 provided us with a meta analysis on the worldwide human milk DHA and AA contents.
Their study was composed of 65 reports of 2474 women with mostly Western dietary habits.
Analogous to at least two previous studies8,99 they concluded that milk DHA is more variable than
milk AA and that the DHA/AA ratio varies widely. The calculated mean SD values for DHA (0.32 0.22
g%) and AA (0.47 0.13 g%) were suggested to serve as a guide for infant feeding.
Although their conclusion on variation is consistent with one of our previous reports8 we currently
feel that the low AA variation might in reality derive from a sampling bias. Much higher milk AA
(median 0.70 mol%) together with high DHA (0.75 mol%) was found by us in lactating women in
Doromoni (Tanzania).59 Their milk showed clear correlation between DHA and AA. Both of these
long chain polyunsaturated fatty acids (LCP) could be traced to life-long consumption of DHA- and
AA-rich !sh from the nearby freshwater lake Kitangiri. It seems that milk AA is notably dependent on
long term AA intake, since supplementation of lactating women in Jerusalem with 300 mg AA for one
week did not increase milk AA.22 The sizeable short and long term dietary in"uences on the human
milk fatty acid composition raise the question whether the resulting variance should be taken as
testimony of the wide variety of foods that are tolerated by human beings and their o#spring, or
that it indicates a lack of evolutionary pressure because of a rather constant dietary composition
in the past. We feel that the worldwide human milk fatty acid composition should not be taken as
guide for infant formula. As much as Western serum cholesterol levels and vitamin D status should
not serve as targets for recommendations, it seems inappropriate to take the calculated mean milk
DHA and AA of mostly Western women as a basis for infant formulae. At least three arguments are
in favor of higher intakes of both DHA and AA by our ancient ancestors, consuming diets that were
much closer to the environment on which our genome has become adapted during the past 2-3
million years of evolution. First, the sites at which their fossil remains have been discovered are in
support of the notion that evolution to Homo sapiens took place on an LCP!3-rich diet from East-
African ecosystems that were located in places where the land meets with water.16,100 Food from
these ecosystems is rich in iodine, vitamins A and D, and !3-fatty acids from both vegetable origin
and !sh. Contrary to popular believe, our ancient ancestors did not need !shing gear to bene!t from
the abundant LCP!3, and probably LCP!6, in such ecosystems, where it is relatively easy to hunt and
gather anything ranging from spawning (cat)!sh, shell!sh, mollusks, jelly!sh, lobsters, eggs, birds
and reptiles, which all ultimately receive their LCP!3 from plankton via the local food-chain. The
resulting high iodine, vitamins A and D, and LCP diet seems somewhat abandoned since the Out-of-
Africa Diaspora, since de!ciencies of these nutrients are among the most widely encountered in the
current world population.16,52 Second, epidemiological data demonstrated a negative association of
!sh oil with coronary artery disease (CAD), and of !sh consumption with (postpartum) depression.
Landmark trials with alpha-linolenic acid (ALA),57 !sh oil101 and eicosapentaenoic acid (EPA)102 in
CAD, and with EPA in depression and schizophrenia58 supported the causality of these relations.
As acknowledged by Brenna et al.98 the intake of marine food in inland and developed countries is
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usually low. Many authorative organizations issued recommendations to the general public ranging
from ‘choose sh as a food item more often’ up to ‘the consumption of three servings of sh per
week’. One may wonder what the milk DHA and resulting DHA status would be of children born to
parents reaching the necessary DHA status to decrease their risks of CAD and psychiatric disease. If
their parents would benet from higher than present Western DHA status, which cannot be achieved
by the mere consumption of ALA, it seems reasonable to assume that this DHA status is appropriate
across the Homo sapiens lifecycle and that also our genes may have evolved on this high DHA status.
Meanwhile, it has also become clear that LCP are not only important structural components of
membranes but, together with their eicosanoid metabolites, rmly implicated in gene expression,
e.g. as modulators of nuclear transcription factors such as PPARs, SREBPs and TNF-alpha. Finally,
many randomized controlled trials using formulae with and without LCP, and measuring outcome
parameters like retinal function, visual acuity, behavior, and cognitive and motor developments,
have shown benecial e!ects of LCP, notably LCP 3, in both preterm and term infants. Preterms
benet most, but many of the e!ects are transient. E!ects are especially on account of DHA, but
addition of AA might be important to preserve 3/ 6 balance. The present consensus from human
and animal studies is that LCP supplements have no e!ect on growth, that neonatal brain DHA is
positively related to cognitive and behavioral performance, that the di!erences are di"cult to detect
with currently available tools, but that the encountered di!erences may nevertheless be relevant.103
All of these studies have been performed with DHA and AA dosages in the current ‘Western’ human
milk range, which might explain the modest e!ects.
In conclusion, we agree that DHA seems the most variable fatty acid in the human milk worldwide.
AA variance may, however, be underestimated due to a sampling bias. Higher AA levels occur in
women consuming diets close to our ancient diet, which is part of the environment on which our
genes evolved. Current Western human milk DHA contents do not comply with recommendations
of authorative organizations issuing advises to increase our sh intake and should consequently
not serve as guide for infant feeding. It would be of interest to see whether infant formulae with
LCP dosages consistent with non-Western, traditionally, eating populations would produce more
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Background. Lower long-chain polyunsaturated (LCP) fatty acid (FA), notably docosahexaenoic
acid (DHA), in term compared to preterm milks is often attributed to more depleted maternal LCP
stores after full term gestation. Depletion of maternal DHA stores is preventable by high maternal
DHA-intakes.
Objective: Investigating FA di!erences between preterm and term milks.
Methods.We compared the FA-compositions of preterm (28-36 weeks) and term (37-42) colostrum
(2-5 days), transitional (6-15) and mature (16-56) milks in African women with stable dietary habits
and lifelong high freshwater "sh intakes.
Results. From colostrum to mature milk, the median DHA and arachidonic acid (AA) contents
decreased from 1.11-0.75, and 0.93-0.69 g% in preterm; and from 0.81-0.53 and 1.08-0.55 g% in
term milk, respectively. Medium-chain FA (MCSAFA) increased from 16.9-33.7, and 7.92-29.0 g%,
while mono-unsaturated FA (MUFA) decreased from 32.5-22.6, and 40.0-26.5 g%, in preterm and
term milk, respectively. Consistent with the literature, preterm colostrum contained higher DHA and
MCSAFA, and lower MUFA compared to term colostrum. These di!erences vanished rapidly with
advancing lactation. MUFA and MCSAFA were inversely related.
Conclusions.African women show much higher milk MCSAFA and lower MUFA contents, compared
to European counterparts. DHA in preterm milks proved the highest reported so far. DHA di!erences
between preterm and term colostrum are unlikely to originate from maternal depletion between
preterm and term delivery. We hypothesize that changes and di!erences in insulin sensitivity may
contribute to the changing FA composition with advancing lactation and to the FA di!erences
between preterm and term colostrum.
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INTRODUCTION
Human milk is the optimal nutrition for the newborn. The milk fatty acid (FA) composition results
from some combination of FA uptake from triglycerides (TG) in circulating VLDL and chylomicrons
by lipoprotein lipase (LPL),104 FA uptake from circulating albumin-bound free-FA105 and endogenous
de novo lipogenesis from glucose in the breast. It was estimated that 10-12% of milk lipids are
derived from de novo lipogenesis in the mammary gland, that 29% originate directly from the diet
and that 60% are derived from maternal stores (104). The essential FA, alpha-linolenic and linoleic
acid may originate for 30% directly from the diet and for 70% from maternal depots.106 The human
milk lipid content varies during the course of a feeding, during the day and longitudinally from
delivery till weaning, but the FA composition seems only to be a!ected by time postpartum,
gestational age, parity and disease.107 The composition is also highly sensitive to changes in the
maternal diet.25,70,108 High intakes of dietary carbohydrates increase milk medium-chain saturated FA
(MCSAFA) that are uniquely de novo synthesized in the mammary.25,26 Consumption of tropical "sh
rich in both arachidonic (AA) and docosahexaenoic (DHA) acid increases both of these long-chain
polyunsaturated FA (LCP) in milk lipids.59,109,110 The worldwide human milk FA composition varies the
most in DHA,8,99,111 but is remarkably uniform in AA98
The milk LCP content decreases consistently with advancing lactation92,112-119 and is consistently
higher in preterm compared to term colostrum.115,120-124 Comparably, human milk mono-unsaturated
FA (MUFA) decrease quite consistently with advancing lactation,92,112-114,118,119,123 while the MCSAFA
content increases.92,112-114,116-119,123 Early preterm milk contains lower MUFA120,121,123,125 and higher
MCSAFA112,120,121,123,126 compared to early term milk, but few of these di!erences are still noticeable
in more mature milk.117 The decrease of milk LCP with advancing lactation and the lower content
of LCP in term compared to preterm human colostrum milk has been ascribed to the depletion of
maternal stores,127 while decreasing MUFA has been attributed to increasing MCSAFA, secondary to
the maturation of the mammary gland (105). The consistently observed di!erences for MUFA and
MCSAFA between preterm and term colostrum remain largely unexplained, although Freed et al.128
suggested that the higher MCSAFA in preterm compared to term colostrum might be attributed to
higher de novo FA synthesis in the preterm mammary gland. Although some di!erences between
preterm and term milk remain mysterious, the advantage of feeding preterm (donor) milk to
premature infants has been advocated,117,122,126 which is in line with the recommendation to supply
the term newborn with human milk rather than infant formulae.129
We recently showed (130) that postpartum decreases in the maternal and infant erythrocyte
(RBC)-DHA contents are dose-dependently abolished by high maternal intakes of tropical
freshwater "sh containing high amounts of AA and DHA.111 More importantly, our data showed that
in this population the maternal RBC-DHA content, a reliable index for DHA status, did not decrease
during pregnancy, and that at delivery mothers with high DHA-status had even higher RBC-DHA
contents compared to their infants, a process that we named bioattenuation130,131 - as opposed
to the biomagni"cation that takes place at lower DHA status.132 We concluded that within this
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unique population, living in Sengerema (Lake Victoria, Tanzania), there is no depletion of maternal
DHA stores at least during pregnancy,131 but that this occurs to some extent during subsequent
lactation.130
We were interested to see whether the lifelong stable dietary habits, including relatively high
intakes of carbohydrates and of DHA and AA by the women in Sengerema cause similar preterm-
term dierences in milk DHA, AA, MUFA and MCSAFA, as previously reported for other countries
in which the populations usually eat much less sh. We were notably curious to see whether the
absence of DHA depletion during pregnancy would equalize the DHA contents of preterm and term
colostrum and thereby test the notion that the lower DHA in term colostrum is due to maternal DHA
depletion in the period between preterm and term delivery.
SUBJECTS AND METHODS
Study design and study groups
The study was conducted in the Sengerema hospital, located at the southern shore of Lake Victoria
in Tanzania. Although the area is densely populated, small villages are widely distributed throughout
the landscape. Patients visit any nearby hospital or dispensary whenever their household work allows
them or when their business brings them into the proximity. Since an initially started longitudinal
study proved logistically almost impossible in this setting, we conducted a mostly cross sectional
study in which we investigated the FA dierences between colostrum (dened 1-5 days), transitional
(6-14 days) and mature breast milk (>14 days) from women who delivered preterm (28-36 weeks of
gestation) and at term (37-42 weeks). The local tribes are mostly Bantu and most families have been
involved in shing for centuries. Ugali (corn porridge), muhogo (cassava root) and plantain (baked
banana) are staple foods, while both fruits and vegetables are eaten on a daily basis. Consumption
of sh is frequent and one type of local sh (local name ‘Dagaa’, Scientic Rastrineobola argentea)
is even regarded as a kind of vegetable. Since the hospital does not provide food to its patients,
women bring their own food and cook it at the spot, after which it is shared with all neighboring
persons. It is not a custom, nor is there any interest or actual possibility, to deviate from their usual
diet during pregnancy or lactation. The average dietary intakes of mothers during lactation were
thus likely to be representative for their lifetime dietary habits. Dierences between dietary intakes
of preterm and term delivering women are very unlikely.
All subjects were apparently healthy and well nourished, and had delivered their infants
2-56 days prior to the day of inclusion. Deliveries that might be related to disturbed maternal
glucose homeostasis, e.g. preeclampsia and maternal (gestational) diabetes, were excluded.
Preterm deliveries were mostly attributed to maternal infections, notably malaria. All mothers
were exclusively breastfeeding and none of the infants received additional parenteral nutrition.
All infants were permitted to suckle on demand and they consequently stimulated the mammary
gland throughout the day. There were in this respect no dierences between preterm and term
delivering women, although milk for preterm infants was sometimes manually extracted and orally
3.4
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administered, since the infants were unable to suckle for longer periods.
Data on age, parity, sh consumption and duration of lactation were obtained from the medical
records or by interviews in Kiswahili, as conducted by local doctors or by one of us. Gestational ages
were determined from the last known menstrual period (LMP). When the LMP was unknown we
employed the fundal height (FH). When either the LMP or the fundal height indicated prematurity
or term age, infants were routinely checked for the signs of prematurity. If no signs of prematurity
were found in an infants previously classied as preterm (e.g. small for gestational age infants), or if
these signs were observed in an infant previously classied as term (e.g. in polyhydramnios), their
mothers were excluded from further analysis. All women provided informed consent. The study
was approved by the National Institute for Medical Research in Dar-es-Salaam (NIMR/HQ/R.8a/Vol.
IX/800, dated April 8, 2009) and was in agreement with the Helsinki declaration of 1975 as revised
in 2000.
Samples and analyses
Although the milk lipid content does not a!ect the FA composition107, milk collection was conducted
uniformly for all groups. All samples were collected in the late morning, prior to consumption of
the main meal around noon, when the MCSAFA content is relatively unin%uenced by the dietary
carbohydrate intake.26,108 Participating women were asked to brie%y suckle their infant. After one
minute, a milk sample of 2-5 ml was taken by manual expression from the same breast. An aliquot
of 200 μL was transferred to a Sovirel tube containing 2 mL of methanol-6 mol/L HCl (5:1 by vol),
1 mg butylated hydroxytoluene (antioxidant) and 100 μg 5:0 up to 15:0 and 50 μg 17:0. In this
ready-to-transmethylate mixture FA are stable at room temperature and in the dark for months.29
All samples were transported at room temperature to the University Medical Center Groningen
(the Netherlands) for FA analysis. Following transmethylation and extraction, analyses of FA methyl
esters (FAME) were performed by capillary gas chromatography/%ame ionization detection using a
series of odd-chain numbered FA (5:0 up to 17:0) as internal quantication standards. MCSAFA (6:0
up to 14:0) were quantied with use of 5:0-15:0 as internal quantication standards.30,78 Long-chain
saturated FA (LCSAFA, ≥16:0) were quantied on the basis of the added 17:0. FA compositions and
their ratios were expressed in g% and g/g. Data are presented as medians (minimum-maximum).
Statistics
Statistical analyses were performed with SPSS version 16.0.1 (SPSS Inc, Chicago, IL). Between-
group di!erences for independent samples (i.e. preterm vs. term milks and term colostrum vs.
term mature milk) were analyzed with the Mann Whitney U-test. For the comparison of preterm
colostrum to preterm mature milk we had to remove 2 milk samples (1 colostrum sample and 1
mature milk sample) from the analysis, since these originated from 2 subjects that had been studied
longitudinally (i.e. there were 2 women from whom we had collected a colostrum and a mature
milk sample). After removal of these samples, the remaining independent samples were analyzed
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milk sample). After removal of these samples, the remaining independent samples were analyzed
with the Mann Whitney U-test. Corrections were made for type-1 errors according to Bonferroni.
Correlations were investigated with linear regression analyses. Dierences and correlations were
considered signicant at p<0.05. Data points in the gures represent the medians.
RESULTS
Study subjects, samples and characteristics
We included a total of 133 milk samples provided by the participants in this study. Term milk samples
were from 83 dierent women at dierent stages of lactation and were collected within two weeks.
We collected 30 colostrum, 19 transitional and 34 mature breast milk samples from women who
delivered at term. Preterm milk samples were collected from 38 women.Taken together, we collected
14 preterm colostrum, 23 transitional and 13 mature preterm milk samples. These numbers do not
sum up to 38, since some of the women who had delivered prematurely remained in the hospital.
From 2 of these subjects we were able to collect longitudinal data for colostrum, transitional and
mature milk, while 8 women provided either a colostrum and a transitional sample or a transitional
and a mature milk sample. For statistical correctness (comparison of independent samples only),
one of the samples of these subjects had to be excluded to compare preterm colostrum with mature
milk. Although this methodology reduced the n in both groups (n-1); medians remained statistically
indistinguishable; therefore these data are not presented separately.
The anthropometrics and other characteristics of the investigated mothers and their infants are
shown in Table 1. At delivery, prematurely delivering women had a lower gestational age and their
infants had lower birth weights. Women delivering at term had a higher parity, but this reached only
signicance for mothers breastfeeding >2 weeks. There were no other between-group dierences
for mothers who delivered prematurely and at term, except for a lower weight and BMI after 2 weeks
of exclusive breastfeeding in women who had delivered prematurely.
Milk fatty acids
The FA compositions of preterm and term colostrum, transitional and mature breast milks are
depicted in Table 2 together with the directions of all signicant changes.
Di erences between preterm and termmilk
SAFA and MUFA. Figure 1 shows the apparent courses of milk MCSAFA and MUFA for both preterm
and term delivering women. It must be noted that the depicted data are for colostrum, transitional
and mature milk of predominately dierent women. Preterm colostrum had higher SAFA and
MCSAFA (≤14C-atoms), specied by higher 8:0, 10:0, 12:0 and 14:0; but showed no dierence with
respect to LCSAFA (>14 C-atoms). Preterm colostrum exhibited lower 16:1ω7, 18:1ω7, ω7, 18:1ω9,
20:1ω9, ω9 and MUFA as compared to term colostrum. All dierences between preterm and term
milk SAFA, ω7 and ω9-FA, as observed in colostrum, disappeared with advancing lactation, with the
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Table 1. Maternal and infant anthropometrics and characteristicsa,b
Preterm milk Term milk
Colostrum Transitional Mature Colostrum Transitional Mature
n = 14 n = 23 n = 13 n = 30 n = 19 n = 34
mean ±SD mean ±SD mean ±SD mean ±SD mean ±SD mean ±SD
Maternal
Age (years) 21.5 ±5.4 22.5 ±5.6 23.8 ±6.0 23.5 ±5.8 22.0 ±4.4 25.7 ±5.4
Length (cm) 154.3 ±6.0 153.1 ±5.4 152.0 ±5.3 154.4 ±5.5 156.4 ±4.6 155.5 ±7.1
Weight (kg) 50.6 ±8.4 49.6 ±6.2 48.3 ±3.0* 54.3 ±9.8 54.9 ±8.8 56.5 ±7.9*
BMI (kg/m2) 21.1 ±2.3 21.1 ±2.0 21.0 ±2.0* 22.7 ±3.7 22.4 ±3.4 23.3 ±2.5*
Parity (n) 1.8 ±1.7 2.4 ±1.7 1.8 ±1.1* 3.0 ±2.6 2.3 ±1.7 3.6 ±2.0*
Fish consumption
(times/week)




32.9 ±2.4* 32.3 ±2.6* 32.2 ±2.1* 39.2 ±1.4* 40.0 ±2.0* 38.2 ±0.8*
Gender (%male) 43.. 39... 20……. 46... 25.. n.e.ce
Birth weight (kg) 1.7 ±0.3* 1.5 ±0.3* 1.5 ±0.4* 3.0 ±0.5* 3.1 ±0.4* 2.9 ±0.2*
Age at milk
sampling (days)
3.5 ±1.0 10.1 ±2 24.5 ±11.5§ 3.1 ±0.5§ 10.6 ±2 27.3 ±8.2§
a, preterm and term counterparts with a common symbol (*) di"er, p<0.05
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Colostrum Transitional Mature milk
Figure 1. The courses of MUFA and MCSAFA from colostrum to transitional and mature milks in Sengerema
(Tanzania) after preterm and term delivery. Data are in g/100 g fatty acids (g%). Preterm delivery (——,
closed #gures, PT), and term delivery (- - -, open #gures, T). MUFA, mono-unsaturated fatty acids; MCSAFA,
medium chain saturated fatty acid (i.e. ≤14C-atoms); Colostrum, 2-5 days; Transitional milk, 6-15 days;
Mature milk,16-56 days; preterm delivery, 28-36 weeks; term delivery, 37-42 weeks. Statistics: *, signi#cant
di"erence between preterm and term milk at p<0.05; †, signi#cant di"erence between colostrum and










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































PUFA. Figure 2 shows the apparent courses of AA and DHA for both preterm and term deliveries
from colostrum to transitional to mature milk. Preterm milk contained higher DHA in colostrum
and transitional milk, and higher AA, 22:4ω6 and LCPω6 in mature milk as compared to the
corresponding term milks.
Di!erences from colostrum to mature milk
SAFA and MUFA. Independent of prematurity, milk 6:0, 8:0, 10:0, 12:0, 14:0, MCSAFA (Figure 1) and
SAFA increased consistently, while 16:0 and 24:0 decreased. Only term milk showed a decrease in
18:0. Also, 18:1ω7, ω7, 18:1ω9, 20:1ω9, 22:1ω9, ω9 and MUFA (Figure 1) decreased with advancing
lactation. Only term milk showed a decrease in 14:1ω5 and 16:1ω7.
PUFA. We noted decreases of 20:2ω6, AA (Figure 2), 22:4ω6, 22:5ω6 and LCPω6. Only term milk
showed a decrease in 22:5ω3, DHA (Figure 2), LCPω3 and ω3.
Milk fatty acid interrelationships.
There was a strong inverse relation (Figure 3) between MUFA and MCSAFA in the combined milk
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Figure 2. The courses of AA and DHA from colostrum to transitional and mature milks in Sengerema
(Tanzania) after preterm and term delivery. Data are in g/100 g fatty acids (g%). Preterm delivery (——,
closed !gures, PT), and term delivery (- - -, open !gures, T). AA, arachidonic acid; DHA docosahexaenoic
acid; for other abbreviations and symbols see legend of Figure 1. Statistics: *, signi!cant di"erence between










Figure 3. The relation between MCSAFA and MUFA in preterm and term milks in Sengerema
(Tanzania) after preterm and term delivery. Preterm milk, open symbols; term milk, closed symbols;
R2, correlation coecient; p, signi!cance; for other abbreviations and symbols see legend of Figure 1.
DISCUSSION
We investigated the FA compositions of preterm and term milks from mothers with lifelong high
intakes of tropical fresh water !sh in Tanzania. Most importantly, we found higher DHA and MCSAFA,
but lower MUFA in preterm colostrum, compared to term colostrum. Di"erences between preterm
and term colostrum vanished with advancing lactation, during which, in both preterm and term
milks, MCSAFA increased, while AA, DHA and MUFA decreased (Figures 1 and 2).
Comparison of current FA data with the literature
The compositions of preterm and term colostrum, transitional and mature milks have been described
for North,115 South,117,125 East123 and West European countries,112,120 two South American124,125 and one
Asian country,126 but no data are available for sub-Saharan African countries. Also, none of these
studies focused on a population with high !sh intakes. A high DHA, EPA and AA status might be
part of human physiology, since there is substantial evidence that Homo sapiens evolved in an East
African water-land ecosystem with abundant sources of LCP.16,100,133,134 The high !sh intakes of the
current Tanzanian population became con!rmed by their high milk AA (overall median 0.71 g%)
and DHA (0.70 g%) contents.




The dierence between the MCSAFA and MUFA content of African compared to European or
Western milks, as noted earlier,135 is remarkable. African preterm and term colostrum, but notably
mature milks, have considerable higher MCSAFA contents (16.9 and 7.92 g% MCSAFA in colostrum,
respectively; 33.7 and 29.0 g% MCSAFA in mature), compared to counterpart Western preterm and
term milks (12 and 10 g% MCSAFA in colostrum, respectively; 15 and 13 g% MCSAFA in mature
milks).112 High milk MCSAFA contents have been related to high carbohydrate intakes26,108, while the
increasing milk MCSAFA content with advancing gestation relates to increasing mammary gland
MCSAFA synthetic activity.105,128 Except for in term colostrum, African milks also show lower MUFA
in preterm and term milks (32.5 and 40.0 g% MUFA in colostrum, respectively; 22.6 and 26.5 g%
MUFA in mature milks), compared to European preterm and term milks (35 and 36 g% MUFA in both
colostrum and mature).122 Both, a higher milk MCSAFA and lower milk MUFA content was noted
earlier in rural South African136 and rural Tanzanian women.111 Although mostly attributed to their
high carbohydrate intakes, we recently suggested,137 that these dierences might in part also be
secondary to a higher insulin sensitivity is these rural women, resulting in lower milk MUFA and
16:0 from insulin induced adipolysis, hepatic VLDL- and de novo lipid synthesis and lower mammary
gland LPL-activity.
DHA and AA
We compared our data with worldwide data from other studies using capillary gas chromatography
columns. We excluded data that derived from analyses with a packed gas chromatography
columns since the use of such columns might lead to arti!cially high values.98 The current median
DHA content of 1.11 in preterm colostrum is higher compared to the 0.30-0.66 g% DHA range as
previously established for preterm colostrum by others.112,115,117,120,123,125,126 This value is consequently
the highest reported in the literature so far by lack of data from prematurely delivering women with
high !sh intakes. The median DHA content of 0.81 g% in term colostrum is, however, within the
0.13-1.10 g% DHA range, as previously established for term colostrum,115-117,119,120,123,126 for review up
to 2000 see.138 The extreme value of 1.10 g% derived from our earlier study in women living on the
Caribbean island of St. Lucia, who also have regular high DHA intakes from local !sh.139
The median AA contents of 0.93 g% in preterm and 1.08 g% in term colostrum are within the
reported range of 0.59-1.13 g% for preterm colostrum [117,126, for review up to 2007,122] and the 0.52-
1.60 g% range for term colostrum [115-117,120,123,126, for review up to 2000 see138]. Apart from dietary
dierences, the wide range in reported values might to some extent also derive from the lack of
uniformity in the reported FA. For instance, the short-chained 6:0 and 8:0, the very long chain 24:0
and 26:0, the uneven carbon chain numbered 17:0 and/or 19:0 or the unsaturated 14:1ω5, 16:1ω9,
24:1ω9 or 20:3ω3 are not always included in the cited references.
The median 0.75 g% DHA in preterm mature milk in the current study is higher compared to the
so far reported 0.19-0.39 g% DHA range in preterm mature milk,117,120,122,124 but the 0.53 g% DHA in
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term mature milk is within the previously reported range of 0.06-1.79 g% DHA.111,119 The median 0.69
g% AA in preterm mature milk in the current study is somewhat higher compared to the previously
reported 0.36-0.59 g% AA range in premature mature milks,115,123 while the 0.55 g% AA in term
mature milk is within the reported range of 0.26-1.00 g% AA in mature term milks.8,115,123,136,140 Finally,
the observation that both AA and DHA are relatively high in milk from women with high sh intakes
is in line with data from term delivering women with high intakes of African freshwater sh59 and
counterparts in St. Lucia with frequent saltwater sh intakes.139
Changes of DHA and AA with advancing lactation
The decreases of both DHA and AA in milk with advancing lactation is well documented112,113,115,119,122,123
It is usually explained by the increasing fat output121,141 and fat globule size142-144 with advancing
lactation, which causes a decrease of the phospholipid/triglyceride ratio.142 The latter coincides
with a decreasing contribution of LCP to the total milk FA content, since LCP have a preference
for incorporation into phospholipids.114,145 The question ‘why lipid droplets increase in size’ has,
however, not been explained clearly as yet. It might simply be secondary to the maturation of the
mammary gland,105,142 but ultimately also be the consequence of the depletion of maternal LCP
stores, necessitating a shift from small lipid droplets (with relatively high phospholipid content)
towards large counterparts (with relatively low phospholipid content). The latter option seems less
likely, in view of the high AA and DHA status of the current women.
We146 recently suggested that the rapidly changing hormonal milieu after delivery, notably
the restoring insulin sensitivity, might in!uence various enzymatic activities such as those of the
FA-desaturases (FADS), those involved in hepatic de novo fatty acid synthesis and in adipolysis. We
hypothesized that the observed postpartum changes in maternal and infant RBC-FA-compositions
might be the result of these changing enzymatic activities, secondary to this restoring insulin
sensitivity. Interestingly, the present results support this previous hypothesis, but this would need
conrmation from longitudinal data and a concurrent estimation of maternal insulin sensitivity.
However, if MUFA are considered as a proxy for hepatic de novo lipogenesis and adipolysys, as we
suggested earlier,146 these preliminary data suggest that with advancing lactation, de novo synthetic
activity in the mammary gland replaces in part those FA derived from adipose tissue lipolysis
and those from de novo synthetic activity in the liver,146 which might be a remnant of the insulin
resistance of late pregnancy.137
Fatty acid di!erences between preterm and term milks
Di"erences between preterm and term human milks do not seem to have a molecular basis, since
no di"erences in triglyceride-structure,147 phospholipid-classes,145 percentages phospholipids from
total lipid,148 average fat globule diameter or fat globule surface area144 have been reported. We have
previously shown that pregnant women in the currently investigated population exhibit no changes
in RBC-DHA during pregnancy131 and have higher RBC-DHA than their infants at delivery.130 The
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maternal RBC-DHA content decreases slightly during subsequent lactation, while the infant RBC-
DHA increases rapidly to reach maternal levels within 3 months.130 This suggests that the lifetime
high sh intake in these women has caused a state of DHA equilibrium during pregnancy and to
a lesser extent during lactation. Consequently, maternal DHA depletion in the period between
preterm and term birth is unlikely to be the cause of the presently observed higher DHA in preterm
colostrum compared with term colostrum or the only cause of the similar preterm-term colostrum
DHA dierences that have consistently been documented in the literature.
Alternatively, dierences in insulin sensitivity at the time of delivery might play a role in the
observed FA dierences between preterm and term colostrum,137 since in premature delivery
pregnancy is terminated at a stage of higher insulin sensitivity compared with termination at term.
Consequently, lower MUFA in preterm colostrum, might also derive from lower insulin induced
adipolysis and de novo FA synthesis in the maternal liver. Thus, in contrast to Freed et al.,128 who
suggested that the higher MCSAFA in preterm milk derives from higher de novo FA synthesis in the
preterm mammary gland, we rather suggest that it derives from lower uptake of FA from adipose
tissue lipolysis and lipogenesis in the preterm maternal liver. Rerouting of lipid and glucose !uxes
after delivery becomes supported by the post delivery upregulation of the number of insulin
receptors149 and of lipoprotein lipase activity in the mammalian mammary gland149,150 and their
concomitant downregulation in the liver and adipose tissue.149
Strengths and limitations
A strength of this study is the uniform lifetime consumption of a diet with very little intra- and inter-
individual variation. We did not investigate maternal RBC or circulating lipids in this particular study
and can therefore not irrefutably exclude some degree of DHA depletion in the currently studied
women during pregnancy. The notion of no depletion rests on a concurrent study of women in the
same hospital who were investigated during pregnancy, at delivery and at 3 months postpartum,
and of which the data showed no DHA depletion as based on RBC-DHA data during pregnancy.130,131
Another limitation is the current cross-sectional design. More statistical power would have been
obtained from truly longitudinal data. We experienced, however, that in the encountered setting
a longitudinal study is almost impossible for both ethical and logistical reasons since the included
African women have more important tasks (multiple children to feed) than regularly (notably
punctually) attending a hospital. Some of them are nomadic and do not ever attend the same
hospital, while very few see the purpose of participation.
CONCLUSIONS
The high lifelong sh intakes by these African women living on the shore of Lake Victoria has
provided us with data on milk AA and DHA that are the highest reported for colostrum (DHA) and
mature preterm (DHA and AA) milks so far. Consistent with the literature, African milks exhibit a
substantially higher MCSAFA, and lower MUFA contents, compared to Western milks. Similarly,
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preterm colostrum contains higher DHA and MCSAFA and lower MUFA compared to term colostrum.
Each of these dierences vanishes rapidly with advancing lactation, during which the LCP and
MUFA decreased and MCSAFA increased both in preterm and term milks. The high DHA status of
these lactating women suggests that the encountered DHA dierences between preterm and term
colostrum are unlikely to originate from maternal DHA depletion taking place in the relatively short
period between preterm and term delivery. Conversely, the consistently found higher MCSAFA and
lower MUFA in preterm compared to term colostrum in the present study and the literature might
derive from insulin-sensitivity driven dierences in maternal lipid and glucose uxes at the time
of delivery and insulin-sensitivity driven changes with advancing lactation, but these speculations
clearly need testing by appropriate measurements of insulin sensitivity and the assays of adipose
tissue lipolytic activities and de novo FA synthetic activities of both the liver and breast by stable
isotope techniques.
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Introduction. Higher LCP in infant compared with maternal lipids at delivery is named
biomagnication. The decline of infant and maternal DHA status during lactation in Western
countries suggests maternal depletion. We investigated whether biomagnication persists at
lifelong high sh intakes and whether it prevents a postpartum decline of infant and/or maternal
DHA status.
Methods. We studied 3 Tanzanian tribes with low (Maasai; 0/week), intermediate (Pare; 2-3/week)
and high (Sengerema; 4-5/week) sh intakes. DHA and AA were determined in maternal (m) and
infant (i) erythrocytes (RBC) during pregnancy (1st trimester n=14; 2nd=103; 3rd=88), and in mother-
infant pairs at delivery (n=63) and at 3 months postpartum (n=104).
Results. At delivery, infants of all tribes had similar iRBC-AA, which was higher than, and unrelated
to, mRBC-AA. Transplacental DHA biomagnication occurred up to 5.6 g% mRBC-DHA; higher
mRBC-DHA was associated with‘bioattenuation’(i.e. iRBC-DHA< mRBC-DHA). Compared to delivery,
mRBC-AA after 3 months was higher, while iRBC-AA was lower. mRBC-DHA after 3 months was lower,
while iRBC-DHA was lower (Maasai), equal (Pare) and higher (Sengerema) compared to delivery.
We estimated that postpartum iRBC-DHA-equilibrium is reached at 5.9 g%, which corresponds to a
mRBC-DHA of 6.1 g% throughout pregnancy.
Conclusion. Uniform high iRBC-AA at delivery might indicate the importance of intrauterine
infant AA-status. Biomagnication re!ects low maternal DHA-status and bioattenuation may
prevent intrauterine competition of DHA with AA. A mRBC-DHA of 6 g% during pregnancy predicts
maternal-fetal equilibrium at delivery, postnatal iRBC-DHA equilibrium, but is unable to prevent a
postnatal mRBC-DHA decline.
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INTRODUCTION
The long-chain polyunsaturated fatty acids (LCP) docosahexaenoic acid (DHA), eicosapentaenoic
acid (EPA) and arachidonic acid (AA) are structural components of membrane phospholipids.1 DHA
and AA are notably abundant in the central nervous system and play important roles in fetal and
infant neurodevelopment.2 DHA, EPA and AA are derived either from the diet or from endogenous
synthesis from their respective parent essential fatty acids (EFA) linoleic acid (LA) and alpha-linolenic
acid (ALA). Fatty sh are rich sources of EPA and DHA.. Dietary sources of preformed AA are meat,
eggs and poultry,3 while lean and tropical sh are rich sources of AA.4 It is suggested that LCP
intakes from our Paleolithic diet have been much higher5-7 than presently observed in the majority
of auent countries.8,9 The high AA and DHA contents of our Paleolithic diet may imply that human
evolution, and thus also intrauterine development, took place at high maternal intakes of both AA
and DHA.7
Pregnant and lactating women have high LCP needs.10 This is notably the case for DHA, which
becomes synthesized from ALA with diculty.11 Both AA and DHA are important during infant
development. More AA than DHA accretes in brain in the intrauterine period, while DHA accretes
rapidly from week 30 of pregnancy to 2 years postpartum.12 The commonly observed higher
LCP in circulating cord plasma lipids as compared to maternal plasma lipids has been coined
‘biomagnication’.13 The decline of infant DHA status during lactation and of the maternal DHA status
during pregnancy14 and lactation15 might reect the low LCPω3 status in many Western countries.
The outcome of randomized controlled trials aiming at improvement of neurodevelopment by
supplementation of pregnant women or their infants with sh oil, DHA,16-18 or DHA+AA,19,20 indicate
subtle positive eects at most. This contrast with the positive relations between neonatal brain
DHA and cognitive and behavioral performance that are noted in the combined human and animal
studies.21,22 Failure to show favorable eects of LCP might, among many other reasons, relate to
the use of too low dosages and the study of Western populations with low sh intakes without
stratication based on baseline DHA status.6
There is substantial evidence that land-water ecosystems have been exploited by our early
African ancestors7,23-26 and it is also known that some rural African populations have much higher
milk LCP contents4,27 as compared to those living in Western countries. Data on the concurrent
maternal and infant LCP status during pregnancy and lactation in these African populations are
however currently lacking.
In view of this lack of data, we determined the maternal and infant DHA and AA status in 3
traditional rural African populations with dierent levels of sh intakes. Since a longitudinal study
design proved impossible in these populations, we collected data deriving from dierent women
during pregnancy, at delivery and at 3 months postpartum. The selected populations live in Tanzania
and have low (Maasai), intermediate (Pare), or high (Sengerema) intakes of freshwater sh. All 3
populations are characterized by the consumption of diets that are constrained in their varieties
by the availability of the food in their immediate environment. Red blood cell (RBC) LCP contents
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served as proxies for LCP status. We were particularly interested to see whether ‘biomagnication’
and maternal DHA losses during pregnancy and lactation also occur at lifetime high intakes of sh
and at what maternal LCP status the infant reaches a state of postnatal LCP equilibrium.
SUBJECTS AND METHODS
Subjects, diet and cultural circumstances
We selected 3 Tanzanian ethnic tribes with di!erent intakes of local freshwater sh, i.e. the Maasai
(no or low sh intake, 0/wk), subjects from the Pare Mountains (intermediate sh intake, 2-3/wk) and
subjects from Sengerema (high sh intake, 4-5/wk). We4 have previously shown that East African
fresh water sh contain high proportions of both DHA and AA and relatively low EPA as compared
to European salt water sh. We experienced that collection of longitudinal data was virtually
impossible. Appointments were not scheduled, nor were we able to motivate subjects to participate
in a longitudinal study.
The selected Maasai were Nilotic pastoralists who live in ‘bomas’ (villages) in the Maasai Steppe
nearby Ruvu. Their diet consists mainly of curdled milk and meat. It has recently become replenished
with some ugali (corn porridge). Consumption of sh is uncommon, since it is considered inedible.
The Pare group was composed of women of the Bantu tribes Pare and Sambaa from the Pare
Mountains. Their diet was mainly composed of vegetables, beans and fruits with ample ugali, rice
and chapati (cornwheat pancakes), and some meat or sh. The third population was composed of
women from Sengerema (southern shore of Lake Victoria). Apart from the abundant consumption
of sh, they also consume ugali, muhogo (cassava root) and plantain (baked banana).
The ethnicity/tribe of each of the study groups was considered to be homogeneous. Most women
were of low socio-economical background. Their incomes were derived from pastoralism (Maasai),
agriculture (Pare) or sheries (Sengerema). The studied populations neither had possibilities nor
interest in changing their cultural habits, including their diets. Local hospital sta! members and
interviews with the participants conrmed that neither pregnancy nor lactation is associated with
any change in dietary habits, or the prohibition of certain foods (F. Peters, R.S. Kuipers, F.A.J. Muskiet,
unpublished data). Their dietary compositions were therefore likely to be representative for the
lifetime dietary habits of each of the ethnical groups.
Women were included if they were apparently healthy and well nourished, and had delivered
an apparently healthy child at term (37-42 weeks, by estimate). Use of tobacco and alcohol are
almost non-existent in these populations, especially among women. Anthropometric data and a
questionnaire on sh intake were obtained from the medical records or by interviews in Kiswahili.
Besides the measurement of fundal heights, reliable data on gestational age were not always
available, since some women had no recollection of their last menstrual period. Devices for echo
imaging were either not available or not operational. All women gave their informed consent. The
study was approved by the National Institute for Medical Research in Dar-es-Salaam (NIMR/HQIR.8a/
Vol. IX/145, dated June 16, 2003 and NIMR/HQ/R.8a/Vol. IX/800, dated April 8, 2009) and was in
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agreement with the Helsinki declaration of 1975 as revised in 2000.
Samples and analyses
We collected about 4 mL EDTA-anticoagulated venous blood of the mothers during pregnancy
and at delivery and about 4 mL EDTA-cord blood at delivery (BD Vacutainer, Plymouth, UK). At 3
months postpartum, about 4 mL EDTA-anticoagulated venous blood of the mothers was collected.
About 250 μL EDTA-anticoagulated blood (250 μL pediatric MiniCollect K3EDTA-tubes; Greiner Bio-
one, Kremsmünster, Austria) was taken by heel prick from the 3 months old infants. The samples
were stored at 4 C in the dark and processed within 2 h after collection. RBC were isolated by
centrifugation and washed three times with 0.9% NaCl. After washing, 200 uL of the RBC suspension
(mothers) or the entire RBC suspension (infants) was transferred to a te#on-sealable Sovirel tube
containing 2 mL of methanol-6 mol/L HCl (5:1 v/v), 1 mg butylated hydroxytoluene (antioxidant)
and 50 μg 17:0. In this ready-to-transmethylate mixture fatty acids are stable at room temperature
and in the dark for months. All samples were transported at ambient temperature to the University
Medical Center Groningen (The Netherlands) for fatty acid analysis. Within 9 months after collection,
the methanol-HCL conserved samples were transmethylated by heating at 90 °C for 4 h. Subsequent
analysis of fatty acid methyl esters was performed, by capillary gas chromatography/#ame ionization
detection according to previously described procedures.28 Fatty acid compositions and their ratios
were expressed in g% and g/g, respectively.
Statistics
Statistical analyses were performed with SPSS version 16.0 (SPSS Inc, Chicago, IL). Within-tribe
di&erences of mothers and infants at delivery were compared with corresponding data at three
months postpartum by use of the Mann-Whitney U-test. Mother-infant pair di&erences were tested
with a Wilcoxon two related samples test. In both instances p<0.05 was considered signi'cant.
Between-group di&erences were studied with the aid of the Kruskal-Wallis test, followed by
analyses with Mann Whitney U-test (non-parametric) at p<0.05. Corrections were made for type-1
errors (Bonferroni correction). Equations were derived from linear regression analysis. We used the





We included 205 di&erent pregnant women. Of these, 14 women were included in their 1st trimester
of pregnancy (de'ned as 1 -13 weeks; 3 Maasai, 4 Pare, 7 Sengerema), 103 women in the 2nd
trimester (14-27 weeks; 14 Maasai, 47 Pare, 42 Sengerema) and 88 women in the 3rd trimester (28
weeks-delivery; 16 Maasai, 41 Pare, 31 Sengerema). Table 1 shows the characteristics of all pregnant
192
Chapter 4.1
women. There were no between-trimester dierences in the general characteristics for each of the
tribes. From the data of dierent trimesters only body weight is shown. The Pare (p<0.005) in the
2nd trimester, and Sengerema (p<0.001) women in the 2nd and 3rd trimester, were heavier than the
Maasai women and had a higher BMI during pregnancy compared to the Maasai (p<0.001). The
number of previous pregnancies was lower in Pare women, compared with Maasai (p=0.003) and
Sengerema (p=0.003) women. The, for the current study most relevant between-tribe dierence,
was in !sh intake. Fish consumption occurred in the order Sengerema>Pare>Maasai.
Mother-infant pairs at delivery and at 3 months postpartum
We included 73 mother-infant pairs at delivery (8 Maasai, 31 Pare, 34 Sengerema) and 110 dierent
mother-infant pairs (9 Maasai, 40 Pare, 61 Sengerema) after three months of exclusive breastfeeding.
Their characteristics are also shown in Table 1. There were no between-tribe dierences for the
mothers at delivery or at 3 months postpartum, except for a lower BMI at delivery (p=0.001) and
higher length (p=0.015) of the Maasai mothers compared to Pare mothers. Also in these groups
Table 1: Characteristics of pregnant women and mother-infant couples at delivery and at 3 months PP
Maasai Pare Sengerema
Pregnant women
Maternal age, y 25 ± 8 (33) 26 ± 6 (92) 26 ± 6 (80)
Weight, kg trimester 1 50.7 ± 6.4 (3) 54.8 ± 16.5 (4) 54.9 ± 8.2 (7)
Weight, kg trimester 2 52.1 ± 4.4 (14)a 56.8 ± 8.2 (47)b 58.6 ± 7.0 (42)b
Weight, kg trimester 3 52.9 ± 4.7 (16)a 59.3 ± 8.9 (41)b 61.5 ± 3.9 (31)b
Height, m 1.60 ± 0.06 (33) 1.57 ± 0.10 (92) 1.59 ± 0.06 (80)
BMI, kg/m² 20.8 ± 1.4 (33)a 23.6 ± 3.2 (92)b 23.6 ± 2.7 (80)b
Gravida, n 4 ± 3 (32)b 3 ± 1 (92)a 4 ± 2 (80)b
Para, n 3 ± 3 (32)b 1 ± 1 (92)a 3 ± 2 (79)b
Fish intake, times/wk 0 ± 0 (33)a 2 ± 1 (92)b 4 ± 2 (70)c
Delivery
Maternal age, y 23 ± 4 (8) 25 ± 7 (31) 24 ± 7 (34)
PP weight, kg 53.0 ± 5.0 (8) 57.3 ± 7.6 (23) 54.4 ±10.2 (31)
Height, m 1.59 ± 0.06 (8)a 1.54 ± 0.04 (27)b 1.56 ±0.06 (31)a,b
BMI, kg/m² 20.9 ±2.0 (8)b 23.9 ± 2.0 (21)a 22.4 ± 3.3 (31)b
Gravida, n 3 ± 1 (8) 3 ± 2 (31) 3 ± 3 (34)
Para , n 2 ± 1 (8) 2 ± 2 (31) 2 ± 3 (34)
Gestational age at birth, wk 40.0 ± 0 (1) 39.9 ± 1.5 (17) 38.9 ± 1.8 (28)
Fish intake, times/wk 0 ± 0 (8)a 3 ± 2 (17)b 5 ± 2 (30)c
Infant birth weight, g 3050 ± 400 (8) 3115 ± 535 (26) 2947 ± 751 (34)
Gender, % male 38 (8) 45 (29) 58 (36)
3 months PP
Maternal age, y 22 ± 4 (9) 24 ± 4 (40) 24 ± 6 (61)
PP weight, kg 52.4 ± 3 (9) 52.2 ±11 (40) 54.6 ± 10 (61)
Height, m 1.60 ± 0 (9) 1.55 ± 0.07 (40) 1.56 ± 0.06 (61)
BMI, kg/m² 20.5 ± 1.1 (9) 21.6 ± 4.0 (40) 22.1 ± 3.0 (61)
Para, n 3 ± 1 (9) 2 ± 1 (40) 3 ± 2 (61)
Fish intake, times/wk 0 ± 0.7 (8)a 3 ± 2 (40)b 4 ± 2 (61)c
Infant age, wk 16 ± 4 (9) 14 ± 3 (40) 13 ± 2 (61)
Gender, % male 67 (9) 47 (40) 55 (61)
Values are mean ± SD (n). Dierent superscripts indicate signi!cant dierent means, P < 0.017.
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sh consumption occurred in the order Sengerema>Pare>Maasai at delivery and at 3 months
postpartum.
Erythrocyte AA and DHA
RBC-FA data were available from all 205 women during pregnancy. At delivery we studied di!erent
subjects. RBCs were available of 6 Maasai, 27 Pare and 34 Sengerema women, and 8 Maasai, 29 Pare
and 36 Sengerema infants. At three months postpartum we included a group of di!erent subjects
including 9 Maasai, 38 Pare and 60 Sengerema women, and 8 Maasai, 38 Pare and 61 Sengerema
infants. Drop-out was due to failure to obtain consent for both mother and infant, early discharge
(only at delivery) and logistical and analytical imperfections (delivery and 3 months postpartum).
Between- and within-tribe RBC-AA dierences and mother-infant RBC-AA relation
Figure 1A (left panel) shows the apparent maternal and infant RBC-AA courses from the rst
trimester to 3 months postpartum. For convenience, data points are connected with dotted lines,
but it should be noted that they are derived from di!erent study groups. Visual inspection of the
apparent courses of maternal RBC-AA during pregnancy did not reveal consistent changes. It
seemed to decreased in Pare (intermediate sh), but appeared constant in Maasai (low sh) and
Sengerema (high sh) mothers. We analyzed between-tribe maternal RBC-AA di!erences at delivery.
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Figure 1. Apparent courses of red blood cell (RBC) arachidonic acid (AA; panel A) and docosahexaenoic acid
(DHA, panel B) from the rst trimester of pregnancy up to 3 months postpartum for Maasai (low sh), Pare
(intermediate sh) and Sengerema (high sh) women and infants. Data represent means±2SEM in g/100 g (g%)
fatty acids. Data derive from di!erent maternal subgroups at the 1st, 2nd and 3rd trimester and di!erent mother-
infant pairs at delivery and 3 months postpartum. Maternal and infant data are represented by closed and open
symbols, respectively. PP, postpartum. + signicantly (sign) di!erent from Maasai, ¶ sign di!erent from Pare, ¥
sign di!erent from Sengerema,  sign di!erent from delivery, ∞ sign di!erent from mother.
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whereas Pare and Sengerema women did not show dierences. The RBC-AA of the infants showed
no between-tribe dierences at delivery.
Within-tribe analysis of RBC-AA showed that in Maasai, Pare and Sengerema mothers RBC-AA
at delivery was lower than at 3 months postpartum (p≤0.001). In Maasai infants, there were no
dierences in RBC-AA between delivery and 3 months postpartum, whereas in Pare and Sengerema
infants, RBC-AA was signi"cantly higher at delivery as compared to 3 months postpartum (p≤0.001).
In all tribes, we found that at delivery, infant RBC-AA was signi"cantly higher compared to maternal
RBC-AA (Maasai p=0.028, Pare p<0.001 and Sengerema p<0.001), but there was no relation between
infant RBC-AA and maternal RBC-AA (Figure 2A).
Taken together, maternal RBC-AA was consistently lower at delivery compared to 3 months
postpartum. Infant RBC-AA contents were similar at delivery and consistently higher than maternal
RBC-AA. Thus, biomagni"cation of AA during pregnancy occurred, irrespective of maternal AA status
(Figures 1A and 2A). After 3 months of exclusive breastfeeding, infant RBC-AA was lower compared
to delivery in Pare and Sengerema. This decline did not reach signi"cance for the Maasai, probably
because of low numbers.
Between- and within-tribe RBC-DHA di!erences, and mother-infant RBC-DHA relation
Figure 1B (right panel) shows the apparent courses of maternal and infant RBC-DHA contents
from the "rst trimester to 3 months postpartum. Visual inspection of maternal RBC-DHA during
pregnancy revealed a trend of higher RBC-DHA in late pregnancy of the Pare and the Maasai, but not
the women in Sengerema. Analysis of the between-tribe maternal and infant RBC-DHA dierences
B
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y = x at 5.6 g% RBC-DHA
y = 0.59x + 2.29, R2 = 0.61, p < 0.001B
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Figure 2. Relations between maternal and infant red blood cell (RBC) contents of AA (panel A) and DHA
(panel B) at delivery for Maasai (n=6), Pare (n=24) and the Sengerema (n=33) women and infants. Dotted
lines indicate y=x for ‘equal AA or DHA sharing’. Maternal vs. infant RBC-AA at delivery is insigni"cant. At
delivery, maternal RBC-DHA equals infant RBC-DHA at 5.6 g%.
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showed that at delivery, RBC-DHA in Sengerema women was higher compared to Pare and Maasai
(p<0.001) whereas Pare and Maasai women showed no di!erences.
Within-tribe RBC-DHA di!erences showed that in all tribes, maternal DHA at delivery was higher
than at 3 months postpartum (Maasai p=0.003; Pare and Sengerema p≤0.001). In the infants, Maasai
had higher RBC-DHA at delivery compared to 3 months postpartum (p=0.039); Pare did not show a
signi#cant di!erence between delivery and 3 months postpartum, while Sengerema infants showed
a lower RBC-DHA at delivery compared to 3 months postpartum (p=0.027).
At delivery, the analysis of mother-infant-pairs di!erences revealed that Maasai (p=0.245) and
Pare (p=0.091) infants, although insigni#cant, tended to have higher RBC-DHA than their mothers,
while (in contrast) the RBC-DHA of the Sengerema infants was lower (p=0.029) compared to their
mothers. The relationship between maternal and infant RBC-DHA at delivery is shown in Figure
2B. For this analysis we selected data of complete mother-infant pairs (6 Maasai, 24 Pare and 33
Sengerema). At low maternal DHA status, infants usually had higher RBC-DHA than their mothers
(biomagni#cation), but in contrast, at high maternal DHA status, infant RBC-DHA was generally
lower (‘bioattenuation’). Figure 2B indicates that equal RBC-DHA in mothers and infants at delivery
was reached at a maternal RBC-DHA of 5.6 g%.
Although our data are not longitudinal, it appeared that at low maternal RBC-DHA infant RBC-
DHA decreased from delivery until 3 months postpartum, whereas at high maternal DHA status,
infant RBC-DHA increased from delivery until 3 months postpartum. We therefore calculated the
maternal DHA status at which the infant appeared to be in a state of postpartum DHA-equilibrium.
In other words, we estimated the maternal RBC-DHA status from which the infant showed no
changes in RBC-DHA from delivery to 3 months postpartum.
Figure 3 shows the relation between infant RBC-DHA at delivery and at 3 months postpartum
for the Maasai, Pare and Sengerema. Only mean values for each of the tribes could be used, since
we did not study the same infants at delivery and at 3 months postpartum. Figure 3 indicates that
a postpartum infant RBC-DHA equilibrium was reached at an infant RBC-DHA of 5.9 g% at delivery.
This infant RBC-DHA in turn corresponds with a maternal RBC-DHA of 6.1 g% at delivery (by inserting
5.9 into equation of Figure 2B). The number of included Maasai was low. Exclusion of their data did,
however not change the equation in Figure 3.
Taken together, maternal RBC-DHA contents at both high and low DHA status were lower after 3
months of exclusive lactation, compared with delivery. Biomagni#cation of DHA seems to occur up
to a maternal RBC-DHA of 5.6 g% at delivery, from this turning point DHA becomes ‘bioattenuated’.
Postpartum infant RBC-DHA equilibrium was reached at an infant RBC-DHA of about 5.9 g% at
delivery, corresponding to a maternal RBC-DHA of 6.1 g% during pregnancy and at delivery. For all
practical reasons we conclude that biomagni#cation takes place up to a maternal RBC-DHA status of




We determined the RBC-AA and DHA contents of pregnant Tanzanian women, and of mother-infant
pairs at delivery and at 3 months postpartum. The mothers had stable dietary intakes characterized
by low (Maasai), intermediate (Pare) and high (Sengerema) consumption of freshwater sh. Our
main ndings are that biomagnication of AA occurs irrespective of maternal AA status. In contrast
to maternal RBC-AA, infant RBC-AA at delivery was remarkably uniform and also after 3 months
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Figure 3. Relation between the mean red blood cell (RBC) docosahexaenoic acid (DHA) at delivery and at 3
months postpartum for the Maasai, Pare and Sengerema infants, respectively. Data represent means±2SEM in
g/100 g (g%) fatty acids. Infant RBC-DHA at delivery equals infant RBC-DHA at 3 months postpartum at 5.9 g%.
RBC-AA. From delivery to 3 months postpartum maternal RBC-AA increased, while infant RBC-AA
decreased. Maternal and infant RBC-DHA was higher in the sequence Sengerema (high sh)>Pare
(intermediate sh)>Maasai (low sh). In contrast to RBC-AA, maternal and infant RBC-DHA were
intimately related. Biomagnication of DHA occurred up to a maternal RBC-DHA of 5.6 g% at delivery;
from this turning point DHA became ‘bioattenuated’. From delivery to 3 months postpartum,
maternal RBC-DHA decreased, while infant RBC-DHA decreased in Maasai (low sh), remained
constant in Pare (intermediate sh) and increased in Sengerema (high sh). Postpartum infant RBC-
DHA equilibrium was reached at an infant RBC-DHA of about 5.9 g% at delivery, corresponding to a
maternal RBC-DHA of 6.1 g% during pregnancy and at delivery.
Arachidonic acid (AA)
The higher RBC-AA contents in Maasai, compared to Pare and Sengerema mothers (Figure 1A), are
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likely to be caused by their higher intakes of AA from meat. Biomagnication of AA12 is consistent
with data from many others studying plasma PL14,30 or RBC.31-33 Higher infant compared to maternal
RBC-AA at delivery was previously found by us in Dominica34 and by others in the Netherlands32
and the data of those 2 studies tted well within the present study (Dominica: mean maternal RBC-
AA 12.4 g%, infant 16.6 g%; Netherlands: mean maternal RBC-AA 10.0 g%, infant 14.2 g% AA). The
uniformly high infant RBC-AA at delivery occurred despite between-tribe dierences in maternal
RBC-AA and DHA (Figure 1 A and B), and in the absence of a relation between maternal and infant
RBC-AA (Figure 2A).
Although we observed no consistent changes in maternal RBC-AA during pregnancy, maternal
RBC-AA was consistently higher after 3 months of exclusive lactation as compared to delivery, which
coincided with a drop of infant RBC-AA. The decreasing maternal AA status during pregnancy found
by Al et al.14 and the well known postnatal drop of infant RBC-AA,35 suggest that the fetus accretes AA
at the expense of maternal AA status. However, no clear relation between maternal and infant RBC-
AA could be demonstrated in our data, which questions the causality of these opposing changes.
The increasing maternal AA status after delivery may derive from the discontinued utilization of AA
by the placenta or discontinued AA transport to the fetus.36,37 Secondly, the postpartum increasing
maternal AA status may result from decreasing maternal adipose tissue lipolysis and decreasing
de novo lipogenesis (DNL), secondary to the changing hormonal milieu after delivery, notably the
restoration of the state of diminished insulin sensitivity/compensatory hyperinsulinemia in the end
of pregnancy.38,39 Discontinuation of the in!ux of both of these sources of SAFA, MUFA and PUFA
(i.e. notably linoleic acid) leads to less dilution of LCP.38,39 The decrease of infant RBC-AA may have
been caused by postpartum changing infant RBC-PL species40 and the interrupted transplacental
AA transport.38,39 It can additionally be explained by a lower conversion of LA to AA, since the
infant’s capacity to synthesize LC-PUFA decreases drastically after delivery.41 This lower conversion
might result from lower activities of the delta-5 and delta-6 desaturase enzymes, secondary to
the changing hormonal milieu after delivery. Finally, LA intakes correlate inversely with RBC-AA.42
Consequently, the high LA content of human milk (Kuipers, unpublished) and the ensuing postnatal
surge in the infant LA status37 suggest that the infant’s RBC-AA decrease may also be a result of the
high LA intake from breast milk.
At 3 months of age, infant RBC-AA in Pare and Sengerema was comparable to that of their
mothers, indicating a rapid postnatal adaptation of RBC-AA to adult levels. Taken together, AA
biomagnication seems to aim at a uniform, high infant AA status during pregnancy, most likely to
sustain neurodevelopment and infant growth.43 A high and uniform AA status seems to be subject
of declining importance after delivery, which is supported by the maternal data.
Docosahexaenoic acid (DHA)
As expected,44 maternal DHA status, and thereby infant RBC-DHA status, appeared highly sensitive
to maternal sh intake. The virtually constant maternal RBC-DHA levels during pregnancy are in
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accordance with earlier data for plasma PL.14,45
At delivery, infant RBC-DHA appeared higher than maternal RBC-DHA, but this‘biomagnication’
occurred only up to about 5.6 g% maternal RBC-DHA. Beyond this point of maternal-fetal
equilibrium, infant RBC-DHA was mostly lower than maternal RBC-DHA, suggesting‘bioattenuation’,
rather than biomagnication (Figure 2B). The mean RBC-DHA data for a Dutch population32 (with
low sh intakes) and a Dominican population34 (Caribbean Sea; with local high sh intakes) are
consistent with the switch from biomagnication to bioattenuation at a higher maternal RBC-DHA
status (Dominica: mean maternal RBC-DHA 7.6 g%%, infants 6.5 g%%; Netherlands: mean maternal
3.9 g%, infants 4.7 g%). In other words, biomagnication might be conned to populations with low
maternal DHA status, such as typically encountered in most Western countries, but also the currently
studied Pare (intermediate sh) and Maasai (no sh), who, in contrast to the high sh consuming
Sengerema women, exhibited tendencies of increasing RBC-DHA during pregnancy (Figure 1 B).
Increasing amounts of DHA in the maternal circulation during pregnancy46,47 might derive from
an insulin-induced augmented elongation/desaturation of ALA in the maternal liver, secondary to
the state of reduced insulin sensitivity/compensatory hyperinsulinism that is characteristic for the
third trimester.38,39 This maternal DHA increase is unlikely to occur at high sh intakes such as in the
women from Sengerema, because of the negative feedback of dietary DHA on delta-5 and delta-6
desaturase activity (Figure 1B). The DHA increase in the maternal circulation might be a driving force
in biomagnication that is further supported by selective transport to the fetal circulation.48 Fetal
albumin has been regarded as a major contributor to LCP biomagnication because of its ability
to bind placentally transferred free LC-PUFA, while fetal albumin concentrations at term are also
10-20% higher, and albumin’s free fatty acid saturation is four times lower, in the fetal circulation
compared to the maternal circulation.49 A role of the uniquely present alpha fetoprotein (AFP) with
similar free fatty acid loading capacity in the fetal circulation was dismissed because of its 1,000
times lower concentration compared to albumin in the fetus.49 AFP, however, has high preference
for AA and DHA and is preferentially to albumin taken up by immature tissues,50,51 suggesting that,
rather than concentrations, notably uxes of LC-PUFA trapping proteins might be important for
biomagnication. Another suggested mechanism for the trapping of LC-PUFA is the incorporation
of free LC-PUFA from the fetal circulation into phospholipids in the liver or other organs.49
Higher maternal compared to infant RBC-DHA contents were previously noted after daily
supplementation of pregnant women from 20 weeks of gestation until delivery with a high sh oil
supplement containing 2.24 g DHA and 1.12 g EPA.52 In this study a maternal-fetal equilibrium was
found at an RBC-DHA of 8.87 g%, named‘saturation point’. A possible explanation for the equilibrium
at higher maternal RBC-DHA than the current about 6 g%, is that sh oil was supplemented during
the 3rd trimester of pregnancy, which is characterized by adipose tissue mobilization.53 Therefore,
the supplemental DHA might have been abundantly available for incorporation into circulating
lipids, and to a lesser extent adipose tissue stores, which might have resulted in an overestimation
of the genuine DHA status during this non-steady state condition characterized by preferential
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nutrient transfer to the rapidly growing infant. In our study, circulating DHA derived from lifelong
stable sh intakes that probably caused a steady-state DHA supply of the infant from both the diet
and adipose tissue stores.
Data from our populations with stable high intakes of sh suggest that DHA bioattenuation aims
at the inhibition of abundant transplacental passage, possibly to prevent undesired competition of
DHA with AA in competition-sensitive fetal organs. Consistent with this notion, we have shown that
at high DHA status, DHA seems to lower AA, at least in postnatal RBC, and that in umbilical vessels
DHA does not seem to exceed certain levels, possibly to avoid competition with AA.54 Prevention
of DHA competition with AA in the fetal period seems important, since fetal AA is implicated in
growth.10,43,55
The consistent decrease of maternal RBC-DHA during lactation suggests that a lactating woman
loses large quantities of DHA to her infant via the milk. This postpartum mother-to-infant DHA
‘surge’37 may represent a genuine form of ‘postnatal DHA biomagnication’, since it clearly occurs at
the expense of the mother. It coincides with a more rapid postnatal accretion of DHA in the infant
brain compared with AA,56 and may therefore illustrate the increasing importance of DHA for retinal
and neurodevelopment56,57 after delivery.
The mother-to-infant DHA surge via the milk seemed unable to prevent a RBC-DHA drop in the
Maasai, prevented a decrease in the Pare infants, but did enable a postpartum RBC-DHA increase
in the infants of the Sengerema women (Figure 1B). A state of postpartum infant DHA equilibrium
can therefore be reached at lifelong DHA intakes that are somewhat below the intakes by the
Sengerema women, who reported to eat sh 4-5 times/wk on average. Using the joined data of
all mothers and infants, we estimated that mothers with an RBC-DHA status of about 6 g% in early
pregnancy will have an RBC-DHA of about 6 g% at delivery and will give birth to infants with about
6 g% RBC-DHA. Whether this maternal RBC-DHA of 6 g% constitutes an appropriate target for the
DHA status of the mother is questionable, since a maternal RBC-DHA of 6 g% is unable to prevent a
drop in maternal RBC-DHA during lactation. We37 recently showed that maternal postpartum DHA-
equilibrium is reached at a maternal RBC-DHA content of 8 g% DHA, which is even higher than the
mean DHA status of the pregnant women in Sengerema, and coincides with an increase of infant
RBC-DHA from 7 g% at delivery to adult levels of 8 g% at 3 months.
We recently estimated that our hunter-gatherer ancestors living in a water-land ecosystem had
daily intakes of gram amounts of AA, EPA and DHA,7 which are substantially higher than the current
daily intakes of about 200 mg AA and 275 mg DHA (men) from a typically Western diet.8,58 There is
also good evidence showing that daily intakes above the recommended 450 mg DHA+EPA might
be benecial for the lowering of heart rate, blood pressure and triglycerides, and to reach maximum
antithrombotic eects.59 It has been proposed that optimal protection from cardiovascular disease
occurs from 8 g% RBC EPA+DHA,60,61 while an RBC-DHA of 7 g% [i.e. RBC-(EPA+DHA) ≥8 g%], as
found in healthy subjects in Japan, might be an appropriate target to minimize major depressive
disorders and bipolar depression.62 The above mentioned maternal postpartum equilibrium of 8
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g%37 is in line with these suggested targets for adequate DHA status and also the observation that
antagonism between EPA+DHA and AA occurs at RBC-(EPA+DHA) contents above 8 g%.54
Pregnant women in Western countries, with low intakes of sh have RBC-DHA contents well
below 8 g%. For example, non-supplemented Dutch pregnant women had RBC-DHA contents
of 4.41 g% at 36 weeks,19 while after 12 weeks of exclusive lactation their infants had an RBC-
DHA content of 4.73 g%. Supplementation of 220 mg DHA or 220 mg DHA + 220 mg AA during
pregnancy resulted in a maternal RBC-DHA contents of 5.51g% and 5.57 g% at 36 weeks gestation,
respectively,19 while their exclusively breastfed infants had RBC-DHA of 5.50 g% and 4.95 g%,
respectively, after 12 weeks. The mean daily intake of EPA+DHA by Dutch women amounted to 84
mg in 2003.63 In another study, daily supplementation of 1.3 g DHA during 3 months of lactation
resulted in a maternal RBC-DHA of 7.9 g%64 that coincided with an infant RBC-DHA content of 9.1
g%65 Taken together, these data suggest that the presently advised intake of 200-300 mg DHA daily
during pregnancy and lactation66 will be insucient to reach the maternal RBC-DHA target of 6 g%
(i.e. postpartum infant equilibrium) and will be grossly insucient to reach the target of 8 g% RBC-
DHA (i.e. postpartum maternal equilibrium and infant increase).
Limitations
It should be noted that, because of local constraints, the data for each tribe were derived from
di!erent subgroups that were studied at various occasions during pregnancy and lactation. We
interpreted di!erences between these subgroups in terms of longitudinal changes, as based
on between-group statistical di!erences. This reasoning seems justied because of their stable
dietary intakes. In addition, the courses of RBC-AA and DHA during pregnancy and lactation
were comparable with those of Dutch women, as determined in plasma-PL.14 Another limitation
might be the use of RBC-LCP data as proxies for whole body LCP status. Their use is supported by
animal experiments67 and therefore RBC-AA and DHA contents are nowadays widely regarded as
reliable parameters for LCP-status.68 There are, however, few data at very high DHA intakes on the
eciency of DHA incorporation in the various compartments (e.g. brain), and it may be expected
that each of these compartments will ultimately become ‘saturated’ to reach compartment-specic
DHA saturation levels, as e.g. suggested by the DHA contents of umbilical arteries and veins.54 The
diculty to include women in their rst trimester of pregnancy resulted into a small sample size.
Few women attend to local hospitals in early pregnancy. Because of the low numbers we refrained
from statistical analyses of these data. Also, the DHA status during pregnancy was previously shown
to be in"uenced by the number of previous pregnancies.29 However, in the present study we found
no signicant DHA status di!erences in women with 1, 2 or multiple previous pregnancies (data
not shown). Finally, the LC-PUFA status of the various tribes might be in"uenced by genetic variants
(e.g. FADS 1 and FADS2 polymorphism), but these were not taken into account in the present study.
201
Infant DHA equilibrium at 6 g% DHA
4.1
CONCLUSIONS
From the present data from populations with lifelong stable dietary habits, we conclude that infant
AA status at delivery is uniform, high, and unrelated to maternal AA status, which might indicate the
importance of fetal AA for growth and brain development. The DHA status of mother and infant on
the other hand, are intimately related and strongly dependent on the DHA intake from sh. Beyond
a maternal steady-state RBC-DHA of about 6 g%, biomagnication turns into bioattenuation,
which may aim at the prevention of DHA competition with AA in infant organs that are sensitive
to DHA vs. AA competition. A maternal RBC-DHA of 6 g% from early pregnancy up to delivery
predicts an infant RBC-DHA of about 6 g% at delivery, which will not change during subsequent
exclusive breastfeeding. Infant equilibrium, however, coincides with maternal DHA losses during
lactation. The mother-to-infant DHA surge during lactation may represent the genuine form
of biomagnication. Bioattenuation, rather than biomagnication, might be the physiological
standard for humans, because of our ancestry from the land-water ecosystem and since studies
on the prevention of cardiovascular disease and depression indicate optimal RBC-DHA contents
above 7 g%. It is important to stress that all of the present data derive from populations with stable
dietary habits and may not be applicable to the state of non-equilibrium that is typical for the so far
conducted short term supplementation studies with DHA and AA during pregnancy and lactation.
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Introduction. Low long-chain polyunsaturated fatty acid (LC-PUFA, LCP) consumption relates to
suboptimal neurodevelopment, coronary artery disease and (postpartum) depression. Maternal-to-
infant LCP-transport during pregnancy and lactation is at expense of the maternal status, a process
known as biomagnication. Despite biomagnication, maternal ánd infant LCP-status generally
declines during lactation.
Materials and Methods. To assess the 1) turning-point of biomagnication (level from which
maternal (m)docosahexaenoic acid (DHA)-status exceeds infant (i)DHA-status), 2) ‘DHA-equilibrium’
(steady-state-level from which mRBC-DHA stop declining during lactation), 3) corresponding iDHA-
status, 4) relationship between RBC-DHA and RBC-arachidonic acid (AA), we measured RBC-FA in
193 Tanzanian mother-infant pairs with no, intermediate (2-3 times/wk) and high (4-5 times/wk)
fresh-water sh-consumption, at delivery and after 3 mo of exclusive breastfeeding.
Results. At 3 mo, mRBC-DHA was lower than the corresponding iRBC-DHA upto a mRBC-DHA of 7.9
g%. mRBC-DHA-equilibrium, with equivalent mRBC-DHA at both delivery and at 3 mo postpartum,
occurred at 8.1 g%. This mRBC-DHA-equilibrium of 8.1 g% corresponded with an iRBC-DHA of
7.1-7.2 g% at delivery that increased to 8.0 g% at 3 mo. We found between-group di!erences in
mRBC-AA, however, no di!erences in iRBC-AA were observed at delivery or 3 mo. Relations between
RBC-DHA vs. RBC-AA were bell-shaped. Discussion. At steady-state LCP intakes during lactation, 1)
biomagnication occurs upto 8 g% mRBC-DHA, 2) mRBC-DHA-equilibrium is reached at 8 g%, 3)
mRBC-DHA-equilibrium corresponds with iRBC-DHA of 7 g% at delivery and 8 g% after 3mo, 4) unlike
RBC-DHA, mRBC-AA and iRBC-AA are independently regulated in these populations, 5) bell-shaped
RBC-DHA vs. RBC-AA-relations might support uniform iRBC-AA. We conclude that 8g% mRBC-DHA
might be optimal for infant neurodevelopment and adult cardiovascular-disease incidence.
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INTRODUCTION
The long-chain polyunsaturated fatty acids (LC-PUFA, short: LCP) docosahexaenoic acid (DHA),
eicosapentaenoic acid (EPA) and arachidonic acid (AA) are structural components of membrane
phospholipids (PL), modulators of gene expression and precursors of eicosanoids (AA, EPA),
resolvins (AA, EPA, DHA) and (neuro)protectins (DHA).1 DHA and AA are notably abundant in the
central nervous system and play important roles in fetal and infant neurodevelopment.69 Horrobin
et al.70 suggested that collaboration between EPA and AA plays a key role in the benecial eects
of low-dose EPA in psychiatric disease. Low DHA in the central nervous system has been suggested
to decrease DHA turnover, with reciprocal increase in AA turnover.71 High-DHA intakes reduce AA
in e.g. RBC72 and possibly in brain.73 Low (n-3) LCP status is intimately related to cardiovascular and
psychiatric diseases at adult age.74 Most populations living in Western countries are characterized
by low intakes of (n-3) LCP (especially EPA and DHA), which contrasts with the derivation of our
ancestors from a land-water ecosystem with abundantly available (n-3) LCP and (n-6) LCP (especially
AA).7,75
With advancing gestation, the pregnant mother increasingly transfers LCP, notably DHA, to the
developing infant. Compared to its mother, infant plasma lipids and erythrocytes (RBC) in the second
half of pregnancy contain higher relative amounts of LCP, which has been coined‘biomagnication’.13
We have recently shown that biomagnication of DHA might actually reect low maternal (n-3) LCP
status, since infants born in a population with lifetime high freshwater sh intakes have lower cord
blood RBC-DHA compared with their mothers. We found that this ‘bioattenuation’ occurs from a
maternal RBC-DHA at term of about 6 g%, which corresponds with a maternal RBC-DHA of about
6 g% in early pregnancy.36 After birth, breastfed infants in Western populations show consistent
decreases of RBC-DHA.76,77 This might, analogous to the intrauterine period, reect low maternal
(n-3) LCP status, since infants born to mothers with lifetime high intakes of freshwater sh exhibit
postpartum RBC-DHA increases.36
Although the transfer of nutrients via lactation is generally considered to be benecial for the
infant, it may diminish maternal stores, resulting in the so called ‘maternal depletion syndrome’.78
Maternal LCP depletion, which aects DHA more than AA, may be most pronounced with longer
gestation, short birth intervals, increasing parity and multiple pregnancy.29,79 While AA in maternal
plasmaPLandRBC-AAincreasetoprepregnancyvaluesafterdelivery,thereisaconsistentpostpartum
decrease of maternal plasma PL- and RBC-DHA in lactating compared to non-lactating women.15
Low intakes of (n-3) LCP during pregnancy were reported to result in slightly shorter gestation,
marginally lower birth weight and increased risk of preterm delivery.80 Low maternal DHA status
in populations with low seafood consumption, has also been associated with a higher incidence
of postpartum depression.81 The causality is however uncertain, since randomized controlled trials
(RCT) with DHA in pregnancy and lactation have been inconclusive.82,83 For instance, in a placebo
controlled trial, supplementation with 200 mg DHA/d for the rst 4 mo after delivery prevented
postpartum decline in plasma PL-DHA, but did not inuence postpartum depressive symptoms.82
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A recent small trial showed benecial eects of (n-3) LCP supplementation on depression during
pregnancy.84 Finally, a declining maternal DHA status during pregnancy was suggested to be
involved in compromised maternal selective attention, a key component of cognition.85
We investigated the transplacental LCP-gradient and the courses of maternal and infant RBC-
LCP during lactation in three rural African tribes with constant, lifetime low, intermediate and
high intakes of tropical freshwater sh. We were particularly interested to determine 1) the point
where biomagnication turns into bioattenuation, i.e. the level from which the maternal LCP-status
exceeds the infant LCP-status 2) the DHA status at which the mother reaches a postpartum RBC-
DHA equilibrium, i.e. the steady-state maternal RBC-DHA level at delivery that suces to prevent a
decline in the maternal DHA status during subsequent lactation, 3) the postpartum course of infant
RBC-DHA that corresponds with maternal postpartum DHA equilibrium and 4) the relation between
RBC-DHA and RBC-AA at low and high sh intakes.
PARTICIPANTS AND METHODS
Study design
We studied the transplacental LCP gradient at delivery and the course of the maternal and infant
LCP status during exclusive lactation. For this we selected 3 ethnic groups in Tanzania with dierent
intakes of (n-3) LCP from local sh, i.e. the Maasai (no or low sh intake), participants from the Pare
Mountains (intermediate sh intake) and participants from Sengerema (high sh intake). Each
of these groups was considered homogeneous with respect to ethnicity/tribe and their lifetime
dietary habits. The data for the transplacental gradient were derived from 3 groups of healthy
and well-nourished mothers who delivered apparently healthy infants at term (37-42 wk). Data on
the course of the LCP status in mothers and infants during exclusive lactation were derived from
the comparisons of the LCP status of these mothers/infants with those of counterparts at 3 mo
postpartum (PP). The latter were healthy, well nourished and had delivered an apparently healthy
mature (37-42 wk of gestation) infant 10-18 wk prior to their visit to the local hospital or dispensary
for the follow-up of their infant in the pediatric department. All women gave their informed consent.
The study was approved by the National Institute for Medical Research in Dar-es-Salaam (NIMR/
HQ/R.8a/Vol. IX/800, dated April 8, 2009) and was in agreement with the Helsinki declaration of 1975
as revised in 2000.
Study groups
The Maasai are a group of Nilotic pastoralists from the Maasai Steppe nearby the dispensary in
Ruvu. Their diet is composed of curdled milk, some ugali (corn porridge) and meat. Because sh
are considered as snake-like creatures, they are usually not eaten. The Pare group included Bantu
women from the agricultural Pare and Sambaa tribes who visited Same hospital from the nearby
Pare Mountains. Their staple foods are ugali, rice and cornwheat pancakes, with some meat, sh and
beans, together with a relatively abundant consumption of fruits and vegetables. Fish consumption
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is irregular since nearest lake is located >30 km from their villages. The Sengerema group included
Bantu women from the shery families living at southern shore of Lake Victoria who attended to
the hospital of Sengerema. Ugali, cassava root and plantain are staple foods, but consumption of
sh is markedly more regular in the Lake Victoria area than for inhabitants of the Pare area. Smoking
and alcohol consumption is very uncommon within these communities, especially among women.
Importantly, included participants had neither the possibility to (Pare and Sengerema), nor major
interest in (Maasai), deviation from their cultural habits, including their diets. We observed, and
local doctors, nurses and participating women conrmed, that neither pregnancy nor lactation is
associated with any change in dietary habits in any of the investigated groups. The average dietary
intakes of mothers at delivery as well as at 3 mo PP were therefore likely to be representative for
the lifetime dietary habits of their respective ethnic group/tribe as a whole. Data on age, parity, sh
consumption and duration of lactation were obtained from the medical records or by interviews in
Kiswahili. Gestational ages were checked by the last known menstrual period and fundal height.
After delivery all infants were routinely checked for signs of prematurity.
Samples and analyses
About 4 mL EDTA-anticoagulated venous blood samples (7.2 mg of sprayed K2EDTA; in 4 mL tubes;
BD Vacutainer, Plymouth, UK) were collected from the mothers at delivery and after 3 mo; and
from the umbilical vein at delivery. An about 250 μL EDTA-anticoagulated blood sample (250 μL
pediatric MiniCollect K3EDTA-tubes; Greiner Bio-one, Kremsmünster, Austria) was taken from the 3
mo old infants via a heel prick. Samples were stored at 4 C in the dark and processed within 2 h after
collection. RBC were separated from plasma by centrifugation and washed three times with 0.9%
NaCl. After washing aliquots of 200 μL of RBC suspension (4 ml tubes) or the entire RBC-suspension
(250 μL tubes) were pipetted into a te#on-sealable Sovirel tube containing 2 mL of methanol-6
mol/L HCl (5:1 v/v), 1 mg butylated hydroxytoluene (antioxidant) and 50 μg 17:0. In this ready-to-
transmethylate mixture FA are stable at room temperature and in the dark for months. All samples
were transported at room temperature to the University Medical Center Groningen (the Netherlands)
for FA analysis. FA were analysed according to previously described methods.28 In short, analyses
of FA methyl esters (FAME) were performed by capillary gas chromatography/#ame ionization
detection following the addition of an internal quantication standard (17:0), transmethylation and
extraction. FA were quantied on the basis of the added 17:0. Fatty acid compositions are expressed
as g/100g FA (g%) for consistency with current literature and the omega-3 index.
Statistics
Statistical analyses were performed with SPSS version 16.0.1 (SPSS Inc, Chicago, IL). Between-group
analyses were tested for normality and subsequently analyzed with an ANOVA and student t-test or
a Kruskal-Wallis test and a Mann Whitney U-test. Di$erences were considered signicant at P<0.05.
Di$erences between mothers and infants were tested with a paired-samples t-tests or a Wilcoxon
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test. Dierences were considered signicant at P<0.05. Bonferroni corrections were made for type-
1 errors by dividing all P-values by the number of comparisons. Consequently, all dierences with
P<0.05 divided by the number of comparisons, were considered signicant. Correlations were
tested by linear regression analysis.
RESULTS
Anthropometrics and sh intakes
We included 193 women/infant pairs in this study: 83 at delivery (63 complete pairs: 6 Maasai, 24
Pare; 33 Sengerema) and 110 after 3 mo of exclusive lactation (104 complete pairs: 8 Maasai, 36
Pare; 60 Sengerema). Drop out was due to obtaining consent for only the mother or the infant, early
discharge, and logistical and analytical imperfections. The anthropometrics and characteristics of
the investigated mothers and their children are shown in Table 1.
There were no between-group dierences for the mothers at delivery or at 3 mo PP, except
for a lower weight at delivery (P<0.05) and higher length at all times (P<0.05) of Maasai mothers,
compared to Pare mothers, and a higher BMI of Sengerema mothers compared to Maasai at 3 mo PP
(P=0.048). The principal relevant between-group maternal dierence was in sh intakes: sh intakes
of the Sengerema mothers at delivery and at 3 mo PP (4-5 times/wk) were higher than the Pare
mothers (2-3 times/wk, P<0.03), which in turn were greater than in the Maasai mothers (0 times/
wk, P<0.004).
Table 1. Anthropometrics of mothers and infants at delivery and at 3 months PP1
Maasai Pare Sengerema
Delivery
Maternal age, y 23 ± 4 [8] 25 ± 7 [31] 24 ± 7 [34]
Postpartum weight, kg 53.0 ± 5b [8] 57.3 ± 8a [23] 54.4 ± 10a.b [31]
Height, m 1.59 ± 0.06a [8] 1.54 ± 0.04b [27] 1.56 ± 0.06a.b [31]
BMI, kg/m2 20.9 ± 2.0 [8] 23.9 ± 2.0 [21] 22.4 ± 3.3 [31]
Gravida, number 3 ± 1 [8] 3 ± 2 [31] 3 ± 3 [34]
Para, number 2 ± 1 [8] 2 ± 2 [31] 2 ± 3 [34]
Gestational age at birth, wks 40.0 ± 0 [1] 39.9 ± 1.5 [17] 38.9 ± 1.8 [2.8]
Fish intake, times/wk 0 ± 0c [8] 3 ± 2b [17] 5 ± 2a [30]
Infant birth weight, g 3050 ± 400 [8] 3115 ± 535 [26] 2947 ± 751 [34]
Gender, % male 38 [8] 45 [29] 58 [36]
3 months PP
Maternal age, y 24 ± 4 [9] 24 ± 4 [40] 24 ± 6 [61]
Weight, kg 52.4 ± 3 [9] 52.2 ± 11 [40] 54.6 ± 10 [61]
Height, m 1.60 ± 0.03a [9] 1.55 ± 0.07b [40] 1.56 ± 0.06a.b [61]
BMI, kg/m2 20.5 ± 1.1b [9] 21.6 ± 4.0a.b [40] 22.1 ± 3.0a [60]
Para, number 3 ± 1 [9] 2 ± 1 [40] 3 ± 2 [61]
Fish intake, times/wk 0 ± 0.7c [8] 3 ± 2b [40] 4 ± 2a [61]
Infant age, wks 16 ± 4 [9] 14 ± 3 [40] 13 ± 2 [61]
Gender, % male 67 [9] 47 [40] 55 [61]
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Figure 1 Maternal and infant RBC-DHA (1A) and RBC-AA (1B) at delivery and ay 3 mo PP by mothers’ sh intake.
Data are means ± 2*SEM. Maasai mothers (n=6 at delivery; n=7 at 3 mo PP), infants (n=8; n=6); Pare mothers
(n=27; n=38), infants (n=29; n=38); Sengerema mothers (n=34; n=60), infants (n=36; n=61). Statistics: only the
non-signicant (P>0.05) comparisons are indicated: Maasai/Pare/Sengerema mother or infant means at a time
with a common letter (a,b,c) do not dier. Mothers and infants in a group at a time with a common symbol (#,§)
do not dier. Corresponding timepoints that do not dier are labelled ¥. Comparisons between mother and
infant were conducted using paired analyses (n= 6 Maasai, 24 Pare, 33 Sengerema). Dotted lines indicate the
minimum and maximum of the mean infant RBC-AA at delivery and 3 mo PP.
Maternal and infant RBC-AA and DHA
Maternal vs. infant RBC-DHA and AA at delivery and at 3 mo PP
At delivery, RBC-DHA in Maasai mothers was not signicantly dierent compared to their infants,
but became signicantly lower (P=0.022) at 3 mo PP. Pare mothers tended to have lower RBC-DHA
at delivery (P=0.091), and had lower RBC-DHA at 3 mo PP compared to their infants (P<0.001).
Compared to their infants, Sengerema mothers had higher RBC-DHA at delivery (P=0.029), but
lower DHA at 3 mo PP (P=0.001) (Table 2; Figure 1A).
Maasai maternal RBC-AA was lower at delivery compared to their infants (P=0.028), but higher at 3
mo PP (P=0.015). RBC-AA of Pare mothers was lower at delivery (P<0.001), compared to their infants,
but there was no dierence at 3 mo PP (P=0.12). RBC-AA of the Sengerema mothers was lower than
that of their infants at delivery (P<0.001) and at 3 mo PP (P<0.001) (Figure 1B).
Delivery vs. 3 months PP RBC-DHA and AA in mothers and infants
Both Maasai mothers (P=0.003) and their infants (P=0.039) had higher RBC-DHA at delivery,
compared to 3 mo PP. From delivery to 3 mo PP, Pare mothers showed a decrease in RBC-DHA
(P<0.001), but the decrease in infant RBC-DHA during lactation was non-signicant (P=0.162).






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In the Maasai, maternal RBC-AA increased from delivery to 3 mo PP (P=0.003), but infant RBC-AA
did not decrease (P=0.12). For the Pare, maternal RBC-AA increased (P<0.001), while infant RBC-AA
decreased (P=0.001). Maternal RBC-AA increased also in Sengerema (P<0.001), and decreased in
their infants (P<0.001) (Figure 1B).
Between-group di!erences in RBC-DHA and AA
Maasai mothers tended to have lower RBC-DHA, compared to Pare mothers at delivery (P=0.06),
while Maasai infants had lower RBC-DHA compared to Pare infants (P=0.040). At 3 mo PP, both Maasai
mothers (P<0.001) and their infants (P=0.004) had lower RBC-DHA compared to Pare. Sengerema
mothers and their infants had higher RBC-DHA compared to Pare counterparts at delivery and at 3
mo PP (all P<0.001). RBC-DHA of Sengerema mothers and their infants were also higher compared
to Maasai counterparts at all times (all P<0.001) (Figure 1A).
Maternal RBC-AA was higher in Maasai compared to Pare mothers at delivery (P=0.005) and
at 3 mo PP (P<0.001), but RBC-AA was not signi!cantly di"erent between Maasai and Pare infants
at delivery nor at 3 mo PP. RBC-AA in Sengerema mothers was higher (P=0.049) compared to Pare
mothers at delivery, but there was no di"erence at 3 mo PP.
Also, there were no di"erences in infant RBC-AA between Sengerema and Pare at delivery, nor
at 3 mo PP. RBC-AA was lower in Sengerema, compared to Maasai mothers at delivery (P=0.042) and
at 3 mo PP (P<0.001). There were no di"erences between Sengerema and Maasai infant RBC-AA at
delivery nor at 3 mo PP (Figure 1B).
Maternal vs. infant RBC-DHA and maternal vs. infant RBC-AA
When the 3 groups were combined, there were signi!cant relations between maternal and infant
RBC-DHA at delivery (Figure 2A) and at 3 mo PP (Figure 2C). Data that were previously reported
for mother-infant pairs in Dominica34 and The Netherlands,32 !tted well within the relationships
(Figure 2A and Figure 2B). Maternal RBC-DHA explained 61% of the variation in infant RBC-DHA
at delivery and 76% at 3 mo PP. In contrast, there were no signi!cant relations between maternal
RBC-AA and infant RBC-AA, neither at delivery, nor at 3 mo PP (Figure 2B and Figure 2D). Using the
equations shown on Figure 2 (at y = x), we calculated that at delivery, maternal RBC-DHA levels <5.6
g% corresponded with higher infant RBC-DHA, while infant RBC-DHA was lower than maternal RBC-
DHA at ≥5.6 g% (Figure 2A). At 3 mo PP, maternal RBC-DHA levels <7.9 g% corresponded with higher
infant RBC-DHA. There were few mothers with RBC-DHA >7.9 g%, but extrapolation suggests that
the reverse may occur beyond this maternal RBC-DHA status (Figure 2C).
Maternal and infant RBC-DHA vs. RBC-AA
The relations between RBC-DHA and RBC-AA for the mothers and the infants at delivery and at 3 mo
PP are presented in Figure 3. We !rst analyzed the DHA compared with AA relations in each of the
3 tribes. Linear regression analyses (Table 3; Figure 3) showed di"erent slopes for the Maasai, Pare,
4.2
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and Sengerema. Those of the Maasai and Pare were mostly positive, whereas those in Sengerema
were mostly negative. Pooling of all data suggested that the relations between RBC-DHA and RBC-
AA were at best bell shaped and were therefore tted in a quadratic function (Table 3; Figure 3). The
calculated curves reached their summits at 5.7, 5.7, 4.8, and 6.2 g% RBC-DHA (Fig. 3A–D, respectively).
The best linear t from a RBC-DHA above the respective summits is also in Table 3. Taken together,
the relations were positive up to ;6 g% RBC-DHA and became negative or nonsignicantly positive
beyond ~6 g%.
Changing postpartum maternal RBC-DHA as a function of RBC-DHA at delivery
The fractional changes of maternal RBC-DHA from delivery to 3 mo PP as a function of maternal RBC-
DHA at delivery (Figure 4A) and infant RBC-DHA at delivery (Figure 4B) derive from the combined
Maasai, Pare and Sengerema participants, studied at delivery and at 3 mo PP. Fractional changes are
given as the ratio (maternal RBC-DHA at 3 mo PP)/(maternal RBC-DHA at delivery) in which a ratio <1
Figure 2. Relations between maternal and infant RBC-DHA (A,C) and between maternal and infant RBC-AA
(B,D) at delivery (A,B) and at 3 mo PP (C,D). Mean data for Dominician (n=7) and Dutch (n=183) mother-infant
pairs are derived from (34) and (32), respectively. Dotted lines represent y = x, i.e. the maternal RBC-DHA




















































































































































































































































































































































































































































































































































































Maternal DHA equilibrium at 8 g% DHA
Figure 3. Relations between maternal RBC-DHA (A,C) and infant (B,D) RBC-DHA vs. RBC-AA at delivery (A,B)
and at 3 mo PP (C,D). Dotted lines indicate the relation RBC-DHA vs. RBC-AA for each group. The solid lines are
the quadratic functions for the combined groups with the 95% CI in gray.
indicates that the mother is in negative DHA balance during lactation and a ratio >1 indicates that
the mother is in positive postnatal DHA balance. By extrapolation, it was found that a maternal RBC-
DHA equilibrium from delivery to 3 mo PP was reached when the maternal RBC-DHA amounted
to 8.1 g% at delivery (Figure 4A). This maternal RBC-DHA equilibrium corresponded with an infant
RBC-DHA of 7.1 g% (calculated from Figure 2A) to 7.2 g% (Figure 4B) at delivery and 8.0 g% at 3 mo
PP (calculated from Figure 2C). Using the 7.2 g% from Figure 4B in Figure 2A, we calculated that
maternal postnatal RBC-DHA equilibrium would occur when the mother reaches an RBC-DHA of 8.3
g% at delivery, which is close to the 8.1 g% from Figure 4A.
Taken together, maternal equilibrium was reached at a maternal RBC-DHA of 8 g% at delivery,
which corresponded with a maternal RBC-DHA of 8 g% at 3 mo PP, an infant RBC-DHA 7 g% at




In this study of 3 populations of mother-infant pairs with dierent maternal consumption of
freshwater sh (Fig 1A), we found that 1) biomagnication occurs up to 8 g% DHA in maternal
RBC, 2) maternal RBC-DHA equilibrium is reached at 8 g%, 3) this maternal RBC- DHA equilibrium
corresponds with an infant RBC-DHA of 7 g% at delivery that increases to 8 g% during 3 mo of
exclusive lactation, 4) unlike RBC-DHA, maternal and infant RBC-AA are independently regulated in
these populations, and 5) bell-shaped RBC-DHA vs. RBC-AA-relations might support uniform iRBC-
AA.
Docosahexaenoic acid (DHA)
Although maternal RBC-DHA decreased during breastfeeding in all groups, the decline was more
pronounced in Maasai and Pare, who have lower sh intakes. The postpartum change in infant RBC-
DHA was dependent on the maternal RBC-DHA status and showed a decrease (Maasai), no-change
(Pare) or increase (Sengerema) (Figure 1) with increasing sh intake. Using data from the same study
population we recently calculated that infants would need an RBC-DHA of 6 g% at delivery to reach
RBC-DHA equilibrium during lactation.36 The present ndings indicate when the mother reaches
DHA equilibrium during lactation. The peculiar mother-infant sharing of DHA during pregnancy and
lactation is presented in simplied form in Figure 5. Postnatal infant DHA equilibrium occurs at an
infant RBC-DHA of about 6 g% at delivery (Figure 5A), which corresponds with a maternal RBC-DHA
of about 6 g% at delivery and 6 g% at early pregnancy.36 Postnatal infant DHA equilibrium coincides
with a mature milk DHA level of about 0.4 g% (Kuipers, unpublished). Under these circumstances
the mother loses DHA during lactation to reach The combination of infant DHA-equilibrium and
maternal DHA losses during lactation can be considered as postnatal DHA-biomagnication. a
maternal RBC-DHA of about 5 g% after 3 mo. This can be calculated by entering an infant RBC-DHA
Figure 4. Maternal RBC-DHA at delivery (A) and infant RBC-DHA at delivery (B) compared with the ratio of
maternal RBC-DHA at 3 mo PP/maternal RBC-DHA at delivery. Data are means ± SEM, n=6 and 9 for Maasai
mothers; n=8 and 8 for Maasai infants at delivery and mo PP, respectively, n=27 and 38 for Pare mothers,
29 and 38 for Pare infants at delivery and 3 mo PP, respectively, n=34 and 60 for Sengerema mothers, 36
and 61 for Sengerema infants at delivery and 3 mo PP, respectively. A ratio of maternal RBC-DHA at 3 mo
postpartum/maternal RBC-DHA at delivery <1 indicates that the mother is in negative DHA balance during
lactation; a ratio >1 indicates that the mother is in positive postnatal DHA balance.
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of 6 g% into Figure 3C or Figure 4B and a maternal RBC-DHA of 6 g% into Figure 4A. Postnatal
maternal DHA equilibrium is reached when maternal RBC-DHA is about 8 g% at delivery (Figure
3A, Figure 5b), which corresponds with 8 g% at early pregnancy36 and a mature milk content of
about 1 g% DHA (Kuipers, unpublished). Under these circumstances, infant RBC-DHA is about 7 g%
at delivery (Figure 3B), which we named ‘bioattenuation’.36 This intrauterine bioattenuation occurs
despite the rapid postnatal infant RBC-DHA increase to adult levels of 8 g% during 3 mo lactation
(Figure 2C), and might illustrate the apparent importance of limiting DHA transplacental transport
at high !sh intakes, which is followed by a postnatal mother-to-child DHA surge via the milk.
While there is consensus on recommending an average DHA intake of at least 200 mg/d
during pregnancy and lactation80 the optimal DHA status for the mother and her infant is currently
unknown. Intake of !sh and !sh oils during pregnancy result in slightly longer gestation, marginally
higher birth weight and a reduced risk of preterm delivery.80 However, RCTs with DHA during
pregnancy targeting infant neurodevelopment are less clear. The largest RCT so far with cod liver oil
(1200 mg DHA/d) on top of a baseline diet containing 200-300 mg DHA/d86-88 showed no di"erences
in cognitive development at 6 and 9 mo, a promising higher IQ at 4 y of age, but not at 7 y. These
outcomes were in line with the negative outcomes for associations between umbilical plasma PL- and
RBC-DHA and infant cognitive development at 4 and 7 y.89,90 Supplementation with !sh oil or DHA
in pregnancy, however, might bene!t infant visual maturation and acuity22,91,92 and newborn sleep
pattern maturity.93 Thus, the inconsistent results of maternal DHA supplementation studies contrast
with positive associations between neonatal brain DHA and cognitive and behavioral performance
noted in combined human and animal studies.69 Discrepancies might relate to e.g. short-term
supplementation of relatively low doses of DHA, di"erences in frequencies of polymorphisms in the









































Infant RBC-DHA equilibrium at 6 g% DHA Maternal RBC-DHA equilibrium at 8 g% DHAA B
Figure 5. Synoptic overview of the infant (A) and maternal (B) RBC-DHA equilibrium during 3 mo lactation.
(A) Infant RBC-DHA equilibrium occurs at 6 g% DHA and coincides with depletion of maternal DHA from 6
g% DHA at delivery to 5 g% DHA at 3 mo PP; a maternal RBC-DHA of 6 g% at 3 mo PP coincided with 0.4 g%
DHA in milk. (B) Maternal RBC-DHA equilibrium occurs at 8 g% DHA, which coincides with an increase in
infant RBC-DHA from 7 g% DHA at delivery to 8 g% at 3 mo PP; a maternal RBC-DHA of 8 g% coincided with
1.0 g% DHA in milk.
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Epidemiological studies have linked sh consumption, EPA+DHA intakes, and EPA+DHA status,
to a reduction in aective disorders, cognitive impairment, Alzheimers disease and postpartum
depression.74 An RBC-(EPA+DHA) ≥8 g%, as found in healthy Japanese, seems an appropriate target
to minimize major depressive disorders and bipolar depression,62 but the relation between (n-3) LCP
and postpartum depression has not been substantiated by RCTs.82,83 With regard to cardiovascular
disease, an RBC-DHA >8 g% (omega-3 index >10 g%) was associated with the lowest risk for acute
coronary syndrome and sudden cardiac death.60,61,94 (n-3) LCP intakes >450 mg/d were shown
benecial for the lowering of heart rate, blood pressure and triglycerides and to reach maximum
antithrombotic eects.59 During 2.5 millions y of evolution our genome has become adapted to
a diet high in both (n-3) and (n-6) LCP.7,75 The presumed high LCP intakes by our ancestors, likely
resulted in development of maternal stores of sucient magnitude to prevent depletion during
lactation and to sustain DHA transfer to the developing infant. The high DHA in milk and RBC that
were observed in populations with high sh consumption are consistent with the high intakes of
AA, EPA and DHA from our Paleolithic diets.7,75
It has been suggested that the RBC-membrane might reach saturation at levels between 8-10
g% DHA.64,65 Supplementation of lactating women with doses up to 1.3 g DHA/d dose-dependently
increased maternal RBC-DHA to 7.9 g%, milk DHA to 1.13 g% and infant RBC to 9.1 g% DHA. While
milk DHA continued to increase, no further increase in infant RBC-DHA from about 0.8 g% DHA in
milk was seen, corresponding to a maternal-infant RBC-DHA of 8-10 g%.64,65 However, we have little
data (Figure 2A and 2C) to show the relation between infant and maternal RBC-DHA beyond 8 g%
DHA.
Arachidonic acid (AA)
Delivering and lactating women with low, intermediate and high sh intakes proved to have dierent
RBC-AA status at both delivery and after 3 mo (Figure 1B), although RBC-AA increased in all maternal
groups after delivery. In contrast, RBC-AA was remarkably similar for all infant groups at delivery and
after 3 mo and decreased consistently after delivery (Figure 1B). Biomagnication of AA across the
placenta is clearly shown in Figure 2B. However, the higher infant RBC-AA, compared to maternal
RBC-AA, vanished within 3 mo of lactation (Figure 2D). The concomitant increase in maternal RBC-
AA might derive from discontinued utilization of AA by the placenta,95 discontinued transport to the
fetus, or both. The postpartum decrease in infant RBC-AA might be consistent with the postpartum
changes in the infant’s RBC-PL species.40 Mechanistically, it might result from the discontinued AA
transport across the placenta and from the change of hormonal milieu that accompanies delivery,
which is likely to in"uence FA enzymatic activities. It was e.g. shown that the infants’ LCP-synthetic
activity decreases drastically after delivery.41 Even high milk AA contents, such as in Pare (0.80 g%,
Kuipers unpublished), were unable to prevent a decrease in infant RBC-AA. This raises the question
whether milk AA is at all intended to sustain infant AA status after delivery. The remarkable between-
group similarity of infant RBC-AA levels at delivery and to a lesser extent at 3 mo PP rather suggests
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a well controlled infant AA status during the intrauterine period that gradually assumes adult levels
after delivery. This suggestion is in line with Hsieh et al.,96 who recently showed that central nervous
system (CNS) AA levels in baboon neonates are tightly controlled at the level of incorporation or
utilization, that CNS AA levels were unaected by dietary AA and that AA decreased in all CNS
structures with age.
Docosahexaenoic acid (DHA) vs. arachidonic acid (AA)
We recently suggested a synergistic relation between DHA and AA at low DHA status and an
antagonistic relationship between DHA and AA at high DHA status.54,97 Such a relationship was
previously proposed by Horrobin et al.70 Our data on the antagonistic relation between DHA and AA
were a.o. based on their contents in RBC. These suggested that RBC-DHA increasingly suppresses
RBC-AA from an RBC-DHA level of about 6 g%.54,97 Interestingly, in the present study we also found
synergism between DHA and AA below an RBC-DHA of about 6 g% and antagonism beyond 6 g%
(Figure 3). This suggests that in Maasai and Pare infants (born to mothers with low !sh intakes),
biomagni!cation of DHA across the placenta indirectly caused a synergistic increase of RBC-AA by
virtue of higher transplacental DHA transport, while in the Sengerema infants (born to mothers
with high !sh intakes), bioattenuation of DHA across the placenta indirectly caused a diminished
antagonistic decrease of RBC-AA. In other words, both biomagni!cation and bioattenuation during
pregnancy may aim at a certain fetal AA status. The subsequent postnatal DHA surge via the milk
may be regarded as a form of postnatal biomagni!cation. This DHA surge was apparently unable to
prevent a postnatal RBC-DHA drop in Maasai infants, caused a non-signi!cant RBC-DHA decrease in
Pare, and an increase in Sengerema infants. Analogous to the intrauterine period, the resulting low
DHA status in Maasai infants might have synergistically lowered their RBC-AA, while the high DHA
status of the Sengerema infants might have lowered their RBC-AA in an antagonistic manner. The
presumed synergy and antagonism may in this manner have contributed to the observed low inter-
individual variation of RBC-AA at 3 mo PP. It is possible that their existence illustrates the important
role of AA for the developing infant during pregnancy, and the increasing postnatal importance of
DHA in the suppression of AA.
It might be considered a limitation that we interpreted the dierences between the subgroups
at delivery and 3 mo in terms of longitudinal changes. This assumption might, however, be justi!ed
by the known and checked lifetime stable dietary intakes in these populations, while in essence no
dierent results have been noted with literature-data deriving from genuine prospective studies.
Our interpretations rest on the reliability of RBC-LCP status as a proxy for whole body LCP status. The
RBC-FA composition is, however, widely considered as a reliable re"ection of whole body status,68
particularly in populations with stable lifetime dietary habits. Maternal to infant FA transport may be
in"uenced by placental size, however we observed no between-group dierences for placental size
or architecture while assisting deliveries. Finally, we interpreted static values in terms of "uxes. Any
of these interpretations may consequently be biased and should be con!rmed by data from tracer
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or other dynamic studies.
We conclude that the postnatal DHA surge via the milk represents a genuine form of
postnatal biomagnication that occurs up to a maternal RBC-DHA status of 8 g%. This contrasts
with biomagnication via the placenta, which occurs up to a maternal RBC-DHA status of 6 g%.
This discrepancy might, together with the postnatal increase in maternal RBC-AA and concurrent
decrease in infant RBC-AA, indicate a switch of the importance of AA during gestation to DHA
during lactation. Unlimited DHA transfer at high maternal DHA status might be undesirable because
of its antagonistic eect on AA, while the postpartum DHA surge via the milk might aim at the
suppression of AA by DHA. An RBC-DHA of 8 g% in adults and the rapid postpartum increase of
infant RBC-DHA to 8 g% might support infant neurological development and prevent adult diseases
linked to low sh intakes. Low DHA status might be associated with diseases in the peripartum
period, but this needs conrmation from RCTs targeting 8 g% RBC-DHA.
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Introduction. The relation between docosahexaenoic (DHA) and eicosapentaenoic (EPA) vs.
arachidonic acid (AA) seems characterized by both synergism and antagonism.
Materials and Methods. Investigate the relation between EPA+DHA and AA in populations with
a wide range of EPA+DHA status and across the life cycle. EPA+DHA and AA were determined in
erythrocytes (RBC; n=1979), umbilical arteries (UA; n=789) and umbilical veins (UV; n=785).
Results. In all compartments, notably RBC, the relation between EPA+DHA and AA appeared
bell-shaped. Populations with low RBC-EPA+DHA (<2g%) exhibited positive relationships; those
with high RBC-EPA+DHA (>8g%) negative relationships. Antagonism in UA and UV could not be
demonstrated.
Conclusion. Both synergism and antagonism might aim at a balance between ω6 and ω3 long-
chain polyunsaturated fatty acid (LCP) to maintain homeostasis. Synergism might be a feature of
low LCPω3 status. AA becomes suppressed by antagonism from an RBC-EPA+DHA >8g%.
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INTRODUCTION
The long-chain polyunsaturated fatty acid (LCP) docosahexaenoic acid (DHA), eicosapentaenoic acid
(EPA) and arachidonic acid (AA) are important for human development and health. They function
as structural components of membrane phospholipids (PL), modulators of gene expression, and
precursors of eicosanoids (AA, EPA), resolvins (AA, EPA, DHA) and (neuro) protectins (DHA).1 Most
Western countries are characterized by low intakes of especially EPA and DHA from sh, which
contrasts with the evolution of our ancestors in a land-water ecosystem with abundantly available
LCPω3 and LCPω6 (especially AA).7,23-26 Low LCPω3 status has been suggested to be disadvantageous
in infant neurodevelopment98,99 and is associated with cardiovascular and psychiatric diseases
at adult age.74 The resulting disbalance between pro-inammatory AA-derived mediators, and
the anti-inammatory mediators from AA, EPA and DHA (1,100,101) may be an important factor
in the development of a state of chronic systemic low grade inammation, which is increasingly
acknowledged to be associated with many typically Western diseases.102 In view of the opposing
roles of ω6 and ω3 fatty acids (FA) in inammation, several authors100,103 suggested that an increased
dietary intake of ω3 FA is desirable to reduce disease susceptibility, secondary to the lowering of the
AA-status.
From the majority of intervention studies that aimed at increasing linoleic acid (LA), AA and DHA
intakes, it might be concluded that the relationship between ω3 and ω6 FA is mainly characterized
by antagonism. However, both synergistic (positive slope) and antagonistic (negative slope)
relationships between ω3 and ω6 FA have been reported in observational and ω3 FA intervention
studies70,104-111 We hypothesized that synergism between LCPω3 and LCPω6 occurs at low LCPω3
status, whereas antagonism occurs at high LCPω3 status.
Testing the suggested bell-shaped relationship between LCPω3 and LCPω6 in a cross sectional
study design requires data from populations with a wide range of notably LCPω3 status. For this
we composed erythrocyte (RBC) and umbilical vessel FA datasets from the various studies that we
performed during the past years in many countries. The subjects were of dierent ages, had typically
Western diets (van Goor, unpublished) or traditional East-African lifestyles36,37 and were either well-
or malnourished.111,112 The dataset also contained information from supplementation studies.19,20 In
this dataset we investigated the relationship between the omega-3 index (i.e. the sum of EPA and
DHA) as a marker of LCPω3 status113,114 and the AA contents in RBC, and in umbilical veins (UV) and
arteries (UA). The RBC-FA composition is a reliable reection of dietary FA intakes68 and umbilical
vessel FA are known to be responsive to the maternal LCPω3 status.115,116
SUBJECTS AND METHODS
Subjects
We included subjects from Tanzania,36,37 The Netherlands,19,20,117-119,55 Pakistan,111 Israel112 and
Curaçao.115 The subjects were infants at various ages, pregnant women, mothers at delivery, mothers
at 3 months postpartum, and apparently healthy males and females. The participants consumed
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either a mixed diet, sh diet, or a diet that consisted of mainly milk and meat (Maasai). Some of them
were supplemented with LCP.19,20,115 The dataset consisted of 1,979 RBC samples, 785 UV and 789 UA.
The ages of the subjects, their geographical location, their study numbers and a very summarily
description of the diets and supplements are shown in Tables 1-3.
Sample collection and analyses
EDTA-anticoagulated venous blood was collected from infants and adults. EDTA-anticoagulated
cord blood was collected at delivery. The samples were stored at 4 C in the dark and processed
within 2 h after collection. RBC were isolated by centrifugation and washed three times with 0.9%
NaCl. After washing, 200 µl of the washed RBC suspension was transferred to a te"on-sealable
Sovirel tube containing 2 mL of methanol-6 mol/L HCl (5:1 v/v), 1 mg butylated hydroxytoluene
(antioxidant) and 50 μg 17:0..
Umbilical cords were collected immediately after delivery. A sample of about 3 cm of the
umbilical cord, located at the proximal site to the placenta, was taken and stored in saline at 4 °C until
further processing. One umbilical artery and the vein were dissected from the surrounding tissue.
Approximately 1 cm of tissue was collected and stored in a te"on-sealable Sovirel tube containing 2
mL of methanol-6 mol/L HCl (5:1 v/v) 1 mg butylated hydroxytoluene (antioxidant) and 50 μg 17:0.
All samples were transported to University Medical Center Groningen (The Netherlands) for fatty
acid analysis by capillary gas chromatography/"ame ionization detection according to previously
described procedures.28 Fatty acid compositions and their ratios were expressed in g% and g/g,
respectively.
Data analysis and statistics
Statistical analyses were performed with PASW version 18.0 (SPSS Inc, Chicago,IL). We subdivided the
RBC EPA+DHA data in parts of 1 g% to construct a bar diagram. Group di'erences were studied with
the aid of the Kruskal-Wallis test (non-parametric) since the FA data were not normally distributed.
Between-group di'erences were tested with the Mann Whitney U-test at p<0.05. We constructed
scatter plots and determined the best tting function. The coe*cient of determination (R2) was
used to estimate the extent to which a given variable was explained by another. Corrections were
made for type-1 errors (i.e. Bonferroni correction).
RESULTS
Figure 1A shows the bell-shaped relationship between the omega-3 index and AA in RBC,
suggesting a synergistic relationship at low omega-3 status, no relation at intermediate status and
an antagonistic relation at a high omega-3 index. Excluding data of supplementation studies did
not a'ect the bell-shape of the curve (data not shown). The synergistic part occurred at an omega-3
index below 2 g% and the antagonistic part occurred beyond 8 g%. Statistical analysis conrmed
lower RBC-AA at both low and high RBC-EPA+DHA contents, since the RBC-AA of subjects with an
omega-3 index of 2-8 g% was signicantly di'erent from the RBC-AA of subjects with an omega-3
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Table 3: Supplement characteristics
Supplement fatty acid dose/day
MUM 1 LA 535 mg
2x placebo ALA 60 mg
AA 0.6 mg
MUM 2 LA 274 mg
placebo + ALA 32 mg
DHA AA 15 mg
EPA 36 mg
DHA 218 mg
MUM 3 LA 46 mg




Frisomum LCPω3 528 mg
EPA 293 mg
DHA 185 mg
Fish oil-1 LCPω3 336 mg
EPA 177 mg
DHA 123 mg
Fish oil-3 LCPω3 1008 mg
EPA 531 mg
DHA 369 mg
LCP 1 GLA 0.31 mol%
LCPω3 0.38 mol %
LCP 2 GLA 0.32 mol%
LCPω3 0.80 mol%
index below 2 g% and subjects with an omega-3 index
above 8 g% (both p<0.001).
In Figure 1B we applied the above mentioned cut-o!
levels. We observed a positive relationship with RBC-AA at
an omega-3 index below 2 g% (y = 7.16x + 0.39; R2=0.59,
p<0.001), no relationship at intermediate omega-3 status
(R2<0.001, p=0.78), and a negative relationship at an
omega-3 index above 8 g% (y = -0.48x + 17.17; R2=0.07,
p<0.001).
It was considered likely that the curve is composed
of many curves, that e.g. each re"ect the in"uence of
age or altered physiology (e.g. pregnancy) and may in
their own right correspond with di!erent EPA+DHA vs.
AA relationships. We therefore subsequently analysed
the relation between the omega-3 index and RBC-AA
in subgroups with su#cient numbers and a su#ciently
wide EPA+DHA range. The bell-shaped relation between
the omega-3 index and AA was also detectable in RBC
deriving from Palestinian, Dutch and Tanzanian infants
at 3-5 months postpartum (Figure 2A; y = 8.47 + 1.92x
+ 0.14x2; R2=0.22, p<0.001). We also found a bell-shaped
relation in RBC from Dutch, Curaçaon and Tanzanian,
women at delivery (Figure 2B; y = 11.40 + 0.41x - 0.04x2;
R2=0.11, p<0.001), though at a seemingly lower AA status.
Pakistani infants, who were either well- or malnourished
and breastfed or formula fed, and all exhibited a very
low ω3 status, showed a synergistic relation between the
omega-3 index and AA in RBC (Figure 2C).
We &nally investigated the relationships between the
EPA+DHA and AA contents in umbilical veins (Figure 3A)
and arteries (Figure 3B) of Dutch, Curaçaon and Tanzanian
infants.
Visual inspection revealed apparent synergism at low
EPA+DHA contents in UV, which was con&rmed by
signi&cantly higher AA in UV with EPA+DHA contents
ranging from 5.0-8.0 g% as compared to UV with EPA+DHA
contents below 5.0 g% (p<0.001). A trend to antagonism
could not be demonstrated. Also in UA, we observed a
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Figure 1A: Diagram representing the relationship between the omega-3 index and AA contents in
erythrocytes (RBC). Dierent lling patterns indicate signicantly dierent (p<0.001) RBC-AA contents. Fatty
acid data are in g/100 g (g%). Bars show mean +/- SEM, gures indicate numbers in subgroups. Subjects were
recruited in Tanzania, The Netherlands, Pakistan, Israel and Curaçao. The subjects were infants at various ages,
pregnant women, mothers at delivery, mothers at 3 months postpartum, and apparently healthy males and
females, supplemented and non-supplemented subjects.
bell-shaped curve, which was conrmed by signicantly higher AA in UV with EPA+DHA ranging
from 6.0-9.0 g% as compared to UV with EPA+DHA below 6.0 g% (p<0.001). The trend to a descent
at higher EPA+DHA status proved statistically insignicant.
DISCUSSION
In a unique dataset from subjects with a wide range of dietary LCP intakes and status, we
investigated the relationships between the omega-3 index as a marker of LCPω3 status and the
AA status in RBC, UV and UA. In all instances, the relationships between the omega-3 index and AA
seemed bell-shaped, suggesting that we are dealing with a general phenomenon. Synergistic and
antagonistic relationships between ω3 and ω6 FA have previously been reported.70,72,103-111,120-122 The
strength of this study is the collection of samples using a single procedure, and the employment of
a single gas chromatographic method for FA proling.28 A limitation might be the relatively poor
information on the dietary compositions and intakes of the investigated subjects. However, RBC-AA
and EPA+DHA are generally regarded as reliable parameters of their status68 that are e.g. responsive
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to augmentation of their dietary intakes in controlled intervention studies.72,122
Mechanistic background of the bell-shape
In this study we concentrated on the univariate relationships between the EPA+DHA and AA status.
Both the EPA+DHA and AA status might be in!uenced by synthesis from the parent precursors
alpha-linolenic acid (ALA) and LA, dietary AA, EPA and DHA intakes and the intake of other FA by
competition.42,58,72,123-125 However, when compared with dietary EPA and DHA, supplementation of
ALA hardly augments EPA and especially DHA status to a physiologically appreciable extent, even
in women.123 At high LA intakes, AA synthesis from LA increases,58 but this remains unnoticed in
RBC. On the contrary, dietary LA intake correlates inversely with AA and also with EPA and DHA, in
RBC-PL.42 Conversely, high AA intakes reduce LA in RBC.124 The LA vs. AA relation seems therefore
likely to be dominated by competition for incorporation, since at a daily intake of 15 g LA, AA
synthesis falls reciprocally from 677 to 326 mg/d when AA intakes are increased from 210 mg to
1.7 g/d.58,122 Analogously, an intake of 6.5 g DHA/d reduces the synthesis of LCPω3 from ALA and
also of the LCPω6 synthesized from LA,125 illustrating that the net e*ect of increased DHA or AA
intakes are the reduced syntheses of both LCPω3 and LCPω6 from their respective precursors by
negative feedback. The presently described bell-shaped relationship between AA and DHA may
result from many factors, including their synthesis from precursors, feed-back inhibition by LCP, and
competition for incorporation, both between AA and DHA and with other FA, notably LA. However,
at RBC-EPA+DHA > 8 g%, RBC-AA was not correlated with RBC-LA (Pearson correlation coe9cient
-0.052, p=0.66), which is likely to be explained by the presence of subjects with both high and low
LA status (:sh Tanzania and high :sh Tanzania respectively; Table 1). Thus, the complex LA vs. AA

























y= 7.16x + 0.39
R2=0.59 p<0.001
y= -0.01x + 13.47
R2<0.001 p=0.78
y= -0.48x + 17.17
R2=0.07 p<0.001
Figure 1B: Scatter plot representing the relationship between EPA+DHA and AA contents in erythrocytes
(RBC). Cut-o* levels are at RBC-EPA+DHA <2 g% for a synergistic relation and at RBC-EPA+DHA >8 g% for an
antagonistic relationship between RBC-EPA+DHA and RBC-AA. Fatty acid data are in g/100 g (g%). Note the
non-linearity of the x-axis.
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The observed bell-shaped curves for RBC were likely to be the result of many bell-shaped EPA+DHA
vs. AA curves, which may each be determined by specic aspects of the life cycle and notably by
their corresponding EFA and LCP status. We37 have previously shown that in dierent age groups,
the bell-shaped relation plateaus at dierent AA levels. For example newborns showed a higher AA-
plateau compared to their mothers and 3 months old infants. The higher RBC-AA in newborns may
at least in part be caused by their lower LA status as compared with adults, which changes rapidly
with the postnatal LA surge from the feeding of breast milk or infant formula.27 We feel that we are
nevertheless dealing with a general mechanism. In line with this notion we also found seemingly
bell shaped relationships between DHA+EPA and AA in UV and UA. Clear antagonism as observed
from an omega-3 index >8 g% in RBC was, however not observed, which is consistent with the
saturation of fetal DHA with increasing maternal DHA intake and status. We reported previously that
from a maternal RBC-DHA of 6 g% at birth the corresponding newborn RBC DHA is lower than that
of its mother, which we named bioattenuation, as opposed to the biomagnication at a maternal
RBC-DHA below 6 g%.36 We suggested that this bioattentuation prevented competition of DHA
with AA and thereby illustrates the importance of AA to the infant during pregnancy, while the
postnatal DHA surge via the milk illustrates the importance of postnatal DHA status. Taken together
this suggests that synergy is the standard prior to birth and that antagonism becomes important
after birth.
EPA+DHA vs. AA synergism
Synergism between LCPω3 and LCPω6 was found in three ALA and LCPω3 supplemented patients
with ω3 FA deciency by Bjerve et al.109 Payet et al.108 showed accretion of both DHA and AA in RBC
of elderly patients after consumption of DHA-enriched eggs. Synergism was also reported in a sh
oil-supplemented malnourished infant111 who, apart from an increase of RBC-DHA from 0.41 to 2.50
mol%, showed a remarkable simultaneous increase of RBC-AA from 4.04 to 13.83 mol%. Positive
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Figure 2: Scatter plot representing the relationship between EPA+DHA and AA contents in erythrocytes
(RBC) of (A) 3-5 months old infants, (B) women at delivery and (C) Pakistani infants. Fatty acid data are in
g/100 g (g%). TZ = Tanzania, NL = The Netherlands, ANT = Curaçao.
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relations between LCPω3 and LCPω6 were observed by Desci et al.106 in malnourished and HIV-
infected infants and by Innis et al.,110 who in non-supplemented young children reported a positive
relation between DHA and 22:5ω6, which is the chain elongation/desaturation product of AA. Taken
together, synergism seems to occur mainly in subjects with a discrepancy between LCPω3 need and
supply.
Some of the rst studies that might have shown the synergism between ω3 and ω6 FA reported
that symptoms of ω6 deciency in rats that had previously been consuming a fat-depleted diet,
could be restored with 20 mg LA/d and with 10 mg LA + 10 mg ALA/d,120 but also when only 0.5 en%
LA (in stead of the usual 2.0 en% to prevent deciency symptoms) was provided in the presence of
0.5 en% ALA.126 Horrobin et al.70 reported that at low intakes of EPA/sh oil, RBC membrane contents
of AA rise, whereas RBC-AA decreases at high EPA/sh oil intakes. The authors70 suggested that
optimum health may require raising both ω3 and ω6 FA at low status and it is therefore likely that
synergism/antagonism actually aims at a certain balance between ω3 and ω6 FA. The importance of
a certain balance also emerged from the U-shaped relation between the infant RBC-DHA/AA ratio
and the percentage of infants with mildly abnormal general movements.19
Tight regulation of the ω3/ω6 balance might have been indicated by the study of Kim et al.,127
who showed that 15 weeks of dietary ω6 FA deprivation in rats caused downregulation of AA
metabolism and upregulation of DHA metabolism in brain. Conversely, Rao et al.71 showed that a
low DHA status decreases DHA in rat frontal cortex and the expression of iPLA2, while increasing
cPLA2, sPLA2 and COX-2 expression. This combination causes DHA conservation and higher AA
metabolism to eicosanoids, seemingly in an attempt to preserve ω3/ω6 balance.
EPA+DHA vs. AA antagonism
A B





































Figure 3: Bar diagram representing the relationship between EPA+DHA and AA contents of A: umbilical veins
(UV) and B: umbilical arteries (UA). Di!erent lling patterns indicate signicantly di!erent (p<0.001) UV/UA-
AA contents. Fatty acid data are in g/100 g (g%). Bars show means +/- SEM, gures indicate numbers in
subgroups. Subjects were recruited in Tanzania, The Netherlands, and Curaçao.
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Many studies related a higher ω3/ω6 ratio to a decreased incidence of cardiovascular disease,
autoimmune disease and psychiatric disease. The common denominator in these ‘Western diseases’
is a state of low grade inammation.6,100 The diet in most Western countries is characterized by
low sh intake and a disturbed ω3/ω6 balance.6 Higher intake of DHA and EPA is likely to result in
incorporation of these FA into (inammatory) cell membrane phospholipids, at the expense of AA.
AA gives rise to eicosanoid mediators that have established roles in inammation.1 By both direct
action and by their competition with AA, LCPω3 are known to exert an anti-inammatory function,
while LCPω6 are predominantly known for their pro-inammatory function.103 More recently, it was
shown that the roles of LCPω3 and LCPω6 in inammatory processes are more complex.103 Some
actions of AA-derived eicosanoids are anti-inammatory while EPA derived eicosanoids may have
the same pro-inammatory potencies as AA derived eicosanoids. This may indicate that the complex
inammatory processes need a tight regulation that is sustained by an optimal ω3/ω6 balance.
In line with the above, the main goal of the many sh oil supplementation studies is to promote
health by improving LCPω3 status, decrease AA status and eventually to improve the ω3/ω6 balance.
In other words, most of them aimed at the antagonistic or competitive relationship between LCPω3
and AA. A study with patients with coronary artery disease105 showed an increase in DHA and
concurrent decrease in AA in plasma phospholipid (PL) after supplementation of 6 or 12 g ω3 FA/d
for 6 months. These results were conrmed in serum lipids of healthy volunteers by DeLany et al.107
in a 42 days supplementation study with 2 or 8 g LCPω3/d. EPA supplementation (1.35, 2.70 or 4.05
g/d for 12 weeks) of healthy young and older men by Rees et al.104 also resulted in opposite changes
in AA and EPA/DHA status in plasma phospholipids.
Optimal EPA+DHA vs. AA balance
The occurrence of a bell-shaped relation between LCPω3 and LCPω6 may reect an attempt to adjust
the AA status to the LCPω3 status. At very low LCPω3 status, AA seems suppressed to maintain the
delicate balance between LCPω3 and LCPω6, whereas at very high DHA status, a second stage of AA
suppression occurs. In view of many Western diseases, an omega-3 index at the antagonistic side of
the curve, i.e. above 8 g% seems desirable. In healthy Japanese,62 it was shown that an RBC-DHA of
>7 g% (i.e. RBC-EPA+DHA ≥8 g%), was associated with the lowest risk of depressive disorders and
bipolar depression. Protection from cardiovascular disease occurred from an omega-3 index of 8
g%.60,61 In line with this, Kuipers et al.37 calculated that RBC-DHA contents above 8 g% were su#cient
to support a stable high maternal DHA status and an increasing infant DHA status during lactation.
There is substantial evidence that our genome evolved during millions of years of evolutionary
adaptations in an East-African water-land ecosystem.7,23-26 Homo sapiens might have left Africa
via the shorelines128 and lived in close vicinity of (fresh) water as a hunter-gatherer until at least
10,000 years ago.129 The reconstruction of several possible hunter-gatherer diets in the water-land
ecosystem revealed that daily intakes of DHA, EPA and AA are likely to have reached gram amounts.7
These intakes are much higher than the recommended 450 mg DHA/d that produced benecially
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eects on cardiovascular disease in randomized controlled trials59 and are certainly higher than
the current daily intakes of about 200 mg AA and 275 mg DHA (for men) from a typically (French)
Western diet.8 The high intakes of EPA+DHA by our ancient ancestors, are in line with an outcome of
the omega-3 index in the highest range,61,94,114,130 and thereby supports a stable maternal DHA status
during pregnancy and lactation and a rapidly increasing postpartum infant DHA status that reaches
adult levels within 3 months.37
CONCLUSION
In conclusion, both synergism and antagonism between EPA+DHA and AA were observed in humans.
Both may aim at a certain LCPω3/LCPω6 balance to maintain homeostasis. Synergism seems to be a
feature of low LCPω3 status that in practice relates mostly to the fetus and LCPω3 de"ciency states.
However, from an evolutionary point of view and in line with the highest protection from psychiatric
and cardiovascular disease, an antagonistic relation between EPA+DHA and AA is likely to be the
physiological standard for adults. There is good evidence that the lowest risk of typically Western
diseases of the heart and the brain occur from RBC- EPA+DHA contents above 8 g%.37,60-62,114
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Introduction. There are no data on the intrauterine fatty acid (FA) compositions of brain, liver and
adipose tissue of infants born to women with high sh intakes.
Subjects and Methods. We analyzed the brain (n=18), liver (n=14) and adipose tissue (n=11) FA
compositions of 20 stillborn infants with di!erent gestational ages (range 8-38 weeks) born to
Tanzanian women with low linoleic acid (LA) intakes and high intakes of docosahexaenoic (DHA)
and arachidonic (AA) acids from local sh.
Results and discussion. With advancing gestation, brain saturated-FA (SAFA; in g/100 g FA),
polyunsaturated-FA (PUFA), DHA, 20:3 6, 22:4 6 and 22:5 6 increased, while monounsaturated-
FA (MUFA), 20:3 9, 22:3 9 and AA decreased. Decreasing brain AA might be caused by increasing
AA-metabolism to 20:3 6, 22:4 6 and 22:5 6. In the liver, SAFA, PUFA and LA increased, while
MUFA decreased with gestation. The steep increase of (mostly de novo synthesized) SAFA in adipose
tissue coincided with relative decreases of MUFA, PUFA, DHA, LA and AA with advancing gestation.
Compared to Western infants, the currently studied African infants had higher DHA, lower AA, and a
higher DHA/AA-ratio in brain and adipose tissue, while the LA content of adipose tissue was lower.
Conclusion. The low LA and high DHA and AA intakes by the mothers of these infants might support
optimal!-linolenic (ALA) vs. LA competition for ∆5D and ∆6D-activities and DHA vs. AA antagonism.
Conversely, the Western diet, characterized by high LA and lower DHA and AA intakes, might disturb
these evolutionary conserved mechanisms aiming at an optimal  3/ 6-balance.
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INTRODUCTION
Low intakes of the long-chain polyunsaturated (LCP) fatty acids (FA) arachidonic (AA) and
docosahexaenoic (DHA) acids have been implicated in suboptimal infant growth, visual maturity
and cognitive development.1 From early gestation till term, the infant’s brain weight increases from
20 to 378 g. At the same time, the lipid content of brain increases from 0.2 to 9.8 g at term, while
the brain LCP content increases concomitantly.2,3 Lipids account for 10% of adult wet brain weight,
which corresponds to about 50% of dry matter.4 These lipids are composed of glycerophospholipids
(e.g. phosphatidylethanolamine, PE; and phosphatidycholine, PC) that are abundant in grey matter,
and of sphingolipids (e.g. cerebrosides) which are notably located in white matter.4
During pregnancy, the fetus accretes substantial amounts of AA and DHA, which become selectively
transported across the placenta by a process known as biomagnication.5,6 Fetal tissues have the
capacity to synthesize AA and to a lesser extent DHA7 from their respective precursors; the essential
FA (EFA)  -linolenic (ALA) and linoleic (LA) acids. The placenta, in contrast, is not considered to
synthesize LCP.7 Consequently, the fetal LCP status during pregnancy relates to the availability of EFA
and LCP from the maternal diet and stores. Due to the small range of the maternal LCP status within
Western countries, there are no studies that relate the maternal LCP status to the infant brain LCP
contents at delivery or shortly thereafter. Postnatal studies indicated that infant tissue LCP contents
are sensitive to dietary supply, since breastfed infants have higher levels of DHA in their brain, liver
and adipose tissue compared to counterparts receiving formula or total parenteral nutrition devoid
of LCP.8-12 The higher LA content of infant formula, in turn, related to higher LA in brain,8,9 liver8 and
adipose tissue.10 The brain AA contents proved less sensitive to dietary deprivation and tended to
increase in infants receiving formula or total parenteral nutrition without preformed DHA and AA,8,9
although the liver8,11 and adipose tissue10 AA contents in these infants tended to be lower compared
to controls receiving human milk.
Several studies9,12,13 suggest that the infant’s capacity to synthesize LCP from precursor is insu!cient
to reach brain DHA levels comparable to levels encountered in breastfed infants. However, the
reference, i.e. Western human milk, in these studies might be questioned, since the current
Western diet is relatively low in notably LCP!3 and high in LA, compared to our early ancestors’
diet.14 Moreover, the intake of LCP!3 by many Western populations does not comply with the
recommendations that currently range from 250-450 mg/day,15 which results in DHA-levels in
Western human milk that are usually in the 0.3-0.4 g% range.16,17 Consequently most Western infants
develop in marginal intrauterine and postnatal LCP!3 environments with potentially adverse
e"ects on brain development, although the latter proved di!cult to attest in randomized controlled
trials.18-20 Also, there are no data that allow for comparison of fetal tissues of infants born to women
with a low as compared to a high LCP status. It was recently shown, however, that baboons, fed with
formula with much higher DHA (i.e. 1.00 g%) than the current milk of Western mothers, reached
higher DHA levels in many organs and central nervous system regions, compared to controls that
were fed with 0.33 g% DHA or no LCP from term birth to 12 weeks postpartum.21 A similar experiment
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in rhesus monkeys showed that a formula with 1% DHA and 1% AA caused earlier visual and motor
abilities, compared to a formula with virtually no LCP.22 Whether human infants from mothers with
a milk DHA status of 1 g% give birth to infants with higher brain DHA levels may be expected, but is
currently unknown, while no randomized controlled trials have focused on the neurodevelopmental
aspects of such a high maternal DHA status during pregnancy, although one trial23 has investigated
the benets of supplementing milk DHA levels around 1 g% on infant postnatal development.
During intrauterine development, the LCP become distributed among the various fetal organs. At
term, the infant’s brain contains the highest relative amounts of LCP,3,9,13,24 but in an absolute sense
most AA is located in the infants’adipose tissue (44%) and skeletal muscle (40%), with a third position
for brain (11%), while DHA is notably in adipose tissue (50%) with second and third positions for
brain (23%) and skeletal muscle (21%), respectively.25 It has been suggested that at least part of
the LCP in the infant’s liver and adipose tissue can be mobilized and thereby have functions in
postdelivery development.26 This suggestion underscores the importance of an adequate maternal
LCP status to support transplacental transport of polyunsaturated FA for both brain development
and the development of infant LCP stores, as well as su!cient maternal LCP stores to support the
subsequent postdelivery increase in infant DHA status, the predominant part of the fetal brain
growth spurt and the continuing accretion of LCP in fetal storage organs. Finally, a high maternal LA
status, such as typically observed in Western women with high intakes of vegetable oils, in"uences
the  3/ 6-balance by its inhibitory e#ect on ALA desaturation and elongation and by competition
with LCP at the level of incorporation.27 Taken together, we hypothesize that the high LCP and low
LA intakes of African women with high sh consumption result in higher LCP and lower LA contents
in fetal brain and storage organs, compared to infants born to Western women with low LCP and
high LA status.
In the present study we studied the brain, liver and adipose tissue FA compositions in Tanzanian
infants of various gestational ages who were stillborn to mothers with lifetime low intakes of LA
from vegetable oils and very high intakes of both AA and DHA from the abundantly available local
freshwater sh,28 leading to mature milk DHA levels of about 0.63 g%.29 The data were compared with
the brain, liver and adipose tissue FA compositions of previously studied Western infants.9-11,13,30 We
were notably interested to link the outcome with our observation that at 10-20 weeks postpartum
infants born to women from the same study area on the shores of Lake Victoria around Sengerema
exhibited a more benecial motor development than Dutch and other Tanzanian children with
much lower sh intakes, which was explained by their higher DHA status after multivariate analysis.31
SUBJECTS AND METHODS
Data collection
Postmortem brain (n=18; gestational age (GA) 8-38 weeks), liver (n=14; GA 8-35) and adipose tissue
(n=11; GA 19-38) samples were collected from 20 stillborn African fetuses and infants who were
studied during a perinatal health project performed on the shorelines of Lake Victoria in Tanzania
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in Sengerema Hospital. All infants were born to women with regular (average 4-5 times/week) sh
intakes from the nearby lake.28 Cases with any kind of neonatal problem that could aect cerebral
integrity were excluded. Causes of death were obstructed labor or cord prolapse during delivery
or premature death within 6 h after delivery due to immaturity, respiratory disease or infection.
One premature infant died 1 day after delivery and had received a small amount of milk from its
mother (infant no. 18); all others had received no oral or intravenous feeding after delivery. Since
no ultrasound was available, gestational ages were approximated with aid of the measured body
weight, crown-rump length (CRL) and head circumference (HC). Outcomes were compared with a
reference database for these parameters in Australian infants,32 since no such data were available
for African infants. The study was approved by the National Institute for Medical Research in Dar-
es-Salaam, Tanzania (NIMR/HQIR.8a/Vol. IX/145, dated June 16, 2003 and NIMR/HQ/R.8a/Vol. IX/800,
dated April 8, 2009) and was in agreement with the Helsinki declaration of 1975 as revised in 2000.
Women who had miscarriages or delivered stillborn infants were asked permission to collect
small (0.5-2 cm3) samples of adipose tissue, liver and brain from their babies by needle biopsy. All
included data derive from infants of whom their mothers gave informed consent. Samples were
collected with 1 h after delivery and the locations of the biopsies were carefully sutured. After
sampling, infants were returned to the mother. Adipose tissue samples were collected from the
lower abdominal wall or the buttocks. Liver and brain samples were collected by direct biopsy from
either the lower right abdominal wall or through the anterior fontanel. Brain samples were obtained
by a 6 mm diameter specially designed cannula that could contain about 2 ml of brain, composed
of a combination of grey and white matter.
Fatty acid analysis
Directly after biopsy, samples were transferred into a te!on-sealable Sovirel tube containing 2 mL of
methanol/6 mol/L HCl (5:1 v/v), 1 mg butylated hydroxytoluene (antioxidant) and 50 μg of 17:0 as
an internal standard.33 All samples were transported at room temperature to the University Medical
Center Groningen (The Netherlands) for FA analysis. Analyses of FA methyl esters were performed
by capillary gas chromatography/!ame ionization detection according to previously described
procedures.33 FA compositions were expressed in g%.
Statistics
Statistical analyses were performed with PSAW version 18.0 (SPSS Inc, Chicago, IL). Correlations
were investigated using Spearman’s rho for non-parametric regression. Plots of linear and curvilinear





Infant anthropometrics are shown in Table 1. Gestational ages derived from the infants’weight. The
crown-rump length (CRL) and head circumference (HC) di!ered 3 weeks at most, but no more than
1 week in the majority (69%) of cases.
Table 1. Infant characteristics and estimated gestational age
Sexe Sexe Weight CRL HC BPD GA Samples collected
male=1 male=1 g cm cm cm weeks brain liver adipose
Infant 1 ? ? <100 4 8 + + -
Infant 2 1 1 <100 8 12 + + -
Infant 3 1 1 <100 8 13 + + -
Infant 4 ? ? 100 12 4 16 + + -
Infant 5 2 2 200 15 17 + + -
Infant 6 2 2 200 15 4 18 + + -
Infant 7 1 1 300 15 19 + + -
Infant 8 2 2 250 17 19 + + +
Infant 9 1 1 400 17 18 5 21 + - -
Infant 10 2 2 400 19 21 + + +
Infant 11 2 2 450 19 17 5 21 + + -
Infant 12 1 1 600 21 23 + + +
Infant 13 2 2 700 21 7 24 + + +
Infant 14 2 2 800 21 24 7 25 + - +
Infant 15 2 2 - 24 26 - + +
Infant 16 2 2 750 24 25 7 26 + - +
Infant 17 1 1 2200 30 30 8 34 + - +
Infant 18 1 1 2200 31 32 35 + + +
Infant 19 2 2 2600 32 33 8 37 + - +
Infant 20 1 1 3100 33 33 9 38 - - +
Abbreviations: CRL, crown rump length; HC, head circumference; BPD, biparietal diameter; GA, gestational age.
The +/-, indicates whether (+) or not (-) a sample was collected
Brain, liver and adipose tissue FA composition during gestation
Data on the brain, liver and adipose tissue compositions (median and ranges) of the infants are
shown in Tables 2-4 and Figures 1-3. Although we performed a cross sectional study, several FA
suggested signi#cant changes with time.
Brain FA composition during gestation
In brain, the saturated 14:0 and 22:0 showed decreases with advancing gestation, but the net
increase of 18:0 resulted in a net increase of saturated FA (SAFA) with length of gestation. Most
individual monounsaturated FA (MUFA) and the sum of MUFA, except for 16:1 7, decreased with
length of gestation (Table 2; Figure 1A). Polyunsaturated FA (PUFA) (Figure 1A), including DHA
(Figure 1B), 20:3 6, 22:4 6 and 22:5 6 (Figure 1C), increased with advancing gestation, but AA,
20:3 9 and 22:3 9 all decreased (Figure 1B and 1D), while LA, which showed no change (Figure 1B).
Using the equations of Figure 1, we found that the LA content of brain remained constant at
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Table 2. Brain tissue total lipid fatty acid composition
n = 6 n = 9 n = 3
Gestational age 14(8-18) wks 22(19-26) wks 35(34-37) wks Spearman
14:0 2.22(1.88-3.09) 2.18(1.72-2.71) 1.58(1.53-1.87) -0.590
16:0 30.4(28.5-31.0) 30.4(29.0-31.3) 30.1(26.8-31.8)
18:0 18.5(14.6-19.3) 19.2(18.3-21.0) 20.9(18.4-22.3) 0.660
20:0 0.17(0.13-0.24) 0.15(0.13-0.19) 0.18(0.16-0.19)
22:0 0.10(0.06-0.12) 0.07(0.05-0.11) 0.06(0.05-0.08) -0.560
24:0 0.08(0.05-0.12) 0.06(0.03-0.18) 0.12(0.05-0.13)
SAFA 50.7(48.4-52.3) 52.2(51.2-54.7) 52.4(51.0-52.9) 0.520
16:1ω7 2.06(1.49-3.94) 1.69(1.16-2.26) 1.75(1.44-4.33)
18:1ω7 4.98(4.75-6.01) 4.65(3.76-5.08) 3.44(3.10-4.06) -0.913
Σω7 7.41(6.29-9.63) 6.40(5.30-6.84) 5.57(5.24-7.47) -0.645
18:1ω9 14.9(13.3-17.6) 14.0(12.4-14.5) 12.8(12.5-15.7) -0.469
20:1ω9 0.70(0.63-1.02) 0.62(0.58-0.74) 0.54(0.44-0.62) -0.722
20:3ω9 1.35(0.87-2.65) 0.92(0.77-1.37) 1.03(0.71-1.07) -0.628
22:3ω9 1.40(1.00-2.87) 0.99(0.73-1.13) 0.80(0.62-1.20) -0.724
24:1ω9 0.29(0.11-0.33) 0.18(0.15-0.30) 0.14(0.11-0.15) -0.517
Σω9 19.6(16.1-23.9) 16.6(15.2-17.5) 15.9(15.0-17.5) -0.620
MUFA 24.4(20.5-28.0) 20.9(18.9-22.3) 18.8(18.7-23.7) -0.654
18:3ω3 0.00(0.00-0.02) 0.00(0.00-0.02) 0.01(0.00-0.01)
20:5ω3 0.05(0.01-0.12) 0.05(0.02-0.10) 0.05(0.05-0.07)
22:5ω3 0.24(0.16-0.56) 0.26(0.15-0.39) 0.24(0.21-0.31)
22:6ω3 5.90(3.15-6.18) 6.78(5.21-7.59) 7.42(7.42-9.00) 0.832
ΣLCPω3 6.13(3.45-6.82) 7.08(5.40-7.95) 7.79(7.74-9.26) 0.817
Σω3 6.13(3.46-6.83) 7.08(5.41-7.96) 7.79(7.75-9.27) 0.817
18:2ω6 0.34(0.21-0.37) 0.34(0.26-0.75) 0.41(0.30-0.42)
20:3ω6 0.35(0.20-0.40) 0.57(0.36-0.77) 0.81(0.75-0.96) 0.895
20:4ω6 10.3(9.55-11.09) 10.1(9.10-10.6) 8.81(7.37-9.10) -0.480
22:4ω6 4.41(2.91-5.33) 4.62(3.86-4.93) 5.31(4.36-5.44) 0.550
22:5ω6 1.39(0.82-2.75) 2.38(1.77-2.95) 2.88(1.89-3.16) 0.527
ΣLCPω6 16.6(13.8-18.9) 17.4(16.4-18.5) 17.9(14.4-18.7)
Σω6 16.9(14.1-19.3) 18.0(16.7-18.7) 18.2(14.9-19.2)
LCPω3+LCPω6 22.4(17.7-25.0) 24.4(23.0-25.9) 25.6(22.1-28.0) 0.621
PUFA 25.6(23.6-27.2) 26.9(25.3-28.0) 28.3(23.9-30.3) 0.519
Abbreviations: wks, weeks; SAFA, saturated fatty acids (FA); MUFA, monounsaturated
FA; LCP, long-chain polyunsaturated FA (≥20); PUFA, polyunsaturated FA. Data are expressed as median (range)
about 0.3-0.4 g% throughout gestation, while brain AA decreased from 11.1 g% (calculated; not
shown) at 8 weeks to about 8.6 g% after 38 weeks and 8.4 g% after 40 weeks gestation (Table 5).
Brain DHA increased from 3.2 g% (calculated, not shown) at 8 weeks gestation to 8.2 g% at 38 weeks
and 8.4 g% at 40 weeks (Table 5).
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Liver FA composition during gestation
In the liver, SAFA increased signicantly, notably because of 18:0. MUFA decreased with length of
gestation, notably on account of 18:1 7 (Table 3; Figure 2A). Similarly, both Mead (20:3 9) and di-
Mead acid (22:3 9) decreased (Table 3), while PUFA, LA, 20:3 6 and 22:4 6 increased with advancing
gestation (Table 3; Figure 2A and 2B). These increases occurred regardless of the inclusion of the 35
weeks old infant who had received oral feeding. Conversely, after exclusion of the 35 weeks old
infant, DHA and AA showed no signicant changes during gestation (Figure 2A and 2B), although
AA decreased when the 35 weeks old infant was included (dotted line, p<0.001).
Liver LA increased from 0.72 g% at 8 weeks to 9.6 g% at 35 weeks gestation, while liver AA
showed no change from early gestation till about 27 weeks gestation (Figure 2). However, if the low
liver AA content of the 35 weeks infant with feeding was included into the calculation (Figure 2B),
AA decreased substantially from 13.6 g% at 8 weeks (calculated, not shown) to 7.2 g% at 35 weeks
Figure 1A-D. Apparent courses of selected fatty acids in the brain of Tanzanian infants as a function of gestation.
The infants were stillborn to mothers with lifetime low intakes of LA from vegetable oils and very high intakes
of both AA and DHA from abundantly available local freshwater sh. One child of 35 weeks was life born and
fed for 1-2 days. Data are in g/100g FA (g%) and weeks. Best ts were obtained by assuming linear, logarithmic,
exponential and inverse relationships. As functions of gestational age (g% and weeks): Brain SAFA = 0.094x +
49.68 (R2=0.27); MUFA = -0.196x + 26.00 (R2=0.39); PUFA = 0.102x + 24.32 (R2=0.23); DHA = 3.199ln(x) - 3.45
(R2=0,70); AA = -0.083x + 11.75 (R2=0.54); LA = 0.002x + 0.33 (R2=0.01); 22:4 6 = 0.061x + 3.40 (R2=0.30); 22:5 6
= 0.049x + 1.07 (R2=0.32); 20:3 6 = 0.023x + 0.024 (R2=0.81); Mead acid (20:3 !" = 8.206x-0.668 (R2=0.57); Di-Mead
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Fetal organ fatty acid compositions in Tanzanian infants born to women with high sh intakes
Table 3. Liver tissue total fatty acid composition
n = 6 n = 7 n = 1
Gestational age 14(8-18) wks 22(19-26) wks 35 wks Spearman
14:0 0.51(0.40-0.76) 0.48(0.36-0.59) 1.30
16:0 23.9(20.5-24.4) 24.8(23.3-27.5) 35.3
18:0 14.8(13.7-17.2) 16.8(16.1-18.2) 9.56 0.592
20:0 0.29(0.26-0.33) 0.38(0.32-0.42) 0.16 0.675
22:0 0.60(0.49-0.68) 0.70(0.66-1.03) 0.32 0.843
24:0 0.92(0.82-1.01) 0.97(0.83-1.30) 0.52
SAFA 40.7(38.4-43.5) 44.4(42.4-46.9) 47.2 0.700
16:1ω7 3.52(2.02-4.51) 2.17(1.47-2.90) 5.87
18:1ω7 5.61(4.17-6.58) 3.96(3.65-4.14) 3.40 -0.085
Σω7 9.22(6.25-10.9) 6.31(5.69-6.62) 9.29 -0.590
18:1ω9 18.8(16.5-25.5) 16.6(9.66-20.3) 19.3
20:1ω9 0.29(0.23-0.36) 0.27(0.10-0.38) 0.12
20:3ω9 1.47(1.04-3.89) 0.98(0.67-1.39) 0.24 -0.518
22:3ω9 0.20(0.15-0.45) 0.16(0.10-0.21) 0.00 -0.573
24:1ω9 1.66(1.41-2.05) 1.75(1.12-2.42) 0.33
Σω9 23.7(20.3-28.9) 20.0(12.4-23.4) 20.0 -0.501
MUFA 30.3(26.0-36.7) 25.2(17.5-28.4) 29.0 -0.658
18:3ω3 0.02(0.01-0.05) 0.04(0.02-0.07) 0.17
20:5ω3 0.37(0.08-1.34) 0.31(0.15-0.66) 0.12
22:5ω3 0.21(0.09-0.45) 0.23(0.12-0.38) 0.30
22:6ω3 4.68(3.73-6.59) 4.92(3.43-6.68) 4.59
ΣLCPω3 5.22(3.91-8.39) 5.44(3.72-7.63) 5.02
Σω3 5.24(3.94-8.44) 5.48(3.76-7.66) 5.19
18:2ω6 2.27(1.20-4.26) 5.13(3.61-5.75) 9.79 0.736
20:3ω6 1.19(0.84-1.46) 1.74(1.45-2.28) 0.75 0.793
20:4ω6 16.0(12.9-18.9) 16.9(14.9-17.9) 6.65
22:4ω6 0.56(0.40-0.89) 0.69(0.56-1.12) 0.36 0.559
22:5ω6 0.68(0.53-1.21) 0.60(0.42-0.92) 0.56
ΣLCPω6 18.7(15.4-21.5) 20.1(17.9-21.2) 8.47
Σω6 20.7(16.8-25.2) 25.0(22.3-26.4) 18.4
LCPω3+LCPω6 25.1(19.6-26.8) 25.4(21.6-28.7) 13.5
PUFA 30.0(23.9-30.5) 30.6(28.1-35.5) 23.8 0.642
Data are expressed as median (range). For abbreviations: seeTable 2. Due to the remarkable di!erences compared
to the younger infants, liver FA compositions from the 35 wks old infant were not included for regression analysis,
since th infant had received a small amount of milk of unknown origin from its mother shortly after delivery.
gestation (calculated, not shown). In this 35 weeks old infant the substantially lower liver AA (6.7
g%) was accompanied by higher 16:0, 16:1 7; 18:1 9 and LA, compared to the other infants, but




Adipose tissue FA composition during gestation
In adipose tissue, the net increase of 14:0 and 16:0 (Table 4) explained the net increase of SAFA
with length of gestation (Table 4, Figure 3A), despite the concurrent decreases of 22:0 and 24:0. The
substantial increase in adipose tissue SAFA towards the pregnancy end coincided with decreases of
MUFA, PUFA, DHA, LA and AA (Figures 3A-D) with advancing gestation.
We could not locate any adipose tissue in infants younger than 19 weeks. Using the equations
from Figure 3, we calculated that LA decreased from about 3.2 g% at 19 weeks gestation to 0.92
g% at 38 weeks, while AA decreased from about 3.9 g% at 19 weeks to 0.42 g% at 38 weeks. DHA
decreased from 3.8 g% at 19 weeks gestation to 0.43 g% at 38 weeks gestation (Table 7).
DISCUSSION
We measured the brain, liver and adipose tissue FA compositions of African infants who were stillborn
to mothers with lifetime low intakes of LA from vegetable oils and very high intakes of both AA and
DHA from abundantly available local freshwater !sh. Our data show that with increasing gestation
brain DHA increases, while AA decreases as a percentage of total FA in brain. In contrast to AA,
all other LCP 6 exhibited concurrent increases, while both 20:3 9 and 22:3 9 showed substantial
decreases from early gestation until term. In the fetal liver, we found no signi!cant changes of DHA
with length of gestation, but LA increased signi!cantly. AA remained constant from early gestation
until about 30 weeks, where after we measured one very low liver AA content in a single infant. In
adipose tissue, a signi!cant increase in SAFA coincided with net decreases of LA, AA and DHA with
advancing gestation.
Figure 2A-B. Apparent courses of selected fatty acids in the liver of Tanzanian infants as a function of gestation.
Insigni!cant relations according to Spearman’s rho are indicated by dotted lines. For further legend see Figure
1. As functions of gestational age (g% and weeks): Liver SAFA = 0.293x + 37.37 (R2=0.50); MUFA (35 weeks infant
included) = -0.282x + 32.79 (R2=0.15); MUFA (35 weeks infant excluded) = -0.62x + 38.51 (R2=0.40); PUFA (35
weeks infant included) = -0.025x2 + 1.093x+19.22 (R2=0.29); PUFA (35 weeks infant excluded) = 0.295x + 24.65
(R2=0.29); DHA = 0.008x + 4.65 (R2=0.002); LA = 0.299x - 1.72 (R2=0.80); AA (35 weeks infant included) = -0.032x2
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Table 4. Adipose tissue total fatty acid composition
n = 6 n = 5
Gestational age 23(19-26) 36(34-38) Spearman
14:0 2.62(2.05-3.57) 3.63(3.26-4.12) 0.797
16:0 34.9(31.1-42.6) 48.2(47.5-52.3) 0.980
18:0 3.80(3.21-8.79) 6.19(4.52-7.11)
20:0 0.06(0.04-0.19) 0.08(0.07-0.11)
22:0 0.05(0.02-0.26) 0.01(0.01-0.01) -0.961
24:0 0.10(0.03-0.45) 0.03(0.02-0.03) -0.961
SAFA 43.1(38.6-49.5) 58.2(56.7-62.3) 0.952
16:1ω7 12.0(6.91-16.2) 10.2(9.39-13.1)
18:1ω7 3.28(2.35-3.90) 1.71(1.45-2.37) -0.847
Σω7 15.6(10.9-18.6) 11.9(10.9-15.6)
18:1ω9 30.8(27.9-35.7) 25.3(23.1-28.8) -0.665
20:1ω9 0.20(0.08-0.39) 0.07(0.07-0.14) -0.861
20:3ω9 0.31(0.12-0.51) 0.09(0.07-0.14) -0.884
22:3ω9 0.05(0.00-0.17) 0.00(0.00-0.00) -0.847
24:1ω9 0.10(0.03-0.60) 0.01(0.01-0.02) -0.925
Σω9 31.3(28.6-36.3) 25.4(23.4-29.0) -0.838
MUFA 47.0(39.9-52.2) 38.8(35.8-39.7) -0.765
18:3ω3 0.06(0.02-0.13) 0.01(0.01-0.05) -0.765
20:5ω3 0.15(0.04-0.20) 0.03(0.02-0.04) -0.866
22:5ω3 0.21(0.06-0.35) 0.06(0.04-0.06) -0.829
22:6ω3 2.38(0.88-3.46) 0.49(0.42-0.54) -0.834
ΣLCPω3 2.72(0.98-4.02) 0.56(0.52-0.63) -0.834
Σω3 2.77(1.00-4.09) 0.59(0.53-0.64) -0.852
18:2ω6 2.48(1.03-4.52) 0.96(0.74-2.23) -0.765
20:3ω6 0.25(0.09-0.82) 0.07(0.05-0.10) -0.911
20:4ω6 2.23(0.82-6.17) 0.56(0.36-0.84) -0.888
22:4ω6 0.39(0.14-1.36) 0.11(0.07-0.18) -0.879
22:5ω6 0.32(0.17-0.68) 0.08(0.05-0.20) -0.879
ΣLCPω6 3.24(1.28-9.22) 0.84(0.58-1.40) -0.843
Σω6 5.88(2.38-13.9) 1.85(1.35-3.73) -0.888
LCPω3+LCPω6 6.14(2.26-11.6) 1.42(1.10-1.99) -0.943
PUFA 9.05(3.52-17.1) 2.53(1.97-4.50) -0.897
Data are expressed as median (range). For abbreviations: see Table 2.
Infant brain FA composition
Our data for the brain FA composition of African infants with duration of gestation (Figure 1) are in
line with earlier reports, showing an increase of DHA and a decrease of AA in infant brain PE with
advancing gestation.3,8 Unfortunately, direct comparison of the present data with most of these
earlier reports is virtually impossible, since these authors reported FA compositions of the separate
PL species in brain,3,8 while another di!erence is the separation of cerebral white and grey matter.24
Nevertheless, our present "ndings suggest that the net e!ect of the sometimes opposing courses of
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AA and DHA in the dierent PL species in white and grey matter24 results into a net increase of DHA
and net decrease of AA with advancing gestation, and that at term age brain DHA levels are equal
to those of AA (Figure 1B).
The increasing similarity of infant brain DHA and AA levels in a term infant supports, to a certain
extent, observations of others who studied the infant whole brain FA composition at term and
shortly after delivery in relation to the infants’diet.8,9,13 Although, to our knowledge no hard data were
published for the FA compositions (in g%) of the preterm or term infant brains prior to the initiation
of feeding, one of the several studies by Martinez30 provides data that allow for the calculation*
of the brain LCP composition of preterm (GA 26-36 weeks) and term (GA 37-42 weeks) Spanish
infants. Two additional studies provide data on the FA composition of the infant brain in relation to
breast or formula feeding at several weeks postpartum.9,13 Data of these studies and the present are
presented in Table 5. A comparison suggests that the presently calculated brain contents of 8.2 g%
DHA at 38 weeks GA in these African infants is higher compared to that of Spanish stillborn preterm
infants (GA 26-36 weeks, 7.3 g% DHA) and stillborn term infants (GA 37-42 weeks, 7.8 g% DHA).
* Using a molecular weight (MW) of 292 mol/g for total FA and MWs of 326, 304, 332 and 328 for DHA, AA,
22:4 6 and 22:5 6, respectively.
Figure 3A-D. Apparent courses of selected fatty acids in adipose tissue (AT) of Tanzanian infants as a function of
gestation. For further legend see Figure 1. As functions of gestational age (g% and weeks): Adipose tissue: SAFA
= 1.003x + 22.24 (R2=0.81); MUFA = 0.012x3 - 1.068x2 + 31.237x - 249.13 (R2=0.62); PUFA = 73138x-2.867 (R2=0.84); LA



















































































































































































































































































































































































































































































































































































































































































































































































































































Since brain DHA is known to increase
rapidly after birth,3,8 it is inappropriate to
compare with postnatal data. However,
whole brain DHA in the term stillborn
African infants seems higher compared
to the cortex white and grey matter DHA
content of formula fed infants (6.6-7.6
g% DHA).9,13
In contrast, brain AA, 22:4 6 and
22:5 6 seem lower in the African infants
compared to Western counterparts
(Table 5). The presently found brain
content of 8.6-8.4 g% AA at term age in
our African infants is lower compared
to the 9.2 g% AA in the Spanish term
infants,30 while despite the postpartum
decrease in brain AA, the older English9
and Australian13 infants had even
higher brain AA contents (breastfed
10.6-10.9; formula-fed 11.2-12.9 g% AA)
between 9-23 weeks postpartum. A
similar picture emerged for 22:4 6 and
22:5 6. Consequently the DHA/AA ratio
in the African infant at term age (0.95-
1.0 g/g) was higher compared to that
of breastfed and formula fed Western
infants (0.52-0.92 g/g).
The rate of LCP synthesis in the
adult vertebrate brain is insigni!cant.34
However, no such data are, as yet,
available for the human fetal brain.34
Stable isotope studies showed that
although ALA becomes primarily
recovered as 22:5 3 and DHA in the
neonatal baboon brain, dietary DHA is
7 times more e"ective than dietary ALA
as a source for brain DHA accretion.35















































































































































































































































































































































































































































































































































































































































































































50% of brain AA derives from dietary LA, while about 20% of brain 22:4 6 and 10% of 22:5 6 derive
from dietary LA.35,36 Taken together, it is assumed that LCP in the mammalian fetal brain derive
either directly from the maternal circulation or from desaturation/elongation of ALA and LA in the
fetal liver. With regard to the latter, it is was shown that in adult rats fed an  3PUFA diet devoid of
DHA, liver synthesis of DHA proved su!cient to maintain brain DHA levels.34 Subsequent studies
with LCP21,36,37 and PUFA deprived diets suggested that the contents of both DHA and AA in the
central nervous system are strictly regulated, but sensitive to dietary intakes. That is,  3-PUFA
deprived diets reduce DHA-turnover, while reciprocally increasing AA-metabolism38 and promoting
accumulation of 22:5 6 in brain,34 while  6-PUFA deprived diets downregulate AA turnover39 and
upregulate DHA-metabolism.39 In summary, the vertebrate brain has limited capacity to synthesize
LCP from precursors, LCP from the circulation are rapidly taken up into the fetal brain, and multiple
mechanisms support a certain equilibrium between LCP from the  3- and  6-series in brain tissue.
In contrast to the above studies that describe observations made under severe LCP deprivation, the
current results suggest that a high intake of "sh increases fetal brain DHA and reduces brain AA,
perhaps because LA metabolism becomes more directed at 20:3 6, while AA becomes converted to
its longer-chain storage forms, notably 22:4 6 (Figure 1C).36 It might in this respect be of importance
to note that 20:3 6 is the precursor of the series-1 prostaglandins, suggesting that major, dietary-
induced, changes might occur in the functional balance between the highly active metabolites of
20:3 6, AA, EPA and DHA40,41 with as yet unknown consequences.
These combined observations support the existence of a bell-shaped relation between DHA and
AA that is synergistic at low and antagonistic at high DHA or AA status.42,43 Moreover, at high intakes
of both AA and DHA, the brain AA content seems secondary to the available DHA for incorporation.
A similar DHA vs. AA competition was previously noted in other compartments, notably erythrocytes
and umbilical vessel walls.43 At low DHA status and insu!cient dietary ALA, brain AA levels become
Table 6. Liver DHA, LA and AA composition and the DHA/AA ratio in the current study and the literature
Kuipers Martineza Farquharsonb
liver liver liver
very preterm preterm preterm preterm term term term
8-18 wks 19-26 wks 35 wks 25-30 wks full term 1 wk PP 10 wk PP
stillborn stillborn stillborn stillborn stillborn calculated calculated
no feeding no feeding milk fed no feeding no feeding breastfed breastfed
n=6 n=7 n=1 n=2 n=3 n=7 n=7
DHA 4.7 4.9 4.6 3.7 4.1 5.8 3.7
LA 2.3 5.1 9.8 6.3 7.9 - -
AA 16.0 16.9 6.7 12.8 8.6 8.4 6.1
DHA/AA 0.29 0.29 0.69 0.29 0.48 0.69 0.61
Abbreviations: DHA, docosahexaenoic acid; LA, linoleic acid; AA, arachidonic acid; wks, weeks. Data are presented
as means (g/100 g fatty acids (g%); and g/g fatty acids). a, Adapted from Martinez30;
b, Calculated from the equations in Farquharson et al.11; which are based on a trendline "ted to a total of 7
sampled infants ranging from 1 to 22 weeks postpartum.
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reduced, while increasing amounts of AA
become deposited as 22:4 6 and 22:5 6;34,38
while at low AA levels and insu!cient dietary
LA, brain DHA levels are reduced39 by some
other mechanism since the amounts of 20:5 3
and 22:5 3 in brain remain low.35 On the other
hand, our results now indicate that at high
intakes of both DHA and AA, increasing brain
DHA levels result in a decrease of brain AA,
while increasing amounts of  6PUFA become
deposited as 20:3 6, 22:4 6 and 22:5 6
(Figure 2C), but 20:5 3 and 22:5 3 again
remain low and virtually unchanged. The
concomitant decreases of 20:3 9 and 22:3 9
with advancing gestation (Figure 2D) suggest
dilution by SAFA, MUFA and PUFA rather
than a decreasing desaturation/elongation
activity per se. More importantly, however, the
nevertheless increasing relative brain DHA
content supports the notion that dietary DHA
is much more e"ective than its precursors as
a source for brain DHA accretion.35 Finally,
high intakes of LA, although sometimes
recommended,44 might interfere with the
desaturation/elongation of ALA, 20:5 3 and
22:5 3 to DHA.27 As such, the high dietary
intakes of LA in Western countries might not
only directly increase the brain AA content
(secondary to the conversion of LA to AA in
the liver and the subsequent uptake of AA
in the brain from the circulation), but high
LA levels also increasingly compete with ALA
for desaturation, resulting in lowers levels of
circulating DHA that are made available for
uptake in the brain.
Taken together, we found an increase in
brain PUFA, DHA, 20:3 6, 22:4 6 and 22:5 6
(and SAFA) at the expense of AA and MUFA
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with advancing gestation. The African infants near lake Victoria had higher DHA and lower AA in
brain than Western counterparts, which clearly relates to the lifetime high intake of DHA-rich, but
also AA-rich, sh by their mothers. We recently found that the high erythrocyte DHA status of 10-
20 weeks old infants living in the same geographical area is related to slightly more optimal motor
development.31 Although erythrocyte and brain DHA contents are intimately related,45 the current
study provides more direct evidence that the observed more benecial motor development in
these infants is indeed associated with higher amounts of DHA in their brains, such as in regions like
the sulcus precentralis,21,37 that is involved in motor coordination and integration of visual signals,
among others.
Infant liver FA composition
In contrast to the constancy of liver DHA in our infants with advancing gestation (Figure 2), Martinez
and Ballabriga8 showed increases in DHA in PE and PC. Recalculation1 of their other data30 also
revealed that as a percentage of total FA, liver DHA increased from 3.7 g% to 4.1 g% between
25-30 weeks gestation and full term age (Table 6). Recalculation** of the data from Farquharson
et al.11 shows that from 1 to 10 weeks postpartum, liver DHA decreased from 5.8 g% to 3.7 g% in
breastfed infants (Table 6). Thus, compared to Western counterparts, our African infants seem to
have somewhat higher liver DHA throughout pregnancy (4.6 g%; Table 6). Further comparison of
the liver DHA content at term or postpartum seems inappropriate, since we as well as Farquharson
et al.11 included only a single infant at 35 weeks and 1 week postpartum, respectively.
Similar to liver DHA, we observed no signicant changes in liver AA in early (<30 weeks) gestation
(16.0-16.9 g%), while Martinez and Ballabriga8 showed decreases of AA in liver PE and PC from early
pregnancy (20-25 weeks) until term age (>36 weeks). Recalculation of their data for total FA showed
that AA decreased from 12.8 g% to 8.6 g% (Table 6) between 25-30 weeks gestation and full term
age. Similarly, Farquharson11 showed that total hepatic AA decreased from 8.4 to 6.1 g% between
delivery and 10 weeks postpartum (Table 6). Thus, the liver AA content of the (preterm) African
infants upto about 30 weeks gestation seems considerably higher compared to those reported for
Western infants.8,11 Conversely, the infant who was born after 35 weeks gestation and who was fed
for 1-2 days before death had a remarkably lower liver AA content (Figure 2) that was accompanied
by a much higher LA content, suggesting that the milk that was fed increased LA and reduced AA in
the liver. The postpartum increase in infant LA status, is indeed supported by the bioattenuation of
LA during pregnancy, in contrast to the postpartum LA surge via the milk.46
Infant adipose tissue FA composition
Our data for the adipose tissue FA composition of African infants (Figure 3) are in line with earlier
data from Farquharson10 and our earlier report on adipose tissue of infants born to African-
Caribbean mothers living in the island of Curaçao47 (Table 7). With advancing gestation the adipose
** Calculated from the amount of DHA and AA in g/kg liver, using a liver lipid content of 50.3 g lipid/kg liver
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tissue FA composition exhibits dramatic decreases of both PUFA and LCP. This occurs secondary to
the increases of MUFA, and notably SAFA, giving rise to a dilution of PUFA, and eventually also of
MUFA by the de novo synthesized SAFA. For instance, the adipose tissue AA content of the African
infants decreased from a maximum of 6.2 g% at 19 weeks to a minimum of 0.36 g% at 40 weeks
gestation. These data support our earlier !nding that the extremely high AA (7.6 g%) and DHA (1.63
g%) contents as reported for infant adipose tissue at 22-43 weeks48 overestimate the actual adipose
tissue LCP contents. These erroneous data, however, have been frequently used as a reference for
term adipose tissue.7,49-51
Comparison of the African fetal adipose tissue FA contents with those of Western counterparts
revealed that term African infants have comparable or slightly higher adipose tissue DHA, but
substantially lower LA and AA, resulting in an about 2 times higher DHA/AA ratio (Table 7). Again, the
higher adipose tissue DHA contents likely results from the high maternal intakes of freshwater !sh
from the nearby Lake Victoria. An even higher adipose tissue DHA content in these infants may have
become prevented by ‘DHA bioattenuation’,52 which is an as yet poorly understood process causing
lower DHA in the fetal circulation as compared with the maternal circulation at high maternal DHA
status, as opposed to the ‘biomagni!cation’ at low DHA status.5 The low adipose tissue LA content
is in line with their previously noted low intakes of LA. The latter becomes translated into the low
LA in milk53 and erythrocytes46 that are observed in several non-Westernized Tanzanian populations.
Interestingly, the low LA contents of breast milk of women living in the Tanzanian islands of Chole
(4.23 g% LA) and Ukerewe (5.20 g% LA), was even lower compared to current recommendations for
the intake of LA from infant formulas.53 The ensuing higher adipose tissue LA content of Western
infants has already been noted in 1975.54 The by then high adipose tissue LA content of Dutch (2.9
g%) compared to British (1.0 g%) infants at delivery was attributed to the high maternal intakes of
LA-rich soft margarines in the Netherlands, while the much higher LA in body fat of 4 months old
breastfed Dutch (32-37 g% g%), compared to British (3-4 g%) infants, was attributed to the addition
of LA to cow’s milk in the Netherlands, as opposed to the addition of carbohydrates in Britain.54
The high adipose tissue and milk LA contents of Western compared to some African countries
has been implicated in the origin of typically Western diseases.55,56 Clearly, milk has to provide
su"cient LA for the synthesis of LA-rich ceramides that constitute the skin-water barrier57,58 and
also for the synthesis of AA for the brain and other organs. However, the latter reaches maximum
capacity from 4 energy% LA.35 The enormous surplus of LA provided with Western milks contrasts
with the low amounts of LA in milk during human evolution, as e.g. supported by the observations
of traditionally living African tribes53 who do not consume high amounts of (re!ned) vegetable oils.
The question whether the resulting composition of body fat matters, has also been posed before,54
but remains unresolved as yet. A recent meta-analysis from LA-intervention studies revealed that
higher LA intakes by adults produced no indication of bene!t but rather a fairly consistent, but non-
signi!cant, signal toward increased risk of coronary heart disease and death.56 These data underscore
the possible adverse e#ects of the high, and still increasing, intakes of LA in Westernized societies.55,56
258
Chapter 5
Secondly, the higher adipose tissue LA contents in infants, coincided with lower amounts of SAFA,54
notably medium-chain-SAFA (MCSAFA). It has been shown earlier, that both dietary lauric (12:0)
and myristic (14:0) acids can be stored in adipose tissue.59 However, while the adipose tissue LA
increases continuously after delivery, MCSAFA show a steep postpartum increase that is followed
by a decrease after the discontinuation of lactation, suggesting that MCSAFA in adipose tissue are
more readily available for energy generation or other metabolic purposes. Indeed, with its long
half-life of 680 days,60 LA has been suggested to play a role in the development of adiposity.55,61
Conversely, MCSAFA have been associated with downregulation of key adipogenic genes such as
peroxisome proliferator activated receptor- (PPAR- ), reduced adipose tissue lipoprotein lipase
activity, reduced fat pads and improved insulin sensitivity in rats fed a high-MCSAFA diet, compared
to counterparts receiving a high-LA diet.62
A !nal concern derives from the well known inhibitory e"ects of high LA intakes on FA desaturase
(FADS)-activities. In their classical study, Mohrhauer and Holman63 showed that a diet high in ALA,
resulted in low tissue AA levels. Conversely, a diet high in LA resulted in low tissue DHA levels.63 It
was also shown64 that at constant high LA intakes, AA synthesis is adjusted to concurrent AA intakes.
Dietary LA intakes also correlate inversely with both DHA and AA in tissue.65 At the already high LA
intakes in Western countries, any further increases in LA intake is unlikely to additionally increase
the, already maximized, AA status. However, the high LA intake by Western women might, secondary
to their concomitantly low DHA intakes, additionally compromise their DHA status and tissue !3/!6
ratio by direct competition for incorporation of LA and AA with DHA and also by negative feedback
of AA on FADS-activity. In contrast to Western counterparts, postnatal African infants have low LA
intakes, but high intakes of both preformed AA and DHA from their mother’s milk, which, in turn,
derives from the frequent intake of AA and DHA-rich local freshwater !sh.
CONCLUSIONS
The present study supports previous FA data for brain, liver and adipose tissue, showing comparable
FA changes with advancing gestation. That is, with advancing gestation, brain SAFA, PUFA, DHA and
20:3!6, 22:4!6 and 22:5!6 increase, while MUFA, 20:3!9, 22:3!9 and AA decrease. The decrease in
brain AA might be secondary to an augmented AA-metabolism that results in increases of 20:3!6
(the precursor of the series-1 prostaglandins), 22:4!6 (the main storage form of AA in the brain)
and 22:5!6. In the liver, SAFA, PUFA and LA increase, while MUFA decreases with gestation. The
steep increase of (mostly de novo synthesized) SAFA in adipose tissue causes relative decreases of
MUFA, PUFA, DHA, LA and AA with advancing gestation. Compared to Western infants, the currently
studied African infants, born to mothers with lifetime low intakes of LA from vegetable oils and
very high intakes of both AA and DHA from abundantly available local freshwater !sh, had higher
DHA, but lower AA, and consequently a higher DHA/AA-ratio in brain; while also their adipose tissue
was higher in DHA, but lower in LA and AA. We suggest that the low LA intake and the high DHA
and AA intakes of African women living close to lake Victoria might support optimal ALA vs. LA
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competition for ∆5D and ∆6D-activities and DHA vs. AA antagonism. Conversely, the Western diet,
which is characterized by much higher intakes of LA and lower DHA and AA consumption, might
disturb these evolutionary conserved mechanisms aiming at an optimal  3/ 6-balance.
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Background. Little is known about the gestational age (GA) dependent content, composition and
intrauterine accretion rates of fatty acids (FA) in fetal white adipose tissue (WAT).
Objective & design. To acquire this information, we collected abdominal subcutaneous WAT
samples from 40 preterm and term fetuses. Their GA ranged from 22-43 weeks. FA were expressed
as mg/g wet WAT and g/100 g FA (g%). Intrauterine WAT FA accretion rates were estimated for
appropriate (AGA) and large (LGA) for gestational age infants.
Results. From 25-40 weeks gestation, saturated-FA (SAFA) increased from 83-298 mg/g WAT and
monounsaturated-FA (MUFA) from 83-226 mg/g WAT, while polyunsaturated-FA (PUFA) increased
insigni!cantly from 18.0-23.2 mg/g WAT. As percentages of total FA, SAFA increased from 46-55
g%, MUFA decreased from 44-41 g%, and PUFA from 10.3-4.26 g%. Docosahexaenoic (DHA) and
arachidonic acid (AA) accretion rates in WAT during the 3rd trimester for AGA infants were 88 and
193 mg/week, respectively. Contemporaneous DHA and AA accretion rates for 4,500 g LGA infants
were 184 and 402 mg/week, respectively. Compared to the whole 3rd trimester, increment rates
during the last 5 weeks of gestation were about 2-fold higher.
Conclusion. FA accretion rates, notably those of DHA and AA, may be important for designing
nutritional regiments for preterm infants. The current WAT-DHA and WAT-AA accretion rates are
considerably lower than previously reported in the literature.
265
Fetal intrauterine adipose fatty acid composition
6.1
INTRODUCTION
Most intrauterine changes in the fetal body composition have been studied in great detail. For
instance, from 12 weeks gestation to term, body water decreases from 92-70 g%, total body protein
increases from 5.5-12 g% and total body lipid increases from 0.5-16 g%.1-4 Little data are, however,
available on the fatty acid (FA) content, composition and accretion rates in fetal adipose tissue
throughout gestation. The amount of infant body lipid at delivery shows great inter-individual
variation,1,5-9 which is notably due to a dierent subcutaneous lipid mass.10 At term birth of an
appropriate for gestational age (AGA) infant, most (~80%) of fetal lipid is located in subcutaneous
adipose tissue,6,11,12 in which lipid by then accounts for 45% of wet weight.13 An average 3,500 g AGA
infant may thus harbor 560 g lipid, of which 448 g is subcutaneous, while the net weight of this
compartment amounts to 996 g (i.e. over 25% of total body weight).
Intrauterine fetal fat deposition is best dened by an accelerating quadratic function.2,14 Typically,
adipose tissue development starts with the formation of preadipose cells that resemble empty
phospholipid (PL) cell membranes. Long-chain polyunsaturated FA (LC-PUFA, LCP) are preferentially
incorporated into PL and therefore mostly found in (adipocyte) cell membranes. Preadipose cells
are subsequently lled with lipid in the form of triacylglycerides (TAG) to become mature adipose
cells.15,16 Both saturated (SAFA) and mono-unsaturated FA (MUFA) are predominantly incorporated
into TAG. Biopsy samples indicate that preadipose cells are formed up to the 23rd week of gestation,
where after their number remains relatively constant, but their size grows continuously.15-18 Light
microscopy studies identied the rst traces of adipose tissue lipid deposition around the 15th week
after conception.15 Macroscopically, fat deposition starts from around the 26th week of gestation.2
The LCP arachidonic acid (AA) and docosahexaenoic acid (DHA) have received great attention
in the last decades because of their abundance in neuronal tissues and their suggested importance
in infant neurological development.19-21 Although LCP reach their highest relative amounts in brain
and liver, the much larger adipose tissue and lean skeletal muscle compartments contain the
largest absolute amounts.22,23 Consequently, infant adipose tissue LCP have been considered to
be a potential postnatal source of DHA.24,25 However, little data have been published on the LCP
composition of adipose tissue during the last trimester of pregnancy22 and during early infancy.26,27
Moreover, the previously reported values of 7.6 g% AA and 1.63 g% DHA in last-trimester fetal
adipose tissue TAG+PL22 contrast markedly with the composition of adipose tissue TAG from infants
up to 2 years postpartum (AA: 0.70 and 0.23 g%; DHA: 0.40 and 0.18 g%).26,27
Even less data are available on intrauterine adipose tissue FA accretion rates. The currently
available LCP accretion rates22 are likely to have been overestimated, since they derive from the
previously noted remarkably high adipose AA and DHA compositions that22 were not conrmed
by others,26,27 while also the relative decrease of the adipose tissue LCP content26 with increasing
adipose tissue lipid content13,28,29 was not taken into account in the calculation of these data. To
address the gestational age dependent adipose tissue lipid and FA content, FA composition and FA
accretion rates, we collected white adipose tissue (WAT) samples from very preterm, preterm and
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term infants ranging from 22 to 43 weeks gestation who had not received oral or parenteral feeding,
except for intravenous glucose. For the calculation of the FA accretion rates we used the weight of
the total WAT mass of infants at 25 and 35 weeks gestation and of term infants with birth weights
ranging from 3,500 to 4,500 g from previously published data,2,8,9 since we had not measured the
total WAT mass of the infants in our study. The raw, unsorted data of this paper were previously
published in the PhD-thesis of one of us in 1990.30
SUBJECTS AND METHODS
Samples
In the period 1986-1987 small samples of WAT were collected from black fetuses and newborns
that were born in Curaçao (the former Netherlands Antilles). They were collected as a part of
a perinatal mortality study by Wildschut et al.31 who performed autopsies on 40 fetuses and
newborns. The group was composed of one subgroup of 22 stillborn fetuses and infants (12 males
and 10 females), and another subgroup of 18 deceased liveborn neonates (11 males and 7 females).
Fourteen of the 18 liveborns died within 3 days, the other four within one week, predominantly of
asphyxia and respiratory causes. Immediately after dead, the bodies were brought to the hospital
mortuary and kept at 4°C. Permission for necropsy was obtained and in most cases autopsy was
performed the next morning. Before autopsy all infants were weighed on a calibrated balance.
The subcutaneous WAT samples were obtained from the lower abdominal wall. Gestational ages
of the infants were estimated by using the physical characteristics according to Farr et al.32 and by
pathological anatomical assessment.33 Both estimates did not di#er more than two weeks and for
statistical analyses the average of the two $gures was used. None of the infants had received oral
or parenteral feeding, except for intravenous glucose. All adipose tissue samples were immediately
put into sealable tubes, and kept at -20º C until analysis in the University Medical Center Groningen
in the Netherlands. The study was in agreement with the Helsinki declaration of 1975. The study
was approved by a local institutional review board31 and local ethical standards were taken into
account.31
Fatty acid analysis
Fifty to 100 mg of accurately weighed frozen WAT was homogenized (Potter apparatus) in
chloroform and adjusted to 10.0 or 25.0 ml with chloroform. A volume corresponding with 1 mg
WAT was transferred into a Sovirel tube, containing a series of odd-chain numbered FA methyl ester
(FAME) internal quali$cation standards (5:0 up to 17:0; 200 μg of each in 200 μl chloroform) and 1
mg butylated hydroxytoluene (BHT) in 100 μl methanol. The $nal solution was taken to 600 μl by
the addition of chloroform. Transmethylation was performed by the addition of 2 ml methanol-
hydrochloric acid solution (methanol-6 mol/L HCl (5:1 v/v)) and heating for 4 hours by 90°C.
Extraction of FAME and subsequent quanti$cation with capillary GC with &ame ionization detection
occurred according to previously described methods.34 Medium-chain saturated FA (MCSAFA, 6:0 up
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to 14:0) were quantied with use of 5:0-15:0 as internal quantication standards.35 Long-chain FA (≥
16:0) were quantied on the basis of the added 17:0.34 FA compositions were expressed in mg/g wet
WAT and normalized to g/100 g FA (g%). We dened mg/g wet WAT as the WAT FA content, and g%
as the WAT FA composition.
Mathematics and Statistics
We divided the total sample of 40 infants into three groups of 15 very preterm infants (gestational
ages 22-29 weeks), 11 preterm infants (29-37 weeks) and 17 term infants (37-43 weeks). The total
sum exceeds 40 since three samples were included twice, i.e. two (29 weeks old) very preterm and
one (37 weeks) term infant were also included in the preterm group to obtain a mean gestational age
of 35 weeks. The middle group was excluded from statistical analyses, since it contained duplicates
that were also incorporated into the very preterm and the term groups. Group characteristics and
anthropometrics are presented in Table 1.
Total fetal white adipose tissue fatty acid contents and increment rates
The total contents and accretion rates of FA in fetal WAT (in mg/week) were calculated using the data
from all fetuses/infants (n=40) from the 22nd to the 43rd week of gestation. Since we only sampled
fetal subcutaneous WAT, we needed an estimation of the total amount of WAT at various ages of
gestation. Widdowson et al.1-4,11,12 reported the total fetal lipid content in AGA fetuses at various
gestational ages, which comprises the amount of lipid in all fetal organs, those in WAT and brown
adipose tissue (BAT) included. To obtain the total amount of lipids in combined white and brown
adipose tissue we subtracted the calculated lipid contents (Chapter 6.2) of the most important fetal
organs.36 Subsequently, we calculated the distribution of adipose tissue between WAT and BAT37,38
to arrive at the total amount of fetal WAT. The outcomes are presented in supplemental Table 1 and
the underlying calculations are explained in the legend. Although no such36 detailed studies are
available for large for gestational age (LGA) infants, it is known that about 50% of the additional
weight in these infants is lipid, most of which is located in adipose tissue.8 To facilitate an estimation
of the WAT weights in LGA infants, we therefore assumed that 95% of the additional lipid was stored
in adipose tissue. Secondly, we estimated (see Results) an adipose tissue FA content of 60% in a
4,000 g and of 65% in a 4,500 g LGA infant.13,39 The remaining weight, including lipid and lean tissue,
Table 1. Characteristics and anthropometrics of the included infants
Very preterm Preterm Term
Number 15 11 17
Sexe (% male) 53 64 59
Birth weight (g) 685 ± 167 1.934 ± 1.014 3.030 ± 565
Length of gestation (weeks) 24.6 ± 1.8 34.5 ± 2.6 40.2 ± 1.5
Postconceptional age (weeks) 24.9 ± 2.0 34.9 ± 2.4 40.5 ± 1.7
Values are expressed as mean ± SD
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was divided equally among the other organs (Chapter 6.2). As explained in detail in the legend of
Supplemental Table 1, we estimated that the amount of lipid stored in total WAT in a 25, 35 and 40
weeks old AGA infant amounted to 12, 151 and 479 g, respectively; while in a term 4,000 g and a
term 4,500 g LGA infant, the amount of lipid stored in WAT amounted 716 and 953 g, respectively.
To verify the outcome of these calculations, we compared our estimates with the available data
for infant adipose tissue from the literature.8-10 From the great similarity we concluded that our
calculated amounts of fetal WAT in preterm, term and LGA infants are of su!cient quality to estimate
the FA accretion rates from very preterm to preterm and term infants.
Fetal adipose tissue fatty acid content and increment rates
From the adipose tissue FA contents in mg/g WAT at 25, 35 and 40 weeks gestation, we calculated the
increment rates of each FA in mg/g WAT/week. From the WAT FA composition (g%), we calculated the
total amount of FA in the total WAT compartment. This was calculated by multiplying the calculated
total amount of WAT lipid (supplemental Table 1) with the mean WAT FA composition (g%) at the
corresponding gestational age. Accretion rates were successively calculated by dividing the change
in the total amount of a certain FA in total WAT by the number of elapsed weeks. The increment rates
in the "rst two trimesters were calculated by assuming zero fat at conception. Increment rates in the
third trimester were calculated from week 25 to 40 weeks. Since lipid accretion occurs in a quadratic




R2 = 0.88, p<0.001
Figure 1. The gestational age dependent changes in fetal weight (A) and the fetal adipose tissue fatty acid
(FA) content (B). Data are in kilogram (kg) and mg FA/g wet white adipose tissue (WAT). Fetuses and infants
range from 22-43 weeks gestational age.
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Statistics
Between-group dierences in the FA content (mg/g WAT) and FA composition (g%) of WAT were
tested only between very preterm (n=15) and term infants (n=17) with 2-sided independent
Student’s t-tests and Mann-Whitney U-tests at p<0.05. In these two groups there were no duplicate
subjects. Finally, we studied for each FA the relations of its content (in mg/g wet WAT) and its relative
contribution (composition; in g%) with gestational age and the total WAT lipid content. Relations
were explored with regression and curve estimation. Linear, inverse (1/x), logarithmic (log{x}),
exponential (x2) and cubic (x3) relations were used. All statistical analyses were performed with the
aid of SPSS 18.0
RESULTS
Anthropometrics and the relation with adipose tissue fatty acid content
Fetal body weight increased from 685±167 g in the group with an average gestational age of 24.9
weeks to 1,934±1,014 g in the group at 34.9 weeks gestation and subsequently to 3,030±565 g at
term birth (40.5 weeks gestation) (Table 1). Figure 1 shows the relationships between gestational
age and fetal weight (A) and between gestational age and the WAT FA content (B). Fetal weight
and the WAT FA content as a function of gestational age increased in an accelerating manner, i.e.
with highest increment rates in the last weeks of gestation. From 25 to 40 weeks gestation the lipid
content of WAT increased from an average of 184 to 547 mg/g AT (Table 2). Finally, the adipose
tissue FA content increased as fetal weight increased (adipose tissue FA content (in mg/g AT) =
221*ln (fetal weight [in kg]) + 297, R2=0.56, not shown). For the total fetal WAT mass in LGA infants
(see above and supplemental Table 1), we estimated that WAT contained about 600 mg FA/g WAT in
a 4,000 g LGA infant and about 650 mg FA/g WAT in a 4,500 g LGA infant.
Fetal white adipose tissue fatty acid content in mg/g AT
The total lipid contents and the FA contents of WAT (mg/g WAT; mean ± SD) at 25, 35 and
40 weeks gestation are presented in Table 2. At 25 weeks, 1 g of WAT contained 83 mg SAFA
(16:0>18:0>14:0>10:0), 83 mg MUFA (18:1 9>16:1 7>18:1 7) and 18 mg PUFA (18:2 6 [linoleic
acid, LA]>AA>DHA). Increment rates for SAFA and MUFA were about 4.5 times higher than for PUFA
(see also Supplemental Table 2). At 40 weeks gestation, 1 g of infant adipose tissue contained
298 mg SAFA (16:0>18:0>14:0>10:0), 226 mg MUFA (18:1 9>16:1 7>18:1 7) and 23.2 mg PUFA
(LA>AA>DHA). As can be deducted from Table 2, SAFA (mainly 16:0) and MUFA (mainly 18:1 9)
increased substantially in the 3rd compared to the "rst two trimesters, while PUFA increased non-
signi"cantly between 25 and 40 weeks gestation from 18.0 to 23.2 mg/g WAT; mainly on account of
the signi"cantly higher LA (p=0.014) in the 3rd compared to the 1st trimester. Increment rates for
SAFA and MUFA during the 3rd trimester were about 30-40 times higher compared to that of PUFA
(Supplemental Table 2). LCP increased during the "rst two trimesters to 7.85 mg/g WAT at 25 weeks
gestation, but subsequently remained constant, constituting 7.80 mg/g WAT in a term infant.
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Table 2. Adipose tissue fatty acid composition in mg/g wet adipose tissue
fatty acids (mg/g wet AT)a regressionb
Fetal age (weeks) 25 (n=15) 35 (n=11) 40 (n=17) GA AT-FA
mean ± SD mean ± SD mean ± SD R2
Total FA 184 ± 90.3 439 ± 174 547 ± 155*** 0.62# 1.00§
6:0 0.28 ± 0.37 1.43 ± 0.94 1.97 ± 2.44*** 0.21§ 0.16§
8:0 0.45 ± 0.30 0.63 ± 0.25 0.59 ± 0.19 0.34§
10:0 4.41 ± 2.17 3.23 ± 0.95 2.78 ± 0.64 0.22$
12:0 0.85 ± 0.36 1.15 ± 0.30 1.29 ± 0.33*** 0.25§ 0.43§
14:0 6.50 ± 6.00 15.5 ± 6.62 19.1 ± 4.97*** 0.48|| 0.62§
16:0 61.1 ± 32.1 187 ± 79.9 241 ± 64.4*** 0.69§ 0.97§
18:0 9.32 ± 4.56 21.0 ± 8.31 30.4 ± 12.9*** 0.57# 0.81§
20:0 0.04 ± 0.09 0.28 ± 0.21 0.50 ± 0.31*** 0.51§ 0.73§
22:0 0.00 ± 0.00 0.00 ± 0.00 0.09 ± 0.21
SAFA 82.9 ± 40.9 230 ± 93.5 298 ± 79.9*** 0.77§ 0.98§
MCSAFA 12.5 ± 7.10 21.9 ± 7.40 25.7 ± 6.35*** 0.44# 0.62§
LCSAFA 70.4 ± 36.4 208 ± 87.3 273 ± 75.2*** 0.77§ 0.97§
14:1ω5 0.42 ± 0.37 1.55 ± 0.82 1.71 ± 0.66*** 0.48§ 0.61§
16:1ω7 19.4 ± 11.7 51.5 ± 23.0 57.8 ± 18.3*** 0.50§ 0.81§
18:1ω7 5.52 ± 3.21 10.1 ± 3.76 12.0 ± 4.72*** 0.35§ 0.72§
ω7 24.9 ± 14.4 61.6 ± 26.6 69.9 ± 22.5*** 0.49§ 0.90§
18:1ω9 57.3 ± 28.0 126 ± 51.3 154 ± 52.0*** 0.54# 0.95§
20:1ω9 0.20 ± 0.31 0.48 ± 0.26 0.71 ± 0.37*** 0.38§ 0.51§
ω9 57.5 ± 28.1 126 ± 51.5 154 ± 52.3*** 0.54§ 0.96§
MUFA 82.8 ± 42.0 190 ± 77.7 226 ± 70.9*** 0.61§ 0.99§
18:3ω3 0.09 ± 0.23 0.07 ± 0.23 0.08 ± 0.23
22:5ω3 0.28 ± 0.70 0.12 ± 0.24 0.11 ± 0.18
22:6ω3 2.27 ± 1.82 1.87 ± 1.51 1.69 ± 0.93
LCPω3 2.54 ± 2.11 1.99 ± 1.72 1.80 ± 1.04
ω3 2.63 ± 2.17 2.06 ± 1.71 1.88 ± 0.97
18:2ω6 9.89 ± 5.12 11.8 ± 5.48 14.8 ± 6.20* 0.15¥ 0.51¥
18:3ω6 0.21 ± 0.30 0.38 ± 0.30 0.44 ± 0.28* 0.12§ 0.41§
20:2ω6 0.10 ± 0.18 0.24 ± 0.21 0.38 ± 0.24** 0.26§ 0.48§
20:3ω6 0.42 ± 0.50 0.49 ± 0.39 0.67 ± 0.37 0.13§
20:4ω6 3.48 ± 2.14 3.56 ± 1.52 3.59 ± 1.52 0.33¥
22:4ω6 0.77 ± 0.95 0.57 ± 0.53 0.92 ± 0.46
22:5ω6 0.53 ± 0.71 0.47 ± 0.39 0.44 ± 0.35
LCPω6 5.30 ± 4.04 5.34 ± 2.93 6.01 ± 2.75 0.32¥
ω6 15.4 ± 8.39 17.5 ± 7.99 21.3 ± 8.92 0.50¥
PUFA 18.0 ± 10.1 19.5 ± 9.43 23.2 ± 9.66 0.44¥
LCPω3+LCPω6 7.85 ± 6.00 7.33 ± 4.62 7.80 ± 3.66
Abbreviations: AT, adipose tissue; FA, fatty acid(s); SAFA, saturated FA; MCSAFA, medium chain SAFA (≤14:0);
LCSAFA, long-chain SAFA (≥ 16:0); MUFA, monounsaturated FA; PUFA, polyunsaturated FA.
a, the adipose tissue (AT) fatty acid (FA) content at 40 weeks gestation di<ers signi>cantly from the composition
at 25 weeks gestation at *, p<0.05; **, p<0.01 and ***, p<0.001
b, signi>cant relations (p<0.05) obtained after regression analysis for the AT-FA content (mg/g AT) as a function
of 1) gestational age (GA), and as a function of 2) the AT-FA content (AT-FA, in mg/g AT). Negative relationships
were investigated using §, linear (y=x) and|| , inverse (x-n) functions, positive relationships using linear; ¶,
logaritmic (ln{x}); #, exponential (abx); and ¥, cubic relations (x3). The indicated value represents the R2 for the best
>tting relation. Relations are shown in Figure 1 and 2.
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Figure 2. The gestational age dependent changes in the wet white adipose tissue (WAT) medium
chain saturated fatty acid (MCSAFA) content (A); long chain saturated fatty acid (LCSAFA) content (B);
monounsaturated fatty acid (MUFA) content (C); docosahexaenoic acid (DHA) content (D); linoleic acid (LA)








While the above describes the between-group dierences, we also evaluated these results with
regression analyses (Table 2). These revealed comparable results for the relation between the WAT
FA content and gestational age (left column under regression in Table 2). Figure 2A-F show the
changes of some selected FA in mg/g WAT as a function of gestational age. It was found that the
WAT MCSAFA contents related exponentially, the long chain saturated (LCSAFA) and MUFA (Figure
2A-C) contents related linearly to gestational age, that those of AA and DHA (Figure 2D and 2F) did
not relate to gestational age, while LA exhibited a cubic relation (Figure 2E). To !nd the strongest
contributors to the increase of the WAT FA content, we also related the individual WAT FA to the
WAT total FA content (right column under regression in table 2). The relation between the speci!c
FA contents and the sum of FA in WAT was strongest for LCSAFA (notably 16:0) and MUFA (notably
18:1 9), but insigni!cant for several PUFA. The  6-PUFA (R2 = 0.50), notably LA (R2 = 0.51) and AA
(R2 = 0.33), and the sum of all PUFA (R2 = 0.44) related positive to the WAT total FA content. However,
neither DHA, nor any of the other  3-PUFA, related to the WAT lipid content.
Fetal white adipose tissue fatty acid composition in g/100 g FA (g%)
Between-group dierences (Table 3) show the relative increase of SAFA with gestational age (from
45.7 g% at 25 weeks to 54.8 g% at 40 weeks gestation, p<0.001), which is explained by an increase in
LCSAFA (from 38.21 to 50.04 g%, p<0.001), mainly 16:0 (from 32.78 to 44.40 g%, p<0.001). MCSAFA
decreased (from 7.44 to 4.81 g%, p<0.001), mainly on account of 10:0 (from 3.15 to 0.54 g%, p<0.001).
The relative increase in SAFA also seemed to be at the expense of MUFA (from 43.89 to 40.57 g%,
p<0.009), mainly 18:1ω9 (from 31.33 to 27.70 g%, p<0.004). PUFA also decreased (from 10.27 to 4.26
g%, p<0.001), notably on account of DHA (from 1.18 to 0.30 g%, p<0.004), 18:2ω6 (from 5.90 to 2.76
g%, p<0.001) and AA (from 2.06 to 0.66 g%, p<0.001).
The observed between-group dierences were also evaluated with regression analysis (Table
3). Subtle dierences were observed, with signi!cant decreases for 18:3 6, 22:4 6 and 22:5 6 with
regression analysis that were not shown in the between-group statistical analysis. Conversely, the
relative increase in 14:0 with gestational age was not con!rmed by regression analysis. However,
most relations between the adipose tissue FA composition and gestational age became con!rmed
by regression analysis (Table 3). The relations were even more pronounced when we analyzed
the relation between the WAT FA composition and the total WAT FA content. Figure 3A-F show
the changes in the WAT FA content of some selected FA as a function of the WAT total FA content.
Interestingly, a negative relation was observed between MCSAFA and the WAT FA content (Figure
3A), a positive relation with LCSAFA (Figure 3B), but no relation with MUFA (Figure 3C). Most PUFA
showed signi!cant (negative) relations with the total WAT FA content (right column under regression
Table 3). The inverse relations between DHA, LA and AA and the WAT total FA content are shown in
Figure 3D-F.
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Table 3: Adipose tissue fatty acid composition in g/100g fatty acids
fatty acids (g/100 g Fatty acids (g%))a regressionb
Fetal age (weeks) 25 (n=15) 35 (n=11) 40 (n=17) GA AT-FA
mean ± SD mean ± SD mean ± SD R2
6:0 0.12 ± 0.18 0.29 ± 0.15 0.36 ± 0.44* 0.14§ 0.14¶
8:0 0.30 ± 0.24 0.14 ± 0.06 0.11 ± 0.02*** 0.21§ 0.67||
10:0 3.15 ± 2.22 1.00 ± 0.94 0.54 ± 0.14*** 0.65|| 0.79||
12:0 0.55 ± 0.27 0.29 ± 0.10 0.24 ± 0.05*** 0.50|| 0.73||
14:0 3.32 ± 1.60 3.57 ± 1.01 3.56 ± 0.58*
16:0 32.8 ± 3.38 41.7 ± 4.20 44.4 ± 2.71*** 0.73§ 0.51¶
18:0 5.41 ± 1.23 4.89 ± 0.85 5.54 ± 1.25
20:0 0.01 ± 0.04 0.06 ± 0.04 0.09 ± 0.04*** 0.45§ 0.42¶
22:0 0.00 ± 0.00 0.00 ± 0.00 0.01 ± 0.03
SAFA 45.7 ± 3.83 51.9 ± 3.30 54.8 ± 3.05*** 0.65¶ 0.30§
MCSAFA 7.44 ± 2.82 5.31 ± 1.31 4.81 ± 0.72*** 0.29|| 0.59||
LCSAFA 38.2 ± 3.71 46.6 ± 3.97 50.0 ± 2.85*** 0.75¶ 0.43¶
14:1ω5 0.19 ± 0.15 0.34 ± 0.08 0.32 ± 0.09* 0.16¶ 0.29¶
16:1ω7 9.50 ± 3.55 11.5 ± 1.40 10.6 ± 1.79 0.31¶
18:1ω7 2.97 ± 0.63 2.35 ± 0.26 2.16 ± 0.44** 0.44|| 0.19§
ω7 12.5 ± 3.71 13.8 ± 1.34 12.8 ± 2.02 0.20¶
18:1ω9 31.3 ± 2.79 29.0 ± 3.31 27.7 ± 3.06** 0.23|| 0.12¶
20:1ω9 0.08 ± 0.12 0.10 ± 0.05 0.13 ± 0.04 0.20¶
ω9 31.4 ± 2.77 29.1 ± 3.27 27.8 ± 3.09** 0.23|| 0.11¶
MUFA 43.9 ± 4.25 43.0 ± 3.11 40.6 ± 3.09** 0.18||
18:3ω3 0.04 ± 0.11 0.03 ± 0.10 0.02 ± 0.05
22:5ω3 0.14 ± 0.39 0.02 ± 0.05 0.02 ± 0.03
22:6ω3 1.18 ± 0.78 0.39 ± 0.30 0.30 ± 0.12** 0.42|| 0.58||
LCPω3 1.33 ± 0.96 0.42 ± 0.33 0.32 ± 0.14** 0.38|| 0.16||
ω3 1.37 ± 1.00 0.45 ± 0.37 0.34 ± 0.12** 0.37|| 0.18||
18:2ω6 5.90 ± 2.88 2.97 ± 1.34 2.76 ± 1.06*** 0.31|| 0.61||
18:3ω6 0.08 ± 0.11 0.08 ± 0.05 0.08 ± 0.05 0.12||
20:2ω6 0.04 ± 0.07 0.05 ± 0.04 0.07 ± 0.04
20:3ω6 0.21 ± 0.24 0.11 ± 0.08 0.12 ± 0.05
20:4ω6 2.06 ± 0.92 0.88 ± 0.31 0.66 ± 0.17*** 0.53|| 0.59||
22:4ω6 0.39 ± 0.48 0.11 ± 0.10 0.17 ± 0.05 0.15|| 0.13||
22:5ω6 0.23 ± 0.25 0.10 ± 0.08 0.07 ± 0.05 0.17|| 0.16||
LCPω6 2.92 ± 1.56 1.24 ± 0.48 1.09 ± 0.30*** 0.42|| 0.28||
ω6 8.90 ± 3.46 4.29 ± 1.65 3.92 ± 1.33*** 0.44|| 0.49||
PUFA 10.3 ± 3.79 4.74 ± 1.88 4.26 ± 1.39*** 0.49|| 0.46||
LCPω3+LCPω6 4.25 ± 2.36 1.66 ± 0.78 1.41 ± 0.38*** 0.45|| 0.25||
For abbreviations: see the legend to Table 2.
a, the adipose tissue (AT) fatty acid (FA) composition at 40 weeks gestation di$ers signi%cantly from the
composition at 25 weeks gestation at *, p<0.05; **, p<0.01 and ***, p<0.001
b, signi%cant relations (p<0.05) obtained after regression analysis for the AT-FA composition (g/100 g FA) as a
function of 1) gestational age (GA), and as a function of 2) the AT-FA content (AT-FA, in mg/g AT). For further
explanation see also the legend to Table 2
Figure 3. The adipose tissue fatty acid (FA) content (in g/100 g FA, g%) as a function of the wet white adipose
tissue (WAT) FA content (in mg FA/g WAT) for MCSAFA (A), LCSAFA (B), MUFA (C), DHA (D), LA (E) and AA (F). For
abbreviations see Figure 2.
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Total fetal white adipose tissue fatty acid content and fatty acid accretion rates
Using the calculated amounts of total lipid (supplemental Table 1) and the FA composition in g%
(Table 3) we calculated the total amount of FA stored in the fetal body at selected gestational age
(Supplemental Table 3). Most importantly, there is about 5.52 g SAFA, 5.31 g MUFA and 1.24 g PUFA
(including 143 mg DHA and 249 mg AA) in WAT of a 25 weeks old fetus. These amounts increased
to 78.3 g SAFA, 64.8 g MUFA and 7.14 g PUFA (including 595 mg DHA and 1,322 mg AA) at 35 weeks
and to 262 g SAFA, 194 g MUFA and 20.4 g PUFA (including 1.46 g DHA and 3.15 g AA) in a 3,500 g
AGA term infant. We nally calculated that, assuming a similar FA composition and a slight increase
in the adipose tissue lipid content (see above), the stored amounts of FA might increase to values
as high as 523 g SAFA, 387 g MUFA and 40.6 g PUFA (including 2.90 g DHA and 6.27 g AA) in a 4,500
g LGA infant.
From the total WAT FA content, we calculated that in the rst part of pregnancy lipid accreted at
484 mg/week, i.e. 69 mg/day (Table 4). This increase in lipids was explained by SAFA (221 mg/week;
mainly 16:0), MUFA (212 mg/week; mainly 18:1 9) and PUFA (49.7 mg/week; mainly 18:2 6, 28.5
mg/week; AA, 10.0 mg/week; and DHA 5.73 mg/week). During the last trimester, lipid accretion rates
increased to 31.1, 46.9 and 62.7 g/week for a 3,500; 4,000 and a 4,500 g term infant, respectively.
These increases are mainly explained by SAFA (17.1, 25.8 and 34.5 g/week; mainly 16:0); MUFA (12.6,
19.0 and 25.4 g/week; mainly 18:1 9) and PUFA (1.28, 1.95 and 2.63 g/week; mainly 18:2 6, AA and
DHA). The accretion rates increased in the last 5 weeks of gestation for SAFA to 36.8; 62.9 and 88.9 g/
week; for MUFA to 25.9; 45.2 and 64.4 g/week; and for PUFA to 2.65; 4.68 and 6.70 g/week for infants
with birth weights of 3,500, 4,000 and 4,500 g, respectively.
Taken together, our data showed di!erent fetal WAT FA compositions in early, mid and late
gestation. All FA showed an accelerating absolute increase, with 2-fold higher increment rates in
the last 5 weeks compared to the whole last trimester of gestation. The much higher accretion rate
of SAFA (17 g/week) compared to MUFA (13 g/week) and PUFA (1.3 g/week) in e.g. the 3,500 g AGA
infant caused a relative dilution of MUFA, PUFA and notably LCP with advancing gestation (Table 3
and Figure 3).
DISCUSSION
We analyzed the FA contents and compositions of fetal WAT of very preterm, preterm and term
newborns ranging from 22 to 43 weeks gestation that had not received oral or parenteral feeding,
except for intravenous glucose. The amount of lipid/gram of fetal WAT increases substantially during
the 3rd trimester, from 18.4 g FA/100 g wet WAT (18.4%) at 25 weeks to 54.7% at term. This increase
was on account of SAFA and MUFA, while PUFA, and notably LCP, remained remarkably constant
(Table 2). The substantial increase of SAFA caused a relative decrease of PUFA, notably LCP, and to
a lesser extent of MUFA (Table 3). Fetal WAT stores contained 1,457 mg DHA and 3,150 mg AA in a
3,500 g AGA term infant, which might increase to 2,901 mg DHA and 6,273 mg AA in a 4,500 g LGA
infant (supplemental Table 3). Increment rates for DHA and AA (Figure 4) increase from 5.7 mg DHA/
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Table 4. Intra-uterine adipose tissue FA increment rates
FA increment rates (mg/wk and g/wk)a
Period (wk-wk)b 0-25 0-25 25-35 25-40 35-40 25-40 35-40 25-40 35-40
ΔFetal BW (g-g)b 0-900 900-2525 2525-3500 2525-4000 2525-4500
Unit mg/wk g/wk g/wk g/wk g/wk g/wk g/wk g/wk g/wk
Total FA 484 0.484 13.89 31.13 65.60 46.93 113.0 62.73 160.4
6:0 0.59 0.001 0.043 0.114 0.256 0.171 0.428 0.228 0.598
8:0 1.47 0.001 0.017 0.033 0.064 0.050 0.116 0.067 0.168
10:0 15.2 0.015 0.113 0.146 0.212 0.231 0.468 0.316 0.722
12:0 2.66 0.003 0.037 0.073 0.144 0.111 0.258 0.149 0.372
14:0 16.1 0.016 0.499 1.107 2.322 1.673 4.022 2.233 5.702
16:0 159 0.159 5.884 13.87 29.84 20.94 51.04 27.94 72.04
18:0 26.2 0.026 0.672 1.723 3.826 2.597 6.446 3.470 9.066
20:0 0.07 0.000 0.009 0.027 0.064 0.041 0.104 0.054 0.144
22:0 0.00 0.000 0.000 0.005 0.014 0.007 0.020 0.009 0.026
SAFA 221 0.221 7.278 17.10 36.74 25.83 62.94 34.50 88.94
MCSAFA 36.0 0.036 0.709 1.473 3.002 2.233 5.282 2.993 7.562
LCSAFA 185 0.185 6.568 15.63 33.74 23.56 57.54 31.49 81.34
14:1ω5 0.90 0.001 0.049 0.100 0.202 0.150 0.352 0.200 0.502
16:1ω7 45.9 0.046 1.615 3.303 6.680 4.983 11.72 6.657 16.74
18:1ω7 14.4 0.014 0.319 0.663 1.350 1.003 2.370 1.349 3.410
ω7 60.3 0.060 1.939 3.966 8.020 5.986 14.08 8.033 20.22
18:1ω9 152 0.152 3.991 8.614 17.86 12.95 30.86 17.35 44.06
20:1ω9 0.41 0.000 0.014 0.039 0.090 0.059 0.150 0.079 0.210
ω9 152 0.152 4.010 8.613 17.82 13.01 31.02 17.41 44.22
MUFA 212 0.212 5.949 12.58 25.84 19.05 45.24 25.45 64.44
18:3ω3 0.21 0.000 0.003 0.005 0.008 0.008 0.018 0.011 0.026
22:5ω3 0.69 0.001 0.001 0.004 0.010 0.007 0.018 0.009 0.024
22:6ω3 5.73 0.006 0.045 0.088 0.174 0.136 0.318 0.184 0.461
LCPω3 6.41 0.006 0.047 0.091 0.180 0.143 0.334 0.193 0.486
ω3 6.62 0.006 0.050 0.097 0.190 0.150 0.350 0.204 0.512
18:2ω6 28.5 0.029 0.377 0.834 1.748 1.273 3.064 1.706 4.364
18:3ω6 0.38 0.000 0.011 0.024 0.050 0.036 0.086 0.048 0.122
20:2ω6 0.20 0.000 0.007 0.022 0.052 0.033 0.084 0.044 0.118
20:3ω6 1.00 0.001 0.014 0.037 0.082 0.055 0.138 0.074 0.194
20:4ω6 10.0 0.010 0.107 0.193 0.366 0.297 0.678 0.402 0.990
22:4ω6 1.89 0.002 0.012 0.050 0.124 0.075 0.202 0.102 0.282
22:5ω6 1.09 0.001 0.012 0.022 0.041 0.033 0.076 0.045 0.112
LCPω6 14.1 0.014 0.152 0.323 0.664 0.495 1.180 0.663 1.686
ω6 43.0 0.043 0.538 1.181 2.468 1.801 4.328 2.421 6.188
PUFA 49.7 0.050 0.590 1.277 2.652 1.951 4.672 2.624 6.692
LCPω3+LCPω6 20.6 0.021 0.199 0.415 0.846 0.639 1.520 0.859 2.180
Abbreviations: wk, week(s); BW, body weight; further abbreviations see Legend to Table 2
a, calculated from: total body FA at given gestational age/elapsed number of weeks from previous timepoint.
b, within the given period (wk-wk), fetal BW increased from x to y gram (g-g).
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week and 10 mg AA/week during the rst trimesters, to 88 mg DHA/week and 193 mg AA/week for a
3,500 g AGA infant during the third trimester, with highest accretion rates of 174 mg DHA/week and
366 mg AA/week during the last 5 weeks of gestation. For a 4,500 LGA infant, increment rates are
even higher: 184 mg DHA/week and 402 mg AA/week during the 3rd trimester and 461 mg DHA/
week and 990 mg AA/week during the last 5 weeks of gestation.
Strengths and limitations
The current data might be used as a reference for the composition of infant WAT at various ages of
gestation, although at rst sight its extrapolation to the total body WAT FA content might have some
limitations. For example, there is some di!erence between the
fetal body weights at the gestational ages in this study and that of the infants in classical reference
works by Widdowson.1,2,4,11,12 The lower fetal weights at comparable gestational age in our study
might be explained by the fact that we studied black fetuses born to women from the Caribbean
island of Curaçao. It is known that infants born to black mothers have lower birth weights compared
to white women.40 More importantly however, this lower birth weight has been attributed to lower
lean body mass, and not to a di!erence in adiposity.41 Since lipid as a percentage of total body
weight in Widdowsons classical studies2,4,11,12 derived from white fetuses, we used the body weight
of reference fetuses from Widdowson, instead of the body weights from this study, to calculate the
total amount of body lipid, since employment of the body weight of our black fetuses would result
in an underestimation of the total amount of body lipid.41 The estimation of the fetal WAT mass
by calculation might be considered as a limitation, but the calculated adipose tissue distributions











































Figure 4. Accretion rates of docosahexaenoic (DHA) and arachidonic acid (AA) in fetal adipose tissue during
the rst (0-25 weeks) and second part (25-35 weeks, 25-40 weeks and 35-40 weeks gestation) of pregnancy
for appropriate for gestational age (AGA) and large for gestational age (LGA) infants. BW, body weight.
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Finally, the current data are to at least some extent inuenced by the maternal diet, which in
Curaçao might be considered as typically Western, also in 1986-1987.42 This limitation may notably
have aected DHA, of which the status is dependent on maternal sh intake.43 To which extent the
typically high intake of LA in Western countries becomes reected in current data is unknown, but
it is conceivable that maternal LA intakes were comparable with those of Western women.42 Since
none of the infants received oral or parenteral feeding except for intraveneous glucose, the LA
status of infant WAT is independent of the known postnatal surge of LA by either human milk or
infant formula.44
Increase in AT lipid content
The increase in the WAT lipid content during gestation is in line with studies showing the increase in
adipose tissue lipid content from 33.5-45.5% in (preterm) newborns13 to 63-66% for 1-10 months old
infants.39 The exponential relations between the infants’ body weight and gestational age (Figure
1A) and its WAT lipid content and gestational age (Figure 1B) are consistent with the fact that the
main increases in infant weight and adipose tissue lipid content occurs in late gestation.2,4,11 Our
data also suggest that the heavier term infants have a slightly increased adipose tissue lipid content
compared to the lighter ones (gure not shown).
SAFA and MUFA during gestation
After 25 weeks gestation, the increase in the WAT lipid content is on account of SAFA (82.9 to 298
mg/g AT) and MUFA (82.8 to 226 mg/g AT), while PUFA (18.03 to 23.16 mg/g AT), and notably
LCP (7.85 and 7.80 mg/g), remain remarkably constant (Table 2, Figure 2). The increase in de novo
synthesized FA in fetal WAT coincides with increasing insulin secretion from the fetal pancreas
after the 26th week of gestation,11 and with the decreasing maternal insulin sensitivity during
late gestation that promotes an increased glucose transport across the placenta.45 Increasing fetal
insulin production and high mother-to-infant glucose transport support fetal de novo lipogenesis
(i.e. SAFA and MUFA) in liver and adipose tissue.4 Additionally, FA from maternal de novo synthesis
are transported across the placenta at increasing rates.24 Interestingly, the substantial increase of
SAFA in fetal WAT (from 45.7 g% to 54.8 g%) caused a relative decrease of PUFA (from 10.27 to 4.26
g%) and notably LCP (4.25 to 1.41 g%), but also of MUFA (from 43.89 to 40.57 g%). The increasing
WAT MCSAFA content but their relative decrease suggest that de novo lipogenesis aims at LCSAFA
rather than MCSAFA, secondary to e.g. insulin induced lipogenic activity in liver and adipose tissue.46
Since de novo lipogenesis is aimed at both SAFA and MUFA, the increase in SAFA but decrease in
MUFA suggests that MUFA are selectively transported to e.g. the infant brain for incorporation into
neuronal tissues,21,47 while SAFA, notably LCSAFA, are primarily stored in adipose tissue.
Higher LCP needs in LGA infants
The higher birth weight of LGA infants is mainly caused by increased adipose tissue deposition.8,9
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LGA infants have a slightly higher adipose
tissue lipid content compared to AGA infants,
while infants born to mothers with impaired
glucose tolerance8 are likely to harbor even
higher amounts of adipose tissue lipids,
notably SAFA and MUFA that are synthesized
from glucose. However, during adipose
tissue development adipocyte hypertrophy
is known to plateau, while hyperplasia
continues.29,48 Thus, the increased deposition
of SAFA and MUFA in the adipose tissue
compartment of LGA infants and infants born
to mothers with disturbed glucose tolerance,
require a concomitantly increased maternal-
to-fetal transport of LCP for adipose tissue
hyperplasia to accommodate an additional
250-500 g of lipid. We suggest that the high
demands for LCP for incorporation into
adipose tissue cell membranes in e.g. LGA
infants might compete with the LCP needed
for incorporation into the rapidly growing
brain, since both adipose tissue and brain
rank high in the evolutionary hierarchy, which
is also known as the ‘survival of the fattest’.49
LCP stores and accretion rates compared
to the literature
Haggarty24 suggested that adipose tissue LCP
may be considered as a potential postnatal
source of DHA, which is conceivable because
the quantitatively highest absolute amount
of LCP in lipid droplets is located in the TAG
fraction.50,51 Our results suggest that in the
AGA infant, about 1,457 mg DHA is stored in
WAT, which is somewhat higher compared
to the 1,053 as calculated by Cunnane et
al.,23 but substantially lower compared to








































































































































































































































































































































































































































































































































































































































































































































































reported by Clandinin et al.22 The discrepancy with the latter data derives from several dierences
in the outcomes, the most important being the inconsistency with the LCP content of fetal adipose
tissue (see also Table 5). Clandinin et al.22 report an average of 1.63 g% DHA and 7.6 g% AA in WAT
of infants ranging from 22-40 weeks gestation, which is considerably higher compared to the ranges
of 0.30-1.18 g% DHA and 0.66-0 2.06 g% AA that we presently report for infants ranging from 25-40
weeks gestation. The lower DHA and AA contents of fetal WAT in our study is in agreement with an
earlier with 1-6 days old preterm and term (30-33 and 37-42 weeks gestation) infants26 and a study
with <2 years old infants.27 These studies reported fetal adipose tissue DHA compositions of 0.18-
0.40 g% and AA compositions of 0.23-0.70 g%, which is comparable to the 0.30 g% DHA and 0.66
g% AA in WAT in the term infants in our study. It should be noted that these two quoted studies
reported adipose tissue TAG-FA compositions, whereas in the current we determined the combined
(PL+TAG)-FA composition of WAT.
The adipose tissue TAG-FA composition is however similar to that of the adipose tissue (PL+TAG)-
FA composition since even in infant AT, with its relatively high contribution of PL, the LCP in PL are
unlikely to contribute substantially to the total amount of LCP.50,51 The discrepancy might relate to the
use of packed gas chromatography (GC) columns in the earlier study22 in contrast to use of capillary
GC columns for FA analysis in the latter26,27 and current study, since use of packed GC columns may
produce arti!cially high LCP values.52 In addition, the calculations of Clandinin et al.22 did not take
into account the decrease of the adipose tissue relative LCP content26 with increasing adipose
tissue lipid content13,28 and with gestational age. This decrease was noted both in an earlier26 and
the present study (Figure 3D-F). Clandinin et al.22 did not specify whether they corrected for these
changes, but careful analysis of their data revealed that these were not made*. Finally, the 340 g lipid
in a 3,500 g term infant, as estimated by Clandinin et al,22 is much lower compared to the actual 560
g reported for a term infant by Widdowson.2 Thus, while the latter might lead to underestimation
of FA accretion rates during the 3rd trimester, the above mentioned other 2 discrepancies might
explain the higher calculated adipose tissue stores and the higher reported accretion rates.
In conclusion, this study presents the changing fetal WAT FA content and composition with
gestation. It provides insight into the physiological development of adipose tissue and gives an
estimation of infant FA requirements during gestation. At delivery, WAT from a 3,500 AGA infant
contains about 1,457 mg DHA and 3,150 mg AA, while LGA infants might have deposited up to
2,901 mg DHA and 6,273 mg AA in their WAT. We calculated that the average WAT accretion rate for
DHA (Figure 4) increases from 5.73 mg DHA/week during the !rst trimesters, to 88 mg DHA/week
for a 3,500 g AGA infant and to 184 mg DHA/week for a 4,500 LGA infant during the 3rd trimester.
* The following example illustrates that no correction for a changing adipose tissue FA composition with in-
creasing gestational age was made. Their22 Table I shows that infant white adipose tissue increases from 3.45 g
in a preterm to 255.6 g at term. Subsequently, the AA accretion rate is calculated by: 255.6 * 7.6 g% (=19.43 g)
minus 3.45 * 7.6 g% (=0.26 g) = 19.16 g AA increase during the last trimester = 19.16/13 (where 13 is the weeks
in 3rd trimester) = 1.470 mg AA/week; similarly, for DHA the accretion rate is 255.6 * 1.63 g% (=4.17) - 3.45 * 1.63
g% (=0.06) = 4.11/13 = 316 mg DHA/week during the last trimester. These accretion rates are the same as those
given in their Table III and results are similar for the other fatty acids.22
281
Fetal intrauterine adipose fatty acid composition
6.1
Accretion rates for AA (Figure 4) increase from 10.0 mg AA/week during the rst trimesters, to 193
mg AA/week for a 3,500 g AGA infant and to 402 mg AA/week for a 4,500 LGA infant during the 3rd
trimester. Increment rates during the last 5 weeks of gestation were about 2-fold higher compared
to the rates during the 3rd trimester. The knowledge on the FA accretion rates in AT, and notably LCP,
might be important for the design of nutritional regiments for preterm infants
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Supplemental Table 1. Changes in the intra-uterine fetal adipose tissue mass and its lipid content during
gestation
Fetal characteristics
Fetal age (weeks, days) 25 (175) 35 (245) 40 (280) 40 (280) 40 (280)
fetal total body weight (g) 900 a 2525 a 3500 a 4000 4500
% Lipid of fetal body weight (%) 2.3 a 7.8 a 16 a 20.3 b 23.6 b
Total body lipid (g) 20.6 a 198 a 560 a 810 c 1060 c
Lipid in internal organs, brown and white adipose tissue (AT)
Sum of internal organ lipids [excl.
internal AT] (g) 7.16
d 32.4 d 60.4 d 63.8 d 69.1 d
Total adipose tissue lipid (g) 13.4 e 166 e 500 e 738 (746) f(e) 975 (991) f(e)
Total brown AT lipid (g) 1.47 g 15.4 g 21.9 g 21.9 g 21.9 g
Total white AT lipid (g) 11.9 h 151 h 479 h 716 h 953 h
Fetal wet AT weights during gestation
Adipose tissue lipid (% of wet AT) 18.4 i 43.9 i 54.7 i 60 j 65 j
Total wet AT weight (g) 73.7 k 378 k 915 k 1230 l 1500 l
% AT of total body weight 8.2 m 15 m 26.1 m 30.8 m 33.3 m
Subcutaneous vs. non-subcutaneous AT
% Lipid as subcutaneous AT (%) 50 n 70 n 80 n
Total subcutaneous AT lipid (g) 10.3 o 139 o 448 o
Total deep body (internal) lipid (g) 10.3 p 59.4 p 112 p
Internal AT lipid (g) 3.26 q 27.4 q 52.4 q
Total subcutaneous AT mass (g) 56 316 819
Total internal AT mass (g) 17.7 62.5 95.9
a, Adapted from Widdowson2
b, Calculated: total lipid/fetal total body weight (TBW)
c, Calculated: 50% of the additional weight in a large for gestational age (LGA) infant is lipid8,9
d, Calculated: see Chapter 6.2 for explanation
e, Calculated: total body lipid - sum of internal, non-adipose tissue, lipid
f, Calculated: total wet AT weight * AT lipid % (1230*0.60 and 1500*0.65); the di"erence between the two
indicated outcomes is explained by the lack to correct for an increase in the lipid content of organs besides
AT in LGA infants
g, Merklin37 states that at 25 weeks gestational age (GA), there is 8 g brown AT and at term about 40 g brown AT
in the fetal body
h, Calculated: total AT lipid - brown AT lipid
i, This study
j, This study, plotted from the available data (#gure not shown, see results for its function)
k, Calculated: total AT lipid/At lipid %
l, Calculated: assuming that 95% of the additional lipid in a LGA infant is in AT: hence 0.95*250=238 g lipid +
the original 500 g lipid in AT = 738 g, which equals 738/0.60 = 1230 g wet AT. Similar calculation for a 4500 g
LGA.
m, Calculated: total wet AT weight/fetal TBW
n, Adapted from Southgate & Hey6, and Widdowson, Southgate & Hey11
o, Calculated: total body lipid * % lipid as subcutaneous AT
p, Calculated: total lipid - total subcutaneous AT lipid
q, Calculated: total deep body lipid - internal organ lipid [excl. internal AT]
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Legend to supplemental Table 1
Calculation of the total white adipose tissue weight in very preterm, preterm and AGA infants.
Fetal weight ranges from 900 g in a 25 weeks old very preterm infant; to 2525 g in a 35 weeks old preterm infant,
while we employed an average birth weight of 3,500 g from an appropriate for gestational age (AGA) term infant.
The average total body weight (TBW) lipid compositions were estimated at 2.3 g% at 25 weeks, 7.8 g% at 35
weeks and 16 g% in a 3,500 g AGA term infant.1-5,11,12 From these data we calculated 20.6 g lipid in the body of a
25 weeks old very preterm infant, 198 g lipid in the body of a 35 weeks old preterm infant and 560 g lipid in the
body of a 3,500 g AGA term infant. To estimate the amount of lipid stored in both subcutaneous and internal
white (WAT) and brown adipose tissue (BAT) we calculated the amounts of lipid stored within all fetal fatty body
organs other than WAT (i.e. brain, liver, skeletal muscle, skeleton, skin, heart, kidney).
Total adipose tissue lipid = total body lipid – total internal organ lipid (Equation A)
The total lipid content of the mentioned organs derived from a detailed study53 of the available literature on the
lipid content of each of these individual organs. The sum of the internal organ lipid weights, amounted to 7.16
g at 25 weeks, 32.4 g at 35 weeks and 60.4 g at term.53 The resulting remaining weight of lipid in adipose tissue
thus ranged from (20.6 minus 7.16) 13.4 g at 25 weeks, to 166 g at 35 weeks and 500 g at term. Merklin37 reported
that a fetus weighing 1 kg has about 8 g of brown AT, which increases to 40 g at term. When assuming that
brown and white AT have a comparable lipid content,38 the 8 g AT amounts to 8*0.18 (adipose tissue contains
18% lipid at 25 weeks, this study)= 1.47 g lipid at 25 weeks gestation, 35*0.44 = 15.4 g at 35 weeks and 40*0.55
= 21.9 g lipid at term. Consequently, there is 13.4–1.47=11.9 g WAT lipid in a 900 g fetus at 25 weeks gestation,
166-15.4=151 g WAT lipid in a 35 weeks preterm infant and 500-21.9=479 g WAT lipid in a 3,500 g AGA term
infant. These values were employed in supplemental Table 3 and Manuscript Table 4 to calculate total WAT
FA accretion rates. From these WAT and BAT lipid weights, we additionally calculated the wet AT (WAT+BAT)
weights. After correction for the adipose tissue water content at various ages of gestation, the total wet adipose
tissue masses amounted to 73.7 g in a 25 weeks old 900 g fetus, 378 g in a 35 weeks old 2525 g infant and 915 g
in a term AGA 3,500 g infant. These outcomes compared well with the reported range of 398 g AT in the average
2,280 g growth retarded infant and 757 g AT in 3,300 g AGA term infant as measured with MRI.10 It can also be
calculated that adipose tissue comprised 26.1% of the fetal TBW for a term AGA infant, which also complies
with the 23.4% of TBW as reported by Harrington.10 From this Table it can also be calculated that at term 89% of
lipid is in adipose tissue. Southgate and Hey6 reported earlier that at 25 weeks gestation body lipid is divided
equally between subcutaneous and deep body sites,2,6,12 but that at term 80% of body lipid is subcutaneous. We
therefore used 50%, 70% and 80% subcutaneous adipose tissue at 25, 35 and 40 weeks respectively to arrive
at 10.3, 139 and 448 g subcutaneous adipose tissue lipid respectively. These adipose tissue lipid weights are in
general agreement with those of Southgate and Hey,6 who reported that subcutaneous lipid increased from
around 20 g at 28 weeks to 350 g at term. When considering that lipid comprises 55% of infant adipose tissue at
term (this study), 448 g lipid also complies with the 381 g lipid (from 693*0.55=381) in a 3,300 g term infant.10 The
di!erence between the total lipid weight and the weight of subcutaneous lipid, was explained by the weight of
lipid stored internally. Calculated internal lipid weights ranged from 10.3 at 25 weeks to 112 at term and comply
well with the reported amounts of 10 g at 200 days and 80 g at term as described by Southgate and Hey.6 The
analysis of lipid stored in fatty organs other than adipose tissue allowed for the calculation of the amount of
internal lipid stored in adipose tissue. We calculated 3.26 g internal adipose tissue lipid at 25 weeks gestation,
27.4 g at 35 weeks gestation and 52.4 g at term. These subcutaneous and internal adipose tissue lipid weights
correspond with subcutaneous wet adipose tissue weights of 56 g at 25 weeks gestation; 316 g at 35 weeks
gestation and 819 g at term; and with internal wet adipose weights of 17.7 g at 25 weeks, 62.5 g at 35 weeks and
95.9 g at term. The calculated 96 g wet internal adipose tissue at term complies reasonably with the 64 g internal
adipose tissue as reported by Harrington.10
Calculation of the total amount of white adipose tissue in large for gestational age infants.
To calculate the amounts of adipose tissue in large for gestational age (LGA) infants we used a di!erent approach.
Large for gestational age (LGA) infants were set at 4,000 g and 4,500 g at delivery. Hammami8 and Schmelze9
showed that the additional weight in a LGA infant is about 50% lipid. Thus when total lipid amounts to 560 g
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in an AGA 3,500 g infant it will increase to 810 g (560+{4,000-3,500}/2) and 1,060 g in a 4,000 and 4,500 g LGA
infant, respectively. From these amounts of lipid we retrospectively calculated that lipid amounted 20.3 and 23.6
g% of TBW in these infants, respectively. These values compare well with the 905 g and 980 g in 4,244 and 4,430
LGA infants.8,9 Next, we assumed that 95% of the additional lipid is stored in adipose tissue. Thus, in a 4,000 g
LGA infant 500 g of additional weight is 250 g, 95% of which (238 g) is additionally stored in AT. Likewise, in a
4,500 LGA infant 475 g is additionally stored in AT. Since in a 3,500 AGA infant 500 g lipid was stored in AT (Table
2), the sums equal 738 and 975 g AT lipid in a 4,000 and 4,500 g infant, respectively. Secondly, we estimated
that in LGA infants, the adipose tissue lipid content increased to 60% in a 4,000 g LGA and to 65% in a 4,500
LGA infant.13,39 Thus, the amounts of total wet adipose tissue are equivalent to (738/0.60) 1,230 and (975/0.65)
1,501 g AT in a 4,000 and 4,500 g LGA term infant, respectively. When assuming that >90% of lipid is in adipose
tissue in a term infant (see above), these amounts compare well with the (905*0.90/0.62) 1,300 g AT in a 4,244
g LGA,8 the (980*0.9/0.65) 1,350 g AT in a 4,430 g LGA9 and the 1,720 g AT in a 4,475 g LGA infant born to a
mother with impaired glucose tolerance.9 We redistributed 95% of lipid in fetal adipose tissue, thus 5% remains
for redistribution in other fatty organs. Secondly, the 238 g and 475 g adipose tissue lipid equal 396 and 731 g
wet adipose tissue, thus there is (500-396) 104 g and (100-731) 269 g weight left, (250*5%) 13 g and (500*5%) 25
g of which is lipid. We redistributed this lipid and remaining lean weight proportionally between the other body
organs. However, for the calculation of the amount of lipid in these organs we assumed that the lipid% in these
organs remained the same. We calculated that the amount of lipid in these organs amounted to 63.8 g and 69.1 g
in a 4,000 g and a 4,500 g LGA infant, respectively. The marginal dierences between the directly calculated (738
and 975 g, respectively) total adipose tissue lipid and those amounts calculated with use of Equation A (746 and
991 g, respectively) conrm that the average increases in the organ lipid contents are negligible for our purpose.
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Supplemental Table 2. Intra-uterine AT-FA increment rates
Fatty acid increment rates (mg/g AT/wk)
Period trim. 1&2 trim. 3 wk 35-40
Total FA 7.35 24.2 21.7
6:0 0.01 0.11 0.11
8:0 0.02 0.01 -0.01
10:0 0.18 -0.11 -0.09
12:0 0.03 0.03 0.03
14:0 0.26 0.84 0.72
16:0 2.44 12.0 11.0
18:0 0.37 1.41 1.89
20:0 0.00 0.03 0.04
22:0 0.00 0.01 0.02
SAFA 3.32 14.4 13.7
MCSAFA 0.50 0.88 0.76
LCSAFA 2.82 13.5 12.9
16:1ω7 0.78 2.56 1.27
18:1ω7 0.22 0.43 0.39
ω7 1.00 3.00 1.66
18:1ω9 2.29 6.42 5.53
20:1ω9 0.01 0.03 0.05
ω9 2.30 6.45 5.57
MUFA 3.31 9.54 7.26
18:3ω3 0.00 0.00 0.00
22:5ω3 0.01 -0.01 0.00
22:6ω3 0.09 -0.04 -0.04
LCPω3 0.10 -0.05 -0.04
ω3 0.11 -0.05 -0.04
14:1ω5 0.02 0.09 0.03
18:2ω6 0.40 0.33 0.62
18:3ω6 0.01 0.02 0.01
20:2ω6 0.00 0.02 0.03
20:3ω6 0.02 0.02 0.04
20:4ω6 0.14 0.01 0.01
22:4ω6 0.03 0.01 0.07
22:5ω6 0.02 -0.01 -0.01
LCPω6 0.21 0.05 0.13
ω6 0.62 0.39 0.76
PUFA 0.72 0.34 0.73
LCPω3+LCPω6 0.31 0.00 0.10
Abbreviations: AT, adipose tissue; FA, fatty acid; trim., trimester; wk, week; SAFA, saturated FA; MCSAFA, medium-




Supplemental Table 3. Intra-uterine AT-FA content
Fatty acid content (g/infants’ total wet WAT)a
25 35 40 40 40
Fetal BWt 900 2525 3500 4000 4500
Total FAb 12.1 151 479 716 953
6:0 0.01 0.44 1.72 2.58 3.43
8:0 0.04 0.21 0.53 0.79 1.05
10:0 0.38 1.51 2.57 3.85 5.12
12:0 0.07 0.44 1.16 1.73 2.30
14:0 0.40 5.39 17.0 25.5 33.9
16:0 3.96 62.8 212 318 423
18:0 0.65 7.37 26.5 39.6 52.7
20:0 0.00 0.09 0.41 0.61 0.81
22:0 0.00 0.00 0.07 0.10 0.13
SAFA 5.52 78.3 262 393 523
MCFA 0.90 7.99 23.0 34.4 45.8
LCFA 4.62 70.3 239 358 477
16:1ω7 1.15 17.3 50.7 75.9 101
18:1ω7 0.36 3.55 10.3 15.4 20.6
ω7 1.51 20.9 61.0 91.3 122
18:1ω9 3.79 43.7 133 198 264
20:1ω9 0.01 0.15 0.60 0.90 1.20
ω9 3.80 43.9 133 199 265
MUFA 5.31 64.8 194 291 387
18:3ω3 0.01 0.04 0.09 0.13 0.17
22:5ω3 0.02 0.03 0.08 0.12 0.15
22:6ω3 0.14 0.59 1.46 2.18 2.90
LCPω3 0.16 0.63 1.53 2.30 3.06
ω3 0.17 0.67 1.62 2.42 3.23
14:1ω5 0.02 0.51 1.52 2.27 3.02
18:2ω6 0.71 4.48 13.2 19.8 26.3
18:3ω6 0.01 0.12 0.37 0.55 0.73
20:2ω6 0.00 0.07 0.33 0.49 0.66
20:3ω6 0.02 0.16 0.57 0.85 1.13
20:4ω6 0.25 1.32 3.15 4.71 6.27
22:4ω6 0.05 0.17 0.79 1.18 1.58
22:5ω6 0.03 0.15 0.35 0.53 0.71
LCPω6 0.35 1.87 5.19 7.77 10.3
ω6 1.08 6.46 18.8 28.1 37.4
PUFA 1.24 7.14 20.4 30.5 40.6
LCPω3+6 0.51 2.50 6.73 10.1 13.4
a, Total body FA content * lipid FA composition (g%)
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Introduction. There is no information on the whole body fatty acid (FA) contents of preterm infants,
although scattered information on the FA-composition of many organs is available.
Material and Methods. We collected data on the weights, lipid contents and FA-compositions of
the quantitatively most important fetal organs of appropriate for gestational age (AGA) Western
infants. From these we estimated the total body contents of linoleic (LA), arachidonic (AA) and
docosahexaenoic (DHA) acids at 25, 35 and 40 weeks of gestation
Results. Western infants accrete FA in the order of LA>AA>DHA at all stages during pregnancy and
the highest accretion rates are reached in the last 5 weeks of gestation, i.e. 342 mg LA, 95 mg AA and
42 mg DHA/day. At term, most of the infant’s LA, AA and DHA is located in adipose tissue (68, 44 and
50%, respectively), with substantial amounts of LA also located in skeletal muscle (17%) and skin
(13%); of AA in skeletal muscle (40%) and brain (11%); and of DHA in brain (23%) and skeletal muscle
(21%). The term AGA infant has accreted about 21 g LA, 7.5 g AA and 3 g DHA, which constitutes a
gap of 12 g LA, 3.3 g AA and 1.5 g DHA compared to a 35 weeks old AGA infant.
Conclusion. The current fetal LA, AA and DHA pool sizes and accretion rates may especially be useful
to estimate the preterm infant’s requirements and the maternal LCP needs during pregnancy. Since
they derive from populations with typically Western diets they do not necessarily re!ect ‘optimality’
or ‘health’.
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INTRODUCTION
Lipids are important constituents of our body and at term age about 50% of our dry body weight is
lipid.1-3,54 The long-chain polyunsaturated (LCP) fatty acids (FA) are important for infant growth, visual
maturity and cognitive development,55,56 but their importance is not unequivocally demonstrated
in randomized controlled trials.57-59 LCP are constituents of phospholipids (PL) in all cell membranes
and of triacylglycerides (TG) in lipoproteins and storage sites. Among the various organs, brain
contains the highest relative amounts of LCP. However, at any given time, most of the brain is water
and although its lipid content increases with age, the about 400 g infant brain at term contains only
9.8 g lipid.36,60 The absolute and relative docosahexaenoic acid (DHA) contents in brain increase
especially in the last trimester of pregnancy. In contrast, the relative amount of brain arachidonic
acid (AA) decreases, but it is conceivable that the absolute content increases due to brain growth.
Little attention has been paid to the observation that, because of its size, higher quantities of LCP
become incorporated into fetal adipose tissue compared to fetal brain,24 while substantial amounts
of LCP, notably AA, are located in the fetal liver.61 The total amount of LCP accreting in the fetus is
currently unknown. This information may be important to estimate the minimum requirements of
pregnant women and infants who are born preterm. Pregnancy causes maternal LCP losses, notably
DHA, that are associated with postnatal depression,62 while, dependent of postnatal feeding
regimen, premature birth may cause a sizeable LCP “gap” that develops in the period between birth
and term age.63
The gestational age dependent whole body LCP content can be estimated from the sum of LCP
in all LCP-rich organs, such as brain, liver, adipose tissue and (other) lean tissues (e.g. skeletal muscle,
skin and the skeleton) at di#erent time points in fetal development. Since after 25 weeks gestation
most LCP are stored in adipose tissue, skeletal muscle and brain,26 it is particularly important to have
accurate estimates of the lipid contents and FA compositions of these three organs. The currently
available data for such calculations are, however, limited, occasionally inaccurate, or based on gross
estimates by the inclusion of animal data. For example, a pivotal study22 that is frequently used for
the calculation of the whole body LCP content24,25,64,65 su#ers from an overestimation of the fetal
adipose tissue LCP contents.54 Finally, there are especially few usable data for calculating the LCP
contents of the remaining lean body tissues. The approaches used by Clandinin22 and Cunnane23 to
estimate the amount of LCP in lean body tissue created a substantial uncertainty level. Clandinin et
al.22 employed a 4% fat content for all remaining wet lean tissue (i.e. all tissues with the exception
of brain, cerebellum, spinal cord, liver and adipose tissue) and assumed its FA-composition to be
similar to that of human skeletal muscle: i.e. containing 24% ω6-FA and 1.0% ω3-FA.22 To circumvent
the same lack of available data, Cunnane et al.23 estimated from a ‘comparable whole body animal
study’ that the remaining lean body tissue (i.e. all tissues with the exception of brain, liver and
adipose tissue) contained 25% of the liver DHA contents at all times. The thus calculated 44% of
whole body DHA in the ‘remaining lean tissue’ is therefore uncertain.
In the current study we estimated the linoleic acid (LA), AA and DHA contents of a ‘reference
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fetus’ from a population with ‘typically Western’ dietary habits. Estimates were done for the whole
body contents of these FA at 25, 35 and 40 weeks of gestation. We calculated organ weights and
their lipid contents and multiplied these with reported LA, AA and DHA contents to arrive at whole
organ FA contents that subsequently summed to a whole body FA contents. From these data, we
estimated the FA-accretion rates from conception to 25 weeks, from 25 to 35 weeks gestation and
during the last 5 weeks of gestation. Gestational ages at 35 and 40 weeks were chosen because FA
increment rates in adipose tissue2 and brain60 are highest between 35 and 40 weeks.
MATERIALS AND METHODS
All data were calculated for appropriate for gestational age (AGA) infants at the !xed gestational
ages of 25, 35 and 40 weeks.
Fetal organ weights
Many of the presently employed data derive from the classical studies of Widdowson and co-workers,
who described the chemical and anatomical compositions of fetuses and infants at the various
stages of development.1-5,11,12,36,66,67 First, we estimated total body weights of AGA infants at 25, 35
and 40 weeks gestation.2,4 Next we collected data on the contributions of the quantitatively most
important fetal organs to total body weight, i.e. skeletal muscle, skeleton, skin, liver, and brain2 and
heart, lung and kidneys68 (Table 1, Fetal organ weight (%) of total body weight). From the available
data we were able to reconstruct the absolute weights of the quantitatively most important fetal
organs during gestation (Table 1, Fetal organ weight). If the reported data did not match exactly with
the 25, 35 and 40 weeks gestation of our infants, we inter- or extrapolated linearly from the available
data. No data were available for the relative adipose tissue weights during gestation. Consequently,
the relative contribution of the adipose tissue mass (Table 1, Fetal organ weight (%) of total body
weight) had to be calculated in retrospect from its absolute weight at various ages of gestation. We
therefore estimated the absolute weight of the adipose tissue mass at various ages of gestation in
AGA infants. A comprehensive explanation of this calculation is given in Supplemental Table 1 of
Chapter 6.1). In short, the weight of the wet adipose tissue compartment derives from the di8erence
between the reported2 total fetal lipid content (Table 1; Fetal organ lipid content (g); total body)
and the sum of the lipid weights of the other organs (Table 1, Fetal organ lipid content (g); sum of
non-adipose lipid), which was subsequently corrected for the adipose tissue water content at the
various gestational ages.54 To support the outcomes of our calculations on relative and absolute
organ weights with the available literature we compared with some detailed post mortem2,22,60,66,68-70
and live born8-10 studies that provided data for the weights of the organs of preterm and term infants
during gestation. The outcomes of our calculations, including those for the weight of the adipose
tissue compartment during gestation,8-10 compared very well with these literature data (see also
Chapter 6.1).
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Table 1. Fetal organ weights and organ lipid contents
Fetal age (weeks) 25 35 40
Fetal weight (g) 900 2525 3500 a
Fetal organ weight (%) of total body weighy
Skeletal muscle 25 25 25 b
Skeleton 21 19 18 b
Skin 13 14 15 b
Liver 4 5 5 b
Brain 13 13 13 b
Heart 0.6 0.5 0.5 c
Lungs 2.5 2.0 1.9 c
Kidneys 1.5 1.2 1.2 c
Adipose tissue 8.2 15 26 d
Sum 88 93 104
Fetal organ weight (g)
Skeletal muscle 225 631 875 e
Skeleton 189 480 630 e
Skin 117 354 525 e
Liver 32.5 99.5 119 f
Brain 104 265 371 g
Heart 5.4 12.6 17.5 e
Lungs 19.2 46.3 62.1 e
Kidneys 13.5 30.3 42.0 e
Adipose tissue 73.7 378 915 d
Sum 760 2250 3494
Missing 15.5 10.9 0.2
Fetal organ lipid content (g/100 g wet weight)
Total body 2.3 7.8 16 b
Skeletal muscle 1.4 1.8 2.0 h
Skeleton 0 0.15 0.14 b
Skin 1 3 5 i
Liver 2.09 3.37 4.01 j
Brain 1.40 1.79 2.37 j.k
Heart 1.8 1.8 1.8 k
Lungs 1.8 1.8 1.8 k
Kidneys 1.9 1.9 1.9 k
Adipose tissue 18.4 43.9 54.7 l
Fetal organ lipid content (g)
Total body 20.7 197 560 m
Skeletal muscle 3.15 11.4 17.5 m
Skeleton 0 0.72 0.88 m
Skin 1.17 10.6 26.3 m
Liver 0.68 3.35 4.77 m
Brain 1.46 4.74 8.79 m
Heart 0.10 0.23 0.32 m
Lungs 0.35 0.83 1.12 m
Kidneys 0.26 0.58 0.80 m
Adipose tissue 13.6 166 501 m
Sum of non-adipose lipid 7.16 32.4 60.4 m
a, from Widdowson1-2; b, from Widdowson2; c, from Phillips68; d, Chapter 6.1 Supplemental Table 1; e, Calculated
from fetal organ weight (%) of total body weight; f, Mean value of Widdowson, and Coppoletta & Wollbach2,69;
g, Mean value of Blinkov & Glezer, and Widdowson & Southgate60,66;
h, Extrapolated from White et al.36, and Dickerson & Widdowson67; i, Extrapolated from Lampe et al. and Williams
et al.71-72
j, Calculated from Martinez73; k, from White et al.36; l, from Chapter 6.1
m, Calculated from fetal organ weight and organ lipid content (g/100 g wet weight)
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Fetal organ lipid contents
To estimate the amounts of lipid in organs other than adipose tissue, we collected data on the
lipid contents (Table 1, Fetal organ lipid content) of the total body,2,4 skeletal muscle36,66 skeleton,2
skin,71,72 heart and kidneys.36 It is in this respect important to note that in the studies that provided
data for the FA composition of the skin, the subcutaneous adipose tissue was carefully removed
during preparation of the skin samples.71,72 Again, when the reported data did not match exactly
with the 25, 35 and 40 weeks gestation of our reference infants, we inter- or extrapolated linearly
from the reported data. If several studies reported data for the same fetal age, we employed their
mean. The lipid content of wet adipose tissue at various times of gestation derived from our earlier
study.54 Data regarding the lipid composition of whole wet brain and liver derived from a study
reporting nmol FA/g wet tissue in developing infants.73 We used this study, since it was the only
study reporting both lipid contents and the individual organ FA contents of both preterm and
term infants. Secondly, we believe that this study by Martinez73 provides the most accurate data,
since a whole homogenized hemisphere was used, while e.g. Farquharson et al.19 measured the
composition of cortex grey matter from the parietal cortex, and Makrides et al.74 collected samples
of frontal lobe, including cortex and underlying white matter. To transform nmol FA/g wet tissue to
the actual organ lipid weight we employed an average molecular weight of 292 g/mol for the sum
of all FA (total FA).
From the organ weights and the relative lipid contents of the organs we calculated the absolute
amount of lipid in each organ (Table 2, Fetal organ lipid content). To evaluate these outcomes, we
compared with other data from the literature. For this we additionally calculated the amount of
lipid in each organ as a percentage of dry weight (i.e. after correcting for organ water content), since
the lipid percentages for most organs are documented as percentage lipid of dry organ weight.
The respective organ water weights, calculated organ dry weights and organ dry weight lipid
percentages are presented in Supplemental Table 1. The calculated lipid contents of brain (1.4 and
2.4 g% of wet weight and 17 and 23% of dry weight at 25 and 40 weeks, respectively) comply well
with the available data for brain.36,75,76 These indicate: 1.0-1.5 g% lipid in brain wet weight at 14-18
weeks and 2.6 g% at 40 weeks gestation;36,75 and 18 and 25 g% lipid of dry brain weight at 25 and 40
weeks of gestation,76 respectively. For the liver, the calculated 2.1 and 4.0 g% lipid comply well with
the reported36,61 2.4 and 4.1-5.0 g% lipid of wet liver weight at 28 and 40 weeks, respectively. Hence,
the calculated lipid contents of the organs in the reconstructed reference infants compare well with
the available literature.
Fetal organ FA composition, organ FA contents, FA distribution among organs and FA
accretion rates
To calculate the LA, AA and DHA contents of all organs (Table 2, mg/organ), we extracted the most
appropriate data from the literature (Table 2, FA%). To estimate the FA compositions of skeletal
muscle, we employed data from infants <2 years of age, since no separate intrauterine data were
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available.27,77,78 Similarly, data for the FA composition of whole skin samples derived from a study
that described the FA composition in skin of 50 year old males,79,80 although there is compelling
evidence of a changing skin lipid composition during gestation.72 For reasons explained earlier,
we used the FA compositions of brain and liver expressed in nmol/g wet tissue from Martinez.73
This study is amongst the few19,74 to report the FA composition as a percentage of total FA in the
combined PL-fractions, as opposed to the most of studies reporting FA compositions of the various
isolated PL fractions.47,75,76,81 To calculate the FA compositions of brain and liver, we used molecular
weights of 280.5 g/mol for LA, 304.5 g/mol for AA and 328.5 g/mol for DHA. The resulting 7.76 g%
DHA and 9.22 g% AA in the brain of a term infant, compared well with the reported postnatal 8.5-
9.7 g% DHA and the 10.6-10.9 g% AA as reported by Farquharson et al.19 and Makrides et al.74 The
outcomes of 4.08 g% DHA and 8.63 g% AA in the infant liver were in reasonable agreement with the
6.18 g% DHA and the 8.84 g% AA as calculated from the equations of Farquharson et al.61 Due to the
Table 2. Fetal organ lipid content. FA composition. FA content and organ distribution of FA
Fetal age (weeks) 25 35 40 25 35 40 25 35 40 25 35 40
Fetal weight (g) 900 2525 3500 900 2525 3500 900 2525 3500 900 2525 3500
Tissue Lipid content (g)a LA (g%)b LA (mg/organ)c LA/total LA (%)d
Skeletal muscle 3.15 11.4 17.5 21.4 21.4 21.4e 674 2430 3743 41 26 17
Skin 1.17 10.6 26.3 10.6 10.6 10.6f 124 1124 2783 7.6 12 13
Liver 0.68 3.35 4.77 5.94 7.26 7.92g 40 243 378 2.5 2.6 1.8
Brain 1.45 4.74 8.79 0.22 0.24 0.25g 3.2 11 22 0.2 0.1 0.1
Adipose tissue 13.6 166 501 5.90 2.97 2.76h 802 4930 13828 48 59 68
Lipid content (g)a AA (g%)b AA (mg/organ)c AA/total AA (%)d
Skeletal muscle 3.15 11.4 17.5 17.2 17.2 17.2e 542 1955 3012 50 46 40
Skin 1.17 10.6 26.3 0.14 0.14 0.14f 1.6 15 37 0.2 0.4 0.5
Liver 0.68 3.35 4.77 13.6 10.3 8.63g 93 345 412 8.6 8.1 5.4
Brain 1.45 4.74 8.79 10.9 9.79 9.22g 158 464 810 15 11 11
Adipose tissue 13.6 166 501 2.06 0.88 0.66h 279 1461 3302 26 34 44
Lipid content (g)a DHA (g%)b DHA (mg/organ)c DHA/total DHA (%)d
Skeletal muscle 3.15 11.4 17.5 3.51 3.51 3.51e 111 399 614 28 26 21
Skin 1.17 10.6 26.3 0 0 0f 0 0 0 0 0 0
Liver 0.68 3.35 4.77 3.62 3.93 4.08g 25 132 195 6.2 8.6 6.5
Brain 1.45 4.74 8.79 7.03 7.52 7.76g 102 356 682 26 23 23
Adipose tissue 13.6 166 501 1.18 0.39 0.30h 160 647 1503 40 42 50
FA, fatty acids; LA, linoleic acid; AA, arachidonic acid; DHA docosahexaenoic acid
a) Calculated from: fetal organ weight*fetal organ lipid content
b) g/100 g FA
c) FA contents (mg/organ) calculated from: organ lipid content (g)*organ lipid FA composition (g/100 g FA)
d) g FA in organ as percentage of whole body FA (in g)
e) Mean of Sanjurjo et al.27 and Baur et al.77-78
f ) From Lampe et al.71,80 and Elias79
g) Calculated from Martinez73
h) From Chapter 6.1, assuming that white and brown adipose tissue have similar FA compositions
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similarity of our term infants with data from others, we assumed that our calculations for preterm
infants, which could not be compared with data from the literature, were of sucient quality to be
used for additional calculations for body FA accretion rates.
Data for the FA composition of white adipose tissue at various ages of gestation derived from
Kuipers et al.54 Due to the high similarity of the FA compositions of brown and white adipose
tissue,82 we did not dierentiate between these two. No data were available for the FA compositions
of heart, lung and kidneys. However their essential-FA (EFA) and LCP contents seem negligible (the
cumulative amount of lipid in heart, lungs and kidneys amounts to 3.4%, 0.8% and 0.4% of total lipid
at 25, 35 and 40 weeks gestation, respectively), when compared to the sum of the EFA and LCP in the
other organs, both because of their relatively low weights and lipid contents (see Table 1).10,28 Thus,
the absence of data for heart, lung and kidneys is unfortunate, but unlikely to have a major inuence
on the calculated sum of FA in the fetal body, although especially lung has a large epithelium surface
area, which might contain considerable amounts of LA and LCP-rich PL.
From the FA compositions of the skin, skeletal muscle, brain, liver and adipose tissue and their
total lipid contents, we calculated the total amounts of LA, AA and DHA in each of these organs
and combined these to arrive at the corresponding amounts in the entire fetal body at 25, 35 and
40 weeks gestation (Table 3, Total amount). Accretion rates (0-25 weeks, 25-35 weeks and 35-40
weeks) were calculated from the dierences between the whole body amounts of LA, AA and DHA
at dierent gestational ages, divided by the time dierence (Table 3, Accretion rate).
RESULTS
Organ and whole body DHA, LA and AA contents
Table 2 and Figure 1 show the LA, AA and DHA contents in skeletal muscle, skin, liver, brain and
adipose tissue, which are organs that together represent 63, 72 and 84 % (Table 1) of the fetal
body weight at 25, 35 and 40 gestational weeks, respectively. Concomitant with fetal growth, the
amounts of LA, AA and DHA increased in all organs with increasing gestational age, while the
relative contributions (g per 100 g FA; g%) either increased (e.g. brain DHA) or decreased (e.g. brain
AA). We estimated (Table 3) that at 25 gestational weeks, the whole fetal body contains about 1.6
g LA, 1.1 g AA and 0.4 g DHA, which subsequently increased to 8.7 g LA, 4.2 g AA and 1.5 g DHA, at
Table 3. Total body FA content and accretion rates for a fetus during gestationa,b
Gestational age (weeks) 25 35 40 0-25 25-35 35-40
Fetal weight (g) 900 2525 3500 0-900 900-2525 2525-3500
Total amount (g/body)c Accretion rate (mg/day)
LA 1.64 8.74 20.73 9.39 101.35 342.49
AA 1.07 4.24 7.57 6.14 45.22 95.25
DHA 0.4 1.53 2.99 2.27 16.25 41.65
a, data are in g/body and mg/day
b, calculated from the dierence in the whole body FA content/elapsed time
c, sum from Table 2
6.2
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35 weeks, while a 3,500 g term infant harbors about 20.7 g LA, 7.6 g AA and 3.0 g DHA (Figure 2A).
LA, AA and DHA organ distribution
Table 2 and Figure 1 show the distributions of LA, AA and DHA among the various organs throughout
gestation. Most of the bodily LA was located in adipose tissue and its local abundance increased
consistently with advancing gestation (from 48% of the whole body LA pool at 25 weeks to 68% at
40 weeks). This increase occurred mainly at the expense of its location in skeletal muscle (from 41 at
25 weeks to 17% at 40 weeks). With advancing gestation LA in skin increased from 7.6% at 25 weeks
to 13% at 40 weeks. Lower percentages of whole body LA were located in the liver, while the LA in
brain had a negligible contribution.
Until 35 gestational weeks, most of bodily AA (50% at 25 weeks and 40% at 40 weeks) was
located in skeletal muscle (Figure 1). Adipose tissue moved to the preferred location of bodily AA
in the last 5 weeks of gestation and at term more AA was located in adipose tissue (44%) than
in skeletal muscle (40%). The third most importance location of AA was in brain, but the brain’s
position of preference decreased with advancing gestation (from 15% at 25 weeks to 11% at 40
weeks). The liver ranked low in the hierarchy of bodily AA and its contribution dropped steeply from
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Figure 1. The gestational age dependent linoleic (LA), arachidonic (AA) and docosahexaenoic acid (DHA)
content and distribution among the quantitatively most important fetal organs. Organ fatty acid distributions





















































































Figure 2. Gestational age dependent A: Fetal whole body linoleic (LA), arachidonic (AA) and docosahexaenoic
acid (DHA) contents (in g/whole body); and B: LA, AA and DHA accretion rates (in mg/day).
extent but at term the contribution had nevertheless increased by 2.5 fold (0.2% at 25 weeks and
0.5% at 40 weeks) (Figure 1).
The majority of bodily DHA was located in adipose tissue (40% at 25 weeks) and its contribution
increased with gestation (to 50% at 40 weeks). The second and third most important locations of
DHA were in brain (26% at 24 weeks; 23% at 40 weeks) and skeletal muscle (28% at 25 weeks to 21%
at 40 weeks). Liver contributed to a seemingly gestational age independent percentage of 6.2-8.6%,
while DHA in skin did not contribute to an appreciable extent (Table 2).
LA, AA and DHA whole body amounts and their accretion rates
Table 3 and Figure 2 show the calculated whole body amounts of LA, AA and DHA and their accretion
rates during gestation. The term infant of 3,500 g has accumulated a total amount of about 20.7 g
LA, 7.6 g AA and 3.0 g DHA (Figure 2A). LA, AA and DHA accretion rates increased from about 9.4, 6.1
and 2.3 mg/day, respectively, in the !rst 25 weeks to 101, 45 and 16 mg/day in week 25-35 (Figure
2B). Subsequently, the accretion rates increased 2-3 fold in the last 5 weeks of gestation, to 342 mg
LA, 95 mg AA and 42 mg DHA per day (Figure 2B).
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DISCUSSION
To estimate fetal whole body LA, AA and DHA contents and accretion rates, we reconstructed
‘Western reference infants’ at 25, 35 and 40 gestational weeks. At all stages during pregnancy,
infants accrete FA in the order of LA>AA>DHA (Figure 2), with the highest accretion rates in the last 5
weeks of gestation (i.e. 342 mg LA, 95 mg AA and 42 mg DHA per day). As expected1, these accretion
rates are lower than earlier estimates of 552 mg  6-FA and 67 mg  3-FA per day during the last
trimester of intrauterine development.22 We calculated that a term AGA infant with a body weight
of 3,500 g has accreted about 21 g LA, 7.6 g AA and 3 g DHA (Figure 2). The whole body FA ‘gap’ with
an AGA infant at 35 weeks amounts to 12 g LA, 3.3 g AA and 1.5 g DHA. With advancing gestation,
LA became increasingly located in adipose tissue (Figure 1). At term whole body LA was distributed
in the order adipose tissue>skeletal muscle>skin. Most AA was located in skeletal muscle until 35
weeks of gestation. The contribution of AA in adipose tissue increased rapidly during the last 5
weeks of gestation, and at term AA was located in the order adipose tissue>skeletal muscle>brain
(Figure 1). With advancing gestation the contribution of DHA in adipose tissue increased, while that
of skeletal muscle decreased. At term, the contribution of DHA in the various organs to whole body
DHA declined in the order adipose tissue>brain>skeletal muscle (Figure 1). Our data reemphasize
that the widely recognized high relative amounts of DHA and AA in brain do not imply that brain
contains the highest absolute amounts of DHA and AA. Adipose tissue seems to be an important
storage compartment of LA, AA and DHA.
What current data are and what they are not
Our data derive from populations with typically Western diets and should therefore be viewed upon
as ‘references’ that do not necessarily re!ect ‘optimality’ or ‘health’. Human evolution is likely to have
occurred in East-African ecosystems where the land meets with water83,84 and the diet consequently
provided considerably lower intakes of LA and much higher intakes of both AA and DHA.83 We
recently showed higher LA in brain and liver (in g per 100 g FA), lower LA in adipose tissue, and both
lower AA and higher DHA in brain, liver and adipose tissue in East-African infants who were (still)
born to women living close the Victoria Lake (Tanzania) (Chapter 5). These women have low intakes
of re&ned vegetable oils and lifetime high intakes of AA and DHA-rich from local &sh.43 Their diets
are consequently much closer to the diet on which homo sapiens’ genome evolved during the 2.5
million years since the rapid growth of our unique brain,84 suggesting that the LA, AA and DHA
contents of their infants are closer to evolutionary optimality than the currently presented.
Adipose tissue as a postnatal mobilizable store
Haggerty24,25,65 suggested that infant adipose tissue might be a store from which DHA can be
mobilized during infant development. It was noted that adipose tissue contains 16-50 times more
DHA compared to the infants’ brain at delivery.24,25,65 The present and the earlier study of Cunnane
et al.23 demonstrate that this &gure constitutes an overestimation, for which the reasons have been
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outlined before,54 (see also footnote **). In the present study we found that the total amount of DHA
in adipose tissue is about 2.2-fold higher than that in brain (Table 2: 1,502 mg/682 mg), which is in
reasonable agreement with Cunnane et al.,23 who calculated a 1.5-times higher DHA in adipose tissue
(1,053 mg/720 mg). Nevertheless, the sizeable amounts of DHA in adipose tissue, may be of great
benet to the term infant receiving human milk or a formula with no or low amounts of preformed
DHA. Intrauterine accretion of LCP in the fetus is likely to be stimulated by the lower maternal
insulin sensitivity with compensatory hyperinsulinemia in the third trimester,46 the hormones of
pregnancy85 and ‘biomagnication’.86 Each of these inuence chain elongation/desaturation via a.o.
FADS1 and FADS2 and also transplacental transfer, while their inuence becomes instantaneously
discontinued after birth. It must, however, be noted that it is currently unknown to what extent the
LCP in adipose tissue can become mobilized. Our data, and those of others, refer to the FA in whole
adipose tissues and therefore do not distinguish between those located in membrane PL and the
intracellular TG droplets. It has also been suggested that LCP may preferentially become mobilized
from stores.87
Filling the preterm ‘gap’
Preterm infants have smaller LCP reserves in adipose tissue (Table 3), which may cause poor
ability to compensate for the discontinued maternal supply after preterm delivery. The current
brain-centered view may convey the suggestion that, upon LCP shortage, brain ranks highest
in the LCP accretion hierarchy. It is, however, questionable whether this is the case. For instance,
RBC-LCP are often used as a proxy for the brain-LCP status,88 which suggests that the available LCP
are distributed among many organs. That is, it seems that during LCP shortage the available LCP
might in reality be proportionately distributed across a huge distribution volume. Moreover, LCP
mobilization from adipose tissue might become inhibited by feeding fortied human milk or special
formulas with extra energy and/or protein in the rst weeks to months after discharge, a regimen
that is often employed to promote catch up growth of preferably lean body mass.89 During these
catch up feeding regimes, a low dietary protein content has been shown to be rate-limiting in the
accretion of lean body mass in preterm infants,89 but it is currently unknown whether an insu"cient
LCP supply is also rate limiting under these conditions. The suggested inability to mobilize LCP from
adipose tissue under such (hypercaloric) catch-up feeding regimes might, especially in the light of
the limited postnatal synthesis from precursors,90 have to become compensated by augmenting
the supply of preformed LCP in the diet. This can be achieved by either augmenting the human
milk concentration via maternal supplements, or by a high infant formula LCP content. The current
LA, AA and DHA pool sizes and accretion rates may be useful to estimate the preterm infant’s
** The much higher adipose tissue LCP contents used for this calculation derived from the study that we recently
criticized because of: 1) the unusually high LCP contents in adipose tissue of preterm and term infants, 2) the use
of packed, as opposed to capillary, gas chromatographic columns, 3) the pooling of preterm and term infants
between 22-43 weeks gestation to calculate an average adipose tissue FA content during gestation, while the
contribution of LCP to the total FA content in adipose tissue is nowadays known26,54 to decrease substantially
during gestation, secondary to the large inux of the mostly de novo synthesized SAFA and MUFA.
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requirements, after correction for oxidation and endogenous synthesis and also to estimate the
maternal LCP needs during pregnancy.
Linoleic acid, skin and the preterm infant dilemma
Skin seems to become an increasingly important organ for LA deposition with advancing gestation
(Table 2). The LA increase occurred in the context of a gestational age dependent growth with
concomitantly decreasing surface/volume ratio. Unfortunately, we were unable to locate data for
the fetal skin FA-composition. The currently employed skin LA content comes from adult males and
is therefore likely to cause an overestimation of the genuine fetal skin LA content. Moreover, the
intrauterine environment is characterized by a low LA status since much of the transplacentally
transported LA is returned to the mother.91 LA is an indispensible building block92 of omega-
O-acylceramides, which are unique to the epidermis and responsible for the skin’s water barrier
function.92,93 After birth, the ceramide content of the human epidermis increases,72 while in mice
the postnatal LA content of the epidermal ceramides increases 4-fold to reach adult values after
50 days.94 The increase of LA in skin coincides with the postnatal mother-to-infant LA surge via
either the human milk or the infant formula, causing a concomitant rapid increase of the infant’s
LA status.44 The low intrauterine LA status may therefore be of importance to preserve maximum
communication with the mother via the amniotic +uid while the postnatal LA surge via the milk
might be a driving force for the postnatal building of the skin’s water barrier.83 We have previously
reported that East-African infants seem to have less trans-epidermal water losses (TEWL) than
Caucasian infants immediately after birth, that weight loss on day 1 postpartum was correlated with
TEWL, that TEWL was highest in the most premature infants, that TEWL in prematures remained
almost constant during the 6rst 4 days after delivery and that large for gestational age infants have
higher TEWL than AGA infants of the same gestational age.95 All of these observations may relate to
LA’s peculiar behavior in the perinatal phase, with low accretion in the intrauterine period and rapid
accretion after birth, when the fetus cannot avoid the sizeable amounts of LA transferred via the
milk, as opposed to the fetus-to-mother return of transplacentally transported LA when still residing
in the womb.91
More data on the genuine LA content of fetal skin will be needed to re6ne the current model.
This is important, since LA might in the above sense be typical for the many dilemma’s that surround
premature birth, in which one cannot ignore premature exposure to the extrauterine environment
but at the same time would like to mimic the intrauterine environment up to corrected term age. The
high postnatal LA transfer, especially in Western populations, where a high LA intake is advocated
for cardiovascular health,96 may be of bene6t to the rapid limitation of TEWL, but may at the same
time compete with both AA and DHA for incorporation into PL and inhibit the conversion of LA and
ALA to LCP.97 A balanced feeding with the minimum amount of LA for the building of a skin water





The organ weights, as calculated from their percentages of total body mass in one of the classical
studies by Widdowson,1,2 compared well with the outcomes of more recently conducted post-
mortem studies.68,70 Unfortunately, very limited data were available to compare the lipid and FA
compositions of various organs during gestation, while for skin and skeletal muscle we were only
able to nd data on the FA composition after delivery. As outlined above, this is likely to have caused
an overestimation of the LA deposits and whole body accretion rate. Nevertheless, the few data that
allowed for comparison (see ‘Materials and Methods’ section) proved highly consistent. Thus, we
are condent that the current estimates of the organ weights, lipid contents and FA compositions
(those of the adipose tissue compartment included), are of sucient quality to provide a reasonable
estimate of fetal organ FA contents, whole body FA contents and FA accretion rates. Secondly, this
is the rst report to provide FA accretion rates after reconstruction of an almost complete Western
infant, while to our knowledge this is also the rst report to include only those data that derive from
FA analyses with capillary GC-columns.
The study suers from some additional weaknesses. The various reports that are at the basis of
our calculations employed dierent analytical methods and included dierent FA in their sum of
total FA. Many of the data are based on limited subject numbers, which may relate to the obvious
ethical issues that are inherent to this kind of research. There might have been important dietary
dierences between populations from which the data have been extracted, while also dietary
changes might have occurred in time. Each of these sources of variation in the original data may
add up to sizeable dierences in the nal outcomes. Also, we did not have information of the FA
compositions of all organs, while the quantitatively less important organs such as the lungs and
the circulatory system have large endothelial surfaces and might thus be expected to be important
FA sources that are presently not accounted for. Finally, it is important to reemphasize that we
reconstructed an infant from data available from Western infants.
CONCLUSIONS
Western infants accrete FA in the order of LA>AA>DHA at all stages during pregnancy and the
highest accretion rates are reached in the last 5 weeks of gestation, i.e. 342 mg LA, 95 mg AA and
42 mg DHA per day. At term, most of the infant’s LA, AA and DHA is located in adipose tissue, with
substantial amounts of LA also located in skeletal muscle and skin, of AA in skeletal muscle and
to a lesser extent in brain, and of DHA in brain and skeletal muscle. The full term AGA infant has
accreted about, 21 g LA, 7.5 g AA and 3 g DHA and the‘gap’with an AGA infant of 35 weeks amounts
to 12 g LA, 3.3 g AA and 1.5 g DHA. This ‘gap’ obviously results from the prematurely discontinued
transplacental LCP transfer and diminished LCP synthesis from precursors. Limited amount of
adipose, hypercaloric postnatal feeding regimens and the low LCP contents in Western human milk
and infant formula however, hamper postnatal lling of this ‘gap’. The current fetal LA, AA and DHA
pool sizes and accretion rates may especially be useful to estimate the preterm infant’s requirements
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and the maternal LCP needs during pregnancy. Since they derive from populations with typically
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Umbilical veins (UV) and arteries (UA) of preeclamptic women in Curaçao harbor lower long chain
polyunsaturated fatty acids (LCP). The present aim was to test these ndings in Mwanza (Tanzania),
whose inhabitants have high LCP 3 and LCP 6 intakes from Lake Victoria sh. Women with
preeclampsia (n=28) in Mwanza had lower PUFA and higher 20:0 in UV and UA, compared with
normotensive/non-proteinuric controls (n=31). Their UV 22:6ω3, 22:4ω6, LCPω6, ω6 and LCPω3+ω6
were lower, while saturated FA, potentially de novo synthesized FA (Σde novo) and (Σde novo)/
(LCPω3+ω6) ratio were higher. Their UA had higher 16:1ω7, ω7, 18:0 and 16:1ω7/16:0. Umbilical
vessels in Mwanza had higher 22:6 3, LCP 3,  3 and 16:0, and lower 22:5 6, 20:2 6, 18:1 9 and
 9, compared with those in Curaçao. Preeclampsia in both Mwanza and Curaçao is characterized by
lower LCP and higher Σde novo. An explanation might be placental dysfunction, while the similarity
of umbilical vessel FA-abnormalities in preeclamptic and diabetic pregnancies suggests insulin
resistance as common denominator.
309
Higher de novo synthesized fatty acids in preeclampsia
7.1
INTRODUCTION
Preeclampsia is a leading cause of fetal and maternal morbidity and mortality in both developing
and developed countries.1,2 Clinically, preeclampsia is characterized by the combination of
hypertension and proteinuria. The etiology is as yet poorly understood and there might be multiple
pathways involved. Important characteristics are supercial placentation and maternal insulin
resistance, dyslipidemia,3 endothelial dysfunction, and augmented systemic vascular resistance,
platelet aggregation and coagulation.4
Long chain polyunsaturated fatty acids (LCP; ≥20 carbon atoms with ≥3 double bonds in the
cis conguration) are either obtained from the diet or synthesized from their parent essential fatty
acids (EFA) linoleic (LA; 18:2 6) and alpha-linolenic (ALA; 18:3 3) acids by alternating desaturation
and elongation. Important LCP are arachidonic (AA, 20:4 6), eicosapentaenoic (EPA, 20:5 3)
and docosahexaenoic (DHA, 22:6 3) acids. AA derives from LA, while both EPA and DHA derive
from ALA. Generally, AA is abundant in meat, poultry and eggs, while EPA and DHA are abundant
in sh, meat and eggs. By their incorporation into phospholipids, LCP are determinants of the
physical-chemical properties of membranes and thereby the function of embedded proteins. Their
eicosanoid metabolites are involved in signal transduction, while both LCP and their metabolites
in!uence phenotype by interacting with our genome.5
We have previously reported that umbilical vessels of preeclamptic women in Curaçao harbor
relatively low contents of both LCPω3 and LCPω6.6 To our knowledge there are no other reports on
the fetal LCP status in preeclampsia. A study on the EFA status of mother and child in pregnancy-
induced hypertension did not reveal di&erences in umbilical vessel wall polyunsaturated fatty acids
(PUFA), compared with normotensive controls.7 Recently, the free fatty acid fraction of placental
tissue in preeclampsia has been reported to harbor lower LCPω3 (DHA) and LCPω6 (AA),8 which
contrasts with the normal levels of these LCP in the plasma free fatty acid fraction of preeclamptic
women as compared to normotensive non-proteinuric women.9
The aim of the present study was to test the consistency of our ndings in Curaçao. We were
interested to see whether studying preeclampsia in a population with high intakes of both LCPω3
and LCPω6 would conrm our previous ndings of lower LCPω3 and LCPω6 in preeclamptic vessels.
For this we conducted a case-control study on the fatty acid composition of the umbilical vessel walls
of preeclamptic and normotensive/non-proteinuretic pregnancies in Mwanza (Tanzania). Mwanza
is located on the southern shore of Lake Victoria, which is the world’s second largest freshwater lake.
The inhabitants of Mwanza are known to have high intakes of DHA, EPA and also AA from the local
sh,10,11 while preeclampsia is a prevalent pregnancy complication in this population.
SUBJECTS AND METHODS
Study design and study groups
Samples were collected by one of us (VJBH) in the labor ward of the Bugando Medical Centre in
Mwanza (North-West Tanzania). They were derived from a single study on consecutive preeclampsia
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cases within a 6 months period. Samples from apparently healthy pregnant controls were
collected in the same period. Matching to preeclampsia cases was based on an as close as possible
comparability of gestational age and parity. All investigated women were of Tanzanian descent.
Their diets were mainly composed of (mostly cottonseed-oil fried) lake !sh and green vegetables,
together with “ugali” (maize porridge) or rice. The anthropometric data of the mothers and their
children were recorded. Data on gestational age, parity, caesarean delivery and diet were obtained
from the medical records, or from translator-assisted interview in Kiswahili by one of us (VJBH).
Preeclampsia was de!ned as a diastolic blood pressure ≥90 mm Hg on ≥2 consecutive occasions
≥4 h apart (or as a diastolic pressure ≥110 mm Hg on any 1 occasion) in previously normotensive
women in combination with proteinuria (2 specimens of urine collected ≥4 h apart with ≥0.3 g
albumin/L).12 The !nal study group was composed of 28 women with preeclampsia, while thirty-
one normotensive, nonproteinuric pregnant women served as controls. Their characteristics are
presented in Table 1 for the whole study group. The study was approved by the National Institute of
Medical Research (NIMR/HQ/R.8a/Vol. IX/145, Dar es Salaam, dated June 16, 2003 and NIMR/HQ/Vol.
IX/369, Dar es Salaam, dated January 17, 2005) and was in agreement with the Helsinki Declaration
of 1975 as revised in 2000.
Samples and analyses
Immediately after delivery an approximately 10 cm sample of the umbilical cord, located at the
most proximal site to the placenta, was removed and rinsed with a 0.9% NaCl solution. This sample
was placed in a cold (4 °C) 0.9% NaCl solution until further processing. The umbilical cord sample
was cut into 1 cm pieces. The two arteries and the vein were subsequently dissected from the
surrounding tissue, preferably from a 1 cm piece located at 6-8 cm from the placenta. The arteries
and vein were thoroughly washed with a cold 0.9 % NaCL solution and transferred to te'on-sealable
Table 1. Clinical characteristics of preeclamptics and normotensive controls
Controls (n=28) Preeclampsia (n=31) p
Age (years) 23.7 (15-37) 24.5 (16-37) ns
Length (m) 1.59 (1.47-1.80) 1.6 (1.47-1.76) ns
Weight (kg) 58.5 (46.5-88.0) 68.8 (46.0-88.6) 0.001
BMI (kg/m2 23 (19.8-28.1) 26.9 (18.9-31.8) <0.0001
Upper arm circumference (cm) 24.8 (21.0-30.0) 27.5 (19.5-33.0) 0.002
Diastolic blood pressure (mm Hg) 74 (60-90) 117 (100-170) <0.0001
Systolic blood pressure (mm Hg) 117 (100-129) 176 (148-220) <0.0001
Nullipara (%)* 54.8 [17] 57.1 [16] ns
Caesarian section (%)* 9.7 [3] 60.7 [17] <0.0001
Gestation age at delivery (weeks) 39 (33.7-41.3) 37.9 (33.9-41.4) 0.03
Infant birth weight (g) 3025 (1600-3800) 2552 (1300-3500) 0.001
Dietary data
Days of !sh/week (number/week) 3 (1-7) 3 (1-7) ns
Days of meat/week (number/week) 2 (0-7) 2 (1-7) ns
Data are means (range) unless indicated otherwise. *Numbers in brackets
Between-group comparisons of clinical characteristics were done with Student’s t or Chi-square test
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tubes that contained 2 mL methanol:HCl (5:1 v/v; 6 mol HCl/L) and 1 mg butylated hydroxytoluene
(antioxidant). Fatty acids are stable in this mixture for months.11
All samples were stored at room temperature and in the dark until transportation to the University
Medical Center Groningen (The Netherlands) for analysis of their long chain fatty acid contents.
Analyses of fatty acid methyl esters (FAME) were performed by capillary gas chromatography with
split injection and ame-ionization detection, following the addition of an internal quantication
standard (17:0 methyl ester), transmethylation and extraction of FAME.13 Fatty acid compositions
were expressed as relative amounts (mol%) and fatty acid ratios in mol/mol. The following fatty
acids were determined: SAFAs 14:0, 16:0, 18:0, 20:0, 22:0; ω3-series, 18:3ω3, 20:5ω3, 22:5ω3, 22:6ω3;
ω6-series, 18:2ω6, 20:2ω6, 20:3ω6, 20:4ω6, 22:4ω6, 22:5ω6; ω7-series, 16:1ω7, 18:1ω7; ω9-series,
18:1ω9, 20:3ω9. Sums of SAFA, MUFA, PUFA, ω6, ω3, ω3+6, LCPω3, LCPω6, LCPω3+6, Σde novo (i.e.
14:0, 16:0, 18:0, 20:0, ω7 and ω9) were calculated as well as ratios of individual fatty acids.
Statistics
Between-group comparisons of clinical characteristics were tested with Student’s t test at p<0.05.14
For the detection of between-group di"erences in fatty acids of the total study population, we
rst tested whether each of the individual fatty acids or ratios correlated with gestational age in
cases and controls, separately, by calculating the Spearman rank coe#cient at p<0.05. The nding
of insignicant correlations in both groups was followed by use of the Mann-Whitney U test at
p<0.05 for the analysis of between-group di"erences. The nding of signicant correlations in cases,
controls, or both, was followed by analysis of covariance (ANCOVA) with gestational age as the
covariate at p<0.05. We were able to match 21 patients and 21 controls on the basis of gestational
age ( 7 days) and parity. For this “matched-group” we tested between-group fatty acid di"erences
with the Wilcoxon Rank test.
The fatty acid compositions of the umbilical arteries and veins of preeclamptic women and their
normotensive controls in Tanzania were also compared with those of their counterparts in Curaçao6
Justication for the comparison with historical data comes from the use of the same fatty acid
analysis protocol in our laboratory for more than 25 years and the favorable results of its accuracy
and reproducibility.13 Between-group fatty acid di"erences for these groups were tested by using
the same approach as described for the total study population.
RESULTS
Study population
In both the total study population (Table 1) and the matched-group (data not shown), preeclamptic
women had higher postpregnancy weights, body mass indices, upper arm circumferences,
maximum diastolic and systolic blood pressures, and percentages caesarian deliveries. In the total
study population newborns of preeclamptic women had lower gestational ages and birth weights


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































years). There were no case-control dierences in the
frequencies of sh and meat consumption.
Fatty acid compositions of umbilical venous and
arterial vessels
Total study population (Table 2). In the total study
population 20:0 was higher, and PUFA lower,
in both umbilical veins (UV) and arteries (UA)
of preeclamptic women, when compared with
controls. In addition, UV of preeclamptic women had
lower: 22:6ω3, 22:4ω6, LCPω6, ω6 and LCPω3+ω6,
while saturated fatty acids (SAFA), the sum of
potentially de novo synthesized fatty acids (Σde
novo; i.e. sum of 14:0, 16:0, 18:0, 20:0, ω7 and ω9)
and the Σde novo/(LCPω3+ω6) ratio were higher.
In UA of preeclamptic women 18:0, 16:1ω7, ω7 and
16:1ω7/16:0 were higher. Data on selected LCPω3,
LCPω6 and potentially de novo synthesized fatty
acids in UV and UA of women with preeclampsia
and controls are depicted in Table 3.
Matched-group (data not shown). In the matched
group 18:0 was higher in both UA and UV of
preeclamptic women, compared with controls. In
UV of preeclamptic women 20:0 was higher, while
16:1ω7 and 16:1ω7/16:0 were higher in UA.
Comparison of umbilical vessel fatty acids in Tanzania and Curaçao (data not shown)
As compared to their healthy or preeclamptic counterparts in Curaçao, Tanzanian women had
higher 16:0 in control UV (p<0.0001), control UA (p=0.003) and preeclamptic UV (p=0.009); higher
22:6ω3, LCPω3 and ω3 in control UV (p=0.001; 0.003; 0.004), control UA (p=0.009; 0.016; 0.022) and
in preeclamptic UA (p<0.0001; 0.001; 0.001); lower 22:5ω6 (a marker of DHA insu$ciency) in control
UV, control UA, preeclamptic UV and preeclamptic UA (all p<0.0001); lower 20:2ω6 (marker of high
LA-intake) in control UV, control UA (both p<0.001) and preeclamptic UV p=0.006); lower 18:1ω9
and ω9 in control UV (p<0.0001; 0.010), preeclamptic UV (p=0.044; 0.027) and preeclamptic UA
(p=0.008; 0.007). Of additional interest is that levels of 22:5ω6 in UA and UV in controls in Curaçao
are signicantly higher (bothl p<0.0001) compared with Tanzanian preeclamptic UA and UV (data
not shown).
Table 3. Synoptic overview of the dierences
in umbilical vein and artery fatty acid
compositions between preeclamptic
and normotensive controls in Tanzania and
Curaçaoa
Tanzania Curaçao
De novo fatty acids UV UA UV UA
16:0  
18:0 ( )  
20:0   
SAFA  
16:1ω7  nd nd




Σde novo   









ω6 ! ! !
LCPω6 ! ! !
PUFA ! ! ! !
LCPω3+ω6 ! ! !
a, data for Curaçao derive from ref.6
 / !, higher/lower in preeclamptics compared to
controls For statistics and abbreviations see legend
to Table 2.
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DISCUSSION
In the present case-control study, we studied the fatty acid compositions of the umbilical veins (UV)
and arteries (UA) of 28 preeclamptic women and 31 healthy pregnant controls living in the sh-
eating town of Mwanza (Tanzania).
The aim of the study was to test whether our previous ndings of lower LCP status in children born
to preeclamptic women in Curaçao (Netherlands Antilles)6 could be conrmed in a population
with relatively high intakes of freshwater sh. The Lake Victoria shes are known to be rich in both
LCPω3 (DHA and EPA) and LCP 6 (AA).10,11 High LCP 3 intakes from sh by both normotensive and
preeclamptic women in Tanzania became indeed conrmed by the data of the dietary questionnaire
(Table 1) and the higher DHA, LCPω3 and ω3, and the lower 20:2ω6 (a marker of high LA-intake) and
22:5ω6 (a marker of DHA insu$ciency) in both the UA and UV of their o%spring, as compared to their
counterparts in Curaçao. Despite higher umbilical LCP 3 in Tanzania we found similar preeclampsia-
control di%erences in UA and UV fatty acid compositions as previously reported in women living in
Curaçao,6 although di%erences in Curaçao were more pronounced (Table 3). Taken together, the
data show that umbilical vessels in preeclampsia, in both Tanzania and Curaçao, contain lower PUFA
(especially LCP), and higher SAFA and potentially de novo synthesized fatty acids than corresponding
vessels of healthy control pregnancies.
Preeclampsia is regarded as a heterogeneous disorder, in which the combination of placental
dysfunction and maternal metabolic state contribute to the phenotypic expression of the disease.
The observed lower LCP content in preeclamptic umbilical vessels ts well with inappropriate
placental functioning as less LCP seem to cross the placenta. Indeed, lower placental LCP 3
(DHA) and LCP 6 (AA) contents in preeclampsia have been reported by Wang et al.,8,9 which was
explained by increased placental oxidative stress. It is of interest that the observed pattern of higher
potentially de novo synthesized fatty acids and lower LCP in preeclamptic umbilical vessels has
previously been noted by us in the o%spring of women with type 1 diabetes mellitus (T1DM) and
gestational diabetes mellitus (GDM) when compared with appropriate controls.15 It is well known
that from the third trimester, the fetus synthesizes large amounts of fat from non-lipid precursors,
notably glucose, which accumulate in adipose tissue as 16:0, 18:1 9 and 16:1 7.5,16-19 From our
observations15 we concluded that children born to mothers with poor glucose homeostasis have
higher intrauterine de novo fatty acid synthetic activity, which tends to ‘dilute’ the available LCP.
Although preeclampsia and maternal diabetes have an insulin resistant state in common, poor
glycemic control is not as evident and a feature of preeclampsia per se. In other words, the magnitude
of the intrauterine de novo fatty acid synthesis is likely to be higher in gestational diabetes, compared
with preeclampsia. As we did not anticipate this nding, our study protocol did not include fasting
glucose and insulin measurements. However, the strong resemblance of diabetic and preeclamptic
umbilical fatty acid patterns is in line with the various reports that link preeclampsia to a state
of insulin resistance. Insulin resistance, as determined in various ways, has been documented to
occur prior to preeclampsia,20-27 during preeclampsia,28-32 and months28,33,34 and years35-38 after
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preeclamptic pregnancy, suggesting that insulin resistance is part of the maternal metabolic state.
The association between preeclampsia and insulin resistance persisted in studies that controlled for
maternal weight, either by including lean women only,21 using BMI-matched controls,22,23,28-32,34,39 or
adjustment by multivariate analysis.20,24,26,27,36-38 A maternal insulin resistant phenotype may perturb
maternal fatty acid metabolism and, consequently, fatty acid supply to the fetus. First, it may perturb
normal adaptive changes in insulin sensitivity during human pregnancy. That is, it may attenuate
the normally higher insulin sensitivity of early pregnancy, which promotes storage of (dietary)
fatty acids (e.g. LCP) in maternal adipose tissue.3,40 Second, it may exacerbate the normal state of
insulin resistance in the second half of pregnancy, which drives free fatty acid (e.g. LCP) release from
maternal adipose stores, their processing in the liver, and their presentation to the placenta, either
as free fatty acids or as part of VLDL-TG.3,4 Since increased insulin resistance may be accompanied
by increased hepatic de novo fatty synthesis,41,42 it is conceivable that a relatively higher proportion
of the potentially de novo fatty acids in VLDL are presented to the fetus. Donnelly et al.41 estimated
that 30% of the fatty acids in hepatic-triglycerides and VLDL-triglycerides are derived from de
novo synthesis in non-alcoholic fatty liver disease (NAFLD), which condition is strongly associated
with insulin resistance.43 Although we did not measure insulin resistance in the present study, the
similarity between the fatty acid composition of preeclamptic and diabetic umbilical vessels inspires
us to speculate that, next to altered placental handling and transport capacity, we are dealing with a
common denominator of maternal insulin resistance, causing secondary e!ects on fetal LCP status
with as yet unknown consequences.
CONCLUSIONS
Preeclampsia in Mwanza is characterized by higher contents of potentially de novo synthesized fatty
acids and lower contents of LCP 3 and LCP 6 in umbilical vessel walls. In essence, we con"rmed the
previously reported di!erences between the fatty acid compositions of preeclamptic and healthy
pregnancies in Curaçao.6 We speculate that these di!erences are derived from a combination of
perturbed placental function and insulin resistance. Detailed studies on the underlying mechanisms
and their consequences are needed.
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Introduction. Perinatal changes in maternal glucose and lipid uxes and de novo lipogenesis
(DNL) are driven by hormones and nutrients. Docosahexaenoic acid (DHA) reduces, whereas insulin
augments, nuclear abundance of sterol-regulatory-element-binding-protein-1 (SREBP-1), which
promotes DNL, stearoyl-CoA-desaturase (SCD/Δ9-desaturase), fatty acid-(FA)-elongation (Elovl)
and FA-desaturation (FADS). Decreasing maternal insulin sensitivity with advancing gestation and
compensatory hyperinsulinemia cause augmented postprandial glucose levels, adipose tissue
lipolysis and hepatic glucose- and VLDL-production. Hepatic VLDL is composed of dietary, body
store and DNL derived FA. Insulin resistance increases the contribution of FA from hepatic-DNL to
VLDL-triacylglycerols; e.g. saturated-FA and monounsaturated-FA (MUFA) in maternal serum lipids
increase during pregnancy. Changes in maternal serum and RBC essential-FA (EFA) after delivery
are described, but no authors went into detail about non-EFA and the mechanisms behind and
functions of observed changes.
Hypothesis. Postpartum FA-changes result from changing enzymatic activities that are inuenced
by the changing hormonal milieu after delivery and DHA-status.
Empirical data. We studied FA-pro#les and FA-ratios (as indices for enzymatic activities) of
maternal and infant RBC at delivery and after 3 months exclusive breastfeeding in 3 populations
with increasing freshwater-#sh intakes. DNL-, SCD- and FADS2-activities decreased after delivery.
Elongation-6 (Elovl-6)- and FADS1-activities increased. The most pronounced postpartum changes
for mothers were increases in 18:0, linoleic (LA), arachidonic acid (AA) and decreases in 16:0, 18:1ω9
and DHA; and for infants increases in 18:1ω9, 22:5ω3, LA and decreases in 16:0 and AA. Changes
were in line with the literature.
Discussion. Postpartum increases in 18:0, and decreases in 16:0 and 18:1ω9, might derive from
reduced insulin-promoted DNL-activity, with more reduced SCD- than Elovl-activity that leaves
more 16:0 to be converted to 18:0 (Elovl-activity) than to MUFA (SCD-activity). Postpartum changes
for ΣDNL, saturated-FA and MUFA related negatively to RBC-DHA. This concurs with suppression
of both SCD- and Elovl-6 activities by DHA, through its inuence on SREBP. Infant MUFA and LA
increased at expense of their mothers. Sustained transport might be important for myelination
(MUFA) and skin development (LA). Maternal postpartum decreases in FADS2-, and apparent
increases in FADS1-activity, together with increases of LA, AA, and 22:5ω3, but decrease of DHA,
con#rm that FADS2 is rate limiting in EFA-desaturation. Maternal LA and AA increases might result
of rerouting from transplacental transfer to the incorporation into milk lipids and discontinued
placental AA-utilization.
Implications. The magnitude of insulin sensitivity and DHA-status may concertedly aim at mother-
to-infant transfer of certain FA during gestation and lactation.
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INTRODUCTION
Long chain polyunsaturated fatty acids (LCP-FA) of the ω3 (LCPω3) and ω6 series (LCPω6) are
important across the entire life cycle,44 but notably during infant development. LCP can be derived
from (fatty) sh (docosahexaenoic acid; DHA, 22:6ω3) and from meat and eggs (arachidonic acid,
AA, 20:4ω6) or derive from endogenous synthesis from the parent essential FA (EFA; linoleic acid, LA,
18:2ω6 and alpha-linolenic acid, ALA, 18:3ω3) by consecutive steps of desaturation and elongation,
in which FADS1 (Δ5-desaturase) and especially FADS2 (Δ6-desaturase) are rate limiting.45-48 LCP are
abundant in brain10 and the absolute content of infant brain AA and DHA increase rapidly from
the last trimester of pregnancy up to 2 years postpartum.49 Insucient LCPω3 intakes have been
implicated in suboptimal (neuro)development, cardiovascular disease and (neuro)psychiatric
disease.44 Obstetric complications such as pregnancy-induced hypertension, gestational diabetes,
preeclampsia and type 2 diabetes mellitus in pregnancy are characterized by a relative LCP
deciency, that is likely to be caused by the dilution of LCP by fatty acids that derive from glucose by
hepatic de novo lipogenesis (DNL).15,50
Hypothesis
We hypothesize that the changing hormonal milieu at the end of pregnancy and the maternal
LCPω3 status might in$uence the magnitudes of both DNL and LCP-synthesis.
Our attention towards the possible in$uence of the changing hormonal milieu at the end of
pregnancy and the possible in$uence of LCPω3 on DNL and LCP-synthesis was drawn after we
studied the postpartum changes in the RBC non-essential FA and EFA composition of mothers, and
their exclusively breastfed infants, with increasing LCPω3 status,51 as derived from their intakes of
tropical freshwater sh52 and as conrmed by their increasing LCPω3 status.53 At the time we did
not measure fasting insulin and glucose levels, nor did we perform oral glucose tolerance tests to
verify insulin sensitivity in the pregnancy-end or after 3 months lactation. However, the decreasing
insulin sensitivity with advancing gestation54 and its rapid restoration thereafter are well known.55
Secondly, after obtaining our results we believe that our data showed several arguments for the
in$uence of both the hormonal milieu at the end of pregnancy and the in$uence of LCP 3 on DNL
and LCP synthesis. In this article we review the literature and discuss the outcomes of our study in
the light of the changing insulin sensitivity during pregnancy and with regard to the in$uence of
the concurrent LCP 3 status.
Evaluation of the hypothesis
Glucose transport across the placenta is unrestricted, while FA cross with more diculty.56
There is sucient evidence to state that maternal insulin sensitivity decreases with advancing
gestation.54,56-59 The decreasing maternal insulin sensitivity and compensatory hyperinsulinemia
facilitate transplacental nutrient transfer by causing a unique combination of augmented glucose
production,54 elevated postprandial glucose levels,54 adipose tissue lipolysis59 and increased hepatic
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VLDL production59 that is likely to result in part from augmented DNL. Interestingly, one study in
an East African population described reduced postprandial glucose levels in pregnant compared
to non-pregnant women,60 but unfortunately did not investigate concomitant insulin levels to
evaluate actual insulin sensitivity.
The liver synthesizes VLDL from FA that are derived from the diet, stores and DNL (which is
directed at ≥16:0 the liver).59,61 Within the liver, saturated-FA (SAFA) may become desaturated by
stearoyl-CoA desaturase (SCD) to form monounsaturated-FA (MUFA) such as 16:1ω7 and 18:1ω9,62
while elongation of 16:0, 16:1ω7 and 18:1ω9 by ‘elongation of very long chain fatty acids family
member 6’ (Elovl-6) will form 18:0, 18:1ω7 and 20:1ω9, respectively.63 High carbohydrate intakes
and insulin resistance in humans increase the contribution of FA from hepatic DNL in VLDL-
triacylglycerols (TG).41,42 Animal studies conrm that insulin positively inuences the activities of
the enzymes involved in DNL (i.e. FA synthase, FAS and acetyl-Coenzyme A carboxylase, ACC), SCD,
Elovl-6, and the desaturase enzymes FADS1 and FADS2;48,61,63,64 while glucose also has positive eects
on DNL, SCD and Elovl-6,61 but negative eects on FADS1 and FADS2 activities.48 In contrast, DHA is
a potent suppressor of DNL, SCD, Elovl-6. and also of FADS1 and FADS2.45,64 Changes in enzymatic
activities have been correlated to their enzyme product/EFA ratios (DNL activity index) and enzyme
product/substrate ratios (SCD, Elovl-6, FADS1 and FADS-2 activity indices) in serum lipids63,65-69 and
adipose tissue,70 although no data are available for these indices in erythrocytes (RBC).
The increasing insulin resistance towards the pregnancy-end causes the ‘hyperlipidemia of
pregnancy’ that is characterized by consistent increases in maternal plasma phospholipids (PL) and
RBC SAFA and MUFA.71-74 These derive from DNL and adipose tissue lipolysis and cause a relative
dilution of PUFA with advancing gestation.71-74 Lower PUFA might in addition be explained by the
selective transfer of LCP across the placenta (‘biomagnication’), which is in contrast to SAFA, MUFA
and their parent EFA.75
After delivery, the rapidly changing hormonal milieu and notably the restoring insulin
sensitivity,54,55 may be expected to drive tremendous FA changes that become reected in the
RBC-FA composition. These changes are mostly opposite to those observed during pregnancy. In
addition, the nutrient supply becomes rerouted from transplacental transfer to breastfeeding and
fat becomes the infant’s main energy source. In contrast to the liver, conversion of SAFA to MUFA
via SCD or chain-elongation via Elovl-676,77 is limited in the lactating breast, and so is FADS-activity.78
Humans have little capacity to convert EFA to LCP.79 Consequently, the developing infant derives its
LCP mainly from breast milk that on its turn derives the LCP mainly from maternal long term storage
organs (70%) and to a lesser extent from the diet (30%).78,80
The FA composition of the maternal stores might become reected in the course of the maternal
plasma PL-FA and RBC-FA. Lactating women show postpartum increases of LA, AA, eicosapentaenoic
acid (EPA, 20:5ω3) and 22:5ω3 to, and even beyond, pre-pregnancy values, while DHA decreases
below preconceptional values.81 The infant’ demands might be reected in the courses of the infant
plasma PL-FA and RBC-FA that show consistent increases of LA, 18:0 and 18:1ω9, and a decrease
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of 16:0 after delivery.82-84 Infants also show a consistent decrease of AA, while DHA showed an
apparently milk DHA-concentration-dependent decrease or no change.84-88
Empirical data
Study design
We studied51 the courses of the RBC-FA and their ratios as proxies for enzymatic activities in 187
mother-infant pairs from delivery to 3 months exclusive lactation in 3 ethnic Tanzanian groups with
di#erent intakes of LCPω3 from local freshwater %sh, i.e. the Maasai (no or very low %sh intake),
subjects from the Pare Mountains (intermediate %sh intake, 2-3 times/wk) and subjects from
Sengerema near Lake Victoria (high %sh intake, 3-4 times/wk). We collected samples at delivery and
at 3 months PP for measurement of RBC-FA. All groups were considered homogeneous with respect
to ethnicity/tribe and their lifetime dietary habits. Our earlier52 and current89 study on the milk FA
composition of these tribes provided us with some information on their dietary habits, since human
milk is known78,80 to re5ect long time storage organs (70%) and the maternal diet (30%). Milk52 and
RBC data51 show that 16:0 is higher in milk from lactating and RBC from non-pregnant/non-lactating
Maasai (27.90 and 25.85 g%, respectively) and lower in counterpart Sengerema (19.65 and 23.99 g%,
respectively), while Maasai have low milk DHA (0.20 g%) and Sengerema high milk DHA (0.64 g%).
RESULTS
Results for SAFA and MUFA and enzyme activity ratio indices are presented in Supplemental Tables
1a, 1b, 2a and 2b. A synoptic overview of the observed di#erences for the RBC-FA and the enzyme
activity indices between delivery and 3 months PP for both mothers and infants is presented in
Figure 1. All women showed a decrease in the sum of the de novo synthesized FA (SAFA + ω7-
FA + ω9-FA; ΣDNL-adult) from delivery to 3 months PP. Mothers at 3 months PP had, compared to
delivery, lower RBC-16:0, 16:1ω7, 18:1ω7, 20:1ω7, 18:1ω9, 22:3ω9, 20:1ω9, 22:1ω9, 24:1ω9, 22:5ω6,
and DHA. These lower values at 3 months PP were compensated for by higher 18:0, 20:0, 22:0, LA,
18:3ω6, AA, ALA, 20:5ω3 and 22:5ω3. The quantitatively most important positive changes occurred
in RBC-LA, AA, and 18:0, the negative changes in DHA, 18:1 9 and 16:0 (Figure 2). Taken together,
ΣDNL-adult decreased consistently after delivery, mainly on account of 16:0 and MUFA. Importantly,
despite their high intake of 16:0 via cow milk, Maasai mothers had the lowest RBC-16:0 at delivery
and at 3 months PP. Also, the lower the maternal DHA status at delivery, the more the RBC-DHA
status decreased during subsequent lactation, while 22:5ω3 increased most. LA and AA increased
in all mothers, independent of DHA status. The indices for DNL, SCD, FADS1, FADS2 and Elovl-6
activities (Figure 1) at 3 months PP compared to delivery indicated a lower maternal DNL, Δ9- and
FADS2 activity but a higher FADS1 and Elovl-6 activity.
In their infants, there was a corresponding decrease in ΣDNL-infant (i.e. ΣDNL-adult minus 14:0
and 18:1ω9, since these derive mainly from maternal breast milk). At 3 months PP, the infants had









































































































































































































































Postpartum changes in maternal and infant erythrocyte fatty acids: roles of insulin and DHA
7.2
months PP were noted for RBC-14:0, 18:0, 20:0, 22:0, 20:1ω7, 18:1ω9, 20:1ω9, 22:1ω9, LA, 20:2ω6,
ALA, EPA and 22:5ω3. The quantitatively most important positive changes occurred in RBC-LA,
18:1ω9 and 14:0 (Figure 2). The major negative changes were noted for 16:0, 24:0, AA, 18:1ω7 and
20:3ω9. Interestingly, RBC-DHA decreased in those two groups with no and low sh intakes, but
increased in the group with high sh intakes.53 The indices for enzymatic activity indicated a lower
infant DNL and FADS2 activity, but a higher FADS1 and Elovl-6 activity at 3 months PP compared to
delivery.
Finally, we found that maternal RBC-DHA was inversely related to maternal RBC-ΣDNL(adult) at
delivery (Figure 3A) and after 3 months lactation (Figure 3B). Most individual FA included in the
sum of DNL-FA showed similar results (Supplemental Figure 1). Generally, a higher maternal DHA
status related to higher RBC-16:0, but lower 18:0, 16:1ω7 and 18:1ω9, while infants with the highest
DHA status had lower RBC-ΣDNL, mainly on account of lower 16:1ω7 and 18:1ω9 at delivery and
18:1ω9 at 3 months PP.
DISCUSSION & CONSEQUENCES OF THE HYPOTHESIS
The many changes in the RBC-FA from delivery to 3 months PP (Figure 1) are in part consistent with
a return to the prepregnancy state90-92 such as e.g. suggested by the presently observed decreases
of 16:0 and 18:1ω9, and the increases of 18:0, LA, AA and EPA. Mechanistically, they might be
explained by: 1) the hormonal changes associated with the transition from pregnancy to lactation,
2) the (consequently) changing bidirectional mother-infant transplacental nutrient transport to a
unidirectional nutrient transport from mother to infant via the milk, 3) di%erences in LCPω3, notably
DHA, status.
Saturated-, ω7- and ω9-fatty acids
The most remarkable changes in maternal RBC-SAFA, ω7-FA and ω9-FA from delivery to 3 months
PP included highly consistent decreases of 16:0, 18:1ω7, 18:1ω9 and 20:1ω9 (and to a lesser extent
16:1ω7, 20:1ω7, 22:1ω9, 24:1ω9, 20:3ω9 and 22:3ω9) and on the other hand, the increases in 18:0,
20:0, 22:0, and to a lesser extent 24:0 (b). These changes indicated no change of maternal SAFA,
a consistent decrease of MUFA, ω7-FA and ω9-FA, and a consistent increase of PUFA (see below).
The maternal changes became to a certain extent re&ected in the infants, who also showed
consistent decreases of 16:0, 18:1ω7, 20:3ω9 and 22:3ω9, and consistent increases of 18:0, 20:0
and 22:0. However, in contrast to the mother, the infants exhibited consistent increases of 14:0,
20:1ω7, 18:1ω9, 20:1ω9 and 22:1ω9, while 24:0 decreased (Figure 1). These results are generally in
agreement with earlier studies (mothers ref;92 infants refs82,84,87,88).
The increase of 14:0 in breastfed infants is explained by the unique ability of the breast to
synthesize medium chain FA (MCFA) from glucose,93 but does not occur at the expense of maternal
14:0. This seems to be in contrast with 20:1ω7, 18:1ω9, 20:1ω9 and 22:1ω9. Very little amounts of
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R2 = 0.31, p<0.001 R2 = 0.21, p<0.001
Figure 3. Relations between maternal RBC-DHA at delivery (A) and at 3 months postpartum (B) and the sum of
maternal de novo synthesized fatty acids. Data are in g%; , Maasai subjects; !, Pare subjects; ", Sengerema
subjects; R2, regression coe!cient; p, signi"cance of the trend line. Sigma DNL, sum of maternal de novo
synthesized fatty acids.
these FA seems to be at the expense of the maternal status at delivery. The seemingly high mother-
to-infant transfer of 18:1ω9 via the breast might be important for growth, and especially that of
the brain, which rapidly accretes 18:1ω9 up to at least 4 years of age.94 This 18:1ω9 accretion might
be important to myelin synthesis and may serve as a precursor for the synthesis of nervonic acid
(24:1ω9).49 Like in adults,42 the infant’s transition from a high carbohydrate:fat (transplacental
glucose) to a high fat:carbohydrate (breast milk) diet is known to reduce DNL-activity, and
consequently the production of 18:1ω9. It is therefore conceivable that the high milk 18:1ω9 ensures
a continuing 18:1ω9 supply to the fetus to compensate for the discontinuation of transplacental
transfer of 18:1ω9 and the discontinuation of the high DNL of the infant in the third trimester.49,94,95
Our data from RBC-FA indicate that hepatic DNL is increased in late pregnancy and decreases
from delivery till 3 months PP (Figure 1). We hypothesize that the driving forces for the observed
maternal SAFA, ω7-FA and ω9-FA changes from delivery to 3 months PP are likely to be found in
the many hormonal changes that accompany the transition from pregnancy to lactation. These
include notably the abolition of diminished insulin sensitivity and compensatory hyperinsulinemia
of late pregnancy, which are essential to arrive at the states of maternal ‘accelerated starvation’ and
‘facilitated anabolism’54 that support the developing fetus by the transplacental transfer of important
nutrients such as glucose and ketone bodies, and also FA.54,56-59 After delivery, the lower insulin
sensitivity of the third trimester vanishes54 and insulin levels fall quickly to become comparable to
non-pregnant controls within 3 days.55 This lower insulin sensitivity at late pregnancy may at least
partially be driven by hormones such as human placental lactogen (hPL), human placental growth
hormone (hPGH)96,97, sex hormones,98,99 cortisol,100 prolactin,101 leptin102,103 and cytokines,104 but each
of these might also have their own speci"c in@uences on FA metabolism.
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The decreasing insulin sensitivity and compensatory hyperinsulinemia of late pregnancy
result in low DNL105 together with facilitated lipolysis106 in maternal adipose tissue, but also with
the promotion of DNL in the maternal liver.41,42 Mechanistically, the lower insulin sensitivity of the
liver promotes DNL via activation of LXR and SREBP-1, while the higher maternal glucose in the
postprandial state54 may activate ChREBP.61,107,108 The outcome is the induction of ACC, FAS, Elovl-6
and SCD-1, which may jointly augment synthesis of 16:0 and 18:0 and their conversion to 16:1ω7,
18:1ω7 and 18:1ω961-63 in the liver. The major SAFA produced in the liver is 18:0, rather than 16:0.109
Our data indeed showed higher DNL and SCD indices, but not higher Elovl-6 activity indices, at
delivery compared to 3 months PP (Figure 1). These coincided with post-delivery decreases of DNL-
FA in maternal RBC, with the exception of 18:0. The paradoxical increase of 18:0 suggests that the
postpartum DNL and SCD-1 activity declines are more pronounced compared with the decline of
Elovl-6 activity. Comparably, Ghebremeskel et al.90 showed higher 16:0, 16:1ω7, 18:1ω9, but lower
18:0 in pregnant women compared to non-pregnant counterparts, supporting high DNL activity,
but an even higher SCD activity in pregnancy, resulting in a high 18:1ω9/18:0 ratio. Interestingly,
Figure 4. Proposed mechanisms for increased de novo lipogenesis (DNL) during pregnancy and the induced
synthesis of monounsaturated fatty acids (MUFA) during pregnancy and long-chain saturated fatty acids
(LC-SAFA) during lactation. The size of the arrow indicates the magnitude of the pathway or in!uence; dotted
line for long-chain polyunsaturated w3-FA is of unknown magnitude. ACC, acetyl Coenzym-A carboxylase;
FAS, fatty acid synthase; SCD-1, stearoyl Coenzym-A desaturase-1; Elovl-6, elongation of very long chain
fatty acids family member 6; LXR, liver-X rexeptor; SREBP-1, sterol regulatory binding protein-1; ChREBP,
carbohydrate responsive element binding protein.
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the 18:0 increase also took place in the infant, which suggests that the post-delivery changing
maternal SCD-1 and Elovl-6 activities might be driving forces for 18:0 transfer to the infant via the
milk. Since Elovl-6 activity is positively associated with insulin levels,63 the apparent postpartum
increase in Elovl-6 activity is more likely to reect a decrease in SCD activity, resulting in increased
substrate availability for Elovl-6, rather than an increase in Elovl-6 activity per se (Figure 4). Finally,
as mentioned above, the decreasing insulin sensitivity in late pregnancy is also associated with high
adipose tissue lipolytic activity.106 How this lipolytic activity a#ects the RBC-FA composition might
be complex, since the natural adipose tissue FA abundance is 16:0>18:1ω9>LA>18:0, while the
selectivity of FA release occurs in sequence 16:1ω7>16:0>14:0>18:1ω7>LA>18:1ω9>18:0.110
Despite the high intakes of 16:0 by Maasai compared to Sengerema, as con%rmed by their milk
and RBC-FA, there is lower maternal RBC-ΣDNL (Figure 2), 18:0, 16:1ω7 and 18:1ω9 and higher RBC-
16:0 with increasing DHA status (Supplemental Figure 1) in the order Maasai<Pare<Sengerema;
while the magnitudes of the PP decreases in ΣDNL, 16:0, 16:1ω7 and 18:1ω9, and increases in 18:0
seemed to occur in the order Maasai>Pare>Sengerema (Figure 2), which is the inverse order of
increasing %sh intake and DHA status. We suggest that these observations might be explained by
suppression of SCD64 and Elovl-663 activities by DHA through its inuence on SREBP-1 and ChREBP
(Figure 4).61,107,108 The rationale for the suppression of SCD64 and Elovl-663 by DHA might lie in the
importance of the ratio between saturated and unsaturated FA, which is known to be of great
importance in membrane functionality, such as e.g. reected by its uidity, permeability, elasticity
and PL ip-op.111-113 This ratio is under tight control and its regulation has been suggested to be the
primary role of SREBP.114,115 Incorporation of DHA in membranes has functional e#ects. For instance,
because of the mutual aversion of DHA and cholesterol, incorporation of DHA into a membrane
causes formation of highly disordered domains of DHA-containing PL, that segregate from the highly
ordered lipid rafts composed of cholesterol and sphingomyelin.112,113 The present study suggests
that DHA suppresses hepatic DNL in late pregnancy. The mechanism may be by improvement
of insulin sensitivity,116 since hepatic DNL in late pregnancy %nds its origin in diminished insulin
sensitivity.61,107,108 The inuence of %sh oil FA on insulin sensitivity and insulin resistance is, however,
controversial,117 possibly because of the many underlying mechanisms that may cause impaired
insulin sensitivity. It is possible that the inuence of LCPω3 on insulin sensitivity might best be
investigated in late pregnancy, which is a state of physiologically reduced insulin sensitivity.
Taken together, the high SAFA and ω7- and ω9-FA in late pregnancy are likely to reect the
mobilization of lipogenesis products that were accumulated in the maternal body during the
period of higher insulin sensitivity in early pregnancy,59 together with the newly formed products of
hepatic DNL and SCD activity. Both adipose tissue lipolysis and hepatic DNL in the end of pregnancy
are likely to be derived from the well known state of reduced insulin sensitivity and compensatory
hyperinsulinemia. We have previously shown that the resulting higher maternal SAFA, ω7-FA and ω9-
FA status causes a relative, rather than absolute, EFA de%ciency at the end of gestation and that this
process occurs more profoundly when the decreased insulin sensitivity of late pregnancy turns into
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insulin resistance such as in maternal obesity,69 diabetes mellitus type 2,118,119 gestational diabetes
mellitus (GDM)15,120,121 and preeclampsia.50 The nding of insulin resistance and hyperinsulinemia in
large-for-gestational-age infants122 supports similar eects in the infant. A high DHA status may, by
virtue of its DNL-suppressing eect, be of benet in the prevention of obstetric complications in
which insulin resistance and impaired glucose homeostasis play central roles.
ω6 and ω3 fatty acids
The increase of maternal ω6-FA from delivery to 3 months PP was notably on account of LA and
AA, while there was a decrease of 22:5ω6. These observations are in line with those of Otto et al.81
LA and AA increases can partly be explained by the decreases of the de novo synthesized ω7-FA
and ω9-FA (see above), since RBC-FA are expressed in g%. Secondly, as mentioned above, FADS2
and FADS1 activities are positively associated with insulin levels, but negatively with glucose and
DHA levels.46,48,64 In subjects with impaired glucose tolerance, an increase in insulin sensitivity by
lifestyle interventions [diet and exercise67 or diet45] consistently resulted in a net decrease of FADS2
activity and a net increase of FADS1 activity. In line with this observation, our RBC-FA data showed a
decrease of FADS2 activity and also suggested an increase of FADS1 activity. The apparent increase
in FADS1 activity is, however, more likely to result from the decrease in FADS2 activity, which is the
rate limiting step in the conversion of LA and ALA to their LCP-metabolites. Lower FADS2 activity
will cause lower 20:3ω6 and the pooling of ALA, 20:5ω3, 22:5ω3, LA, AA and 22:4ω6, giving rise to
an increased AA/20:3ω6 ratio that is not representative for FADS1 activity. Hence the development
of lower insulin sensitivity in late pregnancy may, by stimulating both FADS1 and FADS2 activity,
augment maternal (and fetal) LCP production. Conversely, the postpartum restoration of insulin
sensitivity may result in the observed decrease of FADS2 activity, while the concomitant decrease
of FADS1 activity might have been obscured by the decreasing FADS2 activity. On the other hand,
increasing maternal ω6 (notably LA and AA) status may have added to some extent to the observed
lower DNL during lactation, since ω6 PUFA are known to suppress ChREBP64 although their in$uence
is less strong than ω3 PUFA.
The nal explanation of the increasing maternal ω6-FA is the rerouting of LA and AA from
transplacental transfer to incorporation into milk lipids and the discontinued utilization of AA
by the placenta for the use in structural lipids57 and prostaglandin synthesis.123 Haggarty et al.124
suggested that the placenta has a certain minimal requirement for AA and that AA becomes only
transported to the fetus after satisfaction of this requirement. We showed both increasing maternal
and infant RBC-LA, suggesting a mother-to-infant LA surge via the milk (Figure 1). During pregnancy
the infant accretes little LA, partially because most of the maternally derived LA is not incorporated
into structural lipids but returned to the mother.123,125 A minor part of maternal LA becomes trapped
in the infant, partially by conversion into AA.125,126 The low LA status in utero and its rapid increase
in the infant after birth might be of importance for the postnatal synthesis of unique LA-carrying
ceramides in the skin, which act as barriers to limit water losses. The unidirectional surge of LA via
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the milk may, as opposed to the bidirectional LA exchange via the placenta, force the building of a
water barrier. Possible explanations for the decrease of infant RBC-AA are the interrupted gain via
transplacental transfer and diminishing infant and maternal FADS2 activity (see above).
As reported earlier for ω3-FA,71,72,81 there was an increase during lactation of maternal RBC-ALA,
EPA and 22:5ω3, while DHA and also 22:5ω6 (a marker of DHA status) decreased. These changes
are again in line with a decreasing FADS2 (and FADS1) activity that accompanies the restoration
of insulin sensitivity. The observed changes in the mother coincided with increases of infant RBC-
ALA, EPA and 22:5ω3, while 22:5ω6 decreased as well. The only discrepancy between maternal and
infant changes from delivery to 3 months PP was the constancy of infant RBC-DHA in the Pare, and
its increase in Sengerema. The increase in maternal EPA and 22:5ω3, and the decrease in DHA, were
demonstrated earlier in Danish,127 Dutch81 and Australian128 mothers and emphasize the diculty
by which the last step from 22:5ω3 to DHA proceeds (FADS2), although this step occurs with less
dicult in women compared with men.99 The decreasing magnitudes of the postpartum maternal
and infant RBC-22:5ω3 increases in the order Maasai>Pare>Sengerema (Figure 2) suggest the
highest DHA synthetic-activities in the populations with the lowest DHA-status. The postpartum
maternal DHA losses were accompanied by a seemingly paradoxical decrease of 22:5ω6, which is
a marker of DHA deciency. Also infant RBC-20:3ω9 and 22:3ω9, both markers of EFA deciency,
showed decreases, that occurred concomitant with the decrease of infant RBC-DHA. This suggests
that under these conditions, these markers of DHA and EFA status are of little value and are more
likely to reect the PP decreases in maternal and infant DNL, SCD, FADS1 and FADS2 activities, rather
than an improvement in the EFA or DHA status per se.92 Finally, the previously suggested110 selective
mobilization of LCP from adipose tissue (in the order EPA>AA>ALA>16:1ω7>DHA>16:0>14:0>18:1
ω7>LA>18:1ω9>18:0) might also contribute to the observed specic RBC-FA changes from delivery
to 3 months PP.
CONCLUSION AND IMPLICATIONS
Postdelivery changes in maternal and infant RBC-FA compositions might notably be inuenced by
the restoration of insulin sensitivity and the maternal DHA status, since DHA is a potent suppressor
of ChREBP and SREBP-1, and thereby of DNL and FADS. The changing insulin sensitivity during
pregnancy and lactation, together with the inuence of the maternal DHA status on the activities
of FAS, ACC, SCD, Elovl-6, FADS1 and FADS2, are likely to aim at the transfer to the infant of specic
FA, such as 16:0, 18:1ω9, AA and DHA during gestation and 14:0, 18:0, 18:1ω9, LA, AA and DHA
during lactation. The postpartum maternal and infant increases of ALA, EPA and 22:5ω3 support the
notion that FADS2 is rate limiting in DHA synthesis, especially during lactation. A suciently high
maternal DHA status might not only be important for structural purposes in e.g. the fetal central
nervous system, but also for the modulation of insulin sensitivity and thereby maternal hepatic
DNL in late pregnancy. DHA in pregnancy may therefore be of importance in the prevention of
obstetric complications in which insulin resistance and impaired glucose homeostasis play central
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roles. Taken together, we conclude that perinatal changes in maternal and infant FA status may be
strongly driven by changing insulin sensitivity and DHA status. To test our hypothesis any future
study would need to correlate insulin sensitivity, actual enzymatic activity and use stable isotopically
labeled RBC-FA, preferably in a longitudinal study.
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**R 2 = 0.57, p<0.001































Supplemental Figure 1. Relation between maternal RBC-DHA at delivery and maternal RBC-16:0 (A,E), 18:0
(B,F), 16:1ω7 (C,G) and 18:1ω9 (D,H). Data are in g%. , Maasai subjects; !, Pare subjects; ", Sengerema subjects;
R2, regression coe!cient; p, signi"cance of the trendline; *, signi"cantly di#erent between groups. The bars
in the right panels represent the medians for RBC-16:0, 18:0, 16:1ω7 and 18:1ω9, respectively, for the Maasai







































R 2 = 0.21, p<0.001
R 2 = 0.25, p<0.001
R 2 = 0.10, p=0.001






















Supplemental Figure 2. Relation between maternal RBC-DHA at 3 months postpartum and maternal RBC-16:0
(A,E), 18:0 (B,F), 16:1ω7 (C,G) and 18:1ω9 (D,H). For other legend see supplemental "gure 1.
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Introduction. The hormonal milieus of pregnancy and lactation are driving forces of nutrient uxes
supporting infant growth and development. The decrease of insulin sensitivity with compensatory
hyperinsulinemia with advancing gestation, causes adipose tissue lipolysis and hepatic de novo
lipogenesis (DNL).
Subjects & Methods. We compared fatty acid (FA) contents and FA-indices for enzyme activities
between preterm (28-36 weeks) and term (37-42) milks, and between colostrum (2-5 days),
transitional (6-15) and mature (16-56) milks. We interpreted FA di!erences between preterm
and term milks, and their changes with lactation, in terms of the well known decrease of insulin
sensitivity during gestation and its subsequent postpartum restoration, respectively.
Results. Compared with term colostrum, preterm colostrum contained higher indices of DNL in
the breast (DNL-breast) and medium-chain-saturated-FA (MCSAFA), and lower DNL-liver and
monounsaturated-FA (MUFA). Preterm milk also had higher docosahexaenoic acid (DHA) in
colostrum and transitional milk and higher arachidonic acid (AA) in mature milk. Most preterm-
term di!erences vanished with advancing lactation. In both preterm and term milks, DNL-breast
and MCSAFA increased with advancing lactation, while DNL-liver, MUFA, long-chain-SAFA and AA
decreased. DHA decreased in term milk. MUFA was inversely related to MCSAFA in all samples,
correlated inversely with PUFA in colostrum and transitional milks, but positively in mature milk.
MCSAFA correlated inversely with PUFA in mature milk.
Conclusion. Higher maternal insulin sensitivity at preterm birth may be the cause of lower MUFA (a
proxy for DNL-liver) and higher MCSAFA (a proxy for DNL-breast) in preterm colostrum, compared
with term colostrum. Restoring insulin sensitivity after delivery may be an important driving force
for milk FA-changes in early lactation.
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INTRODUCTION
Milk is composed of fatty acids (FA) from dierent origins.129 Medium chain saturated-FA (MCSAFA;
≤14:0) derive mostly from endogenous mammary gland de novo lipogenesis (DNL). Long chain
saturated-FA (LCSAFA; ≥16:0) and monounsaturated- (MUFA) derive mainly from the circulation,
since their de novo synthesis is limited within the breast.76,77,129 Long-chain polyunsaturated-FA
(LCP), i.e. the long-chain metabolites of the parent essential-FA (EFA) linoleic (LA) and α-linolenic
(ALA) acids, also derive from the circulation, since they cannot be synthesized de novo, while the
conversion of polyunsaturated-FA (PUFA) to LCP within the mammary gland is limited.78,130 The milk
FA composition results from some combination of FA uptake from the triglycerides (TG) in circulating
chylomicrons and VLDL by lipoprotein lipase (LPL),80 FA uptake from circulating albumin-bound
free-FA (FFA)129 and from endogenous DNL from glucose in the breast. Mammary gland FA uptake
from the circulation seems rather unspeci+c.78,131 All together, it was estimated that 10-12% of milk
FA derive from DNL in the mammary gland, that 60% derive from maternal stores, including hepatic
and adipose tissue DNL, and that 29% originate ‘directly’ from the diet, either from chylomicrons
(t½ = 0.1-1 hour) or from chylomicron remnants following the incorporation of their FA into VLDL
(t½ = 1-3 hours) in the liver80,132 About 30% of the EFA are considered to originate ‘directly’ from the
diet and about 70% from maternal depots.78 The milk contents of e.g. MCSAFA and LCP are also
highly dependent on the carbohydrate and +sh contents of the diet, respectively.133,134 However,
many other factors are known to in?uence the milk FA composition.135 Some of these are not directly
related to diet, but associated with the duration of lactation or with the gestational age at delivery.
Several studies investigated the mechanisms underlying milk FA changes with advancing
lactation and milk FA dierences between preterm and term milks. It has been concluded that
MCSAFA synthesis in the mammary gland is triggered by parturition, independent of length
of gestation, and that MCSAFA synthesis increases until week 2-4 of lactation.136-138 LPL-activity
in mammary tissue increases 1-2 days before parturition139 and continues to increase during
lactation.138-141 Prolonged gestation and prolonged lactation may cause depletion of maternal LCP
stores79 and thereby cause lower LCP in preterm, compared to term milk, and a decrease of milk-LCP
with advancing gestation, respectively. Dierences between preterm and term human milks cannot
be explained on a molecular basis, since no dierences in TG-structure,142 PL-classes,143 percentages
PL from total lipid*144 or fat globule surface area145 were noted. Conversely, the percentage LCP-rich
phospholipids (PL) decreases with advancing lactation,137,143,144,146 while TG increases from 96% in
colostrum to 99.5% in mature milk. All of these changes coincide with an increase of the average
fat globule diameter,145 a decline of the cell concentration147 and a decrease of the relative total fat
globule surface area.147,148
Taken together, some combination of these observed changes result in the quite consistently
found higher LCP, notably arachidonic (AA) and docosahexaenoic (DHA) acids,149-153 and
* The higher percentage phospholipids in (very) preterm compared to term milk as noted in the classic study of
Bitman et al.,143 is in?uenced by the movement of one data point for term milk in one publication154 to another
location in the next143, without explanation. We therefore refer to the more recent study from Shoi et al.144
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MCSAFA,149,151,154-157 and lower MUFA151,154-156,158 in early (≤10 days) preterm compared to early term
milk. Likewise, they might explain the consistently observed increase of the milk fat content154,159,160
and the concurrent increase of MCSAFA, and the decrease of MUFA and LCP from colostrum to
mature milk.137,161-163 The driving forces of these changes might be found in the hormonal milieus
of pregnancy and lactation that aim at optimal support of fetal and newborn growth and fat
accretion through the regulation of maternal glucose and lipid uxes across the placenta and
mammary gland, respectively. The second half of pregnancy is characterized by a physiological
state of reduced maternal insulin sensitivity that is followed by compensatory hyperinsulinemia and
progresses towards full term gestation.54,56 This state of reduced insulin sensitivity/compensatory
hyperinsulinemia causes increased adipose tissue lipolytic activity and increased de novo
lipogenesis (DNL) that jointly result in the hyperlipidemia of pregnancy.54,56 Hudgins et al.164 showed
that the great majority of DNL takes places in the liver, rather than in adipose tissue. The increased
DNL activity becomes e.g. reected in the higher SAFA and MUFA contents in maternal plasma-
PL and erythrocytes (RBC) in late, compared to early, gestation.71-74 The reduced insulin sensitivity/
hyperinsulinemia of late gestation, however, vanishes shortly after pregnancy termination.55 From
this perspective, we recently suggested165 that the consistently observed postpartum decreases of
DNL-derived FA in maternal and infant RBC that occur between delivery and 3 months postpartum,
might be the result of the concurrent restoration of insulin sensitivity. However, this hypothesis had
not yet been applied to the di!erences between preterm and term milk FA compositions and the
changes observed in the milk FA composition after delivery.
Compared to a preterm delivery, the lower maternal insulin sensitivity after a term delivery54
is likely to result in a higher adipose tissue lipolytic activity and hepatic DNL-activity, resulting
in higher circulating FFA and VLDL, respectively, and a higher relative contribution of FA from
hepatic DNL-activity to the VLDL-TG. Consequently, we hypothesize that (in women with similar
diets and adiposity) i) the lower maternal insulin sensitivity after term delivery underlies a higher
LCSAFA and MUFA, and lower MCSAFA, in term colostrum compared to preterm colostrum,
secondary to the competition between FA from the circulation (LCSAFA, MUFA, PUFA) and those
from endogenous mammary gland synthesis (MCSAFA). Similarly, we hypothesize that, ii) despite
the increase in mammary gland LPL-activity with advancing lactation,138-141 the restoring insulin
sensitivity after delivery also underlies a decreasing milk LCSAFA and MUFA, and increasing milk
MCSAFA with advancing lactation. To additionally test the suggested depletion of maternal LCP
stores with advancing gestation and lactation,79 we chose to investigate the preterm and term milk
FA compositions of Tanzanian women with very high "sh intakes, resulting in a high DHA status.
We have previously reported that these women exhibit no decreases in their RBC-DHA contents
during gestation.166 At delivery, their infants had lower RBC-DHA contents compared to their
mothers,53 suggesting that under these conditions DHA transfer from mother-to-infant becomes
rather inhibited than stimulated. DHA depletion during pregnancy is therefore unlikely and we
consequently expected no appreciable di!erences in the DHA contents of preterm and term
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colostrum in these women.
MATERIALS AND METHODS
Study design
In a cross sectional study we investigated the FA di!erences between colostrum (by de"nition: 1-5
days), transitional (6-14 days) and mature breast milk (>14 days). The milk samples derived from a
dietary highly homogeneous group of women in Tanzania with high intakes of both carbohydrates
and AA and DHA from local tropical freshwater "sh.52 They delivered either prematurely (28-36 weeks
of gestation) or at term (37-42 weeks). Due to the limited amount of seasonally available nutrients of
the local people, maternal diets are highly homogenous, while neither pregnancy nor lactation are
known to be associated with changes in the local dietary customs or intakes. As such, di!erences
in the dietary intakes between women who deliver preterm or term, or at any time-point during
lactation, are considered negligible. Similarly, adiposity is rare among rural Africans. Consequently,
no di!erence was observed between the BMI of mothers after preterm or term delivery;89 making
di!erences in adiposity an unlikely contributor to preterm-term milk di!erences The study was
conducted in the Sengerema hospital, at the southern shore of Lake Victoria in Tanzania. Part of
the results was published previously.89 High dietary "sh intakes in this population were con"rmed
by their milk LCP contents89 and from the RBC-LCP contents of a population sampled in the same
area.53,166 In the present study, we additionally investigated the FA-sums and FA-indices that might
provide information about enzyme activities in FA metabolism at delivery and their changes
thereafter. Secondly, we reviewed the literature for the consistency of our "ndings, and to support
or falsify the suggested mechanisms that may drive the observed di!erences.
Rationale for FA-sums and FA-indices
Lipid synthesis and 0uxes might become re0ected by the contents of speci"c milk-FA and their
ratios. For instance, hepatic DNL is directed at 16:0 that may subsequently become elongated
to 18:0 by the enzyme for ‘elongation of very long-chain-FA’ (Elovl-6). Both 16:0 and 18:0 may
become desaturated by stearoyl-CoA desaturase (SCD) to form 16:1ω7 and 18:1ω9, respectively62
Subsequent elongation of 16:1ω7 and 18:1ω9 by Elovl-6 will form 18:1ω7 and 20:1ω9, respectively.63
In contrast to DNL in the liver, DNL in the mammary gland is directed at 14:0 and only small amounts
of SAFA are desaturated within the breast.76,77,129 For instance, only 1% of 14:0 is converted to 14:1ω5.
Consequently, one might di!erentiate between the sum of those milk-FA that derive, at least in
part, typically from hepatic DNL (ΣDNL-liver) and those from DNL in the breast (ΣDNL-breast). Upon
interpretation of these proxies, it is important to realize that the majority of FA in the ΣDNL-liver
derive from adipose tissue stores and/or diet. Hence, ΣDNL-liver, but to a much lesser extent ΣDNL-
breast, overestimates the DNL percentages that are obtained from studies with stable isotopes.
Δ5-desaturase (D5D) and Δ6-desaturase (D6D) are both involved in EFA-desaturation.45-48 Since EFA
cannot be synthesized de novo, they are all ultimately derived from the diet and/or from maternal
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stores. Hormone-driven changes in the activities of the many enzymes mentioned above might
consequently become reected by their enzyme product/EFA ratios (DNL activity indices) and
alternatively from their product/substrate ratios (SCD, and D5D and D6D activity indices). The actual
activity and/or expression of these enzymes have been directly or indirectly related to most of these
indices in serum lipids45,47,65-67,69 and adipose tissue.70 To our knowledge they have as yet not been
systematically applied in studies on the human milk-FA composition.
Hormones inuencing FA-enzymatic activities
The activities of hepatic DNL and SCD,64 but also of D5D and D6D are inuenced by glucose,46,48
insulin48,61,63 and LCPω3.45,64 Since dietary LCP 3 intakes were similar in our preterm and term
subjects, we focus our discussion on the possible inuence of insulin sensitivity. However, other
hormones such as human placental lactogen (hPL), human placental growth hormone (hPGH),96,97
sex hormones,98 cortisol,167 prolactin,101 leptin102 and cytokines104,168 likewise have their speci'c
courses during pregnancy and lactation, are known to inuence insulin sensitivity, and might
also inuence FA metabolism directly. To discuss each of these hormones individually is, however,
beyond the scope of the current study.
Fatty acid sums and indices
To di*erentiate between mammary gland and hepatic enzymatic processes for de novo FA synthesis
we applied the sum of FA that are, for the greater part, derived from DNL in the breast (ΣDNL-breast,
sum of 6:0, 8:0, 10:0, 12:0, 14:0 and 14:1ω5) and the sum of FA that may at least partially derive
from DNL in the liver (ΣDNL-liver, sum of 16:0, 16:1ω7, 18:1ω7, 20:1ω7, 18:1ω9, 20:1ω9 and 22:1ω9).
The activities of hepatic DNL, SCD, D5D (Δ5-desaturase), D6D (Δ6-desaturase) were studied from
their product/EFA ratios such as the DNL-activity indices (16:0/18:2ω6, 18:0/18:2ω6, 16:1ω7/18:2ω6,
18:1ω7/18:2ω6 and 18:1ω9/18:2ω6), their product/substrate ratios such as the SCD-activity indices
(16:1ω7/16:0, 18:1ω7/16:0, 18:1ω9/18:0), the D5D activity index (AA/20:3ω6) and the D6D activity
indices (20:3ω6/18:2ω6, DHA/EPA, 22:5ω6/AA).45,47,65-70
Statistics
Statistical analyses were performed with SPSS version 16.0.1 (SPSS Inc, Chicago, IL). Between-group
di*erences were analyzed with student t-test or Mann Whitney U-test at p<0.05. Corrections were
made for type-1 errors according to Bonferroni.
RESULTS
The fat content, MCSAFA, LCSAFA, MUFA, PUFA, LCP, DHA and AA compositions and the FA-sums
and ratios that were calculated for preterm and term colostrum, transitional and mature breast
milks are depicted in Table 1. The directions of the signi'cant changes are presented to visualize
consistencies.
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Dierences from colostrum to mature milk
Fat. The median milk fat content increased from 22.2 g/dL in preterm colostrum (mean 3.5 days
postdelivery) to 26.5 g/dL in preterm mature milk (24.5 days), and from 21.2 g/dL (3.1 days) in term
colostrum to 30.7 g/dL in term mature milk (27.3 days), although the former increase was non-
signicant.
SAFA, MUFA and DNL-indices. Independent of prematurity, milk ΣDNL-breast and MCSAFA increased
consistently, while LCSAFA decreased. ΣDNL-liver and MUFA also decreased. The trend for all DNL-
and SCD-activity indices was a highly consistent decrease with advancing lactation. However,
these decreases were only consistently signicant (for both term and preterm) for two DNL-activity
indices (18:1ω7/18:2ω6 and 18:1ω9/18:2ω6) and one SCD-activity index (18:1ω7/16:0). Only term
milk showed an additional decrease in three other hepatic DNL activity indices (16:0/18:2ω6,
18:0/18:2ω6 and 16:1ω7/18:2ω6) and one SCD activity index (16:1ω7/16:0), while only preterm milk
showed a decrease in the 18:1ω9/18:2ω6 activity index.
PUFA. We noted consistent decreases of AA, while only term milk showed a decrease in DHA
(22:6ω3), the D5D-activity index (20:4ω6/20:3ω6) and two D6D activity indices (20:3ω6/18:2ω6 and
22:6ω3/20:5ω3).
Dierences between preterm and term milk
Fat. There were no signicant di#erences between the fat contents of preterm and term counterparts
milks.
SAFA, MUFA and DNL-indices. Preterm colostrum milk had higher ΣDNL(breast) and MCSAFA
(≤14C-atoms), but showed no di#erence with respect to LCSAFA. In contrast to MCSAFA, preterm
colostrum milk exhibited lower ΣDNL-liver and MUFA as compared to term colostrum. The indices for
hepatic DNL (16:1ω7/18:2ω6, 18:1ω7/18:2ω6, 18:1ω9/18:2ω6, but not 16:0/18:2ω6 or 18:0/18:2ω6)
and SCD activity (16:1ω7/16:0, 18:1ω7/18:0 and 18:1ω9/18:0) were lower in preterm compared to
term colostrum milk. All di#erences between preterm and term milk SAFA, MUFA and FA-indices, as
observed in colostrum, disappeared with advancing lactation, with the exception of the DNL activity
Legend Table 1.
Data are medians (ranges) in g/100 g FA and g/g fatty acids.
PT, preterm (28-36 wks gestation); T, term (37-42 wks gestation)
C, colostrum (2-5 days); T, transitional milk (6-15 days); M, mature (16-56 days)
Signicanct di#erences between preterm and term milk are indicated by §, p<0.05, §§, p<0.01, §§§ p<0.001
Signicant di#erences between colostrum and mature milk ar indicated by *, p<0.05, **, p<0.01 and ***, p<0.001
MCSAFA, medium-chain saturated fatty acids (≤14:0); LCSAFA, long-chain saturated-FA (≥16:0); MUFA,
monounsaturated-FA; PUFA, polyunsaturated-FA; LCP, long chain polyunsaturated-FA.
DNL, de novo lipogenesis; ΣDNL (breast), sum of 6:0, 8:0, 10:0, 12:0, 14:0 and 14:1ω5; ΣDNL (liver), sum of 16:0,
16:1ω7, 18:1ω7, 20:1ω7, 18:1ω9, 20:1ω9 and 22:1ω9
SCD, stearoyl-CoA desaturase (delta9-desaturase); FADS1/2, fatty acid desaturase enzymes 1 and 2 (delta5 and
delta-6 desaturase)
 /! indicates a higher/lower content in preterm vs. term and mature vs. colostrum milk
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index 18:1ω7/18:2ω6 that became higher in preterm mature milk and that of the SCD activity index
18:1ω9/18:0 that was still higher in term compared to preterm mature milk.
PUFA and FA-desaturase-indices. Preterm milk contained higher DHA in colostrum and transitional
milk, and higher AA in mature milk compared to corresponding term milk. The index for activity
of D5D was lower in preterm compared to term colostrum milk, while the D6D activity index
was inconsistently higher (only for 22:5ω6/20:4ω6). In mature milk, two D6D activity indices
(20:3ω6/18:2ω6 and 22:6ω3/20:5ω3) were higher in preterm compared to term milk.
Milk fatty acid interrelationships.
Selected relations between milk FA were studied in more detail. We found a strong inverse relation
between MCSAFA and MUFA in all milk samples of preterm and term delivering women (R2 = 0.83,
p<0.001). MUFA correlated inversely with PUFA in colostrum and transitional milks (Figures 1A and
1B, respectively), but positively in term milk (Figure 1C), while MCSAFA correlated inversely with
PUFA in mature milk (Figure 1F).
Figure 1. The relations between MUFA (panels A,B,C) and MCFA (panels D,E,F) on the one hand and PUFA on
the other in colostrum (panels A,D), transitional milk (panels B,E) and mature milk (panels C,F) after preterm
and term delivery. Data are in g/100g fatty acids (g%). MCFA, medium chain fatty acid (i.e. ≤14C-atoms);
MUFA, mono-unsaturated fatty acids; PUFA, polyunsaturated fatty acids; Colostrum, 2-5 days; Transitional
milk, 6-15 days; Mature milk,16-56 days; preterm delivery, 28-36 weeks; term delivery, 37-42 weeks. R2, cor-




Milk from these African women showed much higher MCSAFA contents, higher LCP contents and
lower MUFA contents compared to Western women (Table 1). These ndings conrm the frequent
consumption of freshwater sh in this African group53 and rearm the higher MCSAFA and lower
MUFA contents of African compared to Western milks, as previously observed by us11 and others.169,170
These dierences have been attributed to the higher carbohydrate intakes of African women, but
have, as yet, not been suggested to relate also to the hormonal levels around parturition.
Our results clearly indicate the increase of MCSAFA, and decreases of both MUFA and LCP with
advancing lactation (Table 1). These results compare well with the data reported by others.137,160-163
Part of these changes have been explained by the increase of the milk fat content154,159,160 with
advancing lactation. Secondly, compared to term milk, preterm milk contained higher MCSAFA in
colostrum, higher DHA in colostrum and transitional milks, and lower MUFA in colostrum. Higher
DHA in preterm milk has been reported before150-155 and corresponding data of others also showed
higher MCSAFA,149,151,154-157 and lower MUFA, notably 18:1ω9151,154-156,158 in early (≤10 days) preterm
compared to term milk. Despite the high degree of consistency in the reported data, they remain
largely unexplained. However, the importance of LCP, especially for the preterm infant,171,172 has been
emphasized and it has also been suggested that preterm infants might benet from the slightly
higher LCP levels in preterm milk.149,150,157,171
Total fat
The current lipid contents of preterm and term milk may not be comparable with the literature, since
the present derive from the total FA contents of single breast milk samples taken during a feeding
and thus not after emptying of the breast. However, given the reproducibility of the employed
collection method, the current similarity between the lipid contents of preterm and term milks are
of importance in this particular study, since they indicate that the observed FA dierences between
preterm and term milks are unlikely to be explained by dierences in total fat contents.
Saturated-, ω7- and ω9-fatty acids
We used the milk MUFA, the sum of MUFA and 16:0 [abbreviated ΣDNL-liver] and the DNL- and SCD-
activity indices as proxies for maternal insulin sensitivity and hepatic DNL synthesis. Justication
comes from the work of Francois et al.134 who showed that short term high intakes of 18:1ω9 and
16:0 have no in"uence on their milk contents, suggesting that these FA derive predominantly from a
combination of hepatic DNL and long term dietary habits (i.e. stores). Adipose tissue lipolytic activity
and hepatic DNL activity are known to be dependent on hormonal levels (e.g. insulin), glucose
availability and LCPω3 status.46,48,61,64 Since our data are in line with the literature and because the
long term dietary habits of the investigated women were highly constant with little intra-individual
and inter-individual variations due to the limited possibilities to change their dietary habits (e.g.
LCPω3 intakes), we assume that the changes of milk MUFA, ΣDNL-liver and the DNL- and SCD-
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activity indices are strongly dependent on corresponding changes in insulin sensitivity and glucose
availability (or other hormonal changes around parturition), but not on dietary changes.
The reduced insulin resistance of late gestation leads not only to (compensatory) elevated
insulin levels, postprandial glucose levels and adipose tissue lipolytic activity (Figure 2; see E) and
thereby circulating FFA,56 but also to insulin- and glucose- stimulated hepatic DNL (Figure 2; see A),61
which, together with diminishing adipose tissue LPL activity (Figure 2; see D), results in increasing
circulating levels of VLDL (Figure 2; see B).56 Of further notice, it has been shown that parturition
and subsequent suckling, irrespective of length of gestation, trigger the synthesis of MCSAFA in
the mammary gland136-138 (Figure 2). The observed higher MCSAFA content of preterm, compared
to term colostrum, renders a higher MCSAFA synthetic activity after term delivery, unlikely. Glucose
transport into the lactating mammary alveolar cell is considered insensitive to insulin,129 with the
exception of certain conditions, such as starvation. Furthermore, mammary gland LPL-activity is
increased 1-2 days before parturition139 and continues to increase during lactation138-141 (Figure 2; see
C), while the LPL-mediated FA uptake into adipose tissue becomes reduced by the insulin resistance
of late pregnancy140,173 (Figure 2; see D).
Consequently, in term milk, compared with preterm milk, one might expect both higher
MCSAFA (due to the elevated postprandial glucose levels) and higher LCSAFA and MUFA (due to
higher adipose tissue FFA release, higher hepatic DNL activity and thus higher contents in the
VLDL-TG, and higher mammary gland LPL-activity). We indeed observed higher MUFA (Table 1),
but lower MCSAFA and no di4erence in LCSAFA (Table 1), in term compared to preterm colostrum,
suggesting that mothers who deliver preterm have higher mammary MCSAFA-synthesis, despite
lower postprandial plasma glucose levels. However, since parturition and not length of gestation
triggers MCSAFA synthesis and because glucose uptake in the mammary gland is mostly insulin
insensitive, the observed di4erences, i.e. the higher MCSAFA and lower MUFA in preterm compared
to term colostrum (Table 1), are not likely to be explained by higher MCSAFA synthesis per se. The
strong inverse relation between MCSAFA and MUFA in milk lipids, rather suggests competition
(Figure 2; see 2) between de novo synthesized FA in the mammary gland (with MCSAFA as a proxy)
and those taken up by the mammary gland either as FFA or via LPL (with MUFA as a proxy). It seems
(Figure 2), consequently, that when the mammary gland in5ux of notably MUFA is low (such as
after preterm delivery), higher amounts of MCSAFA will become incorporated into milk lipids, and
vice versa. Secondly, the higher MCSAFA content of preterm colostrum seems unhampered by the
concurrent lower postprandial glucose levels that come along with preterm delivery, suggesting
that the circulating glucose level is not the principal driving force of mammary gland MCSAFA
synthesis
In line with the above, the present preterm milk FA composition indeed suggests a lower
maternal adipose tissue FFA release and a lower hepatic DNL activity after preterm compared to
term delivery. This became mainly noticeable from the lower hepatic DNL end-products in preterm
colostrum, such as 16:1ω7, 18:1ω7, 18:1ω9 and 20:1ω9 (MUFA), but not by lower 16:0 and 18:0 (i.e.
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Figure 2. Proposed eects of insulin sensitivity on the fatty acid composition of preterm and term colostrum
and with advancing lactation.
Breast milk FA (right side) derive from adipose tissue, the diet and liver (all on the left side), and de novo FA
synthesis in the mammary gland (right side). Dietary FA in chylomicron-TG are transported to the tissues
where they are taken up via an LPL mediated process. Chylomicron remnants are taken up by the liver and
their FA, together with FFA from adipose tissue (process E) and de novo synthesized FA (from glucose; process
A), are incorporated into TG, that are subsequently secreted as VLDL (process B). FA from VLDL-FA are taken
up by the mammary gland via LPL (process C), where they, together with FFA (from adipose tissue; process
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LCSAFA), suggesting that hepatic DNL and hepatic FA-metabolism (of dietary and adipose tissue
derived FA) is aimed at the synthesis of MUFA rather than LCSAFA. This suggestion is supported
by the lower 16:1ω7/18:2ω6; 18:1ω7/18:2ω6 and 18:1ω9/18:2ω6 ratios (as proxies for hepatic DNL
activity) in preterm milk, while this was not observed for the 16:0/18:2ω6 and 18:0/18:2ω6 ratios.
Mechanistically, the observed absence of dierences between preterm and term colostrum in 16:0,
18:0, and the DNL-indices 16:0/18:2ω6 and 18:0/18:2ω6 in our study and those of others149-156,158
might be explained by the eciency of hepatic SCD and Elovl-6 to convert 16:0 to 16:1ω7,
16:1ω7 to 18:1ω7, 16:0 to 18:0, and 18:0 to 18:1ω9, and is probably driven by the compensatory
hyperinsulinemia of late gestation.61,63 The important inuence of insulin in these conversions
might additionally be supported by the decreases in 16:0/18:2ω6, 18:0, 18:0/18:2ω6, 16:1ω7 and
16:1ω7/18:2ω6 in term milks with the duration of lactation (Table 1). These decreases coincide with
the well known restoration of insulin sensitivity/compensatory hyperinsulinemia and, as is the case
in our data, might be more readily observed in the milk of term delivering women because of their
more pronounced postpartum changes in insulin sensitivity, compared with preterm delivering
counterparts.
Our suggestion of a causal relationship between a higher milk MUFA content and lower insulin
sensitivity also becomes supported by the higher MUFA in mature milk of Westernized overweight
urban women compared to normal weight rural South African women169 and also by the higher
MUFA in milk of many Western women compared to non-Western counterparts.129,170 A lower insulin
E) and mammary gland de novo synthesized FA (i.e. MCSAFA; from glucose), are incorporated into milk TG.
In the liver, FA from dietary origin (LCSAFA, MUFA and PUFA) compete with de novo synthesized FA (LCSAFA,
but notably MUFA) for incorporation into VLDL-TG (Process 1). In the mammary gland, FA from VLDL (LCSAFA,
MUFA, PUFA) and FFA from adipose tissue (LCSAFA, MUFA, PUFA) compete with de novo synthesized FA
in the mammary gland (MCSAFA) for incorporation into milk TG (Process 2). The state of reduced insulin
sensitivity/compensatory hyperinsulinemia of the third trimester promotes processes A, B, C and E, while
process D is downregulated. Term birth is characterized by a more pronounced state of reduced insulin
sensitivity/compensatory hyperinsulinemia , which implies higher stimulation of processes A, B, C and E.
Term birth is therefore associated with higher hepatic de novo FA synthesis (with MUFA as a marker), higher
de novo synthesized FA in VLDL and better competition of the hepatic de novo synthesized FA with de novo
synthesized FA in the mammary gland (with MCSAFA as marker), which becomes noticeable by higher MUFA
and lower MCSAFA in term colostrum compared with preterm colostrum. Rapid normalization of the reduced
insulin sensitivity/compensatory hyperinsulinemia after delivery causes a rapidly diminishing de novo FA in
the liver and diminishing of MUFA in VLDL, which ultimately causes in both preterm and term milks a decrease
of MUFA that is compensated for by an increase of de novo synthesized MCSAFA in the mammary gland
Single headed arrows indicate transport of the nutrient from one place to another; double headed arrows
indicate competition. The positive (+), negative (-) or absent (no) signs indicate the inuence of insulin on
the magnitude of the process. The average FA compositions of adipose tissue, the Western diet and of term
colostrum milk are indicated. Data are in g/100 g (g%) fatty acids (FA). Abbreviations: LCSAFA, long chain
saturated fatty acids (≥16:0); LCP, long chain polyunsaturated fatty acids (≥20C, ≥3 double bonds); LPL,
lipoprotein lipase; MCSAFA, medium chain saturated fatty acids (≤14:0); MUFA, monounsaturated fatty acids;
PUFA, polyunsaturated fatty acids (≥2 double bonds), TG, triglycerides; VLDL, very low density lipoprotein.
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sensitivity in Western pregnancies (Figure 2), stimulates mammary gland LPL-activity (C), FFA
release from adipose tissue (E) and hepatic DNL [i.e. LCSAFA and MUFA synthesis (A); followed by
VLDL synthesis and secretion (B)]. The subsequent higher FA uptake from VLDL in the mammary
gland competes successfully with mammary gland DNL (i.e. MCSAFA synthesis; Figure 2, see 2).
Furthermore, the currently studied women had a much higher DHA status compared to most
European women, while DHA is known as a strong suppressor of hepatic DNL.64 In other words, the
currently observed much higher milk MCSAFA, and thus lower MUFA, in developing countries is
usually explained by the higher carbohydrate intakes in these countries, but might at least in part
also be due to the inhibitory eect of a higher DHA status on hepatic DNL-activity.45,64 Other support
for a relation between the milk FA composition and insulin sensitivity comes from the higher 18:1ω9
content in milk of diabetic women.174 The high proportions of MCSAFA (39-53 g%), in the context of
a somewhat lower milk fat content, in a patient with type I hyperlipoproteinemia, in which there is a
genetically-determined decit of LPL-activity,175 also supports a competition between LPL-mediated
FA uptake with de novo MCSAFA synthesis in the breast.
The postpartum restoration of insulin sensitivity after both preterm and term deliveries became
re!ected by decreases in the milk MUFA with concomitant increases in MCSAFA (Table 1). The
rapidity55 by which insulin sensitivity is restored after delivery (about 3 days) is likely to be the cause
of the rapid vanishing of all FA dierences, resulting into no dierences in LCSAFA, MCSAFA and
MUFA between preterm and term transitional and mature milks.
In summary, the data on the milk MCSAFA (a proxy for DNL in the mammary gland) and MUFA
(a proxy for adipose tissue FFA release, and hepatic DNL and VLDL synthesis) show that these
distinct sources compete for incorporation into milk lipids (Figure 2). The competition is likely to
be governed by insulin sensitivity. Mothers who deliver at term are less insulin sensitive than those
who deliver preterm. We suggest that in term delivering mothers, this dierence causes higher FFA
release from adipose tissue, higher DNL and VLDL-synthesis in the liver and a higher mammary
gland LPL-activity (Figure 2). Term colostrum is consequently higher in MUFA and thus lower in
MCSAFA. The restoring insulin sensitivity after delivery causes a decrease of MUFA and an increase
of MCSAFA in both preterm and term milks with the duration of lactation, resulting in the similarity
of the transitional and mature milk FA compositions. This change is more pronounced in term milk,
since mothers who deliver at term experience more pronounced changes of the insulin sensitivity
than counterparts who deliver preterm. Taken together, the MCSAFA and MUFA dierences between
preterm and term milk and their changes with the duration of lactation suggest that mammary
gland DNL is secondary to LPL-mediated and/or direct uptake of (F)FA from the maternal circulation,
which might in turn be driven by the insulin insensitivity of late pregnancy. The favored uptake of FA
from the circulation might not only aim at the provision of an important energy source, but also at
the postdelivery transfer of important tissue building blocks, such as 18:1 9, PUFA and LCP.
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PUFA
In accordance with our data,89 inconsistent increases of ALA and LA137,176,177 have been observed with
advancing lactation, while no dierences are observed between preterm and term milks.150-152,155,156,158
Since mammary gland LPL-activity is stimulated by insulin,16 suggesting less LPL-activity after
preterm delivery, one may expect lower MUFA and PUFA in preterm colostrum and a compensatory
increase of milk MCSAFA. Although lower MUFA and higher MCSAFA were indeed observed (see
above), lower PUFA was not (Table 1). The inverse correlation between MUFA and PUFA in colostrum
and transitional milks even suggest higher PUFA, with lower MUFA in preterm milks (Figures 1A
and 1B). Thus, the absence of any dierence in PUFA between preterm and term milks, except for
AA and DHA (see below), suggests additional inuences that tend to keep milk PUFA constant.
The equal or higher PUFA in preterm colostrum can be explained (Figure 2) by a combination of a
lower circulating VLDL56 in conjunction with a higher VLDL-PUFA content immediately after preterm
delivery. A higher VLDL-PUFA after preterm delivery might result from the lower amount of notably
MUFA (from maternal stores and de novo MUFA synthesis) that is available for competition with
PUFA for incorporation into VLDL (Figure 2; see 1). The postnatal interaction in the liver between
FA derived from DNL and PUFA was characterized by the changes in their relations in colostrum,
transitional and mature milks, respectively (Figure 1, A-C). These showed that in the colostrum-to-
mature milk sequence of restoring insulin sensitivity, the initially weak competition (Figure 1 A and B)
between MUFA (as a proxy for hepatic DNL-FA) and PUFA changed to collaboration (Figure 1 C).
Meanwhile, there was no correlation between MCSAFA and PUFA in colostrum and transitional
milks (Figures 1D-E), but this changed into competition in mature milk (Figure 1F). We suggest that
the hepatic DNL-FA, which are more abundantly synthesized after term birth, initially compete
successfully for incorporation into VLDL (Figure 2, see 1) at the expense of those from the diet and
stores, but that this competition vanishes as a function of insulin sensitivity restoration and turns
into the joint competition of MUFA and PUFA with MCSAFA for incorporation into milk lipids (Figure
1F; Figure 2, see 2). As such, it seems that, by virtue of the higher insulin sensitivity after preterm
birth, the relatively higher PUFA content in VLDL is able to compensate for the lower circulating
VLDL concentration and the lower mammary gland LPL-activity, with the net result that preterm
and term milks do not harbor much dierence in their PUFA contents.
In a mathematical model (not shown), we evaluated the eects of dierent contributions of
MUFA and LCSAFA from adipose tissue lipolysis (increasing FFA; i.e. higher LCSAFA, MUFA and PUFA)
and hepatic DNL [increasing MUFA and LCSAFA; and increasing VLDL, i.e. increasing LCSAFA, MUFA
and PUFA)] on the resulting MUFA, LCSAFA and PUFA levels in milk. Calculations were performed
at !xed milk MCSAFA levels (10, 20 and 30 g%) and a !xed relative contribution of adipose tissue
PUFA (70%) and dietary PUFA (30%) to the total milk PUFA.78 The outcome con!rmed that i) milk
MUFA decrease secondary to lower FA contributions from adipose tissue and hepatic DNL (i.e. with





In contrast to the similarity of ALA, LA and PUFA150-152,155,156,158 between preterm and term milks and
their apparent constancy, or small increases, with advancing lactation (Table 1), many authors have
reported higher LCP in premature milk,150-153,156,157 while there is also a highly consistent LCP decrease
with advancing stage of lactation.161,162 In this study, we found higher DHA in premature colostrum
and transitional milks and higher AA in premature mature milk (Table 1), compared to term milk.
We also found that LCP, DHA (only for term) and AA decreased with advancing lactation (Table1).
These well-documented observations have, to our knowledge, not as yet been explained in terms
of preterm-term dierences in insulin sensitivity or its postdelivery restoration.
Fat output increases with advancing lactation,154,159,160 together with the size of the fat
globules,145,147,148 which causes a decrease of the PL/TG ratio.148 Since LCP have a preference
for incorporation into PL,137,143 this decrease in the PL/TG ratio coincides with a decrease of the
contribution of LCP to the total milk FA content. The mechanism for the increase in fat globule size
is unknown but may be related to the maturation of the mammary gland.129,148 We suggest that the
physiological restoration of insulin sensitivity shortly after delivery might inuence the decrease
of the milk LCP percentage with advancing lactation. The higher relative LCP content of colostrum
compared to mature milk might relate to the higher LCP levels in the livers of pregnant compared
to non-pregnant animals,178 while these levels decrease rapidly after the initiation of lactation. The
high hepatic LCP content is likely to result from the high insulin levels at the pregnancy-end,54 since
insulin not only induces hepatic DNL (see above) but also augments the activities of the enzymes
involved in EFA-desaturation; i.e. D5D and D6D.46,48 Hence, the rapid postpartum restoration
of insulin sensitivity [48] may reduce hepatic LCP synthetic activity and thereby decrease the
contribution of LCP to the total milk FA contents with advancing lactation. Our data indeed suggest
postpartum decreases of some of the proxies of D5D and D6D activities, which, because of the more
pronounced changes in insulin sensitivity of women delivering at term, may notably have become
reected in term milk (Table 1).
Predicting the net eect of a higher maternal insulin level, such as encountered after term
delivery, on the milk LCP content is dicult, since the state of reduced insulin sensitivity/
compensatory hyperinsulinemia of late pregnancy promotes not only the release of FFA from
adipose issue and hepatic DNL (mainly SAFA and MUFA), but also LCP synthesis by augmention of
D5D- and D6D-activities. It seems that the ‘LCP-diluting’ contributions that come from the LCP-poor
adipose tissue FA and DNL-FA (Figure 2) increase with advancing gestation, since preterm colostrum
and transitional milk exhibited higher DHA compared to term milk, but many other mechanisms
may also be involved.
Our data argue against a more pronounced maternal LCP depletion79 as an explanation for
the frequently observed150 lower DHA and AA contents in term compared to preterm colostrum
in Western infants. The currently investigated African women have lifetime high !sh intakes
and are therefore unlikely to become DHA depleted between preterm delivery and term age.166
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Nevertheless, their preterm colostrum also harbored higher DHA than term colostrum. Interestingly,
since no dierences were observed between the average fat globule sizes nor the PL contents of
preterm and term milks,142-145 the currently observed LCP dierences, i.e. higher DHA, but non-
signi!cantly lower AA, between term and preterm colostrum indicate that besides insulin, other
factors might be involved.
The suggested relation between insulin levels and D5D and D6D activities in pregnancy, might
especially be important for the understanding of the LCP needs of preterms, since these become
largely devoid of any LCP, maternally synthesized LCP included, that are normally transferred across
the placenta from the time of delivery to term age. The ensuing “LCP gap” becomes even greater if
the infant subsequently receives infant formula without LCP. The understanding of maternal LCP
synthesis in pregnancy might also be important to diabetic pregnancies, where the stimulatory
eects of the high insulin levels on the D5D- and D6D-activities might become oset by the D5D and
D6D-inhibitory eects of the concomitantly increased glucose levels.46,48 Moreover, those LCP that
are synthesized may under these conditions become even more ‘diluted’ by the more abundantly
de novo synthesized FA from the liver.15,50 Both the insulin resistance and the high glucose levels
may under these conditions promote lipogenesis via LXR and SREBP-1c, and ChREBP, respectively.61
Summarizing the observations on PUFA and LCP, we suggest that the absence of dierences
between the LA, ALA and PUFA contents of premature and term milks, and the absence of changes
in these FA with duration of lactation may result from several opposing mechanisms that keep these
levels constant (Figure 2). Mechanisms that tend to increase milk PUFA are the higher FFA release
from adipose tissue stores, the higher plasma VLDL concentrations (more VLDL synthesis), and the
higher mammary gland LPL activity (more FA uptake from lipoproteins) that comes together with
the lower insulin sensitivity/higher insulin of i) women who deliver at term and ii) early lactation. A
milk PUFA decreasing mechanism is the dilution of PUFA from the diet and stores by DNL FA in the
liver, that comes together with the same conditions.
With regard to LCP we suggest that the decreasing milk LCP content and decreasing PL/TG ratio
in both premature and term milks with advancing lactation may relate to the postnatally decreasing
D5D and D6D-activities, secondary to the restoring insulin sensitivity. The higher DHA in premature,
compared to term, colostrum and transitional milk in the current study population is unlikely to
relate to depletion of maternal stores. LCP are more likely to be dependent on the same mechanisms
as outlined for PUFA (i.e. adipose tissue FFA release, serum VLDL, mammary gland LPL-activity and
hepatic DNL) with in addition their insulin-promoted synthesis from precursors via augmentation
of D5D- and D6D-activities.
CONCLUSIONS, LIMITATIONS AND IMPLICATIONS
We propose that the FA-dierences between preterm and term milks are for a considerable part
caused by the higher maternal insulin sensitivity after preterm birth, compared with term birth.
The restoring insulin sensitivity after delivery may be an important factor in the FA-dierences
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between colostrum, transitional and mature milks. Our interpretations should be viewed upon as
hypotheses that need conrmation from future measurements of a combination of hormones and
FA, and notably by measurements of enzymatic activities and in vivo !uxes with e.g. stable isotopes
in pregnancy and lactation.
The current study may add to the understanding of the mechanisms that cause di"erences in
the body compositions of preterm and term infants and may thereby ultimately provide insight
into the “gaps” that have to be lled by nutritional means. For instance, our data suggest that the
preterm infant is devoid of several weeks of transplacental transfer of insulin-induced synthesis of
MUFA deriving from maternal hepatic-DNL and from LCP that are likely to derive in part from insulin-
induced maternal hepatic D5D and D6D-activities. MUFA, notably oleic acid, might be important
for myelination.94 Meanwhile, premature milk contains lower MUFA, while its somewhat higher
LCP vanishes rapidly with advancing lactation and will not be able to ll the growing “LCP gap”.
Conversely, premature infants are at present precociously exposed to the high levels of LA and
MCSAFA in human milk and formula, while both of these are low in utero. The possible benets of
a high LCP intake by preterm infants have been demonstrated in trials,171,172,179 but no studies have
been performed with higher milk MUFA and lower milk LA and MCSAFA contents. Any lowering
of the LA and MCSAFA intakes must on the other hand be weighed against the building of the
skin’s water barrier by LA180-185 and the ease by which MCSAFA carrying TG are hydrolyzed in the
gastrointestinal tract.186 To arrive at a balanced catch-up growth of preterm infants it is necessary to
know which ‘windows of opportunity’ are still open and which are denitely closed. The mimicking
to some extent of the intrauterine conditions, characterized by high mother-to-infant !uxes of both
MUFA and LCP, and a low LA accretion, might in premature infants be important to the growth of
lean body mass and neurodevelopment, including myelination.
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The dietary intake of saturated fatty acids (SAFA) is associated with a modest increase in serum
total cholesterol, but not with cardiovascular disease (CVD). Replacing dietary SAFA with
carbohydrates (CHO), notably those with high glycemic index, is associated with an increase in
CVD risk in observational cohorts, while replacing SAFA with poly-unsaturated fatty acids (PUFA)
is associated with reduced CVD risk. However, replacing a combination of SAFA and trans-fatty
acids with n-6 PUFA (notably linoleic acid) in controlled trials showed no indication of bene!t and a
signal toward increased coronary heart disease risk, suggesting that n-3 PUFA may be responsible
for the protective association between total PUFA and CVD. High CHO intakes stimulate hepatic
SAFA synthesis and conservation of dietary SAFA. Hepatic de novo lipogenesis from CHO is also
stimulated during eucaloric dietary substitution of SAFA by CHO with high glycemic index in normo-
insulinemic subjects and during hypocaloric high-CHO/low-fat diets in subjects with the metabolic
syndrome. The accumulation of SAFA stimulates chronic systemic low-grade in"ammation through
its mimicking of bacterial lipopolysaccharides and/or the induction of other pro-in"ammatory
stimuli. The resulting systemic low-grade in"ammation promotes insulin resistance, reallocation of
energy-rich substrates and atherogenic dyslipidemia that concertedly give rise to increased CVD
risk. We conclude that avoidance of SAFA accumulation by reducing the intake of CHO with high
glycemic index, is more e#ective in the prevention of CVD, than reducing SAFA intake per se.
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INTRODUCTION
In 2003 in the Netherlands, fat comprised about 34% of total energy intake (en%), and was, after
carbohydrates (CHO), the main energy source. Grains, grain products and non-alcoholic beverages
are the most important source of dietary CHO in the Netherlands (Table 1). Saturated (SAFA), mono-
unsaturated and poly-unsaturated fatty acids (PUFA) each constitute approximately 12.9, 10.8 and
7.1 en% of the total fat intake. Milk, milk products and meat are the main sources of dietary SAFA
(Table 1) in the Netherlands,1,2 as well as in the United States.3 Fatty acids are pleiotropic nutrients
with important functions in the human body in addition to serving as substrates for energy
production. Fatty acids are essential components of the phospholipids in all cell membranes, act as
carriers of the fat-soluble vitamins A, D, E and K, and include the essential n-3 and n-6 PUFA, alpha-
linolenic and linoleic acid, respectively.
The ‘diet-heart hypothesis,’ also named the diet-heart paradigm, is based on the association
between serum cholesterol and dietary SAFA with the risk of cardiovascular disease (CVD) that was
found in the Seven Countries Study by Ancel Keys,4 and the relationship between dietary SAFA
and serum cholesterol that was demonstrated in short5 and long-term feeding trials.6,7 However,
recent evidence from RCTs and observational studies have provided little support for the diet-
heart paradigm and the causality of the association between dietary SAFA and CVD outcomes is
increasingly questioned.8-11
In this paper we discuss the current scienti!c data on the e"ects of dietary SAFA, their
controversies and the potential underlying (patho)physiological mechanisms for the role of SAFA
in CVD.
Lipoproteins, cholesterol, SAFA and CVD
A high serum total cholesterol, and especially LDL-cholesterol, is associated with an increased risk
of CVD, whereas a high HDL-cholesterol has a protective association.12 The serum total cholesterol/
HDL-cholesterol ratio is the consensus risk factor for the estimation of coronary heart disease
risk. The reduction of this ratio by 1 point is classically associated with a coronary heart disease
risk reduction of 52%.13 The metabolic syndrome, also called the “insulin resistance syndrome”,
which is characterized by obesity, impaired glucose homeostasis, hypertension and atherogenic
dyslipidemia (“the deadly quartet”), is a major risk factor for CVD.14 Similarly, atherogenic
dyslipidemia,15 which is characterized by elevated triglycerides, “small dense LDL” particles and
reduced HDL-cholesterol (“deadly lipid triad”),16 is a major risk factor for CVD. These small dense
LDL particles are susceptible to structural modi!cations by oxidation17 and notably oxidized LDL
particles e"ect atherosclerotic plaque formation18 by promoting foam cell generation, endothelial
dysfunction and local in#ammation.
An increase in the consumption of SAFA by 1 energy percent (en%), raises serum total cholesterol
by 0.052 mmol/l.6 However, in the same study, the total cholesterol of subjects consuming 15 en%
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is not on account of the dierences in SAFA intake per se.6 Because of the supposed relationship
between SAFA and CVD, it is nowadays recommended to replace dietary fat, and especially SAFA,
by cis-unsaturated fatty acids.19,20 Between 1987/1988 and 1997/1998 the intake of cis-unsaturated
fatty acids, re!ned CHO and mono-and disaccharides in the Netherlands increased at the expense
of fat, SAFA and trans-fatty acids.19,20 In this review, we will evaluate the current consensus on the
relationship between SAFA and CVD while the consequences of replacing SAFA by CHO, mono-
unsaturates and PUFA will be examined with regard to their in"uence on atherogenic dyslipidemia.
SAFA and CVD
A recent meta-analysis of prospective cohort studies21 showed that the intake of SAFA is not
associated with an increased risk of coronary heart disease, stroke or those two combined (i.e.
cardiovascular disease, CVD), before21 or after22 adjustment for serum total cholesterol. Additionally,
the consumption of milk and milk products was not related to CVD in a meta-analysis of prospective
cohort studies. Consumption of milk and milk products may even decrease CVD risk,23 although
this meta-analysis of prospective cohort studies was not supported by a recent prospective cohort
study in the Netherlands.24
Replacing SAFA by CHO
Replacing 5 en% SAFA with 5 en% CHO, reduced serum total cholesterol by 0.18 mmol/l, LDL-
cholesterol by 0.16 mmol/l and HDL-cholesterol by 0.05 mmol/l, increased the serum triglycerides
by 0.11 mmol/l and had no eect on the total cholesterol/HDL-cholesterol ratio.5 LDL-cholesterol
reduction from isocaloric substitution of SAFA by CHO is accompanied by an increase in the
amount of atherogenic small-dense LDL particles and a decrease in the less atherogenic large LDL
particles15 Because of the increase of triglycerides and the small dense LDL and no change in the
total cholesterol/HDL-cholesterol ratio, replacing SAFA by CHO seems unfavorable with regard to
CVD prevention.
A pooled analysis of 11 cohort studies showed that replacing 5 en% SAFA by CHO was associated
with a slightly increased risk of coronary events (7%), but there was no dierence in mortality25 In
practice, however, SAFA are often replaced by CHO, notably by CHO with a high glycemic index. A
subsequent analysis by Jakobsen et al.26 showed that replacement of 5 en% SAFA by CHO with a low
glycemic index was associated with a non-signi!cant reduction in CVD risk, while replacing SAFA by
CHO with a high glycemic index was associated with a 33% increased risk of myocardial infarction26
Replacing SAFA by mono-unsaturated fatty acids
Replacing 5 en% SAFA by 5% mono-unsaturated fatty acids reduced total cholesterol by 0.21
mmol/l, LDL-cholesterol by 0.20 mmol/l, and HDL-cholesterol by 0.01 mmol/l, and increased the
serum triglycerides by 0.01 mmol/l. The 0.145 reduction in the total cholesterol/HDL-cholesterol
ratio is predicted to translate to a coronary heart disease risk reduction of 7.5%.13 However, in the
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recent pooled analysis of prospective observational cohorts by Jakobsen et al.,26 the intake of
mono-unsaturated fatty acids was associated with a 19% higher risk of CVD events, but not with
cornary heart disease mortality. This outcome contrasts with the benecial eects of the so called
Mediterranean diet, which is typically high in mono-unsaturated fatty acids,27 and the theoretical
decrease of the total cholesterol/HDL-cholesterol ratio, when SAFA are replaced by mono-
unsaturated fatty acids.5 Consequently, it was recently concluded that there is insucient evidence
to advise the replacement of SAFA by mono-unsaturated fatty acids.28
Replacing SAFA by n-6 and n-3 PUFA
Replacing 5 en% SAFA by 5 en% PUFA decreased total cholesterol by 0.29 mmol/l, LDL-cholesterol by
0.26 mmol/l, HDL-cholesterol by 0.02 mmol/l, triglycerides by 0.03 mmol/l and the total cholesterol/
HDL-cholesterol ratio by 0.175, which theoretically corresponds to a coronary heart disease risk
reduction of 9.1%.13 A pooled analysis of 11 cohort studies showed that replacement of 5 en% SAFA
by (n-3 and n-6) PUFA was associated with a signicant 13% reduction in coronary events and a 26%
reduction in coronary heart disease mortality.25 These results are consistent with a meta-analysis of
RCTs,29,30 which showed that replacing 5 en% SAFA by (n-3 and n-6) PUFA reduced coronary heart
disease risk by 10%. These results have been interpreted as providing strong concordant evidence
to support current recommendations to substitute the n-6 PUFA linoleic acid for SAFA, and were
recently translated into an American Heart Association (AHA) advice,31 to consume ‘at least 5 to
10 % of energy as n-6 PUFA’. Importantly however, neither of these pooled analyses made a clear
distinction between n-6 and n-3 PUFA species, and the Mozaarian et al.29 meta-analysis of RCTs
did not consider the potential confounding role of trans-fatty acids. The n-3 PUFA32 and trans-
fatty acids33 have been positively and negatively related to CVD development, respectively. If the
distinction is made between interventions that selectively substituted the SAFA and trans-fatty acids
by n-6 PUFA/linoleic acid, and those that substantially increased both n-3 and n-6 PUFAs, a whole
dierent picture emerges.34 Linoleic acid selective PUFA interventions produced no indication of
benet but rather a fairly consistent, but non-signicant, signal toward increased risk of coronary
heart disease and death. These potentially negative eects of n-6 PUFA acid may even have been
underestimated, since PUFA also replaced trans-fatty acids. If SAFA is replaced by both n-3 and n-6
PUFA, a signicant (22%) decreased coronary heart disease risk is found. However, this reduction
may also be attributable, at least in part, to the reduced consumption of trans-fatty acids.34
Risk reduction in perspective
Besides the already mentioned large variability in the relationship between serum total cholesterol
and SAFA intake,6 there is the well known example of the African Maasai who have very high
intakes of both cholesterol (500-2,000 mg/day) and SAFA from milk,35,36 but exhibit remarkably
low serum cholesterol levels8,11,35,36 and although accompanied by extensive atherosclerosis, with
lipid inltration and brous changes, they have a very low incidence of cardiovascular events8
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Secondly, comparison with other risk factors and the feasibility of a reduced SAFA consumption
also require some attention. In 2003 the average SAFA intake in the Netherlands was estimated at
12.9% of total energy (en%). This intake should be lowered by 38%, i.e. to 7.9 en%, to achieve a 10%
risk reduction in CVD.30 The Dutch National Institute for Public Health and the Environment (RIVM)
calculated that a 5% reduction in SAFA intake would reduce the annual incidence of CVD with
4,300 persons per year and CVD mortality with 1,000 people per year,37 at an annual mortality from
CVD of approximately 40,000/year in the Netherlands.38 For comparison, the estimated mortality
attributable to overweight, insucient fruit and vegetable intake, and low sh intake are 6,900,
7,300, 4,500 persons per year, respectively.37 A recent report from the UK predicted that an increase
in the intake of fruits and vegetables from 279-356 g to 440 g/day would save as many lives as a
reduction in the current SAFA consumption in the UK from >14 to 3 en% and a reduction in salt
intake from >8.1 to 3.5 g/day.39 Consequently, other risk factors seem much simpler to be addressed
and their role seems at least comparable, if not more important, in the current high incidence of
CVD. Recommendations to increase intakes of n-3 PUFA, fruit and vegetables and reduce sodium
intakes,30 to increase physical activity,40 to reduce trans-fatty acid intakes30 and reduce the intake of
CHO with high glycemic index and glycemic load, such as notably found in soft drinks and candy
(Table 1), seem more prudent candidates in the battle against CVD,41 than a recommendation to
reduce SAFA intakes by 10 en%, and also because SAFA are in daily practice mostly replaced by CHO
with high glycemic index.42
The relation between inammation and lipoprotein metabolism
The causal relationship between LDL-cholesterol per se and CVD6 is still a matter of debate.8-11
However, both oxidized and small dense LDL have been related to increased CVD risk.17,18 Moreover,
there is convincing evidence that the LDL-cholesterol reducing statins reduce CVD risk,43-46 but
statins have pleiotropic e!ects. Statins also have an anti-in"ammatory e!ect and equally reduce CRP
and the concentration of LDL-cholesterol.43-47 This observation supports the endotoxin-lipoprotein
hypothesis48 stating that “chronic systemic low grade in"ammation” connects LDL-cholesterol
to CRP. It is becoming clear that changes in serum lipoproteins might be a response to a state of
chronic in"ammation secondary to our current lifestyle that in its turn is composed of many factors.
Besides the in"uence of dietary changes, environmental changes such as stress, sleep deprivation
and environmental pollution, including smoking, have also been related to chronic in"ammation.49
It was recently re-emphasized that these so called gene-environment interactions play important
roles in de development of many, if not all, current diseases of civilization,50,51 while a primary role of
‘faulty’ genes, seems grossly overestimated.52,53
Common metabolic disorders, such as obesity, type 2 diabetes and the metabolic syndrome
are associated with low grade in"ammation and elevations in acute phase proteins such as CRP.54 It
has become increasingly clear that insulin resistance develops secondary to systemic in"ammation
and the compensatory hyperinsulinemia aims primarily at balancing glucose homeostasis.55,56 The
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insulin resistant state, induced by pro-inammatory cytokines, is indispensable for the reallocation
of energy-rich substrates. Glucose is conserved for the metabolically highly active brain and for the
activated immune system, which both rely on glucose metabolism for their energy supply.55 Organs
that would normally also use glucose become insulin resistant and use triglycerides and free fatty
acids, distributed by the liver and adipose tissue, respectively, as energy supplies. At the same time,
the lipoprotein prole might act to ght o inammation and support the repair of tissue damage
secondary to the inammatory reaction.57-66 This is executed via: 1) an increase in cholesterol-rich
lipoproteïns (mainly LDL and VLDL), that have the ability to bind bacterial lipopolysaccharide (LPS)
in proportion to their cholesterol content,16,67,68 although the best determinant of the capacity of
lipoprotein to bind LPS is a high phospholipid/cholesterol ratio (i.e. surface/volume ratio)69 2) the
suppression of reverse cholesterol-transport via multiple pathways66 (i.e. low HDL) 3) increased
oxidation of LDL and VLDL, while HDL becomes proinammatory62 4) increased cholesterol delivery
to the immune system62 and 5) the production of “small dense” LDL particles.70 The latter become
enriched in sphingolipids, are poorly cleared by the LDL-receptor, cross the endothelial barrier more
eectively, bind to the vascular wall intima and are accumulated in macrophages because of their
susceptibility to oxidative modication.62 Taken together, the proatherogenic dyslipidemia of the
metabolic syndrome is in support of the recovery from inammation-induced damage.48,55 However,
when these changes in the lipoprotein prole last for prolonged periods of time, such as in the
chronic low-grade inammation of the metabolic syndrome,14 they give rise to the development of
atherosclerosis.62,66
It is increasingly clear that our current lifestyle includes many factors that 1) initiate and
propagate inammation, 2) give rise to an inadequate capacity to terminate inammatory
responses, and 3) lead to insucient protection from the “collateral damage” caused by the chronic
immune activation. One of these factors is our dietary SAFA intake, that can cause inammation by
their mimicking of a part of bacterial LPS48 and/or by providing other pro-inammatory stimuli.67,68,71
Whether dietary SAFA cause inammation depends on the accumulation of SAFA in the body and
not on the dietary SAFA intakes per se. Accumulation of SAFA can also occur by the synthesis of SAFA
from CHO via de novo fatty acid synthesis. This mainly occurs in the liver, which secretes these de
novo synthesized fatty acids as VLDL.16,72
SAFA vs. carbohydrates, the metabolic syndrome and the immune system
The adverse eects of high SAFA intakes on lipid metabolism, are particularly noted when SAFA
are combined with high CHO intakes. Under these conditions, dietary SAFA are preserved, while
the surplus of the consumed CHO is converted to SAFA by hepatic de novo fatty acid synthesis.
Although the conservation of SAFA during excessive intake of CHO with a high glycemic index
is well known,73-76 the synthesis of SAFA from (surplus) CHO may not have received sucient
attention. Contrary to widespread belief, de novo fatty acid synthesis is not restricted to hyper-
caloric conditions or to excessive intakes of CHO, but also depends on the type of ingested CHO.
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A low-fat eucaloric diet with a high sugar/starch ratio stimulated de novo fatty acid synthesis and
increased serum triglycerides in normal weight individuals.72 When subjects with the metabolic
syndrome, i.e. with pre-existing insulin resistance, were fed either a hypocaloric low-CHO/high-fat
diet with high SAFA content or a hypocaloric high-CHO/low-fat diet with low SAFA content, the
low-CHO/high-SAFA diet resulted in lower SAFA levels in plasma lipids compared to the high-CHO/
low-SAFA diet.75,76 Finally, in subjects with the hepatic manifestation of the metabolic syndrome,
i.e. non-alcoholic fatty liver disease, 26% of the fatty acids in the liver-triglycerides and 23% of the
fatty acids in VLDL- triglycerides derive from de novo fatty acid synthesis in the liver.77 Importantly,
as much as 25-30% of Western adults are su!ering from non-alcoholic fatty liver disease78 in which
the hepatic synthesis of fat, including SAFA, has become independent of the metabolic state, i.e. is
independent of the feeding-fasting-cycle.77 Taken together, SAFA accumulate: 1) under eucaloric
conditions in normal weight subjects who consume a CHO-rich diet with high glycemic index and 2)
under hypocaloric conditions in subjects with the metabolic syndrome and non-alcoholic fatty liver
disease who consume CHO-rich diets. Thus CHO, particularly those with a high glycemic index, and
pre-existing insulin resistance are confounding factors in the discussion on the relation between
CVD and dietary SAFA. This observation underscores the importance of a renewed discussion about
the possible dangers of dietary SAFA.
CONCLUSIONS
The total body of evidence suggests that attention should be shifted from the harmful e!ects of
dietary SAFA per se, to the prevention of the accumulation of SAFA in body lipids. This shift would
emphasize the importance of reducing dietary CHO, especially CHO with high glycemic index, rather
than reducing dietary SAFA. The chronic interaction of SAFA with our immune system elicits so
called “chronic systemic low grade in"ammation”, which underlies the metabolic changes referred
to as the (atherogenic) dyslipidemia of the metabolic syndrome or the lipidemia of sepsis. The
ultimate goal of the ensuing insulin resistance is the re-allocation of energy-rich substrates, such as
glucose, to the immune system while the change in our lipoprotein pro#le aims at the limitation of
the in"ammatory responses and the repair of the resulting tissue damage. Dietary SAFA belong to
the many false triggers of in"ammation that result from the con"ict between our slowly adapting
genome and our rapidly changing lifestyle, but among these many factors they are not the most
important. A reduction in the consumption of CHO with a high glycemic index, trans-fatty acids
and linoleic acid, and an increased consumption of #sh, vegetables and fruit, and a reduction of
inactivity, sleep deprivation and chronic stress seem more realistic approaches to #ght the current
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Introduction. Darwin described two forces in evolution: ‘natural selection’ and ‘the conditions of
existence’, of which, in his mind, the latter was the most important. Our genetic material (genome)
adapts very slowly to the rapidly changing conditions of existence. Evolutionary medicine teaches
us that typical diseases of civilization, such as cardiovascular disease, diabetes, certain cancers and
degenerative brain diseases are caused by a ‘mismatch’ between the manmade rapidly changing
conditions of existence and our ancient genome. For prevention and treatment, it is necessary to
acknowledge the changes in our conditions of existence that have occurred since the agricultural
and the industrial revolutions and to obtain detailed insight into these changes.
Materials and Methods. We performed a multi-disciplinary literature study of the conditions of
existence of our distant ancestors who lived in East-Africa. With these data we reconstructed the
composition of various East-African diets in the Paleolithic era. We also collected milk, red blood
cells, umbilical cord vessels and adipose tissue of traditionally living East-African peoples for the
determination of their respective fatty acid compositions.
Results. Our literature study demonstrated that our hunting and gathering ancestors lived in the
land-water ecosystem, and therefore derived at least part of their diet from this niche. Compared
to our current Western diet, they had lower intakes of carbohydrates and linoleic acid, but higher
intakes of protein and the typical !sh oil fatty acids EPA and DHA. Our !eld research in East-Africa
supported a high intake of !sh oil fatty acids from the local land-water ecosystems.
Conclusions. Di"erences between our current Western diet and the diet of our Paleolithic ances-
tors contribute strongly to the many years that Western populations live with chronic diseases. The
search for answers to the question of how to improve this situation is however hampered by the
present paradigm that prescribes how studies of the health e"ects of our diet and lifestyle should
be performed. It appears simple and that is exactly what it is: for healthy aging we need to return




1.1 Introduction to Evolutionary Medicine and aim of this thesis
The Dutch Nobel prizewinner Nikolaas Tinbergen rst described the important dierences between
proximate (direct) and ultimate (evolutionary) causes for animal behavior1. His observations
were extended to disease occurrence by the pioneers of ‘Evolutionary Medicine’, i.e. Randolph
M. Nesse and George C. Williams2,3. Proximate explanations explain how things (e.g. a disease)
happen, while evolutionary explanations explain why things (e.g. diseases) occur. This dierence
is of great importance, but seems poorly appreciated in health care. In medical practice, proximate
explanations deal mostly with treatment (health care), while evolutionary explanations are useful
for both primary and secondary prevention (public health and health care, respectively). By their
(predominantly drug) treatment, physicians in modern (Western) medicine focus mostly on the
proximate (mechanistic) causes of disease4, with little attention for the secondary prevention lessons
that can be learned from evolutionary medicine. The latter emphasizes the importance of ultimate
explanations of diseases, since these, rather than the treatment of their proximate causes, provide
targets for the reduction of the burden of chronic disease, the suering thereof and their associated
costs. Evidence Based Medicine (EBM) has greatly contributed to the current gap between proximate
and evolutionary medicine, since it focuses preferably on the outcomes of interventions with single
(chemical) components in patients with preexistent pathologies, rather than on holistic approaches
to increase and/or preserve health in healthy subjects, such as advocated in Evolutionary Medicine.
Moreover, such holistic approaches are popularly often dismissed as ‘alternative’ medicine.
Meanwhile, a surprisingly high percentage of about 70% of the Dutch population is considered to
‘believe’ in Evolution while 10% is ‘not sure’5.
Evolutionary medicine acknowledges that many of the present day diseases of civilization,
including cardiovascular disease, diabetes mellitus, certain cancers, certain neuropsychiatric
diseases and osteoporosis, result from con!icts between our rapidly changing environment and our
only slowly adapting genome, which basically still resides in the Paleolithic era. This con!ict can only
be solved by gaining knowledge of our ancient environment and our behavior in this environment
(lifestyle), since man-orchestrated engineering of our genome to make us adapt to the 21st century
environment is no realistic option. This rapidly changing environment includes insu#cient physical
activity, lack of sleep, altered bacterial !ora and exposure to environmental pollution and chronic
stress. Besides these important changes, our diet is an important environmental factor. Our diet
has experienced tremendous changes in the recent past, but it might, among the various lifestyle
factors, be one of the easiest to modify back to what it originally was. For this, reconstruction of
our diet prior to the onset of the agricultural and industrial revolutions is indicated, but there is
still much uncertainty about the ecological niche in which we became to what we currently are.
However, what scientist do agree on is that the major part of human evolution occurred in (East)
Africa.
This thesis describes studies that have been initiated with the Evolutionary Medicine concept in
mind. For many of these we went ‘back-to-Africa’. Our goal is the treatment and notably prevention
of typically Western diseases by looking back into the past, when according to the rules of evolution
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our genome became adapted to our ancient environment. Our contribution aims ultimately at the
modication of our current lifestyle and notably certain aspects of our contemporary diet with the
goal to reduce the burden of degenerative diseases by the promotion of healthy ageing according
to the lessons of Darwin, i.e. ‘adaptation to the conditions of existence’.
1.2 Human origins and the early human niche
In Chapter 1 we update the evidence for healthy ageing among our early ancestors and in the
late and present hunter-gatherer societies. We criticize the long reigning paradigm that our
ancestors evolved on the hot and arid savannah and argue that they rather found an ecological
niche in the proximity of water. Evidence from various disciplines is discussed, including the study
of Paleoenvironments, comparative anatomy, biogeochemistry (which relates isotope abundances
in fossils to dietary habits of the proprietor), archeology, anthropology, (patho)physiology and
epidemiology, and the study of Paleolithic diets that have been reconstructed from naturally available
foods. We also review the limited number of studies that have thus far investigated the health
e!ects of the putative Paleolithic diets. We conclude that there is ample evidence that longevity
was not uncommon among hunter-gatherers. While ageing provided an direct evolutionary
advantage with regard to the quantity of o!spring, the presence of these older individuals also
provided a subsequent evolutionary advantage to their o!spring. These observations suggest that
there has been ample opportunity for the evolution of healthy ageing. We also conclude that our
ancestors evolved in a land-water ecosystem and extracted a substantial part from their diets from
these environments. Rather than rejecting this possibility by a lack of evidence, we propose that the
default assumption should be that hominins*, living in coastal ecosystems with catchable aquatic
resources, consumed the aquatic resources found in their immediate vicinity.
2.1 The early human diet
In Chapter 2 we reconstructed multiple Paleolithic diets to estimate the ranges of nutrient intakes
upon which humans evolved. We composed a database of, predominantly East-African, plant and
animal foods (including both meat and sh) to model multiple Paleolithic diets at known hunter-
gatherer plant/animal food intake ratios [range 70/30 to 30/70 energy% (en%)]. We applied two
pathophysiological constraints to the models. The rst was that protein intakes needed to be below
35 en%; while the second constraint was that the intakes of linoleic acid (18:2 6; LA) needed to be
above 1.0 en%. In the past, Boyd Eaton, Loren Cordain and Michael Crawford, who co-authored the
study, had addressed similar questions, but had more or less concentrated on either a terrestrial diet
or an aquatic diet, or restricted their reconstruction to a xed plant/animal intake ratio. Additionally,
much emphasis had been put on the observation that our ancestors acquired the use of stone tools
*A human or a human ancestor, including all of the Homo species (Homo sapiens, H. ergaster, H. Rudolfensis, etc.),





about 3.4-2.4 million years ago and developed the skills to get access to bone marrow and brain
from hunted or scavenged animals. Consequently, there had been ongoing discussion whether
long-chain polyunsaturated (LCP; ≥3 double bonds, ≥20 C-atoms) fatty acids (FA) derived either
from the aquatic food-chain (i.e. from sh) or might also have been acquired from the terrestrial
food-chain, through the consumption of animal brains after the cracking of their skulls with stone
tools. Regarding the typically opportunistic way of life ascribed to hominins, we investigated the
most plausible scenario in which hominins consumed a mixed diet from both terrestrial and aquatic
resources, with a wide range of dietary intakes from both plant and animal food resources. Therefore,
we investigated selective and non-selective savannah, savannah/aquatic and aquatic hunter-
gatherer/scavenger foraging-strategies. Within the scavenger foraging-strategy, we additionally
varied the amount of organ meats consumed (brain, liver, bone marrow and adipose tissue) within
reasonable limits.
Despite the wide range of dietary possibilities, the outcomes resulted in a remarkably uniform
dietary intake pattern. The macronutrient composition of the presumed Paleolithic diet averaged
from 25-29 en% protein (overall range 8-35 en%); 39-40 en% carbohydrates (CHO; 19-48 en%) and
30-39 en% (20-72 en%) fat. Thus, the various Paleolithic diets provided moderate-to-high protein
and fat intakes and moderate CHO intakes, when compared to the current international and national
(Dutch) intakes and recommendations and were quite similar to, for example, the South Beach diet
(for other examples: see Table 6 in Chapter 1). The reconstructed diets were high in saturated FA
(SAFA) (11.4-12.0 en%) and moderate-to-high in monounsaturated FA (MUFA) (5.6-18.5 en%) and
polyunsaturated FA (PUFA, ≥2 double bonds, ≥18 C-atoms) (8.6-15.2 en%). PUFA intakes were
notably explained by consisted -linolenic (18:3!3; ALA) (3.7-4.7 en%), LCP!3 (2.26-17.0 g/day) and
LCP!6 (2.54-8.84 g/day) intakes, whereas LA intakes were remarkably low (2.3-3.6 en%), compared
with current Western intakes and recommendations. Compared to Western diets, Paleolithic diets
contained consistently higher protein and LCP, and lower LA. These are likely to contribute to
the known benecial e!ects of Paleolithic-like diets. For instance, hypercaloric CHO intakes have
been implicated in dyslipidemia, while increased protein intakes have been related to satiety and
satiation. Disparities between Paleolithic, contemporary and recommended intakes might be
important factors underlying the etiology of common Western diseases. Data on Paleolithic diets
and lifestyle, rather than the investigation of single nutrients, might be useful for the rational design
of clinical trials.
Milk fatty acid compositions in traditional East African populations
3.1 High in AA and DHA
Chapter 3.1 questions the validity of current recommendations for the arachidonic acid (20:4!6;
AA) and docosahexaenoic acid (22:6!3; DHA) contents of human milk, in view of the profound
dietary changes in the past 100 years. Despite these changes, current recommendations are based
on the average breast milk compositions of Western women. In search of the milk AA and DHA
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contents of our African ancestors we initiated an investigation of a Tanzanian population living on
the shores of Lake Kitangiri,(see Figure 1, Scope) where local corn oil-fried sh proved to be the
major lipid source, while corn porridge and local fruits and vegetables constitute their staple foods.
We collected milk samples from 29 lactating women and conducted FA analysis of these milks and
of the sh species available on the local markets. These women exhibited some dietary dierences
compared to the presumed Paleolithic diet (i.e. higher CHO and LA acid intakes). A multivariate
analysis showed that the milk medium-chain SAFA (MCSAFA; which derive from endogenous FA
synthesis from glucose in the mammary gland) and LA contents did not aect the milk AA and/or
DHA contents. The high milk AA (0.70 mol%) and DHA (0.75 mol%) and low AA/DHA ratio (0.91 mol/
mol) traced to the consumption of freshwater sh with both high AA and DHA contents and a high
AA/eicosapenaenic acid (20:5 3; EPA) ratio. We concluded that the milk AA, DHA and the EPA (0.17
mol%) contents of these women might be used to optimize infant formulas and the milk of Western
women. Benecial neurodevelopmental outcomes after supplementation of pregnant women or
infants with LCP, however, proved di!cult to attest in controlled trials thus far, possibly because of
the plasticity of the brain and the subtle eects involved. However, the Barker hypothesis predicts
that the ultimate results of inadequate supply of certain nutrients during intrauterine development
and similarly during the period of exclusive breastfeeding will aect health after the reproductive
period, that is increase the prevalence of chronic degenerative disease at the end of the life cycle.
3.2 Low in LA, high in MCSAFA and LCP
In a subsequent study, described in Chapter 3.2, we investigated the milk FA composition of several
Tanzanian tribes (for locations see Figure 1, Scope). Our primary objective was to dierentiate
between women consuming salt water and freshwater sh, and to compare the outcomes with
those from women with very low sh intakes due to cultural beliefs or the simple absence of sh
in the near environment. We collected milk samples from 20 sh-consuming women living in the
island of Chole, located in the Indian Ocean, 30 women living in the Ukerewe island in Lake Victoria,
30 women living at Matema beach at the north-western shore of Lake Malawi, and 35 women from
the shores of Lake Kitangiri. For non-sh eaters we collected milk from 28 traditional hunting and
gathering Hadzabe women, from 27 traditionally living pastoral Maasai women, from 9 neighboring
Sonjo women, and from 18 Iraqw women who live on the foothills of Mount Hanang. The milk of the
women with high sh intakes showed high mean levels of LCP, ranging from 0.50-0.80 g% AA and
from 0.53-1.79 g% DHA. The mean level of 1.79 g% proved the highest milk DHA content reported
in the literature so far through analysis using capillary GC columns. Women living in the islands of
Chole and Ukerewe showed remarkably low mean levels of LA in their milks (range 4.23-5.20 g%).
High levels of MCSAFA, notably 12:0 and 14:0, compensated for the low levels of LA. The low levels
of LA were explained by the low intake of vegetable oils. Chole women had high levels of both
12:0 (20.17 g%) and 14:0 (21.19 g%), while Ukerewe women had moderate levels of 12:0 (12.28 g%)




from coconuts and their high CHO intakes, respectively. The AA/DHA ratios in the sh-eating groups
related strongly to the AA/DHA ratios in the available sh. Importantly, the milk of a substantial part
of these sh eating populations surpassed the upper level for the 12:0 and 14:0 contents of infant
formulas, while LA levels did not meet the recommendation. Conversely, the milk of a substantial
part of the inland Tanzanian tribes did not meet the minimum intakes for both AA and DHA such as
issued by several Western nutritional boards.
3.3 Western recommendations criticized
Despite the publication of Chapters 3.1 and 3.2, the authors of a subsequent meta-analysis6 of the
world wide human milk DHA and AA contents concluded that the average values of 0.32 g% DHA
and 0.47 g% AA resulting from their search should serve as a guide for infant feeding. In Chapter
3.3 we discuss the consequences of their point of view and we propose that the evidence-based
recommendations issued by various health organizations, i.e. to consume up to 3 servings of sh per
week, should be translated into a recommendation for the breast milk LCP content and hence for
the daily LCP intakes of an infant. In other words, a guide for infant feeding should not derive from
the milk composition of women who typically do not fulll the well-founded recommendation to
consume up to 3 servings of sh a week.
3.4 Di!erences between preterm and term milk in East-Africa
Studies in Western subjects show a decrease in the milk AA and DHA contents with the duration of
lactation, which is often explained by depletion of the maternal stores. Similarly, the higher levels
of DHA and AA in preterm compared to term milk are explained by the depletion of maternal LCP
stores that comes along with advancing gestation. In Chapter 3.4 we discuss whether the same
e!ect is observed in women with lifelong high LCP intakes from freshwater sh, since these high
intakes might be expected to prevent the depletion of maternal LCP stores. For this purpose we
collected preterm and term colostrum, transitional and mature milk samples from women living
in Sengerema, at the southern shore of Lake Victoria (Figure 1, Scope). We collected 30 colostrum,
19 transitional and 34 mature breast milk samples from women who delivered at term. These
numbers were 14, 23 and 13, respectively, for women who delivered prematurely. In our study
population, both DHA and AA decreased from colostrum to mature milk, i.e. both after preterm
and after term delivery. The observed median DHA (1.11-0.75 g%) and AA (0.93-0.69 g%) levels in
preterm milk proved the highest among the reported contents of the worldwide preterm milks so
far. The outcome substantiates our previous statement in Chapter 3.3 that most of the reported
human milk compositions derive from studies with Western women with relatively low sh
intakes. Consistent with the literature, DHA proved higher in preterm compared to term colostrum,
suggesting that other in"uences than the depletion of maternal stores might have caused the
observed di!erence in this particular population with high DHA intakes from freshwater sh. We
suggest that the postpartum increase in MCSAFA, and higher MCSAFA in preterm, compared to
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term colostrum, as well as the decreasing MUFA with advancing lactation, and the lower MUFA in
preterm compared to term colostrum, might derive from dierences in maternal insulin sensitivity.
Insulin sensitivity might ultimately govern the relative contributions of de novo synthesized FA from
the liver and those from the mammary gland. An elaboration on the in!uence of insulin sensitivity
on FA metabolism can be found in Chapter 6.
Erythrocyte fatty acid compositions of traditional East-African populations
4.1.1 Three African tribes with negligible, Western-like, and high !sh intakes
In Chapter 4 we describe the courses of erythrocyte (red blood cell; RBC) FA during the perinatal
period and across the life cycle. In addition, we investigated whether biomagni"cation, i.e. the
higher LCP in infant compared to maternal plasma phospholipid (PL) and RBC (in g/100 g FA), also
occurred in women with very high "sh intakes. Similar to the decreasing milk fat DHA content with
the duration of lactation, the maternal plasma PL- and RBC-DHA contents are known to decrease
during pregnancy and subsequent lactation in Western women. Similarly, the maternal AA status
decreases during pregnancy, but increases again in late pregnancy or early lactation.We investigated
whether these observed changes were similar in Tanzanian women with low, intermediate or high
"sh intakes. For this, we focused on three diverse populations who all live in Tanzania, East-Africa
(see Scope: Figure 1; locations 2, 9 and 10).
The Maasai are pastoralist people from Nilo-Hamitic descent. They inhabit the Maasai Plains that
range from the Kenyan border far into the South of Tanzania. Their original life is centered around
their cattle and their original diet was composed of milk and meat. Governmental pressure has
pursued many of these people to abandon their nomadic lifestyle and settle, which also resulted
in an increase of the incorporation of cereals, mainly corn porridge, into their diets. However, "sh
are still not eaten due to their cultural belief that it is a snake-like creature and therefore not edible.
Maasai are remarkably "t and apparently free of cardiovascular disease. The Maasai were included
for the near absence of preformed DHA from "sh in their diet. The second group lives at the base
of the Pare Mountains in the east of Tanzania. The Pare Mountains are quite fertile and provide the
inhabitant Pare and Sambaa tribes with abundant corn, rice, wheat, fruit and vegetables, while both
meat and "sh are aordable for most of the villagers. Cattle is locally abundant and additionally
brought in by Maasai from the Maasai Plains in the west who trade their cattle for a wide range
of items available in the Pare villages. Fish is obtained from nearby lakes, of which the closest is
located about 30 kilometers away. Their dietary "sh intakes were estimated at 2-3 times/week, but
the consumed "sh rarely exceed the maximum of 15 cm in size. The "nal study population inhabits
the shores of Lake Victoria near Sengerema and consists of a variety of local, mostly Bantu, tribes.
Since we performed our project in a local governmental hospital, visiting patients were all from
the local lower and middle class, since upper class people attend the private hospitals in these
countries. Consequently, most of these families obtained the majority of their dietary protein from




meter (average 30 cm) in size and from ground dwelling catsh, prehistoric lungsh, tilapia and the
recently introduced Nile Perch, to the decimated endemic cichlids of the Lake, locally known as furu,
that however, have begun to recover in multitude again, although most have lost their beautiful
colors. Importantly, the available sardine species, locally known as dagaa, are considered as a
vegetable and are actually consumed as being butter to bread in Western societies. We estimated
that the average sh intake ranged from 4-5 times/week in this population.
4.1.2 Intrauterine bioattenuation and infant DHA equilibrium: 6 g% RBC-DHA
In Chapter 4.1, we investigated whether biomagnication persists at lifelong high maternal sh
intakes. Secondly, we investigated whether the consistently observed decreases in the infant and
maternal DHA status after delivery were also observed in the population with high sh intakes. We
collected blood samples and analyzed their FA contents in 14 women during the rst trimester, 103
women during the second trimester and 88 women during the third trimester of pregnancy. We
also analyzed blood samples from 63 mother-infant pairs at delivery and 103 mother-infant pairs
after 3 months of exclusive lactation. We found that at delivery and after 3 months of breastfeeding
the infants of all three tribes had remarkably similar RBC-AA, which were unrelated to maternal
RBC-AA. RBC-AA decreased in infants after delivery, but meanwhile increased in maternal RBC. A
second nding was that at delivery the Maasai and Pare women had lower RBC-DHA compared to
their infants, but that the RBC-DHA of the Sengerema women was higher than that of their infants.
From these data, we calculated that transplacental biomagnication (i.e. a higher infant compared
to maternal DHA status at delivery) disappears when the mother and infant reach an (equilibrated)
status of 5.6 g% DHA in their respective RBC. In addition, our data revealed that at higher maternal
RBC-DHA, infants had lower RBC-DHA compared to their mothers. We coined this lower infant
compared to the maternal RBC-DHA content at high maternal sh intakes ‘bioattenuation,’ as
opposed to the well-known process of ‘biomagnication’ resulting in a higher infant compared to
maternal DHA status (Figure 1). After delivery, however, the maternal RBC-DHA content decreased
consistently, suggesting higher infant DHA demands during lactation, compared to pregnancy.
This decrease in maternal RBC-DHA resulted in a lower maternal, compared to infant, RBC-DHA
content after 3 months lactation in all tribes. Importantly, however, the concomitant changes in
infant RBC-DHA related to the maternal status; showing a decrease in the Maasai infants, no change
in the Pare infants and an increase in Sengerema infants. From these courses of infant RBC-DHA
after delivery, we estimated that the postpartum infant RBC-DHA content remains constant from
an initial status of 6 g%, which corresponds to a maternal RBC-DHA content of 6 g% throughout
pregnancy. We concluded that a uniformly high infant AA status at delivery might indicate the
importance of a certain intrauterine infant AA-status. Secondly, we propose that biomagnication
re!ects a low maternal DHA-status and that bioattenuation may prevent intrauterine competition
of DHA with AA. Finally, we concluded that a maternal RBC-DHA content of 6 g% during pregnancy
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Figure 1. Relations between the maternal and infant erythrocyte (RBC) docosahexaenoic acid (DHA) content
at delivery and 3 months postpartum at low, intermediate and high maternal DHA status and the concomittant




this infant equilibrium was clearly associated with a decrease of the maternal DHA status during
lactation.
4.2 Postpartum biomagnication and maternal DHA equilibrium: 8 g% RBC-DHA
Although the RBC-DHA content decreased consistently in all women during 3 months of lactation,
the Maasai women showed the most, and the Sengerema women the least, pronounced decreases.
Similarly, the absolute di!erence between the maternal and infant DHA status at delivery and at 3
months postpartum decreased in the order Maasai>Pare>Sengerema, with the noteworthy remark
that Sengerema infants had a lowerDHA status compared to their mothers at delivery (Chapter 4.1),
but not at 3 months postpartum. In a subsequent analysis, Chapter 4.2, we used these observations,
to calculate the postpartum turning-point from DHA biomagni"cation to bioattenuation. Secondly
we estimated from which RBC-DHA content at delivery the lactating mother reaches a postpartum
DHA-equilibrium, i.e. the steady state level from which the maternal RBC-DHA content discontinues
to decline during lactation. We also investigated what would happen concomitantly to the infant
RBC-DHA content. Finally, we investigated the relation between RBC-DHA and RBC-AA in these
three populations with seemingly di!erent intakes of both DHA and AA from local food sources.
We found that after 3 months lactation, the maternal RBC-DHA was lower than the corresponding
infant RBC-DHA content up to a maternal RBC-DHA content of 8 g% at delivery. In other words, at
the stable dietary habits observed in these populations, mothers with an RBC-DHA content of 8.0
g% at delivery had a similar RBC-DHA content at 3 months postpartum. However, this maternal
RBC-DHA equilibrium corresponded with an infant RBC-DHA of 7 g% at delivery that increased to
8.0 g% at 3 months postpartum (Figure 1). The latter indicates that the initial bioattenuation of
DHA during pregnancy in women with high "sh intakes, is followed by a postpartum surge of DHA
via the milk. The fact that biomagni"cation seems to occur up to 6 g% during pregnancy but up
to 8 g% after delivery suggests that DHA becomes increasingly important for the infant directly
after delivery. We also found between-group di!erences in maternal RBC-AA. Despite the observed
di!erences in maternal RBC-DHA and RBC-AA, however, we found no di!erences in infant RBC-AA
at delivery or 3 months postpartum, suggesting that unlike RBC-DHA, maternal RBC-AA and infant
RBC-AA are independently regulated in these populations. We "nally observed bell-shaped relations
between RBC-DHA and RBC-AA, which might (in concert with the processes of biomagni"cation
and bioattenuation) aim at uniform infant AA status. At low DHA status DHA biomagni"cation
might synergistically increase AA status, while at high DHA status, DHA bioattenuation might
antagonistically decrease AA status.
4.3 A bell-shaped relation between DHA and AA
To con"rm the bell-shaped relation between DHA and AA that was found in Chapter 4.2, we
investigated these suggested synergistic and antagonistic relationships in our FA databases
composed of 1,979 RBC, 789 umbilical artery wall and 785 umbilical vein wall samples that had been
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collected during 25 years of previous studies and which consisted of populations with a wide range
of dietary AA and EPA+DHA intakes, Chapter 4.3. We found that in all compartments, but notably
in RBC, the relation between EPA+DHA and AA appeared bell-shaped. Most evidently, populations
with low RBC-(EPA+DHA) (i.e. <2 g%) exhibited positive relationships, while in populations with
high RBC-(EPA+DHA) (i.e. >8 g%) we found negative relationships. Synergism between RBC-
(EPA+DHA) and RBC-AA was also apparent in umbilical arteries and veins, but antagonism could
not be demonstrated. The latter might be explained by our earlier observation that bioattenuation
prevents by some mechanism the accumulation of DHA in the fetus at high maternal RBC-
(EPA+DHA) content, so that an infant RBC-(EPA+DHA) content >6 g% at delivery is rarely observed.
We speculated that synergism and antagonism aim at a certain LCP 3/LCP 6 balance that might be
involved in optimal homeostasis and is favorable for ‘good health’. We suggest that synergism might
be a feature of the typically low LCP 3 status as observed in developing countries with very low
LCP 3 intakes such as in the Maasai -where !sh are considered as inedible- while the antagonistic
suppression of AA at high RBC-(EPA+DHA) might be the physiological standard for human adults.
This antagonistic relation is likely to have occurred in our ancient human ancestors who had both
high intakes of AA and EPA+DHA from their combined terrestrial and aquatic food sources.
5 Brain, liver and adipose tissue FA compositions in an East African population with high !sh
intakes
In Chapter 5 we present the brain, liver and adipose tissue FA compositions of samples collected from
fetuses who were stillborn to women living on the Lake Victoria coastlines around Sengerema (see
Scope, Figure 1) and were known to have high intakes of freshwater !sh. We compared the outcomes
with our !ndings for the adipose tissue FA compositions (Chapter 6.1) and the reconstructed FA
compositions of liver and brain (Chapter 6.2) of fetuses born to women with typically Western diets.
We analyzed the brain (n=18), liver (n=14) and adipose tissue (n=11) FA compositions deriving from
20 stillborn infants of di"erent gestational ages (range 8-38 weeks) born to Tanzanian women with
low LA intakes and high intakes of DHA and AA from local !sh.
We found that with advancing gestation, the relative amounts of brain SAFA, PUFA, DHA and
20:3 6, 22:4 6 and 22:5 6 increased, while MUFA, 20:3 9, 22:3 9 and AA decreased. The decrease
in brain AA might be secondary to an augmented AA-metabolism that results in increases of 20:3 6
(the precursor of the series-1 prostaglandins), 22:4 6 (the main storage form of AA in the brain)
and 22:5 6. In the liver, SAFA, PUFA and LA increased, while MUFA decreased with gestation. In
agreement with our earlier !ndings, the steep increase of (mostly de novo synthesized) SAFA in
adipose tissue caused relative decreases of MUFA, PUFA, DHA, LA and AA with advancing gestation.
Compared to Western infants, the currently studied African infants had higher DHA, lower AA, and a
higher DHA/AA-ratio in brain and adipose tissue, while their LA content in adipose tissue was lower.
We concluded that the low LA and high DHA and AA intakes of these African women might support




DHA vs. AA antagonism. Conversely, the Western diet, characterized by high LA and lower DHA
and AA intakes, might disturb these evolutionary conserved mechanisms aiming at an optimal  3/
 6-balance.
Fetal body fatty acid composition in Western populations
6.1 Fetal adipose tissue fatty acid composition
Chapter 6 describes the FA composition of the fetal body. There is a scarcity of data that allow
calculation of the fetal whole body biochemical composition during gestation and at delivery.
Some investigators have examined the di!erent components in detail but an accurate estimate of
the total amounts of FA in the fetal body at the various times during gestation is missing. These
data might be important, since FA and especially LCP have been implicated in fetal health and
neurodevelopment. Some data are available for the FA compositions of the fetal liver and brain.
It has been suggested that the majority of fetal LCP are not located within these organs but rather
within the fetal adipose tissue compartment. There are very few investigators who reported on the
FA composition of fetal adipose tissue during intrauterine development. We aimed at the elucidation
of the remarkable discrepancy between the outcomes of the only two studies on the fetal adipose
tissue FA composition that to our knowledge have been reported so far.
To gain insight into the intrauterine courses of FA accretion in fetal white adipose tissue (WAT) in
Western infants we measured the WAT-FA compositions of 40 fetuses and newborns with gestational
ages between 22-43 weeks (Chapter 6.1). The samples were collected as part of a perinatal mortality
study in Curaçao (the former Netherlands Antilles). We found that the fetal adipose tissue SAFA and
MUFA contents increased from 83 to 298 mg/g WAT and 83 to 226 mg/g WAT, respectively, while
PUFA increased insigni#cantly from 18.0 to 23.2 mg/g WAT. Consequently, SAFA increased from
46 to 55 g% of total FA, while MUFA and PUFA decreased from 44 to 41 g% and 10.3 to 4.26 g%,
respectively. The infant adipose tissue DHA content decreased from 1.18 g% at 25 weeks to 0.30 g%
at delivery, while AA decreased from 2.06 g% at 25 weeks to 0.66 g% at delivery. These data clearly
demonstrated decreasing relative adipose tissue LCP contents, as a result of the increasing amounts
of SAFA and MUFA that become stored. These declines had not been noted in a previous study7 in
which fetal FA accretion rates during gestation were estimated. The reported LCP accretion rates in
that study and subsequent reviews8-11 are much higher than presently calculated. To arrive at more
realistic accretion rates, we calculated that at term, an appropriate for gestational age (AGA) infant
harbors about 560 g lipid. A large for gestational age (LGA) infant of 4,000 g contains about 810 g
lipid, while a 4,500 g LGA has about 1,060 g lipid. Analogously, an AGA infant contains about 1,460
mg DHA and 3,150 mg AA in its adipose tissue, while a 4,500 g LGA infants may have deposited
in its adipose tissue up to 2,970 mg DHA and 6,420 mg AA. As a result, adipose tissue accretion
rates during the third trimester for DHA increase from 88 mg DHA/week for a 3,500 g AGA infant to
184 mg DHA/week for a 4,500 LGA infant. Accretion rates for AA during the 3rd trimester increase
from 193 mg AA/week for a 3,500 g AGA infant to 402 mg AA/week for a 4,500 LGA infant. Finally,
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increment rates during the last 5 weeks of gestation were about 2-fold higher compared to the rates
during the 3rd trimester. The current WAT-DHA and WAT-AA accretion rates are considerably lower
than previously reported in the literature.
6.2 Fetal whole body LA, AA and DHA contents and accretions in pregnancy
There is no information on the whole body FA contents of preterm infants, although scattered
information on the FA-composition of many organs is available. We therefore performed a second
study, described in Chapter 6.2, to estimate whole body amounts of LA, AA and DHA and whole
body accretion rates during intrauterine fetal development. We collected data on the weights,
lipid contents and FA-compositions of the quantitatively most important fetal organs (i.e. skeletal
muscle, skeleton, skin, liver, brain and adipose tissue) of appropriate for gestational age (AGA)
Western fetuses. Subsequently, we estimated the total body contents of LA, AA and DHA at 25, 35
and 40 weeks of gestation.
We found that Western infants accrete FA in the order of LA>AA>DHA at all stages during
pregnancy and that the highest accretion rates are reached in the last 5 weeks of gestation, i.e. 342
mg LA, 95 mg AA and 42 mg DHA/day. At term, most of the infant’s LA, AA and DHA is located in
adipose tissue (68, 44 and 50%, respectively). Substantial amounts of LA are also located in skeletal
muscle (17%) and skin (13%); while important amounts of AA are located in skeletal muscle (40%)
and brain (11%); and of DHA in brain (23%) and skeletal muscle (21%). At term age, an AGA infant
has accreted about 21 g LA, 7.5 g AA and 3 g DHA, which constitutes a gap of 12 g LA, 3.3 g AA and
1.5 g DHA compared to a 35 weeks old AGA premature infant. We concluded that the presently
estimated fetal LA, AA and DHA pool sizes and accretion rates may be useful to estimate the preterm
infant’s minimal requirements and the maternal LCP needs during pregnancy. However, since these
data derive from populations with typically Western diets they do not necessarily re!ect ‘optima’ for
‘health’.
INSULIN SENSITIVITY AND FATTY ACID STATUS INTERRELATED
In Chapter 7 we related insulin sensitivity to FA metabolism. The relation between insulin sensitivity
and hepatic FA synthesis, i.e. de novo lipogenesis (DNL), has been studied intensively. High insulin
levels are known to increase hepatic DNL. More recent studies showed that certain LCP, notably
DHA, are strong suppressors of hepatic DNL. Lipogenesis might be important in some instances,
i.e. secondary to the decreased insulin sensitivity in late pregnancy, but might be detrimental in
diseased conditions, such as in diabetes and the metabolic syndrome, leading to non alcoholic fatty
liver disease.
7.1 Higher DNL fatty acids in umbilical vessels during preeclamptic pregnancy
Preeclampsia is characterized by a combination of hypertension and proteinuria. The poorly




endothelial dysfunction, augmented systemic vascular resistance, platelet aggregation and
coagulation. In a previous study, we found lower contents of both LCP 3 and LCP 6 in umbilical
vessel walls of preeclamptic women living in Curaçao. In Chapter 7.1 we investigated whether a
similar picture would emerge in Tanzanian women living in Mwanza (see Scope, Figure 1) with high
LCP 3 and LCP 6 intakes from Lake Victoria "sh. We compared FA compositions of umbilical veins
and arteries from 28 preeclamptic women with those of 31 normotensive non-proteinuric controls.
In our preeclampsia cases we found lower DHA, LCP 6 and LCP 3+ 6 and higher SAFA and
potentially de novo synthesized FA in umbilical veins in conjunction with higher 16:1 7, 7 and 18:0
in umbilical arteries. Interestingly, umbilical vessels in Mwanza preeclampsia cases showed higher
DHA, LCP 3 and 3 compared with the controls in Curaçao. We conclude that, both in Tanzania and
Curaçao, preeclampsia is characterized by lower LCP and higher potentially de novo synthesized
FA. We suggest that the similarity of the umbilical vessel FA abnormalities compared to controls in
preeclamptic and diabetic pregnancies points at insulin resistance as a common denominator.
7.2 High DNL fatty acids in fetal and maternal RBC in late pregnancy
While investigating the milk- and RBC-LCP contents of the three Tanzanian populations (Chapters
3 and 4) with di#erent LCP intakes, we did not pay much attention to the changes observed in
those FA that potentially derive from hepatic DNL. In Chapter 7.2, we investigated the postpartum
changes in DNL derived FA in maternal RBC. We focused on their relation with the well-known lower
maternal insulin sensitivity at delivery as compared to the restored maternal insulin sensitivity at 3
months postpartum. Simultaneously, we investigated whether the observed FA changes between
the three study populations from delivery to 3 months postpartum might relate to their di#erences
in LCP, and notably DHA, intakes.
We found that the proxies for DNL activity decreased after delivery. At the same time, the proxy
for the enzymatic activities of stearoyl-CoA desaturase (SCD, involved in desaturating SAFA to
MUFA) decreased, while the proxy for elongation of very long-chain FA (Elovl) seemed to increase.
The most important postpartum increases in maternal RBC-FA were on the account of 18:0, LA and
AA, while the most important decreases were found for 16:0, 18:1 9 and DHA. For infants the most
important increases were for 18:1 9, 22:5 3 and LA, while decreases were noted for 16:0 and AA.
We suggested that the increases in 18:0, and decreases in 16:0 and 18:1 9, might derive from the
postpartum reducing insulin-promoted DNL-activity, causing a more reduced SCD- than Elovl-
activity. As a consequence of the latter, 16:0 increases, but also leaves more 16:0 for conversion
to 18:0. A second "nding was that the postpartum changes in the sum of potentially DNL-derived
FA, as well as the sums of SAFA and MUFA, related negatively to RBC-DHA. This is in line with
the described suppression of both SCD- and Elovl-activities by DHA. This in$uence is most likely
conferred through sterol regulatory element-binding proteins (SREBP). We concluded that perinatal
changes in maternal and infant FA status may be strongly driven by changing insulin sensitivity
and also by DHA status, which concertedly may aim at the transport of certain nutrients across the
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placenta or into the human milk at the various periods of infant development.
7.3 Higher DNL fatty acids in term compared to preterm colostrum milk
In a simultaneous study, Chapter 7.3, we related insulin sensitivity to changes observed in milk FA
from colostrum to mature milk and to FA di!erences between preterm and term colostrum milk.
We compared our data from Chapter 2 with those in the literature and con"rmed that preterm
colostrum generally contains higher MCSAFA and LCP, and lower MUFA. With advancing lactation,
MCSAFA generally increase, while both MUFA and LCP decrease. We investigated whether these
changes, again, might be related to restoring maternal insulin sensitivity after delivery and to
di!erent magnitudes of maternal insulin sensitivity at the time of preterm and term deliveries.
We found a higher index for de novo synthesized FA in the breast, a lower index for de novo
synthesized FA from the liver and lower SCD-activity in preterm compared to term colostrum. In
both preterm and term milks, FA derived from mammary DNL increased with advancing lactation,
while FA from liver DNL, SCD and FADS1 and FADS2 activities decreased. From these data we
concluded that DNL in the breast is likely to be secondary to its lipoprotein lipase (LPL)-mediated
uptake of FA from the circulation, which consists mainly of FA from hepatic DNL and adipose tissue
lipolysis. This might explain lower MCSAFA (from mammary gland DNL) and higher MUFA (from
insulin-induced hepatic-DNL) in term colostrum compared to premature colostrum, and also the
decreasing MUFA, but increasing MCSAFA, with advancing lactation. We also suggested that MUFA
and PUFA might compete for incorporation into very low density liprotein (VLDL). This might cause
the high DHA content of preterm colostrum, secondary to a lower VLDL-MUFA content derived
from hepatic DNL The decrease of milk LCP with advancing lactation seems to be explained by
decreasing hyperlipidemia, LPL- and FADS-activities and an increasing MCSAFA milk content. We
suggested that preterm delivery might thus deprive the infant from increasing transplacental MUFA
and LCP transfer and cause premature exposure to the high PUFA and MCSAFA contents of the milk.
In conclusion, the milk FA composition might be strongly in#uenced by the maternal magnitude of
insulin sensitivity at the time of delivery and the subsequent restoration of insulin sensitivity after
delivery.
8.1 Saturated fat, carbohydrates and cardiovascular disease
Chapter 8, "nally, deals with the reigning paradigm that fat, especially SAFA, is unhealthy since
its consumption is positively associated with cardiovascular disease (CVD) risk. This paradigm
derives from the positive relation between the intake of dietary SAFA and serum cholesterol and
the association between serum cholesterol levels and CVD12-15. In a recent meta-analysis16 of 21
previously conducted prospective cohort studies, however, it was concluded that SAFA are not
associated with CVD. It was shown that replacing dietary SAFA with CHO, notably those with
high glycemic indices, was associated with an increase in CVD risk in observational cohorts, while




combination of SAFA and trans-FA with LA in controlled trials showed no indication of bene!t but
rather a signal towards increased CVD risk19, suggesting that 3-PUFA might have been responsible
for the protective association between total PUFA and CVD.
We evaluated the roles of both CHO and SAFA in the etiology of CVD. High CHO intakes stimulate
hepatic SAFA synthesis and also conservation of dietary SAFA since fat is spared during glucose
excess. Hepatic DNL from CHO is also stimulated during eucaloric dietary substitution of SAFA by
CHO with high glycemic index (GI) in normo-insulinemic subjects and during hypocaloric high-CHO/
low-fat diets in subjects with the metabolic syndrome. The accumulation of SAFA stimulates chronic
systemic low-grade in"ammation through its mimicking of bacterial lipopolysaccharide and/or
the induction of other pro-in"ammatory stimuli. The resulting systemic low-grade in"ammation
promotes insulin resistance, reallocation of energy-rich substrates and atherogenic dyslipidemia
that concertedly give rise to increased CVD risk. We conclude that avoidance of SAFA accumulation
by reducing the intake of CHO with high GI is more e#ective in the prevention of CVD, than reducing
SAFA intake per se. The combined results of this review support the contention that dietary CHO
with high GI, notably in combination with dietary SAFA, give rise to an increased CVD risk, while
LCP 3 reduce CVD risk.
MAIN CONCLUSIONS
9.1 Evolutionary niche, fatty acid intakes and ensuing fatty acid status
This thesis supports the contention that our Paleolithic ancestors evolved in a land-water ecosystem
(Chapter 1). This ecological niche provided a diet rich in LCP 3 and LCP 6 (Chapter 2), which is
re"ected in the high milk (Chapter 3) and RBC (Chapter 4) DHA and AA contents of East-African
women living in a land-water ecosystem. At the same time, the reconstructed Paleolithic diet
was low in LA, which also became re"ected in the low milk LA contents of women belonging to
certain tribes with low intakes of re!ned vegetable oils (Chapter 3). In addition, African infants
have higher whole body DHA (Chapter 5), but lower whole body LA and AA compared to Western
infants (Chapter 6). Lower LA and AA together with higher DHA might support optimal ALA vs. LA
competition for FADS1 and FADS2 enzymes and DHA vs. AA antagonism, while the Western diet,
characterized by high LA and low DHA and AA intakes, might disturb these evolutionary conserved
mechanisms aiming at an optimal  3/ 6-balance.
9.2 Recommendations for 8 g% DHA in RBC and 1 g% DHA in milk
Taken together, the data of Chapter 4 indicate that DHA biomagni!cation and bioattenuation
aim at a certain fetal and infant DHA and AA status, but most importantly, that a maternal RBC-
DHA above 6 g% supports a postpartum infant DHA equilibrium, while 8 g% seems su$cient to
sustain both maternal and infant DHA status (Figure 1). This latter condition coincides with a mature
milk DHA content of 1 g%, which may therefore serve as a target for infant formula. The relation
between RBC-DHA and RBC-AA proved bell-shaped, suggesting that at low DHA levels, AA status
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becomes adjusted by suppression, while at high DHA status both AA incorporation and synthesis
become inhibited, leading to reduced AA status. Both these processes might be important in the
regulation of the tight balance between the  6 and  3 series of LCP, which have both antagonistic
and synergistic e!ects in e.g. metabolism, in"ammation, blood pressure regulation and coagulation
(Chapter 4).
9.3 Fetal DHA accretion rates in late gestation: 42 mg DHA/day
We con#rmed that adipose tissue is the quantitatively most important location for LCP (Chapter
6). In large for gestational age infants and infants born to women with disturbed glucose tolerance,
the expanding fetal adipose tissue compartment might compete with brain for incorporation of
LCP. This Chapter also indicates that the previously reported infant LCP accretion rates were too
high, because of the overestimation of the adipose tissue LCP content in a previous analysis with
packed GC-columns. The estimated whole body increment rates of 95 mg AA/day and 42 mg DHA/
day between 35 and 40 weeks gestation might provide information for the recommended maternal
LCP intakes during pregnancy and the composition of infant formulas.
9.4 Compromised insulin sensitivity causes lower LCP status by dilution
The lower insulin sensitivity in late pregnancy becomes re"ected by the FA composition of the
umbilical cord vessels, RBC and breast milk (Chapter 7). The reduced insulin sensitivity in late
gestation stimulates de novo lipogenesis (DNL), which is re"ected by increasing amounts of DNL-
derived FA in maternal and infant RBC, and in the milk around term birth. These DNL-derived FA
subsequently decrease during lactation, concomitant with the restoration of insulin sensitivity.
Comparably, the higher insulin sensitivity after a preterm compared to a term delivery is re"ected
by a lower content of DNL-derived FA in preterm milk. Similarly, umbilical vessels from preeclamptic
pregnancies, in which reduced insulin sensitivity is a common denominator, contained higher
DNL-FA compared to uncomplicated pregnancies (Chapter 7). These observations indicate that
impaired insulin sensitivity becomes re"ected by the FA compositions of most, if not all, body lipids.
Thus, increased DNL might compromise a subject’s LCP status by dilution, which might especially be
noticeable in e.g. diabetic pregnancies, but might likewise has its in"uence in many other diseases
characterized by impaired insulin sensitivity.
9.5 Not fat or SAFA, but intake of CHO with high GI relates to CVD
The current evidence suggests that SAFA and MUFA intakes are unrelated to CVD risk. Conversely,
CHO, notably those with a high GI, and probably LA, increase cardiovascular disease risk, while  3-
PUFA are protective (Chapter 8). The positive relation between CHO and CVD is likely to relate to
de novo lipogenesis and of sparing of SAFA in circulating lipids and tissues. It is thereby among the
many environmental factors involved in chronic activation of the immune system by false triggers,




altered glucose homeostasis and changes in the lipoprotein prole; all of which are hallmarks of the
metabolic syndrome, which in turn is associated with increased risk of diabetes type 2, CVD and the
many other degenerative diseases typical for Western societies (Chapter 7).
EPILOGUE
10.1 Evidence based medicine and evidence based nutrition
There is no doubt that prevention and treatment in the medical sciences should be supported
by solid evidence. The strength or solidness of evidence is nowadays evaluated by the creation of
a hierarchy in the outcomes of the various study designs (ranging from expert opinion to meta-
analyses of randomized controlled trials) that has become part of what is nowadays commonly
known as ‘evidence based medicine’ (EBM). EBM was rst dened as ‘a systemic approach to analyze
published research as the basis of clinical decision making’. In 1996, Sackett et al.20 more clearly
dened EBM as ‘the conscientious and judicious use of current best evidence from clinical care
research in the management of individual patients’21. In practice, randomized placebo-controlled
trials (RCTs) and notably meta-analyses thereof are considered as the highest level of evidence. In
nutrition, a similar approach has recently been introduced and is known as evidence based nutrition
(EBN).
10.2 This thesis in the light of evidence based nutrition
EBN is much more di!cult to apply in decision making than EBM with e.g. drugs22, although the latter
is also blessed with di!culties in their own right23-26. Above all, there is no evidence for EBM, nor for
EBN, as giving rise to better or more reliable results than other approaches, which actually labels the
concept with the status of a ‘paradigm**’. While people eat whole food or food products, EBN has to
a large extent become the performance of RCTs with single nutrients. RCTs with single nutrients are,
however, hampered by: poorly known dose-response relationships; multiple mechanism of action
of a single nutrient; small dietary changes and in"uences that may induce pathology in the very
long term; the many nutrient interactions; the ethical limitations that limit di#erences between
intervention and control groups; the di!culty of patenting outcome results; and the inevitable
problem that at e.g. isocaloric intakes any macronutrient always has to be replaced by another,
which makes it precarious to attribute observed e#ects either to introduction of one macronutrient
or the omission of the other22,27.
RCTs with single nutrients and hard endpoints have nevertheless become the sole basis of many
recommendations and guidelines by health authorities28, while there is more concern for toxicity
than for adequacy by the employment of the precautionary*** principle29-31. Moreover, in practice
** A set of assumptions, concepts, values, and practices that constitutes a way of viewing reality for the com-
munity that shares them, especially in an intellectual discipline.
*** The precautionary principle or precautionary approach states that if an action or policy has a suspected risk
of causing harm to the public or to the environment, in the absence of scientic consensus that the action or
policy is harmful, the burden of proof that it is not harmful falls on those taking the action.
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the criterion of RCTs with hard endpoints for the preparation of nutritional recommendations is
inconsistently applied. For example, there are no such RCTs supporting either the adverse eects of
dietary cholesterol, SAFA, trans-FA or the bene!cial eects of the consumption of 5-10 en% linoleic
acid19, while within the wealth of non-RCT information on vitamin D, only solid RCTs are eligible for
the establishment of vitamin D adequate intakes25,32. In addition, all meta analyses of RCTs studying
the role of LCP in neurodevelopment are negative33-35, but there are nevertheless recommendations
for their addition to infant formulas36-38.
Most importantly, the currently reigning paradigm of EBN poorly appreciates the many
interactions between dietary nutrients, ranging from synergistic to antagonistic health eects.
The wide range of dietary ingredients creates a seemingly endless range of nutrients that need
(expensive) testing before any recommendation can be made that derives from the highest level
of evidence in EBN. It is high time for reconsidering what should be considered as ‘evidence’ in the
nutritional research39,40. For this it has e.g. been suggested that nutrient policy decisions will have
to be made using the totality of the available evidence22, to make use of the Hill criteria41,42 and to
employ risk-bene!t analyses43.
The current thesis provides some evidence from the study of our ancient diet and the dietary
patterns of traditional hunter-gatherers. It is conceivable that clues to narrow dietary nutrient
ranges that need testing may derive from Evolutionary Medicine, since this discipline teaches us
that our genome has been shaped during millions of years of evolution, during which time it has
become slowly adapted to the contemporaneous conditions of existence, including our diet44,45. In
the current thesis we focused mainly on FA, with some attention for the macronutrient composition
of the ancestral diet. There are, however, at least 7 discrepancies between our current and Paleolithic
diets, as depicted in Chapter 1, Figure 9. These include notably: a dierent FA composition (including
a grossly decreased ω3/ω6 FA ratio, the combining of high intakes of SAFA with CHO, introduction
of industrially produced trans-FA, reduced intakes of LCPω3 and LCPω6); a dierent macronutrient
composition; a lower !ber content; a disbalanced Na-K ratio, a disbalanced acid-base balance (low
vegetables/fruits and high CHO); a low micronutrient density (e.g. by reduced exposure to sunlight,
low vegetables/fruits and high CHO); and a high glycemic load (CHO with high glycemic indices)45,46.
Together with other changes in our lifestyle, these dietary changes may well lie at the basis of many,
if not all, diseases that are typical for a#uent countries. Further studies on the reconstruction of our
ancestral diet will shed more light on the existing discrepancies with our current diet and thereby
provide further clues for the testing of dierent diets, not single nutrients, by RCTs.
10.3 Evidence based medicine, eminence based medicine and biased evidence
There is good evidence that the diet of our earliest ancestors was rich in nutrients from the land-
water ecosystem, whereas !sh consumption is generally limited and unpopular in Western countries,
especially among younger generations. This Paleolithic diet was high in protein and fat, including




when compared to the recommendations in many Western countries. Contrary to various health
campaigns (e.g. in The Netherlands: Let op Vet; Verzadigd = Verkeerd) that have been promoted by
health authorities47,48. and the ensuing public opinion, it now seems that dietary fat and SAFA intake
are unrelated to cardiovascular disease (Chapter 8). On the other hand, CHO, and notably those with
high glycemic indices were shown to increase cardiovascular disease risk.
Thus, in retrospect, the previous 30 years of public campaigns to reduce fat, and notably SAFA
intakes, have been successful in reducing these nutrients; but the net eect of the simultaneously
increasing intakes of CHO, notably those with high glycemic indices, might actually have been
an increased incidence of cardiovascular disease. The reconstructed Paleolithic intakes of SAFA
contrast with the current recommendations to keep SAFA intakes below 10 en% or ‘as low as
possible’. The positive relation between CHO and cardiovascular disease may in part be explained by
the observation that not SAFA intake per se, but rather carbohydrate-induced hepatic de novo lipid
synthesis result in high circulating SAFA, while under these conditions the dietary SAFA are spared
from oxidation. The de novo synthesized and spared SAFA may jointly be among the mediators of
low-grade in!ammation, which has emerged as a major cardiovascular disease risk factor.This notion
is in line with the bene"cial eects observed in the few trials that have thus far investigated the
health eects of a Paleolithic-like diet that was low in re"ned CHO, while it contained considerable
amounts of both protein and fat, including SAFA.
The fat contained within the Paleolithic diets is high in PUFA, notably ALA and LCP from the
 3-series, but low in LA. The inverse relation between LCP 3 intakes and cardiovascular disease risk
is nowadays widely acknowledged and has been translated into the recommendation to eat (fatty)
"sh at least 2 times/week. However, the concurrent recommendation to reduce the consumption
of fat is likely to reduce the SAFA intake, but also that of LCP. The current evidence that supports
the health eects of an increased PUFA intake,was recently translated into a recommendation to
increase LA intakes by a committee of the American Heart Association49. Apart from its contrast with
the low LA intakes by our ancestors, this recommendation is marginally supported by the current
evidence from RCTs, since these clearly demonstrate favorable eects of PUFA of the 3 series, while
PUFA of the  6 series, notably LA, show a borderline insigni"cant tendency towards an increased
cardiovascular disease risk19.
Another example derives from the LCP composition of human milk and infant formula in Western
countries, which contrast with both the recommendations issued for (maternal) "sh intake and the
currently observed LCP levels in the milk of East-African tribes living in the land-water ecosystem.
Similarly, the currently low LCP intakes and low LCP status observed in Western populations
contrast with the acknowledged lowest incidence of cardiovascular and psychiatric disease in
Western populations residing in the highest quadrants of LCP intakes and LCP status, and also with
the high LCP status of our East-African ancestors who evolved in the land-water ecosystem. The
mechanism underlying the lowest cardiovascular and psychiatric disease risk might relate to the
disturbance of an evolutionary conserved equilibrium between LCP 3 and LCP 6 FA, resulting in a
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decreased LCP 3/LCP 6 ratio as a consequence of the low LCP 3 intakes in combination with the
very high intake of LA. Either directly or indirectly through their in!uence on e.g. insulin sensitivity;
the currently observed low LCP 3 status, as well as the high carbohydrate and low protein intakes
in Western countries might be at the basis of metabolic disturbances including hyperinsulinemia,
hyperglycemia and hyperlipidemia that are symptoms of the metabolic syndrome and contributors
to the current burden of cardiovascular diseases in ‘civilized’ countries.
Taken together we contend that the discrepancies between the current nutritional
recommendations and the evidence from a variety of study designs and also the composition of the
diet of our early ancestors deserve to be taken seriously. These discrepancies are to be considered
in the preparation of guidelines, but more research should certainly be done. For this, research
grants may have to become reallocated from nature (genetics) to nurture (environment) notably
because more than 95% of our current diseases are acquired diseases with a primary environmental
background50. We are, however, probably facing a long-lasting aftermath of the health campaigns
that, based on little evidence, have been held during the past 50 years. It is also questionable
whether nutritional boards are willing to reconsider their positions in what should be accepted as
evidence and what should not. This is important since there might be a growing gap between o"cial
guidelines and the information distributed by both laymen and prominent investigators in the #eld
who are not willing to comply with the outcomes of RCTs with hard endpoints as the only criteria
for Evidence Based Medicine and who keep pointing at the inconsistency of reasoning. For example,
the recent doubling of the recommended daily intakes for Vitamin D from 50 to 100 !g/day by the
Institute of Medicine suggests that the previous recommendation had little scienti#c basis, since no
additional reports have been published with regard to the toxicity of Vitamin D in the meantime.
Moreover, there was a jump in vitamin D supplement sales after Oprah Winfrey suggested on her
show that the actual adequate intake of vitamin D is #ve times the current recommended dietary
intake (and the vitamin D supplement sales in de USA are still increasing).
10.4 Strengths, limitations and recommendations for future study designs
A strength of the current thesis is that we have attempted to reconstruct our Paleolithic diet using
a holistic approach, involving several lines of evidence ranging from paleo-environmental science,
comparative anatomy, biogeochemistry, archeology and anthropology to (patho)physiology and
epidemiology. A second strength comes from the fact that the composition of our reconstructed
Paleolithic diets have, to a great extent, been con#rmed by the analysis of the milk and RBC-FA
compositions of traditionally living East-African tribes. Moreover, the observed di$erences between
these traditional hunter-gatherer diets and typically Western diets are in support of the health issues
that are increasingly identi#ed by achievements in the traditional #eld of the nutritional sciences.
Several limitations need to be addressed as well. First, the reconstruction of the Paleolithic diet
is impossible, since there is no such thing as ‘the’ Paleolithic diet, while solid evidence for the wide




need to address the boundaries of our dietary composition as a whole, since some of the current
diseases of civilization might be secondary to dietary nutrient intakes that are either too high (e.g. LA)
or too low (e.g. DHA), compared to the intakes during the major part of human (genome) evolution.
A second limitation is the lack of accurate dietary assessments of the African study populations,
which obscure dose-response relationships between the observed nutrient status and the dietary
intake. Third, although studies in traditional African populations are notoriously dicult to perform
and are hampered by logistical and ethical issues, conrmation of the present results in longitudinal
studies and with e.g. stable isotopes would improve the validity of these data and the impact in
nutritional science. Last but certainly not least, an important limitation is that diet is not the only
environmental factor involved in the epidemiology of the current typically Western diseases of
auence. Other lifestyle factors, such as insucient physical activity, lack of sleep, altered intestinal
ora, environmental pollution and chronic stress are also involved and each of these have largely
unappreciated interactions in their own right.
10.5 Applicability of an evolutionary approach
We are convinced that the currently applied multidisciplinary approach of Evolutionary Medicine
contains the inherent capacity to provide important insight into the components of a healthy
lifestyle, including the composition of a healthy diet. The application of this insight will not so much
increase our life expectancy, but rather increase our number of years without chronic disease. We
therefore strongly support ‘Evolutionary Medicine’to gain a more prominent role in the Medical and
Nutritional sciences by e.g. the design of nutritional intervention trials, as opposed to the mere study
of drugs or single nutrients. Return to the environmental balance of the Paleolithic era as translated
to the culture of the 21st century might be the only e!ective manner to arrive at ‘healthy aging’, but
is likely to become strongly contested by the current believers in the paradigm of ‘Evidence Based
Medicine’and notably the outcomes of RCTs and their meta-analyses, which is, as explained, not the
denition of ‘Evidence Based Medicine’, or at least not intended to be from its very start.
Similarly, the current gene-centric obsession to understand diseases and the ensuing hype
for (expensive) genome wide association studies is largely misplaced and much more attention
should be paid to the understanding of our ‘conditions of existence’ as the most powerful force in
evolution and as already recognized by Darwin. We all harbor alleles that are involved in obesity
and insulin resistance; but this does not mean that these are faulty genes that deserve to become
cured or bombarded with drugs. Most, if not all, of these ‘faulty alleles’, often erroneously named
‘disease susceptibility genes’, were already present in the rst Homo sapiens, some 200,000 years
ago. We were all selected against a background where these alleles produced some evolutionary
advantage, causing conservation of the corresponding traits, such as responses to scarcity, famine
and infection. Rather than accusing these faulty genes, it would be more protable to search for the
precipitating faulty environment, which from a dietary perspective means more attention for the




The present thesis supports the adherence to the diets that have been consumed by our ancestors
during the greater part of our evolution, notably the Paleolithic era stretching from 2.5 million to
10,000 years ago. Such a diet is higher in protein, similar in fat, lower in CHO and therefore richer
in micronutrients, i.e. vitamins and minerals, but also in other bioactive nutrients with functions
that are largely unknown. In practice this diet is composed of abundant vegetables and fruits, as
combined with animal material that notably derives from the land-water ecosystem. The latter is
the ecological niche that our ancient ancestors have inhabited in the past and consequently has
shaped our genome to what it currently still is. CHO with high glycemic indices, and high CHO
intakes combined with SAFA are unfavorable, notably to those of us who have other lifestyle
imperfections, such as insucient physical activity, lack of sleep, altered bacterial ora and exposure
to environmental pollution and chronic stress. All of these are among the many factors contributing
to a state of chronic systemic low-grade inammation that causes functional adaptations in
our sensitivity to insulin, our serum lipoprotein prole and many others. Such adaptations are
evolutionary conserved survival strategies that are intended for the short term but in a chronic state
ultimately result in an increased risk of the degenerative diseases of auence, including diabetes
type 2, CVD, neuropsychiatric diseases and certain types of cancer. The quality of the ingested
fats is to be shifted towards increased intakes of LCP, notably AA, eicosapentaenoic acid (EPA) and
DHA. We criticize the currently recommended, high intakes of CHO and of rened vegetable oils
containing 6-PUFA, notably LA, which have not been part of our Paleolithic diet and which exhibit
well-documented interference with our  3-PUFA status51. Future trials with Paleolithic diets are
needed. These should obviously comply with the culture of the 21st century. They should preferably
also take into account the many other lifestyle factors that we have changed since the agricultural
and notably the industrial revolutions. We hypothesize that the outcomes of these trials will reveal
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Introductie. Darwin beschreef twee krachten in de evolutie: “natuurlijke selectie” en de
“leefomstandigheden”; waarbij zijns inziens de laatste het meest belangrijk is. Ons erfelijk
materiaal (genoom) ondergaat een zeer langzame aanpassing aan de snel veranderende
leefomstandigheden. Evolutionaire geneeskunde leert ons dat typische welvaartsziekten, zoals
hart en vaatziekte, suikerziekte, bepaalde soorten kanker en degeneratieve hersensziektes, worden
veroorzaakt door een “mismatch” tussen onze eigenhandig veranderende leefomstandigheden
en ons oeroude genoom. Voor de preventie en behandeling is het nodig om de veranderingen
van onze leefomstandigheden sinds de landbouw- en de industriële- revolutie te erkennen en om
gedetailleerd inzicht in te krijgen in deze veranderingen.
Materialen en Methoden. We voerden een multi-disciplinaire literatuurstudie uit naar de
leefomstandigheden van onze verre voorouders die leefden in Oost-Afrika. Met deze gegevens
reconstrueerden wij de samenstelling van verschillende Oost-Afrikaanse voedingen in de
Paleolithische tijd. Tevens verzamelden we melk, rode bloedcellen, navelstrengvaten en vetweefsel
van traditioneel levende Oost-Afrikaanse volkeren en bepaalden hiervan de vetzuursamenstelling.
Resultaten. Onze literatuurstudie toonde aan dat onze jagende en verzamelende voorouders
leefden in het land-water ecosysteem en dus tenminste een deel van hun voedsel uit deze niche
betrokken. Ten opzichte van onze huidige Westerse voeding hadden ze o.a. een lagere inname van
koolhydraten en linolzuur, maar hogere innames van eiwit en de typische visolievetzuren EPA en
DHA. Ons veldonderzoek in Oost-Afrika ondersteunde een hoge inname van visolievetzuren uit de
lokale land-water ecosystemen.
Conclusies. Verschillen tussen onze huidige Westerse voeding en die van onze Paleolitische
voorouders dragen sterk bij aan het grote aantal jaren dat de Westerse bevolking leeft met
chronische ziektes. De speurtocht naar antwoorden op de vraag hoe we deze situatie kunnen
verbeteren wordt echter gehinderd door het huidige paradigma dat ons voorschrijft hoe studies
naar de gezondheidsaspecten van onze voeding en leefstijl moeten worden uitgevoerd. Het lijkt
simpel en dat is precies wat het is: om gezond oud te worden moeten we teruggaan naar de




Vetzuren en menselijke evolutie:
Een bijdrage aan de Evolutionaire Geneeskunde
De voeding en de klinisch chemische en metabole karakteristieken van traditionele
bevolkingsgroepen uit de Oost Afrikaanse land-water ecosystemen
De achtergrond van dit proefschrift: Evolutionaire Geneeskunde
Via de nieuwsmedia krijgen we vrijwel dagelijks informatie over nieuw ontdekte erfelijke
“afwijkingen” waarbij niet zelden wordt gesuggereerd dat deze “afwijkingen” ten grondslag liggen
aan de belangrijkste chronische ziektes waarmee we in de Westerse maatschappij te maken
hebben, zoals suikerziekte (diabetes mellitus type 2), hart en vaatziekte, bepaalde vormen van
kanker en degeneratieve ziektes van de hersenen, bijvoorbeeld de ziekte van Alzheimer. Vaak
eindigt zo’n bericht met de boodschap die in essentie neerkomt op: “Het is momenteel nog te
vroeg, maar over een aantal jaren zullen nieuwe geneesmiddelen op de markt verschijnen die deze
foute genen tot de orde zullen roepen”. Het betreft één van de vele voorbeelden van hoe hoog
gespannen onze verwachtingen zijn van het onderzoek van ons genoom*. Ook van hoezeer we
gefocusseerd zijn op het genezen van welvaartsziektes en hoe weinig we aan de preventie hiervan
doen. Merkwaardigerwijs is nagenoeg iedereen het er eveneens over eens dat “Preventieve
Geneeskunde”de beste vorm is van Geneeskunde. Het verrichten van genetisch onderzoek is echter
“sexy” en daar hebben we veel geld voor over in de vorm van subsidie. Onderzoek naar preventie is
daarentegen moeizaam: het proces op weg naar de bovengenoemde welvaartsziektes strekt zich
uit over tientallen jaren en zolang wachten om te zien of een leefstijlverandering zijn nut bewijst is
nagenoeg onuitvoerbaar en onbetaalbaar. Bovendien zijn interventies in onze leefstijl doorgaans
niet te patenteren, treden we bij voorkeur niet teveel in de privacy van een ander, en lijden we aan
de mismoedige gedachte dat “mensen toch niet willen afvallen en ook al niet willen stoppen met
roken als je ze op de gevaren wijst”.
De berichtgevingen over de ontegenzeggelijk indrukwekkende resultaten van het genetisch
onderzoek gaan er in hun enthousiasme aan voorbij dat de leefomstandigheden (“conditions of
existence”) reeds door Charles Darwin (1809-1882) als de verreweg meest belangrijke factoren
werden beschouwd in de evolutie. Darwin heeft ons geleerd dat de evolutie gedreven wordt
door de selectie (“survival”) van dié individuen en soorten die het best zijn aangepast (“"ttest”;
dus nadrukkelijk niet een synoniem van het Nederlandse “"t”) aan hun omgeving zodat zoveel
mogelijk nageslacht kan worden voortgebracht. De primaire invloed van ons erfelijk materiaal in
bovengenoemde typisch Westerse “welvaartziektes” is dan ook gering: de meeste, zo niet alle, met
veel ophef aangekondigde, genetische “afwijkingen” in de mens waren reeds onder ons toen homo
sapiens zo’n 160.000 jaar geleden ergens in Oost-Afrika ontstond en dus ook toen zo’n 100.000 jaar
geleden de uittocht uit Afrika begon. Uitzondering vormen de zeldzame “aangeboren genetische
* Het genoom is ons totaal aan erfelijk materiaal (ons “DNA”).
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fouten”, die minder dan 5% van alle ziektes veroorzaken. Daarentegen wordt geschat dat zo’n 90%
van de patiënten met diabetes mellitus type 2, 80% van de patiënten met hart en vaatziekte, en
70% van de patiënten met een beroerte en met dikke darmkanker kunnen worden voorkómen als
we meer aandacht besteden aan onze voeding, overgewicht, inactiviteit en roken. Het betreft de
zogenaamde “verworven ziektes” waarbij de omgeving de primaire rol speelt. Uiteraard bestaan
er tussen mensen genetische verschillen in de gevoeligheid voor de omgevingsfactoren die een
rol spelen bij het ontstaan van welvaartsziektes. Het zijn deze verschillen in gevoeligheid die met
veel ophef worden aangekondigd. Die ophef onttrekt onze aandacht van de primaire rol van de
omgeving. Dat de oorzakelijke rol van‘foutieve’genen schromelijk wordt overdreven wordt pakkend
weergegeven door de uitspraak dat “onze genetica het pistool laadt, maar dat het de omgeving is
die de trekker overhaalt”. Als we maar doorgaan met het veranderen van onze omgeving zal zelfs de
meest zwaar afgestelde trekker uiteindelijk afgaan.
Algemeen wordt gesteld dat ons genoom sinds de Steentijd (“Paleolithische tijd”: 2,5 miljoen
tot 10.000 jaar geleden) nagenoeg niet is veranderd, hetgeen betekent dat we in essentie genetisch
gelijk zijn aan onze voorouders die toen leefden. Gezien de snelheid waarmee de “typisch
Westerse” ziektes zich hebben verspreid, en zich tegenwoordig verspreiden in de voormalige
ontwikkelingslanden, zullen maar weinigen beweren dat in die korte tijd iets wezenlijks is veranderd
in ons genoom. Het is dan ook op het conto van onze eigenhandige verandering van de omgeving
dat de volstrekt normale genen die verantwoordelijk worden gehouden voor onze typisch Westerse
ziektes momenteel niet meer goed functioneren. Dit wordt door wetenschappers die zich bezig
houden met de “Evolutionaire Geneeskunde”** bedoeld als ze spreken over een slechte afstemming
tussen de door onszelf veranderde omgeving (waaronder onze voeding) en ons oeroude genoom.
Het hieruit voorkomende con!ict begon met de landbouwrevolutie (ongeveer 10.000 jaar geleden)
en is in een stroomversnelling geraakt sinds de industriële revolutie (zo’n 100-200 jaar geleden).
Wat weinig bekend is, is dat, afgelezen aan hun botten, de gezondheid van de mensen die de
landbouwrevolutie begonnen aanvankelijk verslechterde. Dit verlies werd echter gecompenseerd
door het feit dat deze landbouwers meer kinderen kregen dan de hen omringende jager-
verzamelaars. Daarmee bood de omschakeling van jagen-verzamelen naar landbouw en veeteelt
een netto evolutionair voordeel, ondanks de afgenomen gezondheid en levensverwachting. Een
vergelijkbare paradox*** is ontstaan sinds de industriële revolutie. Het zijn vooral de hygiënische
maatregelen, het terugdringen van infecties (o.a. kinderziekten), hongersnoden en oorlogen,
een toegenomen welvaart en de behandeling van chronische degeneratieve aandoeningen
(“ouderdomsziekten”) die hebben geleid tot onze nog steeds toenemende levensverwachting.
Wat hierbij echter zelden wordt belicht is dat er sinds de industriële revolutie een afname is van
het aantal jaren dat we zonder chronische ziekte leven. De toegenomen levensverwachting sinds
de industriële revolutie overschaduwt daarmee het toegenomen aantal jaren met chronische
** In de evolutionaire geneeskunde (in het Engels ook wel Darwinian Medicine genoemd) worden de ziekten van





degeneratieve aandoeningen. Vanuit een evolutionair oogpunt zijn er nagenoeg geen nadelen
aan deze ouderdomsziekten verbonden, omdat ze meestal optreden ver na het bereiken van de
reproductieve leeftijd. Dit ondanks het feit dat de gemiddelde leeftijd voor het krijgen van kinderen
in Westerse landen inmiddels is verschoven naar rond het dertigste levensjaar. Onderzoekers
hebben berekend dat de eliminatie van alle risicofactoren voor de belangrijkste ouderdomsziekten
de levensverwachting met slechts 4 jaar zal doen toenemen. Evolutionair geneeskundigen
benadrukken dan ook dat de werkelijke winst is te behalen in een toegenomen aantal jaren in
goede gezondheid zonder chronisch degeneratieve ouderdomsaandoeningen aan het eind van
onze levenscyclus (“healthy aging”). Dit is niet alleen gunstig voor het betreende individu, maar
tevens de enige werkelijk eectieve manier waarop we de kosten in de Gezondheidszorg kunnen
beheersen zonder de kwaliteit hiervan aan te tasten.
De consequenties van reductionistisch denken
Een tweede wijdverspreide misvatting is dat “de wetenschap het wel zal oplossen”. Dat is, met alle
bijbehorende tekortkomingen, ook inderdaad vaak het geval, tenminste als we het hebben over
“behandeling”. Maar in werkelijkheid weten we vanwege haar enorme complexiteit nog maar
weinig van de ons omringende natuur en dat komt vooral treend naar voren in het onderzoek
van onze voeding. Dat is meer dan “jammer” omdat dit precies de discipline is die zich in hoge
mate leent voor preventie. In de ons omringende natuur heeft alles met alles te maken, maar in
ons onderzoek van deze natuur dienen we vanwege de beperkingen van de menselijke geest
sterke vereenvoudigingen te hanteren, hetgeen ook wel met “reductionisme”**** wordt aangeduid.
Om zeer goede redenen hebben we voor de interpretatie van de resultaten in Medisch onderzoek
objectieve normen geformuleerd, hetgeen we “Evidence Based Medicine” noemen en in de
Voedingswetenschap “Evidence Based Nutrition”. Daarbij is het hoogste niveau van “bewijs” dat
we kunnen bereiken het “gerandomiseerde onderzoek”, waarbij de onderzochte personen in twee
willekeurig gekozen subgroepen worden opgedeeld. De ene groep krijgt dan bijvoorbeeld een
geneesmiddel en de andere een nepstof (“placebo”). Noch de proefpersonen, noch de onderzoekers,
weten wie wat krijgt en na een afgesproken tijd kijken we welke groep nu het meeste baat had van
de behandeling. In het gunstigste geval is de actieve stof beter dan het placebo. Deze benadering
is uitermate geschikt voor het evalueren van een geneesmiddel, maar veel complexer ligt het als we
te maken hebben met een stof die we uit de omgeving dienen te verkrijgen, zoals een voedingsstof.
Want zo’n “nutriënt” staat immers nooit op zichzelf. Het is onderdeel van een systeem, want we eten
niet die ene stof: we eten een stuk vlees, of een tomaat waarin deze stof een functie vervult. In die
tomaat zitten miljoenen stoen en die hebben allemaal met elkaar te maken. Ze maken onderdeel
uit van een levend systeem, zoals wijzelf: onze voeding leeft! Momenteel zou je echter niet direct op
die gedachte komen als je kijkt naar een witte boterham belegd met een plak vlees of besmeerd met
**** De tegenhanger van “reductionisme” heet in de biologie de “systeembiologie”. Dit is de wetenschap die
biologische systemen tracht te bestuderen in hun volledige complexiteit.
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margarine en jam, want elk van deze samenstellende componenten staan, door o.a. het vetmesten
van ons vee met granen in plaats van grassen en onze bewerkingen van de oorspronkelijke granen
(malen, raneren), olie bevattende zaden (persen, raneren) en vruchten (bewerken, toevoegen
suikers, conserveermiddelen), ver van de natuur. De Paleolithische mens zou het niet herkennen als
iets eetbaars (Figuur 1).
Figuur 1. Dit Figuur sierde de kaft van het
maandblad van de Medische Faculteit van de
University of California San Francisco rondom
mei 1986. Het verwees naar een lezing over onze
oervoeding die in de UCSF was gehouden door
Prof. Dr. S. Boyd Eaton.
Als je de e!ecten van een nutriënt in de mens wil bestuderen, dien je dat dus vanwege de
door onszelf opgelegde normen***** in principe te doen volgens de regels van de “Evidence Based
Medicine”, dus via dat “gerandomiseerde onderzoek”. Maar we kennen niet exact de dosering, laat
staan dat we goed weten in welke verhoudingen de bestudeerde stof dient te staan ten opzichte
van de miljoenen andere sto!en die deel uitmaken van dat “levende” systeem dat onze voeding is,
of beter gezegd: onze voeding vroeger was. Ook vervult zo’n nutriënt in ons lichaam vele functies
en dat is dus anders dan wat we willen met een geneesmiddel waarbij we meestal mikken op
een enkele functie en niet de functies die je op de koop toe moet nemen (bijwerkingen). De vele
hieruit voortkomende doseringen, combinaties van nutriënten en te onderzoeken functies zijn
menselijkerwijs niet te bestuderen, nog afgezien van het feit dat dergelijk onderzoek niet is te
betalen.
De oplossingen die de huidige Voedingswetenschap op basis van“gerandomiseerd onderzoek”met
een enkel nutriënt levert draagt dan ook het gevaar in zich dat het vastgestelde gunstige e!ect van
***** Dit heet ook wel een “wetenschappelijk paradigma”: een complex geheel van opvattingen, methoden en
vraagstellingen, dat de wetenschappelijke gemeenschap van een bepaald tijdvak een idee geeft van wat de
belangrijke vragen zijn, en hoe die opgelost moeten worden. Indien vanwege voortschrijdend onderzoek de




die ene dosering van die ene stof (b.v. vitamine D) op de bestudeerde ziekte (b.v. osteoporose), ook
gepaard gaat met bijwerkingen (b.v. meer nierstenen). Want als je hier drukt gaat ergens anders iets
omhoog en wel op een plaats die je niet had verwacht. Misschien hadden we met de inname van
meer vitamine D ook meer water moeten drinken, de inname van koolhydraten moeten verlagen
en meer groente en fruit moeten eten, zodat er meer doorstroming was, meer vitamine K2 werd
gemaakt door de bacteriën in onze dikke darm, de urine minder zuur werd, we minder calcium
gingen uitscheiden en uiteindelijk die nierstenen dus niet zo snel konden ontstaan. Dit voorbeeld
is overigens verre van toevallig of irreëel, want de bovengenoemde combinatie van leefstijlfactoren
waren inderdaad aanwezig in de vroegere tijd. We dienen dus een beetje een idee te hebben over
wat de verhoudingen tussen onze voedingsstoen dienen te zijn, hetgeen we ook wel aanduiden
als “de balans”. Het betreft de balans tussen onze voedingsstoen, maar ook tussen de hoeveelheid
voeding, fysieke activiteit, de mate van stress en het aantal uren dat we dienen te slapen. Al deze
balansen liggen verankerd in onze evolutie zoals die plaats vond in een bepaalde omgeving en
die ons gemaakt heeft tot wat we waren, maar nu niet meer zijn. Darwin leerde ons dat er eerst
een omgeving was en dat daarop een aangepast organisme tot stand kwam, zoals bijvoorbeeld
geïllustreerd door de verschillende snavels van zijn legendarische Galapagos vinken. Tijdens het
allergrootste grootste deel van de evolutie op deze aarde was de omgeving er niet bij de gratie van
de mens: wij zijn ontstaan bij de gratie van de omgeving, waarmee niet de huidige omgeving wordt
bedoeld, maar de oeromgeving van onze verre voorouders.
Terug naar vroeger, zoals vertaald naar de normen van de 21ste eeuw
De snelle opkomst van Westerse ziektes leert ons dat we fouten hebben gemaakt in de
bovengenoemde balans. Zoals gezegd, er zijn maar weinigen die zullen beweren dat in die korte tijd
iets wezenlijks is veranderd in ons genoom. Vanwege de vele fouten die we hebben geïntroduceerd
bestaat er dus ook niet één of andere“magic bullet”, zoals“eet een beetje meer vis en dan komt alles
wel goed”. We zouden dus eigenlijk terug moeten naar de balans van het verleden, maar dan wel met
het behoud van de cultuur van de 21ste eeuw. Daarbij dienen we de ongunstige leefomstandigheden
van destijds te vermijden, zoals infectieziektes, honger en geweld. Vooral de uitbanning van deze
ongunstige omstandigheden hebben, samen met de Gezondheidszorg, gemaakt dat we in de
huidige Westerse maatschappij gemiddeld veel langer leven dan onze voorouders en de mensen in
de huidige ontwikkelingslanden. We worden echter niet gezond oud, sterker nog, ons aantal jaren
in gezondheid daalt en dat is nu precies waar het hier om gaat.
Het doel van dit proefschrift
Het doel van dit proefschrift is dan ook om een bijdrage te leveren aan het “gezond oud worden”.
Hierbij stellen we ons vooral de vraag hoe die balans in de leefstijl van onze voorouders nu eigenlijk
was. In dit proefschrift hebben we getracht om bepaalde aspecten van de voedingsbalans te
reconstrueren waarmee we in de evolutie zijn geworden wat we waren, maar wat we vanwege onze
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eigenhandige veranderingen in de omgeving momenteel niet meer zijn. We focusseren vooral op
vetzuren, hetgeen onderdelen zijn van het vet dat we eten, maar ook de vetten die we in ons lichaam
zelf maken. Ons onderzoek volgde de gedachte van de Evolutionaire Geneeskunde, hetgeen een
jonge discipline is die in zijn activiteiten gebruik maakt van de kennis van vele andere disciplines.
Het betreft vooral enkele onderdelen van de klassieke Geneeskunde, zoals de Fysiologie (leer van
de normale levensverrichtingen), Pathofysiologie (leer van de abnormale levensverrichtingen),
Epidemiologie (leer van de ziekteverspreiding), Genetica (ons erfelijk materiaal) en de modernere
Epigenetica (o.a. hoe onze genen worden aangedreven door de omgeving), maar ook disciplines
die normaliter in de Geneeskunde minder intensief worden bestudeerd zoals de Evolutieleer, de
vergelijkende Biologie, de Archeologie en de Antropologie.
Voor de meer dan geïnteresseerde leek: wat er in de diverse hoofdstukken staat
Concreet is in het eerste deel van dit proefschrift (Hoofdstukken 1 en 2) gewerkt aan de
reconstructie van de voedingssamenstelling van onze Paleolithische voorouders. In het tweede deel
(Hoofdstukken 3-6) doen we verslag van het onderzoek dat we deden aan mensen die er nog een
(zo goed als) traditionele leefwijze op nahouden, zoals bijvoorbeeld de Hadzabe in Tanzania (Oost-
Afrika), die behoren tot één van de laatste volkeren die nog jagen en verzamelen, en de Maasai, een
tevens in Oost Afrika levend zeer traditioneel herdersvolk. In het laatste deel (Hoofdstukken 7 en
8) belichten we de mechanismen die ten grondslag zouden kunnen liggen aan de waargenomen
verschillen.
De reconstructie van de voeding van onze voorouders uit de Steentijd is gebaseerd op
berekeningen waarbij we zijn uitgegaan van een aantal jager-verzamelaar strategieën (b.v. het jagen
op enkel landdieren of jagen-verzamelen in het land-water ecosysteem) van onze voorouders, een
bepaalde fysieke activiteit en de samenstelling van de voedingsproducten zoals die deels in de
literatuur beschreven staan, maar ook deels door onszelf zijn vastgesteld in het onderzoek in Oost-
Afrika. Om een uitspraak te kunnen doen over de omgeving waarin onze voorouders opgroeiden
voerden we eerst een uitgebreide literatuurstudie uit (Hoofdstuk 1).Vanuit verschillende disciplines,
waaronder de wetenschappen van het Paleo-milieu, de vergelijkende Anatomie, de Archeologie,
de Antropologie, de Pathofysiologie, de Epidemiologie en uit isotopen onderzoek, blijkt dat onze
voorouders altijd dicht in de buurt van water hebben geleefd. Een opvallende conclusie van deze
literatuurstudie is dan ook dat we momenteel weinig oog hebben voor de sterke aanwijzingen dat
onze voorouders een deel van hun voedsel betrokken uit het water. Onze voorouders worden bij
voorkeur voorgesteld als heldhaftige jagers, die met speren op grootwild jaagden en met vuistbijlen
schedels en pijpbeenderen kraakten om aan hersenweefsel en beenmerg te komen. Dat er veel
botten zijn gevonden met daarop de inkepingen en snijsporen van vuistbijlen betekent nog niet
dat onze voorouders enkel op de grote graseters van de savanne jaagden. Daarom besluiten wij de
literatuurstudie met de conclusie dat tot het tegendeel bewezen is, de voeding van onze voorouders,




In het daaropvolgende hoofdstuk (Hoofdstuk 2) hebben we een reconstructie gemaakt van de
Paleovoeding. Voor deze reconstructie hebben we gebruik gemaakt van de natuurlijke producten
die, soms ook nu nog, in Oost-Afrika wijdverspreid verkrijgbaar waren voor consumptie. Het
resultaat was een voeding met een hoger eiwit en vetgehalte, maar een lager koolhydraat gehalte
in vergelijking met wat er tegenwoordig gegeten wordt door de “gemiddelde” Nederlander. De
Paleovoeding lijkt voor wat betreft de hoge eiwit (gemiddeld 27 energie%, en%) en vet (34 en%)
gehaltes en het lage koolhydraat gehalte (39 en%) nog het meest op het South-Beach dieet (eiwit
26 en%, vet 40 en% en koolhydraat 33 en%). Ook het Atkins dieet (eiwit 29 en%, vet 62 en% en
koolhydraten 9 en%) is een hoog-eiwit voeding, maar in dit dieet gaat de hoge vetinname ten
koste van de inname van groente en fruit, die o.a. rijk is aan koolhydraten, vitaminen, mineralen
en vele andere bioactieve sto!en. Een duidelijk verschil met het Atkins dieet en bovendien met
de huidige aanbevelingen van de American Heart Association (AHA) ligt in de kwaliteit van het
gegeten vet. In het Atkins dieet ligt de nadruk op verzadigd en enkelvoudig onverzadigd vet,
terwijl de AHA aanbeveelt om de inname van verzadigd vet onder de 7 en% te houden en 5-10
en% van het meervoudig onverzadigde vetzuur linolzuur (LA, o.a. aanwezig in zonnebloemolie) te
consumeren. De gereconstrueerde Paleovoeding laat echter een relatief hoge inname van verzadigd
vet (gemiddeld 12 en%) zien, met daarbij juist een lage inname (<5 en%) van LA, waarbij de lage
linolzuur inname gecompenseerd wordt door een hoge inname van de “lange keten” meervoudig
onverzadigde  3-”vis”-vetzuren, zodat de inname van meervoudig onverzadigde vetzuren boven
de 10 en% ligt. De berekende inname van deze “lange keten” meervoudig onverzadigde  3-“vis”-
vetzuren uit het Afrikaanse land-water ecosysteem is daarmee ongeveer gelijk aan wat de Eskimo’s
in Groenland hieraan eten en dat is ongeveer 100 maal meer dan wat de gemiddelde Nederlander
hiervan at in 2003 (84 mg). Daarbij is het belangrijk om te weten dat een te lage inname van deze
 3-“vis”-vetzuren een intussen bewezen causaal verband heeft met hart en vaatziektes en met
depressie, terwijl een te lage inname van de  3-“vis”-vetzuren door pasgeborenen in verband
wordt gebracht met een suboptimale ontwikkeling van de hersenen.
Om de biochemische e!ecten van de gereconstrueerde samenstelling van de Paleovoeding
nader te evalueren, deden we onderzoek onder enkele traditioneel levende stammen die in Oost-
Afrika nog aanwezig zijn. Die wonen in Tanzania en waren nog niet in aanraking gekomen met
de Westerse voedselketens. Het overgrote deel van hun voedsel bestond uit lokale natuurlijke
producten, waaronder met name veel groente, fruit en vis. In overeenstemming met de verwachting
toonden wij in hun moedermelk (Hoofdstuk 3) hoge gehaltes meervoudig onverzadigde vetzuren
aan. Terwijl vissen afkomstig uit de Noordzee voornamelijk meervoudig onverzadigde vetzuren uit
de 3-serie bevatten (met name eicosapentaeenzuur, EPA; en docosahexaeenzuur, DHA), bleken de
Afrikaanse vissen uit zowel het zoet- als het zoutwater milieu lagere EPA gehaltes te bevatten. Naast




In een daaropvolgende studie (Hoofdstuk 4) toonden we aan dat de hoge gehaltes van DHA
en AA in de Afrikaanse vissen ook terug te vinden waren in de rode bloedcellen die we hadden
geïsoleerd uit het bloed van gezonde proefpersonen. Het bleek dat de gemeten DHA waarden in de
rode bloedcellen van sommige viseters vergelijkbaar waren met de door andere wetenschappers
aangedragen optimale waarden voor de bescherming tegen psychiatrische aandoeningen en hart-
en vaatziekten. De DHA inname van de moeders was in een bepaalde populatie zo hoog dat ze
bij de geboorte van hun kinderen hogere DHA gehaltes in hun rode bloedcellen hadden dan hun
pasgeboren kinderen. Deze opzienbarende nieuwe vondst staat daarmee in tegenstelling tot de
situatie in Westerse vrouwen, die door hun lage DHA inname tijdens de zwangerschap interen op
hun DHA voorraden. Bij de bevalling hebben de meeste Westerse moeders zelfs een lagere DHA
status****** dan kun kinderen. Deze zogenaamde ‘maternale DHA depletie’ is in verband gebracht
met het optreden van depressies tijdens en na de zwangerschap. Uiteindelijk bundelden we de
uitslagen van alle door ons tot nog toe uitgevoerde onderzoeken onder vrouwen met verschillende
innamen van DHA, om tot de conclusie te komen dat de relatie tussen sommige vetzuren niet zo
eenduidig is als dat het aanvankelijk leek. Zo toonden we aan dat bij een lage DHA status, de AA
status ook laag blijft. Als de DHA status stijgt, stijgt ook de AA status tot dat een constante AA
status wordt bereikt. Echter als de DHA status nog verder stijgt wordt vanaf een bepaalde DHA
status de AA status onderdrukt. Deze complexe relatie tussen DHA en AA speelt mogelijk een rol
in de soms controversiële uitkomsten van de onderzoeken die tot nu toe met beide vetzuren zijn
gedaan. De gevonden relatie is mogelijk belangrijk, omdat het onderdrukken van de AA status door
het uit vis afkomstige EPA en DHA, ontstekingsreacties kan onderdrukken. Lang voortdurende
lichte ontstekingsreacties worden in toenemende mate gezien als de belangrijkste oorzaak van het
ontstaan van onze typisch Westerse ziektes, waaronder hart en vaatziekten, depressie en de ziekte
van Alzheimer.
In Hoofdstuk 5 hebben we in een studie van doodgeboren kinderen onderzocht of bij een
hoogfrequente visinname door de moeder ook de hersenen, de lever en het vetweefsel een hoger
gehalte van de eerder genoemde vetzuren AA en DHA bevatten. Zoals gezegd bevat de locale
Afrikaanse vis hoge AA en DHA gehaltes. In vergelijking met studies die in het verleden onder
Westerse kinderen waren uitgevoerd, vonden we in de hersenen en het vetweefsel van deze
Afrikaanse kinderen hogere gehaltes DHA, maar juist iets lagere gehaltes aan AA. Dit komt dus
overeen met de eerder in de rode bloedcellen en navelstrengen aangetoonde competitie tussen
AA en DHA bij een hoge DHA inname. Bovendien vonden we in de Afrikaanse kinderen veel lagere
gehaltes linolzuur (LA, de precursor van AA). LA zit voornamelijk in plantaardige oliën en het ziet
er in toenemende mate naar uit dat de grote hoeveelheid LA in onze Westerse voeding mede
verantwoordelijk is voor onze lage EPA+DHA status, omdat LA de synthese van EPA en DHA uit hun
precursor ( -linoleenzuur; ALA) remt en ook omdat LA de inbouw van EPA en DHA in onze weefsels
remt.





In Hoofdstuk 6 beschrijven we ons onderzoek naar de samenstelling van het onderhuidse
vetweefsel van het kind tijdens de zwangerschap. Het onderhuidse vetweefsel dient als opslagplaats
voor de eerder genoemde vetzuren zoals LA, AA en DHA. Vlak na de geboorte drinkt het kind nog
maar weinig melk en sommige wetenschappers veronderstellen dat in deze belangrijke periode
het vetweefsel van het kind niet alleen de belangrijkste bron is voor het opwekken van energie
maar ook van de AA en DHA die nodig zijn voor de ontwikkeling van de hersenen. De hersenen
ondergaan rondom de geboorte een enorme groei (de zogenaamde groeispurt) en dat vergt een
forse aanvoer van AA en DHA. Ons onderzoek bevestigt dat het vetweefsel van het pasgeboren kind
grote hoeveelheden AA en DHA bevat. Ook was al bekend dat gedurende de zwangerschap zowel
de hoeveelheid vet in het kind alsook het vetgehalte van het vetweefsel (vetweefsel bestaat immers
ook voor een groot gedeelte uit water) toeneemt. Wat wij vanwege ons onderzoek daarin kunnen
nuanceren is dat er tijdens de aangroei van het vet in de baby eigenlijk geen verdere stijging van
AA en DHA in het vetweefsel plaatsvindt, maar dat met name nog veel verzadigde vetzuren in
het vetweefsel worden opgenomen. Eerdere onderzoekers hadden vastgesteld dat er weliswaar
geleidelijk meer vet kwam, maar waren ervan uitgegaan dat het vet steeds dezelfde samenstelling
bleef houden. Zowel de onverzadigde als de verzadigde vetzuren namen weliswaar in absolute
hoeveelheden toe, maar doordat de verzadigde vetzuren wel 100 keer meer toenamen, werden de
meervoudig onverzadigde vet zuren verdund. Door dit onderzoek beschikken we nu over betere
schattingen van de totale hoeveelheden van de belangrijke vetzuren AA en DHA die een kind bij
de geboorte in het vetweefsel heeft. Andere onderzoekers hadden al eens beschreven hoeveel AA
en DHA zich bevinden in organen zoals de hersenen, de lever, de spieren, de huid en de botten van
een pasgeboren kind. Door hun informatie met die van ons te combineren konden we uitrekenen
hoeveel AA en DHA een pasgeboren kind in totaal bevat. Dit is bijvoorbeeld belangrijk bij het geven
van !esvoeding aan prematuur (te vroeg) geboren kinderen, omdat nu kan worden ingeschat hoe
groot hun tekort is aan AA en DHA in vergelijking met een a term (op tijd) geboren kind.
In Hoofdstuk 7 gaan we verder in op de onderliggende mechanismen van onze bevindingen
zoals beschreven in Hoofdstukken 2 en 3. Daar zagen we namelijk dat er vaak grote verschillen
waren tussen de vetzuursamenstelling van de rode bloedcellen van zwangere vrouwen en niet-
zwangere vrouwen, en ook tussen mensen die veel en weinig vis aten. En in het laatste geval waren
de verschillen niet enkel terug te voeren op verschillen in de gehaltes van vetzuren die afkomstig
zijn uit de vis. Om te onderzoeken hoe deze verschillen konden worden verklaard moesten we
dieper ingaan in de mechanismen die we gebruiken voor het maken van vetzuren in ons lichaam.
In dit hoofdstuk richtten we ons juist niet op AA en DHA, maar op de andere vetzuren, namelijk de
al eerder genoemde verzadigde vetzuren (b.v. palmitinezuur, dat veel in dierlijk vet zit), maar ook
op de enkelvoudig onverzadigde vetzuren (b.v. oliezuur, dat veel in olijfolie zit). De verzadigde en
enkelvoudig onverzadigde vetzuren kunnen we, in tegenstelling tot de meervoudig onverzadigde
vetzuren zoals LA, AA en DHA, zelf maken uit sto"en zoals glucose. We kunnen ze echter niet alleen
uit suikers maken, maar bijvoorbeeld ook uit brokstukken van AA en DHA die ontstaan als de lever
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deze afbreekt. Met andere woorden, de belangrijkste fabriek in ons lichaam: de lever, kan wel
verzadigde en onverzadigde vetzuren maken uit suikers en andere stoen, maar kan dat niet voor
AA en DHA.
Wat we in Hoofdstuk 7 lieten zien is dat de zwangere vrouw meer verzadigde en enkelvoudig
onverzadigde vetzuren leek te maken dan de niet-zwangere vrouw. Dit zou een logische
aanpassing zijn om ervoor te zorgen dat haar groeiend kind tijdens de zwangerschap veel vet via
de placenta krijgt aangevoerd. Wij suggereerden dat een verhoogde aanmaak van deze vetzuren
wel eens veroorzaakt zou kunnen worden door de veranderde gevoeligheid voor het hormoon
insuline. Insuline zorgt ervoor dat suikers vanuit het bloed worden opgenomen in de cellen van
het lichaam, maar ook dat suikers in de lever worden omgezet in vet. Nu is het bekend dat de
zwangere vrouw vooral aan het eind van de zwangerschap ongevoeliger wordt voor insuline. Dit
maakt dat de glucose verminderd door haar eigen cellen worden opgenomen en derhalve naar het
nu snel groeiende kind wordt getransporteerd. Tegelijkertijd blijft de lever ook nog eens glucose
maken en daarnaast ook vet. Het vetweefsel draagt ook zijn steentje bij door constant vetzuren af
te geven. Deze bijzondere toestand wordt dus veroorzaakt doordat de moeder ongevoelig wordt
voor insuline en daarmee bouwt ze het kind tegen het eind van de zwangerschap razendsnel op.
In overeenstemming met bovenstaande hypothese vonden we dat in de rode bloedcellen van
zwangere vrouwen en van hun groeiende foetus het aandeel van de verzadigde en enkelvoudig
onverzadigde vetten hoger was dan in vrouwen en kinderen 3 maanden na de bevalling. In vrouwen
die een zwangerschapsvergiftiging opliepen (zogeheten pre-eclampsie) ontdekten we soortgelijke
verschillen, met dien verstande dat deze vrouwen nog meer verzadigde en onverzadigde vetzuren
leken te maken dan hun gezonde tegenhangers. Dit klopt precies met de veronderstelling dat juist
vrouwen die veel te ongevoelig worden voor insuline tijdens de zwangerschap een verhoogde
kans hebben op een zwangerschapsvergiftiging, maar ook op zwangerschapsdiabetes. Met deze
opgedane kennis keken we ook nog eens naar de samenstelling van moedermelk. Immers, aan
het eind van de zwangerschap wordt een zwangere steeds ongevoeliger voor insuline en zal
haar lever onder invloed van de hoge gehaltes insuline steeds meer verzadigde en onverzadigde
vetzuren maken. Hierbij verwachtten we met name in de moedermelk die kort na de bevalling werd
afgenomen (colostrum), hogere gehaltes aan verzadigde en enkelvoudig onverzadigde vetzuren
die door de lever waren aangemaakt en verwachten we dat deze hoge gehaltes in de loop van de
lactatieperiode weer zouden afnemen. Inderdaad bleken er in de melk 2 dagen na de bevalling veel
meer enkelvoudig onverzadigde vetzuren te zitten dan 2 of 6 weken later, waarbij de hoeveelheden
van deze vetzuren na een a terme geboorte nog weer hoger lagen dan na een premature geboorte.
Dus ook in de melk konden we de tekenen van de insuline ongevoeligheid in de late zwangerschap
terugvinden.
In Hoofdstuk 8 bespreken we de gevaren van verzadigd vet en koolhydraten bij het ontstaan
van hart- en vaatziekten aan de hand van een literatuurstudie (een zogenaamd “review”). Het




acties zoals“Let op Vet”en momenteel nog steeds met“Verzadigd=Verkeerd”en“Onverzadigd=Oké.”
Vanuit het perspectief van onze oervoeding zijn deze stellingnames echter bepaald onlogisch. Onze
voorouders aten waarschijnlijk juist vrij veel vet en ook veel verzadigd vet. Het vet in moedermelk
bestaat bovendien voor meer dan 50% uit verzadigd vet en dat kan nagenoeg niet worden
veranderd door de moeder anders te laten eten. Het is puur onlogisch dat een kind na het spenen,
conform de aanbevelingen van degelijke instanties, in een keer zou moeten overgaan naar een “zo
laag mogelijke inname van verzadigd vet”.
Toch is het publiek en de medische wetenschap er al sinds de helft van de vorige eeuw van
overtuigd dat de consumptie van vet en vooral verzadigd vet in hoge mate verantwoordelijk is
voor de stijging van het aantal te dikke mensen, de stijging van het aantal mensen met suikerziekte
en vooral de stijging van het aantal mensen met hart- en vaatziekte. In een onlangs gepubliceerd
onderzoek werd deze relatie tussen verzadigd vet en hart- en vaatziekten ontkracht. De auteurs
hadden alle tot nog toe uitgevoerde onderzoeken gecombineerd en concludeerden dat het netto
eect van de inname van verzadigd vet op hart- en vaatziekten nul was. Daarentegen toonden
ze juist aan dat de inname van koolhydraten, met name koolhydraten met een zogenaamde
hoge glycemische index, zorgt voor een stijging van het aantal gevallen van hart- en vaatziekte.
De glycemische index van een voedingsmiddel is een maat voor de hoeveelheid glucose die in
2 uur na de inname van dit voedingsmiddel, vrijkomt in de bloedbaan. Dit wordt gemeten door
de hoeveelheid glucose in het bloed na de inname van 50 gram van dit product te vergelijking
met de hoeveelheid glucose in het bloed na de inname van 50 g pure glucose. Dus hoe hoger de
glycemische index, des te sneller komt de glucose uit het betreende voedingsmiddel in het bloed.
In de wandelgangen spreekt men ook wel van “snelle suikers/koolhydraten”.
Dus niet vet, of verzadigd vet, maar juist“snelle suikers”zijn geassocieerd met hart- en vaatziekten.
Wij onderzochten de literatuur om te begrijpen hoe we de verhoogde kans op hart- en vaatziekten
vanwege de inname van koolhydraten met een hoge glycemische index konden verklaren. Deze
lijkt gezocht te moeten worden in de reeds genoemde productie van verzadigd vet uit koolhydraten
en vooral “snelle koolhydraten”. Als mensen veel koolhydraten eten worden deze, zoals uitgelegd in
Hoofdstuk 7, deels in de lever omgezet in verzadigd vet. Mensen die ongevoelig zijn geworden
voor insuline zijn meestal te dik en zetten koolhydraten nog beter om in vet. Daarvoor hoeven
ze nog niet eens veel koolhydraten te eten. De meeste van hen stapelen dit vet o.a. in hun lever,
hetgeen we het “Non-Alcoholic Fatty Liver Disease” (NAFLD) noemen. In vele westerse landen gaat
het om maar liefst 25% van de volwassen bevolking. Als mensen koolhydraten en vetten gelijktijdig
eten, zullen eerst de koolhydraten worden verbrand. De vetten worden gespaard en opgeslagen
als reserve-energievoorraad. Bij het eten van veel koolhydraten wordt een deel omgezet naar
vet, o.a. verzadigd vet. Het eten van veel koolhydraten samen met verzadigd vet is dus bij uitstek
een combinatie waarin het verzadigd vet zich in ons lichaam ophoopt. Dat is bepaald ongunstig,
want verhoogde gehaltes aan verzadigde vetzuren in de bloedbaan blijken via verschillende
mechanismen te zorgen voor een ontstekingsreactie. Het lichaam reageert op deze verzadigde
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vetzuren alsof het bacteriën zijn die vernietigd moeten worden om een infectie te bestrijden. Het
gevolg is dat mensen die voortdurend veel verzadigde vetzuren in hun bloedbaan hebben als het
ware een continue ontstekingsreactie ondergaan. Dit staat in de literatuur bekend als een toestand
van “lage graad ontsteking”. Het sparen van verzadigd vet is echter niet de enige oorzaak van een
lage graad ontsteking, en het is waarschijnlijk niet eens de belangrijkste. Er zijn vele oorzaken in
onze leefstijl, waaronder verkeerde voeding (o.a. te weinig groente, fruit, vis), te weinig bewegen, te
weinig slaap, chronische stress en milieuverontreiniging waaronder roken. Zoals gezegd zijn vele,
mogelijk alle, welvaartsziekten, waaronder hart- en vaatziekten, gerelateerd aan deze lage graad
ontsteking. De lage graad ontsteking veroorzaakt vele veranderingen in ons lichaam, waaronder
de veranderingen die we zien in “ons cholesterol”. De veranderingen in “ons cholesterol” zijn dus
niet primair gerelateerd aan de adervervetting die we zien bij de belangrijkste vorm van hart en
vaatziekte, want daarboven staat die “lage graad ontsteking”. Het is niet cholesterol die de oorzaak
is, maar cholesterol heeft wel de schuld gekregen. Evenzo gaat het niet per se over de hoeveelheid
verzadigd vet in onze voeding, maar over het ophopen van verzadigd vet in ons lichaam en het
gemak waarop het vervolgens een ontstekingsreactie kan veroorzaken.
Wij concluderen dan ook dat met name het sparen van verzadigd vet dient te worden voorkomen,
hetgeen dus niet een synoniem is van het eten van minder verzadigd vet. Deze situatie kan vooral
worden bereikt door de koolhydraat inname te verlagen en aan te bevelen om de inname van
snelle koolhydraten sterk te beperken. Dit advies staat lijnrecht tegenover de huidige aanbeveling
waarin koolhydraten kunnen worden ingenomen tot wel 70% van onze totale energiebehoefte, er
bij “gebrek aan bewijs” geen restrictie wordt gesteld aan de consumptie van snelle koolhydraten,
maar we wel de verzadigd vet consumptie dienen terug te brengen naar “zo laag mogelijk”, maar in
ieder geval onder de 10 en%.
Samenvatting en Epiloog
Samenvattend (Hoofdstuk 9) ondersteunen de uitkomsten van de studies in dit proefschrift de
gedachte dat onze voorouders in het land-water ecosysteem zijn geëvolueerd. Dit ecosysteem is
o.a. rijk aan AA en DHA, zoals we hebben geïllustreerd aan de hand van de melk en rode bloedcel
samenstellingen van de onderzochte traditioneel levende Afrikaanse stammen.
Eén van de meest overtuigende bevindingen hiervoor is de ontdekking van “bioattenuatie” (dat
was die lagere DHA status in het pasgeboren kind t.o.v. de moeder) in de Afrikaanse moeders met
een hoge DHA status (~8 g% DHA in rode bloedcellen). Dit in tegenstelling tot de tot op dat moment
voor universeel aangenomen“biomagni#catie”(een hogere DHA status in het kind t.o.v. de moeder),
zoals die vooral wordt aangetro$en in Westerse vrouwen met lage DHA status (~5 g% DHA). De
ontdekking dat deze biomagni#catie zich beperkt tot vrouwen met een lage DHA status betekent in
onze ogen dat de inname van DHA in Westerse moeders onvoldoende is voor het bereiken van een
goede DHA status in haar kind. De evolutie heeft er blijkbaar voor gezorgd dat onder beperkende




koste gaan van de moeder. Echter, in het land-water ecosysteem beschikte de moeder over zoveel
DHA reserves dat het kind het aangeboden surplus gedurende de zwangerschap zelfs weigerde
terwijl de moeder over ruim voldoende voorraden beschikte voor de daaropvolgende lactatie.
Er zijn nog maar weinig onderzoekingen gedaan waarin de eecten van de toediening van
een hoog DHA supplement aan de moeder tijdens zwangerschap en/of lactatie zijn bestudeerd op
de neurologische ontwikkeling van haar kind. De vraag is ook of daarmee een levenslange hoge
DHA voeding uit het land-water ecosysteem kan worden nagebootst. Een zwangerschap duurt
maar 9 maanden, terwijl de halfwaardetijd van DHA in de volwassen hersenen 2,5 jaar bedraagt.
Dit gegeven verschaft ook niet veel hoop op een snelle correctie van een lage DHA status met een
DHA supplement bij de behandeling of de preventie van postpartum depressie, de behandeling
van Attention Decit Hyperactivity Disorders (ADHD), het ten gunste keren van een cognitieve
achteruitgang bij ouderen en het voorkomen van een verdere verslechtering bij de ziekte van
Alzheimer. De enige oplossing lijkt een nabootsing van het land-water ecosysteem die start ruim
voor de conceptie en aanhoudt tot de dood, en hier nog maar alleen bekeken vanuit het perspectief
van DHA.
Naast een onvoldoende inname van LCP, speelt een hoge koolhydraat inname, ten koste van de
eiwitinname, eveneens een rol in het ontstaan van Westerse ziekten. Het zijn echter niet de enige
fouten in onze leefstijl die we hebben geïntroduceerd sinds de landbouwrevolutie, zo’n 10.000 jaar
geleden. De uitkomsten van de reconstructie van onze Paleovoeding zouden een doelwit kunnen
zijn voor toekomstig onderzoek naar de gezondheidseecten hiervan. Hiervoor dient deze voeding
als een geheel te worden bestudeerd en dus niet in zijn losse componenten te worden ontleed.
We eten immers geen losse koolhydraten, eiwitten, jodide of DHA, maar een vis, een biefstuk of
bijvoorbeeld een banaan.
In lijn met het voorgaande concluderen we dat de gegevens die voortkomen uit een Evidence
Based benadering met afzonderlijke nutriënten een belemmering vormen om tot betrouwbare
aanbevelingen te komen. Zoals momenteel gehanteerd zit dit paradigma ons in de weg. Weinigen
realiseren zich dat dit paradigma ontsproten is uit het reductionistisch denken van de mens, dat
er naar de regels van Evidence Based Medicine geen bewijs is voor Evidence Based Medicine, en
dat er maar één paradigma in de wetenschap is en dat is om nooit een paradigma te aanvaarden.
Bovendien lijkt er bij het ontwikkelen van aanbevelingen meer aandacht te zijn voor de giftige
eigenschappen van nutriënten zoals vitaminen en mineralen, hetgeen veroorzaakt wordt door het
hanteren van het voorbehoud principe*******. Zo staat de aanbeveling om een vitamine D status na te
streven van  30 of  50 nmol/L 25-hydroxyvitamine D in schril contrast met het gemiddelde van 120
nmol/L dat wordt aangetroen in Oost-Afrikaanse volkeren die nog traditioneel leven. Het recente
optrekken door het Institute of Medicine (IOM) van de aanvaardbare bovengrens voor de vitamine
******* Het voorbehoudprincipe of de voorbehoud benadering stelt dat indien een actie of beleid een ve-
rondersteld risico in zich draagt om schade te berokkenen aan het publiek of het milieu, terwijl er geen weten-
schappelijke consensus is dat de actie of het beleid schadelijk is, de bewijslast dat er geen schade ontstaat ligt
bij diegenen die de actie nemen.
420
Chapter 9
D inname met een factor 2 (van 50 naar 100  g/dag) doet niet vermoeden dat de vorige grens
gebaseerd was op diepgaand wetenschappelijk inzicht. Want sinds het vorige rapport zijn er inzake
de giftigheid van vitamine D geen relevante gegevens bijgekomen.
Vele zekerheden over de (on)gezondheidsaspecten van nutriënten staan momenteel op de tocht. De
hieruit voortgekomen aanbevelingen zijn in het verleden gebaseerd op onderzoek dat de huidige
toetst der kritiek niet kan doorstaan. Zo zijn de gevaren van het verzadigd vet in onze voeding niet
gebaseerd op het type onderzoek dat Gezondheidsraden wel wensen te zien voor het toetsen van
andere nutriënten. Sterker nog, de beschikbare studies die met verzadigd vet zijn verricht laten
geen gezondheidsrisico’s zien. Evenzo wordt in toenemende mate betwijfeld of een hoog serum
cholesterol per se eigenlijk wel zo’n groot risico is zoals dat sinds de jaren 50 naar het publiek is
gecommuniceerd. De toekomst zal ons leren hoe al dit voortschrijdend inzicht zal worden opgepakt
door de wetenschappers en de beleidsmakers die deze oude aanbevelingen hebben gemaakt. Er
dreigt een schisma te ontstaan tussen de o"ciële aanbevelingen en de praktijk waarbij het dreigt
dat de eerstgenoemde niet meer serieus worden genomen. Want Oprah Winfrey heeft meer invloed
op de dosering van het vitamine D supplement dat het Amerikaanse publiek neemt dan het IOM.
Er is in ieder geval meer onderzoek nodig aan onze leefstijl, daarover zijn de meeste
voedingsdeskundigen het eens. Welke uitkomsten hiervan mogen gelden als een bewijs vergt
een fundamentele discussie, die maar traag op gang lijkt te komen en momenteel vooral wordt
beheerst door inconsequentie. Wij pleiten voor een Evolutionaire benadering die uitmondt in
studies waarbij het onmogelijke niet a priori wordt geëist. Voor zulk onderzoek is in Nederland
ongetwijfeld ondersteuning, want een hoopgevend hoog percentage van 70% van de Nederlanders
gelooft in Evolutie als de oorsprong van ons bestaan. Wij voorspellen dat het onderzoek naar de
gezondheidsaspecten van de Paleovoeding en de Paleoleefstijl, zoals vertaald naar de cultuur van








Als kind bracht ik al een groot deel van mijn tijd door met onderzoeken. Met de paplepel ingegoten
wellicht door een gezin dat bestaat uit een biologieleraar die jaar in jaar uit experimenten doet in
het klaslokaal en een orthopedagoog die dagelijks kinderen onderzoekt op hun leervermogen. Mijn
onderzoek strekte zich uit van natuursteensoorten, fossielen, gedroogde bloemen, insecten, eieren,
vissen en vogels tot etsen, treinen, encyclopedieën, leesboeken en postzegels en al wat ik tot mijn
eigen verbazing nog verder aantref op de zolder bij mijn ouders. Kortom, mijn nieuwsgierigheid
voor allerhande zaken was al vroeg aanwezig. Tijdens mijn studie farmacie vroeg ik me ook al snel af
welk interessante onderzoek ik uiteindelijk als afstudeerproject zou kunnen doen.
Beste Frits, wat is dat al weer een poos geleden. Eerst zou het een onderzoek op de Malediven
worden, vervolgens werd het Afrika. Uiteindelijk zijn we zelfs samen teruggekeerd naar Afrika, om
de door mij gemaakte vrienden te overtuigen van het belang van ons onderzoek; en daar proteren
we nog steeds van. Ik denk dat ik een enorm bevoorrechte promovendus ben in de vrijheden die
je me gegund hebt tijdens mijn promotietraject. Opeens moest ik co-schappen lopen op Curaçao,
vervolgens nog een extra stage op Aruba, en ook ons onderzoek in Afrika moest beslist gedaan
worden met een eigen auto, die we vanuit Kaapstad naar Tanzania wilden rijden, en vervolgens
vanuit Tanzania weer door landen als Sudan en Libië terug naar Nederland. Nooit heb ik van je
gehoord dat het nu echt te gortig werd, waarvoor mijn dank en waardering. Natuurlijk hebben we
ook onze conicten gehad; daar waar ik stukken snel wilde publiceren en verder wilde met een
volgend stuk bleef jij maar hameren dat geen enkel stuk weg mocht voordat het perfect was. Ik
denk dat we er samen een hele bijzondere en unieke tijd van gemaakt hebben.
Beste Janneke, mijn co-promotor. In de eerste jaren van mijn onderzoek zagen en spraken we
elkaar nog weinig. Vanwege mijn inmiddels gestarte studie geneeskunde bezocht ik het lab enkel
op avonden, nachten, weekenden en feestdagen. Bovendien had jij je handen vol aan (behalve
je kinderen) de andere promovendi die toen ook nog op de kamer zaten waar ook sinds jaren
mijn naamkaartje op de deur prijkte, maar waar mijn computer maar zelden werd gebruikt. Maar
zodra mijn datacollectie klaar was, was je er om me te helpen om uit de torenhoge stapels data en
informatie de belangrijke boodschappen te destilleren. Inmiddels weet ik ook zeker dat de initialen
D.A. staan voor delete all. Dank voor je ondersteuning en hulp bij het structureren van de immer
chaotische eerste opzetten van mijn manuscripten!
Mijn dank gaat ook bijzonder uit naar de Junior Scientic Masterclass (JSM), die mij gedurende
de eerste vier jaar van mijn onderzoek nancieel heeft bijgestaan, waardoor ik in staat was om
gedurende mijn co-schappen het onderzoekersbestaan met de studie geneeskunde te combineren.
Geachte Dr. Schaafsma, beste Anne, van alle sponsoren wil ik jou bovenal bedanken voor alle
support die we hebben mogen ontvangen bij ons onderzoek in Afrika. Zonder jullie nanciële steun
was dit proefschrift simpelweg niet tot stand gekomen. Tot slot genoot ik een ruime toelage voor
mijn onderzoek van het VSB-fonds waarvoor ik eveneens mijn dank verschuldigd ben.
423
Dankwoord
Beste Jan, Froukje en Rudy. Als jullie vroege ondersteuning van mijn project er niet was geweest
had ik misschien nu achter de balie van een apotheek in oost Friesland gestaan (NOT!). Maar het
moge duidelijk zijn dat ik bij het opzetten van dit onderzoek ontzettend veel aan jullie heb gehad.
Jan en Froukje, voor het buitengewone hartelijke ontvangst bij jullie thuis, om daar te praten over
de opties van onderzoek in Tanzania. Jan, onze ontmoetingen in Tanzania, waar jij als een vliegende
dokter met een klein vliegtuigje voor mij uit vloog om lokale dokters te overtuigen van het belang
van ons onderzoek. Rudy, dank voor de wijze lessen over Tanzania en de mooie verhalen over je
eigen tijd daar in de jaren 70. Natuurlijk ook mijn bijzondere dank nog, ook aan Rinske en Onno,
voor de mogelijkheid om gebruik te maken van jullie pied a terre en hartelijkheid in Zuid Afrika. Dit
goed begin bleek het halve werk!
Maraki wote wa Tanzania. Shukrani wengi kwa msaada wako wote, hadithi yako na kila kitu tuna
walivumilia. Mimi hasa kumshukuru Dr Mazzuki kutoka Kiomboi, daktari Marie José ya Sengerema,
daktari Sangu kutoka Same na waraki yangu Msari na Martini kutoka Ruvu. Shukrani za pekee
kwa jina la utani wewe alinipa na mimi bado kiburi. Oloshipa: yeye ambaye ni daima furaha!
Beste Annemarie, wat was het toch heerlijk om te weten dat hoe ver ik ook weg was er altijd iemand
op het lab was die af en toe aan me dacht. Zelfs in de diepste bushbush van Tanzania verraste je
me met verjaardagskaartjes en cadeautjes. Omdat heel Kiomboi geen brievenbussen kent en de
postbode blijkbaar wel weet waar hij iedereen op elk moment van de dag moet vinden, werd ik hier
zelfs getrakteerd op een persoonlijk overhandigde kaart. Verder hielp je me altijd uit de brand als ik
logistiek vast kwam te zitten in de machine die UMCG heet of als er voor bureaucratische Afrikanen
documenten met gewichtig aandoende handtekeningen en stempels geregeld moesten worden.
Mijn eeuwige dank!
Beste Ingrid, Marchien en Herman (Manchi). Zonder jullie inzet was ik nog in geen 20 jaar door mijn
sloot data heen gekomen. Marchien, nu ik weet hoeveel werk het is verbaas ik me er nog steeds
over dat bij terugkomst uit Afrika al mijn eerder teruggestuurde melksamples al geanalyseerd
waren. Ingrid, het was altijd weer een genoegen om je verbaasde gezicht te zien als ik weer wat
dubieuze monsters door de GC wilde halen, maar altijd was je er om me bij te staan om de analyse
zo goed mogelijk uit te voeren. Wat er in de afgelopen jaren voor vissen, schelpen, vetweefsel,
navelstrengen, melk, colostrum, stiereballen, koeieogen, broccoli, spinazie, hazelever, patrijzeborst,
foetenhersentjes, foeten levertjes, vissenlevers, vissenhersens maar vooral veel rode bloedcellen
door die GC zijn gepompt…. Ik weet het niet meer! Herman, het was een waar genoegen om op
jouw logistieke vindingrijkheid te kunnen bouwen. Of monsters nu uit Afrika terug moesten of we




Beste Ella, Rebecca en Francien; dank voor jullie hulp bij mijn eerste wankele stappen in de wereld
van onderzoek in het buitenland, de bij onderzoek horende statistiek en het ondersteunen van mijn
onderzoek met interessante ideeën en eigen data.
Dear ‘aquatic origins, fatty acid en Paleo friends.’ It was and is a great pleasure having met and
knowing you all. Jose, what a perfect combination of dierent disciplines to serve one purpose. I
hope you are just as proud of our latest review as we are in Groningen. Maelan and Pedro; thanks
for sharing all those papers and keeping me updated. Chris, for adjusting my terrible English and for
all the fun we had preparing your LA lecture. Michael Crawford, Stephen Cunnane, Boyd Eaton and
Loren Cordain: for intellectual support and never ending enthusiasm!
Beste Saksia, Ramses en Hylco. Ik was er nooit en als ik er was dan waren jullie er niet, want wie
werkt er nu ’s nachts? Het spijt me dat ik geen gezelliger kamergenoot ben geweest. Wel hebben we
gelukkig de nodige borrels, congressen, lezingen en promoties bijgewoond en het was altijd weer
goed om dan onder mekaar over onze promotoren te kunnen keuvelen!
Beste laboranten. Ook aan jullie mijn hartelijke dank voor jullie acceptatie van die mallotige nozem
die te pas en te onpas ineens dagen wel en dan weer dagen niet op het lab kon verschijnen en die
vast veel te vaak potten niet op de juiste plaats terugzette, afval in de verkeerde emmers gooide,
of zijn rommel op de verkeerde plaats achterliet… Ik heb altijd genoten van jullie gezelligheid en
lol onderling; het was rustgevend en genoeglijk om al pipeterend om jullie grappen en grollen te
mogen lachen!
Ook wil ik mijn bijvakkers:Victor, Benjamin-Ben-Bart, Floor, Deti, Jan-Hunter en Stefan, bedanken voor
hun inzet en voor alle data-analyses die jullie hebben gedaan. Hoewel nog niet alles gepubliceerd
is, hoop ik dat, net als bij Victor en Deti, ook uit jullie data uiteindelijk iets gepubliceerd zal kunnen
worden. Succes met jullie verdere carrières in de farmacie en geneeskunde.
Waarde clubgenoten. Hopelijk zal ik er, na afronding van dit monsterproject, weer wat vaker bij zijn.
Ik heb nog met menig een van jullie, in ieder geval naar jullie zeggen, een rekening te vereenen;
dus mocht Amsterdam dan eindelijk onder handbereik komen, dan sluit ik me graag weer aan. We
drinken er 1-tje op.
Yo matties van de farmacie; Ronk, Reneus, Doppie, Pander, Snoek en Luin. Terwijl jullie alle
bestuurlijke taken voor jullie rekening namen binnen de farmacie was ik toch meer gericht op de
overige zaken die het prachtige studentenleven in Groningen ons bood. In de vroege jaren waren
we veel samen op stap, later scheidden onze wegen zich wat meer, maar desalniettemin bleven
er vakanties in Frankrijk en in ranzige bungalows bij Scheveningen op de agenda staan. Ook jullie
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waren druk met promoties, kinderen, trouwen, een burgerbestaan opbouwen, nog meer kinderen,
Volvos, huizen kopen en slopen en het binnendringen van de Quote 500 (Snoek), maar toch is het
goed te merken dat de contacten warm blijven. Ik hoop er weer meer bij te kunnen zijn nu de
promotie af is!
Aan alle Curaçaose Dushi’s en Swa’s! Het was een hopi bijzondere tijd die we met z’n allen
doorbrachten op de Telamonstraat, op Aruba, Bonaire en Curaçao. Des te mooier dat we elkaar nog
steeds zo veel zien en zelfs de eerste Curaçao baby’s al rondkruipen. Kuandu hasi nos enkontra
atrobe?
Jelte, er moet altijd iemand zijn die niet in je onderzoek gelooft, die het genieten van het leven op
een veel hoger voetstuk heeft staan en die je uitlegt dat je van het zo krampachtig proberen gezond
te blijven voor hetzelfde geld al op je vijftigste er door alle stress aan onderdoor gaat. Diegene ben
jij (denk ik). Daarnaast heb je over de afgelopen jaren een manier van koken ontwikkeld die het
bovendien bijzonder moeilijk maakt om het bij 1 gang te houden. Na al mijn jaren van onderzoek
vrees ik dan ook dat het gelijk grotendeels aan jouw kant ligt: voeding is maar een deel, en genieten
van wat rust en het leven is eigenlijk het allerbelangrijkste in het leven. Kook jij, dan geniet ik!?
Paranimfen; Aelwyn en Ron. Het leven is vurrukkulluk zei mijn naamgenoot al eerder. Volgens mij
zijn we het daar al jaren over eens samen. Aelwyn, na onze jaarlijkse liftreizen naar Zuid Frankrijk,
onze vakantie in China en Laos en ons laatste avontuur in onze trouwe 190 om de Zwarte Zee is
het na afronding van dit project tijd voor een echte uitdaging: vanaf Yakutsk, via Oymyakon en
Verkhoyansk naar het Bolsjewieken of Oktoberrevolutie eiland? De weddenschap staat al! Ron, nu
beide daadwerkelijk een vinkje verder wordt de uitdaging daadwerkelijk interessant. Het museum
bezochten we samen al in Stockholm, maar voorlopig ga ik nog liever op je aanbod in om de
continenten te doorkruisen: wat zeg je van een Jägermeistertje terwijl we vanuit de Noordkaap
overweldigd worden door de schoonheid van Aurora Borealis?
Lieve pa en ma. Ontzettend bedankt voor de vrijheden die ik altijd van jullie heb gekregen om
niet alleen als klein kind van alles uit te halen, maar ook de steun bij mijn tijd in Groningen, waar ik
natuurlijk niet de snelste carrière maakte door achtereenvolgens een studie farmacie, geneeskunde
en een promotie in tien jaar proberen af te ronden. Ik ben blij dat jullie me nooit onder druk hebben
gezet en me waar nodig ook altijd wilden steunen. Ik hoop dat mijn onderzoek ook bijdraagt aan
jullie gezondheid, zodat we in de komende jaren nog heel veel samen kunnen genieten. PS: ik zal





Lieve Tini, wat hebben we veel meegemaakt! Ik ben je onnoemelijk dankbaar dat je me altijd door
dik en dun gesteund hebt en we op elkaar konden rekenen in voor- en tegenspoed. Ook heb ik
er nog steeds geen moment spijt van gehad dat we inmiddels nu wel een paar jaartjes ouder zijn
dan de ambitieuze jonge dokters om ons heen, die zich al jaren op hetzelfde einddoel focussen,
maar zich op hun 65e (of al tijdens hun midlife crisis) zullen realiseren dat het inmiddels te is laat
om nog zoals wij met een oude Landcruiser op de bonnefooi onbelemmerd door de binnenlanden
van Afrika te avonturieren! Wat is er bovendien mooier dan een promotie die zowel fysiek als
intellectueel bijdraagt aan je ontwikkeling? Hopelijk hebben we zodra ook jouw proefschrift rond









Remko Kuipers is op 30 maart 1980 in Groningen geboren en groeide op in Buitenpost. Na het
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